data_2mlm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mlm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.727 0.298 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.82 161.48 36.28 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.617 2.211 . . . . 0.0 112.555 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -114.24 173.42 6.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 70.8 mt -106.92 101.11 35.61 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.776 0.322 . . . . 0.0 111.129 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 97.9 Cg_endo -87.59 178.4 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.846 2.364 . . . . 0.0 112.272 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -86.61 -30.74 21.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.1 t70 -60.51 129.54 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.192 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.568 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 43.1 mmtm -96.55 13.21 28.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.896 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -91.74 -21.86 20.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.343 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 45.6 mmtm -91.65 163.31 14.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.651 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.91 116.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.52 -33.92 15.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.19 152.82 24.88 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.729 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.24 122.91 48.88 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 27' ' ' GLU . 9.6 tp -93.55 115.08 31.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.698 0.761 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 42.5 mt-10 -127.92 115.69 18.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.033 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 66.2 mt -122.96 102.49 37.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.652 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -59.23 -33.92 98.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.414 2.743 . . . . 0.0 113.552 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.12 -24.46 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.712 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.47 7.74 16.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.266 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 59.89 25.81 14.98 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.178 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.4 mt -84.61 124.63 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.991 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -144.15 80.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.0 mm-40 -125.43 142.42 41.68 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.161 0.505 . . . . 0.0 111.899 -172.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.69 138.57 38.37 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.064 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 64.1 t -98.38 132.81 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -92.85 105.34 14.47 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.397 0.618 . . . . 0.0 110.51 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 47.2 Cg_endo -69.22 145.94 61.93 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.276 2.651 . . . . 0.0 113.071 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' NZ ' ' A' ' 11' ' ' LYS . . . 129.08 -168.95 20.6 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.804 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.42 162.18 33.75 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.769 2.313 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.8 126.21 31.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.973 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' HD21 ' A' ' 39' ' ' LEU . 47.6 p -132.05 133.94 24.55 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.89 -36.6 27.29 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.471 2.781 . . . . 0.0 113.362 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.567 ' HG2' ' HD2' ' A' ' 41' ' ' ARG . 38.7 tt0 -66.28 -54.25 27.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.568 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 51.1 tp60 -65.43 -34.41 78.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 35' ' ' THR . 4.4 mm? -68.54 -7.87 36.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -101.61 -7.11 23.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.749 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HD2' ' HG2' ' A' ' 37' ' ' GLU . 53.8 mtp180 -104.32 -32.64 8.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.949 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -154.99 9.75 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.241 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' A' ' 72' ' ' PHE . 59.4 t -105.96 133.82 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.83 0.348 . . . . 0.0 110.472 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -135.72 162.04 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 86.5 m-85 -74.01 149.46 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.244 0.545 . . . . 0.0 111.561 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.82 -14.0 23.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.877 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -79.9 133.6 36.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.228 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -83.42 -6.37 59.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.838 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 51' ' ' SER . 0.1 OUTLIER -90.28 128.76 36.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 -177.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.521 ' HA ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -74.98 17.67 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.059 0.457 . . . . 0.0 112.167 -176.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 49' ' ' ASN . 36.8 m -104.15 107.7 18.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.223 0.535 . . . . 0.0 111.618 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 57' ' ' ILE . 1.3 pp -91.05 6.27 45.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.784 0.802 . . . . 0.0 109.433 172.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.43 -9.11 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.625 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.22 159.39 28.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.237 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 3.9 pm0 -86.34 -13.34 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 0.0 110.899 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -105.44 105.94 16.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.123 0.487 . . . . 0.0 110.545 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 52' ' ' LEU . 19.9 mm -115.79 101.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.532 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -93.87 125.72 38.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.44 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -127.37 142.67 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.57 147.13 43.1 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.086 -0.384 . . . . 0.0 111.467 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.21 -171.62 22.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.014 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -136.63 157.68 46.2 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.565 -0.373 . . . . 0.0 110.818 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 6.7 t -79.07 -172.05 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.584 -175.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 35.4 p90 -109.04 142.09 40.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.329 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.28 -90.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.68 -23.73 16.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 109.873 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.39 114.58 65.03 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.189 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HA ' HG22 ' A' ' 73' ' ' THR . 88.5 Cg_endo -82.43 8.78 4.33 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.841 2.36 . . . . 0.0 111.476 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.76 14.61 20.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.902 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.511 ' HB2' HG23 ' A' ' 73' ' ' THR . 40.5 m-85 -89.53 143.14 27.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -69.03 -8.03 41.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 43' ' ' VAL . 43.5 m-85 -130.1 33.06 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.72 0.295 . . . . 0.0 111.392 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 68' ' ' PRO . 13.4 p -64.73 -34.94 79.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.396 . . . . 0.0 111.645 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -99.9 13.13 34.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.5 -12.21 50.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 110.494 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 64' ' ' PHE . 20.1 pttp -63.69 -26.7 68.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.233 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.13 -41.44 25.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.529 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.81 137.76 54.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.073 -173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 8.4 mptt -103.66 173.62 6.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.05 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -74.31 -1.92 22.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.741 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.35 34.04 3.16 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.443 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.6 t -97.78 -172.71 2.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.424 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -119.05 121.7 40.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.297 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.68 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 96.8 t -107.6 110.26 31.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.525 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -95.08 113.85 25.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -102.98 98.71 8.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -94.57 113.06 24.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.214 -172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.96 101.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.595 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.53 -94.52 0.28 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.147 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -119.2 -14.71 9.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.73 125.25 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -101.4 107.1 18.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.852 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -97.04 117.17 30.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.528 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.529 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.6 125.46 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 110.959 -176.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 64.0 m-85 -121.09 148.81 43.67 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -110.0 138.64 46.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.583 ' HE3' HD11 ' A' ' 100' ' ' ILE . 61.2 mtp -76.88 54.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.966 -173.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.1 p -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 7.5 m -116.4 102.0 9.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.012 0.434 . . . . 0.0 111.028 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD11 ' HE3' ' A' ' 97' ' ' MET . 71.4 mt -126.76 125.28 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.648 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 101' ' ' ARG . 14.2 ttp180 -165.68 144.27 6.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.162 0.506 . . . . 0.0 109.865 170.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.975 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 3.1 p-10 -101.7 110.59 22.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.668 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 139' ' ' ARG . 27.0 m -98.63 175.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.449 0.643 . . . . 0.0 112.112 -172.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -85.28 155.41 60.17 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.905 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.47 -174.97 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.735 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m 74.3 -59.49 0.55 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.499 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.13 103.79 10.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.477 . . . . 0.0 111.282 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.48 -21.41 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.448 0.642 . . . . 0.0 109.433 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.82 27.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.835 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 103' ' ' VAL . 10.2 p -61.9 -28.59 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.76 141.27 51.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.366 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -85.76 120.14 26.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.69 141.38 32.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 110.868 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 173.54 13.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.415 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -90.91 -3.54 57.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.0 111.768 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.76 80.44 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -129.46 179.69 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 111.038 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.38 -172.75 2.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 41.9 mttt -71.3 100.84 2.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -135.34 138.06 43.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.088 0.47 . . . . 0.0 111.134 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.5 mt -95.62 114.41 26.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m -96.89 95.08 7.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.94 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.5 mp -93.82 125.83 38.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 0.0 111.619 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.75 91.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.71 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -101.33 98.07 8.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 0.0 110.867 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 122.86 18.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.638 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.739 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -88.11 25.08 1.67 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.25 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.4 t0 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.333 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.975 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 39.4 ttmt -162.4 142.37 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.736 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HG3' HG22 ' A' ' 103' ' ' VAL . 8.4 ptp85 -119.0 108.93 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.256 171.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 1.2 tmtp? -87.86 102.57 14.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -87.8 128.15 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.664 0.745 . . . . 0.0 110.65 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.68 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -127.73 116.92 20.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 78.7 t -113.65 117.83 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.503 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -105.34 118.64 37.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.522 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 m -92.04 141.17 28.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.191 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.443 ' CD ' ' HD3' ' A' ' 119' ' ' LYS . 29.3 tt0 -65.63 134.52 53.43 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 111.488 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.02 165.57 3.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.042 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttp . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.213 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 pttt . . . . . 0 C--O 1.237 0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.89 138.31 62.4 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 111.954 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.5 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.8 tp60 -152.55 159.12 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.88 102.06 5.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 89.4 Cg_endo -83.52 172.47 10.28 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.634 2.223 . . . . 0.0 112.967 -174.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.61 -24.55 19.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -75.07 102.5 4.9 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.062 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -80.46 8.9 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.219 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 p -89.21 -9.4 50.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.401 0.619 . . . . 0.0 109.494 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -91.47 157.51 17.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.415 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -98.96 104.9 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -67.85 -37.34 81.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.936 0.398 . . . . 0.0 110.991 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.35 174.65 41.19 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.264 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.99 130.87 53.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 18' ' ' ILE . 7.2 tp -97.67 109.98 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.639 0.733 . . . . 0.0 109.417 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 39.0 mt-10 -123.1 109.27 13.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.628 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 25' ' ' ILE . 65.0 mt -122.53 101.89 39.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.599 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.44 -23.49 75.05 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 123.022 2.482 . . . . 0.0 112.394 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -68.43 -20.3 64.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.666 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 25' ' ' ILE . . . -133.08 14.38 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.37 32.32 21.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.021 0.439 . . . . 0.0 111.426 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 71' ' ' GLN . 64.1 mt -87.53 129.29 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.253 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 23.7 ttmm -161.95 81.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.119 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 35.9 mt-10 -143.58 158.46 56.99 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.292 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 58.3 Cg_endo -70.91 156.89 59.52 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.683 2.256 . . . . 0.0 112.605 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -112.07 132.32 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.84 111.99 57.79 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-O 121.404 0.621 . . . . 0.0 111.245 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 60.9 Cg_endo -73.82 133.58 18.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.179 2.586 . . . . 0.0 112.396 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.5 -168.51 29.13 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.589 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.03 153.94 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.846 2.364 . . . . 0.0 111.831 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -62.08 101.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.353 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.6 p -132.32 152.21 79.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.656 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.12 -37.94 95.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.984 2.456 . . . . 0.0 112.67 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.26 -51.23 68.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -75.72 -37.65 59.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.11 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HB3' ' NE2' ' A' ' 62' ' ' HIS . 90.5 mt -76.51 -2.77 33.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -94.19 -10.33 33.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.659 0.742 . . . . 0.0 109.352 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.637 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 2.4 mmp_? -105.03 -25.56 12.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.429 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.65 -129.89 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.965 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 59' ' ' ILE . 20.7 t -95.62 126.69 48.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.786 0.327 . . . . 0.0 110.183 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 m -139.87 150.02 44.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 35.0 m-85 -66.26 168.17 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -103.2 -55.02 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.315 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.79 163.1 12.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.417 . . . . 0.0 110.647 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.4 -23.72 17.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.185 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -76.96 -29.4 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.191 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.87 149.57 49.28 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.065 0.46 . . . . 0.0 110.465 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -154.59 150.13 27.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.55 -7.53 33.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.785 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.27 -30.1 25.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t70 -90.02 -160.51 0.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 20.6 pt20 -109.5 -25.37 10.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.334 -0.229 . . . . 0.0 111.273 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -93.01 120.99 33.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.811 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.499 HG21 HD23 ' A' ' 121' ' ' LEU . 34.2 mm -127.83 129.09 69.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.912 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.3 t -133.51 87.93 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -103.62 127.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.05 36.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.892 0.377 . . . . 0.0 110.779 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.29 165.18 17.34 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 39' ' ' LEU . 14.7 m-70 -130.99 142.62 50.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.936 0.368 . . . . 0.0 111.19 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.962 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.1 m -117.78 120.69 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.35 106.93 17.65 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.89 -26.86 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.874 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -98.9 5.77 47.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.191 0.52 . . . . 0.0 110.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.68 87.82 51.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.043 0.449 . . . . 0.0 110.03 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.521 ' HA ' HG22 ' A' ' 73' ' ' THR . 73.3 Cg_endo -77.09 2.78 7.27 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.177 2.585 . . . . 0.0 113.371 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.12 1.68 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.151 0.501 . . . . 0.0 110.228 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.3 t80 -78.13 138.22 38.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.65 ' HB2' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -57.96 -44.07 86.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -167.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.44 ' CD1' ' HG2' ' A' ' 71' ' ' GLN . 3.9 m-30 -88.91 6.35 39.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.013 -0.43 . . . . 0.0 112.125 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.962 ' HA ' HG23 ' A' ' 63' ' ' THR . 86.0 m -76.37 -33.93 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.452 . . . . 0.0 110.512 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 76' ' ' LYS . 62.6 t30 -92.23 14.92 14.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.09 21.77 0.17 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.471 0.653 . . . . 0.0 110.868 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -101.52 -23.41 14.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.69 172.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -73.98 -31.84 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.004 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.17 156.86 29.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.045 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -130.83 -173.8 3.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.338 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -11.8 52.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.613 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.532 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.95 55.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.355 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.503 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 70.0 m -109.11 145.42 35.72 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.208 0.528 . . . . 0.0 109.827 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.484 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -81.25 108.71 15.11 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.811 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.704 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 93.7 t -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.438 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -100.96 117.04 34.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 110.92 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -105.47 101.68 11.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.5 ttpt -98.07 117.54 32.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.08 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 91' ' ' GLU . 3.4 m -113.28 99.87 9.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.343 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.71 -101.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.794 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.81 -2.88 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 109.996 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.559 ' HB2' HG21 ' A' ' 88' ' ' VAL . 7.8 mm-40 -96.61 148.71 22.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.207 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.9 m -134.89 112.4 10.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.765 0.317 . . . . 0.0 110.69 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -101.75 138.89 38.13 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 83' ' ' MET . 19.6 mtmt -99.96 130.02 46.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 86.3 m-85 -127.79 147.17 50.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.547 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 12.1 tppt? -109.34 140.53 42.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.576 ' HE1' HD11 ' A' ' 100' ' ' ILE . 50.2 mtp -77.63 60.16 2.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.206 0.527 . . . . 0.0 110.404 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.0 p -63.51 -36.88 85.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.094 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 73.9 m -124.45 97.37 5.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.502 . . . . 0.0 111.451 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 97' ' ' MET . 69.4 mt -113.18 110.49 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.537 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -146.67 151.65 37.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.828 0.347 . . . . 0.0 110.255 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.43 93.22 5.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.745 0.783 . . . . 0.0 110.475 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.688 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 14.7 m -97.26 95.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.368 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -109.06 90.81 8.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.344 0.592 . . . . 0.0 112.417 -170.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.688 ' HD3' ' O ' ' A' ' 103' ' ' VAL . 94.4 Cg_endo -104.13 -158.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.763 2.975 . . . . 0.0 111.335 172.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -126.48 11.84 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.44 163.99 29.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.303 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 -21.61 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.45 17.11 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 110.936 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 105' ' ' PRO . 19.1 m -66.86 -20.25 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.733 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.87 -178.65 5.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.424 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 3.5 p30 -79.18 167.29 21.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.497 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.53 15.02 22.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.816 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 112' ' ' ASP . 1.7 mp0 -66.75 110.67 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.746 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' H ' ' HD3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -73.57 2.59 7.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.262 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.81 64.96 3.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.636 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -108.48 178.73 4.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.88 -176.79 3.18 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -80.14 93.83 5.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.6 148.84 46.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.581 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 57' ' ' ILE . 19.5 mt -94.13 104.25 16.28 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -77.27 84.02 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.4 mt -86.79 102.1 13.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.536 0.684 . . . . 0.0 110.784 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.7 mt -79.73 99.9 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.738 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 m -87.35 91.78 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.21 0.529 . . . . 0.0 110.12 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.34 101.43 7.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.5 158.28 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.422 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.494 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . 18.2 t0 . . . . . 0 C--O 1.236 0.365 0 O-C-N 123.755 0.659 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 128' ' ' ASP . 46.9 mmtm -79.52 98.64 6.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.679 0.752 . . . . 0.0 111.026 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.654 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 11.5 mmm-85 -89.86 76.73 7.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.356 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -83.16 112.74 20.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tp -93.25 127.8 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 121.814 0.816 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.704 ' HZ ' HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -118.08 100.56 7.62 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.963 178.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.0 t -98.68 112.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . . . -100.88 116.09 31.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.404 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.7 m -89.03 139.84 30.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.146 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.01 130.11 42.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.94 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.85 162.45 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.8 pttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.503 -0.76 . . . . 0.0 110.66 -177.666 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.428 0.156 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.84 107.1 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.978 2.452 . . . . 0.0 113.054 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -140.63 169.31 17.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.934 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.698 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 90.1 mt -121.88 102.62 40.96 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-O 120.75 0.31 . . . . 0.0 110.525 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 5.8 Cg_exo -78.36 144.79 20.73 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.664 2.243 . . . . 0.0 110.606 172.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -89.51 34.08 0.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.35 0.595 . . . . 0.0 110.987 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.42 141.82 30.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.976 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 9.0 mptt -96.0 6.95 47.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.604 -173.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -113.09 -44.93 3.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.14 126.75 31.67 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.494 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.53 116.88 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.576 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . . . -84.89 -37.73 20.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.48 168.32 27.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.86 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.27 135.95 39.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -103.61 125.04 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 37.0 mt-10 -128.68 109.52 11.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.27 0.557 . . . . 0.0 111.29 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.52 103.07 41.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.95 -43.64 41.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.299 2.666 . . . . 0.0 113.938 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.707 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 3.1 p-10 -76.3 -10.69 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.22 2.09 16.47 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.979 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.65 26.22 15.96 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 79.4 mt -93.04 104.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.429 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 51.3 mttt -137.27 81.23 1.86 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -126.85 150.62 72.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.54 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.77 144.08 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.623 2.215 . . . . 0.0 112.309 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.559 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 87.9 t -94.45 132.63 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.533 ' HB2' ' HG ' ' A' ' 44' ' ' SER . 23.8 m-85 -92.06 105.68 14.72 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 121.304 0.573 . . . . 0.0 110.453 -176.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 97.7 Cg_endo -80.6 140.75 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.001 2.467 . . . . 0.0 112.75 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.4 -170.36 29.64 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 72.1 Cg_endo -76.9 149.06 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.468 2.112 . . . . 0.0 111.802 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 98.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.566 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -134.34 142.0 41.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.19 -30.81 43.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.363 2.709 . . . . 0.0 113.208 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 38' ' ' GLN . 10.2 pt-20 -59.99 -30.92 69.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.709 0.29 . . . . 0.0 111.59 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 16.0 mm100 -101.06 -42.57 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.837 0.351 . . . . 0.0 111.024 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 3.9 mm? -74.15 -2.7 25.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -99.88 -9.52 22.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -93.43 -55.88 3.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.886 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.99 -120.83 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.833 -175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG22 ' NE2' ' A' ' 71' ' ' GLN . 35.1 t -109.71 126.63 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.881 0.372 . . . . 0.0 110.688 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HG ' ' HB2' ' A' ' 30' ' ' TYR . 50.1 m -146.54 158.03 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.928 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.064 0.459 . . . . 0.0 111.018 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.74 -12.04 54.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.207 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 46.7 mt-10 -101.08 121.32 41.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.773 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 43.6 mt-10 -65.06 -33.59 76.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.296 -172.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.05 125.52 31.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.164 0.507 . . . . 0.0 110.653 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.698 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 2.7 mp0 -63.27 108.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.481 -175.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -150.35 139.99 21.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD22 HG13 ' A' ' 7' ' ' ILE . 1.5 pp -130.17 6.8 4.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.923 0.392 . . . . 0.0 111.237 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.86 33.49 1.98 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.74 179.94 4.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' NE2' ' HB2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -72.5 -47.48 48.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.11 126.21 51.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.257 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.74 95.07 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.239 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 7.5 m -86.95 111.54 20.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -122.96 120.24 60.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.49 142.75 31.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.724 0.297 . . . . 0.0 110.437 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.58 124.16 4.57 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 39' ' ' LEU . 28.8 t-80 -84.75 132.76 34.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 127' ' ' ASP . 15.1 t -153.25 175.32 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 m-85 -140.95 138.0 33.48 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.224 0.327 . . . . 0.0 110.122 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -17.31 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.835 0.826 . . . . 0.0 108.933 174.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -83.88 -21.05 32.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.089 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 9.6 mmt180 -124.54 111.99 27.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.57 1.58 8.93 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.233 2.622 . . . . 0.0 110.876 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -86.88 14.01 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.334 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.52 -177.29 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.051 0.453 . . . . 0.0 111.639 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' NE2' HG22 ' A' ' 43' ' ' VAL . 10.8 mt-30 -93.97 -31.01 14.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.837 -170.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.38 24.01 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.475 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.9 p -73.96 -38.06 64.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.863 0.364 . . . . 0.0 111.657 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -93.14 18.73 8.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.085 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.07 -10.86 57.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.982 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -22.15 52.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.23 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.63 -4.29 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.621 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.707 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.79 159.6 15.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.086 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 8.9 mptt -121.04 172.59 7.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 111.025 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -74.56 -4.84 39.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.132 -176.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.64 24.92 5.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.792 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -84.74 -173.78 4.91 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.331 0.586 . . . . 0.0 110.3 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.15 107.76 12.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.6 t -93.11 106.05 17.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.014 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.576 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 85.5 m-85 -90.18 128.01 36.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.673 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.08 108.22 15.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -92.36 140.14 29.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.123 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.418 HG21 HD23 ' A' ' 52' ' ' LEU . 8.5 p -163.67 128.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.903 0.382 . . . . 0.0 111.327 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.85 -87.94 0.08 OUTLIER Glycine 0 C--N 1.329 0.169 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.979 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -135.78 0.23 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.095 0.158 . . . . 0.0 111.391 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.34 169.06 11.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 m -148.05 110.73 4.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.913 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -95.51 154.55 17.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.511 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.47 117.44 34.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.535 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -109.4 153.61 23.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.719 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -112.95 150.75 31.4 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.709 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 57.5 mtp -86.72 66.13 9.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.388 0.613 . . . . 0.0 109.978 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -70.44 -37.66 74.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.213 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.4 m -127.07 95.79 4.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.099 0.476 . . . . 0.0 111.482 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD13 ' HB3' ' A' ' 97' ' ' MET . 42.9 mt -110.31 111.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.614 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -139.07 151.24 46.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.842 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.92 126.01 39.97 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.922 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 25.3 t -131.52 93.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.115 0.483 . . . . 0.0 110.933 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 4.3 mtmt -90.44 153.28 46.11 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 6.8 Cg_exo -74.56 14.69 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.272 2.648 . . . . 0.0 113.346 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -70.89 -30.89 67.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.518 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.98 107.88 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.867 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.501 HG21 ' HG3' ' A' ' 109' ' ' GLU . 26.9 m -92.93 -176.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' A' ' 108' ' ' VAL . 44.3 mt-10 67.73 6.75 5.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.034 0.533 . . . . 0.0 111.31 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.675 HG13 ' HG ' ' A' ' 111' ' ' LEU . 5.8 p -64.32 -34.11 67.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.675 ' HG ' HG13 ' A' ' 110' ' ' VAL . 1.2 pp -138.31 147.74 43.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.738 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.484 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 9.5 m-20 -112.23 165.21 12.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 111.203 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -98.17 72.76 2.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.399 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -117.77 157.24 26.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.327 -177.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -82.74 -170.23 2.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.692 177.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.86 6.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.423 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 29.2 mmtp -131.54 -165.01 1.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.6 t70 -104.89 -157.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' H ' ' CG ' ' A' ' 118' ' ' ASP . 41.5 mttp -68.11 95.39 0.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.12 0.486 . . . . 0.0 110.708 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -105.5 126.56 52.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.107 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 106.06 18.06 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 m -83.26 91.48 7.29 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.572 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.554 HD11 ' CD2' ' A' ' 142' ' ' PHE . 32.1 mt -84.25 97.52 9.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.378 0.609 . . . . 0.0 110.271 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mt -80.76 96.22 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -96.52 86.53 4.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.664 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.2 m -73.03 108.53 5.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.591 ' HA ' HG22 ' A' ' 63' ' ' THR . 19.7 t70 -83.61 -21.93 32.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.183 -168.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 38.3 m-20 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 12.9 mm-40 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -121.57 136.89 54.92 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.773 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 15.7 mtm180 -123.49 127.87 48.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.406 ' HZ1' ' HG3' ' A' ' 140' ' ' LYS . 0.7 OUTLIER -106.6 105.01 14.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.28 121.75 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.703 0.763 . . . . 0.0 110.53 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.709 ' HE1' ' HA ' ' A' ' 97' ' ' MET . 6.2 t80 -119.33 109.85 16.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.988 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 53.9 t -102.09 107.19 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.952 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.605 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -94.56 134.29 37.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.5 m -103.66 136.13 43.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.301 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.92 121.87 16.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.247 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.4 164.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.699 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.452 179.612 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 150.97 25.41 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.467 2.112 . . . . 0.0 112.136 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.443 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 mm-40 -118.65 179.25 4.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.871 HD11 ' HB3' ' A' ' 52' ' ' LEU . 3.8 mp -91.37 106.39 16.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 77.8 Cg_endo -96.63 -168.7 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.269 2.646 . . . . 0.0 113.391 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -74.9 -20.92 59.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.607 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.512 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -79.37 105.25 10.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.457 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 23.4 mttp -87.71 -29.34 21.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 110.661 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.4 p -73.9 -13.11 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.542 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 32.1 mmtp -87.18 80.74 8.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.58 113.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.511 0.672 . . . . 0.0 111.189 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.57 -34.12 41.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.79 26.7 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.461 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.82 124.09 41.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.76 118.91 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.541 0.686 . . . . 0.0 110.104 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.566 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 46.6 mt-10 -132.32 123.76 27.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.972 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.78 101.34 29.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.59 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.1 -27.62 85.27 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.958 2.438 . . . . 0.0 112.513 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 82' ' ' SER . 8.9 m-20 -63.07 -27.52 69.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HB1' HG13 ' A' ' 25' ' ' ILE . . . -121.47 10.45 10.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.426 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.31 28.82 18.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.475 HG13 ' HB1' ' A' ' 23' ' ' ALA . 75.8 mt -85.56 129.21 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.487 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 22.7 ttmm -152.52 78.03 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -133.24 148.08 67.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.277 -172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.71 162.11 30.19 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.783 2.322 . . . . 0.0 112.436 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 63.8 t -114.56 129.39 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.41 110.7 53.96 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.822 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 16.9 Cg_exo -66.43 110.76 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.071 2.514 . . . . 0.0 112.069 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.62 168.5 35.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.582 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.15 144.94 38.36 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.873 2.382 . . . . 0.0 111.899 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.95 109.93 0.83 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.996 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -139.65 147.0 50.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.94 -42.33 67.64 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.063 2.508 . . . . 0.0 113.228 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.38 -18.54 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -86.52 -43.3 12.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.78 -8.16 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.515 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.0 -17.5 63.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.638 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.0 -64.86 1.02 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.638 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.14 -113.32 0.29 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.95 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.79 130.53 57.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.1 m -144.34 158.08 43.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -69.71 150.94 46.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 111.347 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.43 -62.79 1.43 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -170.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.927 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.28 39.12 1.12 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.59 90.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.89 -18.36 65.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.764 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.673 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 17.9 m -96.85 110.23 22.77 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.102 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 7' ' ' ILE . 3.6 pp -81.91 -10.0 59.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.59 0.709 . . . . 0.0 109.494 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -100.6 11.07 40.27 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.003 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.6 t70 -82.04 177.41 8.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -83.09 -44.04 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.74 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.422 ' H ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -97.29 117.93 32.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.776 . . . . 0.0 111.034 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.0 136.47 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 m -125.69 112.8 16.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.442 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.485 ' HB ' HD23 ' A' ' 123' ' ' LEU . 2.8 mt -121.38 139.07 49.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.992 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 121.57 44.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.588 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -123.27 77.07 0.36 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.306 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -74.46 121.68 21.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.002 0.43 . . . . 0.0 110.438 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 70' ' ' TYR . 21.7 m -112.71 166.73 11.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.824 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -127.99 116.5 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 tt -55.8 -31.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.527 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 34.3 t70 -66.87 -24.73 66.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 80.2 mtt180 -111.56 93.04 18.22 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 26.5 Cg_exo -62.1 -21.76 73.02 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.369 2.712 . . . . 0.0 113.516 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -91.24 22.43 3.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.835 0.35 . . . . 0.0 111.617 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.699 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.1 OUTLIER -84.2 173.41 11.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 172.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 19.2 pm0 -65.84 -59.07 4.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.588 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 56.3 m-85 -99.97 26.58 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.925 -0.484 . . . . 0.0 112.143 -171.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 p -67.22 -37.4 83.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.122 0.487 . . . . 0.0 111.32 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.1 t30 -98.6 13.8 30.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.46 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.86 -7.89 13.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.49 0.662 . . . . 0.0 110.56 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -68.34 -23.84 64.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.737 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 -5.28 58.63 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.443 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.27 170.4 16.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.04 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -143.99 177.67 8.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.018 0.437 . . . . 0.0 110.854 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.52 1.17 17.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.294 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -150.15 48.68 0.58 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.094 176.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.495 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 17.4 p -86.26 -158.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.222 0.534 . . . . 0.0 110.635 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.503 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -129.11 112.0 13.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.991 176.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.9 t -105.74 119.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.189 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.41 118.32 36.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.95 0.405 . . . . 0.0 110.935 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -106.54 107.2 18.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.765 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -94.9 139.07 31.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 113.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.527 0.68 . . . . 0.0 110.883 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 -86.5 0.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.021 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.25 2.14 1.86 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.19 0.519 . . . . 0.0 110.506 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.87 145.89 37.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.502 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 m -131.02 109.41 10.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.914 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' A' ' 95' ' ' TYR . 4.7 ptm180 -106.77 148.39 28.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.291 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 22.9 mtmt -105.6 141.55 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 -169.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.488 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 95.5 m-85 -129.74 150.06 51.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -116.44 128.22 55.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.303 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -71.43 79.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.981 0.419 . . . . 0.0 110.198 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -82.92 -20.53 35.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.784 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.564 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.6 t -128.68 111.69 13.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -120.14 113.79 41.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.515 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -151.43 163.05 39.85 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.56 133.93 47.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.999 0.428 . . . . 0.0 110.19 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.72 137.9 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.232 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.89 150.79 74.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.313 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.81 71.86 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.729 2.286 . . . . 0.0 111.181 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -143.26 93.8 2.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.312 0.577 . . . . 0.0 110.954 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 54.46 51.45 14.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.333 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -13.24 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.518 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.93 30.64 4.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.076 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.58 -8.46 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.633 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.29 134.53 48.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.799 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.482 ' OD1' ' HG2' ' A' ' 114' ' ' GLN . 11.6 p30 -107.87 -164.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.53 20.22 14.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.482 ' HG2' ' OD1' ' A' ' 112' ' ' ASP . 58.0 mm-40 -71.72 115.95 11.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.113 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.62 69.9 3.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.231 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.35 45.54 3.28 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -93.49 163.77 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.289 -0.455 . . . . 0.0 110.602 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.45 -166.72 1.02 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.535 ' N ' ' HE3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -76.44 101.96 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 161.78 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.536 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -118.47 115.55 24.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -82.7 102.29 11.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.485 HD23 ' HB ' ' A' ' 59' ' ' ILE . 84.8 mt -98.16 107.51 20.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.266 0.555 . . . . 0.0 111.248 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mt -81.18 96.43 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 p -105.61 52.25 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.301 0.572 . . . . 0.0 111.762 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 35.2 m -73.83 152.6 40.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.295 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.513 ' HB2' ' HE ' ' A' ' 139' ' ' ARG . 14.9 t0 -118.82 -54.62 2.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.75 0.786 . . . . 0.0 109.273 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 139' ' ' ARG . 4.3 p-10 . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.581 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.558 0.218 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -176.86 130.54 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.607 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 20.5 tpt180 -161.28 -82.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HD2' ' CE1' ' A' ' 142' ' ' PHE . 14.5 mmtp -157.67 143.35 17.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -167.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.8 tt -135.59 139.39 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.775 166.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' HD2' ' A' ' 140' ' ' LYS . 66.6 m-85 -128.2 125.09 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 46.5 t -110.96 107.84 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.71 113.64 26.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.967 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.8 m -83.67 141.63 31.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.21 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -67.89 128.07 35.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.104 0.478 . . . . 0.0 111.007 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.459 HG23 ' HB2' ' A' ' 96' ' ' LYS . 2.0 t -92.77 166.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.765 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.349 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.604 0.24 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 55.4 Cg_endo -71.2 113.34 3.56 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.532 2.155 . . . . 0.0 112.212 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 32.8 mm-40 -121.13 -166.03 1.3 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.613 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.621 HD12 ' HB3' ' A' ' 52' ' ' LEU . 36.0 mt -106.85 96.61 15.03 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 86.6 Cg_endo -95.77 -169.39 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.029 2.486 . . . . 0.0 113.13 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -82.88 12.59 4.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.64 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 9.5 t70 -108.64 125.65 52.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -109.78 12.39 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.948 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.5 t -106.99 -2.72 20.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.368 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 49.4 mmtm -97.24 178.38 5.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.482 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.66 117.27 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -88.14 -34.21 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.1 31.06 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.607 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.06 129.97 40.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.3 123.67 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.29 0.567 . . . . 0.0 110.346 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 30.5 mt-10 -121.43 121.69 38.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.361 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.2 mt -129.34 94.12 33.97 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.904 172.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.4 Cg_endo -54.7 -33.37 79.81 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.288 2.659 . . . . 0.0 112.407 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.6 -31.43 69.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.45 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.38 11.79 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.917 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.35 27.24 16.91 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.401 0.438 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 64.2 mt -91.24 119.9 39.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -139.3 58.16 1.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.799 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 21.1 mm-40 -108.8 145.01 30.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.281 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 157.9 33.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.828 2.352 . . . . 0.0 112.406 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.463 ' HA ' HG11 ' A' ' 43' ' ' VAL . 60.7 t -111.71 131.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.62 114.21 57.87 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.918 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.607 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -67.07 140.2 53.41 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.099 2.533 . . . . 0.0 112.201 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -168.08 24.98 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.731 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.35 160.23 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.436 2.758 . . . . 0.0 112.038 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.145 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.517 ' H ' HD21 ' A' ' 39' ' ' LEU . 5.1 t -161.82 144.87 9.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.315 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -41.1 -50.63 4.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.527 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -62.5 -46.07 90.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.921 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.65 -48.83 73.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.879 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -78.69 20.65 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.18 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.67 -4.62 8.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 41' ' ' ARG . 46.0 mtp85 -124.85 -32.49 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.346 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.09 -162.1 14.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.074 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.729 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 6.8 p -95.82 140.5 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -138.9 176.6 8.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -90.51 140.5 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.077 0.465 . . . . 0.0 111.262 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.5 -3.68 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.88 154.86 28.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.318 -172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.32 19.25 14.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.62 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -71.34 172.12 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.422 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.41 7.86 35.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.358 0.599 . . . . 0.0 110.837 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 54.0 m -154.06 152.28 30.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.642 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.621 ' HB3' HD12 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -103.94 -7.07 20.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.205 0.526 . . . . 0.0 110.609 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.525 ' OD1' ' HB3' ' A' ' 51' ' ' SER . 9.8 p-10 -95.34 10.25 36.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.605 -178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.74 168.84 19.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.481 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.45 -32.58 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.351 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.38 111.61 24.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.868 0.842 . . . . 0.0 110.847 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 21.0 mm -135.43 102.33 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.839 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 17.1 m -83.06 106.85 15.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 6.4 mt -99.13 111.45 28.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.782 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.42 96.44 6.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -103.02 85.01 0.49 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.198 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 70' ' ' TYR . 86.1 t60 -55.58 138.77 46.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -114.77 147.71 39.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.077 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.522 ' HE2' ' HG2' ' A' ' 67' ' ' ARG . 17.0 t80 -143.82 83.45 1.75 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.721 ' HA ' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -67.56 -13.86 17.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.92 -172.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.04 -51.85 49.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.418 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HG2' ' HE2' ' A' ' 64' ' ' PHE . 5.6 mmp_? -92.38 116.12 65.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HA ' HG23 ' A' ' 73' ' ' THR . 39.5 Cg_endo -66.83 -15.66 47.83 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.187 2.591 . . . . 0.0 114.301 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.21 12.98 32.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.536 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 43.8 t80 -80.33 156.45 26.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 75.3 mt-30 -52.11 -49.09 64.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.826 0.345 . . . . 0.0 111.64 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.729 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 82.1 m-85 -116.34 92.64 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.049 0.452 . . . . 0.0 110.283 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 65' ' ' ILE . 24.3 m -133.3 -46.11 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.255 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.14 16.11 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -57.45 -25.09 59.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.748 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -55.8 -23.86 32.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.024 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.93 2.68 45.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.29 176.26 8.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.022 0.439 . . . . 0.0 110.642 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -148.75 -178.23 6.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.351 -178.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.05 -16.19 59.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 -175.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -139.34 45.24 1.03 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.308 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 5.7 p -85.67 -162.05 0.68 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.532 ' HA ' ' HE3' ' A' ' 83' ' ' MET . 1.1 tpt -129.51 98.25 4.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.078 0.465 . . . . 0.0 109.819 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' SD ' ' A' ' 97' ' ' MET . 97.1 t -84.85 126.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.038 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.3 m-85 -104.98 116.73 32.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.931 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.415 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 52.6 t80 -110.3 111.68 23.14 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.483 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -102.46 140.63 36.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.448 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.462 HG23 HD12 ' A' ' 52' ' ' LEU . 2.6 p -140.69 111.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.246 0.546 . . . . 0.0 109.881 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.523 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 63.82 -98.06 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.501 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.38 0.35 10.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.209 0.528 . . . . 0.0 110.414 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB2' HG11 ' A' ' 88' ' ' VAL . 33.1 mm-40 -94.27 157.43 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.389 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -150.2 129.92 13.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.75 152.92 32.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -103.04 137.98 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.48 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 96.8 m-85 -128.58 145.48 51.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.06 0.457 . . . . 0.0 111.286 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.517 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 11.6 tppt? -112.04 129.17 56.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.493 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 84' ' ' VAL . 75.6 mmm -78.87 48.29 0.82 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.259 0.552 . . . . 0.0 110.329 -176.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 t -84.58 6.81 22.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.955 -171.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 58.8 m -136.25 106.72 6.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.013 171.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.87 96.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 101' ' ' ARG . 25.3 mtm180 -145.17 138.24 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.566 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 8.2 p-10 -108.2 175.12 5.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.342 0.591 . . . . 0.0 111.659 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.21 147.59 14.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.744 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -110.61 132.55 21.52 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 5.9 Cg_exo -78.98 67.7 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 112.876 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 p -67.54 -28.49 67.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.61 0.719 . . . . 0.0 109.647 172.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.98 160.33 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.082 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.61 -23.63 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.346 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.85 29.19 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 111.047 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.645 HG21 ' HG ' ' A' ' 111' ' ' LEU . 29.8 m -66.64 -17.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.261 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.645 ' HG ' HG21 ' A' ' 110' ' ' VAL . 72.0 mt -131.33 -175.31 3.66 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.4 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -146.73 -167.91 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.96 88.62 7.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.07 0.462 . . . . 0.0 110.101 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.95 105.99 6.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.743 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.03 -15.55 61.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.021 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.44 80.71 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.039 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -96.78 168.08 10.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.3 0.571 . . . . 0.0 110.911 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.92 -166.86 2.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -78.16 94.71 4.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.57 137.99 16.72 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.5 mt -101.5 122.72 44.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.7 m -84.0 82.67 8.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.297 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 7.7 mp -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.788 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mt -83.99 78.56 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.609 ' HG1' ' HD2' ' A' ' 142' ' ' PHE . 23.0 m -78.19 88.26 4.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 139' ' ' ARG . 31.0 p -109.6 112.71 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.365 0.602 . . . . 0.0 112.202 -173.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 26.7 t70 -108.08 164.45 12.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 127' ' ' ASP . 3.5 t70 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.424 0.63 . . . . 0.0 112.145 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -78.45 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -164.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 126' ' ' CYS . 5.4 mpt_? -109.12 91.05 3.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.595 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.6 OUTLIER -90.11 96.81 10.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.81 -174.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -77.44 135.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.633 0.73 . . . . 0.0 110.499 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.609 ' HD2' ' HG1' ' A' ' 125' ' ' THR . 63.7 m-85 -120.01 109.23 15.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.657 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 51.1 t -97.5 102.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.04 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -99.73 112.6 24.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.132 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -77.74 139.0 39.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.909 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 119' ' ' LYS . 41.6 tt0 -65.05 132.97 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 110.977 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.04 153.4 11.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.1 pttp . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.33 -173.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.006 0.431 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.5 Cg_endo -78.72 133.74 11.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.706 2.27 . . . . 0.0 112.821 -175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.574 HE22 ' HB2' ' A' ' 53' ' ' ASP . 87.6 mm-40 -94.01 160.58 14.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.669 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 31' ' ' PRO . 58.4 mt -59.9 109.84 2.31 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.712 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 96.8 Cg_endo -96.16 -178.66 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.508 2.806 . . . . 0.0 114.238 -170.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 33.3 ttmt -64.01 -44.55 92.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.009 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 1.6 m-20 -75.64 108.6 8.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.414 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HD2' ' HA2' ' A' ' 32' ' ' GLY . 45.7 mmtm -83.67 5.25 25.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.01 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -97.86 -4.05 37.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.2 mmtp -91.9 105.41 17.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG21 ' CB ' ' A' ' 28' ' ' PRO . 5.1 p -62.14 121.27 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.734 0.778 . . . . 0.0 111.101 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 52' ' ' LEU . . . -89.15 -28.63 19.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.464 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.12 27.62 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.659 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.485 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -117.6 141.23 48.61 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.3 127.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.089 0.471 . . . . 0.0 109.848 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 41.1 mt-10 -134.97 122.93 22.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 -176.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.36 104.7 19.72 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.765 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.73 -32.92 96.42 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.359 2.706 . . . . 0.0 113.811 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.56 -29.97 70.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.961 0.41 . . . . 0.0 111.559 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 25' ' ' ILE . . . -112.24 2.14 16.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.074 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.07 27.48 17.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.699 0.762 . . . . 0.0 110.184 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 60.7 mt -81.71 118.08 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.663 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -141.05 83.79 1.9 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.415 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.61 150.36 76.1 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.086 0.47 . . . . 0.0 111.36 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' CB ' HG21 ' A' ' 14' ' ' VAL . 60.4 Cg_endo -73.46 140.11 29.6 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.864 2.376 . . . . 0.0 112.433 175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.552 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.4 t -88.7 134.62 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.51 104.02 18.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.398 0.618 . . . . 0.0 111.097 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HB2' HG21 ' A' ' 7' ' ' ILE . 61.7 Cg_endo -76.76 109.39 2.84 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.83 2.353 . . . . 0.0 111.442 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.606 ' HA2' ' HD2' ' A' ' 11' ' ' LYS . . . 177.18 -162.0 29.88 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.452 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.31 149.39 17.0 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.182 2.588 . . . . 0.0 112.028 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.556 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -73.41 120.21 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.495 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -159.61 135.35 6.05 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.01 -47.81 11.68 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.935 3.09 . . . . 0.0 113.93 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -56.21 -46.78 79.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.315 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -77.22 -35.63 55.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.337 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 -14.24 62.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -87.97 -15.6 36.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.154 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 41' ' ' ARG . 63.2 mtt180 -87.28 -40.31 14.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.92 -172.55 44.04 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.224 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' ALA . 2.1 m -67.77 125.01 24.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.703 0.763 . . . . 0.0 111.973 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.9 m -130.17 146.03 51.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.925 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 63.8 m-85 -59.25 135.89 57.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.207 0.527 . . . . 0.0 111.664 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -92.92 3.12 56.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.803 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 42.6 mt-10 -121.32 147.94 45.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 80.36 7.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.758 0.79 . . . . 0.0 109.827 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -114.95 149.31 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.313 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 1.5 mp0 -94.4 7.12 46.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.217 0.532 . . . . 0.0 110.734 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -149.77 151.68 34.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.119 0.485 . . . . 0.0 111.56 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -120.71 16.89 11.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.726 174.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.574 ' HB2' HE22 ' A' ' 6' ' ' GLN . 26.8 t70 -88.19 -11.9 45.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.151 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -77.9 -167.48 1.0 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.58 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -117.6 -11.63 10.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' C ' HD21 ' A' ' 56' ' ' ASN . 0.2 OUTLIER -137.22 90.07 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -174.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.543 HG21 HD13 ' A' ' 121' ' ' LEU . 4.0 tt -121.92 148.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 -175.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -99.51 122.09 42.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.526 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.0 mt -123.53 131.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' VAL . . . -102.15 146.05 28.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.673 0.273 . . . . 0.0 110.613 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.78 171.43 29.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.181 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -127.75 138.42 52.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.623 HG23 ' HZ3' ' A' ' 140' ' ' LYS . 1.2 p -94.26 -86.1 0.28 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 43.1 p90 -161.6 155.1 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.534 0.683 . . . . 0.0 112.684 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 mm -127.49 -72.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.262 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 2.3 m-20 -129.24 14.44 6.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.1 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -104.31 101.0 24.32 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.508 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.626 ' HA ' HG23 ' A' ' 73' ' ' THR . 97.4 Cg_endo -89.7 0.56 5.74 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.413 2.742 . . . . 0.0 112.685 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -104.33 22.81 14.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.392 0.615 . . . . 0.0 110.026 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 20.5 t80 -104.47 155.98 18.34 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -56.25 21.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.311 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 65.8 m-85 -79.9 9.19 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.626 HG23 ' HA ' ' A' ' 68' ' ' PRO . 7.0 m -72.71 -26.44 61.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.154 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -94.87 4.91 53.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.51 -16.0 63.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.476 . . . . 0.0 110.509 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -22.66 65.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.804 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.47 -14.66 59.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.027 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.44 173.61 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -177.71 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.249 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -66.47 -10.95 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.973 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.28 55.12 0.66 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.189 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.625 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 62.3 m -111.11 137.68 48.48 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.214 0.531 . . . . 0.0 109.734 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.5 ' HE2' ' HA ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -80.69 104.33 11.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.341 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.684 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 90.2 t -96.14 124.29 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.054 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 83.1 m-85 -99.42 122.98 43.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -116.05 116.52 28.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.524 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 9.1 ttmt -113.16 135.12 54.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.951 -172.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 91' ' ' GLU . 3.0 m -141.77 100.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.625 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.25 -83.15 0.53 Allowed Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.612 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -14.21 6.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 109.648 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HB2' HG21 ' A' ' 88' ' ' VAL . 58.0 mt-10 -93.07 136.44 33.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.649 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 m -140.85 101.61 4.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.14 161.88 13.37 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.504 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -102.97 125.17 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 65.5 m-85 -121.54 144.95 48.43 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.523 ' HD2' ' HB ' ' A' ' 98' ' ' THR . 36.7 ttmt -108.46 145.37 34.75 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.679 ' HB3' HD13 ' A' ' 100' ' ' ILE . 56.3 mtp -81.67 46.88 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.378 0.609 . . . . 0.0 109.604 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 4.4 t -81.67 8.67 9.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.448 -168.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.6 m -145.25 93.03 2.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.582 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 97' ' ' MET . 66.8 mt -126.73 137.04 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.762 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -165.43 147.78 7.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.786 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 24.8 t70 -89.85 93.11 9.3 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.45 86.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.872 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.45 126.24 78.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.58 ' HD3' ' HG2' ' A' ' 139' ' ' ARG . 77.1 Cg_endo -76.58 46.23 1.81 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.166 2.578 . . . . 0.0 113.727 -171.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 t -76.72 -14.28 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.6 144.67 25.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.093 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.19 4.88 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -119.67 24.61 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.426 0.631 . . . . 0.0 110.081 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.73 15.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.841 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.28 162.89 13.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.279 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.89 149.24 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.33 -40.38 97.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -75.56 133.54 40.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.749 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -106.59 97.15 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.643 0.259 . . . . 0.0 110.857 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.75 134.8 24.19 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.97 167.21 9.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.884 0.85 . . . . 0.0 112.562 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 175.19 -164.99 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.103 -1.862 . . . . 0.0 106.483 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -95.72 96.08 8.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -145.0 113.12 6.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.457 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.26 114.67 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -88.04 128.53 35.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.389 0.614 . . . . 0.0 110.046 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 17.8 mt -107.86 105.2 14.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.337 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.51 85.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.591 ' HB ' HG21 ' A' ' 63' ' ' THR . 31.9 p -87.05 86.43 7.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.569 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 42.9 m -64.84 106.01 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.407 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.31 -67.29 0.79 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.498 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.8 t70 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.018 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 CA--C 1.518 -0.263 0 CA-C-O 121.14 0.495 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 37.9 mtmm -80.67 89.33 5.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.215 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.58 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 5.8 ptt180 -106.22 81.41 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.21 118.03 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.308 -178.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.11 126.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.684 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.3 t80 -113.77 108.86 17.66 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.795 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.9 t -110.86 112.1 39.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -101.97 111.11 23.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.001 0.429 . . . . 0.0 110.549 177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.0 m -89.77 137.22 32.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.726 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.405 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 32.3 tt0 -59.8 124.53 20.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.829 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.44 ' CG1' ' HE1' ' A' ' 83' ' ' MET . 3.2 p -110.6 155.21 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 122.21 1.005 . . . . 0.0 110.849 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.559 -168.334 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.467 ' HZ2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.775 0.322 . . . . 0.0 110.589 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.17 113.99 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 111.318 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -151.5 159.28 44.23 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 77.8 mt -101.07 103.24 24.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 1.6 Cg_endo -84.34 167.49 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.04 2.494 . . . . 0.0 112.587 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -77.9 -12.87 60.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.291 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 18.5 t70 -84.65 123.37 30.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.138 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -95.67 12.31 30.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.655 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -93.86 -4.45 50.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.261 0.553 . . . . 0.0 110.154 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 49.9 mmtm -95.8 172.71 7.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.51 98.23 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.41 -32.27 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.077 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -148.73 156.13 26.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.902 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.453 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 1.0 OUTLIER -123.48 128.3 49.6 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 HG11 ' A' ' 84' ' ' VAL . 9.1 tp -102.31 117.82 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.525 0.678 . . . . 0.0 110.503 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.7 mt-10 -128.99 119.34 24.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.488 0.661 . . . . 0.0 111.466 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.67 102.06 39.14 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.753 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -25.68 75.48 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.023 2.482 . . . . 0.0 112.78 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.07 -3.16 54.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.19 10.99 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.541 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.21 20.79 10.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.769 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 67.6 mt -86.77 119.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.542 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 8.9 mtpm? -144.58 68.75 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 25.0 mm-40 -113.74 145.58 33.74 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.474 -172.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.28 149.73 57.8 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.652 2.235 . . . . 0.0 111.934 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.31 130.52 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -88.68 111.68 45.69 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.746 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 37.9 Cg_endo -67.62 152.83 77.63 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.021 2.481 . . . . 0.0 112.797 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.46 177.54 16.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.046 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.37 136.11 25.78 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.999 2.466 . . . . 0.0 111.448 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -52.1 115.06 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.773 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -128.71 151.7 77.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.494 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.3 -46.06 36.61 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.192 2.594 . . . . 0.0 113.404 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.53 -8.6 58.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.306 0.574 . . . . 0.0 111.26 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -101.69 -41.27 6.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.866 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 34' ' ' ALA . 71.1 mt -67.74 -32.16 72.58 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.984 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.36 -12.98 57.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.207 0.527 . . . . 0.0 110.064 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -87.89 -40.06 14.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.503 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -127.17 0.91 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.018 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -122.29 138.06 53.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.7 p -135.9 174.79 10.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 0.0 110.988 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.6 m-85 -84.12 165.34 18.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.92 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.135 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 37.4 mt-10 -117.08 177.22 4.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 26.3 tt0 -114.6 13.88 17.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.998 0.904 . . . . 0.0 109.185 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.78 -34.97 11.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.645 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 1.7 pm0 -82.5 142.37 31.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.234 0.54 . . . . 0.0 111.233 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -86.68 152.02 22.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.342 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.83 9.28 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 111.272 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -119.96 -1.8 10.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.437 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -84.91 -173.77 4.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.122 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HB3' HE21 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -102.18 41.53 1.22 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.625 0.25 . . . . 0.0 111.112 -173.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -171.94 126.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.81 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 23.8 mm -118.93 104.66 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 m -98.29 99.19 10.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.093 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 ' HB ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt -120.98 148.14 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.04 140.07 32.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.702 0.287 . . . . 0.0 110.681 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -161.35 116.05 0.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.865 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -83.88 122.49 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 73' ' ' THR . 58.5 m -107.27 118.69 37.39 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.284 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.458 ' CE2' ' HG2' ' A' ' 67' ' ' ARG . 12.4 p90 -108.54 139.48 43.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.071 0.462 . . . . 0.0 111.368 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -49.46 -34.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.302 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.44 -29.31 48.98 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 mmt85 -113.56 101.88 54.18 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.204 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 73' ' ' THR . 8.2 Cg_exo -74.21 -10.73 22.77 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 123.097 2.532 . . . . 0.0 111.39 175.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -106.71 22.44 15.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.084 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -82.79 163.19 21.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 4.1 mp0 -52.08 -39.79 60.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 76.3 m-85 -128.88 25.53 5.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 68' ' ' PRO . 3.0 m -68.24 -27.35 66.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.37 21.56 12.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 75' ' ' LEU . 11.7 mt -65.5 -11.64 45.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.478 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -71.43 -24.43 62.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.247 0.546 . . . . 0.0 110.76 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -81.2 -17.78 48.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.058 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.93 150.33 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -129.68 179.42 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -65.56 -6.55 11.23 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -171.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.52 23.74 7.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.1 m -87.87 130.68 34.82 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.483 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -69.92 113.05 6.78 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 HD12 ' A' ' 18' ' ' ILE . 94.6 t -89.7 106.6 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.588 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.01 107.35 19.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.053 0.454 . . . . 0.0 110.323 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 31.8 t80 -108.65 101.0 10.17 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.283 0.564 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 54.5 mtmt -85.65 125.43 33.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.5 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 88' ' ' VAL . 17.8 m -107.9 92.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.822 0.82 . . . . 0.0 109.67 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.95 -89.0 1.42 Allowed Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -127.71 -17.92 4.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 111.138 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 26.1 mt-10 -84.24 142.42 30.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.741 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.3 m -108.78 112.24 24.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.529 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -89.11 130.75 35.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 33.8 mtmt -100.8 125.89 47.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.936 0.398 . . . . 0.0 110.265 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 78.7 m-85 -123.28 144.31 49.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.015 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HE2' HG12 ' A' ' 147' ' ' VAL . 5.4 tppt? -101.85 139.48 37.42 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.524 ' HB3' HD11 ' A' ' 100' ' ' ILE . 70.1 mtp -77.64 59.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.43 . . . . 0.0 110.393 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.8 p -59.3 -44.55 92.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.282 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.563 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.9 m -113.16 98.89 7.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.981 0.42 . . . . 0.0 111.543 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 97' ' ' MET . 58.8 mt -122.31 105.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -149.8 150.53 32.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.71 127.81 38.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.509 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.44 148.14 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 104' ' ' LYS . 44.6 mtpt -57.74 123.29 62.35 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.22 -8.4 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.764 2.309 . . . . 0.0 112.544 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 p -93.75 -16.06 24.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.164 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.92 120.43 19.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.659 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 m -98.57 2.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -76.06 -20.77 57.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.04 7.1 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.72 -174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.37 113.64 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.252 0.548 . . . . 0.0 111.132 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.94 133.29 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.413 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.2 125.21 51.99 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.646 -169.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -120.23 139.46 52.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.938 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -83.38 51.79 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 110.113 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 145.29 15.64 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.154 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -133.51 168.75 18.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -175.23 -178.83 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.65 86.96 7.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.47 145.58 31.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.386 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -104.63 115.75 30.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.213 175.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.634 ' HA ' HG21 ' A' ' 143' ' ' VAL . 5.1 t -87.77 59.62 5.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.781 0.801 . . . . 0.0 110.436 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.497 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 5.7 mt -54.92 113.99 1.56 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.219 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.78 97.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.413 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 9.2 p -111.33 107.74 17.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -79.5 140.55 37.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.442 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.14 -46.19 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.279 0.561 . . . . 0.0 111.086 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.158 -172.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.79 ' HZ1' ' HB3' ' A' ' 138' ' ' LYS . 10.1 mtpm? -63.26 130.64 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.905 0.383 . . . . 0.0 111.167 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -118.43 98.53 6.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -78.53 127.86 32.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.21 131.3 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.712 0.767 . . . . 0.0 109.988 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.4 t80 -129.18 98.78 5.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.241 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 122' ' ' THR . 58.6 t -106.06 104.46 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.9 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . . . -90.31 133.38 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.841 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.6 m -104.86 138.43 41.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.513 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.97 113.87 4.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.244 0.545 . . . . 0.0 110.576 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.462 HG12 ' HE2' ' A' ' 96' ' ' LYS . 2.1 p -116.58 153.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.068 0.937 . . . . 0.0 112.367 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--N 1.308 -1.201 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.359 -178.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.632 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 26.0 Cg_endo -63.29 120.1 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.761 2.307 . . . . 0.0 112.309 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -141.89 159.21 42.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 31' ' ' PRO . 46.6 mt -103.49 110.93 64.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.63 0.253 . . . . 0.0 110.68 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.31 -176.22 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.681 2.254 . . . . 0.0 111.292 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.24 -19.77 21.85 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.412 0.625 . . . . 0.0 109.608 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 2.7 p-10 -92.32 165.1 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -116.46 16.33 15.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.092 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -89.33 -27.35 20.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 110.045 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 29.8 mmmt -84.0 113.84 21.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.14 97.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.899 0.38 . . . . 0.0 110.588 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 -30.38 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.734 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -146.99 157.74 27.51 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.948 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 2.4 t80 -137.77 124.98 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -95.06 121.58 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.152 0.501 . . . . 0.0 110.243 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.1 mt-10 -128.5 106.43 8.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.548 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.8 mt -120.42 98.78 48.36 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.185 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 -33.39 93.83 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.043 2.496 . . . . 0.0 112.486 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.36 -19.9 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.548 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -128.04 16.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.4 23.09 12.65 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.217 0.323 . . . . 0.0 111.636 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 81.1 mt -94.18 112.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.635 0.255 . . . . 0.0 111.342 -172.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 54.5 mtmt -141.05 86.16 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.668 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -123.61 141.33 36.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.65 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.3 146.24 56.28 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.262 1.975 . . . . 0.0 111.449 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.608 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 58.0 t -100.08 127.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.702 ' HB3' ' HB2' ' A' ' 11' ' ' LYS . 23.7 m-85 -95.48 105.18 18.74 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.592 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -66.61 143.43 68.41 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.996 2.464 . . . . 0.0 112.284 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.67 -134.26 6.15 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.434 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -95.87 155.05 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.406 2.737 . . . . 0.0 112.797 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.83 129.58 35.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.28 138.95 7.67 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.54 -31.97 80.85 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.178 2.586 . . . . 0.0 112.925 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.31 -35.41 77.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 111.354 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.9 tt0 -85.52 -34.7 21.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.892 0.377 . . . . 0.0 110.345 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.71 -16.64 61.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.581 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 65.8 t30 -82.29 3.74 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.727 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 11.7 ptp180 -137.11 -43.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.304 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 30' ' ' TYR . . . -139.15 169.7 24.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.192 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.63 140.03 16.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -139.29 174.52 10.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.05 144.8 25.89 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.325 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -83.96 -79.93 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.0 77.32 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.378 0.608 . . . . 0.0 111.122 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -16.67 35.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.6 36.11 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.758 -1.564 . . . . 0.0 111.976 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -156.97 -150.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.126 0.489 . . . . 0.0 111.224 -172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 68.8 m -103.03 159.47 15.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.312 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.41 2.12 4.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.761 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 51' ' ' SER . 1.2 p-10 -91.1 -5.77 54.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.56 166.35 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.943 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -85.71 -35.32 20.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.583 0.23 . . . . 0.0 111.432 -173.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.34 85.81 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.648 0.737 . . . . 0.0 111.625 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.82 132.61 30.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.675 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 p -130.55 107.85 9.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.325 0.583 . . . . 0.0 110.578 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.467 ' HB ' HD21 ' A' ' 123' ' ' LEU . 4.0 mt -107.55 143.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 46' ' ' ALA . . . -120.29 149.33 42.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.203 0.525 . . . . 0.0 111.887 -173.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.7 -165.15 21.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -145.34 137.72 25.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.434 0.617 . . . . 0.0 110.57 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -89.72 132.89 34.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.959 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.525 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.67 121.72 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.937 0.399 . . . . 0.0 111.057 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tt -88.55 -30.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.59 -42.2 82.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -105.85 104.47 49.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.198 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.43 -35.65 38.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.414 2.076 . . . . 0.0 112.568 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -87.71 52.35 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.438 0.637 . . . . 0.0 110.302 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' A' ' 40' ' ' ASN . 15.6 t80 -104.25 -167.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.001 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 3.6 pt20 -82.16 -38.25 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.705 0.288 . . . . 0.0 111.171 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 71' ' ' GLN . 78.1 m-85 -131.19 97.86 4.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.116 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.498 HG21 ' HB3' ' A' ' 70' ' ' TYR . 25.5 p -130.88 -48.96 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.6 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 62.3 t30 -84.77 16.85 3.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.1 tp -66.58 -13.87 61.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 110.781 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -68.56 -24.0 64.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 175.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.0 9.1 20.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.751 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -103.0 129.29 49.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.1 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 3.0 mppt? -112.84 -178.5 3.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.907 -172.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.49 -6.62 15.47 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 112.017 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -132.0 19.93 4.59 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.442 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 49.9 m -74.12 115.27 13.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 4.2 tpt -65.01 112.64 3.42 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.757 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 95.2 t -96.71 123.41 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.391 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -106.05 126.68 52.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.025 0.44 . . . . 0.0 110.663 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.507 ' HE1' HG21 ' A' ' 29' ' ' VAL . 24.9 t80 -115.76 103.86 11.09 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.413 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 12.0 ttmm -78.83 138.4 38.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.61 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.5 m -136.56 102.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.247 0.546 . . . . 0.0 110.559 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.33 -81.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.162 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -135.79 -5.12 2.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 110.324 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -101.58 156.97 17.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.372 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 m -123.35 125.16 44.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.65 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -105.97 137.34 44.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 31.7 mtmt -103.2 135.4 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.511 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 81.1 m-85 -132.52 146.72 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.254 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 9.9 tppt? -109.42 139.34 44.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.606 ' HB3' HD12 ' A' ' 100' ' ' ILE . 68.4 mtp -77.63 79.76 4.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.9 p -80.77 -43.1 20.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 4.5 m -112.72 108.34 17.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 110.57 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.606 HD12 ' HB3' ' A' ' 97' ' ' MET . 71.6 mt -128.66 102.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.713 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -153.6 174.08 14.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.8 143.18 50.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 t -111.36 148.67 14.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.147 -172.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 1.7 tmtp? -121.9 89.82 48.29 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -101.73 -150.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.778 2.985 . . . . 0.0 111.843 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.2 m -144.49 -46.92 0.25 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.39 -154.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.558 HG21 ' HG2' ' A' ' 109' ' ' GLU . 21.9 m -91.16 -173.8 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.328 -0.232 . . . . 0.0 111.282 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HG2' HG21 ' A' ' 108' ' ' VAL . 4.9 mm-40 69.41 -3.91 1.48 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.062 0.945 . . . . 0.0 113.011 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.65 -23.77 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.097 0.475 . . . . 0.0 110.815 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -114.22 131.32 56.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.805 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -89.65 130.7 35.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.67 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.556 ' CD ' ' HZ2' ' A' ' 117' ' ' LYS . 8.5 tp10 -102.16 141.15 35.46 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.635 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -154.49 157.24 38.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.075 -176.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -79.17 79.7 5.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.931 0.872 . . . . 0.0 111.163 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.26 43.19 0.49 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.996 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.556 ' HZ2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -102.53 -165.21 1.16 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.16 0.505 . . . . 0.0 110.86 -177.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.7 -174.35 4.13 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -78.25 96.93 5.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -134.67 146.44 49.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.26 100.49 12.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 90.19 3.37 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 59' ' ' ILE . 7.6 mt -84.16 114.46 21.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.771 0.796 . . . . 0.0 111.291 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.555 HG21 ' NH2' ' A' ' 139' ' ' ARG . 73.3 mt -91.91 94.13 4.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.906 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.4 p -115.81 85.56 2.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.499 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.3 p -78.58 135.23 37.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 140' ' ' LYS . 2.3 m-20 -89.72 -60.83 1.84 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.755 0.788 . . . . 0.0 109.688 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 4.7 t70 . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 114.163 -1.38 . . . . 0.0 111.132 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 43.7 mt-10 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 28.5 mttp -104.37 97.46 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.265 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' NH2' HG21 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -119.92 117.59 28.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.638 0.732 . . . . 0.0 111.427 -177.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.5 ' HB2' ' OD1' ' A' ' 127' ' ' ASP . 2.3 tmtm? -77.5 124.56 28.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.72 121.78 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 121.597 0.713 . . . . 0.0 110.139 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 144' ' ' ALA . 3.1 t80 -120.59 115.88 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.84 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.5 t -111.8 116.96 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.366 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . . . -105.33 119.78 39.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.337 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 m -87.0 138.87 31.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.3 112.35 5.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 96' ' ' LYS . 2.6 p -122.57 150.49 26.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--N 1.31 -1.13 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.211 -174.24 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm . . . . . 0 C--O 1.232 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.52 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 17.1 Cg_endo -56.95 145.84 82.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.25 2.633 . . . . 0.0 112.744 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.456 ' HA ' HD23 ' A' ' 52' ' ' LEU . 26.0 mm-40 -129.32 168.36 16.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.912 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.665 HG13 HD21 ' A' ' 52' ' ' LEU . 82.7 mt -100.02 105.77 37.25 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.02 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 10.8 Cg_endo -89.41 -93.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.959 2.439 . . . . 0.0 113.176 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 9' ' ' LYS . 13.4 ttpp -164.97 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.23 124.2 16.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.001 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.803 ' HD3' ' HB2' ' A' ' 38' ' ' GLN . 77.4 mttt -90.09 13.34 15.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.266 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -120.13 6.7 10.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -105.88 144.16 33.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.412 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.83 102.5 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.825 0.345 . . . . 0.0 110.289 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB1' ' HG3' ' A' ' 31' ' ' PRO . . . -84.66 -31.69 24.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.235 0.541 . . . . 0.0 110.203 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.15 178.24 31.92 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.017 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.01 144.44 50.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tp -117.13 118.75 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.549 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.8 mt-10 -126.4 113.0 16.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.46 0.648 . . . . 0.0 111.671 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.54 99.66 45.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.45 -29.79 89.44 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.164 2.576 . . . . 0.0 112.673 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.28 -21.23 66.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.599 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -125.86 8.81 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.131 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 56.64 31.19 18.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.418 0.628 . . . . 0.0 111.121 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 78.0 mt -83.32 110.01 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.07 67.6 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 35.3 mm-40 -120.4 157.02 54.82 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.793 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.84 160.68 30.71 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.533 2.155 . . . . 0.0 112.563 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -112.43 132.93 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -92.82 111.19 50.09 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 0.0 110.522 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.648 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 55.7 Cg_endo -70.38 98.69 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.364 2.709 . . . . 0.0 112.918 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.27 173.57 41.15 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 154.01 43.64 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.738 2.292 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 107.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.548 0.53 . . . . 0.0 111.034 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.471 ' HB ' ' OE1' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -136.58 142.23 38.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.915 -176.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -47.85 -49.54 13.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.981 3.12 . . . . 0.0 114.245 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.471 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.12 -28.28 39.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -174.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.803 ' HB2' ' HD3' ' A' ' 11' ' ' LYS . 9.3 tt0 -73.41 -39.57 64.96 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 35' ' ' THR . 91.1 mt -63.74 -36.64 84.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.752 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -32.89 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -86.75 -12.36 48.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.676 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.422 ' HA3' ' NE2' ' A' ' 71' ' ' GLN . . . 162.05 -96.25 0.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.322 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.484 HG22 ' HA2' ' A' ' 61' ' ' GLY . 5.0 p -154.28 140.86 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 120.78 0.324 . . . . 0.0 110.607 -175.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . 19.8 p -125.05 174.75 7.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.09 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.44 164.07 24.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.908 0.385 . . . . 0.0 110.747 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.75 -55.13 5.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.064 0.459 . . . . 0.0 110.99 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.651 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -112.69 151.25 30.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.48 -177.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -74.27 -36.87 63.84 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.165 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -89.3 19.0 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.223 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 41.1 mt-10 -84.86 102.27 12.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 109.849 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 m -72.89 133.36 44.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD21 HG13 ' A' ' 7' ' ' ILE . 2.0 pp -70.53 -2.46 14.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.54 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -109.07 -3.46 17.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.371 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.79 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.487 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 pt20 172.27 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -94.24 119.69 33.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.295 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 52' ' ' LEU . 17.2 mm -123.39 100.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.066 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 122' ' ' THR . 4.5 m -92.8 114.47 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 110.347 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.658 ' HB ' ' HG ' ' A' ' 123' ' ' LEU . 3.0 mt -111.52 108.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 121.62 33.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.803 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 43' ' ' VAL . . . -99.14 175.48 28.47 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.517 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.466 ' O ' ' HB ' ' A' ' 63' ' ' THR . 23.2 t-160 -84.0 -84.16 0.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.381 0.134 . . . . 0.0 111.144 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 62' ' ' HIS . 15.2 t 171.75 -170.04 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.21 150.31 30.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.35 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.697 HG13 ' H ' ' A' ' 66' ' ' ASP . 10.7 tp -158.47 177.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.697 ' H ' HG13 ' A' ' 65' ' ' ILE . 38.8 t70 -76.77 34.65 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.689 0.757 . . . . 0.0 111.221 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 65' ' ' ILE . 5.1 mpt_? -125.3 105.36 28.21 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 121.977 -0.452 . . . . 0.0 110.298 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.597 ' HA ' HG23 ' A' ' 73' ' ' THR . 57.0 Cg_endo -72.32 -4.96 16.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -103.4 16.81 25.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.511 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.4 t80 -84.66 151.77 24.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.133 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.572 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 12.3 mp0 -46.55 -39.76 11.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.54 17.69 9.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -171.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.597 HG23 ' HA ' ' A' ' 68' ' ' PRO . 38.5 m -69.15 -39.7 78.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.491 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -99.0 7.4 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.086 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.18 -13.48 37.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 110.754 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -63.78 -23.84 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.232 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.49 -8.31 59.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.686 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.425 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -85.7 158.67 19.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.57 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -128.2 -178.16 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.277 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -5.47 35.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.437 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.31 8.21 12.32 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.473 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.8 m -74.04 155.71 38.25 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.731 0.777 . . . . 0.0 110.915 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.92 120.05 35.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.102 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 72.1 t -103.23 108.68 24.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.323 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 42.0 m-85 -90.05 109.81 20.84 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.286 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -99.07 110.39 22.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -109.1 142.54 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.256 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG23 HD22 ' A' ' 52' ' ' LEU . 2.9 p -150.64 103.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.83 0.824 . . . . 0.0 110.091 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 62.58 -98.29 0.2 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.226 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.58 -7.16 17.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.45 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.455 ' HB2' HG13 ' A' ' 88' ' ' VAL . 6.4 mm-40 -92.89 145.06 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.443 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 m -150.04 99.93 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.225 0.536 . . . . 0.0 110.01 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -106.03 136.87 44.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.615 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 0.9 OUTLIER -89.96 133.29 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.993 0.425 . . . . 0.0 110.336 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -126.94 147.35 50.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.27 148.31 30.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.543 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 68.3 mtp -80.65 56.6 2.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.199 0.523 . . . . 0.0 110.27 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.1 p -60.98 -38.5 86.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.187 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.518 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.1 m -119.42 95.59 4.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.014 0.435 . . . . 0.0 111.489 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 97' ' ' MET . 59.3 mt -115.66 103.39 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -132.33 147.17 52.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.957 0.408 . . . . 0.0 110.621 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 36.3 t70 -112.78 120.22 40.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.635 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.622 HG23 HD23 ' A' ' 111' ' ' LEU . 15.7 t -123.43 154.88 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.223 -173.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 92.1 mttt -90.57 138.32 26.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 12.6 Cg_exo -74.06 42.92 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.84 3.027 . . . . 0.0 113.02 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -59.05 -48.51 81.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.411 0.624 . . . . 0.0 109.797 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -143.84 171.62 13.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.112 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.0 m -88.68 -8.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.443 0.639 . . . . 0.0 109.476 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.44 -12.87 59.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.881 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.629 HG13 ' HG ' ' A' ' 111' ' ' LEU . 12.5 p -69.88 -24.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.065 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.629 ' HG ' HG13 ' A' ' 110' ' ' VAL . 90.6 mt -121.05 135.47 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -166.2 143.72 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.36 114.38 27.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.998 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.437 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -95.76 161.4 14.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.577 -176.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.48 23.67 13.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 123.693 0.621 . . . . 0.0 111.343 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.26 -149.12 21.77 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.4 158.74 43.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.854 0.359 . . . . 0.0 111.583 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -111.98 -161.31 0.75 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 6.1 mptt -80.64 97.47 7.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.81 138.78 24.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.651 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.8 mt -96.28 101.77 13.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 143' ' ' VAL . 16.4 m -90.09 85.77 6.38 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.86 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.658 ' HG ' ' HB ' ' A' ' 59' ' ' ILE . 7.2 mp -77.3 104.11 7.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.239 0.543 . . . . 0.0 110.895 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.86 82.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.306 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.5 p -104.66 98.52 8.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.73 113.52 4.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.807 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 1.6 t70 -64.26 -39.1 93.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.77 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.964 176.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -156.61 135.23 11.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.807 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 3.4 ptp180 -145.02 108.96 4.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.421 0.629 . . . . 0.0 111.569 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -88.62 109.96 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.666 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.9 tp -88.69 127.14 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 110.31 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.745 ' HZ ' HG22 ' A' ' 84' ' ' VAL . 2.7 t80 -118.54 114.57 23.03 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.32 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.9 t -112.44 115.01 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.104 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . . . -97.03 117.77 31.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.385 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.1 m -89.83 142.31 27.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.185 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.44 138.34 56.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.6 t -111.11 161.85 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.309 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.666 0.27 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.0 116.99 4.92 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.251 1.968 . . . . 0.0 111.639 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -130.05 175.25 9.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.204 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 31' ' ' PRO . 48.0 mm -113.44 89.28 14.69 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -92.73 -176.84 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.202 2.601 . . . . 0.0 113.086 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -74.96 -25.41 58.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.63 118.5 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 56.4 mttp -87.1 -46.64 9.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -56.32 -36.27 68.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -167.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.637 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.56 142.38 58.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.247 0.546 . . . . 0.0 110.98 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.28 126.06 49.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -103.07 -22.74 13.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.908 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.35 160.72 28.68 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.531 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.32 127.48 53.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.54 118.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.334 0.588 . . . . 0.0 109.43 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 34.2 mt-10 -125.4 112.0 15.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.799 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 HG11 ' A' ' 84' ' ' VAL . 76.2 mt -125.22 102.65 30.36 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.901 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -29.74 81.63 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.129 2.553 . . . . 0.0 113.095 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.37 -16.74 61.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.53 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.44 8.82 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.327 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 58.55 34.71 24.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.764 0.792 . . . . 0.0 110.722 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 71.3 mt -95.66 120.88 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.745 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -145.3 79.64 1.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.823 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 31.7 mm-40 -122.4 141.65 35.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.676 -169.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.21 134.4 21.03 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.575 2.183 . . . . 0.0 111.7 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.573 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.3 t -96.2 138.13 22.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.357 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -109.46 91.02 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -68.28 133.43 28.43 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.88 2.386 . . . . 0.0 112.272 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.38 175.79 34.7 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HG2' ' HE3' ' A' ' 11' ' ' LYS . 19.6 Cg_endo -59.84 118.09 4.93 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.662 2.241 . . . . 0.0 112.237 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -55.8 126.32 25.09 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -142.25 139.02 17.2 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.83 -35.43 88.56 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.023 2.482 . . . . 0.0 113.01 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.47 -17.51 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.412 ' CD ' ' HD3' ' A' ' 11' ' ' LYS . 37.6 tt0 -88.92 -48.59 7.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.49 -22.9 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.808 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.12 -15.09 60.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.209 0.528 . . . . 0.0 110.582 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -100.01 -20.98 15.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.944 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.89 178.55 41.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.057 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.84 123.87 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -136.17 153.06 51.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.368 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.38 168.94 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -85.99 -64.39 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -105.65 158.73 16.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.124 0.487 . . . . 0.0 111.174 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.25 5.01 52.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.786 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -98.53 -0.42 43.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -107.78 135.55 49.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.852 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' HD13 ' A' ' 57' ' ' ILE . 27.6 t -118.72 157.95 26.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.277 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.78 -2.23 16.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.578 0.704 . . . . 0.0 110.219 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -92.25 -16.45 26.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.972 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.91 178.54 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.825 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 -26.93 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.96 124.13 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.852 0.358 . . . . 0.0 110.657 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.444 HG23 HD12 ' A' ' 121' ' ' LEU . 25.4 mm -135.25 139.88 46.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.78 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 m -132.97 114.4 13.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 110.257 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -123.02 136.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.6 174.18 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.28 -172.45 40.87 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.763 ' CD2' ' HA ' ' A' ' 127' ' ' ASP . 10.4 t60 78.18 122.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.983 0.913 . . . . 0.0 111.651 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -153.98 151.3 29.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.701 171.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.49 83.89 7.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.694 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 11.2 tp -99.57 18.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.796 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 14.3 t70 83.33 -25.4 0.14 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.346 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -75.76 108.19 5.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 60.2 Cg_endo -77.4 0.35 9.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.511 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -111.14 9.78 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 175.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.17 101.64 0.93 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.823 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -1.17 -71.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 19.3 m-85 -79.47 6.46 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.7 p -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -92.73 10.41 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.228 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.93 1.22 5.85 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.569 0.7 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -75.77 -25.05 56.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.198 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.72 59.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -84.07 149.16 26.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -112.72 173.93 6.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.172 -176.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -77.83 -6.01 52.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.619 . . . . 0.0 110.665 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.11 10.66 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.975 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.566 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 24.3 m -73.86 129.76 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.519 0.676 . . . . 0.0 110.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.465 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -75.91 108.29 8.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.816 173.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.82 HG23 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -97.07 134.4 34.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.659 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -108.53 127.5 53.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.038 0.447 . . . . 0.0 110.228 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -123.3 113.18 18.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.383 0.611 . . . . 0.0 109.361 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -89.97 132.63 35.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.715 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.04 117.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.364 0.602 . . . . 0.0 109.843 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 -99.81 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.316 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -131.01 11.09 5.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.831 0.348 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -125.83 156.48 39.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.6 m -126.47 130.15 50.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 79.1 mmt-85 -101.56 153.71 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.145 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 44.2 mtmt -102.56 131.57 49.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 109.891 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 83.2 m-85 -127.36 145.1 50.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.678 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -107.39 143.87 35.09 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.711 ' HE1' HD12 ' A' ' 100' ' ' ILE . 56.9 mtp -83.5 44.61 0.98 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.766 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -74.72 -9.45 58.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.463 -171.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.7 m -123.85 84.41 2.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.281 0.563 . . . . 0.0 110.892 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.711 HD12 ' HE1' ' A' ' 97' ' ' MET . 64.4 mt -120.12 113.68 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.248 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 141' ' ' ILE . 50.9 ttt85 -127.87 155.22 44.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.307 . . . . 0.0 110.542 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 138' ' ' LYS . 27.1 t70 -81.18 122.26 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.026 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 46.6 t -129.29 98.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.032 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 32.0 mttp -76.33 166.81 42.08 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.0 -13.19 21.93 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.257 1.971 . . . . 0.0 112.161 174.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 t -106.75 3.19 26.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.027 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 3.5 m-20 -112.12 29.26 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.342 0.591 . . . . 0.0 110.395 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -71.24 169.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.509 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 48.42 23.35 0.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.596 1.159 . . . . 0.0 113.414 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.56 -21.83 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.959 0.409 . . . . 0.0 110.098 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.51 107.94 17.02 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -93.54 174.32 7.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.229 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.09 109.02 20.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -168.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -103.22 140.87 36.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.588 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.3 148.12 26.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.859 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.51 49.23 2.4 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.537 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -105.65 -170.62 1.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.561 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.65 -169.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.61 100.04 8.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -119.95 126.62 51.31 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.748 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.44 105.0 17.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.4 m -75.19 90.8 2.58 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 31.2 mt -84.95 112.42 20.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.591 0.71 . . . . 0.0 110.05 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.0 mt -84.27 91.44 2.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.006 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.4 m -77.32 88.32 3.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.698 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.4 75.41 7.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.135 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.763 ' HA ' ' CD2' ' A' ' 62' ' ' HIS . 4.5 t0 -83.52 -15.36 49.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.213 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.498 ' CG ' ' HE ' ' A' ' 139' ' ' ARG . 19.2 p-10 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.965 -171.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' H ' ' CB ' ' A' ' 128' ' ' ASP . 39.4 mt-10 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 2.9 mtpm? -145.5 138.55 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.989 -173.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.498 ' HE ' ' CG ' ' A' ' 128' ' ' ASP . 95.6 mtt180 -103.34 108.21 19.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.516 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -76.97 103.53 6.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 101' ' ' ARG . 16.0 tt -70.26 122.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.593 0.711 . . . . 0.0 109.783 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.82 ' HZ ' HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -103.37 96.05 6.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.747 -174.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 68.8 t -106.5 104.11 16.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.743 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.579 ' HB1' ' CE1' ' A' ' 142' ' ' PHE . . . -97.68 123.96 41.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.276 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 m -95.78 139.9 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.566 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 40.5 tt0 -61.84 123.03 16.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.229 0.537 . . . . 0.0 111.257 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.64 165.33 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.82 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 148' ' ' LYS . 2.9 pptp? . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.05 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 pttt . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 33.1 Cg_endo -65.21 116.4 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.276 1.984 . . . . 0.0 111.785 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.31 -166.69 1.29 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.922 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.57 104.49 56.16 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.877 0.37 . . . . 0.0 110.592 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.04 -176.57 2.91 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.749 2.3 . . . . 0.0 111.852 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -100.52 4.31 43.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.781 0.324 . . . . 0.0 110.974 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -107.72 152.77 23.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.817 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' HG2' ' NE2' ' A' ' 38' ' ' GLN . 3.1 mptt -102.44 -8.23 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.714 -169.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.4 p -73.35 -19.87 60.91 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.193 0.52 . . . . 0.0 110.744 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -96.09 106.22 18.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.792 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.07 102.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 110.221 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.02 63.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.06 35.93 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.047 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.82 144.96 49.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.312 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.2 tp -115.79 113.19 42.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.669 0.747 . . . . 0.0 109.395 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -125.16 113.96 18.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.348 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 25' ' ' ILE . 51.9 mt -122.65 101.34 40.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 12.0 Cg_endo -57.82 -32.22 94.37 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.042 2.495 . . . . 0.0 112.343 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -29.05 69.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.633 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.03 9.37 12.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.706 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.02 19.48 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.357 0.411 . . . . 0.0 111.605 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 20' ' ' ILE . 67.8 mt -84.45 134.86 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.27 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -158.67 61.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 27.5 mm-40 -123.8 153.78 67.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.616 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 158.36 43.61 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.802 2.335 . . . . 0.0 112.386 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.32 133.52 53.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.48 109.46 40.76 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.07 148.43 75.5 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.501 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.45 -174.76 21.37 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.34 143.48 13.9 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.45 2.1 . . . . 0.0 112.001 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -64.79 131.98 48.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -166.07 145.49 5.11 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.676 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -42.32 -46.71 7.49 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.918 3.079 . . . . 0.0 114.17 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.47 -37.9 65.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.471 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.508 ' NE2' ' HG2' ' A' ' 11' ' ' LYS . 15.9 mm100 -72.3 -60.29 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.355 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.8 mm? -69.05 -7.14 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.675 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -68.93 -33.7 74.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.289 0.566 . . . . 0.0 109.792 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -111.44 -37.27 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.138 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -159.15 -169.31 22.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.232 -175.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.847 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 7.9 p -88.42 148.56 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.017 0.437 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.7 m -144.26 -179.51 6.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.38 147.62 22.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.924 0.393 . . . . 0.0 110.719 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.719 ' HB3' ' HB2' ' A' ' 60' ' ' ALA . . . -98.36 -58.27 2.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.932 -174.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -88.76 -169.64 2.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 111.961 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 50.49 0.53 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.625 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.87 94.96 5.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.3 -3.93 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.1 0.952 . . . . 0.0 110.033 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -143.99 130.67 20.17 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.755 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.85 1.77 46.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.682 0.753 . . . . 0.0 109.391 171.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.43 1.23 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.946 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.5 t70 -94.64 -157.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.692 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 13.2 pt20 -106.42 -41.5 5.28 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.81 118.58 26.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.539 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.75 104.41 14.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.923 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.7 m -102.14 99.23 9.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.016 0.436 . . . . 0.0 110.736 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -99.59 143.28 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 -178.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . . . -121.37 133.37 55.1 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.06 156.39 26.89 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.357 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -102.0 101.62 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.593 HG21 ' HB ' ' A' ' 125' ' ' THR . 6.7 t -87.61 98.29 11.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.024 0.916 . . . . 0.0 110.124 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 12.6 t80 -111.91 92.38 4.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.837 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -58.72 -27.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.553 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 27.2 m-20 -67.46 -4.78 12.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.079 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -135.09 105.76 10.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.599 ' HA ' HG22 ' A' ' 73' ' ' THR . 14.1 Cg_exo -69.78 -12.12 32.22 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.696 2.264 . . . . 0.0 111.84 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -88.24 5.9 39.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.404 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 151.93 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 95.7 mt-30 -62.29 -33.96 75.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.264 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.847 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 97.3 m-85 -122.84 78.74 1.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.205 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 68' ' ' PRO . 5.2 t -113.07 -29.38 7.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.345 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -98.75 21.74 11.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -172.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 75' ' ' LEU . 13.4 mt -71.18 -5.12 29.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -23.37 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.24 0.543 . . . . 0.0 109.711 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.52 0.43 42.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.309 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.68 114.06 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.299 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -175.41 2.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -5.11 1.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' CA ' ' HE3' ' A' ' 96' ' ' LYS . . . -141.38 31.64 2.13 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.961 -1.114 . . . . 0.0 112.448 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.1 m -78.3 117.56 19.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 94' ' ' LYS . 25.1 tpp -68.53 119.85 13.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.02 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.489 HG23 ' SD ' ' A' ' 97' ' ' MET . 73.0 t -110.63 122.79 65.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.28 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -101.89 117.13 34.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.185 0.517 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -104.8 123.58 47.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -110.25 132.52 54.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -137.66 116.67 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.516 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 69.28 -82.39 0.26 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -135.3 -16.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.662 0.268 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.46 156.66 16.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.079 0.466 . . . . 0.0 110.916 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -135.49 119.99 18.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.025 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 89.1 mtt180 -104.79 154.77 19.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.628 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -104.15 125.67 50.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.582 -178.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 91.3 m-85 -123.73 150.42 44.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.259 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HE3' ' CA ' ' A' ' 81' ' ' GLY . 11.5 tttp -119.79 144.46 47.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.489 ' SD ' HG23 ' A' ' 84' ' ' VAL . 76.5 mmm -77.36 81.33 3.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 p -83.83 -16.36 44.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.388 -171.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 47.1 m -147.05 104.98 3.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.35 0.595 . . . . 0.0 111.538 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.48 111.75 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.888 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -127.2 148.68 50.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.195 0.521 . . . . 0.0 111.349 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.405 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 30.8 m-20 -109.42 134.87 51.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.62 176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 108' ' ' VAL . 58.6 t -122.91 126.17 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -78.35 146.76 71.05 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.15 -20.54 67.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.327 2.685 . . . . 0.0 113.953 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -81.82 -29.92 32.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.831 0.348 . . . . 0.0 111.681 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.22 81.63 2.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 103' ' ' VAL . 6.4 p -101.47 -8.62 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.713 0.768 . . . . 0.0 109.935 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.67 34.68 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.2 m -82.15 16.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.238 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.74 171.0 14.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.462 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.516 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 7.5 m-20 -84.12 152.85 24.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.86 97.76 1.46 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.454 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 19.8 mt-30 -135.18 95.29 3.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -109.96 116.97 32.58 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.22 31.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.807 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 118' ' ' ASP . 24.9 tptt -76.19 -161.67 0.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.417 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 3.4 t70 -71.86 -168.23 0.35 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.762 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 3.2 mppt? -76.55 85.09 3.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -136.97 135.37 37.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.825 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.74 107.1 18.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -93.04 94.36 8.83 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.5 mp -83.36 110.26 17.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mt -88.77 99.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.763 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 14.4 p -114.31 104.44 12.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.744 -175.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.1 m -70.76 123.16 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.5 -79.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.748 -177.326 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.774 ' HG3' ' H ' ' A' ' 138' ' ' LYS . 8.3 pt-20 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.774 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 14.0 ptmm? -117.64 166.13 12.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -107.46 156.88 18.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.304 172.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.455 ' HG2' ' HZ1' ' A' ' 138' ' ' LYS . 5.9 tmtp? -133.92 127.85 33.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.998 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.39 128.41 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 120.986 0.422 . . . . 0.0 110.492 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 76.0 m-85 -121.73 107.61 12.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.218 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 52.9 t -102.24 107.18 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.0 110.599 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -101.62 107.42 18.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.396 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.7 m -85.78 140.18 30.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.194 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.474 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 30.9 tt0 -64.63 120.64 12.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.405 ' HB ' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t -84.49 165.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.184 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.79 158.2 52.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.617 2.211 . . . . 0.0 111.521 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.445 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 mm-40 -116.09 168.47 10.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.753 0.311 . . . . 0.0 110.588 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.584 HD11 ' HB3' ' A' ' 52' ' ' LEU . 87.2 mt -98.04 102.25 13.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 79.0 Cg_endo -93.2 -173.84 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.069 2.512 . . . . 0.0 113.504 -174.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -81.44 -17.85 47.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.565 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.1 137.88 53.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.615 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 32.9 mmtp -88.56 -33.34 17.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.604 -167.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -101.23 8.57 42.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.869 0.366 . . . . 0.0 111.627 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -86.06 90.25 8.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.615 0.245 . . . . 0.0 110.836 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.78 115.57 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.88 -28.26 15.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.195 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.17 155.39 25.07 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.344 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 131.56 55.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -102.81 130.47 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 50.3 mt-10 -136.79 109.56 7.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.274 0.559 . . . . 0.0 111.049 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.9 mt -118.93 95.41 49.25 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.67 -36.36 98.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.152 2.568 . . . . 0.0 113.064 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.58 -30.06 70.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -111.18 5.04 19.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.068 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 58.4 25.43 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.297 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 58.9 mt -85.1 99.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 40.1 ttmt -134.98 88.12 2.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.695 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 5.7 mm-40 -144.97 153.39 53.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.884 -170.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.0 153.99 52.64 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.194 2.596 . . . . 0.0 112.918 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -107.26 139.15 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -113.08 103.12 55.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.568 ' HB3' HG23 ' A' ' 7' ' ' ILE . 77.8 Cg_exo -51.88 161.72 2.15 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.825 3.017 . . . . 0.0 113.421 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.73 165.87 12.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.48 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HD2' ' HE2' ' A' ' 11' ' ' LYS . 34.4 Cg_endo -65.22 141.08 67.5 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.515 2.143 . . . . 0.0 111.761 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.2 101.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.169 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -139.09 155.76 72.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.9 Cg_endo -54.26 -35.24 82.68 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.902 2.401 . . . . 0.0 112.6 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.67 -45.82 77.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.235 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 11.1 mm100 -72.71 -47.14 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.553 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.0 mm? -68.1 -9.51 46.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.44 . . . . 0.0 111.003 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 24.3 t-20 -78.5 -32.27 48.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.823 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -93.74 -46.37 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.89 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.447 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -160.29 -156.45 8.18 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.818 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 60' ' ' ALA . 87.0 t -97.13 135.22 32.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 67.6 m -127.72 151.32 49.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.834 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 97.0 m-85 -71.38 147.07 48.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.08 0.467 . . . . 0.0 111.59 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.99 -28.38 29.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.85 99.26 9.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.558 173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -83.15 17.11 2.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.302 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.65 172.68 12.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.776 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -82.52 14.31 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.212 -173.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -102.37 101.7 11.97 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.584 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -110.83 4.95 20.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.521 0.677 . . . . 0.0 109.874 172.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.54 20.99 7.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.581 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -74.6 -170.05 0.97 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.6 pt20 -93.22 -29.09 15.88 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -111.02 143.5 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.464 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 15.1 mm -138.07 100.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -93.79 116.04 28.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.498 ' HB ' HD22 ' A' ' 123' ' ' LEU . 1.6 mt -122.36 138.3 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -91.16 118.28 30.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.76 ' HA3' HG22 ' A' ' 125' ' ' THR . . . -105.16 114.58 4.66 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.494 -175.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.423 ' HB3' HD13 ' A' ' 39' ' ' LEU . 25.1 p80 -73.62 141.76 46.54 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.1 t -74.08 175.34 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' A' ' 73' ' ' THR . 42.1 p90 -82.86 161.27 21.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.46 -80.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.007 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -115.54 -10.93 11.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.075 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -98.11 109.76 53.15 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.736 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 -13.82 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.086 2.524 . . . . 0.0 111.949 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' A' ' 69' ' ' ASN . 8.1 m120 -116.92 61.82 0.73 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 109.764 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.74 179.46 4.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.599 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.695 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 14.9 mp0 -53.83 -40.91 66.82 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.498 0.499 . . . . 0.0 112.129 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.839 ' HE1' HD22 ' A' ' 75' ' ' LEU . 71.5 t80 -131.57 101.59 5.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.0 109.923 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 64' ' ' PHE . 15.4 p -141.75 -62.84 0.45 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.209 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 66.2 t30 -94.15 27.01 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -167.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.839 HD22 ' HE1' ' A' ' 72' ' ' PHE . 16.6 tp -62.86 -18.55 63.07 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.615 -0.678 . . . . 0.0 111.404 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -64.12 -22.23 66.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.49 -16.01 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.412 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.88 169.41 18.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.594 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -137.42 168.08 20.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 111.494 -176.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.33 59.19 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.08 -173.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -131.47 39.34 1.78 Allowed Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.002 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.4 p -85.24 -150.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.967 0.413 . . . . 0.0 110.106 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.529 ' HE1' ' HA ' ' A' ' 83' ' ' MET . 1.5 tpt -139.3 105.36 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.782 0.325 . . . . 0.0 110.187 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 97.9 t -96.19 120.99 46.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.044 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.561 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 80.8 m-85 -101.04 129.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -123.41 106.15 10.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 49.4 mtmt -102.02 114.85 29.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.398 -175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.91 101.99 13.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.571 0.7 . . . . 0.0 109.122 173.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.77 -89.29 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -12.5 4.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.136 0.493 . . . . 0.0 109.818 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 3.5 mm-40 -76.91 117.67 18.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.803 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.4 m -103.16 112.49 25.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.112 0.482 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -102.23 136.17 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 21.6 mtmm -104.34 140.06 38.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.468 . . . . 0.0 110.629 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 74.8 m-85 -132.69 148.56 52.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 13.3 tppt? -107.76 137.89 44.97 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.528 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 69.3 mtp -79.06 61.91 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.8 p -68.63 -41.21 79.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.211 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.556 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -116.37 101.37 8.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.333 0.587 . . . . 0.0 111.343 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 97' ' ' MET . 57.0 mt -119.75 114.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.025 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -134.63 140.22 45.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.382 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.54 108.38 16.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.254 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 -169.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -130.3 155.85 80.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.562 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.69 106.48 2.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.617 2.212 . . . . 0.0 114.096 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -119.58 -51.38 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -109.34 120.43 42.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.068 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -104.04 -26.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.278 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.49 19.84 14.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.309 0.576 . . . . 0.0 110.804 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.16 -0.24 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.651 0.738 . . . . 0.0 110.046 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.75 12.21 26.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.551 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.44 5.06 18.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.993 0.901 . . . . 0.0 110.825 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 11.9 pt-20 -108.08 94.07 4.87 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.419 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.83 121.74 42.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.045 0.45 . . . . 0.0 110.674 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -106.62 -0.94 23.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.9 -162.6 21.72 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.644 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -153.54 177.6 10.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.169 0.485 . . . . 0.0 110.908 176.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.57 -171.51 2.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.663 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 27.8 mttm -85.58 96.14 9.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.893 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 14.0 pt20 -162.84 139.81 7.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.447 -173.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.464 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 17.2 mt -88.84 130.88 35.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 171.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 m -104.73 87.53 2.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.502 HD13 ' CD2' ' A' ' 142' ' ' PHE . 26.3 mt -85.8 96.99 9.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.146 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.93 95.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.76 HG22 ' HA3' ' A' ' 61' ' ' GLY . 50.7 p -109.18 99.34 8.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.875 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 34.6 m -61.99 116.3 4.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.577 0.703 . . . . 0.0 110.833 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 35.3 t70 -91.75 161.31 14.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.944 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 4.8 t0 . . . . . 0 N--CA 1.466 0.352 0 O-C-N 123.767 0.667 . . . . 0.0 111.018 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 6.3 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.753 0.311 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 27.7 mttp -128.02 -178.84 4.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.172 0.51 . . . . 0.0 109.994 174.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.814 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.9 ptt180 -154.87 100.59 2.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.8 171.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 116.07 26.35 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 tt -100.42 117.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 CA-C-O 122.128 0.966 . . . . 0.0 110.443 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.744 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 3.3 t80 -101.64 113.95 27.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.291 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 94.7 t -109.36 112.09 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.744 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -103.93 116.38 32.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -79.23 136.05 36.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.307 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.46 122.95 15.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.836 0.35 . . . . 0.0 110.467 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.39 153.57 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.753 0.787 . . . . 0.0 111.166 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.296 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 4' ' ' LYS . 19.6 ptmt . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.051 0.453 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' O ' HD22 ' A' ' 52' ' ' LEU . 68.6 Cg_endo -79.44 120.69 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.495 2.13 . . . . 0.0 113.362 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -106.81 128.74 54.51 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 165.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 31' ' ' PRO . 69.6 mt -51.04 107.24 0.78 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -168.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.728 ' HD2' ' HZ3' ' A' ' 13' ' ' LYS . 9.7 Cg_endo -90.82 -170.01 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.627 2.884 . . . . 0.0 113.048 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -68.46 -41.6 79.98 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 4.1 m-20 -59.62 149.55 30.0 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.737 0.415 . . . . 0.0 111.782 -171.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.827 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 90.9 mttt -95.05 -40.7 9.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.758 0.313 . . . . 0.0 110.735 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -73.15 -5.58 40.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.749 ' HE2' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -80.87 132.38 35.45 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.45 126.73 50.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.294 0.568 . . . . 0.0 110.592 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 31' ' ' PRO . . . -106.75 -23.68 12.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.704 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.84 148.19 19.83 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.903 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.4 121.8 45.97 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.82 116.42 33.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.517 0.675 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.9 mt-10 -127.64 109.54 11.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.104 -173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.24 101.22 44.5 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.066 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 83' ' ' MET . 31.1 Cg_endo -63.12 -22.86 73.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 123.184 2.589 . . . . 0.0 112.964 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 82' ' ' SER . 9.3 m-20 -69.82 -29.78 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.78 13.37 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.26 23.13 11.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.497 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 69.6 mt -83.56 113.11 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.239 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -144.36 77.65 1.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -134.0 154.3 80.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.938 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.66 139.54 34.15 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.083 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.61 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.5 t -94.58 136.71 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.576 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 11' ' ' LYS . 44.9 m-85 -108.65 92.53 10.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.998 0.428 . . . . 0.0 110.549 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' HD2' ' HE2' ' A' ' 13' ' ' LYS . 7.4 Cg_exo -73.78 102.39 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.308 2.672 . . . . 0.0 112.616 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.74 -179.72 42.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.539 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.827 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 18.3 Cg_endo -62.07 99.62 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.293 1.995 . . . . 0.0 111.091 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.58 124.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.208 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.6 p -127.03 159.5 64.46 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.13 -37.72 58.83 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.916 2.411 . . . . 0.0 112.902 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -66.05 -41.02 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 11' ' ' LYS . 14.7 pt20 -83.18 -21.56 33.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.271 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.695 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 93.3 mt -87.38 11.19 15.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.519 0.676 . . . . 0.0 110.095 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -112.44 -13.94 13.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.845 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -121.69 -16.9 7.59 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.549 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -147.12 5.68 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.87 140.31 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.052 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -134.75 161.56 34.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 27.8 m-85 -72.6 160.43 32.27 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.274 175.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.31 68.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.5 170.61 7.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.041 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.17 -35.64 59.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 69.41 160.31 0.19 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.529 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' HG ' ' A' ' 51' ' ' SER . 12.2 pt-20 -139.32 -3.77 1.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.322 0.582 . . . . 0.0 110.991 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.438 ' HG ' ' HG3' ' A' ' 50' ' ' GLU . 13.9 m -143.84 99.9 3.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -78.69 -6.22 55.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.838 0.828 . . . . 0.0 109.749 175.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.1 10.94 37.94 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.196 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -86.02 154.07 21.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 3.5 pm0 -83.58 -19.83 34.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.17 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.33 93.43 4.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 110.398 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.403 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 19.9 mm -116.26 129.92 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 118.84 28.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 45' ' ' PHE . 2.0 mt -107.65 129.71 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.2 115.11 29.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.935 0.397 . . . . 0.0 110.973 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -111.17 86.69 0.44 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.202 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 85.4 t60 -87.79 128.3 35.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.065 0.46 . . . . 0.0 110.129 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 127' ' ' ASP . 87.7 m -146.39 133.77 20.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -146.74 17.55 1.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.368 0.604 . . . . 0.0 110.008 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.475 HG13 ' HG3' ' A' ' 67' ' ' ARG . 10.7 tp -88.73 -13.29 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.663 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.94 37.86 27.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.299 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HG3' HG13 ' A' ' 65' ' ' ILE . 99.5 mtt180 -105.86 118.04 56.22 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.644 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.94 0.85 5.17 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.958 2.439 . . . . 0.0 113.439 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 24.98 11.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.026 0.441 . . . . 0.0 110.775 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 179.83 6.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.18 -73.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -91.13 14.76 13.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 m -80.61 -34.15 35.3 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.205 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.69 3.39 33.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.1 -8.78 18.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -62.95 -23.72 67.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.558 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.74 6.94 28.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.284 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.18 144.41 25.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 110.848 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.32 177.63 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.72 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -15.03 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.643 0.735 . . . . 0.0 110.477 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -130.14 57.24 0.73 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.497 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 13.1 m -86.18 -160.9 0.58 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 6.8 tpt -135.56 103.46 5.46 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.075 0.464 . . . . 0.0 109.975 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.594 HG23 ' SD ' ' A' ' 97' ' ' MET . 96.7 t -97.55 125.12 50.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.476 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.4 m-85 -108.45 123.4 48.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.466 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -110.0 104.32 13.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 24.3 ttpp -99.96 105.51 17.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.721 0.772 . . . . 0.0 111.159 -173.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 91' ' ' GLU . 2.4 p -93.56 104.63 15.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.704 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.4 -103.05 0.74 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -113.68 -9.83 13.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 110.596 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.508 ' HB2' HG13 ' A' ' 88' ' ' VAL . 37.9 mt-10 -79.94 131.39 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -108.32 117.22 33.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -99.65 145.02 28.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -110.82 129.29 55.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.383 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -132.91 151.94 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.822 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 14.2 tppt? -117.42 137.15 52.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.594 ' SD ' HG23 ' A' ' 84' ' ' VAL . 90.1 mmm -78.02 43.35 0.43 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.166 0.508 . . . . 0.0 110.906 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -89.1 23.59 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.357 0.599 . . . . 0.0 112.023 -170.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 54.8 m -143.84 51.4 1.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.498 0.666 . . . . 0.0 110.274 174.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 97' ' ' MET . 71.1 mt -91.63 118.19 36.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.641 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.65 148.25 31.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.619 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -104.81 135.19 46.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.314 0.578 . . . . 0.0 111.017 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.94 147.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.215 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -138.9 86.6 15.15 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.48 0.657 . . . . 0.0 111.127 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -96.2 -158.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.352 2.701 . . . . 0.0 111.291 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -172.38 20.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.68 0.753 . . . . 0.0 110.243 171.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -145.08 154.3 42.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 110' ' ' VAL . 28.1 m -120.97 170.29 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.663 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 64.61 -0.77 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.1 0.96 . . . . 0.0 112.823 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 108' ' ' VAL . 13.0 p -84.6 -19.63 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 0.0 110.115 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.8 142.28 31.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.18 145.24 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.296 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.76 137.51 33.7 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -106.68 145.74 31.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.374 0.607 . . . . 0.0 111.84 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 115' ' ' LYS . 10.7 mptt -104.09 150.54 24.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.088 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.99 50.39 1.48 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -94.06 176.13 6.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 0.0 111.546 -176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -117.46 -174.68 2.66 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 169.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 55' ' ' GLN . 3.5 mppt? -74.39 100.25 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -141.23 132.84 27.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.018 0.437 . . . . 0.0 111.138 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.403 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 11.9 mt -99.26 115.23 28.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.602 HG21 HG22 ' A' ' 143' ' ' VAL . 14.3 m -97.19 96.67 8.58 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.321 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.47 104.1 14.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.8 mt -90.24 99.93 10.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.781 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 21.4 p -91.65 141.2 28.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.95 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 31.1 p -151.03 130.66 13.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.9 m-20 -97.11 -54.64 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 109.441 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.966 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.583 ' O ' ' HD2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -165.26 153.64 11.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -170.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.95 ' HG3' ' HA ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -172.47 139.93 1.03 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.433 ' HD3' ' CG2' ' A' ' 100' ' ' ILE . 5.4 tmmm? -78.86 128.62 33.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.96 140.02 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.025 0.441 . . . . 0.0 111.37 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.475 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 97.1 m-85 -109.43 108.44 18.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.424 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 122' ' ' THR . 41.1 t -110.13 121.45 63.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.347 . . . . 0.0 110.43 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -112.12 118.59 35.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.703 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.8 m -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -62.66 124.49 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.58 154.68 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.8 pttt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.683 -175.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.37 125.44 10.74 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.447 2.098 . . . . 0.0 112.472 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.48 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.8 tp60 -150.7 165.79 32.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.04 104.29 35.23 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 110.434 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 10.9 Cg_endo -89.48 -179.82 2.05 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.177 2.585 . . . . 0.0 111.607 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -90.47 -6.15 55.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.839 0.352 . . . . 0.0 110.569 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.4 t0 -81.74 125.32 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.297 0.57 . . . . 0.0 109.917 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 13.8 mttp -92.7 1.64 57.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.321 -173.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.73 -16.16 28.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.064 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 32.2 mmmt -88.39 172.85 9.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.39 108.0 23.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.517 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.44 -31.61 22.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.141 0.496 . . . . 0.0 110.77 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.59 165.56 29.15 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.732 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -129.88 132.65 46.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -107.57 124.04 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.148 0.499 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 33.8 mt-10 -129.54 116.13 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.443 0.64 . . . . 0.0 111.637 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.448 HD13 HD12 ' A' ' 25' ' ' ILE . 63.5 mt -127.44 100.58 25.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.41 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.25 -38.38 95.15 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.156 2.571 . . . . 0.0 112.903 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.998 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -123.67 13.75 9.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.316 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 54.95 28.61 10.85 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 74.5 mt -89.9 116.07 30.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 27.8 mtpp -144.48 59.19 1.33 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.907 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 42.6 mm-40 -122.62 156.06 61.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.19 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.54 162.23 40.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.044 2.496 . . . . 0.0 113.166 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.68 134.11 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -91.67 116.15 65.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.024 0.44 . . . . 0.0 111.095 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.25 148.55 80.49 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.379 . . . . 0.0 112.043 175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.93 172.91 13.18 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.348 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.29 166.84 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.909 2.406 . . . . 0.0 111.836 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.558 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -68.15 111.16 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.268 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 p -128.4 139.83 36.64 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.405 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.26 -47.54 19.47 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.592 2.861 . . . . 0.0 113.253 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.47 -42.23 92.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 111.03 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 43.1 tt0 -74.86 -36.97 62.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 34' ' ' ALA . 90.8 mt -79.75 -11.16 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.606 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -98.68 -21.28 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.0 110.114 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.95 -33.5 18.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.07 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -161.28 -145.19 4.23 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.415 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.536 HG21 HG22 ' A' ' 59' ' ' ILE . 11.6 p -115.13 138.95 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 58.5 m -150.03 158.2 43.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 58' ' ' SER . 96.3 m-85 -66.52 158.82 28.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.718 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.558 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -98.96 -46.27 5.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.561 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -96.68 144.21 26.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.638 0.733 . . . . 0.0 111.908 -174.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.6 -2.4 55.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.325 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -117.99 18.6 13.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.707 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 15.4 pt-20 -105.84 138.82 41.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.2 m -117.26 150.32 38.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.646 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 pp -73.92 -8.14 54.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.359 0.6 . . . . 0.0 110.419 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.74 2.59 21.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.416 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 5.9 t70 -92.09 -159.23 0.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 55' ' ' GLN . 2.1 tt0 -99.81 -36.23 9.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -95.43 132.43 40.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.111 0.482 . . . . 0.0 110.941 -175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.454 HG22 HD21 ' A' ' 121' ' ' LEU . 28.0 mm -129.71 120.9 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.504 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 32.7 t -127.68 106.28 9.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.921 0.391 . . . . 0.0 110.334 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG22 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -122.07 119.02 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.07 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.12 42.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.908 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.17 98.15 0.2 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 126' ' ' CYS . 3.6 p-80 -116.19 159.79 21.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.322 0.561 . . . . 0.0 112.32 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.402 ' CG2' ' HG2' ' A' ' 67' ' ' ARG . 12.9 t 176.7 -176.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -145.71 2.79 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.393 0.615 . . . . 0.0 109.934 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 67' ' ' ARG . 12.2 mm -91.32 47.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.139 0.495 . . . . 0.0 111.76 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.8 -29.9 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.168 0.987 . . . . 0.0 113.061 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.63 ' HD2' ' OD1' ' A' ' 127' ' ' ASP . 6.6 mtp85 60.56 67.55 1.54 Allowed Pre-proline 0 N--CA 1.465 0.305 0 C-N-CA 124.26 1.024 . . . . 0.0 111.903 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 10.6 Cg_endo -103.52 -12.97 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.005 2.47 . . . . 0.0 112.718 170.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -133.85 25.96 3.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.947 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.406 ' O ' HG21 ' A' ' 73' ' ' THR . 9.3 m-85 -100.33 172.9 6.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.775 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.907 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.2 pm0 -72.89 -22.1 60.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.797 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.448 ' CD2' ' HG2' ' A' ' 71' ' ' GLN . 69.3 m-85 -125.35 92.92 3.72 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 173.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 67' ' ' ARG . 34.2 p -107.33 -67.28 0.96 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.018 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.602 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.7 t30 -86.89 25.47 1.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.534 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -66.24 -2.45 4.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.624 0.726 . . . . 0.0 110.528 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 74' ' ' ASN . 20.4 pttp -80.02 -30.22 39.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.172 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.55 -15.25 38.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.843 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.498 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -66.52 135.31 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.997 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -95.7 -175.87 3.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.006 0.431 . . . . 0.0 110.884 -176.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -4.02 53.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . -123.07 28.56 5.58 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.89 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 3.8 m -85.85 131.91 34.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.311 0.577 . . . . 0.0 109.859 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 109.51 10.11 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.669 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.824 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 84.4 t -96.43 116.01 37.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.653 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -98.77 126.38 44.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.458 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' C ' ' HG1' ' A' ' 92' ' ' THR . 52.4 t80 -122.02 110.81 16.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.656 ' HG2' ' HB ' ' A' ' 92' ' ' THR . 46.4 mtmt -101.51 142.89 32.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.246 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.21 89.1 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.765 0.793 . . . . 0.0 109.171 169.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.06 -54.58 4.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.505 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.4 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.0 110.22 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.49 130.57 39.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.518 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.656 ' HB ' ' HG2' ' A' ' 87' ' ' LYS . 2.8 t -121.18 149.59 42.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.558 0.694 . . . . 0.0 111.864 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 146' ' ' GLU . 30.7 mmm180 -115.46 141.34 48.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.27 129.58 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 110.387 -177.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -127.2 147.86 50.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 37.4 ttmt -111.35 149.35 31.28 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.774 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.581 ' HB3' HD11 ' A' ' 100' ' ' ILE . 49.7 mtp -79.77 64.16 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 0.0 110.296 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.3 p -73.45 -34.45 65.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.828 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 8.4 m -115.41 95.36 5.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.187 0.517 . . . . 0.0 110.818 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 97' ' ' MET . 63.2 mt -120.45 119.73 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -151.44 151.26 31.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.807 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -108.24 129.01 55.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.806 HG21 ' HD3' ' A' ' 105' ' ' PRO . 7.5 p -121.06 126.68 75.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.771 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 77.2 52.34 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 111.768 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.806 ' HD3' HG21 ' A' ' 103' ' ' VAL . 97.0 Cg_endo -97.34 170.99 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.268 2.646 . . . . 0.0 111.346 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -66.15 -51.46 57.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -133.54 121.41 22.08 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -61.26 150.87 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HB2' HD23 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -65.71 -24.7 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 0.0 110.694 -175.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.531 ' H ' HG12 ' A' ' 108' ' ' VAL . 9.8 p 48.79 21.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.771 1.228 . . . . 0.0 113.588 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -82.66 176.46 9.34 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.933 -0.479 . . . . 0.0 110.171 174.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.83 152.23 42.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.965 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -94.08 137.01 33.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.64 168.23 9.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 110.388 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -73.38 161.84 30.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.4 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.4 36.52 0.64 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -131.98 -167.44 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -124.81 -168.14 1.77 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.22 104.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -130.22 136.98 49.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.454 HD21 HG22 ' A' ' 57' ' ' ILE . 26.5 mt -92.11 100.26 12.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.1 m -78.53 88.88 4.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 142' ' ' PHE . 39.4 mt -95.37 99.89 11.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.518 0.675 . . . . 0.0 110.262 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -99.56 97.38 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.053 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -92.71 91.76 7.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.917 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 62' ' ' HIS . 2.9 m -73.62 100.55 3.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.63 ' OD1' ' HD2' ' A' ' 67' ' ' ARG . 28.8 t70 -115.52 47.13 1.37 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.937 0.875 . . . . 0.0 108.769 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.769 ' HB2' ' H ' ' A' ' 137' ' ' GLU . 4.5 p-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.933 -170.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.769 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 82.2 mt-10 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.421 ' HG3' ' HB3' ' A' ' 137' ' ' GLU . 26.5 mttp -130.18 112.72 13.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.574 -169.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -104.47 129.97 52.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.343 0.592 . . . . 0.0 110.118 175.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.516 ' HE3' HG21 ' A' ' 100' ' ' ILE . 1.8 tmtp? -95.46 126.64 40.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.524 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.63 131.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.054 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.824 ' HZ ' HG22 ' A' ' 84' ' ' VAL . 4.3 t80 -132.14 110.75 10.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.143 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.1 t -114.89 105.95 19.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.922 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.592 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -92.58 125.38 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.249 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.4 m -97.27 140.83 31.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 93' ' ' ARG . 42.0 tt0 -58.31 121.66 11.34 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.69 0.619 . . . . 0.0 111.009 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 148' ' ' LYS . 2.7 p -124.03 162.9 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.832 0.825 . . . . 0.0 111.654 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.842 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.557 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.7 Cg_endo -73.8 136.89 23.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.234 1.956 . . . . 0.0 111.629 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.495 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 35.2 mm-40 -85.17 -167.72 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 52' ' ' LEU . 5.3 mp -81.02 101.53 0.99 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 98.6 Cg_endo -94.32 -166.5 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.05 2.5 . . . . 0.0 113.081 -169.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -75.02 -23.41 58.19 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.554 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 29.4 m-20 -79.17 83.79 5.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.818 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 2.3 pptp? -85.48 -3.27 58.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.359 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.9 m -101.13 3.47 41.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 0.0 111.166 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.546 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 34.1 mmtp -90.6 173.82 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.071 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.17 95.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.802 0.334 . . . . 0.0 110.456 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -82.58 -27.87 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.343 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.29 31.01 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.95 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -135.36 132.94 38.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -103.31 125.57 57.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.3 mt-10 -135.57 104.49 5.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 25' ' ' ILE . 55.9 mt -116.51 100.23 53.31 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 83' ' ' MET . 17.8 Cg_endo -59.85 -30.74 92.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.034 2.489 . . . . 0.0 112.478 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.03 -12.76 61.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.696 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 4.36 3.8 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.551 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.48 27.94 17.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.163 0.506 . . . . 0.0 111.195 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 80.2 mt -88.0 107.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.122 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -139.27 86.38 2.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.276 . . . . 0.0 110.426 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' OE1' ' HB3' ' A' ' 71' ' ' GLN . 53.6 mt-10 -135.54 153.29 77.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.599 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.88 150.37 78.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.6 2.2 . . . . 0.0 112.152 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.09 129.46 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 47.2 m-85 -95.17 107.67 33.64 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.97 -177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 11.3 Cg_endo -54.95 154.01 23.33 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.3 2.666 . . . . 0.0 112.194 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.31 -161.04 18.86 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.767 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' O ' HG21 ' A' ' 35' ' ' THR . 57.4 Cg_endo -93.09 157.86 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.163 2.575 . . . . 0.0 112.435 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 111.34 10.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.251 0.548 . . . . 0.0 110.162 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 33' ' ' PRO . 1.4 t -149.89 143.29 16.54 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.082 -175.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 -23.12 33.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.133 2.555 . . . . 0.0 112.503 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.14 -50.87 66.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 1.3 tt0 -88.56 -29.54 19.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.838 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.13 1.32 13.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 110.63 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.44 -18.54 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -99.03 -65.16 0.98 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.583 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.59 -148.88 4.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.386 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.57 140.98 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.672 0.272 . . . . 0.0 110.395 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.566 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 15.9 m -131.06 -170.55 2.38 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 56.9 m-85 -99.12 173.41 6.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.27 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.513 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -97.3 -174.48 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -134.84 27.81 3.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.765 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.6 -3.08 6.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.053 0.454 . . . . 0.0 111.009 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -90.41 159.74 16.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.321 0.581 . . . . 0.0 111.717 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -107.22 147.79 29.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.224 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD21 ' O ' ' A' ' 5' ' ' PRO . 3.0 pp -85.62 2.59 44.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.384 0.611 . . . . 0.0 110.282 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.33 4.87 50.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.6 164.91 12.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -94.73 -9.47 34.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.719 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -106.7 90.79 3.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.165 0.507 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -109.59 133.86 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.387 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -123.26 116.79 23.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 5.7 mt -108.74 133.23 54.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.69 123.9 46.04 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.905 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -112.66 -171.79 18.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.375 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -139.43 148.52 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.574 0.226 . . . . 0.0 110.728 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.558 ' OG1' ' HD3' ' A' ' 67' ' ' ARG . 10.1 t -162.07 143.87 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.55 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.73 -158.81 0.66 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.67 -66.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.63 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.26 84.16 5.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.396 0.617 . . . . 0.0 110.316 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -161.29 105.14 1.23 Allowed Pre-proline 0 C--O 1.213 -0.863 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.381 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.562 ' HA ' HG21 ' A' ' 73' ' ' THR . 71.7 Cg_endo -100.47 -0.82 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.911 2.407 . . . . 0.0 111.908 169.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -118.71 11.99 12.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.928 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.735 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -82.94 160.29 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.676 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.542 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 3.7 pt20 -52.63 -41.67 63.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.386 0.429 . . . . 0.0 111.038 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.905 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 23.4 m-85 -113.66 90.12 3.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.104 0.478 . . . . 0.0 111.062 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 68' ' ' PRO . 6.6 m -150.55 -40.28 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.709 171.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.77 13.82 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.055 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.63 -10.96 56.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.127 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -75.41 -23.18 56.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.14 -13.4 50.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.168 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.82 20.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.676 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -132.42 176.39 8.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.184 0.516 . . . . 0.0 111.089 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 -1.98 54.65 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.828 0.823 . . . . 0.0 109.162 172.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -147.39 38.79 1.07 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.506 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -86.03 -169.89 2.85 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.555 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -115.04 109.29 17.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -177.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 82.0 t -103.34 121.33 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.034 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 67.3 m-85 -101.71 128.55 47.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.813 0.339 . . . . 0.0 110.622 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -116.87 111.39 19.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HE2' ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -100.18 135.71 41.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.838 -176.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 91' ' ' GLU . 3.2 p -159.09 112.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.68 -101.82 0.44 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.865 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -112.99 1.47 15.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.947 0.403 . . . . 0.0 110.492 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.508 ' HB2' HG12 ' A' ' 88' ' ' VAL . 16.0 mm-40 -97.44 134.85 40.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.417 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 m -134.16 93.97 3.17 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 22.9 mmt85 -99.27 141.91 31.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HD2' ' SD ' ' A' ' 83' ' ' MET . 25.1 mtmm -102.78 132.16 49.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 86.6 m-85 -119.84 145.29 46.78 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.965 0.412 . . . . 0.0 111.06 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 17.7 tttt -102.04 133.42 46.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.995 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.3 mtp -86.59 53.37 2.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.503 0.668 . . . . 0.0 109.531 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.67 -14.95 59.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.266 -172.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.7 m -124.18 88.31 2.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.582 176.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.0 mt -107.69 108.75 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.973 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -134.09 150.0 51.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.174 0.511 . . . . 0.0 110.554 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.736 ' HB3' ' HZ2' ' A' ' 140' ' ' LYS . 1.9 p-10 -116.27 144.44 44.22 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.5 134.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.574 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.6 mptt -79.78 130.65 66.55 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 9.3 Cg_exo -73.39 41.42 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.636 2.891 . . . . 0.0 113.034 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -71.42 -34.23 70.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.337 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -161.68 151.8 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.779 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.56 -22.02 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.923 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.92 -5.51 56.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.182 0.515 . . . . 0.0 110.628 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.98 -25.21 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.095 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 pp -105.56 153.12 22.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.104 0.478 . . . . 0.0 111.956 -172.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.31 160.07 42.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.72 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CD ' ' HZ1' ' A' ' 117' ' ' LYS . 10.4 pt-20 -130.52 -179.93 5.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -116.36 161.83 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.327 0.584 . . . . 0.0 112.077 -172.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -90.26 132.3 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.714 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.39 64.38 0.35 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.552 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.511 ' HZ1' ' CD ' ' A' ' 113' ' ' GLU . 34.3 mmtp -89.86 165.98 13.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.712 0.768 . . . . 0.0 111.863 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -108.89 -168.18 1.31 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 55' ' ' GLN . 3.4 mppt? -74.52 102.88 4.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -137.92 142.51 40.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 116.62 32.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m -96.48 94.12 7.2 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.701 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -82.13 107.32 14.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.752 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.73 81.71 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 24.5 m -91.87 96.67 10.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.606 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 95.4 m -71.45 90.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.631 ' OD2' ' HE2' ' A' ' 138' ' ' LYS . 25.9 t0 -80.14 9.32 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.048 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.623 ' HB2' ' HZ1' ' A' ' 138' ' ' LYS . 15.9 t70 . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.574 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.23 0.073 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.631 ' HE2' ' OD2' ' A' ' 127' ' ' ASP . 24.2 pttm -116.06 123.98 49.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 111.579 -174.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 139' ' ' ARG . 37.8 ttm-85 -110.88 103.5 12.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.918 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.736 ' HZ2' ' HB3' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -97.08 101.93 13.6 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 110.332 -177.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.26 130.13 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.626 0.727 . . . . 0.0 111.514 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.53 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 97.9 m-85 -106.16 119.55 39.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.117 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.8 t -105.4 102.33 13.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.17 120.91 43.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.735 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.6 m -92.32 140.26 29.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.59 116.66 6.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.902 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.57 157.33 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.807 0.813 . . . . 0.0 110.569 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.488 -172.257 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 6' ' ' GLN . 62.9 pttt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.787 0.327 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -55.23 117.64 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.984 2.456 . . . . 0.0 111.967 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.507 ' OE1' ' HE3' ' A' ' 4' ' ' LYS . 6.7 tp60 -141.29 169.79 16.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.941 HD12 ' HB3' ' A' ' 52' ' ' LEU . 16.0 mm -97.82 110.83 57.11 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 6.7 Cg_exo -73.78 173.32 14.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.62 2.213 . . . . 0.0 111.4 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -108.39 22.39 16.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.652 0.739 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.85 145.38 47.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.215 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.7 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 1.5 mptt -88.04 -14.23 39.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.655 0.264 . . . . 0.0 111.3 -171.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.0 t -89.16 -17.86 28.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.468 0.651 . . . . 0.0 109.712 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -80.08 86.34 5.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.55 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.43 104.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.743 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 -27.68 25.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -157.61 177.17 34.52 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.175 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 132.58 39.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.54 122.9 55.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.039 0.447 . . . . 0.0 109.862 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mt-10 -135.16 120.27 18.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.437 0.637 . . . . 0.0 111.751 -177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 25' ' ' ILE . 74.1 mt -124.97 103.23 30.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.305 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.17 -22.72 72.97 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.164 2.576 . . . . 0.0 112.854 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.67 -31.38 72.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.041 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.26 3.96 10.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.928 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 63.33 24.65 14.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.606 0.717 . . . . 0.0 110.464 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.2 mt -75.97 112.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.97 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 61.0 mtpt -145.64 95.09 2.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.744 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' CD ' ' HB3' ' A' ' 71' ' ' GLN . 11.9 pt-20 -152.13 155.69 33.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.25 154.41 74.23 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.485 2.123 . . . . 0.0 112.369 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.614 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 62.6 t -97.56 129.64 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -93.21 107.24 24.05 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.992 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 24.2 Cg_exo -64.95 144.69 83.61 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.01 2.474 . . . . 0.0 112.118 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.48 179.56 17.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.697 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.26 145.61 19.17 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.67 99.98 0.17 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -129.05 144.46 52.75 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.297 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.51 -41.05 76.41 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.143 2.562 . . . . 0.0 113.029 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.04 -43.39 87.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.717 0.294 . . . . 0.0 111.173 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.07 -40.25 65.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.81 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.46 -15.84 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.874 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.27 -9.84 58.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.246 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -104.54 -21.51 13.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 -167.19 40.16 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.542 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.567 HG22 HG21 ' A' ' 59' ' ' ILE . 14.8 p -86.93 137.45 20.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.119 0.485 . . . . 0.0 110.242 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 m -139.28 171.67 13.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -82.1 171.13 14.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.396 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -123.67 -33.88 3.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.727 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 1.5 pm0 -81.02 -177.44 6.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.791 -169.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.88 -18.27 16.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.65 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -90.2 134.97 33.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.695 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.07 28.89 0.87 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.054 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.6 m -105.51 160.59 15.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.593 . . . . 0.0 111.078 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.941 ' HB3' HD12 ' A' ' 7' ' ' ILE . 1.5 pp -123.58 -1.97 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.425 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -149.16 54.46 0.97 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.408 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 11.1 p-10 -89.79 -61.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER 178.82 -65.27 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 122.764 0.426 . . . . 0.0 110.688 178.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 97.17 7.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.546 0.689 . . . . 0.0 112.1 -172.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 30.4 mm -103.44 140.5 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.704 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -127.91 96.59 4.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.091 0.472 . . . . 0.0 110.229 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.567 HG21 HG22 ' A' ' 43' ' ' VAL . 1.1 mt -93.13 118.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 136.34 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.725 0.298 . . . . 0.0 111.541 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.74 134.38 7.54 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -136.46 19.83 3.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.408 0.604 . . . . 0.0 111.489 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -88.07 15.94 6.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.539 0.685 . . . . 0.0 111.132 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HD1' HG21 ' A' ' 73' ' ' THR . 88.1 t80 -93.22 94.22 8.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.565 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -164.66 -51.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -96.0 -28.12 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.226 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -111.3 122.6 37.22 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.675 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.18 0.22 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.432 2.755 . . . . 0.0 111.425 171.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.94 50.8 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.71 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.704 ' HD2' ' HG2' ' A' ' 71' ' ' GLN . 2.0 t80 -132.17 -169.12 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.266 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.765 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 2.8 pt20 -33.06 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.765 ' H ' ' HG3' ' A' ' 71' ' ' GLN . 55.3 m-85 -96.15 29.8 2.68 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.95 -0.469 . . . . 0.0 111.7 -169.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.625 HG21 ' HD1' ' A' ' 64' ' ' PHE . 73.4 p -78.08 -41.13 36.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.233 0.539 . . . . 0.0 110.876 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.66 12.69 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.034 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.404 HD23 ' CD1' ' A' ' 72' ' ' PHE . 24.0 tp -63.13 -15.31 56.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.007 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -62.92 -23.29 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.297 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.99 -10.09 59.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.417 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.8 133.87 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.25 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.04 -176.55 3.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.074 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -70.61 -0.75 9.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.847 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.66 62.66 0.54 Allowed Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 p -96.78 -159.1 0.71 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.577 ' HE1' ' HA ' ' A' ' 83' ' ' MET . 2.2 tpt -139.35 89.94 2.38 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.1 t -77.23 117.19 21.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.004 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -98.1 109.35 22.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.293 0.568 . . . . 0.0 110.594 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 33.9 t80 -99.55 99.1 9.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 42.2 mtpt -94.93 140.49 29.87 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.452 -177.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 91' ' ' GLU . 2.9 m -143.83 108.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.857 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.89 -98.18 0.54 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.35 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -124.56 6.86 8.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.49 ' HB2' HG22 ' A' ' 88' ' ' VAL . 14.4 mm-40 -85.04 142.95 29.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -126.1 112.71 16.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.101 0.477 . . . . 0.0 110.026 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 7.9 mmm180 -106.92 120.78 42.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.48 ' HB3' ' HE2' ' A' ' 83' ' ' MET . 17.8 mtmt -96.71 133.72 40.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.503 ' CD2' HD23 ' A' ' 121' ' ' LEU . 94.0 m-85 -130.52 146.21 52.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.187 0.518 . . . . 0.0 111.474 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 14.8 tptm -108.24 127.85 54.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.188 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.437 ' HB3' HD13 ' A' ' 100' ' ' ILE . 65.9 mtp -78.4 70.41 4.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.91 -175.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.3 p -67.92 -42.14 81.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.536 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.7 m -114.15 105.89 13.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 97' ' ' MET . 66.3 mt -126.83 95.05 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.623 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -145.49 152.31 39.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.868 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.806 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 9.3 p-10 -104.06 137.71 41.63 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.083 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.73 139.26 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.27 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 137' ' ' GLU . 82.7 tttt -112.49 90.67 15.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.896 0.379 . . . . 0.0 110.334 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HB2' HG12 ' A' ' 110' ' ' VAL . 97.3 Cg_endo -88.84 -31.85 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.2 m 72.57 -46.73 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.416 0.687 . . . . 0.0 112.16 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.36 162.89 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 110.24 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.4 -34.39 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.416 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.56 80.8 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.447 0.641 . . . . 0.0 111.444 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 105' ' ' PRO . 27.7 m -111.48 -6.2 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.972 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.733 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -146.36 170.1 17.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.654 0.264 . . . . 0.0 110.367 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.75 92.17 5.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.283 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.73 133.99 44.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.958 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mttp 52.3 -172.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.712 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.1 130.92 24.86 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -90.33 -178.65 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.76 -174.55 2.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.618 ' HE3' ' OE1' ' A' ' 146' ' ' GLU . 17.4 mtpp -93.71 95.56 9.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.005 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -145.87 162.51 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.435 -172.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.503 HD23 ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -112.66 120.69 42.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 171.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.5 m -83.16 89.72 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 92.2 mt -76.05 104.44 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.355 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.19 100.17 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.545 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.1 p -109.8 103.79 12.66 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.095 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.7 m -70.22 92.6 0.78 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -134.59 99.41 4.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 39.6 mt-10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.284 0.564 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.806 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 32.8 ttmt -80.25 135.61 36.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 -172.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.24 101.18 13.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HZ2' ' HG3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -83.73 113.07 20.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.113 -175.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.77 136.2 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.677 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 96.5 m-85 -117.16 112.22 20.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.474 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 89.5 t -99.89 111.62 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -110.9 114.11 27.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.545 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -90.69 146.64 23.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.934 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.618 ' OE1' ' HE3' ' A' ' 119' ' ' LYS . 70.4 tt0 -62.92 141.11 58.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.217 0.532 . . . . 0.0 111.934 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 1.4 t -114.62 163.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.023 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.312 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.36 109.57 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.846 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.89 160.9 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.904 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HD11 ' A' ' 7' ' ' ILE . 3.5 mp -70.39 116.88 49.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.18 150.73 71.97 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.198 2.598 . . . . 0.0 113.376 -174.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -70.87 -27.42 63.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.064 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -84.5 159.35 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.782 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.62 22.93 14.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -172.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 t -120.56 -33.02 3.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.68 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -63.52 105.61 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 28' ' ' PRO . 1.3 p -58.2 112.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.999 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.07 24.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.588 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.98 157.6 24.89 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -121.45 131.48 54.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD11 HG11 ' A' ' 84' ' ' VAL . 8.1 tp -105.93 121.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.214 0.53 . . . . 0.0 110.334 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 94.8 mt-10 -129.78 109.64 11.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.468 0.652 . . . . 0.0 111.186 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.475 HD12 HD12 ' A' ' 25' ' ' ILE . 66.5 mt -120.64 99.21 47.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.047 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.43 -35.54 98.57 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.049 2.499 . . . . 0.0 113.128 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.21 -33.57 71.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.472 ' HB1' HG13 ' A' ' 25' ' ' ILE . . . -111.6 7.21 20.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.949 -175.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.07 26.58 16.01 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.585 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.899 HG23 ' HB2' ' A' ' 71' ' ' GLN . 61.6 mt -81.17 115.03 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.824 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 6.1 ttpm? -147.12 61.57 1.18 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.8 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 26.2 mm-40 -121.67 153.37 59.69 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.886 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HB3' HG23 ' A' ' 14' ' ' VAL . 7.8 Cg_exo -70.15 147.98 61.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.526 2.151 . . . . 0.0 111.84 175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.1 t -96.34 123.97 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.491 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.8 m-85 -97.03 102.32 11.79 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.831 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 11.5 Cg_endo -55.42 139.7 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.403 2.735 . . . . 0.0 112.735 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.34 170.22 11.94 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 162.0 37.51 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.71 2.273 . . . . 0.0 112.435 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -65.4 100.4 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.646 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 p -130.62 140.36 38.43 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.065 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.53 -8.39 10.81 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.254 2.636 . . . . 0.0 113.319 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -94.75 -38.93 10.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.616 0.246 . . . . 0.0 110.795 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.08 -37.82 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.422 . . . . 0.0 110.171 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.09 -13.13 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.8 -38.96 92.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.367 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.4 -40.09 89.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.36 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.9 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.832 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 60' ' ' ALA . 2.6 p -138.45 139.59 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.306 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -140.09 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -74.22 140.24 44.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.697 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -87.35 -43.6 12.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.71 177.85 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.096 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.4 55.2 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.867 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.31 89.58 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.073 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.22 7.15 43.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.86 0.838 . . . . 0.0 109.764 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m -130.0 147.92 51.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.541 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.97 7.68 10.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.374 0.607 . . . . 0.0 110.505 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.27 35.71 2.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.617 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 5.9 p-10 -86.8 -95.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.442 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -173.45 -18.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 176.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -112.31 83.25 1.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.282 0.563 . . . . 0.0 109.715 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 40.8 mm -94.6 86.74 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.389 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -91.73 103.65 16.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.254 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.492 HD13 HD22 ' A' ' 121' ' ' LEU . 1.1 mt -101.56 137.58 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.697 ' HB1' ' HB1' ' A' ' 46' ' ' ALA . . . -104.41 123.83 48.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.993 0.425 . . . . 0.0 111.205 -176.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.68 -179.15 16.1 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -159.79 155.97 26.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.428 0.614 . . . . 0.0 110.882 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.17 162.73 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.519 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.51 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 12.7 t80 -146.34 113.2 6.08 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 tp -83.67 -21.12 8.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.885 -170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 57.0 m-20 -82.3 -34.46 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.73 -176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.51 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 32.0 mmm-85 -135.01 120.49 14.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.687 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 2.9 Cg_exo -77.74 -12.52 16.52 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.064 2.509 . . . . 0.0 112.903 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -81.87 16.73 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.908 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.88 -169.12 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.899 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.18 -51.62 3.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.79 0.329 . . . . 0.0 111.5 -178.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.805 ' HD1' ' HG2' ' A' ' 71' ' ' GLN . 9.2 m-85 -84.46 22.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 0.0 111.494 -175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 p -89.95 -34.86 15.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.5 t30 -102.94 19.59 19.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.164 0.507 . . . . 0.0 111.082 -173.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.494 HD13 ' CE2' ' A' ' 142' ' ' PHE . 11.5 mt -64.1 -5.99 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.01 -18.76 60.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.89 5.39 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.422 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.31 145.52 25.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.333 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 8.3 mptt -117.36 173.82 6.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.0 110.253 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -3.17 27.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.756 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.7 25.38 4.73 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.466 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 75.7 m -78.16 -165.12 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.258 0.551 . . . . 0.0 110.443 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -131.35 120.3 22.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.813 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 18' ' ' ILE . 87.3 t -107.41 109.81 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.577 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.05 119.46 32.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.396 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -112.7 110.25 20.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.962 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.46 146.66 27.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 91' ' ' GLU . 3.4 p -156.78 112.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.25 0.548 . . . . 0.0 109.925 174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 -98.24 0.33 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -125.56 6.99 7.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.262 0.554 . . . . 0.0 109.881 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 88' ' ' VAL . 20.1 mm-40 -90.11 139.11 30.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.468 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -145.86 120.57 9.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 3.3 mpt_? -122.14 153.93 38.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -102.83 126.64 50.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.186 -176.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 90.5 m-85 -124.84 155.83 38.81 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 24.7 ttmm -128.62 150.12 50.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.447 ' SD ' ' HB2' ' A' ' 78' ' ' ALA . 48.6 mtp -83.94 59.59 5.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.515 0.674 . . . . 0.0 109.959 -173.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -66.22 -45.43 80.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.175 -172.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.6 m -106.97 100.75 10.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.31 0.576 . . . . 0.0 110.745 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' CG2' ' HE3' ' A' ' 140' ' ' LYS . 59.7 mt -118.31 112.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.596 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.07 141.59 34.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 1.9 p-10 -108.68 121.12 44.37 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.437 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 139' ' ' ARG . 15.7 t -77.96 121.95 31.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.664 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.716 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -103.63 132.7 20.81 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.6 99.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.319 2.679 . . . . 0.0 113.728 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.3 m -126.98 -49.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.681 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.5 144.28 30.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.966 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.04 -28.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -94.85 35.39 1.26 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.667 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.24 8.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.239 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.81 153.27 38.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.594 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -130.09 154.83 47.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.722 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -100.58 6.51 44.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.056 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.18 98.13 9.2 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -96.23 33.5 1.74 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.631 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.88 87.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.416 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -135.22 -173.67 3.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 0.0 110.93 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.78 -161.91 0.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.585 ' HZ3' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.91 103.18 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.61 146.84 52.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.529 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 57' ' ' ILE . 6.2 mp -107.35 109.96 21.83 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.518 HG23 HG22 ' A' ' 143' ' ' VAL . 19.9 m -89.43 99.07 12.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.892 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 81.0 mt -80.05 108.28 13.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 0.0 110.464 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.479 HG23 HH21 ' A' ' 139' ' ' ARG . 58.5 mt -93.77 103.65 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.424 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 m -99.73 129.05 45.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.267 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.9 m -87.12 96.32 10.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.029 170.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 138' ' ' LYS . 3.3 m-20 -89.99 161.68 15.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.52 -0.204 0 O-C-N 123.701 0.626 . . . . 0.0 111.361 170.083 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 127' ' ' ASP . 4.1 ttpm? -80.94 137.75 36.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.779 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 21.3 mmm-85 -125.9 86.43 2.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.515 ' HE3' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -76.09 108.01 8.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 0.0 110.295 -176.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.8 mm -97.11 130.34 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.335 0.588 . . . . 0.0 110.659 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 81.5 m-85 -120.04 101.16 7.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.675 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.5 t -93.04 102.07 13.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -89.97 110.69 21.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.807 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 m -83.85 143.85 29.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.206 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 34.0 tt0 -62.97 129.73 41.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.815 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.82 155.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 pttp . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.456 -174.481 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 tttt . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CG ' ' HB ' ' A' ' 88' ' ' VAL . 31.5 Cg_endo -63.55 126.79 18.3 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.009 2.473 . . . . 0.0 113.147 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -134.48 -171.98 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.181 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.432 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 62.7 mt -110.98 104.62 56.44 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.896 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 31' ' ' PRO . 86.7 Cg_endo -84.46 -170.52 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.122 2.548 . . . . 0.0 112.54 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 37.6 mtmt -84.37 -13.18 53.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 m-20 -94.84 106.58 18.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.729 -172.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.605 ' HD3' ' H ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -82.55 13.48 3.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.092 173.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 p -98.83 -7.93 26.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.661 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -91.34 179.85 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.741 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.77 109.04 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.753 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB2' HD12 ' A' ' 52' ' ' LEU . . . -88.74 -28.93 20.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.248 0.547 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.55 37.29 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.207 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 124.23 37.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tp -99.28 123.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 109.892 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 87' ' ' LYS . 38.3 mt-10 -134.86 128.19 32.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.049 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.4 mt -129.25 96.84 27.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.2 Cg_endo -59.55 -25.31 78.38 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.4 2.733 . . . . 0.0 112.545 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.35 -24.72 67.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.8 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.94 7.14 9.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 58.21 25.42 12.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.299 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 61.3 mt -77.48 131.63 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.012 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -158.71 90.07 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.63 150.24 53.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.273 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.4 152.53 60.68 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.861 2.374 . . . . 0.0 112.045 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.504 ' HA ' HG13 ' A' ' 43' ' ' VAL . 47.7 t -106.99 132.14 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.1 m-85 -91.39 111.07 47.02 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.744 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 Cg_endo -62.66 116.39 3.5 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.238 2.625 . . . . 0.0 112.63 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.48 -179.55 37.71 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.71 154.87 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.599 2.199 . . . . 0.0 112.073 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.86 131.52 44.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 111.072 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 t -155.96 148.5 17.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.807 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.27 -37.69 24.8 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.797 2.998 . . . . 0.0 112.88 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 74.0 mm-40 -62.84 -52.12 64.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.125 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 11' ' ' LYS . 13.1 mm100 -65.37 -42.91 92.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.699 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.23 -6.16 32.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.567 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -100.33 -10.13 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 0.0 109.934 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 62.8 mtt180 -111.65 -37.7 5.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.249 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.15 -166.78 36.51 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 29' ' ' VAL . 6.3 p -90.6 137.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.24 0.543 . . . . 0.0 111.074 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -134.6 -171.87 2.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.704 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.47 ' CZ ' HD23 ' A' ' 52' ' ' LEU . 77.3 m-85 -99.25 156.0 17.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.003 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.69 -66.98 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.248 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 43.3 mt-10 -82.49 121.11 26.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.915 0.388 . . . . 0.0 110.879 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.88 -1.25 27.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.682 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.74 -6.66 17.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.187 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 22.5 tt0 -86.38 158.79 19.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.577 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.7 m -122.17 142.38 50.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.762 0.315 . . . . 0.0 111.712 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 57' ' ' ILE . 14.3 mt -64.35 -12.49 42.88 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.024 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -119.39 26.28 9.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.859 0.838 . . . . 0.0 109.806 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 2.9 t70 -95.58 -166.58 1.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.296 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.757 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.7 pt20 -81.09 -34.08 32.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.719 0.295 . . . . 0.0 110.675 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -122.39 146.66 47.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 52' ' ' LEU . 7.9 mm -128.63 108.02 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.536 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -91.49 105.89 18.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 HG21 ' CG2' ' A' ' 43' ' ' VAL . 1.3 mt -103.59 140.03 22.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.96 126.01 48.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.793 0.33 . . . . 0.0 110.899 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -140.99 -177.32 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -138.07 122.15 17.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.547 0.674 . . . . 0.0 111.93 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 5.6 m -79.25 154.48 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.966 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 67' ' ' ARG . 4.1 t80 -164.72 86.0 0.43 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.0 mt -59.19 -35.64 58.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.347 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -68.56 -23.13 64.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 0.0 111.717 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -116.14 102.42 53.74 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.889 -178.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.604 ' HA ' HG21 ' A' ' 73' ' ' THR . 32.2 Cg_exo -59.28 -23.93 72.01 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.994 2.463 . . . . 0.0 112.685 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -88.63 13.93 11.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -92.8 -172.15 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.124 173.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.412 HE22 ' HB ' ' A' ' 43' ' ' VAL . 45.0 mt-30 -74.93 -81.44 0.07 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.558 0.694 . . . . 0.0 112.347 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 90.9 m-85 -89.82 37.11 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.211 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.604 HG21 ' HA ' ' A' ' 68' ' ' PRO . 2.8 m -62.14 -29.13 70.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.975 0.417 . . . . 0.0 110.975 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -102.04 6.38 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.37 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.709 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 1.8 tm? -61.19 -27.53 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.362 0.601 . . . . 0.0 109.529 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -56.1 -24.42 40.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.945 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -87.31 0.19 55.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.04 165.33 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.78 -176.78 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.014 0.435 . . . . 0.0 110.744 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -1.61 25.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.495 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.92 27.28 5.44 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 74.9 m -82.67 155.59 24.28 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.381 0.61 . . . . 0.0 109.704 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.482 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -97.94 111.82 23.98 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.212 -176.515 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.29 116.5 36.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.64 130.53 54.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.509 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -121.15 106.47 11.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HZ2' ' CD ' ' A' ' 19' ' ' GLU . 14.7 mtmm -86.25 136.8 33.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.93 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 91' ' ' GLU . 3.2 m -139.87 93.14 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.0 -117.2 4.64 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.12 -9.54 33.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.505 0.669 . . . . 0.0 109.941 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 1.5 mm-40 -77.62 144.17 37.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.482 0.658 . . . . 0.0 111.218 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -141.47 97.54 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.471 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -80.3 135.39 36.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.316 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 20.7 mtmm -103.48 125.17 49.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 146' ' ' GLU . 85.3 m-85 -123.22 150.6 43.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HZ1' ' HB ' ' A' ' 98' ' ' THR . 25.3 ttpp -114.05 139.2 49.47 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 82' ' ' SER . 69.4 mtp -83.88 50.6 1.85 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 109.934 -174.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.483 ' HB ' ' HZ1' ' A' ' 96' ' ' LYS . 1.8 t -78.43 2.46 18.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.253 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.533 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.8 m -145.18 102.6 3.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.77 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.98 137.04 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.556 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 34.0 ttm-85 -154.02 157.89 39.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.369 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.424 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 7.1 p-10 -129.44 137.34 50.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 139' ' ' ARG . 26.5 m -117.57 -177.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.342 . . . . 0.0 111.456 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' HZ1' ' HB ' ' A' ' 110' ' ' VAL . 26.2 pttm -90.65 154.92 46.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.334 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 137' ' ' GLU . 74.2 Cg_endo -77.51 178.84 7.13 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.874 2.383 . . . . 0.0 112.431 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.6 p 54.02 23.61 4.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.656 0.782 . . . . 0.0 111.92 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -165.44 141.32 5.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.05 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.5 -2.99 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 112' ' ' ASP . 12.3 pt-20 -93.77 -3.1 52.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.528 -174.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.509 HG11 ' HB ' ' A' ' 103' ' ' VAL . 4.9 p -56.04 -39.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.75 100.89 5.44 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.107 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 109' ' ' GLU . 37.9 t0 -152.93 -169.78 3.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.627 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.503 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 10.2 pt-20 42.27 63.69 1.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.138 0.899 . . . . 0.0 111.077 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 116' ' ' GLY . 1.3 mp0 -61.94 132.95 54.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.019 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.88 36.02 0.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.423 0.63 . . . . 0.0 109.921 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . 107.58 143.59 10.95 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.372 -175.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.54 168.77 18.97 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.4 t70 -127.41 -161.32 1.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -102.63 83.4 2.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.685 0.755 . . . . 0.0 109.511 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -165.37 177.12 7.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.794 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 15.7 mt -107.6 132.45 53.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.3 m -101.14 86.27 2.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.584 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.1 mp -79.95 110.87 15.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.361 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.6 mt -96.64 93.88 3.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.508 ' HB ' ' HE2' ' A' ' 142' ' ' PHE . 13.9 m -123.55 71.4 1.08 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.961 0.41 . . . . 0.0 110.699 -174.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.37 120.31 7.44 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 75.5 m-20 -65.73 -41.64 91.99 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.505 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.022 -179.394 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 105' ' ' PRO . 39.5 mt-10 . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 120.882 0.372 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -79.85 96.34 6.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.376 0.608 . . . . 0.0 111.371 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 103' ' ' VAL . 40.1 mmm-85 -80.61 103.27 10.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.815 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.522 ' HD2' ' CZ ' ' A' ' 142' ' ' PHE . 8.3 mmtp -96.35 129.45 43.68 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 tp -123.33 123.24 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.624 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 70.7 m-85 -112.92 109.58 19.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.334 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 95.8 t -93.94 102.89 14.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.0 110.03 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -106.96 101.14 10.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.146 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 120' ' ' GLN . 3.1 m -83.81 143.51 29.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 44.9 tt0 -60.99 129.8 43.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.2 0.524 . . . . 0.0 111.593 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.48 160.49 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.324 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 75.2 mttt . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.696 -169.629 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HZ2' ' CD ' ' A' ' 91' ' ' GLU . 20.4 ptmt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.521 ' O ' HD21 ' A' ' 52' ' ' LEU . 61.7 Cg_endo -79.31 114.72 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.665 2.243 . . . . 0.0 113.273 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 52' ' ' LEU . 11.0 tp60 -95.82 89.23 5.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.737 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.488 HD13 ' O ' ' A' ' 50' ' ' GLU . 76.8 mt 24.98 91.57 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 125.068 1.48 . . . . 0.0 113.657 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.5 -179.93 5.9 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.664 2.243 . . . . 0.0 112.581 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -75.09 -44.6 46.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.075 0.464 . . . . 0.0 110.897 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.99 140.71 37.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.851 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -109.67 18.9 19.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.807 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -90.9 -17.31 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.156 0.503 . . . . 0.0 110.37 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.82 154.78 19.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG22 ' CB ' ' A' ' 28' ' ' PRO . 6.9 p -97.68 135.7 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.96 -21.14 13.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.637 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.78 174.9 37.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.249 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -126.73 139.95 52.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.217 0.207 . . . . 0.0 110.628 178.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.41 127.91 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.5 mt-10 -136.21 122.31 20.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.042 0.448 . . . . 0.0 111.561 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.474 HD13 HD13 ' A' ' 25' ' ' ILE . 67.7 mt -129.55 95.57 29.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -58.34 -33.59 97.9 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.082 2.522 . . . . 0.0 112.702 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.09 -15.66 63.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.131 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.38 4.87 9.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 60.63 26.17 15.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.982 0.42 . . . . 0.0 111.628 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.6 mt -86.26 120.2 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 22.8 ttmm -156.09 98.61 1.89 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' A' ' 71' ' ' GLN . 12.5 pt-20 -152.0 156.89 34.3 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.585 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.44 ' CB ' HG22 ' A' ' 14' ' ' VAL . 57.3 Cg_endo -74.15 152.34 45.21 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.608 2.205 . . . . 0.0 112.043 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.05 132.79 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -93.94 111.36 52.69 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.47 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 12.2 Cg_endo -56.98 130.88 42.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.031 2.488 . . . . 0.0 111.848 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.9 174.33 16.08 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.55 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.24 169.94 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.432 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 39' ' ' LEU . . . -73.7 121.78 21.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.908 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.805 ' H ' HD22 ' A' ' 39' ' ' LEU . 2.2 t -161.01 141.38 8.36 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -38.43 -66.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.487 3.458 . . . . 0.0 115.489 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -28.9 69.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.45 ' HB3' HG23 ' A' ' 35' ' ' THR . 7.1 tp60 -72.55 -52.23 16.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.389 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.805 HD22 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -65.47 -20.95 66.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.469 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.37 -29.3 67.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.9 0.381 . . . . 0.0 110.412 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -82.35 -38.78 23.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.76 -158.63 21.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.611 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.413 HG23 ' OE2' ' A' ' 27' ' ' GLU . 41.0 t -77.41 141.31 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.714 0.293 . . . . 0.0 110.804 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -142.36 167.33 22.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m-85 -87.58 176.57 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.973 0.416 . . . . 0.0 111.405 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.73 -40.19 7.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.189 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 42.8 mt-10 -108.69 141.55 40.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.42 -0.86 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.141 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.19 -13.03 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.68 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' O ' HD13 ' A' ' 7' ' ' ILE . 13.1 pt-20 -63.25 131.92 49.95 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 16.7 m -94.29 121.29 35.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.894 0.378 . . . . 0.0 110.745 -173.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.66 ' HA ' HD12 ' A' ' 57' ' ' ILE . 1.3 pp -71.13 -5.56 32.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.48 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -110.84 2.76 18.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.109 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.0 t70 -108.08 -156.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.774 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.551 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 48.7 tt0 -91.46 -42.79 10.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.941 0.496 . . . . 0.0 111.88 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -91.75 123.33 35.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 111.489 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 52' ' ' LEU . 24.2 mm -132.4 132.75 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.153 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.448 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 7.2 p -139.67 84.83 2.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.268 0.556 . . . . 0.0 110.506 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.498 ' HB ' HD22 ' A' ' 123' ' ' LEU . 3.2 mt -92.36 140.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.667 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.12 154.12 17.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.323 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.535 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -157.79 156.47 27.34 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.071 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.403 ' HE1' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 p80 -150.08 168.86 22.68 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.423 -0.457 . . . . 0.0 111.059 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.86 5.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.631 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.592 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 27.8 m-85 -145.03 171.08 14.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 171.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.0 -20.72 5.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.369 0.604 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.88 -40.24 9.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.833 -175.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.632 ' HG3' ' H ' ' A' ' 69' ' ' ASN . 18.1 tpt180 -96.61 127.04 41.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.057 -168.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.512 ' C ' HG23 ' A' ' 73' ' ' THR . 93.6 Cg_endo -91.12 7.96 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.986 2.457 . . . . 0.0 111.551 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.632 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 21.6 m120 -125.38 20.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.147 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 19.4 p90 -86.37 166.42 15.6 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.704 172.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.559 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 1.7 pt20 -25.46 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.535 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 50.6 m-85 -113.39 45.91 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 68' ' ' PRO . 32.5 p -72.98 -51.81 16.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.449 0.642 . . . . 0.0 110.835 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -88.69 17.25 5.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.65 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.439 ' O ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -60.25 -25.71 65.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.829 179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -65.6 -25.06 67.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.733 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.49 -11.1 59.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.805 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.647 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -84.05 140.98 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.862 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -105.79 176.79 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.308 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -75.25 0.45 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.281 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.09 21.92 5.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.822 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -85.6 165.02 17.38 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.466 0.651 . . . . 0.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.434 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -99.9 123.66 44.4 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.51 -174.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.876 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -115.2 127.03 72.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.747 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.9 m-85 -115.4 137.16 52.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -122.36 121.25 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 14.9 ttmm -108.6 140.42 41.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.454 -173.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.69 111.28 8.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.97 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.92 -104.43 1.02 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.073 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -116.28 -1.78 12.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 110.911 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' CD ' ' HZ2' ' A' ' 4' ' ' LYS . 92.5 mt-10 -87.85 139.86 30.09 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.434 ' OG1' ' HG3' ' A' ' 87' ' ' LYS . 36.5 m -145.71 116.81 7.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.645 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -91.02 152.14 20.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.529 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -111.18 123.16 49.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.354 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.64 152.58 39.16 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 36.5 ttmt -107.21 149.57 27.58 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.688 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 62.7 mtp -84.12 70.7 10.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 110.451 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.5 p -70.64 -46.5 63.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.784 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 10.5 m -118.48 110.33 17.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.971 0.415 . . . . 0.0 111.073 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 97' ' ' MET . 43.7 mt -126.32 89.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -125.87 143.4 51.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.2 0.524 . . . . 0.0 111.51 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 13.2 t70 -101.94 116.45 32.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.074 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.444 HG21 ' HD3' ' A' ' 105' ' ' PRO . 19.7 m -133.3 178.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 0.0 111.244 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 50.3 mtpt -133.17 81.26 57.05 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.72 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HG2' ' HD2' ' A' ' 139' ' ' ARG . 17.4 Cg_endo -93.98 107.39 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.476 2.784 . . . . 0.0 111.359 170.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -80.77 -24.21 38.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.878 0.37 . . . . 0.0 111.357 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.482 ' OD1' HG22 ' A' ' 110' ' ' VAL . 18.0 t70 -88.38 143.67 26.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.236 0.541 . . . . 0.0 111.431 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.63 19.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.49 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.83 -47.9 2.39 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG22 ' OD1' ' A' ' 107' ' ' ASP . 20.1 m -76.44 -4.31 6.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.7 60.33 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.425 . . . . 0.0 111.328 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.06 149.79 32.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.475 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.37 33.57 20.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.864 0.84 . . . . 0.0 110.05 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -72.37 96.0 1.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.857 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 115' ' ' LYS . 13.4 ptpt -76.56 151.58 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.534 -175.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.76 84.73 1.81 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.869 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.84 161.33 25.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -155.57 -176.68 6.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 90.1 3.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 15.6 pt20 -146.08 133.74 21.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 57' ' ' ILE . 37.5 mt -86.29 99.69 11.75 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 6.4 m -77.14 89.4 3.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.93 0.395 . . . . 0.0 109.987 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 142' ' ' PHE . 23.7 mt -91.2 108.18 19.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.01 147.66 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.596 ' HB ' ' CG ' ' A' ' 140' ' ' LYS . 22.9 m -146.43 98.83 3.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.534 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 139' ' ' ARG . 3.4 m -56.74 109.14 0.58 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.607 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 2.1 t70 -89.21 -23.9 22.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.531 -170.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.828 178.513 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 21.3 ttpp -90.43 137.72 32.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.076 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.607 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 12.1 ptp180 -153.46 138.21 17.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.121 0.486 . . . . 0.0 110.408 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.596 ' CG ' ' HB ' ' A' ' 125' ' ' THR . 5.0 ptpp? -89.39 144.17 26.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -119.54 119.43 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 CA-C-O 121.938 0.875 . . . . 0.0 109.853 170.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.876 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.0 t80 -105.89 113.43 26.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.307 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.8 t -104.62 113.09 40.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.968 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -100.03 111.86 24.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.2 m -90.3 144.61 25.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.97 135.19 48.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.79 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.37 168.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.928 0 CA-C-O 118.936 -0.555 . . . . 0.0 110.359 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.639 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 68.7 Cg_endo -74.74 151.23 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.194 1.929 . . . . 0.0 111.841 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.518 ' NE2' ' HA ' ' A' ' 51' ' ' SER . 6.6 tp60 -132.22 172.51 12.32 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 52' ' ' LEU . 89.6 mt -114.72 103.51 54.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 111.714 -174.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -94.52 -159.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.468 2.779 . . . . 0.0 111.048 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -99.15 11.91 37.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.964 0.412 . . . . 0.0 110.525 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -78.38 98.91 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.189 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.2 16.72 21.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -93.95 -34.5 13.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.371 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.68 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -97.79 160.39 14.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.427 175.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.41 118.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.41 -42.44 12.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 109.963 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.719 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.83 171.32 23.62 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.005 -172.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.15 121.96 18.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.353 -0.423 . . . . 0.0 109.915 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.91 117.97 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.812 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 3.0 pt-20 -129.25 112.48 13.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.795 0.807 . . . . 0.0 111.806 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 55.7 mt -116.39 100.69 53.64 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.769 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 18.9 Cg_endo -58.88 -27.93 85.82 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.02 -21.26 63.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.724 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.89 15.3 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.31 26.93 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.89 0.852 . . . . 0.0 110.73 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.3 mt -95.72 118.52 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.99 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 40.4 mtpt -144.87 81.78 1.66 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.876 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 48.8 mm-40 -124.15 152.09 66.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.06 153.18 46.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.563 2.175 . . . . 0.0 112.835 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 48.7 t -113.26 130.97 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.21 112.29 62.87 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.951 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HB3' HG22 ' A' ' 7' ' ' ILE . 26.2 Cg_exo -62.18 139.31 77.38 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.324 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.95 173.64 13.43 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.03 151.03 73.27 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.287 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.29 157.79 21.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.764 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 38' ' ' GLN . 2.8 t -176.11 150.94 1.1 Allowed Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -46.54 -37.23 19.75 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.102 2.535 . . . . 0.0 112.669 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.28 -46.75 85.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.26 0.552 . . . . 0.0 111.192 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 35' ' ' THR . 55.3 tp60 -72.75 -37.13 67.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.775 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -77.72 -15.06 59.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.135 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.55 -18.9 56.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.546 0.688 . . . . 0.0 109.209 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -90.58 -46.07 8.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.78 -138.66 2.99 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.275 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 60' ' ' ALA . 85.5 t -112.57 137.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.379 . . . . 0.0 110.402 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -150.28 165.95 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.908 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -71.99 134.5 45.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.311 -176.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.4 65.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -128.17 118.41 23.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.378 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 50' ' ' GLU . 2.5 mp0 -54.85 -38.44 67.46 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.493 0.495 . . . . 0.0 110.439 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 70.8 -22.67 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.738 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 48' ' ' GLU . 43.0 tt0 82.34 -22.7 0.24 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.559 1.143 . . . . 0.0 111.326 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.518 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 66.9 m -128.74 141.68 51.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.309 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -103.22 -14.86 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -99.15 25.15 7.07 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.934 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.49 -167.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.745 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -115.19 -29.03 6.74 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.174 -0.329 . . . . 0.0 111.495 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.475 ' H ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -108.18 97.33 7.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.069 0.938 . . . . 0.0 111.125 -178.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 21.6 mm -116.62 138.36 47.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.985 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 t -128.67 113.71 15.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.858 0.361 . . . . 0.0 110.206 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 3.4 mt -111.1 128.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -101.52 142.86 32.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.85 27.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.282 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -124.14 144.65 49.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 127' ' ' ASP . 67.8 p -111.47 169.16 9.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.673 0.273 . . . . 0.0 110.747 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 22.7 t80 -154.55 134.87 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.24 -48.19 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.37 . . . . 0.0 111.742 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.8 t70 -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 53.8 mmm-85 -99.3 106.62 40.12 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 -174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 3.2 Cg_exo -76.83 -4.18 14.64 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.541 2.828 . . . . 0.0 111.206 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -74.27 -23.18 59.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.24 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 64.5 m-85 -74.21 116.26 14.64 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.069 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.876 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 5.1 pt20 -48.91 -41.92 35.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.559 ' CZ ' HD22 ' A' ' 123' ' ' LEU . 10.2 m-30 -78.64 -2.58 39.77 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.225 -0.297 . . . . 0.0 111.789 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 16.8 m -68.42 -34.74 76.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.693 0.282 . . . . 0.0 110.946 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.05 14.72 22.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.625 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.08 -15.3 59.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -22.44 62.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 111.015 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.81 -6.81 56.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.537 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.56 131.12 47.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -111.64 177.7 4.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.702 -175.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -56.06 -21.14 20.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.007 -175.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.49 43.53 1.45 Allowed Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.165 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 m -95.41 -177.27 4.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.142 0.496 . . . . 0.0 109.779 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.51 ' HE1' ' HA ' ' A' ' 83' ' ' MET . 1.8 tpt -118.36 104.56 10.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.403 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.02 107.01 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.729 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.812 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . 58.8 m-85 -89.28 117.9 28.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.268 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -104.17 99.27 9.0 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -97.06 146.16 25.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.342 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 7.6 p -162.0 118.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.141 0.496 . . . . 0.0 109.686 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.639 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 60.63 -111.49 3.76 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -107.87 2.09 23.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.16 0.505 . . . . 0.0 110.089 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.98 141.52 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 m -141.47 98.01 3.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.242 0.544 . . . . 0.0 110.346 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.2 134.02 52.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.908 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 28.8 mtmt -103.58 140.4 37.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -169.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.535 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.7 m-85 -131.11 147.82 52.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.847 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -105.84 148.81 27.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.537 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 66.4 mtp -82.77 72.05 9.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.402 0.62 . . . . 0.0 110.478 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.4 p -72.3 -42.19 65.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.614 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.57 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 31.5 m -113.09 99.97 8.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 111.629 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.99 76.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -93.58 155.57 17.22 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.867 0.841 . . . . 0.0 112.831 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.531 ' OD2' ' HE3' ' A' ' 138' ' ' LYS . 9.9 t70 -109.72 100.83 9.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.695 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.28 145.59 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.046 0.451 . . . . 0.0 110.659 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -95.19 140.42 22.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.52 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.96 127.91 19.58 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.53 2.154 . . . . 0.0 111.972 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.44 HG21 HG13 ' A' ' 110' ' ' VAL . 1.9 t -153.99 -55.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.586 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.671 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . 30.0 t70 -142.21 167.59 21.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.563 0.22 . . . . 0.0 110.623 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.37 -45.78 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.689 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.5 31.03 5.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.462 . . . . 0.0 111.207 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 p -81.02 -7.8 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.025 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.43 127.69 35.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.36 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.76 133.27 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.306 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.72 36.22 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.782 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -100.09 142.21 31.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -89.89 166.49 13.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 177.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.0 75.75 1.03 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.568 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.06 167.0 15.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.158 0.504 . . . . 0.0 111.457 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 34.1 t0 -155.5 -166.66 2.3 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' H ' ' CG ' ' A' ' 118' ' ' ASP . 9.3 mttp -74.92 101.75 4.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.942 0.401 . . . . 0.0 110.163 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -142.18 145.67 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.896 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 12.4 mt -107.84 114.35 28.22 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.461 HG22 HG21 ' A' ' 143' ' ' VAL . 23.7 m -89.08 95.64 10.4 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -83.35 120.35 25.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.527 0.68 . . . . 0.0 110.526 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.69 HG21 HH22 ' A' ' 139' ' ' ARG . 61.9 mt -79.6 86.1 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 1.9 m -98.04 100.15 11.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.536 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.9 m -81.32 -25.8 36.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -94.56 167.57 11.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 111.302 -174.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.485 171.559 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.605 0.717 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.531 ' HE3' ' OD2' ' A' ' 102' ' ' ASP . 29.2 mtmm -112.94 -172.81 2.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.811 -167.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.69 HH22 HG21 ' A' ' 124' ' ' ILE . 28.6 ttt-85 -114.58 66.33 0.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.819 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.632 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -69.53 96.86 0.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.231 0.539 . . . . 0.0 109.962 -179.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.6 tt -85.6 139.79 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 144' ' ' ALA . 15.6 t80 -114.86 124.26 51.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.038 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.6 t -121.05 123.96 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . . . -106.34 130.27 54.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.295 -176.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.8 m -99.58 137.25 38.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.993 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.407 ' OE1' ' HD3' ' A' ' 119' ' ' LYS . 37.6 tt0 -65.0 121.8 15.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.134 0.492 . . . . 0.0 111.181 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.12 161.23 4.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.69 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HB3' ' H ' ' A' ' 3' ' ' ALA . 2.4 mp0 -122.68 -164.7 1.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.466 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' H ' ' HB3' ' A' ' 2' ' ' GLN . . . -163.22 -179.43 6.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -70.11 120.19 76.56 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.202 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.82 161.48 36.28 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.617 2.211 . . . . 0.0 112.555 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -114.24 173.42 6.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 70.8 mt -106.92 101.11 35.61 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.776 0.322 . . . . 0.0 111.129 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 97.9 Cg_endo -87.59 178.4 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.846 2.364 . . . . 0.0 112.272 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -86.61 -30.74 21.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.1 t70 -60.51 129.54 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.192 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.568 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 43.1 mmtm -96.55 13.21 28.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.896 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -91.74 -21.86 20.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.343 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 45.6 mmtm -91.65 163.31 14.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.651 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.91 116.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.52 -33.92 15.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.19 152.82 24.88 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.729 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.24 122.91 48.88 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 27' ' ' GLU . 9.6 tp -93.55 115.08 31.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.698 0.761 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 42.5 mt-10 -127.92 115.69 18.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.033 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 66.2 mt -122.96 102.49 37.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.652 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -59.23 -33.92 98.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.414 2.743 . . . . 0.0 113.552 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.12 -24.46 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.712 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.47 7.74 16.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.266 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 59.89 25.81 14.98 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.178 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.4 mt -84.61 124.63 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.991 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -144.15 80.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.0 mm-40 -125.43 142.42 41.68 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.161 0.505 . . . . 0.0 111.899 -172.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.69 138.57 38.37 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.064 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 64.1 t -98.38 132.81 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -92.85 105.34 14.47 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.397 0.618 . . . . 0.0 110.51 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 47.2 Cg_endo -69.22 145.94 61.93 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.276 2.651 . . . . 0.0 113.071 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' NZ ' ' A' ' 11' ' ' LYS . . . 129.08 -168.95 20.6 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.804 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.42 162.18 33.75 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.769 2.313 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.8 126.21 31.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.973 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' HD21 ' A' ' 39' ' ' LEU . 47.6 p -132.05 133.94 24.55 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.89 -36.6 27.29 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.471 2.781 . . . . 0.0 113.362 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.567 ' HG2' ' HD2' ' A' ' 41' ' ' ARG . 38.7 tt0 -66.28 -54.25 27.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.568 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 51.1 tp60 -65.43 -34.41 78.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 35' ' ' THR . 4.4 mm? -68.54 -7.87 36.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -101.61 -7.11 23.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.749 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HD2' ' HG2' ' A' ' 37' ' ' GLU . 53.8 mtp180 -104.32 -32.64 8.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.949 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -154.99 9.75 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.241 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' A' ' 72' ' ' PHE . 59.4 t -105.96 133.82 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.83 0.348 . . . . 0.0 110.472 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -135.72 162.04 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 86.5 m-85 -74.01 149.46 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.244 0.545 . . . . 0.0 111.561 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.82 -14.0 23.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.877 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -79.9 133.6 36.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.228 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -83.42 -6.37 59.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.838 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 51' ' ' SER . 0.1 OUTLIER -90.28 128.76 36.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 -177.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' HA ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -74.98 17.67 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.059 0.457 . . . . 0.0 112.167 -176.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 49' ' ' ASN . 36.8 m -104.15 107.7 18.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.223 0.535 . . . . 0.0 111.618 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 57' ' ' ILE . 1.3 pp -91.05 6.27 45.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.784 0.802 . . . . 0.0 109.433 172.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.43 -9.11 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.625 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.22 159.39 28.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.237 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 3.9 pm0 -86.34 -13.34 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 0.0 110.899 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -105.44 105.94 16.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.123 0.487 . . . . 0.0 110.545 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 52' ' ' LEU . 19.9 mm -115.79 101.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.532 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -93.87 125.72 38.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.44 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -127.37 142.67 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.57 147.13 43.1 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.086 -0.384 . . . . 0.0 111.467 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.21 -171.62 22.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.014 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -136.63 157.68 46.2 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.565 -0.373 . . . . 0.0 110.818 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 6.7 t -79.07 -172.05 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.584 -175.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 35.4 p90 -109.04 142.09 40.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.329 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.28 -90.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.68 -23.73 16.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 109.873 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.39 114.58 65.03 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.189 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HA ' HG22 ' A' ' 73' ' ' THR . 88.5 Cg_endo -82.43 8.78 4.33 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.841 2.36 . . . . 0.0 111.476 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.76 14.61 20.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.902 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.511 ' HB2' HG23 ' A' ' 73' ' ' THR . 40.5 m-85 -89.53 143.14 27.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -69.03 -8.03 41.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 43' ' ' VAL . 43.5 m-85 -130.1 33.06 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.72 0.295 . . . . 0.0 111.392 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 68' ' ' PRO . 13.4 p -64.73 -34.94 79.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.396 . . . . 0.0 111.645 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -99.9 13.13 34.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.5 -12.21 50.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 110.494 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HD3' ' CZ ' ' A' ' 64' ' ' PHE . 20.1 pttp -63.69 -26.7 68.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.233 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.13 -41.44 25.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.529 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.81 137.76 54.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.073 -173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 8.4 mptt -103.66 173.62 6.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.05 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -74.31 -1.92 22.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.741 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.35 34.04 3.16 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.443 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.6 t -97.78 -172.71 2.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.424 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -119.05 121.7 40.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.297 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.68 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 96.8 t -107.6 110.26 31.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.525 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -95.08 113.85 25.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -102.98 98.71 8.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -94.57 113.06 24.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.214 -172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.96 101.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.595 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.53 -94.52 0.28 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.147 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -119.2 -14.71 9.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.73 125.25 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -101.4 107.1 18.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.852 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -97.04 117.17 30.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.528 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.529 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.6 125.46 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 110.959 -176.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 64.0 m-85 -121.09 148.81 43.67 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -110.0 138.64 46.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.583 ' HE3' HD11 ' A' ' 100' ' ' ILE . 61.2 mtp -76.88 54.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.966 -173.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.1 p -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 7.5 m -116.4 102.0 9.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.012 0.434 . . . . 0.0 111.028 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD11 ' HE3' ' A' ' 97' ' ' MET . 71.4 mt -126.76 125.28 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.648 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 101' ' ' ARG . 14.2 ttp180 -165.68 144.27 6.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.162 0.506 . . . . 0.0 109.865 170.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.975 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 3.1 p-10 -101.7 110.59 22.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.668 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 139' ' ' ARG . 27.0 m -98.63 175.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.449 0.643 . . . . 0.0 112.112 -172.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -85.28 155.41 60.17 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.905 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.47 -174.97 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.735 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m 74.3 -59.49 0.55 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.499 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.13 103.79 10.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.477 . . . . 0.0 111.282 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.48 -21.41 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.448 0.642 . . . . 0.0 109.433 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.82 27.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.835 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 103' ' ' VAL . 10.2 p -61.9 -28.59 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.76 141.27 51.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.366 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -85.76 120.14 26.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.69 141.38 32.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 110.868 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 173.54 13.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.415 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -90.91 -3.54 57.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.0 111.768 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.76 80.44 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -129.46 179.69 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 111.038 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.38 -172.75 2.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 41.9 mttt -71.3 100.84 2.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -135.34 138.06 43.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.088 0.47 . . . . 0.0 111.134 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.5 mt -95.62 114.41 26.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m -96.89 95.08 7.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.94 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.5 mp -93.82 125.83 38.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 0.0 111.619 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.75 91.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.71 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -101.33 98.07 8.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 0.0 110.867 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 122.86 18.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.638 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.739 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -88.11 25.08 1.67 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.25 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -169.11 160.23 9.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -171.82 103.11 0.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.423 . . . . 0.0 111.719 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -113.04 107.96 16.68 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 168.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.93 -24.08 66.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.735 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.09 -58.22 5.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.479 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 p -92.32 -16.2 26.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 111.116 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.03 49.07 8.96 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.046 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.41 152.96 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -147.17 123.55 10.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.307 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.85 -9.26 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.975 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 39.4 ttmt -162.4 142.37 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.736 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' NH2' ' O2 ' ' A' ' 201' ' ' 2W7 . 8.4 ptp85 -119.0 108.93 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.256 171.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 1.2 tmtp? -87.86 102.57 14.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -87.8 128.15 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.664 0.745 . . . . 0.0 110.65 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.68 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -127.73 116.92 20.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 78.7 t -113.65 117.83 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.503 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -105.34 118.64 37.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.522 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 m -92.04 141.17 28.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.191 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.443 ' CD ' ' HD3' ' A' ' 119' ' ' LYS . 29.3 tt0 -65.63 134.52 53.43 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 111.488 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.02 165.57 3.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.042 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttp . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.213 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.55 ' O2 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.891 0.377 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.93 -9.16 26.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.78 -179.92 3.77 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.142 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -56.32 143.93 63.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.89 138.31 62.4 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 111.954 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.8 tp60 -152.55 159.12 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.88 102.06 5.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 89.4 Cg_endo -83.52 172.47 10.28 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.634 2.223 . . . . 0.0 112.967 -174.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.61 -24.55 19.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -75.07 102.5 4.9 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.062 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -80.46 8.9 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.219 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 p -89.21 -9.4 50.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.401 0.619 . . . . 0.0 109.494 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -91.47 157.51 17.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.415 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -98.96 104.9 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -67.85 -37.34 81.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.936 0.398 . . . . 0.0 110.991 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.35 174.65 41.19 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.264 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.99 130.87 53.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 18' ' ' ILE . 7.2 tp -97.67 109.98 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.639 0.733 . . . . 0.0 109.417 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 39.0 mt-10 -123.1 109.27 13.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.628 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 HD11 HD11 ' A' ' 25' ' ' ILE . 65.0 mt -122.53 101.89 39.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.599 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.44 -23.49 75.05 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 123.022 2.482 . . . . 0.0 112.394 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -68.43 -20.3 64.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.666 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB2' HG13 ' A' ' 25' ' ' ILE . . . -133.08 14.38 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.37 32.32 21.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.021 0.439 . . . . 0.0 111.426 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 71' ' ' GLN . 64.1 mt -87.53 129.29 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.253 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 23.7 ttmm -161.95 81.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.119 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 35.9 mt-10 -143.58 158.46 56.99 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.292 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 58.3 Cg_endo -70.91 156.89 59.52 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.683 2.256 . . . . 0.0 112.605 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -112.07 132.32 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.84 111.99 57.79 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-O 121.404 0.621 . . . . 0.0 111.245 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 60.9 Cg_endo -73.82 133.58 18.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.179 2.586 . . . . 0.0 112.396 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.5 -168.51 29.13 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.589 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.03 153.94 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.846 2.364 . . . . 0.0 111.831 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -62.08 101.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.353 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.6 p -132.32 152.21 79.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.656 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.12 -37.94 95.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.984 2.456 . . . . 0.0 112.67 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.26 -51.23 68.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -75.72 -37.65 59.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.11 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HB3' ' NE2' ' A' ' 62' ' ' HIS . 90.5 mt -76.51 -2.77 33.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -94.19 -10.33 33.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.659 0.742 . . . . 0.0 109.352 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.637 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 2.4 mmp_? -105.03 -25.56 12.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.429 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.65 -129.89 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.965 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 59' ' ' ILE . 20.7 t -95.62 126.69 48.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.786 0.327 . . . . 0.0 110.183 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 m -139.87 150.02 44.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 35.0 m-85 -66.26 168.17 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -103.2 -55.02 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.315 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.79 163.1 12.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.417 . . . . 0.0 110.647 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.4 -23.72 17.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.185 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -76.96 -29.4 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.191 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.87 149.57 49.28 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.065 0.46 . . . . 0.0 110.465 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -154.59 150.13 27.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.55 -7.53 33.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.785 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.27 -30.1 25.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t70 -90.02 -160.51 0.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 20.6 pt20 -109.5 -25.37 10.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.334 -0.229 . . . . 0.0 111.273 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -93.01 120.99 33.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.811 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.499 HG21 HD23 ' A' ' 121' ' ' LEU . 34.2 mm -127.83 129.09 69.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.912 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.3 t -133.51 87.93 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -103.62 127.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.05 36.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.892 0.377 . . . . 0.0 110.779 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.29 165.18 17.34 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 39' ' ' LEU . 14.7 m-70 -130.99 142.62 50.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.936 0.368 . . . . 0.0 111.19 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.962 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.1 m -117.78 120.69 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.35 106.93 17.65 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.89 -26.86 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.874 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -98.9 5.77 47.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.191 0.52 . . . . 0.0 110.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.68 87.82 51.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.043 0.449 . . . . 0.0 110.03 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.521 ' HA ' HG22 ' A' ' 73' ' ' THR . 73.3 Cg_endo -77.09 2.78 7.27 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.177 2.585 . . . . 0.0 113.371 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.12 1.68 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.151 0.501 . . . . 0.0 110.228 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.3 t80 -78.13 138.22 38.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.65 ' HB2' HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -57.96 -44.07 86.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -167.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.44 ' CD1' ' HG2' ' A' ' 71' ' ' GLN . 3.9 m-30 -88.91 6.35 39.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.013 -0.43 . . . . 0.0 112.125 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.962 ' HA ' HG23 ' A' ' 63' ' ' THR . 86.0 m -76.37 -33.93 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.452 . . . . 0.0 110.512 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 76' ' ' LYS . 62.6 t30 -92.23 14.92 14.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.09 21.77 0.17 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.471 0.653 . . . . 0.0 110.868 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -101.52 -23.41 14.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.69 172.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -73.98 -31.84 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.004 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.17 156.86 29.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.045 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -130.83 -173.8 3.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.338 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -11.8 52.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.613 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.532 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.95 55.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.355 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.503 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 70.0 m -109.11 145.42 35.72 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.208 0.528 . . . . 0.0 109.827 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.484 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -81.25 108.71 15.11 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.811 177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.704 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 93.7 t -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.438 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -100.96 117.04 34.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 110.92 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -105.47 101.68 11.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.5 ttpt -98.07 117.54 32.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.08 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 91' ' ' GLU . 3.4 m -113.28 99.87 9.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.343 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.71 -101.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.794 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.81 -2.88 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 109.996 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.559 ' HB2' HG21 ' A' ' 88' ' ' VAL . 7.8 mm-40 -96.61 148.71 22.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.207 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.9 m -134.89 112.4 10.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.765 0.317 . . . . 0.0 110.69 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -101.75 138.89 38.13 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 83' ' ' MET . 19.6 mtmt -99.96 130.02 46.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 86.3 m-85 -127.79 147.17 50.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.547 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 12.1 tppt? -109.34 140.53 42.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.576 ' HE1' HD11 ' A' ' 100' ' ' ILE . 50.2 mtp -77.63 60.16 2.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.206 0.527 . . . . 0.0 110.404 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.0 p -63.51 -36.88 85.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.094 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 73.9 m -124.45 97.37 5.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.502 . . . . 0.0 111.451 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 97' ' ' MET . 69.4 mt -113.18 110.49 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.537 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -146.67 151.65 37.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.828 0.347 . . . . 0.0 110.255 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.43 93.22 5.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.745 0.783 . . . . 0.0 110.475 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.688 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 14.7 m -97.26 95.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.368 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -109.06 90.81 8.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.344 0.592 . . . . 0.0 112.417 -170.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.688 ' HD3' ' O ' ' A' ' 103' ' ' VAL . 94.4 Cg_endo -104.13 -158.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.763 2.975 . . . . 0.0 111.335 172.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -126.48 11.84 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.44 163.99 29.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.303 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 -21.61 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.45 17.11 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 110.936 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 105' ' ' PRO . 19.1 m -66.86 -20.25 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.733 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.87 -178.65 5.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.424 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 3.5 p30 -79.18 167.29 21.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.497 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.53 15.02 22.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.816 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 112' ' ' ASP . 1.7 mp0 -66.75 110.67 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.746 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' H ' ' HD3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -73.57 2.59 7.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.262 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.81 64.96 3.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.636 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -108.48 178.73 4.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.88 -176.79 3.18 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 0.6 OUTLIER -80.14 93.83 5.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.6 148.84 46.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.581 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 57' ' ' ILE . 19.5 mt -94.13 104.25 16.28 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -77.27 84.02 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.4 mt -86.79 102.1 13.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.536 0.684 . . . . 0.0 110.784 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.485 HD11 ' N4 ' ' A' ' 201' ' ' 2W7 . 40.7 mt -79.73 99.9 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 m -87.35 91.78 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.21 0.529 . . . . 0.0 110.12 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.34 101.43 7.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.5 158.28 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.422 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.494 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . 18.2 t0 55.76 93.62 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.755 0.659 . . . . 0.0 111.798 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.669 ' HB2' ' O ' ' A' ' 135' ' ' VAL . 38.4 p90 -167.81 170.45 10.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.739 ' H ' ' HB ' ' A' ' 135' ' ' VAL . 21.5 t-20 -104.45 134.0 48.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.4 -35.68 68.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.201 0.524 . . . . 0.0 111.289 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -86.87 -55.53 3.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.235 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.3 p -75.83 -10.38 59.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.35 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.59 71.24 1.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.319 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.739 ' HB ' ' H ' ' A' ' 130' ' ' ASN . 61.6 t -118.36 146.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.32 79.08 1.63 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG2' HG13 ' A' ' 135' ' ' VAL . 23.5 mm-40 -81.57 -75.48 0.29 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 128' ' ' ASP . 46.9 mmtm -79.52 98.64 6.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.679 0.752 . . . . 0.0 111.026 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.654 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 11.5 mmm-85 -89.86 76.73 7.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.356 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -83.16 112.74 20.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tp -93.25 127.8 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 121.814 0.816 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.704 ' HZ ' HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -118.08 100.56 7.62 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.963 178.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.0 t -98.68 112.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . . . -100.88 116.09 31.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.404 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.7 m -89.03 139.84 30.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.146 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.01 130.11 42.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.94 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.85 162.45 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.8 pttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.503 -0.76 . . . . 0.0 110.66 -177.666 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.485 ' N4 ' HD11 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.504 0.193 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 2' ' ' GLN . 13.9 mm-40 -92.5 25.9 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.351 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.16 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.373 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -62.29 152.4 79.26 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 123.484 0.49 . . . . 0.0 110.699 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.84 107.1 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.978 2.452 . . . . 0.0 113.054 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -140.63 169.31 17.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.934 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.698 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 90.1 mt -121.88 102.62 40.96 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-O 120.75 0.31 . . . . 0.0 110.525 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 5.8 Cg_exo -78.36 144.79 20.73 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.664 2.243 . . . . 0.0 110.606 172.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -89.51 34.08 0.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.35 0.595 . . . . 0.0 110.987 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.42 141.82 30.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.976 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 9.0 mptt -96.0 6.95 47.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.604 -173.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -113.09 -44.93 3.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.14 126.75 31.67 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.494 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.53 116.88 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.576 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . . . -84.89 -37.73 20.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.48 168.32 27.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.86 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.27 135.95 39.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -103.61 125.04 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 37.0 mt-10 -128.68 109.52 11.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.27 0.557 . . . . 0.0 111.29 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.1 mt -121.52 103.07 41.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.95 -43.64 41.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.299 2.666 . . . . 0.0 113.938 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.707 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 3.1 p-10 -76.3 -10.69 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.22 2.09 16.47 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.979 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.65 26.22 15.96 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 79.4 mt -93.04 104.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.429 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 51.3 mttt -137.27 81.23 1.86 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -126.85 150.62 72.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.54 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.77 144.08 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.623 2.215 . . . . 0.0 112.309 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.559 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 87.9 t -94.45 132.63 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.533 ' HB2' ' HG ' ' A' ' 44' ' ' SER . 23.8 m-85 -92.06 105.68 14.72 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 121.304 0.573 . . . . 0.0 110.453 -176.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 97.7 Cg_endo -80.6 140.75 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.001 2.467 . . . . 0.0 112.75 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.4 -170.36 29.64 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 72.1 Cg_endo -76.9 149.06 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.468 2.112 . . . . 0.0 111.802 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.8 98.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.566 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -134.34 142.0 41.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.19 -30.81 43.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.363 2.709 . . . . 0.0 113.208 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 38' ' ' GLN . 10.2 pt-20 -59.99 -30.92 69.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.709 0.29 . . . . 0.0 111.59 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.447 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 16.0 mm100 -101.06 -42.57 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.837 0.351 . . . . 0.0 111.024 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 3.9 mm? -74.15 -2.7 25.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -99.88 -9.52 22.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -93.43 -55.88 3.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.886 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.99 -120.83 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.833 -175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG22 ' NE2' ' A' ' 71' ' ' GLN . 35.1 t -109.71 126.63 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.881 0.372 . . . . 0.0 110.688 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HG ' ' HB2' ' A' ' 30' ' ' TYR . 50.1 m -146.54 158.03 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.928 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.064 0.459 . . . . 0.0 111.018 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.74 -12.04 54.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.207 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 46.7 mt-10 -101.08 121.32 41.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.773 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 43.6 mt-10 -65.06 -33.59 76.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.296 -172.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.05 125.52 31.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.164 0.507 . . . . 0.0 110.653 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.698 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 2.7 mp0 -63.27 108.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.481 -175.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -150.35 139.99 21.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD22 HG13 ' A' ' 7' ' ' ILE . 1.5 pp -130.17 6.8 4.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.923 0.392 . . . . 0.0 111.237 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.86 33.49 1.98 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.74 179.94 4.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' NE2' ' HB2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -72.5 -47.48 48.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.11 126.21 51.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.257 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.74 95.07 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.239 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 7.5 m -86.95 111.54 20.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -122.96 120.24 60.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.49 142.75 31.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.724 0.297 . . . . 0.0 110.437 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.58 124.16 4.57 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 39' ' ' LEU . 28.8 t-80 -84.75 132.76 34.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 127' ' ' ASP . 15.1 t -153.25 175.32 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 m-85 -140.95 138.0 33.48 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.224 0.327 . . . . 0.0 110.122 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -17.31 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.835 0.826 . . . . 0.0 108.933 174.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -83.88 -21.05 32.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.089 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 9.6 mmt180 -124.54 111.99 27.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.57 1.58 8.93 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.233 2.622 . . . . 0.0 110.876 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -86.88 14.01 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.334 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.52 -177.29 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.051 0.453 . . . . 0.0 111.639 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' NE2' HG22 ' A' ' 43' ' ' VAL . 10.8 mt-30 -93.97 -31.01 14.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.837 -170.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.38 24.01 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.475 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.9 p -73.96 -38.06 64.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.863 0.364 . . . . 0.0 111.657 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -93.14 18.73 8.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.085 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.07 -10.86 57.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.982 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -22.15 52.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.23 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.63 -4.29 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.621 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.707 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.79 159.6 15.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.086 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 8.9 mptt -121.04 172.59 7.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 111.025 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -74.56 -4.84 39.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.132 -176.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.64 24.92 5.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.792 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -84.74 -173.78 4.91 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.331 0.586 . . . . 0.0 110.3 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.15 107.76 12.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.6 t -93.11 106.05 17.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.014 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.576 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 85.5 m-85 -90.18 128.01 36.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.673 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.08 108.22 15.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -92.36 140.14 29.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.123 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.418 HG21 HD23 ' A' ' 52' ' ' LEU . 8.5 p -163.67 128.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.903 0.382 . . . . 0.0 111.327 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.85 -87.94 0.08 OUTLIER Glycine 0 C--N 1.329 0.169 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.979 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -135.78 0.23 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.095 0.158 . . . . 0.0 111.391 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.34 169.06 11.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 m -148.05 110.73 4.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.913 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -95.51 154.55 17.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.511 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.47 117.44 34.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.535 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -109.4 153.61 23.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.719 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -112.95 150.75 31.4 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.709 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 57.5 mtp -86.72 66.13 9.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.388 0.613 . . . . 0.0 109.978 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -70.44 -37.66 74.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.213 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.4 m -127.07 95.79 4.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.099 0.476 . . . . 0.0 111.482 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD13 ' HB3' ' A' ' 97' ' ' MET . 42.9 mt -110.31 111.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.614 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -139.07 151.24 46.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.842 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.92 126.01 39.97 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.922 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 25.3 t -131.52 93.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.115 0.483 . . . . 0.0 110.933 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 4.3 mtmt -90.44 153.28 46.11 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 6.8 Cg_exo -74.56 14.69 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.272 2.648 . . . . 0.0 113.346 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -70.89 -30.89 67.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.518 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.98 107.88 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.867 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG21 ' HG3' ' A' ' 109' ' ' GLU . 26.9 m -92.93 -176.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' A' ' 108' ' ' VAL . 44.3 mt-10 67.73 6.75 5.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.034 0.533 . . . . 0.0 111.31 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.675 HG13 ' HG ' ' A' ' 111' ' ' LEU . 5.8 p -64.32 -34.11 67.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.675 ' HG ' HG13 ' A' ' 110' ' ' VAL . 1.2 pp -138.31 147.74 43.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.738 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.484 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 9.5 m-20 -112.23 165.21 12.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 111.203 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -98.17 72.76 2.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.399 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -117.77 157.24 26.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.327 -177.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -82.74 -170.23 2.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.692 177.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.86 6.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.423 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 29.2 mmtp -131.54 -165.01 1.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.6 t70 -104.89 -157.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' H ' ' CG ' ' A' ' 118' ' ' ASP . 41.5 mttp -68.11 95.39 0.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.12 0.486 . . . . 0.0 110.708 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -105.5 126.56 52.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.107 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 106.06 18.06 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 m -83.26 91.48 7.29 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.572 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD11 ' CD2' ' A' ' 142' ' ' PHE . 32.1 mt -84.25 97.52 9.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.378 0.609 . . . . 0.0 110.271 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mt -80.76 96.22 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -96.52 86.53 4.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.664 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.2 m -73.03 108.53 5.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.591 ' HA ' HG22 ' A' ' 63' ' ' THR . 19.7 t70 -83.61 -21.93 32.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.183 -168.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.506 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 38.3 m-20 -139.27 138.89 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -152.99 134.72 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -118.64 120.97 39.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -68.07 -48.87 64.36 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.698 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 132' ' ' LYS . 9.1 tmtm? -59.44 -63.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.103 0.478 . . . . 0.0 111.331 -170.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.2 p -73.89 -12.04 60.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.424 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.84 57.15 10.2 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.777 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.64 146.51 32.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.487 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CD1' ' HD3' ' A' ' 139' ' ' ARG . 2.7 p90 -129.5 104.13 7.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.57 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 12.9 mm-40 -57.04 -57.84 10.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.011 -172.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -121.57 136.89 54.92 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.773 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 15.7 mtm180 -123.49 127.87 48.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.406 ' HZ1' ' HG3' ' A' ' 140' ' ' LYS . 0.7 OUTLIER -106.6 105.01 14.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.28 121.75 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.703 0.763 . . . . 0.0 110.53 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.709 ' HE1' ' HA ' ' A' ' 97' ' ' MET . 6.2 t80 -119.33 109.85 16.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.988 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 53.9 t -102.09 107.19 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.952 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.605 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -94.56 134.29 37.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.5 m -103.66 136.13 43.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.301 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -67.92 121.87 16.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.247 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.4 164.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.699 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.452 179.612 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.484 ' O2 ' ' HD2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.204 0.526 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -123.49 -96.84 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.725 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.0 -178.48 2.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.559 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -62.47 116.27 21.94 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 123.413 0.445 . . . . 0.0 110.581 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 150.97 25.41 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.467 2.112 . . . . 0.0 112.136 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.443 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 mm-40 -118.65 179.25 4.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.871 HD11 ' HB3' ' A' ' 52' ' ' LEU . 3.8 mp -91.37 106.39 16.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 77.8 Cg_endo -96.63 -168.7 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.269 2.646 . . . . 0.0 113.391 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -74.9 -20.92 59.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.607 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.512 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -79.37 105.25 10.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.457 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 23.4 mttp -87.71 -29.34 21.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 110.661 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.4 p -73.9 -13.11 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.542 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 32.1 mmtp -87.18 80.74 8.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.58 113.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.511 0.672 . . . . 0.0 111.189 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.57 -34.12 41.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.79 26.7 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.461 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.82 124.09 41.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.76 118.91 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.541 0.686 . . . . 0.0 110.104 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.566 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 46.6 mt-10 -132.32 123.76 27.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.972 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.78 101.34 29.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.59 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.1 -27.62 85.27 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.958 2.438 . . . . 0.0 112.513 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 82' ' ' SER . 8.9 m-20 -63.07 -27.52 69.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HB1' HG13 ' A' ' 25' ' ' ILE . . . -121.47 10.45 10.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.426 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.31 28.82 18.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.475 HG13 ' HB1' ' A' ' 23' ' ' ALA . 75.8 mt -85.56 129.21 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.487 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 22.7 ttmm -152.52 78.03 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -133.24 148.08 67.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.277 -172.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.71 162.11 30.19 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.783 2.322 . . . . 0.0 112.436 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 63.8 t -114.56 129.39 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.41 110.7 53.96 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.822 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 16.9 Cg_exo -66.43 110.76 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.071 2.514 . . . . 0.0 112.069 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.62 168.5 35.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.582 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.15 144.94 38.36 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.873 2.382 . . . . 0.0 111.899 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.95 109.93 0.83 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.996 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -139.65 147.0 50.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.94 -42.33 67.64 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.063 2.508 . . . . 0.0 113.228 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.38 -18.54 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -86.52 -43.3 12.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.78 -8.16 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.515 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.0 -17.5 63.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.638 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.0 -64.86 1.02 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.638 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.14 -113.32 0.29 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.95 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.79 130.53 57.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.1 m -144.34 158.08 43.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -69.71 150.94 46.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 111.347 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.43 -62.79 1.43 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -170.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.927 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.28 39.12 1.12 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.59 90.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.89 -18.36 65.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.764 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.673 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 17.9 m -96.85 110.23 22.77 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.102 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 7' ' ' ILE . 3.6 pp -81.91 -10.0 59.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.59 0.709 . . . . 0.0 109.494 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -100.6 11.07 40.27 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.003 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.6 t70 -82.04 177.41 8.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -83.09 -44.04 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.74 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' H ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -97.29 117.93 32.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.776 . . . . 0.0 111.034 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.0 136.47 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 m -125.69 112.8 16.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.442 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' HB ' HD23 ' A' ' 123' ' ' LEU . 2.8 mt -121.38 139.07 49.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.992 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 121.57 44.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -123.27 77.07 0.36 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.306 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.757 ' CE1' ' HB2' ' A' ' 129' ' ' TYR . 3.5 t-80 -74.46 121.68 21.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.002 0.43 . . . . 0.0 110.438 -175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.699 HG23 ' HB3' ' A' ' 70' ' ' TYR . 21.7 m -112.71 166.73 11.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.824 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.552 ' HE1' ' HB3' ' A' ' 129' ' ' TYR . 63.7 m-85 -127.99 116.5 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 tt -55.8 -31.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.527 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 34.3 t70 -66.87 -24.73 66.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 80.2 mtt180 -111.56 93.04 18.22 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 26.5 Cg_exo -62.1 -21.76 73.02 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.369 2.712 . . . . 0.0 113.516 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -91.24 22.43 3.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.835 0.35 . . . . 0.0 111.617 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.699 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.1 OUTLIER -84.2 173.41 11.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 172.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 19.2 pm0 -65.84 -59.07 4.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.588 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 56.3 m-85 -99.97 26.58 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.925 -0.484 . . . . 0.0 112.143 -171.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 p -67.22 -37.4 83.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.122 0.487 . . . . 0.0 111.32 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.1 t30 -98.6 13.8 30.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.46 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.86 -7.89 13.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.49 0.662 . . . . 0.0 110.56 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -68.34 -23.84 64.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.737 174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 -5.28 58.63 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.443 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.27 170.4 16.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.04 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -143.99 177.67 8.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.018 0.437 . . . . 0.0 110.854 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.52 1.17 17.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.294 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -150.15 48.68 0.58 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.094 176.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.495 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 17.4 p -86.26 -158.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.222 0.534 . . . . 0.0 110.635 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.503 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -129.11 112.0 13.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.991 176.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.9 t -105.74 119.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.189 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.41 118.32 36.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.95 0.405 . . . . 0.0 110.935 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -106.54 107.2 18.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.765 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -94.9 139.07 31.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 113.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.527 0.68 . . . . 0.0 110.883 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 -86.5 0.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.021 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.25 2.14 1.86 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.19 0.519 . . . . 0.0 110.506 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.87 145.89 37.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.502 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 m -131.02 109.41 10.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.914 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' A' ' 95' ' ' TYR . 4.7 ptm180 -106.77 148.39 28.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.291 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 22.9 mtmt -105.6 141.55 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 -169.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.488 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 95.5 m-85 -129.74 150.06 51.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -116.44 128.22 55.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.303 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -71.43 79.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.981 0.419 . . . . 0.0 110.198 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -82.92 -20.53 35.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.784 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.564 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.6 t -128.68 111.69 13.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -120.14 113.79 41.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.515 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -151.43 163.05 39.85 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.56 133.93 47.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.999 0.428 . . . . 0.0 110.19 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.72 137.9 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.232 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.89 150.79 74.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.313 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.81 71.86 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.729 2.286 . . . . 0.0 111.181 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -143.26 93.8 2.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.312 0.577 . . . . 0.0 110.954 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 54.46 51.45 14.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.333 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -13.24 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.518 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.93 30.64 4.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.076 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.58 -8.46 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.633 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.29 134.53 48.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.799 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.482 ' OD1' ' HG2' ' A' ' 114' ' ' GLN . 11.6 p30 -107.87 -164.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.53 20.22 14.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.482 ' HG2' ' OD1' ' A' ' 112' ' ' ASP . 58.0 mm-40 -71.72 115.95 11.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.113 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.62 69.9 3.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.231 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.35 45.54 3.28 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -93.49 163.77 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.289 -0.455 . . . . 0.0 110.602 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.45 -166.72 1.02 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.535 ' N ' ' HE3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -76.44 101.96 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 161.78 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.536 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -118.47 115.55 24.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -82.7 102.29 11.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.485 HD23 ' HB ' ' A' ' 59' ' ' ILE . 84.8 mt -98.16 107.51 20.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.266 0.555 . . . . 0.0 111.248 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mt -81.18 96.43 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 p -105.61 52.25 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.301 0.572 . . . . 0.0 111.762 -171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 35.2 m -73.83 152.6 40.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.295 178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.513 ' HB2' ' HE ' ' A' ' 139' ' ' ARG . 14.9 t0 -118.82 -54.62 2.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.75 0.786 . . . . 0.0 109.273 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.607 ' OD1' ' HB2' ' A' ' 139' ' ' ARG . 4.3 p-10 -54.02 121.32 7.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.581 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.757 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 84.0 t80 -168.13 114.07 0.67 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.713 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.482 ' HB3' HG12 ' A' ' 135' ' ' VAL . 40.1 t30 -87.88 109.21 19.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.623 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 8.2 pt-20 -64.26 -18.57 64.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -64.49 -49.37 71.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.963 0.411 . . . . 0.0 110.401 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.3 p -102.96 -34.97 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.884 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.48 ' HA2' ' CE1' ' A' ' 129' ' ' TYR . . . 89.26 44.97 4.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.473 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.482 HG12 ' HB3' ' A' ' 130' ' ' ASN . 11.0 p -95.93 144.81 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -126.07 139.18 53.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.733 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.39 -64.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.558 0.218 . . . . 0.0 111.486 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -176.86 130.54 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.607 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 20.5 tpt180 -161.28 -82.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HD2' ' CE1' ' A' ' 142' ' ' PHE . 14.5 mmtp -157.67 143.35 17.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -167.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.8 tt -135.59 139.39 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.775 166.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' HD2' ' A' ' 140' ' ' LYS . 66.6 m-85 -128.2 125.09 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 46.5 t -110.96 107.84 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.71 113.64 26.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.967 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.8 m -83.67 141.63 31.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.21 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -67.89 128.07 35.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.104 0.478 . . . . 0.0 111.007 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.459 HG23 ' HB2' ' A' ' 96' ' ' LYS . 2.0 t -92.77 166.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.765 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.349 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.521 ' N3 ' ' S2 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.764 0.316 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -99.12 -8.48 25.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.904 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.98 156.41 30.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.709 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -89.84 128.23 51.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.493 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 55.4 Cg_endo -71.2 113.34 3.56 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.532 2.155 . . . . 0.0 112.212 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 32.8 mm-40 -121.13 -166.03 1.3 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.613 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.621 HD12 ' HB3' ' A' ' 52' ' ' LEU . 36.0 mt -106.85 96.61 15.03 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 86.6 Cg_endo -95.77 -169.39 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.029 2.486 . . . . 0.0 113.13 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -82.88 12.59 4.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.64 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 9.5 t70 -108.64 125.65 52.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -109.78 12.39 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.948 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.5 t -106.99 -2.72 20.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.368 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 49.4 mmtm -97.24 178.38 5.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.482 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.66 117.27 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -88.14 -34.21 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.1 31.06 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.607 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.06 129.97 40.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.3 123.67 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.29 0.567 . . . . 0.0 110.346 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 30.5 mt-10 -121.43 121.69 38.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.361 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.2 mt -129.34 94.12 33.97 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.904 172.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.4 Cg_endo -54.7 -33.37 79.81 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.288 2.659 . . . . 0.0 112.407 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.6 -31.43 69.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.45 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.38 11.79 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.917 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.35 27.24 16.91 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.401 0.438 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 64.2 mt -91.24 119.9 39.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -139.3 58.16 1.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.799 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 21.1 mm-40 -108.8 145.01 30.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.281 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 157.9 33.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.828 2.352 . . . . 0.0 112.406 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.463 ' HA ' HG11 ' A' ' 43' ' ' VAL . 60.7 t -111.71 131.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.62 114.21 57.87 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.918 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.607 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -67.07 140.2 53.41 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.099 2.533 . . . . 0.0 112.201 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -168.08 24.98 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.731 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.35 160.23 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.436 2.758 . . . . 0.0 112.038 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.145 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.517 ' H ' HD21 ' A' ' 39' ' ' LEU . 5.1 t -161.82 144.87 9.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.315 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -41.1 -50.63 4.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.527 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -62.5 -46.07 90.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.921 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.65 -48.83 73.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.879 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -78.69 20.65 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.18 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.67 -4.62 8.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 41' ' ' ARG . 46.0 mtp85 -124.85 -32.49 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.346 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.09 -162.1 14.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.074 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.729 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 6.8 p -95.82 140.5 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.3 m -138.9 176.6 8.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -90.51 140.5 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.077 0.465 . . . . 0.0 111.262 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.5 -3.68 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.88 154.86 28.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.318 -172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.32 19.25 14.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.62 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -71.34 172.12 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.422 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.41 7.86 35.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.358 0.599 . . . . 0.0 110.837 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.525 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 54.0 m -154.06 152.28 30.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.642 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.621 ' HB3' HD12 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -103.94 -7.07 20.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.205 0.526 . . . . 0.0 110.609 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.525 ' OD1' ' HB3' ' A' ' 51' ' ' SER . 9.8 p-10 -95.34 10.25 36.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.605 -178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.74 168.84 19.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.481 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.45 -32.58 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.351 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.38 111.61 24.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.868 0.842 . . . . 0.0 110.847 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 21.0 mm -135.43 102.33 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.839 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 17.1 m -83.06 106.85 15.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 6.4 mt -99.13 111.45 28.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.782 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.427 ' HB1' ' H7 ' ' A' ' 201' ' ' 2W7 . . . -80.42 96.44 6.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -103.02 85.01 0.49 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.198 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 70' ' ' TYR . 86.1 t60 -55.58 138.77 46.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -114.77 147.71 39.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.077 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.522 ' HE2' ' HG2' ' A' ' 67' ' ' ARG . 17.0 t80 -143.82 83.45 1.75 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.721 ' HA ' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -67.56 -13.86 17.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.92 -172.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.04 -51.85 49.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.418 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HG2' ' HE2' ' A' ' 64' ' ' PHE . 5.6 mmp_? -92.38 116.12 65.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HA ' HG23 ' A' ' 73' ' ' THR . 39.5 Cg_endo -66.83 -15.66 47.83 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.187 2.591 . . . . 0.0 114.301 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.21 12.98 32.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.536 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 43.8 t80 -80.33 156.45 26.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 75.3 mt-30 -52.11 -49.09 64.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.826 0.345 . . . . 0.0 111.64 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.729 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 82.1 m-85 -116.34 92.64 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.049 0.452 . . . . 0.0 110.283 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 65' ' ' ILE . 24.3 m -133.3 -46.11 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.255 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.14 16.11 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -57.45 -25.09 59.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.748 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -55.8 -23.86 32.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.024 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.93 2.68 45.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.29 176.26 8.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.022 0.439 . . . . 0.0 110.642 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -148.75 -178.23 6.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.351 -178.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.05 -16.19 59.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 -175.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -139.34 45.24 1.03 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.308 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 5.7 p -85.67 -162.05 0.68 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.532 ' HA ' ' HE3' ' A' ' 83' ' ' MET . 1.1 tpt -129.51 98.25 4.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.078 0.465 . . . . 0.0 109.819 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' SD ' ' A' ' 97' ' ' MET . 97.1 t -84.85 126.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.038 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.3 m-85 -104.98 116.73 32.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.931 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.415 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 52.6 t80 -110.3 111.68 23.14 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.483 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -102.46 140.63 36.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.448 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.462 HG23 HD12 ' A' ' 52' ' ' LEU . 2.6 p -140.69 111.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.246 0.546 . . . . 0.0 109.881 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.523 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 63.82 -98.06 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.501 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.38 0.35 10.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.209 0.528 . . . . 0.0 110.414 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.407 ' HB2' HG11 ' A' ' 88' ' ' VAL . 33.1 mm-40 -94.27 157.43 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.389 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -150.2 129.92 13.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.75 152.92 32.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -103.04 137.98 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.48 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 96.8 m-85 -128.58 145.48 51.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.06 0.457 . . . . 0.0 111.286 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.517 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 11.6 tppt? -112.04 129.17 56.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.493 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.558 ' SD ' HG22 ' A' ' 84' ' ' VAL . 75.6 mmm -78.87 48.29 0.82 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.259 0.552 . . . . 0.0 110.329 -176.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 t -84.58 6.81 22.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.955 -171.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 58.8 m -136.25 106.72 6.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.013 171.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.87 96.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 101' ' ' ARG . 25.3 mtm180 -145.17 138.24 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.566 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 8.2 p-10 -108.2 175.12 5.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.342 0.591 . . . . 0.0 111.659 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.21 147.59 14.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.744 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -110.61 132.55 21.52 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 5.9 Cg_exo -78.98 67.7 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 112.876 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 p -67.54 -28.49 67.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.61 0.719 . . . . 0.0 109.647 172.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.98 160.33 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.082 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.61 -23.63 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.346 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -100.85 29.19 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 111.047 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.645 HG21 ' HG ' ' A' ' 111' ' ' LEU . 29.8 m -66.64 -17.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.261 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.645 ' HG ' HG21 ' A' ' 110' ' ' VAL . 72.0 mt -131.33 -175.31 3.66 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.4 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -146.73 -167.91 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.96 88.62 7.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.07 0.462 . . . . 0.0 110.101 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -74.95 105.99 6.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.743 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.03 -15.55 61.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.021 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.44 80.71 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.039 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -96.78 168.08 10.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.3 0.571 . . . . 0.0 110.911 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.92 -166.86 2.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -78.16 94.71 4.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.57 137.99 16.72 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.5 mt -101.5 122.72 44.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.7 m -84.0 82.67 8.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.297 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 7.7 mp -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.788 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mt -83.99 78.56 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.609 ' HG1' ' HD2' ' A' ' 142' ' ' PHE . 23.0 m -78.19 88.26 4.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 139' ' ' ARG . 31.0 p -109.6 112.71 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.365 0.602 . . . . 0.0 112.202 -173.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 26.7 t70 -108.08 164.45 12.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 127' ' ' ASP . 3.5 t70 76.22 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.424 0.63 . . . . 0.0 112.145 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -176.36 157.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.066 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.434 ' HB3' HG13 ' A' ' 135' ' ' VAL . 47.3 t-20 -123.31 119.52 30.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.36 -31.48 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.692 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -72.19 -65.12 0.82 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.274 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 p -79.35 -43.31 23.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.58 57.21 1.0 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.151 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 130' ' ' ASN . 12.3 p -120.3 152.69 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -151.03 135.46 16.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.93 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -118.73 -76.23 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -78.45 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -164.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 126' ' ' CYS . 5.4 mpt_? -109.12 91.05 3.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.595 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.6 OUTLIER -90.11 96.81 10.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.81 -174.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -77.44 135.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.633 0.73 . . . . 0.0 110.499 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.609 ' HD2' ' HG1' ' A' ' 125' ' ' THR . 63.7 m-85 -120.01 109.23 15.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.657 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 51.1 t -97.5 102.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.04 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -99.73 112.6 24.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.132 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -77.74 139.0 39.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.909 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 119' ' ' LYS . 41.6 tt0 -65.05 132.97 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 110.977 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.04 153.4 11.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.1 pttp . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.33 -173.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.427 ' H7 ' ' HB1' ' A' ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -160.27 174.77 13.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.164 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.32 177.28 8.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.284 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -75.84 113.22 25.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.006 0.431 . . . . 0.0 110.15 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' O ' HD12 ' A' ' 52' ' ' LEU . 66.5 Cg_endo -78.72 133.74 11.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.706 2.27 . . . . 0.0 112.821 -175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.574 HE22 ' HB2' ' A' ' 53' ' ' ASP . 87.6 mm-40 -94.01 160.58 14.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.669 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 31' ' ' PRO . 58.4 mt -59.9 109.84 2.31 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.712 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 96.8 Cg_endo -96.16 -178.66 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.508 2.806 . . . . 0.0 114.238 -170.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 33.3 ttmt -64.01 -44.55 92.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.009 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 1.6 m-20 -75.64 108.6 8.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.414 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HD2' ' HA2' ' A' ' 32' ' ' GLY . 45.7 mmtm -83.67 5.25 25.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.01 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -97.86 -4.05 37.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.2 mmtp -91.9 105.41 17.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG21 ' CB ' ' A' ' 28' ' ' PRO . 5.1 p -62.14 121.27 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.734 0.778 . . . . 0.0 111.101 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 52' ' ' LEU . . . -89.15 -28.63 19.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.464 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.12 27.62 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.659 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -117.6 141.23 48.61 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp -117.3 127.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.089 0.471 . . . . 0.0 109.848 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 41.1 mt-10 -134.97 122.93 22.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 -176.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.36 104.7 19.72 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.765 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.73 -32.92 96.42 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.359 2.706 . . . . 0.0 113.811 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.56 -29.97 70.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.961 0.41 . . . . 0.0 111.559 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.44 ' HB2' HG13 ' A' ' 25' ' ' ILE . . . -112.24 2.14 16.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.074 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.07 27.48 17.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.699 0.762 . . . . 0.0 110.184 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 60.7 mt -81.71 118.08 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.663 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -141.05 83.79 1.9 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.415 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.61 150.36 76.1 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.086 0.47 . . . . 0.0 111.36 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' CB ' HG21 ' A' ' 14' ' ' VAL . 60.4 Cg_endo -73.46 140.11 29.6 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.864 2.376 . . . . 0.0 112.433 175.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.552 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.4 t -88.7 134.62 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.51 104.02 18.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.398 0.618 . . . . 0.0 111.097 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HB2' HG21 ' A' ' 7' ' ' ILE . 61.7 Cg_endo -76.76 109.39 2.84 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.83 2.353 . . . . 0.0 111.442 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.606 ' HA2' ' HD2' ' A' ' 11' ' ' LYS . . . 177.18 -162.0 29.88 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.452 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.31 149.39 17.0 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.182 2.588 . . . . 0.0 112.028 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.556 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -73.41 120.21 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.495 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -159.61 135.35 6.05 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.01 -47.81 11.68 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.935 3.09 . . . . 0.0 113.93 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -56.21 -46.78 79.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.315 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -77.22 -35.63 55.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.337 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.27 -14.24 62.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -87.97 -15.6 36.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.154 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 41' ' ' ARG . 63.2 mtt180 -87.28 -40.31 14.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.92 -172.55 44.04 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.224 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' ALA . 2.1 m -67.77 125.01 24.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.703 0.763 . . . . 0.0 111.973 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.9 m -130.17 146.03 51.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.925 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 63.8 m-85 -59.25 135.89 57.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.207 0.527 . . . . 0.0 111.664 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -92.92 3.12 56.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.803 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 42.6 mt-10 -121.32 147.94 45.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.22 80.36 7.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.758 0.79 . . . . 0.0 109.827 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -114.95 149.31 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.313 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 1.5 mp0 -94.4 7.12 46.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.217 0.532 . . . . 0.0 110.734 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -149.77 151.68 34.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.119 0.485 . . . . 0.0 111.56 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -120.71 16.89 11.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.726 174.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.574 ' HB2' HE22 ' A' ' 6' ' ' GLN . 26.8 t70 -88.19 -11.9 45.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.151 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -77.9 -167.48 1.0 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.58 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -117.6 -11.63 10.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' C ' HD21 ' A' ' 56' ' ' ASN . 0.2 OUTLIER -137.22 90.07 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -174.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG21 HD13 ' A' ' 121' ' ' LEU . 4.0 tt -121.92 148.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 -175.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -99.51 122.09 42.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.526 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.0 mt -123.53 131.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' VAL . . . -102.15 146.05 28.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.673 0.273 . . . . 0.0 110.613 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.78 171.43 29.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.181 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -127.75 138.42 52.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.623 HG23 ' HZ3' ' A' ' 140' ' ' LYS . 1.2 p -94.26 -86.1 0.28 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 43.1 p90 -161.6 155.1 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.534 0.683 . . . . 0.0 112.684 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 mm -127.49 -72.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.262 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 2.3 m-20 -129.24 14.44 6.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.1 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -104.31 101.0 24.32 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.508 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.626 ' HA ' HG23 ' A' ' 73' ' ' THR . 97.4 Cg_endo -89.7 0.56 5.74 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.413 2.742 . . . . 0.0 112.685 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -104.33 22.81 14.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.392 0.615 . . . . 0.0 110.026 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 20.5 t80 -104.47 155.98 18.34 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -56.25 21.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.311 -174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 65.8 m-85 -79.9 9.19 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.626 HG23 ' HA ' ' A' ' 68' ' ' PRO . 7.0 m -72.71 -26.44 61.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.154 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -94.87 4.91 53.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.51 -16.0 63.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.476 . . . . 0.0 110.509 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -22.66 65.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.804 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.47 -14.66 59.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.027 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.44 173.61 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -177.71 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.249 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -66.47 -10.95 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.973 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.28 55.12 0.66 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.189 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.625 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 62.3 m -111.11 137.68 48.48 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.214 0.531 . . . . 0.0 109.734 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.5 ' HE2' ' HA ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -80.69 104.33 11.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.341 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.684 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 90.2 t -96.14 124.29 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.054 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 83.1 m-85 -99.42 122.98 43.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -116.05 116.52 28.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.524 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 9.1 ttmt -113.16 135.12 54.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.951 -172.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 91' ' ' GLU . 3.0 m -141.77 100.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.625 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.25 -83.15 0.53 Allowed Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.612 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -14.21 6.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 109.648 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HB2' HG21 ' A' ' 88' ' ' VAL . 58.0 mt-10 -93.07 136.44 33.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.649 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 m -140.85 101.61 4.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.14 161.88 13.37 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.504 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -102.97 125.17 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 65.5 m-85 -121.54 144.95 48.43 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.523 ' HD2' ' HB ' ' A' ' 98' ' ' THR . 36.7 ttmt -108.46 145.37 34.75 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.679 ' HB3' HD13 ' A' ' 100' ' ' ILE . 56.3 mtp -81.67 46.88 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.378 0.609 . . . . 0.0 109.604 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 4.4 t -81.67 8.67 9.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.448 -168.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.6 m -145.25 93.03 2.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.582 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 97' ' ' MET . 66.8 mt -126.73 137.04 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.762 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -165.43 147.78 7.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.786 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 24.8 t70 -89.85 93.11 9.3 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.45 86.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.872 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.45 126.24 78.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.58 ' HD3' ' HG2' ' A' ' 139' ' ' ARG . 77.1 Cg_endo -76.58 46.23 1.81 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.166 2.578 . . . . 0.0 113.727 -171.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 t -76.72 -14.28 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.6 144.67 25.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.093 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.19 4.88 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -119.67 24.61 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.426 0.631 . . . . 0.0 110.081 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.73 15.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.841 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.28 162.89 13.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.279 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.89 149.24 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.33 -40.38 97.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -75.56 133.54 40.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.749 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -106.59 97.15 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.643 0.259 . . . . 0.0 110.857 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.75 134.8 24.19 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.97 167.21 9.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.884 0.85 . . . . 0.0 112.562 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 175.19 -164.99 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.103 -1.862 . . . . 0.0 106.483 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -95.72 96.08 8.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -145.0 113.12 6.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.457 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.543 HD13 HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.26 114.67 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -88.04 128.53 35.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.389 0.614 . . . . 0.0 110.046 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 17.8 mt -107.86 105.2 14.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.337 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.51 85.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.591 ' HB ' HG21 ' A' ' 63' ' ' THR . 31.9 p -87.05 86.43 7.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.569 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 42.9 m -64.84 106.01 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.407 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.31 -67.29 0.79 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.498 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.8 t70 -81.55 126.2 31.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.018 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -151.97 124.33 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.751 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -87.71 136.37 32.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.64 -40.29 14.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.247 -168.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -64.92 -62.35 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.086 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -83.91 -14.8 50.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.94 59.82 4.52 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.535 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.08 152.78 33.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -136.92 129.33 29.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.326 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -95.76 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.14 0.495 . . . . 0.0 109.975 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 37.9 mtmm -80.67 89.33 5.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.215 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.58 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 5.8 ptt180 -106.22 81.41 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.678 ' HZ2' ' HB3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.21 118.03 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.308 -178.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.11 126.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.684 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.3 t80 -113.77 108.86 17.66 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.795 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.9 t -110.86 112.1 39.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -101.97 111.11 23.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.001 0.429 . . . . 0.0 110.549 177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.0 m -89.77 137.22 32.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.726 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 32.3 tt0 -59.8 124.53 20.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.829 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.44 ' CG1' ' HE1' ' A' ' 83' ' ' MET . 3.2 p -110.6 155.21 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 122.21 1.005 . . . . 0.0 110.849 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.559 -168.334 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.47 ' O3 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HE2' ' HA2' ' A' ' 89' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 65.0 27.34 12.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.486 0.66 . . . . 0.0 110.256 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.45 173.31 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.194 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' HZ2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -76.27 147.16 79.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.589 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.17 113.99 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 111.318 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -151.5 159.28 44.23 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 77.8 mt -101.07 103.24 24.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 1.6 Cg_endo -84.34 167.49 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.04 2.494 . . . . 0.0 112.587 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -77.9 -12.87 60.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.291 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 18.5 t70 -84.65 123.37 30.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.138 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -95.67 12.31 30.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.655 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -93.86 -4.45 50.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.261 0.553 . . . . 0.0 110.154 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 49.9 mmtm -95.8 172.71 7.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.51 98.23 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.41 -32.27 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.077 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -148.73 156.13 26.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.902 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.453 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 1.0 OUTLIER -123.48 128.3 49.6 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 HG11 ' A' ' 84' ' ' VAL . 9.1 tp -102.31 117.82 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.525 0.678 . . . . 0.0 110.503 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.7 mt-10 -128.99 119.34 24.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.488 0.661 . . . . 0.0 111.466 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.67 102.06 39.14 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.753 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -25.68 75.48 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.023 2.482 . . . . 0.0 112.78 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.07 -3.16 54.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.19 10.99 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.541 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.21 20.79 10.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.769 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 67.6 mt -86.77 119.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.542 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 8.9 mtpm? -144.58 68.75 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.796 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 25.0 mm-40 -113.74 145.58 33.74 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.474 -172.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.28 149.73 57.8 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.652 2.235 . . . . 0.0 111.934 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.31 130.52 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -88.68 111.68 45.69 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.746 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 37.9 Cg_endo -67.62 152.83 77.63 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.021 2.481 . . . . 0.0 112.797 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.46 177.54 16.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.046 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.37 136.11 25.78 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.999 2.466 . . . . 0.0 111.448 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -52.1 115.06 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.773 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -128.71 151.7 77.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.494 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.3 -46.06 36.61 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.192 2.594 . . . . 0.0 113.404 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.53 -8.6 58.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.306 0.574 . . . . 0.0 111.26 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -101.69 -41.27 6.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.866 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 34' ' ' ALA . 71.1 mt -67.74 -32.16 72.58 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.984 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.36 -12.98 57.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.207 0.527 . . . . 0.0 110.064 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -87.89 -40.06 14.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.503 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -127.17 0.91 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.018 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -122.29 138.06 53.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.7 p -135.9 174.79 10.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 0.0 110.988 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.6 m-85 -84.12 165.34 18.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.92 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.135 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 37.4 mt-10 -117.08 177.22 4.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 26.3 tt0 -114.6 13.88 17.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.998 0.904 . . . . 0.0 109.185 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.78 -34.97 11.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.645 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 1.7 pm0 -82.5 142.37 31.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.234 0.54 . . . . 0.0 111.233 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -86.68 152.02 22.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.342 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.83 9.28 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 111.272 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -119.96 -1.8 10.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.437 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -84.91 -173.77 4.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.122 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HB3' HE21 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -102.18 41.53 1.22 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.625 0.25 . . . . 0.0 111.112 -173.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -171.94 126.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.81 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 23.8 mm -118.93 104.66 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 m -98.29 99.19 10.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.093 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 ' HB ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt -120.98 148.14 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.04 140.07 32.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.702 0.287 . . . . 0.0 110.681 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -161.35 116.05 0.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.865 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -83.88 122.49 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 73' ' ' THR . 58.5 m -107.27 118.69 37.39 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.284 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.458 ' CE2' ' HG2' ' A' ' 67' ' ' ARG . 12.4 p90 -108.54 139.48 43.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.071 0.462 . . . . 0.0 111.368 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -49.46 -34.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.302 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.44 -29.31 48.98 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 mmt85 -113.56 101.88 54.18 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.204 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 73' ' ' THR . 8.2 Cg_exo -74.21 -10.73 22.77 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 123.097 2.532 . . . . 0.0 111.39 175.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -106.71 22.44 15.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.084 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -82.79 163.19 21.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 4.1 mp0 -52.08 -39.79 60.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 76.3 m-85 -128.88 25.53 5.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 68' ' ' PRO . 3.0 m -68.24 -27.35 66.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.37 21.56 12.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 75' ' ' LEU . 11.7 mt -65.5 -11.64 45.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -71.43 -24.43 62.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.247 0.546 . . . . 0.0 110.76 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -81.2 -17.78 48.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.058 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.93 150.33 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -129.68 179.42 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -65.56 -6.55 11.23 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -171.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.52 23.74 7.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.1 m -87.87 130.68 34.82 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.483 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -69.92 113.05 6.78 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 HD12 ' A' ' 18' ' ' ILE . 94.6 t -89.7 106.6 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.588 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.01 107.35 19.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.053 0.454 . . . . 0.0 110.323 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 31.8 t80 -108.65 101.0 10.17 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.283 0.564 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 54.5 mtmt -85.65 125.43 33.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.5 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 88' ' ' VAL . 17.8 m -107.9 92.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.822 0.82 . . . . 0.0 109.67 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.494 ' HA2' ' HE2' ' A' ' 1' ' ' MET . . . 81.95 -89.0 1.42 Allowed Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -172.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -127.71 -17.92 4.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 111.138 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 26.1 mt-10 -84.24 142.42 30.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.741 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.3 m -108.78 112.24 24.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.529 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -89.11 130.75 35.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 33.8 mtmt -100.8 125.89 47.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.936 0.398 . . . . 0.0 110.265 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.511 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 78.7 m-85 -123.28 144.31 49.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.015 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.462 ' HE2' HG12 ' A' ' 147' ' ' VAL . 5.4 tppt? -101.85 139.48 37.42 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.524 ' HB3' HD11 ' A' ' 100' ' ' ILE . 70.1 mtp -77.64 59.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.43 . . . . 0.0 110.393 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.8 p -59.3 -44.55 92.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.282 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.563 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.9 m -113.16 98.89 7.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.981 0.42 . . . . 0.0 111.543 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 97' ' ' MET . 58.8 mt -122.31 105.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -149.8 150.53 32.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.71 127.81 38.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.509 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.44 148.14 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 104' ' ' LYS . 44.6 mtpt -57.74 123.29 62.35 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.22 -8.4 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.764 2.309 . . . . 0.0 112.544 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 p -93.75 -16.06 24.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.164 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.92 120.43 19.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.659 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.457 HG12 ' HY3' ' A' ' 201' ' ' 2W7 . 33.6 m -98.57 2.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -76.06 -20.77 57.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.04 7.1 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.72 -174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.37 113.64 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.252 0.548 . . . . 0.0 111.132 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.94 133.29 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.413 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.2 125.21 51.99 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.646 -169.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -120.23 139.46 52.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.938 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -83.38 51.79 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 110.113 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 145.29 15.64 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.154 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -133.51 168.75 18.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -175.23 -178.83 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.65 86.96 7.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.47 145.58 31.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.386 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -104.63 115.75 30.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.213 175.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.634 ' HA ' HG21 ' A' ' 143' ' ' VAL . 5.1 t -87.77 59.62 5.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.781 0.801 . . . . 0.0 110.436 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.497 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 5.7 mt -54.92 113.99 1.56 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.219 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.78 97.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.413 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 9.2 p -111.33 107.74 17.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -79.5 140.55 37.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.442 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.14 -46.19 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.279 0.561 . . . . 0.0 111.086 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -88.42 169.11 12.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.158 -172.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 16.6 p90 -156.23 127.57 7.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.701 172.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -93.59 109.01 20.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.02 -27.33 65.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.9 -171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 4.8 tmtt? -73.28 -79.77 0.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 111.35 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -97.63 -1.08 44.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.9 76.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.049 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 48.2 t -121.31 141.02 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.21 104.64 10.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.77 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 -174.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.79 ' HZ1' ' HB3' ' A' ' 138' ' ' LYS . 10.1 mtpm? -63.26 130.64 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.905 0.383 . . . . 0.0 111.167 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -118.43 98.53 6.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -78.53 127.86 32.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.21 131.3 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.712 0.767 . . . . 0.0 109.988 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.4 t80 -129.18 98.78 5.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.241 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.634 HG21 ' HA ' ' A' ' 122' ' ' THR . 58.6 t -106.06 104.46 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.9 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . . . -90.31 133.38 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.841 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.6 m -104.86 138.43 41.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.513 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.97 113.87 4.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.244 0.545 . . . . 0.0 110.576 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.462 HG12 ' HE2' ' A' ' 96' ' ' LYS . 2.1 p -116.58 153.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.068 0.937 . . . . 0.0 112.367 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--N 1.308 -1.201 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.359 -178.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.459 ' O2 ' ' HG2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.667 0.27 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.62 52.73 2.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.094 0.473 . . . . 0.0 110.145 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.23 155.25 5.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.414 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -67.14 147.34 99.03 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.793 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.632 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 26.0 Cg_endo -63.29 120.1 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.761 2.307 . . . . 0.0 112.309 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -141.89 159.21 42.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 31' ' ' PRO . 46.6 mt -103.49 110.93 64.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.63 0.253 . . . . 0.0 110.68 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.31 -176.22 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.681 2.254 . . . . 0.0 111.292 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.24 -19.77 21.85 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.412 0.625 . . . . 0.0 109.608 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 2.7 p-10 -92.32 165.1 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -116.46 16.33 15.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.092 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -89.33 -27.35 20.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 110.045 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 29.8 mmmt -84.0 113.84 21.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.14 97.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.899 0.38 . . . . 0.0 110.588 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 -30.38 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.734 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -146.99 157.74 27.51 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.948 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 2.4 t80 -137.77 124.98 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -95.06 121.58 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.152 0.501 . . . . 0.0 110.243 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.1 mt-10 -128.5 106.43 8.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.548 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.8 mt -120.42 98.78 48.36 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.185 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 -33.39 93.83 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.043 2.496 . . . . 0.0 112.486 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.36 -19.9 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.548 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -128.04 16.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.4 23.09 12.65 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.217 0.323 . . . . 0.0 111.636 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 81.1 mt -94.18 112.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.635 0.255 . . . . 0.0 111.342 -172.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 54.5 mtmt -141.05 86.16 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.668 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -123.61 141.33 36.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.65 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.3 146.24 56.28 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.262 1.975 . . . . 0.0 111.449 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.608 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 58.0 t -100.08 127.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.702 ' HB3' ' HB2' ' A' ' 11' ' ' LYS . 23.7 m-85 -95.48 105.18 18.74 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.592 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -66.61 143.43 68.41 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.996 2.464 . . . . 0.0 112.284 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.67 -134.26 6.15 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.434 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -95.87 155.05 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.406 2.737 . . . . 0.0 112.797 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.83 129.58 35.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.28 138.95 7.67 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.54 -31.97 80.85 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.178 2.586 . . . . 0.0 112.925 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.31 -35.41 77.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 111.354 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.9 tt0 -85.52 -34.7 21.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.892 0.377 . . . . 0.0 110.345 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.71 -16.64 61.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.581 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 65.8 t30 -82.29 3.74 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.727 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 11.7 ptp180 -137.11 -43.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.304 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 30' ' ' TYR . . . -139.15 169.7 24.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.192 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.63 140.03 16.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -139.29 174.52 10.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.05 144.8 25.89 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.325 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -83.96 -79.93 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.0 77.32 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.378 0.608 . . . . 0.0 111.122 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -16.67 35.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.6 36.11 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.758 -1.564 . . . . 0.0 111.976 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -156.97 -150.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.126 0.489 . . . . 0.0 111.224 -172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 68.8 m -103.03 159.47 15.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.312 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.41 2.12 4.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.761 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 51' ' ' SER . 1.2 p-10 -91.1 -5.77 54.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.56 166.35 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.943 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -85.71 -35.32 20.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.583 0.23 . . . . 0.0 111.432 -173.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.34 85.81 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.648 0.737 . . . . 0.0 111.625 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.82 132.61 30.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.675 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 p -130.55 107.85 9.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.325 0.583 . . . . 0.0 110.578 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.467 ' HB ' HD21 ' A' ' 123' ' ' LEU . 4.0 mt -107.55 143.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 46' ' ' ALA . . . -120.29 149.33 42.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.203 0.525 . . . . 0.0 111.887 -173.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.7 -165.15 21.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -145.34 137.72 25.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.434 0.617 . . . . 0.0 110.57 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -89.72 132.89 34.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.959 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.525 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.67 121.72 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.937 0.399 . . . . 0.0 111.057 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tt -88.55 -30.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.59 -42.2 82.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -105.85 104.47 49.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.198 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.43 -35.65 38.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.414 2.076 . . . . 0.0 112.568 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -87.71 52.35 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.438 0.637 . . . . 0.0 110.302 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.581 ' OH ' ' HA ' ' A' ' 40' ' ' ASN . 15.6 t80 -104.25 -167.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.001 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 3.6 pt20 -82.16 -38.25 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.705 0.288 . . . . 0.0 111.171 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 71' ' ' GLN . 78.1 m-85 -131.19 97.86 4.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.116 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.498 HG21 ' HB3' ' A' ' 70' ' ' TYR . 25.5 p -130.88 -48.96 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.6 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 62.3 t30 -84.77 16.85 3.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.1 tp -66.58 -13.87 61.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 110.781 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -68.56 -24.0 64.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 175.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.0 9.1 20.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.751 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -103.0 129.29 49.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.1 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 3.0 mppt? -112.84 -178.5 3.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.907 -172.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.49 -6.62 15.47 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 112.017 -175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -132.0 19.93 4.59 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.442 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 49.9 m -74.12 115.27 13.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 4.2 tpt -65.01 112.64 3.42 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.757 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 95.2 t -96.71 123.41 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.391 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -106.05 126.68 52.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.025 0.44 . . . . 0.0 110.663 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.507 ' HE1' HG21 ' A' ' 29' ' ' VAL . 24.9 t80 -115.76 103.86 11.09 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.413 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 12.0 ttmm -78.83 138.4 38.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.61 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.5 m -136.56 102.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.247 0.546 . . . . 0.0 110.559 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.33 -81.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.162 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -135.79 -5.12 2.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 110.324 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -101.58 156.97 17.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.372 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 m -123.35 125.16 44.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.65 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -105.97 137.34 44.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 31.7 mtmt -103.2 135.4 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.511 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 81.1 m-85 -132.52 146.72 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.254 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 9.9 tppt? -109.42 139.34 44.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.606 ' HB3' HD12 ' A' ' 100' ' ' ILE . 68.4 mtp -77.63 79.76 4.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.9 p -80.77 -43.1 20.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 4.5 m -112.72 108.34 17.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 110.57 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.606 HD12 ' HB3' ' A' ' 97' ' ' MET . 71.6 mt -128.66 102.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.713 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -153.6 174.08 14.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.8 143.18 50.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 t -111.36 148.67 14.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.147 -172.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 1.7 tmtp? -121.9 89.82 48.29 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -101.73 -150.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.778 2.985 . . . . 0.0 111.843 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.2 m -144.49 -46.92 0.25 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.39 -154.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG21 ' HG2' ' A' ' 109' ' ' GLU . 21.9 m -91.16 -173.8 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.328 -0.232 . . . . 0.0 111.282 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HG2' HG21 ' A' ' 108' ' ' VAL . 4.9 mm-40 69.41 -3.91 1.48 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.062 0.945 . . . . 0.0 113.011 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.65 -23.77 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.097 0.475 . . . . 0.0 110.815 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -114.22 131.32 56.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.805 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -89.65 130.7 35.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.67 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.556 ' CD ' ' HZ2' ' A' ' 117' ' ' LYS . 8.5 tp10 -102.16 141.15 35.46 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.635 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -154.49 157.24 38.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.075 -176.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -79.17 79.7 5.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.931 0.872 . . . . 0.0 111.163 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.26 43.19 0.49 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.996 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.556 ' HZ2' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -102.53 -165.21 1.16 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.16 0.505 . . . . 0.0 110.86 -177.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.7 -174.35 4.13 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -78.25 96.93 5.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -134.67 146.44 49.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.4 mt -95.26 100.49 12.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 90.19 3.37 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.467 HD21 ' HB ' ' A' ' 59' ' ' ILE . 7.6 mt -84.16 114.46 21.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.771 0.796 . . . . 0.0 111.291 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.555 HG21 ' NH2' ' A' ' 139' ' ' ARG . 73.3 mt -91.91 94.13 4.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.906 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.4 p -115.81 85.56 2.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.499 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.637 ' HB3' ' O2 ' ' A' ' 201' ' ' 2W7 . 26.3 p -78.58 135.23 37.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 140' ' ' LYS . 2.3 m-20 -89.72 -60.83 1.84 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.755 0.788 . . . . 0.0 109.688 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 4.7 t70 -86.56 138.31 31.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.163 -1.38 . . . . 0.0 111.132 -174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -160.97 142.23 11.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.72 110.48 22.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -57.56 -29.51 64.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.991 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -70.76 -62.03 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.8 p -83.12 -31.81 27.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.622 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.95 43.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.55 153.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -123.91 134.73 53.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.274 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 43.7 mt-10 -98.24 -54.74 2.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.332 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 28.5 mttp -104.37 97.46 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.265 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' NH2' HG21 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -119.92 117.59 28.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.638 0.732 . . . . 0.0 111.427 -177.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.5 ' HB2' ' OD1' ' A' ' 127' ' ' ASP . 2.3 tmtm? -77.5 124.56 28.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.72 121.78 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 121.597 0.713 . . . . 0.0 110.139 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 144' ' ' ALA . 3.1 t80 -120.59 115.88 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.84 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.5 t -111.8 116.96 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.366 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . . . -105.33 119.78 39.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.337 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 m -87.0 138.87 31.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.3 112.35 5.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 96' ' ' LYS . 2.6 p -122.57 150.49 26.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--N 1.31 -1.13 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.211 -174.24 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.637 ' O2 ' ' HB3' ' A' ' 126' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 66.63 24.98 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.546 0.529 . . . . 0.0 110.9 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.9 173.24 12.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.83 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.82 122.14 84.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.378 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.52 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 17.1 Cg_endo -56.95 145.84 82.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.25 2.633 . . . . 0.0 112.744 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.456 ' HA ' HD23 ' A' ' 52' ' ' LEU . 26.0 mm-40 -129.32 168.36 16.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.912 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.665 HG13 HD21 ' A' ' 52' ' ' LEU . 82.7 mt -100.02 105.77 37.25 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.02 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 10.8 Cg_endo -89.41 -93.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.959 2.439 . . . . 0.0 113.176 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 9' ' ' LYS . 13.4 ttpp -164.97 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.23 124.2 16.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.001 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.803 ' HD3' ' HB2' ' A' ' 38' ' ' GLN . 77.4 mttt -90.09 13.34 15.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.266 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -120.13 6.7 10.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -105.88 144.16 33.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.412 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.83 102.5 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.825 0.345 . . . . 0.0 110.289 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB1' ' HG3' ' A' ' 31' ' ' PRO . . . -84.66 -31.69 24.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.235 0.541 . . . . 0.0 110.203 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.15 178.24 31.92 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.017 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.01 144.44 50.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tp -117.13 118.75 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.549 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.8 mt-10 -126.4 113.0 16.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.46 0.648 . . . . 0.0 111.671 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.54 99.66 45.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.45 -29.79 89.44 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.164 2.576 . . . . 0.0 112.673 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.28 -21.23 66.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.599 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -125.86 8.81 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.131 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 56.64 31.19 18.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.418 0.628 . . . . 0.0 111.121 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 78.0 mt -83.32 110.01 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.07 67.6 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 35.3 mm-40 -120.4 157.02 54.82 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.793 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.84 160.68 30.71 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.533 2.155 . . . . 0.0 112.563 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -112.43 132.93 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -92.82 111.19 50.09 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 0.0 110.522 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.648 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 55.7 Cg_endo -70.38 98.69 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.364 2.709 . . . . 0.0 112.918 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.27 173.57 41.15 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 154.01 43.64 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.738 2.292 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 107.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.548 0.53 . . . . 0.0 111.034 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.471 ' HB ' ' OE1' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -136.58 142.23 38.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.915 -176.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -47.85 -49.54 13.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.981 3.12 . . . . 0.0 114.245 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.471 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.12 -28.28 39.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -174.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.803 ' HB2' ' HD3' ' A' ' 11' ' ' LYS . 9.3 tt0 -73.41 -39.57 64.96 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 35' ' ' THR . 91.1 mt -63.74 -36.64 84.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.752 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -32.89 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -86.75 -12.36 48.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.676 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' HA3' ' NE2' ' A' ' 71' ' ' GLN . . . 162.05 -96.25 0.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.322 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG22 ' HA2' ' A' ' 61' ' ' GLY . 5.0 p -154.28 140.86 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 120.78 0.324 . . . . 0.0 110.607 -175.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . 19.8 p -125.05 174.75 7.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.09 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.44 164.07 24.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.908 0.385 . . . . 0.0 110.747 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.75 -55.13 5.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.064 0.459 . . . . 0.0 110.99 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.651 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -112.69 151.25 30.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.48 -177.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -74.27 -36.87 63.84 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.165 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -89.3 19.0 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.223 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 41.1 mt-10 -84.86 102.27 12.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 109.849 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 m -72.89 133.36 44.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD21 HG13 ' A' ' 7' ' ' ILE . 2.0 pp -70.53 -2.46 14.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.54 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -109.07 -3.46 17.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.371 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.79 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.487 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 pt20 172.27 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -94.24 119.69 33.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.295 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 52' ' ' LEU . 17.2 mm -123.39 100.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.066 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 122' ' ' THR . 4.5 m -92.8 114.47 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 110.347 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.658 ' HB ' ' HG ' ' A' ' 123' ' ' LEU . 3.0 mt -111.52 108.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 121.62 33.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.803 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 43' ' ' VAL . . . -99.14 175.48 28.47 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.517 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.466 ' O ' ' HB ' ' A' ' 63' ' ' THR . 23.2 t-160 -84.0 -84.16 0.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.381 0.134 . . . . 0.0 111.144 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 62' ' ' HIS . 15.2 t 171.75 -170.04 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.21 150.31 30.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.35 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.697 HG13 ' H ' ' A' ' 66' ' ' ASP . 10.7 tp -158.47 177.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.697 ' H ' HG13 ' A' ' 65' ' ' ILE . 38.8 t70 -76.77 34.65 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.689 0.757 . . . . 0.0 111.221 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 65' ' ' ILE . 5.1 mpt_? -125.3 105.36 28.21 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 121.977 -0.452 . . . . 0.0 110.298 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.597 ' HA ' HG23 ' A' ' 73' ' ' THR . 57.0 Cg_endo -72.32 -4.96 16.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -103.4 16.81 25.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.511 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.4 t80 -84.66 151.77 24.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.133 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.572 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 12.3 mp0 -46.55 -39.76 11.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.54 17.69 9.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -171.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.597 HG23 ' HA ' ' A' ' 68' ' ' PRO . 38.5 m -69.15 -39.7 78.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.491 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -99.0 7.4 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.086 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.18 -13.48 37.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 110.754 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -63.78 -23.84 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.232 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.49 -8.31 59.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.686 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.425 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -85.7 158.67 19.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.57 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -128.2 -178.16 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.277 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -5.47 35.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.437 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.31 8.21 12.32 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.473 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.8 m -74.04 155.71 38.25 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.731 0.777 . . . . 0.0 110.915 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.487 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.92 120.05 35.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.102 -177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 72.1 t -103.23 108.68 24.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.323 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 42.0 m-85 -90.05 109.81 20.84 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.286 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -99.07 110.39 22.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -109.1 142.54 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.256 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG23 HD22 ' A' ' 52' ' ' LEU . 2.9 p -150.64 103.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.83 0.824 . . . . 0.0 110.091 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 62.58 -98.29 0.2 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.226 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.58 -7.16 17.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.45 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.455 ' HB2' HG13 ' A' ' 88' ' ' VAL . 6.4 mm-40 -92.89 145.06 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.443 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 m -150.04 99.93 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.225 0.536 . . . . 0.0 110.01 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -106.03 136.87 44.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.615 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 0.9 OUTLIER -89.96 133.29 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.993 0.425 . . . . 0.0 110.336 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -126.94 147.35 50.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.27 148.31 30.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.543 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 68.3 mtp -80.65 56.6 2.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.199 0.523 . . . . 0.0 110.27 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.1 p -60.98 -38.5 86.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.187 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.518 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.1 m -119.42 95.59 4.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.014 0.435 . . . . 0.0 111.489 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 97' ' ' MET . 59.3 mt -115.66 103.39 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -132.33 147.17 52.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.957 0.408 . . . . 0.0 110.621 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 36.3 t70 -112.78 120.22 40.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.635 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.622 HG23 HD23 ' A' ' 111' ' ' LEU . 15.7 t -123.43 154.88 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.223 -173.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 92.1 mttt -90.57 138.32 26.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 12.6 Cg_exo -74.06 42.92 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.84 3.027 . . . . 0.0 113.02 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -59.05 -48.51 81.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.411 0.624 . . . . 0.0 109.797 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -143.84 171.62 13.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.112 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.577 ' HB ' ' C26' ' A' ' 201' ' ' 2W7 . 31.0 m -88.68 -8.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.443 0.639 . . . . 0.0 109.476 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.44 -12.87 59.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.881 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.629 HG13 ' HG ' ' A' ' 111' ' ' LEU . 12.5 p -69.88 -24.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.065 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.629 ' HG ' HG13 ' A' ' 110' ' ' VAL . 90.6 mt -121.05 135.47 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -166.2 143.72 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.36 114.38 27.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.998 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.437 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -95.76 161.4 14.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.577 -176.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.48 23.67 13.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 123.693 0.621 . . . . 0.0 111.343 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.26 -149.12 21.77 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.4 158.74 43.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.854 0.359 . . . . 0.0 111.583 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -111.98 -161.31 0.75 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 6.1 mptt -80.64 97.47 7.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.81 138.78 24.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.651 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.8 mt -96.28 101.77 13.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 143' ' ' VAL . 16.4 m -90.09 85.77 6.38 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.86 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.658 ' HG ' ' HB ' ' A' ' 59' ' ' ILE . 7.2 mp -77.3 104.11 7.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.239 0.543 . . . . 0.0 110.895 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.86 82.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.306 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.5 p -104.66 98.52 8.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.73 113.52 4.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.807 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 1.6 t70 -64.26 -39.1 93.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.77 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.72 137.99 46.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.964 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -156.84 118.46 3.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.23 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.443 ' HB3' HG11 ' A' ' 135' ' ' VAL . 39.9 t30 -104.05 122.47 45.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -71.53 -29.06 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -76.39 -60.4 2.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.716 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.2 p -84.28 -8.72 58.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.517 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.02 95.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.309 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 130' ' ' ASN . 9.2 p -115.94 152.18 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 0.0 110.745 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.433 ' O ' ' HG2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -142.92 118.77 10.56 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.649 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.1 2.24 34.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -156.61 135.23 11.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.807 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 3.4 ptp180 -145.02 108.96 4.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.421 0.629 . . . . 0.0 111.569 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -88.62 109.96 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.666 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.9 tp -88.69 127.14 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 110.31 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.745 ' HZ ' HG22 ' A' ' 84' ' ' VAL . 2.7 t80 -118.54 114.57 23.03 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.32 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.9 t -112.44 115.01 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.104 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . . . -97.03 117.77 31.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.385 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.1 m -89.83 142.31 27.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.185 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.44 138.34 56.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.6 t -111.11 161.85 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.309 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.577 ' C26' ' HB ' ' A' ' 108' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.641 0.258 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.88 -174.36 3.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.395 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.66 105.6 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 124.286 0.991 . . . . 0.0 111.658 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -105.45 140.1 20.82 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.0 116.99 4.92 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.251 1.968 . . . . 0.0 111.639 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -130.05 175.25 9.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.204 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 31' ' ' PRO . 48.0 mm -113.44 89.28 14.69 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -92.73 -176.84 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.202 2.601 . . . . 0.0 113.086 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -74.96 -25.41 58.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.63 118.5 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 56.4 mttp -87.1 -46.64 9.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -56.32 -36.27 68.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -167.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.637 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.56 142.38 58.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.247 0.546 . . . . 0.0 110.98 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.28 126.06 49.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -103.07 -22.74 13.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.908 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.35 160.72 28.68 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.531 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.32 127.48 53.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.54 118.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.334 0.588 . . . . 0.0 109.43 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 34.2 mt-10 -125.4 112.0 15.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.799 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 HG11 ' A' ' 84' ' ' VAL . 76.2 mt -125.22 102.65 30.36 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.901 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.09 -29.74 81.63 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.129 2.553 . . . . 0.0 113.095 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.37 -16.74 61.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.53 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.44 8.82 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.327 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 58.55 34.71 24.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.764 0.792 . . . . 0.0 110.722 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 71.3 mt -95.66 120.88 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.745 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -145.3 79.64 1.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.823 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 31.7 mm-40 -122.4 141.65 35.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.676 -169.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.21 134.4 21.03 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.575 2.183 . . . . 0.0 111.7 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.573 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.3 t -96.2 138.13 22.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.357 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -109.46 91.02 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -68.28 133.43 28.43 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.88 2.386 . . . . 0.0 112.272 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.38 175.79 34.7 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' HG2' ' HE3' ' A' ' 11' ' ' LYS . 19.6 Cg_endo -59.84 118.09 4.93 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.662 2.241 . . . . 0.0 112.237 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -55.8 126.32 25.09 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -142.25 139.02 17.2 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.83 -35.43 88.56 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.023 2.482 . . . . 0.0 113.01 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.47 -17.51 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' CD ' ' HD3' ' A' ' 11' ' ' LYS . 37.6 tt0 -88.92 -48.59 7.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.49 -22.9 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.808 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.12 -15.09 60.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.209 0.528 . . . . 0.0 110.582 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -100.01 -20.98 15.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.944 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.89 178.55 41.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.057 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.84 123.87 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -136.17 153.06 51.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.368 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.38 168.94 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -85.99 -64.39 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -105.65 158.73 16.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.124 0.487 . . . . 0.0 111.174 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.25 5.01 52.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.786 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -98.53 -0.42 43.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -107.78 135.55 49.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.852 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' O ' HD13 ' A' ' 57' ' ' ILE . 27.6 t -118.72 157.95 26.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.277 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.78 -2.23 16.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.578 0.704 . . . . 0.0 110.219 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -92.25 -16.45 26.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.972 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.91 178.54 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.825 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 -26.93 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.96 124.13 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.852 0.358 . . . . 0.0 110.657 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.444 HG23 HD12 ' A' ' 121' ' ' LEU . 25.4 mm -135.25 139.88 46.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.78 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 m -132.97 114.4 13.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 110.257 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -123.02 136.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.6 174.18 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.28 -172.45 40.87 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.763 ' CD2' ' HA ' ' A' ' 127' ' ' ASP . 10.4 t60 78.18 122.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.983 0.913 . . . . 0.0 111.651 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -153.98 151.3 29.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.701 171.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' HB2' ' HA ' ' A' ' 130' ' ' ASN . 24.1 m-85 -82.49 83.89 7.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 11.2 tp -99.57 18.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.796 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 14.3 t70 83.33 -25.4 0.14 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.346 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -75.76 108.19 5.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 60.2 Cg_endo -77.4 0.35 9.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.511 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -111.14 9.78 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 175.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.17 101.64 0.93 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.823 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -1.17 -71.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 19.3 m-85 -79.47 6.46 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.7 p -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -92.73 10.41 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.228 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.93 1.22 5.85 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.569 0.7 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -75.77 -25.05 56.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.198 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.72 59.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -84.07 149.16 26.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -112.72 173.93 6.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.172 -176.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -77.83 -6.01 52.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.619 . . . . 0.0 110.665 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.11 10.66 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.975 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.566 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 24.3 m -73.86 129.76 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.519 0.676 . . . . 0.0 110.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.465 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -75.91 108.29 8.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.816 173.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.82 HG23 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -97.07 134.4 34.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.659 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -108.53 127.5 53.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.038 0.447 . . . . 0.0 110.228 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -123.3 113.18 18.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.383 0.611 . . . . 0.0 109.361 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -89.97 132.63 35.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.715 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.04 117.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.364 0.602 . . . . 0.0 109.843 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 -99.81 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.316 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -131.01 11.09 5.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.831 0.348 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -125.83 156.48 39.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.6 m -126.47 130.15 50.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 79.1 mmt-85 -101.56 153.71 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.145 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 44.2 mtmt -102.56 131.57 49.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 109.891 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 83.2 m-85 -127.36 145.1 50.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.678 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -107.39 143.87 35.09 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.711 ' HE1' HD12 ' A' ' 100' ' ' ILE . 56.9 mtp -83.5 44.61 0.98 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.766 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -74.72 -9.45 58.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.463 -171.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.7 m -123.85 84.41 2.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.281 0.563 . . . . 0.0 110.892 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.711 HD12 ' HE1' ' A' ' 97' ' ' MET . 64.4 mt -120.12 113.68 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.248 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 141' ' ' ILE . 50.9 ttt85 -127.87 155.22 44.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.307 . . . . 0.0 110.542 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' OD1' ' HB3' ' A' ' 138' ' ' LYS . 27.1 t70 -81.18 122.26 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.026 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 46.6 t -129.29 98.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.032 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 32.0 mttp -76.33 166.81 42.08 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.499 ' HG2' ' CD1' ' A' ' 136' ' ' TRP . 34.7 Cg_exo -60.0 -13.19 21.93 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.257 1.971 . . . . 0.0 112.161 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 t -106.75 3.19 26.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.027 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 3.5 m-20 -112.12 29.26 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.342 0.591 . . . . 0.0 110.395 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.5 t -71.24 169.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.509 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 48.42 23.35 0.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.596 1.159 . . . . 0.0 113.414 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -90.56 -21.83 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.959 0.409 . . . . 0.0 110.098 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.51 107.94 17.02 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -93.54 174.32 7.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.229 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.09 109.02 20.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -168.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -103.22 140.87 36.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.588 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.3 148.12 26.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.859 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.51 49.23 2.4 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.537 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -105.65 -170.62 1.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.561 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.65 -169.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.61 100.04 8.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -119.95 126.62 51.31 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.748 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.44 105.0 17.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.4 m -75.19 90.8 2.58 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 31.2 mt -84.95 112.42 20.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.591 0.71 . . . . 0.0 110.05 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.54 HD11 ' H4 ' ' A' ' 201' ' ' 2W7 . 22.0 mt -84.27 91.44 2.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.006 -176.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.4 m -77.32 88.32 3.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.698 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.4 75.41 7.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.135 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.763 ' HA ' ' CD2' ' A' ' 62' ' ' HIS . 4.5 t0 -83.52 -15.36 49.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.213 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.498 ' CG ' ' HE ' ' A' ' 139' ' ' ARG . 19.2 p-10 -90.49 23.89 2.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.965 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -115.29 92.94 4.08 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.159 -0.617 . . . . 0.0 111.296 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -102.69 96.9 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 171.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -40.03 78.02 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -170.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -64.36 -58.4 6.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.881 0.372 . . . . 0.0 111.179 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.4 p -84.8 -23.84 28.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.844 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.99 40.89 29.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.248 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.07 142.8 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.86 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.499 ' CD1' ' HG2' ' A' ' 105' ' ' PRO . 48.0 p90 -126.9 151.84 47.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.792 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' H ' ' CB ' ' A' ' 128' ' ' ASP . 39.4 mt-10 -129.21 -92.55 0.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.906 0.384 . . . . 0.0 111.265 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 2.9 mtpm? -145.5 138.55 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.989 -173.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.498 ' HE ' ' CG ' ' A' ' 128' ' ' ASP . 95.6 mtt180 -103.34 108.21 19.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.516 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -76.97 103.53 6.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 101' ' ' ARG . 16.0 tt -70.26 122.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.593 0.711 . . . . 0.0 109.783 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.82 ' HZ ' HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -103.37 96.05 6.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.747 -174.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 68.8 t -106.5 104.11 16.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.743 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.579 ' HB1' ' CE1' ' A' ' 142' ' ' PHE . . . -97.68 123.96 41.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.276 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 m -95.78 139.9 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.566 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 40.5 tt0 -61.84 123.03 16.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.229 0.537 . . . . 0.0 111.257 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.64 165.33 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.82 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' ' 148' ' ' LYS . 2.9 pptp? . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.05 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.54 ' H4 ' HD11 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -78.09 -20.12 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.418 0.628 . . . . 0.0 110.536 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.15 148.85 18.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.384 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.82 135.94 37.22 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 33.1 Cg_endo -65.21 116.4 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.276 1.984 . . . . 0.0 111.785 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.31 -166.69 1.29 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.922 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.57 104.49 56.16 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.877 0.37 . . . . 0.0 110.592 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.04 -176.57 2.91 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.749 2.3 . . . . 0.0 111.852 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -100.52 4.31 43.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.781 0.324 . . . . 0.0 110.974 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -107.72 152.77 23.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.817 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' HG2' ' NE2' ' A' ' 38' ' ' GLN . 3.1 mptt -102.44 -8.23 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.714 -169.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.4 p -73.35 -19.87 60.91 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.193 0.52 . . . . 0.0 110.744 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -96.09 106.22 18.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.792 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.07 102.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 110.221 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.02 63.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.06 35.93 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.047 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.82 144.96 49.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.312 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.2 tp -115.79 113.19 42.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.669 0.747 . . . . 0.0 109.395 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -125.16 113.96 18.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.348 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 25' ' ' ILE . 51.9 mt -122.65 101.34 40.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 12.0 Cg_endo -57.82 -32.22 94.37 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.042 2.495 . . . . 0.0 112.343 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -29.05 69.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.633 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.03 9.37 12.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.706 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.02 19.48 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.357 0.411 . . . . 0.0 111.605 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 20' ' ' ILE . 67.8 mt -84.45 134.86 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.27 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -158.67 61.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 27.5 mm-40 -123.8 153.78 67.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.616 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 158.36 43.61 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.802 2.335 . . . . 0.0 112.386 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.32 133.52 53.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -93.48 109.46 40.76 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.07 148.43 75.5 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.501 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.45 -174.76 21.37 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.34 143.48 13.9 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.45 2.1 . . . . 0.0 112.001 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -64.79 131.98 48.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -166.07 145.49 5.11 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.676 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -42.32 -46.71 7.49 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.918 3.079 . . . . 0.0 114.17 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -54.47 -37.9 65.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.471 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.508 ' NE2' ' HG2' ' A' ' 11' ' ' LYS . 15.9 mm100 -72.3 -60.29 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.355 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.8 mm? -69.05 -7.14 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.675 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -68.93 -33.7 74.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.289 0.566 . . . . 0.0 109.792 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -111.44 -37.27 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.138 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -159.15 -169.31 22.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.232 -175.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.847 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 7.9 p -88.42 148.56 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.017 0.437 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.7 m -144.26 -179.51 6.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -93.38 147.62 22.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.924 0.393 . . . . 0.0 110.719 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.719 ' HB3' ' HB2' ' A' ' 60' ' ' ALA . . . -98.36 -58.27 2.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.932 -174.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -88.76 -169.64 2.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 111.961 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 50.49 0.53 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.625 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.87 94.96 5.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.3 -3.93 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.1 0.952 . . . . 0.0 110.033 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -143.99 130.67 20.17 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.755 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.85 1.77 46.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.682 0.753 . . . . 0.0 109.391 171.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.43 1.23 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.946 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.5 t70 -94.64 -157.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.692 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 13.2 pt20 -106.42 -41.5 5.28 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.81 118.58 26.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.539 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.75 104.41 14.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.923 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.7 m -102.14 99.23 9.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.016 0.436 . . . . 0.0 110.736 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -99.59 143.28 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 -178.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . . . -121.37 133.37 55.1 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.06 156.39 26.89 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.357 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -102.0 101.62 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.593 HG21 ' HB ' ' A' ' 125' ' ' THR . 6.7 t -87.61 98.29 11.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.024 0.916 . . . . 0.0 110.124 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 12.6 t80 -111.91 92.38 4.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.837 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -58.72 -27.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.553 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 27.2 m-20 -67.46 -4.78 12.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.079 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -135.09 105.76 10.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.599 ' HA ' HG22 ' A' ' 73' ' ' THR . 14.1 Cg_exo -69.78 -12.12 32.22 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.696 2.264 . . . . 0.0 111.84 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -88.24 5.9 39.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.404 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 151.93 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 95.7 mt-30 -62.29 -33.96 75.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.264 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.847 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 97.3 m-85 -122.84 78.74 1.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.205 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 68' ' ' PRO . 5.2 t -113.07 -29.38 7.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.345 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -98.75 21.74 11.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -172.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 75' ' ' LEU . 13.4 mt -71.18 -5.12 29.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -23.37 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.24 0.543 . . . . 0.0 109.711 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.52 0.43 42.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.309 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.68 114.06 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.299 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -175.41 2.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -5.11 1.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' CA ' ' HE3' ' A' ' 96' ' ' LYS . . . -141.38 31.64 2.13 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.961 -1.114 . . . . 0.0 112.448 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.1 m -78.3 117.56 19.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 94' ' ' LYS . 25.1 tpp -68.53 119.85 13.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.02 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.489 HG23 ' SD ' ' A' ' 97' ' ' MET . 73.0 t -110.63 122.79 65.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.28 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -101.89 117.13 34.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.185 0.517 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -104.8 123.58 47.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -110.25 132.52 54.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -137.66 116.67 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.516 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 69.28 -82.39 0.26 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -135.3 -16.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.662 0.268 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.46 156.66 16.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.079 0.466 . . . . 0.0 110.916 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -135.49 119.99 18.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.025 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 89.1 mtt180 -104.79 154.77 19.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.628 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -104.15 125.67 50.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.582 -178.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 91.3 m-85 -123.73 150.42 44.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.259 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' HE3' ' CA ' ' A' ' 81' ' ' GLY . 11.5 tttp -119.79 144.46 47.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.489 ' SD ' HG23 ' A' ' 84' ' ' VAL . 76.5 mmm -77.36 81.33 3.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 p -83.83 -16.36 44.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.388 -171.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 47.1 m -147.05 104.98 3.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.35 0.595 . . . . 0.0 111.538 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.48 111.75 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.888 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -127.2 148.68 50.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.195 0.521 . . . . 0.0 111.349 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 30.8 m-20 -109.42 134.87 51.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.62 176.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 108' ' ' VAL . 58.6 t -122.91 126.17 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -78.35 146.76 71.05 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.15 -20.54 67.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.327 2.685 . . . . 0.0 113.953 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -81.82 -29.92 32.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.831 0.348 . . . . 0.0 111.681 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.22 81.63 2.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 103' ' ' VAL . 6.4 p -101.47 -8.62 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.713 0.768 . . . . 0.0 109.935 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.67 34.68 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.2 m -82.15 16.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.238 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.74 171.0 14.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.462 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.516 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 7.5 m-20 -84.12 152.85 24.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.86 97.76 1.46 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.454 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 19.8 mt-30 -135.18 95.29 3.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -109.96 116.97 32.58 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.22 31.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.807 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 118' ' ' ASP . 24.9 tptt -76.19 -161.67 0.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.417 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 3.4 t70 -71.86 -168.23 0.35 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.762 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 3.2 mppt? -76.55 85.09 3.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -136.97 135.37 37.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.825 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.74 107.1 18.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -93.04 94.36 8.83 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.5 mp -83.36 110.26 17.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.554 HD11 ' O3 ' ' A' ' 201' ' ' 2W7 . 50.2 mt -88.77 99.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.763 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 14.4 p -114.31 104.44 12.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.744 -175.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.1 m -70.76 123.16 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.5 -79.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.835 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 2.2 t70 -95.53 -176.89 3.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.748 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -147.41 138.74 23.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.134 0.493 . . . . 0.0 111.448 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' HB2' ' HA ' ' A' ' 136' ' ' TRP . 52.0 t-20 -144.17 117.45 9.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.346 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.52 -17.04 64.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 132' ' ' LYS . 8.5 tmtm? -61.32 -40.23 93.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.566 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.79 -40.23 1.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.62 -42.2 0.76 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.67 158.73 42.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.835 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 29.0 t-105 -85.26 -42.92 14.22 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.931 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.774 ' HG3' ' H ' ' A' ' 138' ' ' LYS . 8.3 pt-20 -139.15 -84.28 0.26 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.774 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 14.0 ptmm? -117.64 166.13 12.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.548 ' NH2' ' O2 ' ' A' ' 201' ' ' 2W7 . 4.9 mpt_? -107.46 156.88 18.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.304 172.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.455 ' HG2' ' HZ1' ' A' ' 138' ' ' LYS . 5.9 tmtp? -133.92 127.85 33.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.998 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.39 128.41 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 120.986 0.422 . . . . 0.0 110.492 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 76.0 m-85 -121.73 107.61 12.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.218 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 52.9 t -102.24 107.18 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.0 110.599 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -101.62 107.42 18.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.396 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.7 m -85.78 140.18 30.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.194 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.474 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 30.9 tt0 -64.63 120.64 12.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.405 ' HB ' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t -84.49 165.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.184 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.554 ' O3 ' HD11 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.447 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 34.4 tt0 -87.5 111.9 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 2' ' ' GLN . . . 73.16 151.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 123.966 0.792 . . . . 0.0 110.69 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -126.17 145.27 51.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.459 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.79 158.2 52.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.617 2.211 . . . . 0.0 111.521 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.445 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 mm-40 -116.09 168.47 10.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.753 0.311 . . . . 0.0 110.588 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.584 HD11 ' HB3' ' A' ' 52' ' ' LEU . 87.2 mt -98.04 102.25 13.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 79.0 Cg_endo -93.2 -173.84 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.069 2.512 . . . . 0.0 113.504 -174.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -81.44 -17.85 47.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.565 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.1 137.88 53.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.615 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 32.9 mmtp -88.56 -33.34 17.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.604 -167.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -101.23 8.57 42.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.869 0.366 . . . . 0.0 111.627 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -86.06 90.25 8.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.615 0.245 . . . . 0.0 110.836 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.78 115.57 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.88 -28.26 15.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.195 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.17 155.39 25.07 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.344 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 131.56 55.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -102.81 130.47 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 50.3 mt-10 -136.79 109.56 7.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.274 0.559 . . . . 0.0 111.049 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.9 mt -118.93 95.41 49.25 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.67 -36.36 98.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.152 2.568 . . . . 0.0 113.064 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.58 -30.06 70.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.551 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -111.18 5.04 19.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.068 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 58.4 25.43 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.297 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 58.9 mt -85.1 99.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 40.1 ttmt -134.98 88.12 2.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.695 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 5.7 mm-40 -144.97 153.39 53.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.884 -170.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.0 153.99 52.64 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.194 2.596 . . . . 0.0 112.918 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -107.26 139.15 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -113.08 103.12 55.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.568 ' HB3' HG23 ' A' ' 7' ' ' ILE . 77.8 Cg_exo -51.88 161.72 2.15 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.825 3.017 . . . . 0.0 113.421 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.73 165.87 12.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.48 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HD2' ' HE2' ' A' ' 11' ' ' LYS . 34.4 Cg_endo -65.22 141.08 67.5 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.515 2.143 . . . . 0.0 111.761 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.2 101.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.169 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -139.09 155.76 72.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.9 Cg_endo -54.26 -35.24 82.68 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.902 2.401 . . . . 0.0 112.6 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.67 -45.82 77.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.235 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 11.1 mm100 -72.71 -47.14 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.553 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.0 mm? -68.1 -9.51 46.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.44 . . . . 0.0 111.003 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 24.3 t-20 -78.5 -32.27 48.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.823 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -93.74 -46.37 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.89 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.447 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -160.29 -156.45 8.18 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.818 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 60' ' ' ALA . 87.0 t -97.13 135.22 32.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 67.6 m -127.72 151.32 49.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.834 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 97.0 m-85 -71.38 147.07 48.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.08 0.467 . . . . 0.0 111.59 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.99 -28.38 29.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.85 99.26 9.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.558 173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -83.15 17.11 2.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.302 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.65 172.68 12.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.776 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -82.52 14.31 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.212 -173.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -102.37 101.7 11.97 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.584 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -110.83 4.95 20.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.521 0.677 . . . . 0.0 109.874 172.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.54 20.99 7.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.581 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -74.6 -170.05 0.97 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.6 pt20 -93.22 -29.09 15.88 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -111.02 143.5 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.464 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 15.1 mm -138.07 100.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -93.79 116.04 28.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.498 ' HB ' HD22 ' A' ' 123' ' ' LEU . 1.6 mt -122.36 138.3 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -91.16 118.28 30.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.76 ' HA3' HG22 ' A' ' 125' ' ' THR . . . -105.16 114.58 4.66 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.494 -175.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.423 ' HB3' HD13 ' A' ' 39' ' ' LEU . 25.1 p80 -73.62 141.76 46.54 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 129' ' ' TYR . 15.1 t -74.08 175.34 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' A' ' 73' ' ' THR . 42.1 p90 -82.86 161.27 21.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.46 -80.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.007 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -115.54 -10.93 11.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.075 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -98.11 109.76 53.15 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.736 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 -13.82 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.086 2.524 . . . . 0.0 111.949 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' A' ' 69' ' ' ASN . 8.1 m120 -116.92 61.82 0.73 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 109.764 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.74 179.46 4.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.599 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.695 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 14.9 mp0 -53.83 -40.91 66.82 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.498 0.499 . . . . 0.0 112.129 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.839 ' HE1' HD22 ' A' ' 75' ' ' LEU . 71.5 t80 -131.57 101.59 5.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.0 109.923 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 64' ' ' PHE . 15.4 p -141.75 -62.84 0.45 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.209 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 66.2 t30 -94.15 27.01 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -167.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.839 HD22 ' HE1' ' A' ' 72' ' ' PHE . 16.6 tp -62.86 -18.55 63.07 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.615 -0.678 . . . . 0.0 111.404 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -64.12 -22.23 66.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.49 -16.01 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.412 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.88 169.41 18.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.594 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -137.42 168.08 20.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 111.494 -176.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.33 59.19 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.08 -173.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.417 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -131.47 39.34 1.78 Allowed Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.002 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.4 p -85.24 -150.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.967 0.413 . . . . 0.0 110.106 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.529 ' HE1' ' HA ' ' A' ' 83' ' ' MET . 1.5 tpt -139.3 105.36 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.782 0.325 . . . . 0.0 110.187 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 97.9 t -96.19 120.99 46.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.044 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.561 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 80.8 m-85 -101.04 129.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -123.41 106.15 10.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 49.4 mtmt -102.02 114.85 29.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.398 -175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.91 101.99 13.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.571 0.7 . . . . 0.0 109.122 173.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.77 -89.29 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -12.5 4.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.136 0.493 . . . . 0.0 109.818 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 3.5 mm-40 -76.91 117.67 18.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.803 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.4 m -103.16 112.49 25.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.112 0.482 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -102.23 136.17 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 21.6 mtmm -104.34 140.06 38.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.468 . . . . 0.0 110.629 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 74.8 m-85 -132.69 148.56 52.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 13.3 tppt? -107.76 137.89 44.97 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.528 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 69.3 mtp -79.06 61.91 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.8 p -68.63 -41.21 79.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.211 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.556 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -116.37 101.37 8.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.333 0.587 . . . . 0.0 111.343 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD13 ' HB3' ' A' ' 97' ' ' MET . 57.0 mt -119.75 114.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.025 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -134.63 140.22 45.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.382 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.54 108.38 16.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.254 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 -169.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -130.3 155.85 80.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.562 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.69 106.48 2.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.617 2.212 . . . . 0.0 114.096 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -119.58 -51.38 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -109.34 120.43 42.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.068 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -104.04 -26.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.278 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.49 19.84 14.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.309 0.576 . . . . 0.0 110.804 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.16 -0.24 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.651 0.738 . . . . 0.0 110.046 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.75 12.21 26.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.551 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.44 5.06 18.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.993 0.901 . . . . 0.0 110.825 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 11.9 pt-20 -108.08 94.07 4.87 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.419 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.83 121.74 42.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.045 0.45 . . . . 0.0 110.674 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -106.62 -0.94 23.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.9 -162.6 21.72 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.644 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -153.54 177.6 10.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.169 0.485 . . . . 0.0 110.908 176.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.57 -171.51 2.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.663 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 27.8 mttm -85.58 96.14 9.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.893 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 14.0 pt20 -162.84 139.81 7.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.447 -173.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.464 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 17.2 mt -88.84 130.88 35.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 171.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 m -104.73 87.53 2.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.502 HD13 ' CD2' ' A' ' 142' ' ' PHE . 26.3 mt -85.8 96.99 9.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.146 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.646 HD12 HZ22 ' A' ' 201' ' ' 2W7 . 57.1 mt -87.93 95.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.76 HG22 ' HA3' ' A' ' 61' ' ' GLY . 50.7 p -109.18 99.34 8.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.875 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 34.6 m -61.99 116.3 4.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.577 0.703 . . . . 0.0 110.833 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 35.3 t70 -91.75 161.31 14.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.944 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 4.8 t0 67.25 108.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.767 0.667 . . . . 0.0 111.018 175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.448 ' HB3' HG22 ' A' ' 63' ' ' THR . 30.2 p90 -130.89 157.54 42.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.571 -170.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.478 ' HB3' HG11 ' A' ' 135' ' ' VAL . 23.9 t30 -106.3 107.37 18.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -57.08 -25.59 58.99 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -72.88 -59.58 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.373 0.606 . . . . 0.0 110.522 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.3 p -88.21 -49.62 6.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.297 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.02 41.32 2.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.634 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 130' ' ' ASN . 11.6 p -82.7 147.8 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 4.1 m-90 -106.59 113.82 27.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.061 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 6.3 mm-40 -91.12 -26.34 19.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.139 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 27.7 mttp -128.02 -178.84 4.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.172 0.51 . . . . 0.0 109.994 174.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.814 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.9 ptt180 -154.87 100.59 2.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.8 171.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 116.07 26.35 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 tt -100.42 117.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 CA-C-O 122.128 0.966 . . . . 0.0 110.443 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.744 ' CZ ' ' HB1' ' A' ' 144' ' ' ALA . 3.3 t80 -101.64 113.95 27.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.291 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 94.7 t -109.36 112.09 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.744 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -103.93 116.38 32.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -79.23 136.05 36.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.307 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.46 122.95 15.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.836 0.35 . . . . 0.0 110.467 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.39 153.57 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.753 0.787 . . . . 0.0 111.166 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.296 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.652 ' O2 ' ' N4 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 65.52 25.65 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 110.576 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.0 158.0 43.95 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 4' ' ' LYS . 19.6 ptmt -64.77 135.17 96.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.051 0.453 . . . . 0.0 110.274 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' O ' HD22 ' A' ' 52' ' ' LEU . 68.6 Cg_endo -79.44 120.69 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.495 2.13 . . . . 0.0 113.362 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -106.81 128.74 54.51 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 165.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.485 HG23 ' HB2' ' A' ' 31' ' ' PRO . 69.6 mt -51.04 107.24 0.78 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -168.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.728 ' HD2' ' HZ3' ' A' ' 13' ' ' LYS . 9.7 Cg_endo -90.82 -170.01 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.627 2.884 . . . . 0.0 113.048 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -68.46 -41.6 79.98 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 4.1 m-20 -59.62 149.55 30.0 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.737 0.415 . . . . 0.0 111.782 -171.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.827 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 90.9 mttt -95.05 -40.7 9.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.758 0.313 . . . . 0.0 110.735 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -73.15 -5.58 40.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.749 ' HE2' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -80.87 132.38 35.45 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.45 126.73 50.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.294 0.568 . . . . 0.0 110.592 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 31' ' ' PRO . . . -106.75 -23.68 12.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.704 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.84 148.19 19.83 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.903 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.4 121.8 45.97 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.82 116.42 33.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.517 0.675 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.9 mt-10 -127.64 109.54 11.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.104 -173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.24 101.22 44.5 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.066 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 83' ' ' MET . 31.1 Cg_endo -63.12 -22.86 73.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 123.184 2.589 . . . . 0.0 112.964 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 82' ' ' SER . 9.3 m-20 -69.82 -29.78 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.78 13.37 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.26 23.13 11.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.497 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 69.6 mt -83.56 113.11 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.239 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -144.36 77.65 1.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -134.0 154.3 80.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.938 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.66 139.54 34.15 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.083 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.61 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.5 t -94.58 136.71 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.576 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 11' ' ' LYS . 44.9 m-85 -108.65 92.53 10.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.998 0.428 . . . . 0.0 110.549 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' HD2' ' HE2' ' A' ' 13' ' ' LYS . 7.4 Cg_exo -73.78 102.39 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.308 2.672 . . . . 0.0 112.616 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.74 -179.72 42.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.539 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.827 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 18.3 Cg_endo -62.07 99.62 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.293 1.995 . . . . 0.0 111.091 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.58 124.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.208 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.6 p -127.03 159.5 64.46 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.13 -37.72 58.83 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.916 2.411 . . . . 0.0 112.902 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -66.05 -41.02 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' OE1' ' HD3' ' A' ' 11' ' ' LYS . 14.7 pt20 -83.18 -21.56 33.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.271 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.695 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 93.3 mt -87.38 11.19 15.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.519 0.676 . . . . 0.0 110.095 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -112.44 -13.94 13.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.845 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -121.69 -16.9 7.59 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.549 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -147.12 5.68 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.6 t -125.87 140.31 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.052 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -134.75 161.56 34.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 27.8 m-85 -72.6 160.43 32.27 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.274 175.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.31 68.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.5 170.61 7.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.041 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.17 -35.64 59.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 69.41 160.31 0.19 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.529 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' HG ' ' A' ' 51' ' ' SER . 12.2 pt-20 -139.32 -3.77 1.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.322 0.582 . . . . 0.0 110.991 177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.438 ' HG ' ' HG3' ' A' ' 50' ' ' GLU . 13.9 m -143.84 99.9 3.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 -174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -78.69 -6.22 55.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.838 0.828 . . . . 0.0 109.749 175.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.1 10.94 37.94 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.196 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -86.02 154.07 21.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 3.5 pm0 -83.58 -19.83 34.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.17 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.33 93.43 4.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 110.398 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.403 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 19.9 mm -116.26 129.92 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 118.84 28.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 45' ' ' PHE . 2.0 mt -107.65 129.71 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.2 115.11 29.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.935 0.397 . . . . 0.0 110.973 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -111.17 86.69 0.44 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.202 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 85.4 t60 -87.79 128.3 35.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.065 0.46 . . . . 0.0 110.129 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 127' ' ' ASP . 87.7 m -146.39 133.77 20.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -146.74 17.55 1.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.368 0.604 . . . . 0.0 110.008 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.475 HG13 ' HG3' ' A' ' 67' ' ' ARG . 10.7 tp -88.73 -13.29 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.663 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.94 37.86 27.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.299 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HG3' HG13 ' A' ' 65' ' ' ILE . 99.5 mtt180 -105.86 118.04 56.22 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.644 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.94 0.85 5.17 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.958 2.439 . . . . 0.0 113.439 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 24.98 11.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.026 0.441 . . . . 0.0 110.775 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 179.83 6.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.18 -73.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -91.13 14.76 13.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 m -80.61 -34.15 35.3 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.205 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.69 3.39 33.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.1 -8.78 18.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -62.95 -23.72 67.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.558 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.74 6.94 28.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.284 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.18 144.41 25.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 110.848 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.32 177.63 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.72 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.72 -15.03 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.643 0.735 . . . . 0.0 110.477 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -130.14 57.24 0.73 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.497 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 13.1 m -86.18 -160.9 0.58 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 6.8 tpt -135.56 103.46 5.46 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.075 0.464 . . . . 0.0 109.975 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.594 HG23 ' SD ' ' A' ' 97' ' ' MET . 96.7 t -97.55 125.12 50.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.476 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.4 m-85 -108.45 123.4 48.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.466 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -110.0 104.32 13.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 24.3 ttpp -99.96 105.51 17.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.721 0.772 . . . . 0.0 111.159 -173.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 91' ' ' GLU . 2.4 p -93.56 104.63 15.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.704 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.4 -103.05 0.74 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -113.68 -9.83 13.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 110.596 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.508 ' HB2' HG13 ' A' ' 88' ' ' VAL . 37.9 mt-10 -79.94 131.39 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -108.32 117.22 33.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -99.65 145.02 28.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -110.82 129.29 55.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.383 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -132.91 151.94 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.822 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 14.2 tppt? -117.42 137.15 52.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.594 ' SD ' HG23 ' A' ' 84' ' ' VAL . 90.1 mmm -78.02 43.35 0.43 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.166 0.508 . . . . 0.0 110.906 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -89.1 23.59 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.357 0.599 . . . . 0.0 112.023 -170.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 54.8 m -143.84 51.4 1.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.498 0.666 . . . . 0.0 110.274 174.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 97' ' ' MET . 71.1 mt -91.63 118.19 36.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.641 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.65 148.25 31.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.619 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -104.81 135.19 46.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.314 0.578 . . . . 0.0 111.017 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.94 147.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.215 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -138.9 86.6 15.15 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.48 0.657 . . . . 0.0 111.127 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -96.2 -158.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.352 2.701 . . . . 0.0 111.291 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -172.38 20.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.68 0.753 . . . . 0.0 110.243 171.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -145.08 154.3 42.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 110' ' ' VAL . 28.1 m -120.97 170.29 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.663 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 64.61 -0.77 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.1 0.96 . . . . 0.0 112.823 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' H ' ' C ' ' A' ' 108' ' ' VAL . 13.0 p -84.6 -19.63 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 0.0 110.115 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.8 142.28 31.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.18 145.24 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.296 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.76 137.51 33.7 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -106.68 145.74 31.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.374 0.607 . . . . 0.0 111.84 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 115' ' ' LYS . 10.7 mptt -104.09 150.54 24.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.088 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.99 50.39 1.48 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -94.06 176.13 6.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 0.0 111.546 -176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -117.46 -174.68 2.66 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 169.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 55' ' ' GLN . 3.5 mppt? -74.39 100.25 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -141.23 132.84 27.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.018 0.437 . . . . 0.0 111.138 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.403 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 11.9 mt -99.26 115.23 28.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.602 HG21 HG22 ' A' ' 143' ' ' VAL . 14.3 m -97.19 96.67 8.58 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.321 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.47 104.1 14.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.8 mt -90.24 99.93 10.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.781 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 21.4 p -91.65 141.2 28.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.95 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 31.1 p -151.03 130.66 13.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.9 m-20 -97.11 -54.64 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 109.441 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.28 91.07 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.966 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 62.1 t80 -160.3 116.33 2.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.163 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -110.41 123.11 49.27 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.48 -24.38 62.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.258 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -58.94 -68.3 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.872 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.38 -17.54 19.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.481 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.8 82.58 0.71 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.177 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 14.4 p -131.54 146.35 33.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.714 0.292 . . . . 0.0 110.45 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.442 ' HB2' H122 ' A' ' 201' ' ' 2W7 . 6.7 p90 -152.57 140.9 20.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.348 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -119.77 -70.0 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.714 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.583 ' O ' ' HD2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -165.26 153.64 11.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -170.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.95 ' HG3' ' HA ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -172.47 139.93 1.03 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.433 ' HD3' ' CG2' ' A' ' 100' ' ' ILE . 5.4 tmmm? -78.86 128.62 33.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.96 140.02 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.025 0.441 . . . . 0.0 111.37 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.475 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 97.1 m-85 -109.43 108.44 18.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.424 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 122' ' ' THR . 41.1 t -110.13 121.45 63.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.347 . . . . 0.0 110.43 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -112.12 118.59 35.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.703 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.8 m -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -62.66 124.49 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.58 154.68 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.8 pttt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.683 -175.476 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.707 ' C11' ' H4 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.469 0.176 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -74.63 -177.48 3.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.647 0.737 . . . . 0.0 112.858 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.85 -179.28 4.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.047 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -92.58 146.27 32.03 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.203 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.37 125.44 10.74 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.447 2.098 . . . . 0.0 112.472 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.48 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.8 tp60 -150.7 165.79 32.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.04 104.29 35.23 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 110.434 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 10.9 Cg_endo -89.48 -179.82 2.05 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.177 2.585 . . . . 0.0 111.607 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -90.47 -6.15 55.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.839 0.352 . . . . 0.0 110.569 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.4 t0 -81.74 125.32 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.297 0.57 . . . . 0.0 109.917 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 13.8 mttp -92.7 1.64 57.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.321 -173.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.73 -16.16 28.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.064 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 32.2 mmmt -88.39 172.85 9.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.39 108.0 23.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.517 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.44 -31.61 22.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.141 0.496 . . . . 0.0 110.77 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.59 165.56 29.15 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.732 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -129.88 132.65 46.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -107.57 124.04 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.148 0.499 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 33.8 mt-10 -129.54 116.13 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.443 0.64 . . . . 0.0 111.637 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 HD13 HD12 ' A' ' 25' ' ' ILE . 63.5 mt -127.44 100.58 25.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.41 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.25 -38.38 95.15 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.156 2.571 . . . . 0.0 112.903 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.998 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -123.67 13.75 9.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.316 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 54.95 28.61 10.85 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 74.5 mt -89.9 116.07 30.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 27.8 mtpp -144.48 59.19 1.33 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.907 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 42.6 mm-40 -122.62 156.06 61.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.19 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.54 162.23 40.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.044 2.496 . . . . 0.0 113.166 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.68 134.11 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -91.67 116.15 65.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.024 0.44 . . . . 0.0 111.095 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.25 148.55 80.49 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.379 . . . . 0.0 112.043 175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.93 172.91 13.18 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.348 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.29 166.84 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.909 2.406 . . . . 0.0 111.836 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.558 ' HB1' ' HA ' ' A' ' 46' ' ' ALA . . . -68.15 111.16 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.268 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 p -128.4 139.83 36.64 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.405 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.26 -47.54 19.47 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.592 2.861 . . . . 0.0 113.253 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.47 -42.23 92.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 111.03 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 43.1 tt0 -74.86 -36.97 62.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 34' ' ' ALA . 90.8 mt -79.75 -11.16 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.606 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -98.68 -21.28 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.0 110.114 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.95 -33.5 18.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.07 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -161.28 -145.19 4.23 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.415 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG21 HG22 ' A' ' 59' ' ' ILE . 11.6 p -115.13 138.95 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 58.5 m -150.03 158.2 43.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 58' ' ' SER . 96.3 m-85 -66.52 158.82 28.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.718 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.558 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -98.96 -46.27 5.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.561 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -96.68 144.21 26.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.638 0.733 . . . . 0.0 111.908 -174.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.6 -2.4 55.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.325 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -117.99 18.6 13.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.707 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 15.4 pt-20 -105.84 138.82 41.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.2 m -117.26 150.32 38.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.646 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 pp -73.92 -8.14 54.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.359 0.6 . . . . 0.0 110.419 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.74 2.59 21.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.416 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 5.9 t70 -92.09 -159.23 0.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 55' ' ' GLN . 2.1 tt0 -99.81 -36.23 9.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -95.43 132.43 40.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.111 0.482 . . . . 0.0 110.941 -175.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.454 HG22 HD21 ' A' ' 121' ' ' LEU . 28.0 mm -129.71 120.9 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.504 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 32.7 t -127.68 106.28 9.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.921 0.391 . . . . 0.0 110.334 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG22 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -122.07 119.02 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.07 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.12 42.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.908 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.17 98.15 0.2 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 126' ' ' CYS . 3.6 p-80 -116.19 159.79 21.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.322 0.561 . . . . 0.0 112.32 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 ' CG2' ' HG2' ' A' ' 67' ' ' ARG . 12.9 t 176.7 -176.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -145.71 2.79 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.393 0.615 . . . . 0.0 109.934 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 67' ' ' ARG . 12.2 mm -91.32 47.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.139 0.495 . . . . 0.0 111.76 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.8 -29.9 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.168 0.987 . . . . 0.0 113.061 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.63 ' HD2' ' OD1' ' A' ' 127' ' ' ASP . 6.6 mtp85 60.56 67.55 1.54 Allowed Pre-proline 0 N--CA 1.465 0.305 0 C-N-CA 124.26 1.024 . . . . 0.0 111.903 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 10.6 Cg_endo -103.52 -12.97 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.005 2.47 . . . . 0.0 112.718 170.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -133.85 25.96 3.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.947 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.406 ' O ' HG21 ' A' ' 73' ' ' THR . 9.3 m-85 -100.33 172.9 6.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.775 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.907 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.2 pm0 -72.89 -22.1 60.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.797 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.448 ' CD2' ' HG2' ' A' ' 71' ' ' GLN . 69.3 m-85 -125.35 92.92 3.72 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 173.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 67' ' ' ARG . 34.2 p -107.33 -67.28 0.96 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.018 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.602 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.7 t30 -86.89 25.47 1.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.534 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -66.24 -2.45 4.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.624 0.726 . . . . 0.0 110.528 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 74' ' ' ASN . 20.4 pttp -80.02 -30.22 39.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.172 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.55 -15.25 38.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.843 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.498 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -66.52 135.31 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.997 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -95.7 -175.87 3.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.006 0.431 . . . . 0.0 110.884 -176.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -4.02 53.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . -123.07 28.56 5.58 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.89 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 3.8 m -85.85 131.91 34.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.311 0.577 . . . . 0.0 109.859 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 109.51 10.11 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.669 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.824 HG22 ' HZ ' ' A' ' 142' ' ' PHE . 84.4 t -96.43 116.01 37.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.653 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -98.77 126.38 44.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.458 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' C ' ' HG1' ' A' ' 92' ' ' THR . 52.4 t80 -122.02 110.81 16.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.656 ' HG2' ' HB ' ' A' ' 92' ' ' THR . 46.4 mtmt -101.51 142.89 32.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.246 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.21 89.1 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.765 0.793 . . . . 0.0 109.171 169.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.06 -54.58 4.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.505 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.4 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.0 110.22 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.49 130.57 39.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.518 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.656 ' HB ' ' HG2' ' A' ' 87' ' ' LYS . 2.8 t -121.18 149.59 42.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.558 0.694 . . . . 0.0 111.864 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 146' ' ' GLU . 30.7 mmm180 -115.46 141.34 48.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.27 129.58 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 110.387 -177.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -127.2 147.86 50.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 37.4 ttmt -111.35 149.35 31.28 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.774 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.581 ' HB3' HD11 ' A' ' 100' ' ' ILE . 49.7 mtp -79.77 64.16 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 0.0 110.296 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.3 p -73.45 -34.45 65.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.828 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 8.4 m -115.41 95.36 5.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.187 0.517 . . . . 0.0 110.818 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 97' ' ' MET . 63.2 mt -120.45 119.73 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -151.44 151.26 31.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.807 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -108.24 129.01 55.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.806 HG21 ' HD3' ' A' ' 105' ' ' PRO . 7.5 p -121.06 126.68 75.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.771 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 77.2 52.34 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 111.768 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.806 ' HD3' HG21 ' A' ' 103' ' ' VAL . 97.0 Cg_endo -97.34 170.99 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.268 2.646 . . . . 0.0 111.346 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -66.15 -51.46 57.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -133.54 121.41 22.08 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -61.26 150.87 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HB2' HD23 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -65.71 -24.7 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 0.0 110.694 -175.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.531 ' H ' HG12 ' A' ' 108' ' ' VAL . 9.8 p 48.79 21.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.771 1.228 . . . . 0.0 113.588 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -82.66 176.46 9.34 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.933 -0.479 . . . . 0.0 110.171 174.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.83 152.23 42.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.965 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -94.08 137.01 33.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.64 168.23 9.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 110.388 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -73.38 161.84 30.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.4 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.4 36.52 0.64 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -131.98 -167.44 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -124.81 -168.14 1.77 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.22 104.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -130.22 136.98 49.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.454 HD21 HG22 ' A' ' 57' ' ' ILE . 26.5 mt -92.11 100.26 12.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.1 m -78.53 88.88 4.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 142' ' ' PHE . 39.4 mt -95.37 99.89 11.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.518 0.675 . . . . 0.0 110.262 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.512 HD13 ' H4 ' ' A' ' 201' ' ' 2W7 . 68.9 mt -99.56 97.38 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.053 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -92.71 91.76 7.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.917 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 62' ' ' HIS . 2.9 m -73.62 100.55 3.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.63 ' OD1' ' HD2' ' A' ' 67' ' ' ARG . 28.8 t70 -115.52 47.13 1.37 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.937 0.875 . . . . 0.0 108.769 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.769 ' HB2' ' H ' ' A' ' 137' ' ' GLU . 4.5 p-10 -141.65 -1.47 1.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.933 -170.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.59 109.93 22.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.399 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.48 ' HB3' HG11 ' A' ' 135' ' ' VAL . 14.4 t30 -116.71 113.48 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -34.93 67.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.459 ' HE3' HG21 ' A' ' 133' ' ' THR . 0.1 OUTLIER -57.46 -50.75 72.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.318 0.58 . . . . 0.0 110.501 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.459 HG21 ' HE3' ' A' ' 132' ' ' LYS . 25.5 p -92.02 -22.29 20.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.399 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.63 41.23 29.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.611 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 130' ' ' ASN . 13.7 p -105.3 143.53 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.404 . . . . 0.0 110.93 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.478 ' HB3' ' NH2' ' A' ' 139' ' ' ARG . 2.6 m-90 -128.38 116.24 19.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.999 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.769 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 82.2 mt-10 -104.63 -95.31 0.33 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.421 ' HG3' ' HB3' ' A' ' 137' ' ' GLU . 26.5 mttp -130.18 112.72 13.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.574 -169.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -104.47 129.97 52.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.343 0.592 . . . . 0.0 110.118 175.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.516 ' HE3' HG21 ' A' ' 100' ' ' ILE . 1.8 tmtp? -95.46 126.64 40.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.524 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.63 131.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.054 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.824 ' HZ ' HG22 ' A' ' 84' ' ' VAL . 4.3 t80 -132.14 110.75 10.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.143 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.1 t -114.89 105.95 19.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.922 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.592 ' HB1' ' CZ ' ' A' ' 142' ' ' PHE . . . -92.58 125.38 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.249 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.4 m -97.27 140.83 31.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 93' ' ' ARG . 42.0 tt0 -58.31 121.66 11.34 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.69 0.619 . . . . 0.0 111.009 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.485 HG21 ' N ' ' A' ' 148' ' ' LYS . 2.7 p -124.03 162.9 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.832 0.825 . . . . 0.0 111.654 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.842 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.512 ' H4 ' HD13 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.504 0.192 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -149.24 178.95 8.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.491 0.662 . . . . 0.0 111.434 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.84 -177.94 3.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.657 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -76.8 113.1 26.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.557 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.7 Cg_endo -73.8 136.89 23.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.234 1.956 . . . . 0.0 111.629 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.495 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 35.2 mm-40 -85.17 -167.72 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 52' ' ' LEU . 5.3 mp -81.02 101.53 0.99 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 98.6 Cg_endo -94.32 -166.5 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.05 2.5 . . . . 0.0 113.081 -169.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -75.02 -23.41 58.19 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.554 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 29.4 m-20 -79.17 83.79 5.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.818 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 2.3 pptp? -85.48 -3.27 58.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.359 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.9 m -101.13 3.47 41.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 0.0 111.166 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.546 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 34.1 mmtp -90.6 173.82 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.071 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.17 95.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.802 0.334 . . . . 0.0 110.456 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -82.58 -27.87 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.343 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.29 31.01 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.95 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -135.36 132.94 38.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -103.31 125.57 57.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.3 mt-10 -135.57 104.49 5.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 25' ' ' ILE . 55.9 mt -116.51 100.23 53.31 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 83' ' ' MET . 17.8 Cg_endo -59.85 -30.74 92.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.034 2.489 . . . . 0.0 112.478 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.03 -12.76 61.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.696 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 4.36 3.8 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.551 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.48 27.94 17.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.163 0.506 . . . . 0.0 111.195 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 80.2 mt -88.0 107.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.122 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -139.27 86.38 2.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.276 . . . . 0.0 110.426 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' OE1' ' HB3' ' A' ' 71' ' ' GLN . 53.6 mt-10 -135.54 153.29 77.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.599 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.88 150.37 78.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.6 2.2 . . . . 0.0 112.152 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.09 129.46 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 47.2 m-85 -95.17 107.67 33.64 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.97 -177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 11.3 Cg_endo -54.95 154.01 23.33 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.3 2.666 . . . . 0.0 112.194 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.31 -161.04 18.86 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.767 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' O ' HG21 ' A' ' 35' ' ' THR . 57.4 Cg_endo -93.09 157.86 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.163 2.575 . . . . 0.0 112.435 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 111.34 10.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.251 0.548 . . . . 0.0 110.162 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.417 HG21 ' O ' ' A' ' 33' ' ' PRO . 1.4 t -149.89 143.29 16.54 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.082 -175.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 -23.12 33.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.133 2.555 . . . . 0.0 112.503 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.14 -50.87 66.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.566 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 1.3 tt0 -88.56 -29.54 19.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.838 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.13 1.32 13.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 110.63 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.44 -18.54 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -99.03 -65.16 0.98 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.583 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.59 -148.88 4.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.386 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.57 140.98 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.672 0.272 . . . . 0.0 110.395 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.566 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 15.9 m -131.06 -170.55 2.38 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 56.9 m-85 -99.12 173.41 6.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.27 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.513 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -97.3 -174.48 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -134.84 27.81 3.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.765 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.6 -3.08 6.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.053 0.454 . . . . 0.0 111.009 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -90.41 159.74 16.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.321 0.581 . . . . 0.0 111.717 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -107.22 147.79 29.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.224 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD21 ' O ' ' A' ' 5' ' ' PRO . 3.0 pp -85.62 2.59 44.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.384 0.611 . . . . 0.0 110.282 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.33 4.87 50.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.6 164.91 12.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -94.73 -9.47 34.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.719 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -106.7 90.79 3.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.165 0.507 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mt -109.59 133.86 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.387 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -123.26 116.79 23.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 5.7 mt -108.74 133.23 54.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.69 123.9 46.04 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.905 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -112.66 -171.79 18.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.375 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -139.43 148.52 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.574 0.226 . . . . 0.0 110.728 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.565 ' H ' ' HE2' ' A' ' 129' ' ' TYR . 10.1 t -162.07 143.87 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.55 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.73 -158.81 0.66 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.67 -66.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.63 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.26 84.16 5.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.396 0.617 . . . . 0.0 110.316 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -161.29 105.14 1.23 Allowed Pre-proline 0 C--O 1.213 -0.863 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.381 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.562 ' HA ' HG21 ' A' ' 73' ' ' THR . 71.7 Cg_endo -100.47 -0.82 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.911 2.407 . . . . 0.0 111.908 169.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -118.71 11.99 12.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.928 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.735 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -82.94 160.29 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.676 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.542 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 3.7 pt20 -52.63 -41.67 63.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.386 0.429 . . . . 0.0 111.038 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.905 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 23.4 m-85 -113.66 90.12 3.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.104 0.478 . . . . 0.0 111.062 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 68' ' ' PRO . 6.6 m -150.55 -40.28 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.709 171.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.77 13.82 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.055 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.63 -10.96 56.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.127 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -75.41 -23.18 56.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.14 -13.4 50.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.168 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.82 20.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.676 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -132.42 176.39 8.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.184 0.516 . . . . 0.0 111.089 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 -1.98 54.65 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.828 0.823 . . . . 0.0 109.162 172.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -147.39 38.79 1.07 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.506 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -86.03 -169.89 2.85 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.555 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -115.04 109.29 17.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -177.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 82.0 t -103.34 121.33 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.034 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 67.3 m-85 -101.71 128.55 47.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.813 0.339 . . . . 0.0 110.622 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -116.87 111.39 19.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.5 ' HE2' ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -100.18 135.71 41.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.838 -176.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 91' ' ' GLU . 3.2 p -159.09 112.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.68 -101.82 0.44 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.865 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -112.99 1.47 15.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.947 0.403 . . . . 0.0 110.492 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.508 ' HB2' HG12 ' A' ' 88' ' ' VAL . 16.0 mm-40 -97.44 134.85 40.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.417 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 m -134.16 93.97 3.17 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 22.9 mmt85 -99.27 141.91 31.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HD2' ' SD ' ' A' ' 83' ' ' MET . 25.1 mtmm -102.78 132.16 49.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 86.6 m-85 -119.84 145.29 46.78 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.965 0.412 . . . . 0.0 111.06 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 17.7 tttt -102.04 133.42 46.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.995 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.3 mtp -86.59 53.37 2.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.503 0.668 . . . . 0.0 109.531 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.67 -14.95 59.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.266 -172.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.7 m -124.18 88.31 2.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.582 176.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.0 mt -107.69 108.75 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.973 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -134.09 150.0 51.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.174 0.511 . . . . 0.0 110.554 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.736 ' HB3' ' HZ2' ' A' ' 140' ' ' LYS . 1.9 p-10 -116.27 144.44 44.22 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.5 134.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.574 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.6 mptt -79.78 130.65 66.55 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 9.3 Cg_exo -73.39 41.42 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.636 2.891 . . . . 0.0 113.034 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -71.42 -34.23 70.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.337 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -161.68 151.8 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.779 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.56 -22.02 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.923 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.92 -5.51 56.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.182 0.515 . . . . 0.0 110.628 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.98 -25.21 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.095 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 pp -105.56 153.12 22.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.104 0.478 . . . . 0.0 111.956 -172.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.31 160.07 42.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.72 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CD ' ' HZ1' ' A' ' 117' ' ' LYS . 10.4 pt-20 -130.52 -179.93 5.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -116.36 161.83 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.327 0.584 . . . . 0.0 112.077 -172.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -90.26 132.3 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.714 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.39 64.38 0.35 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.552 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.511 ' HZ1' ' CD ' ' A' ' 113' ' ' GLU . 34.3 mmtp -89.86 165.98 13.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.712 0.768 . . . . 0.0 111.863 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -108.89 -168.18 1.31 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 55' ' ' GLN . 3.4 mppt? -74.52 102.88 4.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -137.92 142.51 40.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 116.62 32.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m -96.48 94.12 7.2 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.701 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -82.13 107.32 14.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.752 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.73 81.71 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 24.5 m -91.87 96.67 10.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.606 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 95.4 m -71.45 90.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.631 ' OD2' ' HE2' ' A' ' 138' ' ' LYS . 25.9 t0 -80.14 9.32 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.048 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.623 ' HB2' ' HZ1' ' A' ' 138' ' ' LYS . 15.9 t70 -164.81 106.8 0.84 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.574 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.565 ' HE2' ' H ' ' A' ' 63' ' ' THR . 32.1 p90 -146.11 137.11 24.48 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -97.97 115.13 27.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.38 -14.8 62.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.8 -174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -76.1 -67.78 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.216 0.531 . . . . 0.0 110.461 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -19.28 23.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.912 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.01 38.08 14.27 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.263 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.74 149.09 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.625 0.25 . . . . 0.0 110.334 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -140.87 123.34 15.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.598 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.32 -58.94 2.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.631 ' HE2' ' OD2' ' A' ' 127' ' ' ASP . 24.2 pttm -116.06 123.98 49.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 111.579 -174.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 139' ' ' ARG . 37.8 ttm-85 -110.88 103.5 12.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.918 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.736 ' HZ2' ' HB3' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -97.08 101.93 13.6 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 110.332 -177.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.26 130.13 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.626 0.727 . . . . 0.0 111.514 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.53 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 97.9 m-85 -106.16 119.55 39.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.117 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.8 t -105.4 102.33 13.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.17 120.91 43.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.735 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.6 m -92.32 140.26 29.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.59 116.66 6.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.902 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.57 157.33 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.807 0.813 . . . . 0.0 110.569 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.488 -172.257 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HG3' ' H ' ' A' ' 2' ' ' GLN . 19.5 ptt? . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.44 0.162 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.653 ' H ' ' HG3' ' A' ' 1' ' ' MET . 43.0 mt-30 -142.62 -155.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.92 157.39 7.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.251 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 6' ' ' GLN . 62.9 pttt -72.34 146.33 89.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -55.23 117.64 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.984 2.456 . . . . 0.0 111.967 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.507 ' OE1' ' HE3' ' A' ' 4' ' ' LYS . 6.7 tp60 -141.29 169.79 16.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.941 HD12 ' HB3' ' A' ' 52' ' ' LEU . 16.0 mm -97.82 110.83 57.11 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 6.7 Cg_exo -73.78 173.32 14.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.62 2.213 . . . . 0.0 111.4 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -108.39 22.39 16.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.652 0.739 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.85 145.38 47.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.215 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.7 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 1.5 mptt -88.04 -14.23 39.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.655 0.264 . . . . 0.0 111.3 -171.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.0 t -89.16 -17.86 28.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.468 0.651 . . . . 0.0 109.712 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -80.08 86.34 5.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.55 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.43 104.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.743 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 -27.68 25.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -157.61 177.17 34.52 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.175 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 132.58 39.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.54 122.9 55.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.039 0.447 . . . . 0.0 109.862 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mt-10 -135.16 120.27 18.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.437 0.637 . . . . 0.0 111.751 -177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 25' ' ' ILE . 74.1 mt -124.97 103.23 30.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.305 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.17 -22.72 72.97 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.164 2.576 . . . . 0.0 112.854 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.67 -31.38 72.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.041 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.26 3.96 10.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.928 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 63.33 24.65 14.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.606 0.717 . . . . 0.0 110.464 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.2 mt -75.97 112.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.97 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 61.0 mtpt -145.64 95.09 2.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.744 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' CD ' ' HB3' ' A' ' 71' ' ' GLN . 11.9 pt-20 -152.13 155.69 33.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.25 154.41 74.23 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.485 2.123 . . . . 0.0 112.369 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.614 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 62.6 t -97.56 129.64 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -93.21 107.24 24.05 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.992 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 24.2 Cg_exo -64.95 144.69 83.61 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.01 2.474 . . . . 0.0 112.118 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.48 179.56 17.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.697 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.26 145.61 19.17 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.67 99.98 0.17 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -129.05 144.46 52.75 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.297 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.51 -41.05 76.41 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.143 2.562 . . . . 0.0 113.029 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.04 -43.39 87.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.717 0.294 . . . . 0.0 111.173 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.07 -40.25 65.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.81 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.46 -15.84 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.874 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.27 -9.84 58.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.246 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -104.54 -21.51 13.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 -167.19 40.16 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.542 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.567 HG22 HG21 ' A' ' 59' ' ' ILE . 14.8 p -86.93 137.45 20.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.119 0.485 . . . . 0.0 110.242 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 m -139.28 171.67 13.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -82.1 171.13 14.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.396 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -123.67 -33.88 3.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.727 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 1.5 pm0 -81.02 -177.44 6.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.791 -169.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.88 -18.27 16.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.65 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -90.2 134.97 33.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.695 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.07 28.89 0.87 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.054 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.6 m -105.51 160.59 15.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.593 . . . . 0.0 111.078 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.941 ' HB3' HD12 ' A' ' 7' ' ' ILE . 1.5 pp -123.58 -1.97 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.425 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -149.16 54.46 0.97 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.408 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 11.1 p-10 -89.79 -61.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER 178.82 -65.27 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 122.764 0.426 . . . . 0.0 110.688 178.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 97.17 7.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.546 0.689 . . . . 0.0 112.1 -172.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 30.4 mm -103.44 140.5 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.704 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -127.91 96.59 4.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.091 0.472 . . . . 0.0 110.229 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.567 HG21 HG22 ' A' ' 43' ' ' VAL . 1.1 mt -93.13 118.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 136.34 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.725 0.298 . . . . 0.0 111.541 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.74 134.38 7.54 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -136.46 19.83 3.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.408 0.604 . . . . 0.0 111.489 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -88.07 15.94 6.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.539 0.685 . . . . 0.0 111.132 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HD1' HG21 ' A' ' 73' ' ' THR . 88.1 t80 -93.22 94.22 8.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.565 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.6 tp -164.66 -51.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -96.0 -28.12 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.226 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -111.3 122.6 37.22 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.675 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -87.18 0.22 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.432 2.755 . . . . 0.0 111.425 171.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.94 50.8 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.71 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.704 ' HD2' ' HG2' ' A' ' 71' ' ' GLN . 2.0 t80 -132.17 -169.12 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.266 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.765 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 2.8 pt20 -33.06 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.765 ' H ' ' HG3' ' A' ' 71' ' ' GLN . 55.3 m-85 -96.15 29.8 2.68 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.95 -0.469 . . . . 0.0 111.7 -169.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.625 HG21 ' HD1' ' A' ' 64' ' ' PHE . 73.4 p -78.08 -41.13 36.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.233 0.539 . . . . 0.0 110.876 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.66 12.69 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.034 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.404 HD23 ' CD1' ' A' ' 72' ' ' PHE . 24.0 tp -63.13 -15.31 56.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.007 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -62.92 -23.29 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.297 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.99 -10.09 59.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.417 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.8 133.87 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.25 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.04 -176.55 3.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.074 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -70.61 -0.75 9.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.847 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.66 62.66 0.54 Allowed Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 p -96.78 -159.1 0.71 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.577 ' HE1' ' HA ' ' A' ' 83' ' ' MET . 2.2 tpt -139.35 89.94 2.38 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.1 t -77.23 117.19 21.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.004 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -98.1 109.35 22.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.293 0.568 . . . . 0.0 110.594 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 33.9 t80 -99.55 99.1 9.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 42.2 mtpt -94.93 140.49 29.87 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.452 -177.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 91' ' ' GLU . 2.9 m -143.83 108.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.857 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.89 -98.18 0.54 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.35 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -124.56 6.86 8.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.49 ' HB2' HG22 ' A' ' 88' ' ' VAL . 14.4 mm-40 -85.04 142.95 29.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -126.1 112.71 16.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.101 0.477 . . . . 0.0 110.026 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 7.9 mmm180 -106.92 120.78 42.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.48 ' HB3' ' HE2' ' A' ' 83' ' ' MET . 17.8 mtmt -96.71 133.72 40.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.503 ' CD2' HD23 ' A' ' 121' ' ' LEU . 94.0 m-85 -130.52 146.21 52.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.187 0.518 . . . . 0.0 111.474 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 14.8 tptm -108.24 127.85 54.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.188 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.437 ' HB3' HD13 ' A' ' 100' ' ' ILE . 65.9 mtp -78.4 70.41 4.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.91 -175.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.3 p -67.92 -42.14 81.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.536 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.7 m -114.15 105.89 13.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 97' ' ' MET . 66.3 mt -126.83 95.05 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.623 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -145.49 152.31 39.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.868 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.806 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 9.3 p-10 -104.06 137.71 41.63 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.083 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.73 139.26 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.27 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 137' ' ' GLU . 82.7 tttt -112.49 90.67 15.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.896 0.379 . . . . 0.0 110.334 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HB2' HG12 ' A' ' 110' ' ' VAL . 97.3 Cg_endo -88.84 -31.85 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.2 m 72.57 -46.73 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.416 0.687 . . . . 0.0 112.16 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.36 162.89 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 110.24 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.4 -34.39 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.416 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.56 80.8 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.447 0.641 . . . . 0.0 111.444 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.593 HG12 ' HB2' ' A' ' 105' ' ' PRO . 27.7 m -111.48 -6.2 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.972 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.733 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -146.36 170.1 17.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.654 0.264 . . . . 0.0 110.367 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.75 92.17 5.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.283 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.73 133.99 44.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.958 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mttp 52.3 -172.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.712 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.1 130.92 24.86 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -90.33 -178.65 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.76 -174.55 2.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.618 ' HE3' ' OE1' ' A' ' 146' ' ' GLU . 17.4 mtpp -93.71 95.56 9.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.005 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -145.87 162.51 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.435 -172.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.503 HD23 ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -112.66 120.69 42.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 171.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.5 m -83.16 89.72 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 92.2 mt -76.05 104.44 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.355 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.19 100.17 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.545 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.1 p -109.8 103.79 12.66 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.095 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.7 m -70.22 92.6 0.78 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -134.59 99.41 4.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.4 OUTLIER 175.61 93.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.56 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 52.9 p90 -74.18 137.97 43.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.724 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 132' ' ' LYS . 25.5 p-10 -81.0 12.05 3.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.305 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 129' ' ' TYR . 12.7 pt-20 53.8 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.445 1.898 . . . . 0.0 114.718 -178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 130' ' ' ASN . 9.3 tmtm? -61.24 -57.74 11.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.336 0.588 . . . . 0.0 110.053 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -126.78 -24.23 3.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.511 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' A' ' 129' ' ' TYR . . . 98.21 44.05 2.66 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.18 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 p -94.16 148.34 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -80.63 94.14 6.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.22 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 39.6 mt-10 -84.4 -59.16 2.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.284 0.564 . . . . 0.0 111.513 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.806 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 32.8 ttmt -80.25 135.61 36.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 -172.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' NH1' ' O3 ' ' A' ' 201' ' ' 2W7 . 0.0 OUTLIER -94.24 101.18 13.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HZ2' ' HG3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -83.73 113.07 20.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.113 -175.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.77 136.2 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.677 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 96.5 m-85 -117.16 112.22 20.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.474 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 89.5 t -99.89 111.62 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -110.9 114.11 27.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.545 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -90.69 146.64 23.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.934 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.618 ' OE1' ' HE3' ' A' ' 119' ' ' LYS . 70.4 tt0 -62.92 141.11 58.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.217 0.532 . . . . 0.0 111.934 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 1.4 t -114.62 163.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.023 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.312 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.491 ' O3 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.48 135.94 45.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.33 87.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.871 0.732 . . . . 0.0 109.708 -170.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -62.01 141.53 95.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.988 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.36 109.57 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.846 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.89 160.9 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.904 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HD11 ' A' ' 7' ' ' ILE . 3.5 mp -70.39 116.88 49.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.18 150.73 71.97 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.198 2.598 . . . . 0.0 113.376 -174.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -70.87 -27.42 63.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.064 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -84.5 159.35 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.782 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.62 22.93 14.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -172.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 t -120.56 -33.02 3.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.68 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -63.52 105.61 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 28' ' ' PRO . 1.3 p -58.2 112.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.999 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.07 24.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.588 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.98 157.6 24.89 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -121.45 131.48 54.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD11 HG11 ' A' ' 84' ' ' VAL . 8.1 tp -105.93 121.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.214 0.53 . . . . 0.0 110.334 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 94.8 mt-10 -129.78 109.64 11.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.468 0.652 . . . . 0.0 111.186 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.475 HD12 HD12 ' A' ' 25' ' ' ILE . 66.5 mt -120.64 99.21 47.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.047 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.43 -35.54 98.57 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.049 2.499 . . . . 0.0 113.128 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.21 -33.57 71.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.472 ' HB1' HG13 ' A' ' 25' ' ' ILE . . . -111.6 7.21 20.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.949 -175.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.07 26.58 16.01 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.585 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.899 HG23 ' HB2' ' A' ' 71' ' ' GLN . 61.6 mt -81.17 115.03 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.824 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 6.1 ttpm? -147.12 61.57 1.18 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.8 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 26.2 mm-40 -121.67 153.37 59.69 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.886 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HB3' HG23 ' A' ' 14' ' ' VAL . 7.8 Cg_exo -70.15 147.98 61.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.526 2.151 . . . . 0.0 111.84 175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.1 t -96.34 123.97 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.491 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.8 m-85 -97.03 102.32 11.79 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.831 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.491 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 11.5 Cg_endo -55.42 139.7 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.403 2.735 . . . . 0.0 112.735 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.34 170.22 11.94 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 162.0 37.51 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.71 2.273 . . . . 0.0 112.435 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -65.4 100.4 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.646 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 p -130.62 140.36 38.43 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.065 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.53 -8.39 10.81 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.254 2.636 . . . . 0.0 113.319 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -94.75 -38.93 10.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.616 0.246 . . . . 0.0 110.795 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.08 -37.82 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.422 . . . . 0.0 110.171 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.09 -13.13 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.8 -38.96 92.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.367 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.4 -40.09 89.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.36 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.9 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.832 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 60' ' ' ALA . 2.6 p -138.45 139.59 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.306 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -140.09 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -74.22 140.24 44.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.697 ' HB1' ' HB1' ' A' ' 60' ' ' ALA . . . -87.35 -43.6 12.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.71 177.85 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.096 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.4 55.2 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.867 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.31 89.58 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.073 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.22 7.15 43.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.86 0.838 . . . . 0.0 109.764 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m -130.0 147.92 51.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.541 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.97 7.68 10.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.374 0.607 . . . . 0.0 110.505 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.27 35.71 2.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.617 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 5.9 p-10 -86.8 -95.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.442 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -173.45 -18.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 176.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -112.31 83.25 1.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.282 0.563 . . . . 0.0 109.715 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 40.8 mm -94.6 86.74 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.389 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -91.73 103.65 16.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.254 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.492 HD13 HD22 ' A' ' 121' ' ' LEU . 1.1 mt -101.56 137.58 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.697 ' HB1' ' HB1' ' A' ' 46' ' ' ALA . . . -104.41 123.83 48.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.993 0.425 . . . . 0.0 111.205 -176.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.68 -179.15 16.1 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -159.79 155.97 26.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.428 0.614 . . . . 0.0 110.882 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.17 162.73 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.519 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.51 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 12.7 t80 -146.34 113.2 6.08 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 tp -83.67 -21.12 8.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.885 -170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 57.0 m-20 -82.3 -34.46 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.73 -176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 32.0 mmm-85 -135.01 120.49 14.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.687 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 2.9 Cg_exo -77.74 -12.52 16.52 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.064 2.509 . . . . 0.0 112.903 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -81.87 16.73 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.908 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.88 -169.12 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.899 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.18 -51.62 3.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.79 0.329 . . . . 0.0 111.5 -178.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.805 ' HD1' ' HG2' ' A' ' 71' ' ' GLN . 9.2 m-85 -84.46 22.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 0.0 111.494 -175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 p -89.95 -34.86 15.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.5 t30 -102.94 19.59 19.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.164 0.507 . . . . 0.0 111.082 -173.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.494 HD13 ' CE2' ' A' ' 142' ' ' PHE . 11.5 mt -64.1 -5.99 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.01 -18.76 60.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.89 5.39 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.422 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.31 145.52 25.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.333 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 79' ' ' LYS . 8.3 mptt -117.36 173.82 6.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.0 110.253 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -3.17 27.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.756 177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.7 25.38 4.73 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.466 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 75.7 m -78.16 -165.12 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.258 0.551 . . . . 0.0 110.443 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -131.35 120.3 22.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.813 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 18' ' ' ILE . 87.3 t -107.41 109.81 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.577 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.05 119.46 32.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.396 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -112.7 110.25 20.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.962 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.46 146.66 27.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 91' ' ' GLU . 3.4 p -156.78 112.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.25 0.548 . . . . 0.0 109.925 174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 -98.24 0.33 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -125.56 6.99 7.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.262 0.554 . . . . 0.0 109.881 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.491 ' HB2' HG12 ' A' ' 88' ' ' VAL . 20.1 mm-40 -90.11 139.11 30.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.468 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -145.86 120.57 9.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 3.3 mpt_? -122.14 153.93 38.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -102.83 126.64 50.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.186 -176.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 90.5 m-85 -124.84 155.83 38.81 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 96' ' ' LYS . 24.7 ttmm -128.62 150.12 50.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.447 ' SD ' ' HB2' ' A' ' 78' ' ' ALA . 48.6 mtp -83.94 59.59 5.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.515 0.674 . . . . 0.0 109.959 -173.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -66.22 -45.43 80.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.175 -172.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.6 m -106.97 100.75 10.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.31 0.576 . . . . 0.0 110.745 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' CG2' ' HE3' ' A' ' 140' ' ' LYS . 59.7 mt -118.31 112.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.596 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.07 141.59 34.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 1.9 p-10 -108.68 121.12 44.37 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.437 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.779 ' HB ' ' HB2' ' A' ' 139' ' ' ARG . 15.7 t -77.96 121.95 31.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.664 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.716 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -103.63 132.7 20.81 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.6 99.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.319 2.679 . . . . 0.0 113.728 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.3 m -126.98 -49.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.681 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.5 144.28 30.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.966 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.04 -28.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -94.85 35.39 1.26 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.667 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.24 8.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.239 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.523 HD23 ' HY2' ' A' ' 201' ' ' 2W7 . 2.9 mm? -74.81 153.27 38.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.594 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -130.09 154.83 47.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.722 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -100.58 6.51 44.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.056 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.18 98.13 9.2 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -96.23 33.5 1.74 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.631 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.88 87.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.416 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -135.22 -173.67 3.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 0.0 110.93 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.78 -161.91 0.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.585 ' HZ3' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.91 103.18 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.61 146.84 52.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.529 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.529 ' HG ' ' HB ' ' A' ' 57' ' ' ILE . 6.2 mp -107.35 109.96 21.83 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.518 HG23 HG22 ' A' ' 143' ' ' VAL . 19.9 m -89.43 99.07 12.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.892 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 81.0 mt -80.05 108.28 13.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 0.0 110.464 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.479 HG23 HH21 ' A' ' 139' ' ' ARG . 58.5 mt -93.77 103.65 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.424 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 m -99.73 129.05 45.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.267 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.9 m -87.12 96.32 10.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.029 170.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 138' ' ' LYS . 3.3 m-20 -89.99 161.68 15.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 52.57 47.4 24.77 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.701 0.626 . . . . 0.0 111.361 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 19.8 p90 -82.48 144.02 30.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.731 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -112.26 107.4 16.25 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.09 -26.85 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.085 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -70.86 -55.93 7.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.609 0.242 . . . . 0.0 111.317 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.529 ' HG1' HG22 ' A' ' 135' ' ' VAL . 43.0 p -96.47 -22.18 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.98 32.87 9.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.599 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.529 HG22 ' HG1' ' A' ' 133' ' ' THR . 87.6 t -89.13 139.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 110.824 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -133.19 114.61 14.04 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.849 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -91.54 -67.23 0.87 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.257 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 127' ' ' ASP . 4.1 ttpm? -80.94 137.75 36.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.779 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 21.3 mmm-85 -125.9 86.43 2.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.515 ' HE3' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -76.09 108.01 8.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 0.0 110.295 -176.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.8 mm -97.11 130.34 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.335 0.588 . . . . 0.0 110.659 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 81.5 m-85 -120.04 101.16 7.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.675 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.5 t -93.04 102.07 13.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -89.97 110.69 21.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.807 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 m -83.85 143.85 29.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.206 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 34.0 tt0 -62.97 129.73 41.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.815 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.82 155.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 pttp . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.456 -174.481 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.523 ' HY2' HD23 ' A' ' 111' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.019 0.438 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -87.8 -179.46 6.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.892 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 -175.27 3.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.42 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -62.41 131.92 94.03 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.296 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' CG ' ' HB ' ' A' ' 88' ' ' VAL . 31.5 Cg_endo -63.55 126.79 18.3 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.009 2.473 . . . . 0.0 113.147 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -134.48 -171.98 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.181 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.432 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 62.7 mt -110.98 104.62 56.44 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.896 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 31' ' ' PRO . 86.7 Cg_endo -84.46 -170.52 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.122 2.548 . . . . 0.0 112.54 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 37.6 mtmt -84.37 -13.18 53.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 m-20 -94.84 106.58 18.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.729 -172.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.605 ' HD3' ' H ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -82.55 13.48 3.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.092 173.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 p -98.83 -7.93 26.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.661 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -91.34 179.85 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.741 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.77 109.04 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.753 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB2' HD12 ' A' ' 52' ' ' LEU . . . -88.74 -28.93 20.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.248 0.547 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.55 37.29 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.207 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 124.23 37.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tp -99.28 123.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 109.892 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 87' ' ' LYS . 38.3 mt-10 -134.86 128.19 32.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.049 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.4 mt -129.25 96.84 27.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.2 Cg_endo -59.55 -25.31 78.38 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.4 2.733 . . . . 0.0 112.545 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.35 -24.72 67.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.8 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.94 7.14 9.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.712 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 58.21 25.42 12.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.299 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 61.3 mt -77.48 131.63 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.012 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -158.71 90.07 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.63 150.24 53.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.273 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.4 152.53 60.68 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.861 2.374 . . . . 0.0 112.045 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.504 ' HA ' HG13 ' A' ' 43' ' ' VAL . 47.7 t -106.99 132.14 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.1 m-85 -91.39 111.07 47.02 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.744 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 Cg_endo -62.66 116.39 3.5 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.238 2.625 . . . . 0.0 112.63 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.48 -179.55 37.71 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.71 154.87 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.599 2.199 . . . . 0.0 112.073 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.86 131.52 44.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 111.072 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 t -155.96 148.5 17.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.807 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.27 -37.69 24.8 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.797 2.998 . . . . 0.0 112.88 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 74.0 mm-40 -62.84 -52.12 64.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.125 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 11' ' ' LYS . 13.1 mm100 -65.37 -42.91 92.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.699 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.23 -6.16 32.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.567 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -100.33 -10.13 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 0.0 109.934 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 62.8 mtt180 -111.65 -37.7 5.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.249 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.15 -166.78 36.51 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.504 HG13 ' HA ' ' A' ' 29' ' ' VAL . 6.3 p -90.6 137.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.24 0.543 . . . . 0.0 111.074 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -134.6 -171.87 2.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.704 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.47 ' CZ ' HD23 ' A' ' 52' ' ' LEU . 77.3 m-85 -99.25 156.0 17.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.003 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.69 -66.98 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.248 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 43.3 mt-10 -82.49 121.11 26.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.915 0.388 . . . . 0.0 110.879 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.88 -1.25 27.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.682 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.74 -6.66 17.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.187 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 22.5 tt0 -86.38 158.79 19.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.577 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.7 m -122.17 142.38 50.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.762 0.315 . . . . 0.0 111.712 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 57' ' ' ILE . 14.3 mt -64.35 -12.49 42.88 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.024 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -119.39 26.28 9.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.859 0.838 . . . . 0.0 109.806 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 2.9 t70 -95.58 -166.58 1.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.296 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.757 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.7 pt20 -81.09 -34.08 32.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.719 0.295 . . . . 0.0 110.675 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -122.39 146.66 47.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 52' ' ' LEU . 7.9 mm -128.63 108.02 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.536 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -91.49 105.89 18.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 HG21 ' CG2' ' A' ' 43' ' ' VAL . 1.3 mt -103.59 140.03 22.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.96 126.01 48.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.793 0.33 . . . . 0.0 110.899 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -140.99 -177.32 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -138.07 122.15 17.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.547 0.674 . . . . 0.0 111.93 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 5.6 m -79.25 154.48 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.966 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 67' ' ' ARG . 4.1 t80 -164.72 86.0 0.43 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.0 mt -59.19 -35.64 58.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.347 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -68.56 -23.13 64.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 0.0 111.717 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -116.14 102.42 53.74 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.889 -178.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.604 ' HA ' HG21 ' A' ' 73' ' ' THR . 32.2 Cg_exo -59.28 -23.93 72.01 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.994 2.463 . . . . 0.0 112.685 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -88.63 13.93 11.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -92.8 -172.15 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.124 173.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.412 HE22 ' HB ' ' A' ' 43' ' ' VAL . 45.0 mt-30 -74.93 -81.44 0.07 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.558 0.694 . . . . 0.0 112.347 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 90.9 m-85 -89.82 37.11 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.211 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.604 HG21 ' HA ' ' A' ' 68' ' ' PRO . 2.8 m -62.14 -29.13 70.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.975 0.417 . . . . 0.0 110.975 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -102.04 6.38 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.37 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.709 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 1.8 tm? -61.19 -27.53 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.362 0.601 . . . . 0.0 109.529 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -56.1 -24.42 40.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.945 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -87.31 0.19 55.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.04 165.33 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.78 -176.78 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.014 0.435 . . . . 0.0 110.744 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -1.61 25.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.495 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.92 27.28 5.44 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 74.9 m -82.67 155.59 24.28 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.381 0.61 . . . . 0.0 109.704 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.482 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -97.94 111.82 23.98 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.212 -176.515 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.29 116.5 36.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -107.64 130.53 54.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.509 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -121.15 106.47 11.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HZ2' ' CD ' ' A' ' 19' ' ' GLU . 14.7 mtmm -86.25 136.8 33.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.93 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 91' ' ' GLU . 3.2 m -139.87 93.14 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.0 -117.2 4.64 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.12 -9.54 33.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.505 0.669 . . . . 0.0 109.941 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 1.5 mm-40 -77.62 144.17 37.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.482 0.658 . . . . 0.0 111.218 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -141.47 97.54 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.471 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -80.3 135.39 36.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.316 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 20.7 mtmm -103.48 125.17 49.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 146' ' ' GLU . 85.3 m-85 -123.22 150.6 43.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HZ1' ' HB ' ' A' ' 98' ' ' THR . 25.3 ttpp -114.05 139.2 49.47 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 82' ' ' SER . 69.4 mtp -83.88 50.6 1.85 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 109.934 -174.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.483 ' HB ' ' HZ1' ' A' ' 96' ' ' LYS . 1.8 t -78.43 2.46 18.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.253 -170.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.533 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.8 m -145.18 102.6 3.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.77 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.98 137.04 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.556 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 34.0 ttm-85 -154.02 157.89 39.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.369 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.424 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 7.1 p-10 -129.44 137.34 50.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 139' ' ' ARG . 26.5 m -117.57 -177.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.342 . . . . 0.0 111.456 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' HZ1' ' HB ' ' A' ' 110' ' ' VAL . 26.2 pttm -90.65 154.92 46.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.334 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 136' ' ' TRP . 74.2 Cg_endo -77.51 178.84 7.13 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.874 2.383 . . . . 0.0 112.431 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.6 p 54.02 23.61 4.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.656 0.782 . . . . 0.0 111.92 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -165.44 141.32 5.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.05 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.5 -2.99 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 112' ' ' ASP . 12.3 pt-20 -93.77 -3.1 52.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.528 -174.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.509 HG11 ' HB ' ' A' ' 103' ' ' VAL . 4.9 p -56.04 -39.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 mp -130.75 100.89 5.44 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.107 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 109' ' ' GLU . 37.9 t0 -152.93 -169.78 3.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.627 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.503 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 10.2 pt-20 42.27 63.69 1.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.138 0.899 . . . . 0.0 111.077 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.416 ' C ' ' H ' ' A' ' 116' ' ' GLY . 1.3 mp0 -61.94 132.95 54.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.019 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.88 36.02 0.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.423 0.63 . . . . 0.0 109.921 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . 107.58 143.59 10.95 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.372 -175.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.54 168.77 18.97 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.4 t70 -127.41 -161.32 1.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -102.63 83.4 2.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.685 0.755 . . . . 0.0 109.511 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.535 ' CB ' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -165.37 177.12 7.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.794 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.509 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 15.7 mt -107.6 132.45 53.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.3 m -101.14 86.27 2.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.584 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.1 mp -79.95 110.87 15.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.361 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.551 HD11 ' H4 ' ' A' ' 201' ' ' 2W7 . 37.6 mt -96.64 93.88 3.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.508 ' HB ' ' HE2' ' A' ' 142' ' ' PHE . 13.9 m -123.55 71.4 1.08 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.961 0.41 . . . . 0.0 110.699 -174.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.37 120.31 7.44 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 75.5 m-20 -65.73 -41.64 91.99 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.505 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.07 149.74 21.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.022 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -179.14 102.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.832 0.708 . . . . 0.0 110.22 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.33 98.41 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -166.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 132' ' ' LYS . 1.4 tmtp? -62.53 -61.02 2.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.284 0.564 . . . . 0.0 110.551 -176.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.1 p -75.83 -28.85 58.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.43 40.91 9.52 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.148 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.18 133.92 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.367 0.603 . . . . 0.0 111.323 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.546 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 4.5 p90 -146.9 85.8 1.63 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.672 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 105' ' ' PRO . 39.5 mt-10 -65.01 -67.0 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.789 -172.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -79.85 96.34 6.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.376 0.608 . . . . 0.0 111.371 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.687 HH21 ' C11' ' A' ' 201' ' ' 2W7 . 40.1 mmm-85 -80.61 103.27 10.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.815 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.522 ' HD2' ' CZ ' ' A' ' 142' ' ' PHE . 8.3 mmtp -96.35 129.45 43.68 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 tp -123.33 123.24 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.624 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 70.7 m-85 -112.92 109.58 19.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.334 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 95.8 t -93.94 102.89 14.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.0 110.03 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -106.96 101.14 10.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.146 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 120' ' ' GLN . 3.1 m -83.81 143.51 29.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 44.9 tt0 -60.99 129.8 43.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.2 0.524 . . . . 0.0 111.593 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.48 160.49 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.324 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 75.2 mttt . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.696 -169.629 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.687 ' C11' HH21 ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' ' HA2' ' A' ' 89' ' ' GLY . 21.5 ptp . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.694 0.283 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.25 -14.73 16.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.66 174.29 12.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.192 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HZ2' ' CD ' ' A' ' 91' ' ' GLU . 20.4 ptmt -74.69 117.41 62.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.557 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' O ' HD21 ' A' ' 52' ' ' LEU . 61.7 Cg_endo -79.31 114.72 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.665 2.243 . . . . 0.0 113.273 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 52' ' ' LEU . 11.0 tp60 -95.82 89.23 5.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.737 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.488 HD13 ' O ' ' A' ' 50' ' ' GLU . 76.8 mt 24.98 91.57 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 125.068 1.48 . . . . 0.0 113.657 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.5 -179.93 5.9 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.664 2.243 . . . . 0.0 112.581 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -75.09 -44.6 46.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.075 0.464 . . . . 0.0 110.897 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.99 140.71 37.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.851 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -109.67 18.9 19.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.807 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -90.9 -17.31 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.156 0.503 . . . . 0.0 110.37 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.82 154.78 19.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG22 ' CB ' ' A' ' 28' ' ' PRO . 6.9 p -97.68 135.7 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.96 -21.14 13.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.637 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.78 174.9 37.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.249 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -126.73 139.95 52.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.217 0.207 . . . . 0.0 110.628 178.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.41 127.91 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.5 mt-10 -136.21 122.31 20.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.042 0.448 . . . . 0.0 111.561 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.474 HD13 HD13 ' A' ' 25' ' ' ILE . 67.7 mt -129.55 95.57 29.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -58.34 -33.59 97.9 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.082 2.522 . . . . 0.0 112.702 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.09 -15.66 63.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.131 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.38 4.87 9.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 60.63 26.17 15.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.982 0.42 . . . . 0.0 111.628 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.6 mt -86.26 120.2 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 22.8 ttmm -156.09 98.61 1.89 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' A' ' 71' ' ' GLN . 12.5 pt-20 -152.0 156.89 34.3 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.585 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.44 ' CB ' HG22 ' A' ' 14' ' ' VAL . 57.3 Cg_endo -74.15 152.34 45.21 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.608 2.205 . . . . 0.0 112.043 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.05 132.79 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -93.94 111.36 52.69 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.47 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 12.2 Cg_endo -56.98 130.88 42.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.031 2.488 . . . . 0.0 111.848 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.9 174.33 16.08 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.55 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.24 169.94 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.432 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 39' ' ' LEU . . . -73.7 121.78 21.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.908 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.805 ' H ' HD22 ' A' ' 39' ' ' LEU . 2.2 t -161.01 141.38 8.36 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -38.43 -66.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.487 3.458 . . . . 0.0 115.489 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -28.9 69.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.45 ' HB3' HG23 ' A' ' 35' ' ' THR . 7.1 tp60 -72.55 -52.23 16.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.389 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.805 HD22 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -65.47 -20.95 66.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.469 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.37 -29.3 67.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.9 0.381 . . . . 0.0 110.412 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -82.35 -38.78 23.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.76 -158.63 21.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.611 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG23 ' OE2' ' A' ' 27' ' ' GLU . 41.0 t -77.41 141.31 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.714 0.293 . . . . 0.0 110.804 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -142.36 167.33 22.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m-85 -87.58 176.57 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.973 0.416 . . . . 0.0 111.405 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.73 -40.19 7.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.189 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 42.8 mt-10 -108.69 141.55 40.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.42 -0.86 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.141 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.19 -13.03 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.68 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' O ' HD13 ' A' ' 7' ' ' ILE . 13.1 pt-20 -63.25 131.92 49.95 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 16.7 m -94.29 121.29 35.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.894 0.378 . . . . 0.0 110.745 -173.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.66 ' HA ' HD12 ' A' ' 57' ' ' ILE . 1.3 pp -71.13 -5.56 32.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.48 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -110.84 2.76 18.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.109 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.0 t70 -108.08 -156.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.774 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.551 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 48.7 tt0 -91.46 -42.79 10.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.941 0.496 . . . . 0.0 111.88 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -91.75 123.33 35.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 111.489 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 52' ' ' LEU . 24.2 mm -132.4 132.75 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.153 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.448 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 7.2 p -139.67 84.83 2.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.268 0.556 . . . . 0.0 110.506 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.498 ' HB ' HD22 ' A' ' 123' ' ' LEU . 3.2 mt -92.36 140.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.667 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.554 ' HB1' ' H9 ' ' A' ' 201' ' ' 2W7 . . . -95.12 154.12 17.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.323 -174.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.535 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -157.79 156.47 27.34 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.071 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' HE1' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 p80 -150.08 168.86 22.68 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.423 -0.457 . . . . 0.0 111.059 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.86 5.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.631 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.592 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 27.8 m-85 -145.03 171.08 14.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 171.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.0 -20.72 5.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.369 0.604 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.88 -40.24 9.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.833 -175.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.632 ' HG3' ' H ' ' A' ' 69' ' ' ASN . 18.1 tpt180 -96.61 127.04 41.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.057 -168.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.512 ' C ' HG23 ' A' ' 73' ' ' THR . 93.6 Cg_endo -91.12 7.96 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.986 2.457 . . . . 0.0 111.551 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.632 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 21.6 m120 -125.38 20.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.147 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 19.4 p90 -86.37 166.42 15.6 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.704 172.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.559 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 1.7 pt20 -25.46 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.535 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 50.6 m-85 -113.39 45.91 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.512 HG23 ' C ' ' A' ' 68' ' ' PRO . 32.5 p -72.98 -51.81 16.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.449 0.642 . . . . 0.0 110.835 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -88.69 17.25 5.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.65 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.439 ' O ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -60.25 -25.71 65.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.829 179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -65.6 -25.06 67.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.733 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.49 -11.1 59.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.805 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.647 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -84.05 140.98 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.862 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -105.79 176.79 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.308 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -75.25 0.45 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.281 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.09 21.92 5.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.822 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -85.6 165.02 17.38 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.466 0.651 . . . . 0.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.434 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -99.9 123.66 44.4 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.51 -174.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.876 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -115.2 127.03 72.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.747 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.9 m-85 -115.4 137.16 52.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -122.36 121.25 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 14.9 ttmm -108.6 140.42 41.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.454 -173.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.69 111.28 8.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.97 171.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.557 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 65.92 -104.43 1.02 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.073 -172.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -116.28 -1.78 12.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 110.911 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' CD ' ' HZ2' ' A' ' 4' ' ' LYS . 92.5 mt-10 -87.85 139.86 30.09 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.434 ' OG1' ' HG3' ' A' ' 87' ' ' LYS . 36.5 m -145.71 116.81 7.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.645 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -91.02 152.14 20.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.529 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -111.18 123.16 49.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.354 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.64 152.58 39.16 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 36.5 ttmt -107.21 149.57 27.58 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.688 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 62.7 mtp -84.12 70.7 10.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 110.451 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.5 p -70.64 -46.5 63.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.784 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 10.5 m -118.48 110.33 17.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.971 0.415 . . . . 0.0 111.073 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 97' ' ' MET . 43.7 mt -126.32 89.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -125.87 143.4 51.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.2 0.524 . . . . 0.0 111.51 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 13.2 t70 -101.94 116.45 32.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.074 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.444 HG21 ' HD3' ' A' ' 105' ' ' PRO . 19.7 m -133.3 178.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 0.0 111.244 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 50.3 mtpt -133.17 81.26 57.05 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.72 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.454 ' HG2' ' HD2' ' A' ' 139' ' ' ARG . 17.4 Cg_endo -93.98 107.39 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.476 2.784 . . . . 0.0 111.359 170.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -80.77 -24.21 38.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.878 0.37 . . . . 0.0 111.357 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.482 ' OD1' HG22 ' A' ' 110' ' ' VAL . 18.0 t70 -88.38 143.67 26.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.236 0.541 . . . . 0.0 111.431 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.63 19.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.49 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.83 -47.9 2.39 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG22 ' OD1' ' A' ' 107' ' ' ASP . 20.1 m -76.44 -4.31 6.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.7 60.33 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.425 . . . . 0.0 111.328 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.06 149.79 32.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.475 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.37 33.57 20.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.864 0.84 . . . . 0.0 110.05 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -72.37 96.0 1.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.857 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 115' ' ' LYS . 13.4 ptpt -76.56 151.58 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.534 -175.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.76 84.73 1.81 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.869 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.84 161.33 25.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -155.57 -176.68 6.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 90.1 3.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 15.6 pt20 -146.08 133.74 21.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 HG21 ' A' ' 57' ' ' ILE . 37.5 mt -86.29 99.69 11.75 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 6.4 m -77.14 89.4 3.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.93 0.395 . . . . 0.0 109.987 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 142' ' ' PHE . 23.7 mt -91.2 108.18 19.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.492 HG23 ' H3 ' ' A' ' 201' ' ' 2W7 . 23.8 mt -89.01 147.66 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.596 ' HB ' ' CG ' ' A' ' 140' ' ' LYS . 22.9 m -146.43 98.83 3.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.534 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 129' ' ' TYR . 3.4 m -56.74 109.14 0.58 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.607 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 2.1 t70 -89.21 -23.9 22.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.531 -170.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -145.33 117.2 8.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.828 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.488 ' HD2' ' HB3' ' A' ' 126' ' ' CYS . 17.0 p90 -162.18 173.41 14.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -122.3 131.75 54.07 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.45 41.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 132' ' ' LYS . 2.9 tmtp? -90.81 -58.03 2.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 110.816 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -77.94 -9.72 59.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.491 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.77 65.26 2.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.873 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 12.9 p -139.02 145.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -142.26 136.06 29.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.071 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.38 -78.99 0.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 21.3 ttpp -90.43 137.72 32.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.076 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.607 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 12.1 ptp180 -153.46 138.21 17.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.121 0.486 . . . . 0.0 110.408 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.596 ' CG ' ' HB ' ' A' ' 125' ' ' THR . 5.0 ptpp? -89.39 144.17 26.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -119.54 119.43 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 CA-C-O 121.938 0.875 . . . . 0.0 109.853 170.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.876 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.0 t80 -105.89 113.43 26.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.307 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.8 t -104.62 113.09 40.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.968 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -100.03 111.86 24.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.2 m -90.3 144.61 25.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.97 135.19 48.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.79 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.37 168.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.531 ' HD3' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.928 0 CA-C-O 118.936 -0.555 . . . . 0.0 110.359 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.554 ' H9 ' ' HB1' ' A' ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.18 -36.86 85.04 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.263 0.554 . . . . 0.0 111.352 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.54 82.36 6.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.306 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -146.9 138.16 13.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.963 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.639 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 68.7 Cg_endo -74.74 151.23 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.194 1.929 . . . . 0.0 111.841 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.518 ' NE2' ' HA ' ' A' ' 51' ' ' SER . 6.6 tp60 -132.22 172.51 12.32 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 52' ' ' LEU . 89.6 mt -114.72 103.51 54.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 111.714 -174.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -94.52 -159.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.468 2.779 . . . . 0.0 111.048 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -99.15 11.91 37.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.964 0.412 . . . . 0.0 110.525 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -78.38 98.91 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.189 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.2 16.72 21.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -93.95 -34.5 13.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.371 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.68 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -97.79 160.39 14.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.427 175.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.41 118.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.41 -42.44 12.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 109.963 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.719 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.83 171.32 23.62 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.005 -172.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.15 121.96 18.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.353 -0.423 . . . . 0.0 109.915 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.91 117.97 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.812 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 3.0 pt-20 -129.25 112.48 13.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.795 0.807 . . . . 0.0 111.806 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 55.7 mt -116.39 100.69 53.64 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.769 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 18.9 Cg_endo -58.88 -27.93 85.82 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.02 -21.26 63.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.724 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.89 15.3 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.31 26.93 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.89 0.852 . . . . 0.0 110.73 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.3 mt -95.72 118.52 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.99 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 40.4 mtpt -144.87 81.78 1.66 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.876 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 48.8 mm-40 -124.15 152.09 66.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.06 153.18 46.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.563 2.175 . . . . 0.0 112.835 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 48.7 t -113.26 130.97 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.21 112.29 62.87 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.951 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HB3' HG22 ' A' ' 7' ' ' ILE . 26.2 Cg_exo -62.18 139.31 77.38 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.324 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.95 173.64 13.43 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.03 151.03 73.27 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.287 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.29 157.79 21.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.764 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 38' ' ' GLN . 2.8 t -176.11 150.94 1.1 Allowed Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -46.54 -37.23 19.75 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.102 2.535 . . . . 0.0 112.669 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.28 -46.75 85.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.26 0.552 . . . . 0.0 111.192 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 35' ' ' THR . 55.3 tp60 -72.75 -37.13 67.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.775 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -77.72 -15.06 59.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.135 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.55 -18.9 56.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.546 0.688 . . . . 0.0 109.209 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -90.58 -46.07 8.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.78 -138.66 2.99 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.275 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 60' ' ' ALA . 85.5 t -112.57 137.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.379 . . . . 0.0 110.402 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -150.28 165.95 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.908 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -71.99 134.5 45.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.311 -176.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.4 65.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -128.17 118.41 23.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.378 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 50' ' ' GLU . 2.5 mp0 -54.85 -38.44 67.46 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.493 0.495 . . . . 0.0 110.439 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 70.8 -22.67 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.738 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 48' ' ' GLU . 43.0 tt0 82.34 -22.7 0.24 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.559 1.143 . . . . 0.0 111.326 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.518 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 66.9 m -128.74 141.68 51.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.309 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -103.22 -14.86 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -99.15 25.15 7.07 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.934 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.49 -167.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.745 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -115.19 -29.03 6.74 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.174 -0.329 . . . . 0.0 111.495 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.475 ' H ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -108.18 97.33 7.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.069 0.938 . . . . 0.0 111.125 -178.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 21.6 mm -116.62 138.36 47.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.985 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 t -128.67 113.71 15.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.858 0.361 . . . . 0.0 110.206 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 3.4 mt -111.1 128.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -101.52 142.86 32.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.85 27.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.282 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -124.14 144.65 49.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 127' ' ' ASP . 67.8 p -111.47 169.16 9.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.673 0.273 . . . . 0.0 110.747 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 22.7 t80 -154.55 134.87 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.728 HG13 ' HB2' ' A' ' 129' ' ' TYR . 3.7 mp -66.24 -48.19 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.37 . . . . 0.0 111.742 -172.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.8 t70 -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 53.8 mmm-85 -99.3 106.62 40.12 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 -174.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 3.2 Cg_exo -76.83 -4.18 14.64 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.541 2.828 . . . . 0.0 111.206 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -74.27 -23.18 59.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.24 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 64.5 m-85 -74.21 116.26 14.64 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.069 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.876 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 5.1 pt20 -48.91 -41.92 35.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.559 ' CZ ' HD22 ' A' ' 123' ' ' LEU . 10.2 m-30 -78.64 -2.58 39.77 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.225 -0.297 . . . . 0.0 111.789 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 16.8 m -68.42 -34.74 76.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.693 0.282 . . . . 0.0 110.946 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.05 14.72 22.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.625 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.08 -15.3 59.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -22.44 62.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 111.015 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.81 -6.81 56.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.56 131.12 47.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -111.64 177.7 4.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.702 -175.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -56.06 -21.14 20.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.007 -175.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.49 43.53 1.45 Allowed Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.165 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 m -95.41 -177.27 4.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.142 0.496 . . . . 0.0 109.779 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.51 ' HE1' ' HA ' ' A' ' 83' ' ' MET . 1.8 tpt -118.36 104.56 10.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.403 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.02 107.01 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.729 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.812 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . 58.8 m-85 -89.28 117.9 28.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.268 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -104.17 99.27 9.0 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -97.06 146.16 25.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.342 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 7.6 p -162.0 118.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.141 0.496 . . . . 0.0 109.686 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.639 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 60.63 -111.49 3.76 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -107.87 2.09 23.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.16 0.505 . . . . 0.0 110.089 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.98 141.52 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 m -141.47 98.01 3.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.242 0.544 . . . . 0.0 110.346 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.2 134.02 52.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.908 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 28.8 mtmt -103.58 140.4 37.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -169.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.535 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.7 m-85 -131.11 147.82 52.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.847 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -105.84 148.81 27.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.537 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 66.4 mtp -82.77 72.05 9.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.402 0.62 . . . . 0.0 110.478 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.4 p -72.3 -42.19 65.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.614 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.57 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 31.5 m -113.09 99.97 8.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 111.629 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.99 76.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -93.58 155.57 17.22 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.867 0.841 . . . . 0.0 112.831 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' OD2' ' HE3' ' A' ' 138' ' ' LYS . 9.9 t70 -109.72 100.83 9.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.695 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.28 145.59 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.046 0.451 . . . . 0.0 110.659 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -95.19 140.42 22.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.52 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.514 ' HB3' ' H7 ' ' A' ' 201' ' ' 2W7 . 32.1 Cg_endo -64.96 127.91 19.58 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.53 2.154 . . . . 0.0 111.972 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.44 HG21 HG13 ' A' ' 110' ' ' VAL . 1.9 t -153.99 -55.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.586 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.671 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . 30.0 t70 -142.21 167.59 21.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.563 0.22 . . . . 0.0 110.623 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.37 -45.78 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.689 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.5 31.03 5.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.462 . . . . 0.0 111.207 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 p -81.02 -7.8 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.025 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.43 127.69 35.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.36 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.76 133.27 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.306 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.72 36.22 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.782 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -100.09 142.21 31.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -89.89 166.49 13.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 177.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.0 75.75 1.03 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.568 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.06 167.0 15.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.158 0.504 . . . . 0.0 111.457 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 34.1 t0 -155.5 -166.66 2.3 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' H ' ' CG ' ' A' ' 118' ' ' ASP . 9.3 mttp -74.92 101.75 4.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.942 0.401 . . . . 0.0 110.163 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -142.18 145.67 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.896 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 12.4 mt -107.84 114.35 28.22 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.461 HG22 HG21 ' A' ' 143' ' ' VAL . 23.7 m -89.08 95.64 10.4 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -83.35 120.35 25.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.527 0.68 . . . . 0.0 110.526 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.69 HG21 HH22 ' A' ' 139' ' ' ARG . 61.9 mt -79.6 86.1 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 1.9 m -98.04 100.15 11.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.536 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.9 m -81.32 -25.8 36.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -94.56 167.57 11.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 111.302 -174.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -155.16 103.41 2.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.485 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.728 ' HB2' HG13 ' A' ' 65' ' ' ILE . 7.7 p90 -69.81 133.84 47.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.209 0.528 . . . . 0.0 111.411 -170.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.43 106.49 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.27 -36.16 60.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.207 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 132' ' ' LYS . 4.3 tmtm? -59.32 -62.87 1.56 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -175.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.506 HG23 HG12 ' A' ' 135' ' ' VAL . 0.8 OUTLIER -108.57 3.05 22.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.209 -169.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.7 49.64 62.97 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.301 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 133' ' ' THR . 14.3 p -136.39 156.14 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -90.42 123.76 34.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.11 -70.65 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.605 0.717 . . . . 0.0 112.092 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.531 ' HE3' ' OD2' ' A' ' 102' ' ' ASP . 29.2 mtmm -112.94 -172.81 2.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.811 -167.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.69 HH22 HG21 ' A' ' 124' ' ' ILE . 28.6 ttt-85 -114.58 66.33 0.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.819 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.632 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -69.53 96.86 0.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.231 0.539 . . . . 0.0 109.962 -179.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.6 tt -85.6 139.79 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 144' ' ' ALA . 15.6 t80 -114.86 124.26 51.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.038 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.6 t -121.05 123.96 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . . . -106.34 130.27 54.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.295 -176.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.8 m -99.58 137.25 38.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.993 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.407 ' OE1' ' HD3' ' A' ' 119' ' ' LYS . 37.6 tt0 -65.0 121.8 15.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.134 0.492 . . . . 0.0 111.181 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.12 161.23 4.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.69 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' 2W7 . . . . . 0.755 ' O2 ' ' N4 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.727 0.298 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.82 161.48 36.28 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.617 2.211 . . . . 0.0 112.555 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -114.24 173.42 6.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 70.8 mt -106.92 101.11 35.61 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.776 0.322 . . . . 0.0 111.129 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 97.9 Cg_endo -87.59 178.4 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.846 2.364 . . . . 0.0 112.272 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -86.61 -30.74 21.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.1 t70 -60.51 129.54 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.192 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 43.1 mmtm -96.55 13.21 28.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.896 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -91.74 -21.86 20.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.343 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 45.6 mmtm -91.65 163.31 14.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.651 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.91 116.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.52 -33.92 15.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.19 152.82 24.88 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.729 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.24 122.91 48.88 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 27' ' ' GLU . 9.6 tp -93.55 115.08 31.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.698 0.761 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 42.5 mt-10 -127.92 115.69 18.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.033 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 66.2 mt -122.96 102.49 37.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.652 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -59.23 -33.92 98.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.414 2.743 . . . . 0.0 113.552 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.12 -24.46 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.712 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.47 7.74 16.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.266 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 59.89 25.81 14.98 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.178 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.4 mt -84.61 124.63 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.991 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -144.15 80.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.0 mm-40 -125.43 142.42 41.68 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.161 0.505 . . . . 0.0 111.899 -172.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.69 138.57 38.37 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.064 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 64.1 t -98.38 132.81 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -92.85 105.34 14.47 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.397 0.618 . . . . 0.0 110.51 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 47.2 Cg_endo -69.22 145.94 61.93 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.276 2.651 . . . . 0.0 113.071 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 11' ' ' LYS . . . 129.08 -168.95 20.6 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.804 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.42 162.18 33.75 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.769 2.313 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.8 126.21 31.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.973 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.504 ' O ' HD23 ' A' ' 39' ' ' LEU . 47.6 p -132.05 133.94 24.55 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.89 -36.6 27.29 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.471 2.781 . . . . 0.0 113.362 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' HD2' ' A' ' 41' ' ' ARG . 38.7 tt0 -66.28 -54.25 27.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.56 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 51.1 tp60 -65.43 -34.41 78.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 35' ' ' THR . 4.4 mm? -68.54 -7.87 36.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -101.61 -7.11 23.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.749 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HD2' ' HG2' ' A' ' 37' ' ' GLU . 53.8 mtp180 -104.32 -32.64 8.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.949 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -154.99 9.75 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.241 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.502 HG21 ' CE2' ' A' ' 72' ' ' PHE . 59.4 t -105.96 133.82 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.83 0.348 . . . . 0.0 110.472 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -135.72 162.04 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 86.5 m-85 -74.01 149.46 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.244 0.545 . . . . 0.0 111.561 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.82 -14.0 23.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.877 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -79.9 133.6 36.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.228 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -83.42 -6.37 59.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.838 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.28 128.76 36.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -74.98 17.67 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.059 0.457 . . . . 0.0 112.167 -176.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 m -104.15 107.7 18.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.223 0.535 . . . . 0.0 111.618 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -91.05 6.27 45.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.784 0.802 . . . . 0.0 109.433 172.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.43 -9.11 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.625 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.22 159.39 28.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.237 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 3.9 pm0 -86.34 -13.34 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 0.0 110.899 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -105.44 105.94 16.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.123 0.487 . . . . 0.0 110.545 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 52' ' ' LEU . 19.9 mm -115.79 101.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.532 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -93.87 125.72 38.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.44 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -127.37 142.67 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.57 147.13 43.1 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.086 -0.384 . . . . 0.0 111.467 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.21 -171.62 22.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.014 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -136.63 157.68 46.2 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.565 -0.373 . . . . 0.0 110.818 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 6.7 t -79.07 -172.05 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.584 -175.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 35.4 p90 -109.04 142.09 40.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.329 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.28 -90.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.68 -23.73 16.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 109.873 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.39 114.58 65.03 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.189 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HA ' HG21 ' A' ' 73' ' ' THR . 88.5 Cg_endo -82.43 8.78 4.33 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.841 2.36 . . . . 0.0 111.476 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -94.76 14.61 20.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.902 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 73' ' ' THR . 40.5 m-85 -89.53 143.14 27.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -69.03 -8.03 41.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' VAL . 43.5 m-85 -130.1 33.06 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.72 0.295 . . . . 0.0 111.392 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 68' ' ' PRO . 13.4 p -64.73 -34.94 79.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.396 . . . . 0.0 111.645 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -99.9 13.13 34.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.5 -12.21 50.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 110.494 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 64' ' ' PHE . 20.1 pttp -63.69 -26.7 68.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.233 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.13 -41.44 25.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.529 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.81 137.76 54.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.073 -173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.4 mptt -103.66 173.62 6.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.05 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -74.31 -1.92 22.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.741 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.35 34.04 3.16 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.443 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.6 t -97.78 -172.71 2.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -119.05 121.7 40.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.297 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 96.8 t -107.6 110.26 31.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.525 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -95.08 113.85 25.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -102.98 98.71 8.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -94.57 113.06 24.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.214 -172.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.96 101.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.595 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.53 -94.52 0.28 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.147 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -119.2 -14.71 9.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.73 125.25 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -101.4 107.1 18.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.852 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -97.04 117.17 30.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.528 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.6 125.46 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 110.959 -176.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 64.0 m-85 -121.09 148.81 43.67 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -110.0 138.64 46.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.562 ' HB3' HD11 ' A' ' 100' ' ' ILE . 61.2 mtp -76.88 54.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.966 -173.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.1 p -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 7.5 m -116.4 102.0 9.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.012 0.434 . . . . 0.0 111.028 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.4 mt -126.76 125.28 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.648 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 101' ' ' ARG . 14.2 ttp180 -165.68 144.27 6.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.162 0.506 . . . . 0.0 109.865 170.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.996 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 3.1 p-10 -101.7 110.59 22.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.668 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 139' ' ' ARG . 27.0 m -98.63 175.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.449 0.643 . . . . 0.0 112.112 -172.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -85.28 155.41 60.17 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.905 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.47 -174.97 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.735 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m 74.3 -59.49 0.55 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.499 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.13 103.79 10.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.477 . . . . 0.0 111.282 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.48 -21.41 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.448 0.642 . . . . 0.0 109.433 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -90.82 27.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.835 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 103' ' ' VAL . 10.2 p -61.9 -28.59 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.76 141.27 51.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.366 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -85.76 120.14 26.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.69 141.38 32.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 110.868 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 173.54 13.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.415 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -90.91 -3.54 57.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.0 111.768 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.76 80.44 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -129.46 179.69 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 111.038 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.38 -172.75 2.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.46 ' HD3' ' CD ' ' A' ' 146' ' ' GLU . 41.9 mttt -71.3 100.84 2.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -135.34 138.06 43.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.088 0.47 . . . . 0.0 111.134 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.5 mt -95.62 114.41 26.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m -96.89 95.08 7.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.94 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.5 mp -93.82 125.83 38.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 0.0 111.619 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.75 91.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.71 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -101.33 98.07 8.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 0.0 110.867 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 122.86 18.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.638 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.738 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -88.11 25.08 1.67 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.25 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.4 t0 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.333 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.996 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 39.4 ttmt -162.4 142.37 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.736 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.469 ' HG3' HG23 ' A' ' 103' ' ' VAL . 8.4 ptp85 -119.0 108.93 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.256 171.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 1.2 tmtp? -87.86 102.57 14.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -87.8 128.15 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.664 0.745 . . . . 0.0 110.65 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -127.73 116.92 20.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 78.7 t -113.65 117.83 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.503 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -105.34 118.64 37.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.522 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 m -92.04 141.17 28.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.191 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.46 ' CD ' ' HD3' ' A' ' 119' ' ' LYS . 29.3 tt0 -65.63 134.52 53.43 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 111.488 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.02 165.57 3.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.042 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttp . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.213 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 pttt . . . . . 0 C--O 1.237 0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.89 138.31 62.4 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 111.954 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.8 tp60 -152.55 159.12 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.88 102.06 5.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 89.4 Cg_endo -83.52 172.47 10.28 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.634 2.223 . . . . 0.0 112.967 -174.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.61 -24.55 19.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -75.07 102.5 4.9 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.062 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -80.46 8.9 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.219 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 p -89.21 -9.4 50.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.401 0.619 . . . . 0.0 109.494 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -91.47 157.51 17.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.415 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -98.96 104.9 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -67.85 -37.34 81.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.936 0.398 . . . . 0.0 110.991 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.35 174.65 41.19 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.264 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.99 130.87 53.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.67 109.98 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.639 0.733 . . . . 0.0 109.417 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 39.0 mt-10 -123.1 109.27 13.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.628 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 25' ' ' ILE . 65.0 mt -122.53 101.89 39.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.599 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.44 -23.49 75.05 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 123.022 2.482 . . . . 0.0 112.394 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -68.43 -20.3 64.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.666 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.08 14.38 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.37 32.32 21.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.021 0.439 . . . . 0.0 111.426 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.67 HG23 ' HB2' ' A' ' 71' ' ' GLN . 64.1 mt -87.53 129.29 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.253 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 23.7 ttmm -161.95 81.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.119 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 35.9 mt-10 -143.58 158.46 56.99 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.292 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 58.3 Cg_endo -70.91 156.89 59.52 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.683 2.256 . . . . 0.0 112.605 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -112.07 132.32 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.84 111.99 57.79 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-O 121.404 0.621 . . . . 0.0 111.245 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 60.9 Cg_endo -73.82 133.58 18.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.179 2.586 . . . . 0.0 112.396 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.5 -168.51 29.13 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.589 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.03 153.94 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.846 2.364 . . . . 0.0 111.831 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.08 101.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.353 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.6 p -132.32 152.21 79.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.656 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.12 -37.94 95.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.984 2.456 . . . . 0.0 112.67 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.26 -51.23 68.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -75.72 -37.65 59.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.11 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 62' ' ' HIS . 90.5 mt -76.51 -2.77 33.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -94.19 -10.33 33.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.659 0.742 . . . . 0.0 109.352 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.637 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 2.4 mmp_? -105.03 -25.56 12.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.429 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.65 -129.89 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.965 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 59' ' ' ILE . 20.7 t -95.62 126.69 48.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.786 0.327 . . . . 0.0 110.183 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 m -139.87 150.02 44.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 35.0 m-85 -66.26 168.17 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -103.2 -55.02 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.315 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.79 163.1 12.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.417 . . . . 0.0 110.647 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.4 -23.72 17.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.185 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -76.96 -29.4 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.191 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.87 149.57 49.28 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.065 0.46 . . . . 0.0 110.465 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -154.59 150.13 27.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.55 -7.53 33.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.785 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.27 -30.1 25.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t70 -90.02 -160.51 0.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 20.6 pt20 -109.5 -25.37 10.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.334 -0.229 . . . . 0.0 111.273 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -93.01 120.99 33.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.811 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 121' ' ' LEU . 34.2 mm -127.83 129.09 69.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.912 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.3 t -133.51 87.93 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -103.62 127.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.05 36.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.892 0.377 . . . . 0.0 110.779 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.29 165.18 17.34 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 39' ' ' LEU . 14.7 m-70 -130.99 142.62 50.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.936 0.368 . . . . 0.0 111.19 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.973 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.1 m -117.78 120.69 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.35 106.93 17.65 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.89 -26.86 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.874 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -98.9 5.77 47.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.191 0.52 . . . . 0.0 110.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.68 87.82 51.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.043 0.449 . . . . 0.0 110.03 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 73' ' ' THR . 73.3 Cg_endo -77.09 2.78 7.27 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.177 2.585 . . . . 0.0 113.371 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -102.12 1.68 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.151 0.501 . . . . 0.0 110.228 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.491 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.3 t80 -78.13 138.22 38.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.67 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -57.96 -44.07 86.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -167.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 71' ' ' GLN . 3.9 m-30 -88.91 6.35 39.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.013 -0.43 . . . . 0.0 112.125 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.973 ' HA ' HG23 ' A' ' 63' ' ' THR . 86.0 m -76.37 -33.93 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.452 . . . . 0.0 110.512 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 76' ' ' LYS . 62.6 t30 -92.23 14.92 14.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.09 21.77 0.17 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.471 0.653 . . . . 0.0 110.868 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -101.52 -23.41 14.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.69 172.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -73.98 -31.84 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.004 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.17 156.86 29.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.045 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -130.83 -173.8 3.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.338 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -11.8 52.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.613 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.95 55.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.355 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.511 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 70.0 m -109.11 145.42 35.72 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.208 0.528 . . . . 0.0 109.827 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 108.71 15.11 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.811 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 93.7 t -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.438 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -100.96 117.04 34.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 110.92 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -105.47 101.68 11.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.5 ttpt -98.07 117.54 32.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.08 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.4 m -113.28 99.87 9.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.343 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.71 -101.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.794 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -111.81 -2.88 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 109.996 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.622 ' HB2' HG23 ' A' ' 88' ' ' VAL . 7.8 mm-40 -96.61 148.71 22.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.207 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.9 m -134.89 112.4 10.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.765 0.317 . . . . 0.0 110.69 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -101.75 138.89 38.13 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -99.96 130.02 46.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 86.3 m-85 -127.79 147.17 50.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.547 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 12.1 tppt? -109.34 140.53 42.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.572 ' HB3' HD11 ' A' ' 100' ' ' ILE . 50.2 mtp -77.63 60.16 2.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.206 0.527 . . . . 0.0 110.404 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.0 p -63.51 -36.88 85.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.094 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 73.9 m -124.45 97.37 5.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.502 . . . . 0.0 111.451 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 97' ' ' MET . 69.4 mt -113.18 110.49 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.537 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -146.67 151.65 37.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.828 0.347 . . . . 0.0 110.255 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.43 93.22 5.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.745 0.783 . . . . 0.0 110.475 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.705 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 14.7 m -97.26 95.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.368 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.651 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -109.06 90.81 8.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.344 0.592 . . . . 0.0 112.417 -170.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 103' ' ' VAL . 94.4 Cg_endo -104.13 -158.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.763 2.975 . . . . 0.0 111.335 172.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -126.48 11.84 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.44 163.99 29.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.303 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 -21.61 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.45 17.11 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 110.936 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 105' ' ' PRO . 19.1 m -66.86 -20.25 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.733 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -90.87 -178.65 5.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 3.5 p30 -79.18 167.29 21.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.497 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.53 15.02 22.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.816 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 112' ' ' ASP . 1.7 mp0 -66.75 110.67 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.746 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -73.57 2.59 7.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.262 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.81 64.96 3.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.636 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -108.48 178.73 4.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.88 -176.79 3.18 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -80.14 93.83 5.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.6 148.84 46.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.581 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 57' ' ' ILE . 19.5 mt -94.13 104.25 16.28 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -77.27 84.02 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.4 mt -86.79 102.1 13.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.536 0.684 . . . . 0.0 110.784 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.7 mt -79.73 99.9 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.738 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 m -87.35 91.78 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.21 0.529 . . . . 0.0 110.12 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.34 101.43 7.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.5 158.28 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.422 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . 18.2 t0 . . . . . 0 C--O 1.236 0.365 0 O-C-N 123.755 0.659 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 128' ' ' ASP . 46.9 mmtm -79.52 98.64 6.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.679 0.752 . . . . 0.0 111.026 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.689 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 11.5 mmm-85 -89.86 76.73 7.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.356 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -83.16 112.74 20.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tp -93.25 127.8 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 121.814 0.816 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.714 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -118.08 100.56 7.62 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.963 178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.0 t -98.68 112.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.88 116.09 31.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.404 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.7 m -89.03 139.84 30.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.146 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.01 130.11 42.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.94 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.85 162.45 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 46.8 pttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.503 -0.76 . . . . 0.0 110.66 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.428 0.156 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.84 107.1 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.978 2.452 . . . . 0.0 113.054 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -140.63 169.31 17.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.934 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.713 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 90.1 mt -121.88 102.62 40.96 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-O 120.75 0.31 . . . . 0.0 110.525 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 5.8 Cg_exo -78.36 144.79 20.73 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.664 2.243 . . . . 0.0 110.606 172.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 40.1 pttt -89.51 34.08 0.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.35 0.595 . . . . 0.0 110.987 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.42 141.82 30.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.976 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 9.0 mptt -96.0 6.95 47.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.604 -173.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -113.09 -44.93 3.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.14 126.75 31.67 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.494 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.53 116.88 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.576 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . . . -84.89 -37.73 20.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.48 168.32 27.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.86 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.27 135.95 39.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -103.61 125.04 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 37.0 mt-10 -128.68 109.52 11.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.27 0.557 . . . . 0.0 111.29 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.1 mt -121.52 103.07 41.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.95 -43.64 41.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.299 2.666 . . . . 0.0 113.938 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 3.1 p-10 -76.3 -10.69 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.22 2.09 16.47 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.979 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.65 26.22 15.96 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 79.4 mt -93.04 104.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.429 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 51.3 mttt -137.27 81.23 1.86 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -126.85 150.62 72.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.54 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.77 144.08 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.623 2.215 . . . . 0.0 112.309 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 87.9 t -94.45 132.63 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.06 105.68 14.72 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 121.304 0.573 . . . . 0.0 110.453 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 97.7 Cg_endo -80.6 140.75 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.001 2.467 . . . . 0.0 112.75 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.4 -170.36 29.64 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 72.1 Cg_endo -76.9 149.06 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.468 2.112 . . . . 0.0 111.802 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -63.8 98.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.566 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -134.34 142.0 41.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.19 -30.81 43.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.363 2.709 . . . . 0.0 113.208 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 38' ' ' GLN . 10.2 pt-20 -59.99 -30.92 69.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.709 0.29 . . . . 0.0 111.59 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 16.0 mm100 -101.06 -42.57 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.837 0.351 . . . . 0.0 111.024 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 3.9 mm? -74.15 -2.7 25.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -99.88 -9.52 22.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -93.43 -55.88 3.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.886 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.99 -120.83 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.833 -175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 t -109.71 126.63 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.881 0.372 . . . . 0.0 110.688 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -146.54 158.03 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.928 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.064 0.459 . . . . 0.0 111.018 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.74 -12.04 54.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.207 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 46.7 mt-10 -101.08 121.32 41.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.773 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 43.6 mt-10 -65.06 -33.59 76.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.296 -172.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -83.05 125.52 31.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.164 0.507 . . . . 0.0 110.653 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 2.7 mp0 -63.27 108.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.481 -175.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -150.35 139.99 21.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 7' ' ' ILE . 1.5 pp -130.17 6.8 4.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.923 0.392 . . . . 0.0 111.237 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.86 33.49 1.98 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.74 179.94 4.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -72.5 -47.48 48.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.11 126.21 51.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.257 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.74 95.07 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.239 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 7.5 m -86.95 111.54 20.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -122.96 120.24 60.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.49 142.75 31.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.724 0.297 . . . . 0.0 110.437 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.58 124.16 4.57 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 39' ' ' LEU . 28.8 t-80 -84.75 132.76 34.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 127' ' ' ASP . 15.1 t -153.25 175.32 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 m-85 -140.95 138.0 33.48 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.224 0.327 . . . . 0.0 110.122 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -69.57 -17.31 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.835 0.826 . . . . 0.0 108.933 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -83.88 -21.05 32.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.089 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 9.6 mmt180 -124.54 111.99 27.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 5.5 Cg_exo -78.57 1.58 8.93 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.233 2.622 . . . . 0.0 110.876 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -86.88 14.01 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.334 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.52 -177.29 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.051 0.453 . . . . 0.0 111.639 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -93.97 -31.01 14.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.837 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.38 24.01 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.475 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 68' ' ' PRO . 23.9 p -73.96 -38.06 64.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.863 0.364 . . . . 0.0 111.657 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -93.14 18.73 8.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.085 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.07 -10.86 57.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.982 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -77.19 -22.15 52.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.23 176.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.63 -4.29 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.621 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.71 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.79 159.6 15.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.086 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.9 mptt -121.04 172.59 7.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 111.025 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -74.56 -4.84 39.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.132 -176.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.64 24.92 5.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.792 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -84.74 -173.78 4.91 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.331 0.586 . . . . 0.0 110.3 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.15 107.76 12.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.401 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.6 t -93.11 106.05 17.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.014 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 85.5 m-85 -90.18 128.01 36.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.673 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.08 108.22 15.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -92.36 140.14 29.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.123 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 52' ' ' LEU . 8.5 p -163.67 128.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.903 0.382 . . . . 0.0 111.327 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.85 -87.94 0.08 OUTLIER Glycine 0 C--N 1.329 0.169 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.979 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -135.78 0.23 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.095 0.158 . . . . 0.0 111.391 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.34 169.06 11.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 m -148.05 110.73 4.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.913 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 92.5 mtt180 -95.51 154.55 17.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.511 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.47 117.44 34.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.535 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 63.2 m-85 -109.4 153.61 23.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.719 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 96' ' ' LYS . 39.6 ttmt -112.95 150.75 31.4 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.731 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 57.5 mtp -86.72 66.13 9.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.388 0.613 . . . . 0.0 109.978 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -70.44 -37.66 74.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.213 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.4 m -127.07 95.79 4.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.099 0.476 . . . . 0.0 111.482 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 42.9 mt -110.31 111.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.614 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -139.07 151.24 46.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.842 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.92 126.01 39.97 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.922 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 25.3 t -131.52 93.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.115 0.483 . . . . 0.0 110.933 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 4.3 mtmt -90.44 153.28 46.11 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 6.8 Cg_exo -74.56 14.69 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.272 2.648 . . . . 0.0 113.346 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -70.89 -30.89 67.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.518 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.98 107.88 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.867 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 109' ' ' GLU . 26.9 m -92.93 -176.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 108' ' ' VAL . 44.3 mt-10 67.73 6.75 5.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.034 0.533 . . . . 0.0 111.31 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.698 HG13 ' HG ' ' A' ' 111' ' ' LEU . 5.8 p -64.32 -34.11 67.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.698 ' HG ' HG13 ' A' ' 110' ' ' VAL . 1.2 pp -138.31 147.74 43.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.738 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.649 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 9.5 m-20 -112.23 165.21 12.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 111.203 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -98.17 72.76 2.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.399 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.649 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -117.77 157.24 26.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.327 -177.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -82.74 -170.23 2.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.692 177.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.86 6.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.423 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 29.2 mmtp -131.54 -165.01 1.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -104.89 -157.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -68.11 95.39 0.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.12 0.486 . . . . 0.0 110.708 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 16.0 pt20 -105.5 126.56 52.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.107 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 106.06 18.06 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 m -83.26 91.48 7.29 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.572 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 142' ' ' PHE . 32.1 mt -84.25 97.52 9.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.378 0.609 . . . . 0.0 110.271 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mt -80.76 96.22 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -96.52 86.53 4.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.664 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.2 m -73.03 108.53 5.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 63' ' ' THR . 19.7 t70 -83.61 -21.93 32.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.183 -168.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 38.3 m-20 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 12.9 mm-40 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -121.57 136.89 54.92 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.773 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 15.7 mtm180 -123.49 127.87 48.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.6 105.01 14.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.28 121.75 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.703 0.763 . . . . 0.0 110.53 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.731 ' HE1' ' HA ' ' A' ' 97' ' ' MET . 6.2 t80 -119.33 109.85 16.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.988 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 53.9 t -102.09 107.19 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.952 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -94.56 134.29 37.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.5 m -103.66 136.13 43.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.301 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.415 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 31.7 tt0 -67.92 121.87 16.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.247 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.4 164.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.699 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.452 179.612 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 150.97 25.41 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.467 2.112 . . . . 0.0 112.136 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.442 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 mm-40 -118.65 179.25 4.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 52' ' ' LEU . 3.8 mp -91.37 106.39 16.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 77.8 Cg_endo -96.63 -168.7 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.269 2.646 . . . . 0.0 113.391 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -74.9 -20.92 59.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.607 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -79.37 105.25 10.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.457 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 23.4 mttp -87.71 -29.34 21.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 110.661 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.4 p -73.9 -13.11 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.542 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.524 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 32.1 mmtp -87.18 80.74 8.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.58 113.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.511 0.672 . . . . 0.0 111.189 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.57 -34.12 41.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.79 26.7 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.461 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.82 124.09 41.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.76 118.91 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.541 0.686 . . . . 0.0 110.104 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 46.6 mt-10 -132.32 123.76 27.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.972 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.78 101.34 29.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.59 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.1 -27.62 85.27 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.958 2.438 . . . . 0.0 112.513 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 82' ' ' SER . 8.9 m-20 -63.07 -27.52 69.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -121.47 10.45 10.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.426 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.31 28.82 18.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 23' ' ' ALA . 75.8 mt -85.56 129.21 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.487 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 22.7 ttmm -152.52 78.03 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -133.24 148.08 67.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.277 -172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.71 162.11 30.19 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.783 2.322 . . . . 0.0 112.436 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 63.8 t -114.56 129.39 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.41 110.7 53.96 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.822 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 16.9 Cg_exo -66.43 110.76 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.071 2.514 . . . . 0.0 112.069 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.62 168.5 35.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.582 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.15 144.94 38.36 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.873 2.382 . . . . 0.0 111.899 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -57.95 109.93 0.83 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.996 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -139.65 147.0 50.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.94 -42.33 67.64 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.063 2.508 . . . . 0.0 113.228 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.38 -18.54 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -86.52 -43.3 12.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.78 -8.16 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.515 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -70.0 -17.5 63.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.638 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.0 -64.86 1.02 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.638 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.14 -113.32 0.29 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.95 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.79 130.53 57.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.1 m -144.34 158.08 43.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 87.9 m-85 -69.71 150.94 46.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 111.347 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -86.43 -62.79 1.43 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -170.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.927 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.28 39.12 1.12 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.59 90.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.89 -18.36 65.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.764 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.712 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 17.9 m -96.85 110.23 22.77 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.102 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' ' 7' ' ' ILE . 3.6 pp -81.91 -10.0 59.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.59 0.709 . . . . 0.0 109.494 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -100.6 11.07 40.27 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.003 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.6 t70 -82.04 177.41 8.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -83.09 -44.04 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.74 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -97.29 117.93 32.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.776 . . . . 0.0 111.034 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.0 136.47 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 m -125.69 112.8 16.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.442 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' HB ' HD23 ' A' ' 123' ' ' LEU . 2.8 mt -121.38 139.07 49.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.992 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 121.57 44.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -123.27 77.07 0.36 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.306 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -74.46 121.68 21.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.002 0.43 . . . . 0.0 110.438 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 70' ' ' TYR . 21.7 m -112.71 166.73 11.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.824 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' N ' HG22 ' A' ' 63' ' ' THR . 63.7 m-85 -127.99 116.5 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 tt -55.8 -31.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.527 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 34.3 t70 -66.87 -24.73 66.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 80.2 mtt180 -111.56 93.04 18.22 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 26.5 Cg_exo -62.1 -21.76 73.02 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.369 2.712 . . . . 0.0 113.516 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -91.24 22.43 3.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.835 0.35 . . . . 0.0 111.617 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.1 OUTLIER -84.2 173.41 11.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 172.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 19.2 pm0 -65.84 -59.07 4.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.598 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 56.3 m-85 -99.97 26.58 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.925 -0.484 . . . . 0.0 112.143 -171.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 p -67.22 -37.4 83.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.122 0.487 . . . . 0.0 111.32 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.1 t30 -98.6 13.8 30.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.46 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.86 -7.89 13.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.49 0.662 . . . . 0.0 110.56 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 19.9 pttp -68.34 -23.84 64.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.737 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 -5.28 58.63 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.443 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.27 170.4 16.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.04 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -143.99 177.67 8.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.018 0.437 . . . . 0.0 110.854 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.52 1.17 17.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.294 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -150.15 48.68 0.58 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.094 176.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 17.4 p -86.26 -158.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.222 0.534 . . . . 0.0 110.635 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -129.11 112.0 13.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.991 176.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.9 t -105.74 119.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.189 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.41 118.32 36.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.95 0.405 . . . . 0.0 110.935 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -106.54 107.2 18.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.765 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -94.9 139.07 31.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 113.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.527 0.68 . . . . 0.0 110.883 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 -86.5 0.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.021 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -140.25 2.14 1.86 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.19 0.519 . . . . 0.0 110.506 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.87 145.89 37.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.502 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 m -131.02 109.41 10.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.914 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE1' ' A' ' 95' ' ' TYR . 4.7 ptm180 -106.77 148.39 28.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.291 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -105.6 141.55 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 95.5 m-85 -129.74 150.06 51.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -116.44 128.22 55.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.303 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -71.43 79.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.981 0.419 . . . . 0.0 110.198 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -82.92 -20.53 35.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.784 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.6 t -128.68 111.69 13.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -120.14 113.79 41.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.515 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -151.43 163.05 39.85 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.56 133.93 47.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.999 0.428 . . . . 0.0 110.19 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.72 137.9 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.232 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.89 150.79 74.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.313 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.81 71.86 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.729 2.286 . . . . 0.0 111.181 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -143.26 93.8 2.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.312 0.577 . . . . 0.0 110.954 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 54.46 51.45 14.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.333 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -13.24 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.518 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.93 30.64 4.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.076 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.58 -8.46 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.633 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.29 134.53 48.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.799 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.493 ' OD1' ' HG2' ' A' ' 114' ' ' GLN . 11.6 p30 -107.87 -164.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.53 20.22 14.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 112' ' ' ASP . 58.0 mm-40 -71.72 115.95 11.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.113 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.62 69.9 3.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.231 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.35 45.54 3.28 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -93.49 163.77 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.289 -0.455 . . . . 0.0 110.602 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.45 -166.72 1.02 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.528 ' N ' ' HE3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -76.44 101.96 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 161.78 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.536 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -118.47 115.55 24.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -82.7 102.29 11.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.517 HD23 ' HB ' ' A' ' 59' ' ' ILE . 84.8 mt -98.16 107.51 20.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.266 0.555 . . . . 0.0 111.248 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mt -81.18 96.43 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.553 ' HG1' ' HD1' ' A' ' 142' ' ' PHE . 8.9 p -105.61 52.25 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.301 0.572 . . . . 0.0 111.762 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 35.2 m -73.83 152.6 40.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.295 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.532 ' HB2' ' HE ' ' A' ' 139' ' ' ARG . 14.9 t0 -118.82 -54.62 2.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.75 0.786 . . . . 0.0 109.273 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.62 ' OD1' ' HB2' ' A' ' 139' ' ' ARG . 4.3 p-10 . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.581 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.558 0.218 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -176.86 130.54 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.62 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 20.5 tpt180 -161.28 -82.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HD2' ' CE1' ' A' ' 142' ' ' PHE . 14.5 mmtp -157.67 143.35 17.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -167.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.8 tt -135.59 139.39 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.775 166.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.553 ' HD1' ' HG1' ' A' ' 125' ' ' THR . 66.6 m-85 -128.2 125.09 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 46.5 t -110.96 107.84 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.571 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.71 113.64 26.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.967 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.8 m -83.67 141.63 31.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.21 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -67.89 128.07 35.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.104 0.478 . . . . 0.0 111.007 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 96' ' ' LYS . 2.0 t -92.77 166.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.765 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.349 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.604 0.24 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 55.4 Cg_endo -71.2 113.34 3.56 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.532 2.155 . . . . 0.0 112.212 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 32.8 mm-40 -121.13 -166.03 1.3 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.613 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 52' ' ' LEU . 36.0 mt -106.85 96.61 15.03 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 86.6 Cg_endo -95.77 -169.39 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.029 2.486 . . . . 0.0 113.13 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -82.88 12.59 4.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.64 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 9.5 t70 -108.64 125.65 52.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -109.78 12.39 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.948 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.5 t -106.99 -2.72 20.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.368 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 49.4 mmtm -97.24 178.38 5.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.482 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.66 117.27 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -88.14 -34.21 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.1 31.06 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.607 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.06 129.97 40.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.3 123.67 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.29 0.567 . . . . 0.0 110.346 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 30.5 mt-10 -121.43 121.69 38.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.361 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.2 mt -129.34 94.12 33.97 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.904 172.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.4 Cg_endo -54.7 -33.37 79.81 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.288 2.659 . . . . 0.0 112.407 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.6 -31.43 69.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.45 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.38 11.79 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.917 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.35 27.24 16.91 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.401 0.438 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 64.2 mt -91.24 119.9 39.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -139.3 58.16 1.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.799 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 21.1 mm-40 -108.8 145.01 30.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.281 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 157.9 33.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.828 2.352 . . . . 0.0 112.406 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.489 ' HA ' HG13 ' A' ' 43' ' ' VAL . 60.7 t -111.71 131.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.3 m-85 -87.62 114.21 57.87 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.918 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -67.07 140.2 53.41 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.099 2.533 . . . . 0.0 112.201 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -168.08 24.98 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.731 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.35 160.23 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.436 2.758 . . . . 0.0 112.038 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.145 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.58 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.1 t -161.82 144.87 9.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.315 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -41.1 -50.63 4.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.527 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -62.5 -46.07 90.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.921 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.411 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 14.7 mm100 -64.65 -48.83 73.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.879 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -78.69 20.65 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.18 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.67 -4.62 8.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 41' ' ' ARG . 46.0 mtp85 -124.85 -32.49 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.346 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.09 -162.1 14.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.074 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 6.8 p -95.82 140.5 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 50.3 m -138.9 176.6 8.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -90.51 140.5 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.077 0.465 . . . . 0.0 111.262 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.5 -3.68 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.88 154.86 28.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.318 -172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.32 19.25 14.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.62 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -71.34 172.12 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.422 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.41 7.86 35.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.358 0.599 . . . . 0.0 110.837 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 54.0 m -154.06 152.28 30.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.642 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -103.94 -7.07 20.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.205 0.526 . . . . 0.0 110.609 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' OD1' ' HB3' ' A' ' 51' ' ' SER . 9.8 p-10 -95.34 10.25 36.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.605 -178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.74 168.84 19.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.481 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.45 -32.58 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.351 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.38 111.61 24.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.868 0.842 . . . . 0.0 110.847 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 21.0 mm -135.43 102.33 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.839 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 17.1 m -83.06 106.85 15.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 6.4 mt -99.13 111.45 28.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.782 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.42 96.44 6.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.425 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -103.02 85.01 0.49 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.198 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 70' ' ' TYR . 86.1 t60 -55.58 138.77 46.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' PHE . 9.8 m -114.77 147.71 39.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.077 -174.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' HE2' ' HG2' ' A' ' 67' ' ' ARG . 17.0 t80 -143.82 83.45 1.75 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.741 ' HA ' HG23 ' A' ' 73' ' ' THR . 0.5 OUTLIER -67.56 -13.86 17.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.92 -172.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 23.3 t70 -67.04 -51.85 49.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.418 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG2' ' HE2' ' A' ' 64' ' ' PHE . 5.6 mmp_? -92.38 116.12 65.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.67 ' HA ' HG21 ' A' ' 73' ' ' THR . 39.5 Cg_endo -66.83 -15.66 47.83 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.187 2.591 . . . . 0.0 114.301 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.21 12.98 32.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 43.8 t80 -80.33 156.45 26.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 75.3 mt-30 -52.11 -49.09 64.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.826 0.345 . . . . 0.0 111.64 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.731 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 82.1 m-85 -116.34 92.64 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.049 0.452 . . . . 0.0 110.283 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 65' ' ' ILE . 24.3 m -133.3 -46.11 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.255 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.14 16.11 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -57.45 -25.09 59.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.748 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -55.8 -23.86 32.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.024 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.93 2.68 45.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.29 176.26 8.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.022 0.439 . . . . 0.0 110.642 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -148.75 -178.23 6.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.351 -178.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.05 -16.19 59.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 -175.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -139.34 45.24 1.03 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.308 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 5.7 p -85.67 -162.05 0.68 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 tpt -129.51 98.25 4.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.078 0.465 . . . . 0.0 109.819 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG21 ' SD ' ' A' ' 97' ' ' MET . 97.1 t -84.85 126.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.038 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.3 m-85 -104.98 116.73 32.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.931 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 52.6 t80 -110.3 111.68 23.14 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.483 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -102.46 140.63 36.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.448 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 52' ' ' LEU . 2.6 p -140.69 111.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.246 0.546 . . . . 0.0 109.881 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.57 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 63.82 -98.06 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.501 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.38 0.35 10.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.209 0.528 . . . . 0.0 110.414 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HB2' HG13 ' A' ' 88' ' ' VAL . 33.1 mm-40 -94.27 157.43 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.389 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -150.2 129.92 13.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.75 152.92 32.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -103.04 137.98 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.58 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 96.8 m-85 -128.58 145.48 51.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.06 0.457 . . . . 0.0 111.286 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 11.6 tppt? -112.04 129.17 56.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.493 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.562 ' SD ' HG21 ' A' ' 84' ' ' VAL . 75.6 mmm -78.87 48.29 0.82 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.259 0.552 . . . . 0.0 110.329 -176.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 98' ' ' THR . 3.5 t -84.58 6.81 22.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.955 -171.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 58.8 m -136.25 106.72 6.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.013 171.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.87 96.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 101' ' ' ARG . 25.3 mtm180 -145.17 138.24 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.566 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 8.2 p-10 -108.2 175.12 5.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.342 0.591 . . . . 0.0 111.659 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.21 147.59 14.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.744 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -110.61 132.55 21.52 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 5.9 Cg_exo -78.98 67.7 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 112.876 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 p -67.54 -28.49 67.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.61 0.719 . . . . 0.0 109.647 172.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.98 160.33 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.082 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG23 ' HG3' ' A' ' 109' ' ' GLU . 34.8 m -83.61 -23.63 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.346 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 108' ' ' VAL . 41.0 mt-10 -100.85 29.19 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 111.047 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.664 HG23 ' HG ' ' A' ' 111' ' ' LEU . 29.8 m -66.64 -17.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.261 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 110' ' ' VAL . 72.0 mt -131.33 -175.31 3.66 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.4 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' A' ' 114' ' ' GLN . 2.5 t70 -146.73 -167.91 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.96 88.62 7.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.07 0.462 . . . . 0.0 110.101 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 112' ' ' ASP . 1.8 mp0 -74.95 105.99 6.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.743 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.03 -15.55 61.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.021 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.44 80.71 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.039 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -96.78 168.08 10.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.3 0.571 . . . . 0.0 110.911 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.92 -166.86 2.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -78.16 94.71 4.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.57 137.99 16.72 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.5 mt -101.5 122.72 44.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.7 m -84.0 82.67 8.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.297 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 7.7 mp -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.788 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mt -83.99 78.56 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 23.0 m -78.19 88.26 4.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 139' ' ' ARG . 31.0 p -109.6 112.71 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.365 0.602 . . . . 0.0 112.202 -173.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 26.7 t70 -108.08 164.45 12.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 127' ' ' ASP . 3.5 t70 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.424 0.63 . . . . 0.0 112.145 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -78.45 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -164.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 126' ' ' CYS . 5.4 mpt_? -109.12 91.05 3.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.589 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.6 OUTLIER -90.11 96.81 10.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.81 -174.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -77.44 135.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.633 0.73 . . . . 0.0 110.499 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.01 109.23 15.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.657 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 51.1 t -97.5 102.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.04 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -99.73 112.6 24.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.132 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -77.74 139.0 39.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.909 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 119' ' ' LYS . 41.6 tt0 -65.05 132.97 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 110.977 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.04 153.4 11.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.1 pttp . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.33 -173.935 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.006 0.431 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' HD11 ' A' ' 52' ' ' LEU . 66.5 Cg_endo -78.72 133.74 11.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.706 2.27 . . . . 0.0 112.821 -175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.583 HE22 ' HB2' ' A' ' 53' ' ' ASP . 87.6 mm-40 -94.01 160.58 14.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.669 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 31' ' ' PRO . 58.4 mt -59.9 109.84 2.31 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.712 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 96.8 Cg_endo -96.16 -178.66 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.508 2.806 . . . . 0.0 114.238 -170.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 33.3 ttmt -64.01 -44.55 92.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.009 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 1.6 m-20 -75.64 108.6 8.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.414 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.629 ' HD2' ' HA2' ' A' ' 32' ' ' GLY . 45.7 mmtm -83.67 5.25 25.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.01 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -97.86 -4.05 37.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.2 mmtp -91.9 105.41 17.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG21 ' CB ' ' A' ' 28' ' ' PRO . 5.1 p -62.14 121.27 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.734 0.778 . . . . 0.0 111.101 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 52' ' ' LEU . . . -89.15 -28.63 19.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.464 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.12 27.62 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.659 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -117.6 141.23 48.61 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 84' ' ' VAL . 10.0 tp -117.3 127.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.089 0.471 . . . . 0.0 109.848 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 41.1 mt-10 -134.97 122.93 22.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 -176.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 71.9 mt -128.36 104.7 19.72 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 16.7 Cg_endo -59.73 -32.92 96.42 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.359 2.706 . . . . 0.0 113.811 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.56 -29.97 70.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.961 0.41 . . . . 0.0 111.559 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.24 2.14 16.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.074 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.07 27.48 17.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.699 0.762 . . . . 0.0 110.184 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 60.7 mt -81.71 118.08 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.663 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -141.05 83.79 1.9 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.415 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.61 150.36 76.1 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.086 0.47 . . . . 0.0 111.36 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CB ' HG21 ' A' ' 14' ' ' VAL . 60.4 Cg_endo -73.46 140.11 29.6 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.864 2.376 . . . . 0.0 112.433 175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.568 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.4 t -88.7 134.62 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.51 104.02 18.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.398 0.618 . . . . 0.0 111.097 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 61.7 Cg_endo -76.76 109.39 2.84 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.83 2.353 . . . . 0.0 111.442 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 11' ' ' LYS . . . 177.18 -162.0 29.88 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.452 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.31 149.39 17.0 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.182 2.588 . . . . 0.0 112.028 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -73.41 120.21 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.495 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -159.61 135.35 6.05 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.01 -47.81 11.68 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.935 3.09 . . . . 0.0 113.93 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -56.21 -46.78 79.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.315 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -77.22 -35.63 55.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.337 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 44' ' ' SER . 96.1 mt -71.27 -14.24 62.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -87.97 -15.6 36.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.154 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 41' ' ' ARG . 63.2 mtt180 -87.28 -40.31 14.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.92 -172.55 44.04 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.224 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' ALA . 2.1 m -67.77 125.01 24.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.703 0.763 . . . . 0.0 111.973 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.422 ' HB2' HD23 ' A' ' 39' ' ' LEU . 14.9 m -130.17 146.03 51.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.925 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 63.8 m-85 -59.25 135.89 57.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.207 0.527 . . . . 0.0 111.664 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -92.92 3.12 56.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.803 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 42.6 mt-10 -121.32 147.94 45.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.1 pm0 -88.22 80.36 7.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.758 0.79 . . . . 0.0 109.827 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -114.95 149.31 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.313 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.5 mp0 -94.4 7.12 46.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.217 0.532 . . . . 0.0 110.734 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -149.77 151.68 34.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.119 0.485 . . . . 0.0 111.56 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -120.71 16.89 11.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.726 174.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HB2' HE22 ' A' ' 6' ' ' GLN . 26.8 t70 -88.19 -11.9 45.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.151 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -77.9 -167.48 1.0 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.58 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -117.6 -11.63 10.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -137.22 90.07 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.745 HG22 HD12 ' A' ' 121' ' ' LEU . 4.0 tt -121.92 148.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 -175.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -99.51 122.09 42.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.526 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.0 mt -123.53 131.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' VAL . . . -102.15 146.05 28.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.673 0.273 . . . . 0.0 110.613 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.78 171.43 29.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.181 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -127.75 138.42 52.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.642 HG21 ' HZ1' ' A' ' 140' ' ' LYS . 1.2 p -94.26 -86.1 0.28 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 43.1 p90 -161.6 155.1 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.534 0.683 . . . . 0.0 112.684 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 mm -127.49 -72.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.262 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 2.3 m-20 -129.24 14.44 6.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.1 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -104.31 101.0 24.32 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.508 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.819 ' HA ' HG21 ' A' ' 73' ' ' THR . 97.4 Cg_endo -89.7 0.56 5.74 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.413 2.742 . . . . 0.0 112.685 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -104.33 22.81 14.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.392 0.615 . . . . 0.0 110.026 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 20.5 t80 -104.47 155.98 18.34 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.403 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -61.73 -56.25 21.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.311 -174.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 65.8 m-85 -79.9 9.19 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.819 HG21 ' HA ' ' A' ' 68' ' ' PRO . 7.0 m -72.71 -26.44 61.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.154 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -94.87 4.91 53.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.51 -16.0 63.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.476 . . . . 0.0 110.509 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -22.66 65.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.804 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.47 -14.66 59.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.027 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.44 173.61 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -177.71 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.249 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -66.47 -10.95 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.973 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.28 55.12 0.66 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.189 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 62.3 m -111.11 137.68 48.48 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.214 0.531 . . . . 0.0 109.734 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.448 ' HE2' ' HA ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -80.69 104.33 11.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.341 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 90.2 t -96.14 124.29 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.054 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 83.1 m-85 -99.42 122.98 43.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -116.05 116.52 28.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.524 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 9.1 ttmt -113.16 135.12 54.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.951 -172.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.0 m -141.77 100.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.625 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.25 -83.15 0.53 Allowed Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.612 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -14.21 6.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 109.648 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 88' ' ' VAL . 58.0 mt-10 -93.07 136.44 33.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.649 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 m -140.85 101.61 4.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.14 161.88 13.37 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.504 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -102.97 125.17 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 65.5 m-85 -121.54 144.95 48.43 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 98' ' ' THR . 36.7 ttmt -108.46 145.37 34.75 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.3 mtp -81.67 46.88 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.378 0.609 . . . . 0.0 109.604 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 4.4 t -81.67 8.67 9.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.448 -168.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.6 m -145.25 93.03 2.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.582 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.8 mt -126.73 137.04 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.762 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -165.43 147.78 7.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.786 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 24.8 t70 -89.85 93.11 9.3 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.45 86.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.872 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.45 126.24 78.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD3' ' HG2' ' A' ' 139' ' ' ARG . 77.1 Cg_endo -76.58 46.23 1.81 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.166 2.578 . . . . 0.0 113.727 -171.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 t -76.72 -14.28 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.6 144.67 25.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.093 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.19 4.88 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -119.67 24.61 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.426 0.631 . . . . 0.0 110.081 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.73 15.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.841 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.28 162.89 13.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.279 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 1.3 m-20 -64.89 149.24 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.33 -40.38 97.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 112' ' ' ASP . 23.8 pt20 -75.56 133.54 40.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.749 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -106.59 97.15 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.643 0.259 . . . . 0.0 110.857 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.75 134.8 24.19 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.97 167.21 9.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.884 0.85 . . . . 0.0 112.562 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 175.19 -164.99 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.103 -1.862 . . . . 0.0 106.483 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -95.72 96.08 8.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -145.0 113.12 6.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.457 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.26 114.67 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -88.04 128.53 35.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.389 0.614 . . . . 0.0 110.046 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 17.8 mt -107.86 105.2 14.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.337 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.51 85.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.604 ' HB ' HG23 ' A' ' 63' ' ' THR . 31.9 p -87.05 86.43 7.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.569 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 42.9 m -64.84 106.01 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.407 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.31 -67.29 0.79 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.498 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 7.8 t70 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.018 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 CA--C 1.518 -0.263 0 CA-C-O 121.14 0.495 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.467 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 37.9 mtmm -80.67 89.33 5.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.215 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 5.8 ptt180 -106.22 81.41 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.642 ' HZ1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -62.21 118.03 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.308 -178.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.11 126.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.3 t80 -113.77 108.86 17.66 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.795 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.9 t -110.86 112.1 39.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -101.97 111.11 23.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.001 0.429 . . . . 0.0 110.549 177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.0 m -89.77 137.22 32.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.726 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 32.3 tt0 -59.8 124.53 20.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.829 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.6 155.21 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 122.21 1.005 . . . . 0.0 110.849 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.559 -168.334 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.775 0.322 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.17 113.99 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 111.318 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -151.5 159.28 44.23 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 77.8 mt -101.07 103.24 24.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 1.6 Cg_endo -84.34 167.49 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.04 2.494 . . . . 0.0 112.587 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -77.9 -12.87 60.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.291 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 18.5 t70 -84.65 123.37 30.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.138 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -95.67 12.31 30.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.655 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -93.86 -4.45 50.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.261 0.553 . . . . 0.0 110.154 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 49.9 mmtm -95.8 172.71 7.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.51 98.23 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.41 -32.27 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.077 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -148.73 156.13 26.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.902 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.497 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 1.0 OUTLIER -123.48 128.3 49.6 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.557 HD11 HG13 ' A' ' 84' ' ' VAL . 9.1 tp -102.31 117.82 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.525 0.678 . . . . 0.0 110.503 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.7 mt-10 -128.99 119.34 24.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.488 0.661 . . . . 0.0 111.466 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.67 102.06 39.14 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.753 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -25.68 75.48 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.023 2.482 . . . . 0.0 112.78 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.07 -3.16 54.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.19 10.99 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.541 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.21 20.79 10.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.769 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 67.6 mt -86.77 119.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 8.9 mtpm? -144.58 68.75 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.813 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 25.0 mm-40 -113.74 145.58 33.74 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.474 -172.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.28 149.73 57.8 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.652 2.235 . . . . 0.0 111.934 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.31 130.52 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -88.68 111.68 45.69 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.746 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 37.9 Cg_endo -67.62 152.83 77.63 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.021 2.481 . . . . 0.0 112.797 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.46 177.54 16.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.046 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.37 136.11 25.78 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.999 2.466 . . . . 0.0 111.448 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.1 115.06 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.773 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -128.71 151.7 77.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.494 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.3 -46.06 36.61 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.192 2.594 . . . . 0.0 113.404 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.53 -8.6 58.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.306 0.574 . . . . 0.0 111.26 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -101.69 -41.27 6.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.866 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.1 mt -67.74 -32.16 72.58 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.984 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.36 -12.98 57.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.207 0.527 . . . . 0.0 110.064 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -87.89 -40.06 14.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.503 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -127.17 0.91 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.018 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -122.29 138.06 53.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.7 p -135.9 174.79 10.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 0.0 110.988 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.6 m-85 -84.12 165.34 18.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.92 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.135 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 37.4 mt-10 -117.08 177.22 4.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.3 tt0 -114.6 13.88 17.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.998 0.904 . . . . 0.0 109.185 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.78 -34.97 11.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.645 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 1.7 pm0 -82.5 142.37 31.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.234 0.54 . . . . 0.0 111.233 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -86.68 152.02 22.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.342 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.83 9.28 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 111.272 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -119.96 -1.8 10.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.437 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -84.91 -173.77 4.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.122 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.18 41.53 1.22 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.625 0.25 . . . . 0.0 111.112 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -171.94 126.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.81 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 23.8 mm -118.93 104.66 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 m -98.29 99.19 10.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.093 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt -120.98 148.14 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.04 140.07 32.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.702 0.287 . . . . 0.0 110.681 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -161.35 116.05 0.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.865 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -83.88 122.49 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 73' ' ' THR . 58.5 m -107.27 118.69 37.39 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.284 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' A' ' 67' ' ' ARG . 12.4 p90 -108.54 139.48 43.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.071 0.462 . . . . 0.0 111.368 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -49.46 -34.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.302 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.44 -29.31 48.98 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 mmt85 -113.56 101.88 54.18 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.204 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.675 ' HA ' HG21 ' A' ' 73' ' ' THR . 8.2 Cg_exo -74.21 -10.73 22.77 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 123.097 2.532 . . . . 0.0 111.39 175.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -106.71 22.44 15.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.084 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -82.79 163.19 21.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.813 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 4.1 mp0 -52.08 -39.79 60.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 76.3 m-85 -128.88 25.53 5.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.675 HG21 ' HA ' ' A' ' 68' ' ' PRO . 3.0 m -68.24 -27.35 66.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.37 21.56 12.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 75' ' ' LEU . 11.7 mt -65.5 -11.64 45.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -71.43 -24.43 62.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.247 0.546 . . . . 0.0 110.76 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -81.2 -17.78 48.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.058 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.93 150.33 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -129.68 179.42 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -65.56 -6.55 11.23 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -171.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.52 23.74 7.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.1 m -87.87 130.68 34.82 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.92 113.05 6.78 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 18' ' ' ILE . 94.6 t -89.7 106.6 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.588 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.01 107.35 19.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.053 0.454 . . . . 0.0 110.323 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 31.8 t80 -108.65 101.0 10.17 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.283 0.564 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 54.5 mtmt -85.65 125.43 33.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.5 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 88' ' ' VAL . 17.8 m -107.9 92.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.822 0.82 . . . . 0.0 109.67 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.95 -89.0 1.42 Allowed Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -127.71 -17.92 4.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 111.138 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 26.1 mt-10 -84.24 142.42 30.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.741 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.3 m -108.78 112.24 24.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.529 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 12.9 mmt180 -89.11 130.75 35.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -100.8 125.89 47.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.936 0.398 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 78.7 m-85 -123.28 144.31 49.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.015 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HE2' HG11 ' A' ' 147' ' ' VAL . 5.4 tppt? -101.85 139.48 37.42 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 100' ' ' ILE . 70.1 mtp -77.64 59.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.43 . . . . 0.0 110.393 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.8 p -59.3 -44.55 92.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.282 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.9 m -113.16 98.89 7.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.981 0.42 . . . . 0.0 111.543 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 97' ' ' MET . 58.8 mt -122.31 105.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -149.8 150.53 32.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.71 127.81 38.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.509 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.44 148.14 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 104' ' ' LYS . 44.6 mtpt -57.74 123.29 62.35 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.22 -8.4 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.764 2.309 . . . . 0.0 112.544 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 p -93.75 -16.06 24.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.164 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.92 120.43 19.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.659 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 m -98.57 2.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -76.06 -20.77 57.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.04 7.1 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.72 -174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.37 113.64 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.252 0.548 . . . . 0.0 111.132 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.94 133.29 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.413 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.2 125.21 51.99 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.646 -169.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -120.23 139.46 52.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.938 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -83.38 51.79 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 110.113 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 145.29 15.64 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.154 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -133.51 168.75 18.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -175.23 -178.83 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.65 86.96 7.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.47 145.58 31.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.386 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -104.63 115.75 30.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.213 175.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.654 ' HA ' HG22 ' A' ' 143' ' ' VAL . 5.1 t -87.77 59.62 5.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.781 0.801 . . . . 0.0 110.436 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.499 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 5.7 mt -54.92 113.99 1.56 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.219 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.78 97.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.413 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 9.2 p -111.33 107.74 17.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -79.5 140.55 37.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.442 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 5.7 m-20 -89.14 -46.19 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.279 0.561 . . . . 0.0 111.086 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.158 -172.059 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 10.1 mtpm? -63.26 130.64 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.905 0.383 . . . . 0.0 111.167 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -118.43 98.53 6.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.118 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -78.53 127.86 32.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.21 131.3 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.712 0.767 . . . . 0.0 109.988 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.4 t80 -129.18 98.78 5.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.241 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 122' ' ' THR . 58.6 t -106.06 104.46 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.9 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.573 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -90.31 133.38 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.841 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.6 m -104.86 138.43 41.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.513 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 41.6 tt0 -64.97 113.87 4.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.244 0.545 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 96' ' ' LYS . 2.1 p -116.58 153.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.068 0.937 . . . . 0.0 112.367 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--N 1.308 -1.201 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.359 -178.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.686 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 26.0 Cg_endo -63.29 120.1 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.761 2.307 . . . . 0.0 112.309 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -141.89 159.21 42.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 31' ' ' PRO . 46.6 mt -103.49 110.93 64.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.63 0.253 . . . . 0.0 110.68 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.31 -176.22 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.681 2.254 . . . . 0.0 111.292 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.24 -19.77 21.85 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.412 0.625 . . . . 0.0 109.608 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 2.7 p-10 -92.32 165.1 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -116.46 16.33 15.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.092 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -89.33 -27.35 20.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 110.045 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 29.8 mmmt -84.0 113.84 21.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.14 97.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.899 0.38 . . . . 0.0 110.588 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 -30.38 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.734 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -146.99 157.74 27.51 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.948 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 2.4 t80 -137.77 124.98 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -95.06 121.58 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.152 0.501 . . . . 0.0 110.243 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.1 mt-10 -128.5 106.43 8.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.548 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.8 mt -120.42 98.78 48.36 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.185 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 -33.39 93.83 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.043 2.496 . . . . 0.0 112.486 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.36 -19.9 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.548 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -128.04 16.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.4 23.09 12.65 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.217 0.323 . . . . 0.0 111.636 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 81.1 mt -94.18 112.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.635 0.255 . . . . 0.0 111.342 -172.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 54.5 mtmt -141.05 86.16 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.668 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -123.61 141.33 36.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.65 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.3 146.24 56.28 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.262 1.975 . . . . 0.0 111.449 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 58.0 t -100.08 127.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.705 ' HB3' ' HB2' ' A' ' 11' ' ' LYS . 23.7 m-85 -95.48 105.18 18.74 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.592 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -66.61 143.43 68.41 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.996 2.464 . . . . 0.0 112.284 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.67 -134.26 6.15 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.434 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -95.87 155.05 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.406 2.737 . . . . 0.0 112.797 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.83 129.58 35.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.28 138.95 7.67 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.54 -31.97 80.85 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.178 2.586 . . . . 0.0 112.925 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.31 -35.41 77.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 111.354 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.9 tt0 -85.52 -34.7 21.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.892 0.377 . . . . 0.0 110.345 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.71 -16.64 61.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.599 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 65.8 t30 -82.29 3.74 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.727 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 11.7 ptp180 -137.11 -43.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.304 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' TYR . . . -139.15 169.7 24.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.192 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.63 140.03 16.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -139.29 174.52 10.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.05 144.8 25.89 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.325 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -83.96 -79.93 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.0 77.32 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.378 0.608 . . . . 0.0 111.122 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -16.67 35.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.6 36.11 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.758 -1.564 . . . . 0.0 111.976 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -156.97 -150.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.126 0.489 . . . . 0.0 111.224 -172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 68.8 m -103.03 159.47 15.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.312 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.41 2.12 4.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.761 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 51' ' ' SER . 1.2 p-10 -91.1 -5.77 54.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.56 166.35 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.943 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -85.71 -35.32 20.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.583 0.23 . . . . 0.0 111.432 -173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.34 85.81 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.648 0.737 . . . . 0.0 111.625 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.535 HG21 HD22 ' A' ' 121' ' ' LEU . 34.4 mm -82.82 132.61 30.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.675 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 p -130.55 107.85 9.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.325 0.583 . . . . 0.0 110.578 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 123' ' ' LEU . 4.0 mt -107.55 143.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -120.29 149.33 42.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.203 0.525 . . . . 0.0 111.887 -173.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.7 -165.15 21.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -145.34 137.72 25.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.434 0.617 . . . . 0.0 110.57 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -89.72 132.89 34.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.959 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.67 121.72 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.937 0.399 . . . . 0.0 111.057 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tt -88.55 -30.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.59 -42.2 82.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 76.0 mtt180 -105.85 104.47 49.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.198 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.43 -35.65 38.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.414 2.076 . . . . 0.0 112.568 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -87.71 52.35 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.438 0.637 . . . . 0.0 110.302 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 40' ' ' ASN . 15.6 t80 -104.25 -167.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.001 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 3.6 pt20 -82.16 -38.25 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.705 0.288 . . . . 0.0 111.171 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 71' ' ' GLN . 78.1 m-85 -131.19 97.86 4.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.116 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 70' ' ' TYR . 25.5 p -130.88 -48.96 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.6 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 62.3 t30 -84.77 16.85 3.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.1 tp -66.58 -13.87 61.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 110.781 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -68.56 -24.0 64.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 175.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.0 9.1 20.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.751 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -103.0 129.29 49.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.1 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 3.0 mppt? -112.84 -178.5 3.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.907 -172.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -66.49 -6.62 15.47 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 112.017 -175.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -132.0 19.93 4.59 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.456 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 49.9 m -74.12 115.27 13.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.2 tpt -65.01 112.64 3.42 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.757 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 95.2 t -96.71 123.41 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.391 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 63.0 m-85 -106.05 126.68 52.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.025 0.44 . . . . 0.0 110.663 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.507 ' HE1' HG21 ' A' ' 29' ' ' VAL . 24.9 t80 -115.76 103.86 11.09 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.413 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.513 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 12.0 ttmm -78.83 138.4 38.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.61 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.5 m -136.56 102.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.247 0.546 . . . . 0.0 110.559 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.33 -81.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.162 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.79 -5.12 2.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 110.324 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -101.58 156.97 17.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.372 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 m -123.35 125.16 44.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.65 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HB2' ' HE1' ' A' ' 95' ' ' TYR . 15.1 mmm180 -105.97 137.34 44.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -103.2 135.4 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.618 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 81.1 m-85 -132.52 146.72 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.254 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.554 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 9.9 tppt? -109.42 139.34 44.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 100' ' ' ILE . 68.4 mtp -77.63 79.76 4.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.9 p -80.77 -43.1 20.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 4.5 m -112.72 108.34 17.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 110.57 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.6 mt -128.66 102.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.713 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -153.6 174.08 14.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.8 143.18 50.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 t -111.36 148.67 14.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.147 -172.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 1.7 tmtp? -121.9 89.82 48.29 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -101.73 -150.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.778 2.985 . . . . 0.0 111.843 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.2 m -144.49 -46.92 0.25 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 108' ' ' VAL . 2.6 t70 -138.39 -154.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 109' ' ' GLU . 21.9 m -91.16 -173.8 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.328 -0.232 . . . . 0.0 111.282 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 108' ' ' VAL . 4.9 mm-40 69.41 -3.91 1.48 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.062 0.945 . . . . 0.0 113.011 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.65 -23.77 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.097 0.475 . . . . 0.0 110.815 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -114.22 131.32 56.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.805 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -89.65 130.7 35.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.67 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.439 ' CD ' ' HZ1' ' A' ' 117' ' ' LYS . 8.5 tp10 -102.16 141.15 35.46 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -154.49 157.24 38.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.075 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -79.17 79.7 5.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.931 0.872 . . . . 0.0 111.163 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.26 43.19 0.49 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.996 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HZ1' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -102.53 -165.21 1.16 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.16 0.505 . . . . 0.0 110.86 -177.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.7 -174.35 4.13 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -78.25 96.93 5.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -134.67 146.44 49.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 57' ' ' ILE . 18.4 mt -95.26 100.49 12.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 90.19 3.37 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 59' ' ' ILE . 7.6 mt -84.16 114.46 21.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.771 0.796 . . . . 0.0 111.291 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.552 HG23 ' NH2' ' A' ' 139' ' ' ARG . 73.3 mt -91.91 94.13 4.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.906 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.4 p -115.81 85.56 2.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.499 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.3 p -78.58 135.23 37.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.512 ' OD1' ' HB2' ' A' ' 140' ' ' LYS . 2.3 m-20 -89.72 -60.83 1.84 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.755 0.788 . . . . 0.0 109.688 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 4.7 t70 . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 114.163 -1.38 . . . . 0.0 111.132 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 43.7 mt-10 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 28.5 mttp -104.37 97.46 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.265 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.552 ' NH2' HG23 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -119.92 117.59 28.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.638 0.732 . . . . 0.0 111.427 -177.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.543 ' HE3' HG23 ' A' ' 100' ' ' ILE . 2.3 tmtm? -77.5 124.56 28.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.72 121.78 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 121.597 0.713 . . . . 0.0 110.139 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.1 t80 -120.59 115.88 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.84 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.5 t -111.8 116.96 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.366 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -105.33 119.78 39.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.337 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 m -87.0 138.87 31.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.3 112.35 5.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 96' ' ' LYS . 2.6 p -122.57 150.49 26.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--N 1.31 -1.13 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.211 -174.24 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm . . . . . 0 C--O 1.232 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 17.1 Cg_endo -56.95 145.84 82.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.25 2.633 . . . . 0.0 112.744 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.468 ' HA ' HD21 ' A' ' 52' ' ' LEU . 26.0 mm-40 -129.32 168.36 16.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.912 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.667 HG13 HD23 ' A' ' 52' ' ' LEU . 82.7 mt -100.02 105.77 37.25 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.02 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 10.8 Cg_endo -89.41 -93.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.959 2.439 . . . . 0.0 113.176 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 9' ' ' LYS . 13.4 ttpp -164.97 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.23 124.2 16.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.001 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 38' ' ' GLN . 77.4 mttt -90.09 13.34 15.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.266 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -120.13 6.7 10.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -105.88 144.16 33.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.412 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.83 102.5 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.825 0.345 . . . . 0.0 110.289 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -84.66 -31.69 24.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.235 0.541 . . . . 0.0 110.203 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.15 178.24 31.92 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.017 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.01 144.44 50.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tp -117.13 118.75 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.549 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.8 mt-10 -126.4 113.0 16.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.46 0.648 . . . . 0.0 111.671 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.54 99.66 45.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.45 -29.79 89.44 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.164 2.576 . . . . 0.0 112.673 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.28 -21.23 66.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.599 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -125.86 8.81 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.131 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 56.64 31.19 18.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.418 0.628 . . . . 0.0 111.121 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 78.0 mt -83.32 110.01 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.07 67.6 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 35.3 mm-40 -120.4 157.02 54.82 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.793 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.84 160.68 30.71 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.533 2.155 . . . . 0.0 112.563 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -112.43 132.93 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 35.4 m-85 -92.82 111.19 50.09 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 0.0 110.522 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 55.7 Cg_endo -70.38 98.69 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.364 2.709 . . . . 0.0 112.918 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.27 173.57 41.15 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 154.01 43.64 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.738 2.292 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 107.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.548 0.53 . . . . 0.0 111.034 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.477 ' HB ' ' OE1' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -136.58 142.23 38.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.915 -176.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -47.85 -49.54 13.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.981 3.12 . . . . 0.0 114.245 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.12 -28.28 39.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -174.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.824 ' HB2' ' HD3' ' A' ' 11' ' ' LYS . 9.3 tt0 -73.41 -39.57 64.96 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 35' ' ' THR . 91.1 mt -63.74 -36.64 84.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.752 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -32.89 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -86.75 -12.36 48.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.676 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 71' ' ' GLN . . . 162.05 -96.25 0.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.322 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 59' ' ' ILE . 5.0 p -154.28 140.86 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 120.78 0.324 . . . . 0.0 110.607 -175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . 19.8 p -125.05 174.75 7.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.09 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.44 164.07 24.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.908 0.385 . . . . 0.0 110.747 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' SER . . . -79.75 -55.13 5.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.064 0.459 . . . . 0.0 110.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -112.69 151.25 30.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.48 -177.011 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -74.27 -36.87 63.84 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.165 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -89.3 19.0 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.223 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 41.1 mt-10 -84.86 102.27 12.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 109.849 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 m -72.89 133.36 44.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 7' ' ' ILE . 2.0 pp -70.53 -2.46 14.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.54 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -109.07 -3.46 17.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.371 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.79 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.487 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 pt20 172.27 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' HD3' ' A' ' 117' ' ' LYS . 7.4 t30 -94.24 119.69 33.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.295 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 52' ' ' LEU . 17.2 mm -123.39 100.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.066 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' THR . 4.5 m -92.8 114.47 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 110.347 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.685 ' HB ' ' HG ' ' A' ' 123' ' ' LEU . 3.0 mt -111.52 108.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 121.62 33.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.803 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -99.14 175.48 28.47 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.517 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' THR . 23.2 t-160 -84.0 -84.16 0.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.381 0.134 . . . . 0.0 111.144 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 62' ' ' HIS . 15.2 t 171.75 -170.04 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.21 150.31 30.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.35 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.666 HG13 ' H ' ' A' ' 66' ' ' ASP . 10.7 tp -158.47 177.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.666 ' H ' HG13 ' A' ' 65' ' ' ILE . 38.8 t70 -76.77 34.65 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.689 0.757 . . . . 0.0 111.221 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -125.3 105.36 28.21 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 121.977 -0.452 . . . . 0.0 110.298 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 57.0 Cg_endo -72.32 -4.96 16.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -103.4 16.81 25.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.531 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.4 t80 -84.66 151.77 24.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.133 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 12.3 mp0 -46.55 -39.76 11.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.54 17.69 9.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -171.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 38.5 m -69.15 -39.7 78.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.491 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -99.0 7.4 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.086 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.18 -13.48 37.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 110.754 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -63.78 -23.84 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.232 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.49 -8.31 59.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.686 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -85.7 158.67 19.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.57 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -128.2 -178.16 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.277 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -72.06 -5.47 35.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.437 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.31 8.21 12.32 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.473 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.8 m -74.04 155.71 38.25 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.731 0.777 . . . . 0.0 110.915 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.92 120.05 35.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.102 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.755 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 72.1 t -103.23 108.68 24.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.323 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 42.0 m-85 -90.05 109.81 20.84 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.286 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HB2' HD11 ' A' ' 121' ' ' LEU . 38.9 t80 -99.07 110.39 22.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -109.1 142.54 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.256 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 52' ' ' LEU . 2.9 p -150.64 103.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.83 0.824 . . . . 0.0 110.091 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 62.58 -98.29 0.2 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.226 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.58 -7.16 17.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.45 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 6.4 mm-40 -92.89 145.06 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.443 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 m -150.04 99.93 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.225 0.536 . . . . 0.0 110.01 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -106.03 136.87 44.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.615 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -89.96 133.29 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.993 0.425 . . . . 0.0 110.336 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -126.94 147.35 50.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.27 148.31 30.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.56 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 68.3 mtp -80.65 56.6 2.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.199 0.523 . . . . 0.0 110.27 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.1 p -60.98 -38.5 86.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.187 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.1 m -119.42 95.59 4.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.014 0.435 . . . . 0.0 111.489 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 97' ' ' MET . 59.3 mt -115.66 103.39 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -132.33 147.17 52.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.957 0.408 . . . . 0.0 110.621 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 36.3 t70 -112.78 120.22 40.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.635 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 111' ' ' LEU . 15.7 t -123.43 154.88 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.223 -173.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 92.1 mttt -90.57 138.32 26.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 12.6 Cg_exo -74.06 42.92 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.84 3.027 . . . . 0.0 113.02 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -59.05 -48.51 81.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.411 0.624 . . . . 0.0 109.797 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -143.84 171.62 13.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.112 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.0 m -88.68 -8.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.443 0.639 . . . . 0.0 109.476 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.44 -12.87 59.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.881 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 111' ' ' LEU . 12.5 p -69.88 -24.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.065 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 110' ' ' VAL . 90.6 mt -121.05 135.47 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -166.2 143.72 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.36 114.38 27.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.998 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -95.76 161.4 14.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.577 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.48 23.67 13.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 123.693 0.621 . . . . 0.0 111.343 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.26 -149.12 21.77 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -145.4 158.74 43.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.854 0.359 . . . . 0.0 111.583 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -111.98 -161.31 0.75 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 6.1 mptt -80.64 97.47 7.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.81 138.78 24.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.651 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.8 mt -96.28 101.77 13.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 143' ' ' VAL . 16.4 m -90.09 85.77 6.38 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.86 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.685 ' HG ' ' HB ' ' A' ' 59' ' ' ILE . 7.2 mp -77.3 104.11 7.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.239 0.543 . . . . 0.0 110.895 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.86 82.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.306 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.5 p -104.66 98.52 8.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.73 113.52 4.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.844 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 1.6 t70 -64.26 -39.1 93.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.77 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.964 176.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -156.61 135.23 11.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.844 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 3.4 ptp180 -145.02 108.96 4.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.421 0.629 . . . . 0.0 111.569 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -88.62 109.96 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.666 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 141' ' ' ILE . 3.9 tp -88.69 127.14 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 110.31 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.755 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.7 t80 -118.54 114.57 23.03 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.32 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.9 t -112.44 115.01 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.104 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -97.03 117.77 31.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.385 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.1 m -89.83 142.31 27.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.185 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.44 138.34 56.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.6 t -111.11 161.85 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.309 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.666 0.27 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.0 116.99 4.92 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.251 1.968 . . . . 0.0 111.639 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -130.05 175.25 9.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.204 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 31' ' ' PRO . 48.0 mm -113.44 89.28 14.69 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -92.73 -176.84 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.202 2.601 . . . . 0.0 113.086 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -74.96 -25.41 58.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.63 118.5 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 56.4 mttp -87.1 -46.64 9.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -56.32 -36.27 68.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -167.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.611 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.56 142.38 58.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.247 0.546 . . . . 0.0 110.98 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.28 126.06 49.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -103.07 -22.74 13.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.908 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.35 160.72 28.68 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.531 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.32 127.48 53.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.54 118.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.334 0.588 . . . . 0.0 109.43 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 34.2 mt-10 -125.4 112.0 15.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.799 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 84' ' ' VAL . 76.2 mt -125.22 102.65 30.36 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.901 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 20.2 Cg_endo -62.09 -29.74 81.63 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.129 2.553 . . . . 0.0 113.095 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.37 -16.74 61.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.53 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.44 8.82 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.327 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 58.55 34.71 24.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.764 0.792 . . . . 0.0 110.722 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 71.3 mt -95.66 120.88 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.745 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -145.3 79.64 1.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 31.7 mm-40 -122.4 141.65 35.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.676 -169.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.21 134.4 21.03 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.575 2.183 . . . . 0.0 111.7 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.593 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.3 t -96.2 138.13 22.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.357 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -109.46 91.02 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -68.28 133.43 28.43 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.88 2.386 . . . . 0.0 112.272 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.38 175.79 34.7 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HG2' ' HE3' ' A' ' 11' ' ' LYS . 19.6 Cg_endo -59.84 118.09 4.93 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.662 2.241 . . . . 0.0 112.237 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -55.8 126.32 25.09 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -142.25 139.02 17.2 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.83 -35.43 88.56 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.023 2.482 . . . . 0.0 113.01 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.47 -17.51 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.419 ' CD ' ' HD3' ' A' ' 11' ' ' LYS . 37.6 tt0 -88.92 -48.59 7.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 35' ' ' THR . 4.5 mm? -60.49 -22.9 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.808 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.12 -15.09 60.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.209 0.528 . . . . 0.0 110.582 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -100.01 -20.98 15.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.944 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.89 178.55 41.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.057 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.84 123.87 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -136.17 153.06 51.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.368 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.38 168.94 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.99 -64.39 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -105.65 158.73 16.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.124 0.487 . . . . 0.0 111.174 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.25 5.01 52.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.786 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.53 -0.42 43.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -107.78 135.55 49.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.852 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 57' ' ' ILE . 27.6 t -118.72 157.95 26.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.277 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.78 -2.23 16.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.578 0.704 . . . . 0.0 110.219 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -92.25 -16.45 26.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.972 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.91 178.54 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.825 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 -26.93 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.96 124.13 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.852 0.358 . . . . 0.0 110.657 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 121' ' ' LEU . 25.4 mm -135.25 139.88 46.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.78 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 m -132.97 114.4 13.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 110.257 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -123.02 136.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.6 174.18 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.28 -172.45 40.87 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.773 ' CD2' ' HA ' ' A' ' 127' ' ' ASP . 10.4 t60 78.18 122.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.983 0.913 . . . . 0.0 111.651 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -153.98 151.3 29.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.701 171.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.49 83.89 7.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.694 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 11.2 tp -99.57 18.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.796 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 14.3 t70 83.33 -25.4 0.14 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.346 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -75.76 108.19 5.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 60.2 Cg_endo -77.4 0.35 9.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.511 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.14 9.78 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.17 101.64 0.93 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.837 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -1.17 -71.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 19.3 m-85 -79.47 6.46 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.7 p -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -92.73 10.41 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.228 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.93 1.22 5.85 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.569 0.7 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -75.77 -25.05 56.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.198 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.72 59.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.07 149.16 26.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -112.72 173.93 6.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.172 -176.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -77.83 -6.01 52.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.619 . . . . 0.0 110.665 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.11 10.66 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.975 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.582 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 24.3 m -73.86 129.76 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.519 0.676 . . . . 0.0 110.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.414 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -75.91 108.29 8.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.816 173.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.826 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -97.07 134.4 34.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.659 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.5 m-85 -108.53 127.5 53.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.038 0.447 . . . . 0.0 110.228 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.415 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 57.2 t80 -123.3 113.18 18.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.383 0.611 . . . . 0.0 109.361 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.6 ttmm -89.97 132.63 35.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.715 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.04 117.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.364 0.602 . . . . 0.0 109.843 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 -99.81 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.316 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -131.01 11.09 5.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.831 0.348 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -125.83 156.48 39.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 11.6 m -126.47 130.15 50.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 79.1 mmt-85 -101.56 153.71 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.145 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 44.2 mtmt -102.56 131.57 49.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 109.891 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.2 m-85 -127.36 145.1 50.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.678 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -107.39 143.87 35.09 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.607 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.9 mtp -83.5 44.61 0.98 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.766 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 98' ' ' THR . 1.8 t -74.72 -9.45 58.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.463 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.7 m -123.85 84.41 2.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.281 0.563 . . . . 0.0 110.892 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 97' ' ' MET . 64.4 mt -120.12 113.68 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.248 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 141' ' ' ILE . 50.9 ttt85 -127.87 155.22 44.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.307 . . . . 0.0 110.542 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 138' ' ' LYS . 27.1 t70 -81.18 122.26 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.026 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 46.6 t -129.29 98.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.032 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 32.0 mttp -76.33 166.81 42.08 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.0 -13.19 21.93 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.257 1.971 . . . . 0.0 112.161 174.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 t -106.75 3.19 26.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.027 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 3.5 m-20 -112.12 29.26 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.342 0.591 . . . . 0.0 110.395 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 109' ' ' GLU . 16.5 t -71.24 169.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.509 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER 48.42 23.35 0.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.596 1.159 . . . . 0.0 113.414 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.437 HG13 HD22 ' A' ' 111' ' ' LEU . 8.9 p -90.56 -21.83 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.959 0.409 . . . . 0.0 110.098 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.437 HD22 HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -84.51 107.94 17.02 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -93.54 174.32 7.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.229 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.09 109.02 20.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -168.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -103.22 140.87 36.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.588 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.3 148.12 26.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.859 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.51 49.23 2.4 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.537 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -105.65 -170.62 1.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.561 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.65 -169.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.61 100.04 8.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -119.95 126.62 51.31 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.748 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.44 105.0 17.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.4 m -75.19 90.8 2.58 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 31.2 mt -84.95 112.42 20.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.591 0.71 . . . . 0.0 110.05 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.0 mt -84.27 91.44 2.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.006 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.4 m -77.32 88.32 3.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.698 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.4 75.41 7.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.135 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.773 ' HA ' ' CD2' ' A' ' 62' ' ' HIS . 4.5 t0 -83.52 -15.36 49.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.213 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' CG ' ' HE ' ' A' ' 139' ' ' ARG . 19.2 p-10 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.965 -171.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 2.9 mtpm? -145.5 138.55 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.989 -173.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' A' ' 128' ' ' ASP . 95.6 mtt180 -103.34 108.21 19.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.516 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -76.97 103.53 6.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 101' ' ' ARG . 16.0 tt -70.26 122.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.593 0.711 . . . . 0.0 109.783 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.826 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -103.37 96.05 6.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.747 -174.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 68.8 t -106.5 104.11 16.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.743 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -97.68 123.96 41.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.276 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 m -95.78 139.9 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.566 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 40.5 tt0 -61.84 123.03 16.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.229 0.537 . . . . 0.0 111.257 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 148' ' ' LYS . 6.4 p -131.64 165.33 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.82 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.9 pptp? . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.05 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 pttt . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 33.1 Cg_endo -65.21 116.4 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.276 1.984 . . . . 0.0 111.785 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.31 -166.69 1.29 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.922 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.57 104.49 56.16 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.877 0.37 . . . . 0.0 110.592 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.04 -176.57 2.91 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.749 2.3 . . . . 0.0 111.852 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -100.52 4.31 43.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.781 0.324 . . . . 0.0 110.974 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -107.72 152.77 23.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.817 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 3.1 mptt -102.44 -8.23 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.714 -169.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.4 p -73.35 -19.87 60.91 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.193 0.52 . . . . 0.0 110.744 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -96.09 106.22 18.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.792 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.07 102.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 110.221 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.02 63.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.06 35.93 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.047 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.82 144.96 49.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.312 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.79 113.19 42.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.669 0.747 . . . . 0.0 109.395 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -125.16 113.96 18.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.348 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 25' ' ' ILE . 51.9 mt -122.65 101.34 40.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 12.0 Cg_endo -57.82 -32.22 94.37 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.042 2.495 . . . . 0.0 112.343 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -29.05 69.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.633 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.03 9.37 12.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.706 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.02 19.48 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.357 0.411 . . . . 0.0 111.605 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 20' ' ' ILE . 67.8 mt -84.45 134.86 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.27 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -158.67 61.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 27.5 mm-40 -123.8 153.78 67.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.616 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 158.36 43.61 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.802 2.335 . . . . 0.0 112.386 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.32 133.52 53.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 33.4 m-85 -93.48 109.46 40.76 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 38.9 Cg_endo -68.07 148.43 75.5 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.501 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.45 -174.76 21.37 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.34 143.48 13.9 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.45 2.1 . . . . 0.0 112.001 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -64.79 131.98 48.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -166.07 145.49 5.11 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.676 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -42.32 -46.71 7.49 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.918 3.079 . . . . 0.0 114.17 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mp0 -54.47 -37.9 65.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.471 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.3 -60.29 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.355 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.8 mm? -69.05 -7.14 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.675 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -68.93 -33.7 74.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.289 0.566 . . . . 0.0 109.792 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -111.44 -37.27 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.138 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -159.15 -169.31 22.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.232 -175.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.846 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 7.9 p -88.42 148.56 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.017 0.437 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.7 m -144.26 -179.51 6.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 63.9 m-85 -93.38 147.62 22.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.924 0.393 . . . . 0.0 110.719 176.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -98.36 -58.27 2.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.932 -174.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -88.76 -169.64 2.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 111.961 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 50.49 0.53 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.625 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.87 94.96 5.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.3 -3.93 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.1 0.952 . . . . 0.0 110.033 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -143.99 130.67 20.17 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.755 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.85 1.77 46.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.682 0.753 . . . . 0.0 109.391 171.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.43 1.23 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.946 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.5 t70 -94.64 -157.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.692 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 13.2 pt20 -106.42 -41.5 5.28 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.81 118.58 26.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.539 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.75 104.41 14.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.923 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.7 m -102.14 99.23 9.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.016 0.436 . . . . 0.0 110.736 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -99.59 143.28 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 -178.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -121.37 133.37 55.1 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.06 156.39 26.89 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.357 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -102.0 101.62 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.592 HG22 ' HB ' ' A' ' 125' ' ' THR . 6.7 t -87.61 98.29 11.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.024 0.916 . . . . 0.0 110.124 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 12.6 t80 -111.91 92.38 4.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.837 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -58.72 -27.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 27.2 m-20 -67.46 -4.78 12.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.079 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.8 mmt85 -135.09 105.76 10.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 14.1 Cg_exo -69.78 -12.12 32.22 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.696 2.264 . . . . 0.0 111.84 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -88.24 5.9 39.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.404 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.32 151.93 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 177.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 95.7 mt-30 -62.29 -33.96 75.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.264 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.846 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 97.3 m-85 -122.84 78.74 1.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.205 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 5.2 t -113.07 -29.38 7.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.345 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -98.75 21.74 11.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -172.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 75' ' ' LEU . 13.4 mt -71.18 -5.12 29.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -23.37 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.24 0.543 . . . . 0.0 109.711 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.52 0.43 42.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.309 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.68 114.06 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.299 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.5 -175.41 2.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 -178.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -61.4 -5.11 1.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.503 ' CA ' ' HE3' ' A' ' 96' ' ' LYS . . . -141.38 31.64 2.13 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.961 -1.114 . . . . 0.0 112.448 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.1 m -78.3 117.56 19.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 94' ' ' LYS . 25.1 tpp -68.53 119.85 13.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.02 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 97' ' ' MET . 73.0 t -110.63 122.79 65.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.28 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -101.89 117.13 34.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.185 0.517 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -104.8 123.58 47.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -110.25 132.52 54.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -137.66 116.67 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.516 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 69.28 -82.39 0.26 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -135.3 -16.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.662 0.268 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.46 156.66 16.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.079 0.466 . . . . 0.0 110.916 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -135.49 119.99 18.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.025 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 89.1 mtt180 -104.79 154.77 19.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.628 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.671 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -104.15 125.67 50.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.582 -178.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 91.3 m-85 -123.73 150.42 44.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.259 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HE3' ' CA ' ' A' ' 81' ' ' GLY . 11.5 tttp -119.79 144.46 47.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 84' ' ' VAL . 76.5 mmm -77.36 81.33 3.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 p -83.83 -16.36 44.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.388 -171.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 47.1 m -147.05 104.98 3.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.35 0.595 . . . . 0.0 111.538 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.48 111.75 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.888 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -127.2 148.68 50.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.195 0.521 . . . . 0.0 111.349 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.404 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 30.8 m-20 -109.42 134.87 51.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.62 176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.471 HG11 HG23 ' A' ' 108' ' ' VAL . 58.6 t -122.91 126.17 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 104' ' ' LYS . 16.1 pttp -78.35 146.76 71.05 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.15 -20.54 67.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.327 2.685 . . . . 0.0 113.953 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -81.82 -29.92 32.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.831 0.348 . . . . 0.0 111.681 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.22 81.63 2.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 HG11 ' A' ' 103' ' ' VAL . 6.4 p -101.47 -8.62 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.713 0.768 . . . . 0.0 109.935 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.67 34.68 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.2 m -82.15 16.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.238 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.74 171.0 14.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.462 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.533 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 7.5 m-20 -84.12 152.85 24.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.86 97.76 1.46 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.454 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 19.8 mt-30 -135.18 95.29 3.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -109.96 116.97 32.58 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.22 31.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.807 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 118' ' ' ASP . 24.9 tptt -76.19 -161.67 0.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 3.4 t70 -71.86 -168.23 0.35 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.762 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 3.2 mppt? -76.55 85.09 3.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -136.97 135.37 37.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.825 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.74 107.1 18.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -93.04 94.36 8.83 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.5 mp -83.36 110.26 17.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mt -88.77 99.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.763 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 14.4 p -114.31 104.44 12.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.744 -175.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.1 m -70.76 123.16 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.5 -79.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.748 -177.326 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.789 ' HG3' ' H ' ' A' ' 138' ' ' LYS . 8.3 pt-20 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.789 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 14.0 ptmm? -117.64 166.13 12.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -107.46 156.88 18.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.304 172.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.452 ' HG2' ' HZ1' ' A' ' 138' ' ' LYS . 5.9 tmtp? -133.92 127.85 33.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.998 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.39 128.41 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 120.986 0.422 . . . . 0.0 110.492 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 76.0 m-85 -121.73 107.61 12.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.218 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 52.9 t -102.24 107.18 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.0 110.599 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -101.62 107.42 18.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.396 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.7 m -85.78 140.18 30.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.194 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.493 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 30.9 tt0 -64.63 120.64 12.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.435 ' HB ' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t -84.49 165.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.184 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.79 158.2 52.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.617 2.211 . . . . 0.0 111.521 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 mm-40 -116.09 168.47 10.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.753 0.311 . . . . 0.0 110.588 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 31' ' ' PRO . 87.2 mt -98.04 102.25 13.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 79.0 Cg_endo -93.2 -173.84 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.069 2.512 . . . . 0.0 113.504 -174.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -81.44 -17.85 47.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.565 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.1 137.88 53.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.615 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 32.9 mmtp -88.56 -33.34 17.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.604 -167.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -101.23 8.57 42.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.869 0.366 . . . . 0.0 111.627 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -86.06 90.25 8.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.615 0.245 . . . . 0.0 110.836 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.78 115.57 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.88 -28.26 15.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.195 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.17 155.39 25.07 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.344 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 131.56 55.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -102.81 130.47 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 50.3 mt-10 -136.79 109.56 7.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.274 0.559 . . . . 0.0 111.049 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 55.9 mt -118.93 95.41 49.25 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.67 -36.36 98.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.152 2.568 . . . . 0.0 113.064 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.58 -30.06 70.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -111.18 5.04 19.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.068 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 58.4 25.43 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.297 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 58.9 mt -85.1 99.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 40.1 ttmt -134.98 88.12 2.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 5.7 mm-40 -144.97 153.39 53.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.884 -170.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.0 153.99 52.64 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.194 2.596 . . . . 0.0 112.918 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -107.26 139.15 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -113.08 103.12 55.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' HG23 ' A' ' 7' ' ' ILE . 77.8 Cg_exo -51.88 161.72 2.15 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.825 3.017 . . . . 0.0 113.421 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.73 165.87 12.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.48 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 11' ' ' LYS . 34.4 Cg_endo -65.22 141.08 67.5 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.515 2.143 . . . . 0.0 111.761 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.2 101.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.169 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -139.09 155.76 72.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.9 Cg_endo -54.26 -35.24 82.68 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.902 2.401 . . . . 0.0 112.6 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.67 -45.82 77.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.235 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 11.1 mm100 -72.71 -47.14 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.553 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.0 mm? -68.1 -9.51 46.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.44 . . . . 0.0 111.003 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 24.3 t-20 -78.5 -32.27 48.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.823 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -93.74 -46.37 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.89 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -160.29 -156.45 8.18 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.818 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 71' ' ' GLN . 87.0 t -97.13 135.22 32.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.536 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 67.6 m -127.72 151.32 49.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.834 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 97.0 m-85 -71.38 147.07 48.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.08 0.467 . . . . 0.0 111.59 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.99 -28.38 29.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.85 99.26 9.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.558 173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -83.15 17.11 2.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.302 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.65 172.68 12.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.776 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -82.52 14.31 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.212 -173.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -102.37 101.7 11.97 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -110.83 4.95 20.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.521 0.677 . . . . 0.0 109.874 172.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.54 20.99 7.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.581 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -74.6 -170.05 0.97 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.6 pt20 -93.22 -29.09 15.88 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -111.02 143.5 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 15.1 mm -138.07 100.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -93.79 116.04 28.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.6 mt -122.36 138.3 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -91.16 118.28 30.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 125' ' ' THR . . . -105.16 114.58 4.66 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.494 -175.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' HB3' HD12 ' A' ' 39' ' ' LEU . 25.1 p80 -73.62 141.76 46.54 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.1 t -74.08 175.34 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.518 ' HB3' HG22 ' A' ' 73' ' ' THR . 42.1 p90 -82.86 161.27 21.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.46 -80.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.007 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -115.54 -10.93 11.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.075 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -98.11 109.76 53.15 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.736 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 -13.82 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.086 2.524 . . . . 0.0 111.949 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -116.92 61.82 0.73 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 109.764 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.74 179.46 4.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.599 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.719 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 14.9 mp0 -53.83 -40.91 66.82 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.498 0.499 . . . . 0.0 112.129 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 75' ' ' LEU . 71.5 t80 -131.57 101.59 5.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.0 109.923 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 64' ' ' PHE . 15.4 p -141.75 -62.84 0.45 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.209 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 66.2 t30 -94.15 27.01 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -167.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 72' ' ' PHE . 16.6 tp -62.86 -18.55 63.07 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.615 -0.678 . . . . 0.0 111.404 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -64.12 -22.23 66.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.49 -16.01 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.412 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.88 169.41 18.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.594 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -137.42 168.08 20.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 111.494 -176.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -68.26 -11.33 59.19 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.08 -173.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -131.47 39.34 1.78 Allowed Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.002 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.4 p -85.24 -150.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.967 0.413 . . . . 0.0 110.106 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.485 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.5 tpt -139.3 105.36 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.782 0.325 . . . . 0.0 110.187 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.9 t -96.19 120.99 46.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.044 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 80.8 m-85 -101.04 129.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.406 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 33.6 t80 -123.41 106.15 10.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 49.4 mtmt -102.02 114.85 29.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.398 -175.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.91 101.99 13.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.571 0.7 . . . . 0.0 109.122 173.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.77 -89.29 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -12.5 4.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.136 0.493 . . . . 0.0 109.818 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 3.5 mm-40 -76.91 117.67 18.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.803 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.4 m -103.16 112.49 25.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.112 0.482 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -102.23 136.17 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 21.6 mtmm -104.34 140.06 38.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.468 . . . . 0.0 110.629 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 74.8 m-85 -132.69 148.56 52.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 13.3 tppt? -107.76 137.89 44.97 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.531 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 69.3 mtp -79.06 61.91 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.8 p -68.63 -41.21 79.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.211 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -116.37 101.37 8.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.333 0.587 . . . . 0.0 111.343 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 97' ' ' MET . 57.0 mt -119.75 114.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.025 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -134.63 140.22 45.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.382 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.54 108.38 16.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.254 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 -169.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -130.3 155.85 80.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.562 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.69 106.48 2.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.617 2.212 . . . . 0.0 114.096 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -119.58 -51.38 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -109.34 120.43 42.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.068 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -104.04 -26.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.278 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.49 19.84 14.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.309 0.576 . . . . 0.0 110.804 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.16 -0.24 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.651 0.738 . . . . 0.0 110.046 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.75 12.21 26.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.551 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.44 5.06 18.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.993 0.901 . . . . 0.0 110.825 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 11.9 pt-20 -108.08 94.07 4.87 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.419 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.83 121.74 42.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.045 0.45 . . . . 0.0 110.674 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -106.62 -0.94 23.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.018 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.9 -162.6 21.72 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.644 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -153.54 177.6 10.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.169 0.485 . . . . 0.0 110.908 176.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.57 -171.51 2.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.663 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 27.8 mttm -85.58 96.14 9.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.893 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 14.0 pt20 -162.84 139.81 7.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.447 -173.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.475 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 17.2 mt -88.84 130.88 35.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 171.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 m -104.73 87.53 2.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 59' ' ' ILE . 26.3 mt -85.8 96.99 9.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.146 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.93 95.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 61' ' ' GLY . 50.7 p -109.18 99.34 8.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.875 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 34.6 m -61.99 116.3 4.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.577 0.703 . . . . 0.0 110.833 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 35.3 t70 -91.75 161.31 14.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.944 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 4.8 t0 . . . . . 0 N--CA 1.466 0.352 0 O-C-N 123.767 0.667 . . . . 0.0 111.018 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 6.3 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.753 0.311 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 27.7 mttp -128.02 -178.84 4.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.172 0.51 . . . . 0.0 109.994 174.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.9 ptt180 -154.87 100.59 2.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.8 171.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 116.07 26.35 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 tt -100.42 117.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 CA-C-O 122.128 0.966 . . . . 0.0 110.443 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.3 t80 -101.64 113.95 27.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.291 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 94.7 t -109.36 112.09 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -103.93 116.38 32.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -79.23 136.05 36.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.307 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.46 122.95 15.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.836 0.35 . . . . 0.0 110.467 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.39 153.57 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.753 0.787 . . . . 0.0 111.166 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.296 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 19.6 ptmt . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.051 0.453 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' HD21 ' A' ' 52' ' ' LEU . 68.6 Cg_endo -79.44 120.69 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.495 2.13 . . . . 0.0 113.362 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -106.81 128.74 54.51 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 165.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 31' ' ' PRO . 69.6 mt -51.04 107.24 0.78 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -168.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD2' ' HZ2' ' A' ' 13' ' ' LYS . 9.7 Cg_endo -90.82 -170.01 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.627 2.884 . . . . 0.0 113.048 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -68.46 -41.6 79.98 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.49 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 4.1 m-20 -59.62 149.55 30.0 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.737 0.415 . . . . 0.0 111.782 -171.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.849 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 90.9 mttt -95.05 -40.7 9.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.758 0.313 . . . . 0.0 110.735 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -73.15 -5.58 40.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.778 ' HE2' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -80.87 132.38 35.45 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.45 126.73 50.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.294 0.568 . . . . 0.0 110.592 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -106.75 -23.68 12.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.704 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.84 148.19 19.83 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.903 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.4 121.8 45.97 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.82 116.42 33.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.517 0.675 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.9 mt-10 -127.64 109.54 11.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.104 -173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.24 101.22 44.5 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.066 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 83' ' ' MET . 31.1 Cg_endo -63.12 -22.86 73.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 123.184 2.589 . . . . 0.0 112.964 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 82' ' ' SER . 9.3 m-20 -69.82 -29.78 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.78 13.37 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.26 23.13 11.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.497 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 69.6 mt -83.56 113.11 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.239 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -144.36 77.65 1.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -134.0 154.3 80.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.938 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.66 139.54 34.15 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.083 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.622 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.5 t -94.58 136.71 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.576 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 11' ' ' LYS . 44.9 m-85 -108.65 92.53 10.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.998 0.428 . . . . 0.0 110.549 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.778 ' HD2' ' HE2' ' A' ' 13' ' ' LYS . 7.4 Cg_exo -73.78 102.39 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.308 2.672 . . . . 0.0 112.616 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.74 -179.72 42.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.539 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.849 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 18.3 Cg_endo -62.07 99.62 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.293 1.995 . . . . 0.0 111.091 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.58 124.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.208 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.407 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 77.6 p -127.03 159.5 64.46 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.13 -37.72 58.83 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.916 2.411 . . . . 0.0 112.902 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -66.05 -41.02 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' OE1' ' HD3' ' A' ' 11' ' ' LYS . 14.7 pt20 -83.18 -21.56 33.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.271 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 93.3 mt -87.38 11.19 15.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.519 0.676 . . . . 0.0 110.095 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -13.94 13.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.845 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -121.69 -16.9 7.59 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.549 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -147.12 5.68 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.401 HG11 ' HE2' ' A' ' 72' ' ' PHE . 99.6 t -125.87 140.31 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.052 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -134.75 161.56 34.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 27.8 m-85 -72.6 160.43 32.27 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.274 175.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.31 68.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.5 170.61 7.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.041 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.17 -35.64 59.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 69.41 160.31 0.19 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.529 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.32 -3.77 1.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.322 0.582 . . . . 0.0 110.991 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -143.84 99.9 3.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -78.69 -6.22 55.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.838 0.828 . . . . 0.0 109.749 175.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.1 10.94 37.94 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.196 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -86.02 154.07 21.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 119' ' ' LYS . 3.5 pm0 -83.58 -19.83 34.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.17 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.33 93.43 4.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 110.398 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 19.9 mm -116.26 129.92 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 118.84 28.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 45' ' ' PHE . 2.0 mt -107.65 129.71 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.2 115.11 29.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.935 0.397 . . . . 0.0 110.973 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -111.17 86.69 0.44 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.202 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 85.4 t60 -87.79 128.3 35.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.065 0.46 . . . . 0.0 110.129 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 127' ' ' ASP . 87.7 m -146.39 133.77 20.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -146.74 17.55 1.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.368 0.604 . . . . 0.0 110.008 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.5 HG13 ' HG3' ' A' ' 67' ' ' ARG . 10.7 tp -88.73 -13.29 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.663 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.94 37.86 27.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.299 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' A' ' 65' ' ' ILE . 99.5 mtt180 -105.86 118.04 56.22 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.644 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.94 0.85 5.17 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.958 2.439 . . . . 0.0 113.439 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -115.17 24.98 11.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.026 0.441 . . . . 0.0 110.775 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 179.83 6.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.18 -73.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.401 ' HE2' HG11 ' A' ' 43' ' ' VAL . 12.9 m-85 -91.13 14.76 13.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 m -80.61 -34.15 35.3 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.205 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.69 3.39 33.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.1 -8.78 18.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -62.95 -23.72 67.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.558 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.74 6.94 28.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.284 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.18 144.41 25.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 110.848 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.32 177.63 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.72 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -72.72 -15.03 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.643 0.735 . . . . 0.0 110.477 179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -130.14 57.24 0.73 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.497 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 13.1 m -86.18 -160.9 0.58 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.427 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 6.8 tpt -135.56 103.46 5.46 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.075 0.464 . . . . 0.0 109.975 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 97' ' ' MET . 96.7 t -97.55 125.12 50.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.476 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.4 m-85 -108.45 123.4 48.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.466 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -110.0 104.32 13.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 24.3 ttpp -99.96 105.51 17.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.721 0.772 . . . . 0.0 111.159 -173.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 91' ' ' GLU . 2.4 p -93.56 104.63 15.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.704 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.4 -103.05 0.74 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -113.68 -9.83 13.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 110.596 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HB2' HG13 ' A' ' 88' ' ' VAL . 37.9 mt-10 -79.94 131.39 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -108.32 117.22 33.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -175.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -99.65 145.02 28.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -110.82 129.29 55.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.383 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 82.3 m-85 -132.91 151.94 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.822 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -117.42 137.15 52.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 84' ' ' VAL . 90.1 mmm -78.02 43.35 0.43 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.166 0.508 . . . . 0.0 110.906 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -89.1 23.59 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.357 0.599 . . . . 0.0 112.023 -170.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 54.8 m -143.84 51.4 1.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.498 0.666 . . . . 0.0 110.274 174.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.1 mt -91.63 118.19 36.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.641 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.65 148.25 31.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.619 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -104.81 135.19 46.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.314 0.578 . . . . 0.0 111.017 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.94 147.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.215 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -138.9 86.6 15.15 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.48 0.657 . . . . 0.0 111.127 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -96.2 -158.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.352 2.701 . . . . 0.0 111.291 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -172.38 20.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.68 0.753 . . . . 0.0 110.243 171.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -145.08 154.3 42.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.97 170.29 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.663 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 64.61 -0.77 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.1 0.96 . . . . 0.0 112.823 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.6 -19.63 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 0.0 110.115 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.8 142.28 31.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.18 145.24 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.296 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.76 137.51 33.7 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -106.68 145.74 31.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.374 0.607 . . . . 0.0 111.84 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.7 mptt -104.09 150.54 24.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.088 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.99 50.39 1.48 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -94.06 176.13 6.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 0.0 111.546 -176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -117.46 -174.68 2.66 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 169.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 3.5 mppt? -74.39 100.25 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -141.23 132.84 27.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.018 0.437 . . . . 0.0 111.138 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 11.9 mt -99.26 115.23 28.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.61 HG23 HG22 ' A' ' 143' ' ' VAL . 14.3 m -97.19 96.67 8.58 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.321 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.47 104.1 14.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.8 mt -90.24 99.93 10.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.781 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 21.4 p -91.65 141.2 28.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.974 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 31.1 p -151.03 130.66 13.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.9 m-20 -97.11 -54.64 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 109.441 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.966 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.583 ' O ' ' HD2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -165.26 153.64 11.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -170.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -172.47 139.93 1.03 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.447 ' HD3' ' CG2' ' A' ' 100' ' ' ILE . 5.4 tmmm? -78.86 128.62 33.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.96 140.02 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.025 0.441 . . . . 0.0 111.37 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.43 108.44 18.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.424 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 122' ' ' THR . 41.1 t -110.13 121.45 63.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.347 . . . . 0.0 110.43 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -112.12 118.59 35.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.703 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.8 m -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -62.66 124.49 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.58 154.68 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 41.8 pttt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.683 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.37 125.44 10.74 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.447 2.098 . . . . 0.0 112.472 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.8 tp60 -150.7 165.79 32.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.04 104.29 35.23 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 110.434 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 10.9 Cg_endo -89.48 -179.82 2.05 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.177 2.585 . . . . 0.0 111.607 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -90.47 -6.15 55.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.839 0.352 . . . . 0.0 110.569 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.4 t0 -81.74 125.32 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.297 0.57 . . . . 0.0 109.917 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 13.8 mttp -92.7 1.64 57.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.321 -173.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.73 -16.16 28.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.064 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 32.2 mmmt -88.39 172.85 9.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.39 108.0 23.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.517 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.44 -31.61 22.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.141 0.496 . . . . 0.0 110.77 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.59 165.56 29.15 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.732 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -129.88 132.65 46.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -107.57 124.04 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.148 0.499 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 33.8 mt-10 -129.54 116.13 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.443 0.64 . . . . 0.0 111.637 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 63.5 mt -127.44 100.58 25.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.41 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.25 -38.38 95.15 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.156 2.571 . . . . 0.0 112.903 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.998 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -123.67 13.75 9.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.316 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 54.95 28.61 10.85 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 74.5 mt -89.9 116.07 30.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 27.8 mtpp -144.48 59.19 1.33 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.931 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 42.6 mm-40 -122.62 156.06 61.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.19 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.54 162.23 40.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.044 2.496 . . . . 0.0 113.166 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.68 134.11 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.2 m-85 -91.67 116.15 65.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.024 0.44 . . . . 0.0 111.095 -174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 36.9 Cg_endo -67.25 148.55 80.49 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.379 . . . . 0.0 112.043 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.93 172.91 13.18 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.348 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.29 166.84 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.909 2.406 . . . . 0.0 111.836 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -68.15 111.16 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.268 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 p -128.4 139.83 36.64 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.405 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.26 -47.54 19.47 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.592 2.861 . . . . 0.0 113.253 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.47 -42.23 92.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 111.03 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 43.1 tt0 -74.86 -36.97 62.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 34' ' ' ALA . 90.8 mt -79.75 -11.16 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.606 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -98.68 -21.28 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.0 110.114 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.95 -33.5 18.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.07 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -161.28 -145.19 4.23 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.415 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.821 HG22 HG22 ' A' ' 59' ' ' ILE . 11.6 p -115.13 138.95 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 58.5 m -150.03 158.2 43.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' SER . 96.3 m-85 -66.52 158.82 28.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.718 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -98.96 -46.27 5.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.561 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -96.68 144.21 26.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.638 0.733 . . . . 0.0 111.908 -174.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.6 -2.4 55.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.325 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -117.99 18.6 13.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.707 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 15.4 pt-20 -105.84 138.82 41.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.2 m -117.26 150.32 38.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.646 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 pp -73.92 -8.14 54.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.359 0.6 . . . . 0.0 110.419 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.74 2.59 21.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.416 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 5.9 t70 -92.09 -159.23 0.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -99.81 -36.23 9.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -95.43 132.43 40.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.111 0.482 . . . . 0.0 110.941 -175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG21 HD22 ' A' ' 121' ' ' LEU . 28.0 mm -129.71 120.9 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.504 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 32.7 t -127.68 106.28 9.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.921 0.391 . . . . 0.0 110.334 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.821 HG22 HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -122.07 119.02 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.07 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.12 42.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.908 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.17 98.15 0.2 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 126' ' ' CYS . 10.4 p80 -116.19 159.79 21.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.322 0.561 . . . . 0.0 112.32 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 67' ' ' ARG . 12.9 t 176.7 -176.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -145.71 2.79 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.393 0.615 . . . . 0.0 109.934 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 67' ' ' ARG . 12.2 mm -91.32 47.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.139 0.495 . . . . 0.0 111.76 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.8 -29.9 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.168 0.987 . . . . 0.0 113.061 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.629 ' HD2' ' OD1' ' A' ' 127' ' ' ASP . 6.6 mtp85 60.56 67.55 1.54 Allowed Pre-proline 0 N--CA 1.465 0.305 0 C-N-CA 124.26 1.024 . . . . 0.0 111.903 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 10.6 Cg_endo -103.52 -12.97 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.005 2.47 . . . . 0.0 112.718 170.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -133.85 25.96 3.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.947 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 73' ' ' THR . 9.3 m-85 -100.33 172.9 6.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.775 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.2 pm0 -72.89 -22.1 60.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.797 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' CD2' ' HG2' ' A' ' 71' ' ' GLN . 69.3 m-85 -125.35 92.92 3.72 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 173.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 70' ' ' TYR . 34.2 p -107.33 -67.28 0.96 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.018 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.618 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.7 t30 -86.89 25.47 1.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.534 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -66.24 -2.45 4.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.624 0.726 . . . . 0.0 110.528 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 20.4 pttp -80.02 -30.22 39.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.172 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.55 -15.25 38.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.843 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -66.52 135.31 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.997 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -95.7 -175.87 3.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.006 0.431 . . . . 0.0 110.884 -176.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -80.97 -4.02 53.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . -123.07 28.56 5.58 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.89 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 3.8 m -85.85 131.91 34.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.311 0.577 . . . . 0.0 109.859 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 109.51 10.11 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.669 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.833 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 84.4 t -96.43 116.01 37.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.653 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -98.77 126.38 44.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.458 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -122.02 110.81 16.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.661 ' HG2' ' HB ' ' A' ' 92' ' ' THR . 46.4 mtmt -101.51 142.89 32.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.246 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.21 89.1 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.765 0.793 . . . . 0.0 109.171 169.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.06 -54.58 4.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.505 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.4 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.0 110.22 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.49 130.57 39.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.518 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.661 ' HB ' ' HG2' ' A' ' 87' ' ' LYS . 2.8 t -121.18 149.59 42.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.558 0.694 . . . . 0.0 111.864 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 146' ' ' GLU . 30.7 mmm180 -115.46 141.34 48.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.27 129.58 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 110.387 -177.295 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' A' ' 121' ' ' LEU . 54.7 m-85 -127.2 147.86 50.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 37.4 ttmt -111.35 149.35 31.28 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.774 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.608 ' HB3' HD11 ' A' ' 100' ' ' ILE . 49.7 mtp -79.77 64.16 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 0.0 110.296 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.3 p -73.45 -34.45 65.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.828 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 8.4 m -115.41 95.36 5.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.187 0.517 . . . . 0.0 110.818 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 63.2 mt -120.45 119.73 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -151.44 151.26 31.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.807 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -108.24 129.01 55.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.82 HG22 ' HD3' ' A' ' 105' ' ' PRO . 7.5 p -121.06 126.68 75.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.771 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 77.2 52.34 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 111.768 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.82 ' HD3' HG22 ' A' ' 103' ' ' VAL . 97.0 Cg_endo -97.34 170.99 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.268 2.646 . . . . 0.0 111.346 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -66.15 -51.46 57.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -133.54 121.41 22.08 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -61.26 150.87 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -65.71 -24.7 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 0.0 110.694 -175.145 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.601 ' H ' HG13 ' A' ' 108' ' ' VAL . 9.8 p 48.79 21.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.771 1.228 . . . . 0.0 113.588 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -82.66 176.46 9.34 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.933 -0.479 . . . . 0.0 110.171 174.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.83 152.23 42.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.965 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -94.08 137.01 33.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.64 168.23 9.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 110.388 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -73.38 161.84 30.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.4 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.4 36.52 0.64 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -131.98 -167.44 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -124.81 -168.14 1.77 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -68.22 104.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -130.22 136.98 49.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 57' ' ' ILE . 26.5 mt -92.11 100.26 12.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.1 m -78.53 88.88 4.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.534 HD12 ' CE2' ' A' ' 142' ' ' PHE . 39.4 mt -95.37 99.89 11.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.518 0.675 . . . . 0.0 110.262 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -99.56 97.38 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.053 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -92.71 91.76 7.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.917 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' HIS . 2.9 m -73.62 100.55 3.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 67' ' ' ARG . 28.8 t70 -115.52 47.13 1.37 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.937 0.875 . . . . 0.0 108.769 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.651 ' HB2' ' N ' ' A' ' 137' ' ' GLU . 4.5 p-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.933 -170.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.651 ' N ' ' HB2' ' A' ' 128' ' ' ASP . 82.2 mt-10 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 137' ' ' GLU . 26.5 mttp -130.18 112.72 13.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.574 -169.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.74 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -104.47 129.97 52.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.343 0.592 . . . . 0.0 110.118 175.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HE3' HG23 ' A' ' 100' ' ' ILE . 1.8 tmtp? -95.46 126.64 40.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.524 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.63 131.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.054 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.833 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 4.3 t80 -132.14 110.75 10.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.143 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.1 t -114.89 105.95 19.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.922 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -92.58 125.38 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.249 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.4 m -97.27 140.83 31.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 42.0 tt0 -58.31 121.66 11.34 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.69 0.619 . . . . 0.0 111.009 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.7 p -124.03 162.9 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.832 0.825 . . . . 0.0 111.654 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.842 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.562 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.7 Cg_endo -73.8 136.89 23.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.234 1.956 . . . . 0.0 111.629 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 35.2 mm-40 -85.17 -167.72 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.3 mp -81.02 101.53 0.99 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 98.6 Cg_endo -94.32 -166.5 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.05 2.5 . . . . 0.0 113.081 -169.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -75.02 -23.41 58.19 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.554 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 29.4 m-20 -79.17 83.79 5.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.818 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 2.3 pptp? -85.48 -3.27 58.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.359 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.9 m -101.13 3.47 41.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 0.0 111.166 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.1 mmtp -90.6 173.82 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.071 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.17 95.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.802 0.334 . . . . 0.0 110.456 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -82.58 -27.87 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.343 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.29 31.01 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.95 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -135.36 132.94 38.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -103.31 125.57 57.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.3 mt-10 -135.57 104.49 5.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.46 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -116.51 100.23 53.31 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 83' ' ' MET . 17.8 Cg_endo -59.85 -30.74 92.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.034 2.489 . . . . 0.0 112.478 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.03 -12.76 61.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.696 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 4.36 3.8 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.551 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.48 27.94 17.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.163 0.506 . . . . 0.0 111.195 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 80.2 mt -88.0 107.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.122 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -139.27 86.38 2.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.276 . . . . 0.0 110.426 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' A' ' 71' ' ' GLN . 53.6 mt-10 -135.54 153.29 77.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.599 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.88 150.37 78.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.6 2.2 . . . . 0.0 112.152 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.09 129.46 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 47.2 m-85 -95.17 107.67 33.64 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.97 -177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 7' ' ' ILE . 11.3 Cg_endo -54.95 154.01 23.33 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.3 2.666 . . . . 0.0 112.194 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.31 -161.04 18.86 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.767 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.424 ' O ' HG22 ' A' ' 35' ' ' THR . 57.4 Cg_endo -93.09 157.86 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.163 2.575 . . . . 0.0 112.435 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 111.34 10.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.251 0.548 . . . . 0.0 110.162 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 33' ' ' PRO . 1.4 t -149.89 143.29 16.54 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.082 -175.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 -23.12 33.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.133 2.555 . . . . 0.0 112.503 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.14 -50.87 66.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 1.3 tt0 -88.56 -29.54 19.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.838 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.13 1.32 13.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 110.63 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.44 -18.54 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -99.03 -65.16 0.98 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.583 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.59 -148.88 4.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.386 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.57 140.98 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.672 0.272 . . . . 0.0 110.395 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 15.9 m -131.06 -170.55 2.38 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 56.9 m-85 -99.12 173.41 6.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.27 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.513 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 14.3 mm-40 -97.3 -174.48 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -134.84 27.81 3.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.765 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.6 -3.08 6.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.053 0.454 . . . . 0.0 111.009 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 15.1 mp0 -90.41 159.74 16.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.321 0.581 . . . . 0.0 111.717 -173.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 6' ' ' GLN . 45.2 m -107.22 147.79 29.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.224 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.562 HD21 ' O ' ' A' ' 5' ' ' PRO . 3.0 pp -85.62 2.59 44.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.384 0.611 . . . . 0.0 110.282 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.33 4.87 50.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.6 164.91 12.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -94.73 -9.47 34.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.719 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -106.7 90.79 3.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.165 0.507 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 4.2 mt -109.59 133.86 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.387 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -123.26 116.79 23.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 5.7 mt -108.74 133.23 54.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.69 123.9 46.04 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.899 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -112.66 -171.79 18.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.375 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -139.43 148.52 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.574 0.226 . . . . 0.0 110.728 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.568 ' OG1' ' HD3' ' A' ' 67' ' ' ARG . 10.1 t -162.07 143.87 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.55 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.73 -158.81 0.66 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.67 -66.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.63 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.26 84.16 5.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.396 0.617 . . . . 0.0 110.316 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -161.29 105.14 1.23 Allowed Pre-proline 0 C--O 1.213 -0.863 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.381 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.584 ' HA ' HG21 ' A' ' 73' ' ' THR . 71.7 Cg_endo -100.47 -0.82 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.911 2.407 . . . . 0.0 111.908 169.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -118.71 11.99 12.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.928 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -82.94 160.29 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.676 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 3.7 pt20 -52.63 -41.67 63.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.386 0.429 . . . . 0.0 111.038 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.899 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 23.4 m-85 -113.66 90.12 3.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.104 0.478 . . . . 0.0 111.062 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 68' ' ' PRO . 6.6 m -150.55 -40.28 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.709 171.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.77 13.82 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.055 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 72' ' ' PHE . 16.7 mt -67.63 -10.96 56.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.127 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -75.41 -23.18 56.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.14 -13.4 50.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.168 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.82 20.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.676 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -132.42 176.39 8.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.184 0.516 . . . . 0.0 111.089 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 -1.98 54.65 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.828 0.823 . . . . 0.0 109.162 172.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -147.39 38.79 1.07 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.506 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -86.03 -169.89 2.85 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.558 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -115.04 109.29 17.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -177.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 82.0 t -103.34 121.33 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.034 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 67.3 m-85 -101.71 128.55 47.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.813 0.339 . . . . 0.0 110.622 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -116.87 111.39 19.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -100.18 135.71 41.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.838 -176.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 3.2 p -159.09 112.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.68 -101.82 0.44 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.865 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -112.99 1.47 15.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.947 0.403 . . . . 0.0 110.492 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 16.0 mm-40 -97.44 134.85 40.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.417 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 m -134.16 93.97 3.17 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 22.9 mmt85 -99.27 141.91 31.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 83' ' ' MET . 25.1 mtmm -102.78 132.16 49.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 86.6 m-85 -119.84 145.29 46.78 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.965 0.412 . . . . 0.0 111.06 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.498 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 17.7 tttt -102.04 133.42 46.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.995 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.3 mtp -86.59 53.37 2.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.503 0.668 . . . . 0.0 109.531 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.67 -14.95 59.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.266 -172.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.7 m -124.18 88.31 2.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.582 176.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.0 mt -107.69 108.75 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.973 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -134.09 150.0 51.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.174 0.511 . . . . 0.0 110.554 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.461 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 1.9 p-10 -116.27 144.44 44.22 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.5 134.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.574 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.6 mptt -79.78 130.65 66.55 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 9.3 Cg_exo -73.39 41.42 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.636 2.891 . . . . 0.0 113.034 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -71.42 -34.23 70.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.337 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -161.68 151.8 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.779 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.56 -22.02 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.923 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.92 -5.51 56.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.182 0.515 . . . . 0.0 110.628 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.98 -25.21 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.095 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 pp -105.56 153.12 22.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.104 0.478 . . . . 0.0 111.956 -172.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.31 160.07 42.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.72 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.52 -179.93 5.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -116.36 161.83 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.327 0.584 . . . . 0.0 112.077 -172.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -90.26 132.3 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.714 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.39 64.38 0.35 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.552 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -89.86 165.98 13.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.712 0.768 . . . . 0.0 111.863 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -108.89 -168.18 1.31 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.4 mppt? -74.52 102.88 4.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -137.92 142.51 40.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 14.8 mt -106.38 116.62 32.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m -96.48 94.12 7.2 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.701 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -82.13 107.32 14.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.752 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.73 81.71 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 24.5 m -91.87 96.67 10.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.606 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 95.4 m -71.45 90.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.647 ' OD2' ' HE2' ' A' ' 138' ' ' LYS . 25.9 t0 -80.14 9.32 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.048 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 15.9 t70 . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.574 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.23 0.073 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.647 ' HE2' ' OD2' ' A' ' 127' ' ' ASP . 24.2 pttm -116.06 123.98 49.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 111.579 -174.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 37.8 ttm-85 -110.88 103.5 12.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.918 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -97.08 101.93 13.6 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 110.332 -177.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.26 130.13 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.626 0.727 . . . . 0.0 111.514 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 97.9 m-85 -106.16 119.55 39.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.117 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.8 t -105.4 102.33 13.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.17 120.91 43.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.735 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.6 m -92.32 140.26 29.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.59 116.66 6.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.902 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.57 157.33 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.807 0.813 . . . . 0.0 110.569 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.488 -172.257 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HE3' ' OE1' ' A' ' 6' ' ' GLN . 62.9 pttt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.787 0.327 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -55.23 117.64 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.984 2.456 . . . . 0.0 111.967 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.515 ' OE1' ' HE3' ' A' ' 4' ' ' LYS . 6.7 tp60 -141.29 169.79 16.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.934 HD11 ' HB3' ' A' ' 52' ' ' LEU . 16.0 mm -97.82 110.83 57.11 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 6.7 Cg_exo -73.78 173.32 14.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.62 2.213 . . . . 0.0 111.4 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -108.39 22.39 16.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.652 0.739 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.85 145.38 47.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.215 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.764 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 1.5 mptt -88.04 -14.23 39.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.655 0.264 . . . . 0.0 111.3 -171.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.0 t -89.16 -17.86 28.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.468 0.651 . . . . 0.0 109.712 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -80.08 86.34 5.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.55 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.43 104.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.743 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 -27.68 25.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -157.61 177.17 34.52 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.175 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 132.58 39.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.54 122.9 55.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.039 0.447 . . . . 0.0 109.862 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mt-10 -135.16 120.27 18.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.437 0.637 . . . . 0.0 111.751 -177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 74.1 mt -124.97 103.23 30.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.305 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.17 -22.72 72.97 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.164 2.576 . . . . 0.0 112.854 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.67 -31.38 72.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.041 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.26 3.96 10.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.928 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 63.33 24.65 14.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.606 0.717 . . . . 0.0 110.464 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.2 mt -75.97 112.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.97 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 61.0 mtpt -145.64 95.09 2.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.744 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 71' ' ' GLN . 11.9 pt-20 -152.13 155.69 33.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.25 154.41 74.23 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.485 2.123 . . . . 0.0 112.369 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.613 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 62.6 t -97.56 129.64 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -93.21 107.24 24.05 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.992 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 24.2 Cg_exo -64.95 144.69 83.61 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.01 2.474 . . . . 0.0 112.118 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.48 179.56 17.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.697 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.26 145.61 19.17 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.67 99.98 0.17 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -129.05 144.46 52.75 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.297 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.51 -41.05 76.41 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.143 2.562 . . . . 0.0 113.029 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.04 -43.39 87.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.717 0.294 . . . . 0.0 111.173 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.07 -40.25 65.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.81 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.46 -15.84 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.874 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.27 -9.84 58.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.246 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -104.54 -21.51 13.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 -167.19 40.16 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.542 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 59' ' ' ILE . 14.8 p -86.93 137.45 20.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.119 0.485 . . . . 0.0 110.242 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 m -139.28 171.67 13.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -82.1 171.13 14.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.396 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -123.67 -33.88 3.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.727 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 pm0 -81.02 -177.44 6.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.791 -169.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.88 -18.27 16.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.65 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -90.2 134.97 33.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.695 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.07 28.89 0.87 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.054 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.6 m -105.51 160.59 15.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.593 . . . . 0.0 111.078 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.5 pp -123.58 -1.97 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.425 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -149.16 54.46 0.97 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.408 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.79 -61.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.8 mt-30 178.82 -65.27 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 122.764 0.426 . . . . 0.0 110.688 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 97.17 7.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.546 0.689 . . . . 0.0 112.1 -172.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.44 140.5 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.704 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -127.91 96.59 4.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.091 0.472 . . . . 0.0 110.229 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 43' ' ' VAL . 1.1 mt -93.13 118.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 136.34 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.725 0.298 . . . . 0.0 111.541 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.74 134.38 7.54 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -136.46 19.83 3.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.408 0.604 . . . . 0.0 111.489 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -88.07 15.94 6.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.539 0.685 . . . . 0.0 111.132 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.628 ' HD1' HG22 ' A' ' 73' ' ' THR . 88.1 t80 -93.22 94.22 8.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.565 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 66' ' ' ASP . 7.6 tp -164.66 -51.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' N ' HG23 ' A' ' 65' ' ' ILE . 20.1 t70 -96.0 -28.12 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.226 -175.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.8 mmt180 -111.3 122.6 37.22 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.675 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -87.18 0.22 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.432 2.755 . . . . 0.0 111.425 171.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -124.94 50.8 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.71 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.717 ' HD2' ' HG2' ' A' ' 71' ' ' GLN . 2.0 t80 -132.17 -169.12 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.266 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.76 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 2.8 pt20 -33.06 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.76 ' H ' ' HG3' ' A' ' 71' ' ' GLN . 55.3 m-85 -96.15 29.8 2.68 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.95 -0.469 . . . . 0.0 111.7 -169.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.628 HG22 ' HD1' ' A' ' 64' ' ' PHE . 73.4 p -78.08 -41.13 36.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.233 0.539 . . . . 0.0 110.876 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.66 12.69 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.034 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 72' ' ' PHE . 24.0 tp -63.13 -15.31 56.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.007 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -62.92 -23.29 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.297 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.99 -10.09 59.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.417 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.8 133.87 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.25 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.04 -176.55 3.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.074 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -70.61 -0.75 9.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.847 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.66 62.66 0.54 Allowed Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 p -96.78 -159.1 0.71 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 tpt -139.35 89.94 2.38 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.1 t -77.23 117.19 21.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.004 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -98.1 109.35 22.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.293 0.568 . . . . 0.0 110.594 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 33.9 t80 -99.55 99.1 9.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 42.2 mtpt -94.93 140.49 29.87 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.452 -177.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 91' ' ' GLU . 2.9 m -143.83 108.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.857 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.89 -98.18 0.54 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.35 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -124.56 6.86 8.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 88' ' ' VAL . 14.4 mm-40 -85.04 142.95 29.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -126.1 112.71 16.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.101 0.477 . . . . 0.0 110.026 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 7.9 mmm180 -106.92 120.78 42.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -96.71 133.72 40.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.512 ' CD2' HD21 ' A' ' 121' ' ' LEU . 94.0 m-85 -130.52 146.21 52.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.187 0.518 . . . . 0.0 111.474 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 14.8 tptm -108.24 127.85 54.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.188 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.468 ' HB3' HD11 ' A' ' 100' ' ' ILE . 65.9 mtp -78.4 70.41 4.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.91 -175.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.3 p -67.92 -42.14 81.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.536 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.7 m -114.15 105.89 13.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.3 mt -126.83 95.05 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.623 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -145.49 152.31 39.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.868 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.824 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 9.3 p-10 -104.06 137.71 41.63 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.083 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.73 139.26 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.27 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 137' ' ' GLU . 82.7 tttt -112.49 90.67 15.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.896 0.379 . . . . 0.0 110.334 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 110' ' ' VAL . 97.3 Cg_endo -88.84 -31.85 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.2 m 72.57 -46.73 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.416 0.687 . . . . 0.0 112.16 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.36 162.89 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 110.24 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.4 -34.39 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.416 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.56 80.8 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.447 0.641 . . . . 0.0 111.444 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 105' ' ' PRO . 27.7 m -111.48 -6.2 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.972 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.733 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -146.36 170.1 17.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.654 0.264 . . . . 0.0 110.367 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.75 92.17 5.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.283 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.73 133.99 44.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.958 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mttp 52.3 -172.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.712 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.1 130.92 24.86 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -90.33 -178.65 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.76 -174.55 2.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 146' ' ' GLU . 17.4 mtpp -93.71 95.56 9.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.005 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -145.87 162.51 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.435 -172.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -112.66 120.69 42.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 171.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.5 m -83.16 89.72 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 92.2 mt -76.05 104.44 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.355 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.19 100.17 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.545 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.1 p -109.8 103.79 12.66 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.095 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.7 m -70.22 92.6 0.78 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -134.59 99.41 4.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 39.6 mt-10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.284 0.564 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 32.8 ttmt -80.25 135.61 36.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 -172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.24 101.18 13.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 113.07 20.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.113 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.77 136.2 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.677 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 96.5 m-85 -117.16 112.22 20.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.474 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 89.5 t -99.89 111.62 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -110.9 114.11 27.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.545 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -90.69 146.64 23.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.934 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 119' ' ' LYS . 70.4 tt0 -62.92 141.11 58.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.217 0.532 . . . . 0.0 111.934 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 1.4 t -114.62 163.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.023 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.312 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.36 109.57 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.846 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.89 160.9 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.904 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -70.39 116.88 49.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 31.5 Cg_exo -59.18 150.73 71.97 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.198 2.598 . . . . 0.0 113.376 -174.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -70.87 -27.42 63.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.064 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -84.5 159.35 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.77 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.62 22.93 14.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -172.138 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 t -120.56 -33.02 3.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.68 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -63.52 105.61 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 28' ' ' PRO . 1.3 p -58.2 112.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.999 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.07 24.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.588 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.98 157.6 24.89 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -121.45 131.48 54.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 8.1 tp -105.93 121.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.214 0.53 . . . . 0.0 110.334 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 94.8 mt-10 -129.78 109.64 11.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.468 0.652 . . . . 0.0 111.186 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' ILE . 66.5 mt -120.64 99.21 47.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.047 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.43 -35.54 98.57 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.049 2.499 . . . . 0.0 113.128 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.21 -33.57 71.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -111.6 7.21 20.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.949 -175.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.07 26.58 16.01 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.585 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 71' ' ' GLN . 61.6 mt -81.17 115.03 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 6.1 ttpm? -147.12 61.57 1.18 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 26.2 mm-40 -121.67 153.37 59.69 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.886 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' VAL . 7.8 Cg_exo -70.15 147.98 61.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.526 2.151 . . . . 0.0 111.84 175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.1 t -96.34 123.97 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.8 m-85 -97.03 102.32 11.79 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.831 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 11.5 Cg_endo -55.42 139.7 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.403 2.735 . . . . 0.0 112.735 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.34 170.22 11.94 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 162.0 37.51 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.71 2.273 . . . . 0.0 112.435 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -65.4 100.4 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.646 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 21.0 p -130.62 140.36 38.43 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.065 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 36.9 Cg_exo -61.53 -8.39 10.81 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.254 2.636 . . . . 0.0 113.319 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -94.75 -38.93 10.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.616 0.246 . . . . 0.0 110.795 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.08 -37.82 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.422 . . . . 0.0 110.171 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.09 -13.13 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.8 -38.96 92.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.367 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.4 -40.09 89.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.36 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.9 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.832 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 60' ' ' ALA . 2.6 p -138.45 139.59 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.306 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -140.09 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -74.22 140.24 44.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -87.35 -43.6 12.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.71 177.85 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.096 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.4 55.2 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.867 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.31 89.58 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.073 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.22 7.15 43.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.86 0.838 . . . . 0.0 109.764 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m -130.0 147.92 51.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.541 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.97 7.68 10.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.374 0.607 . . . . 0.0 110.505 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.27 35.71 2.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.617 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 5.9 p-10 -86.8 -95.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.442 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -173.45 -18.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 176.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -112.31 83.25 1.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.282 0.563 . . . . 0.0 109.715 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 40.8 mm -94.6 86.74 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.389 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -91.73 103.65 16.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.254 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 121' ' ' LEU . 1.1 mt -101.56 137.58 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -104.41 123.83 48.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.993 0.425 . . . . 0.0 111.205 -176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.68 -179.15 16.1 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 126' ' ' CYS . 30.3 p80 -159.79 155.97 26.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.428 0.614 . . . . 0.0 110.882 -177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.17 162.73 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.519 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 12.7 t80 -146.34 113.2 6.08 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 tp -83.67 -21.12 8.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.885 -170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.493 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 57.0 m-20 -82.3 -34.46 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.73 -176.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 32.0 mmm-85 -135.01 120.49 14.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.687 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 2.9 Cg_exo -77.74 -12.52 16.52 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.064 2.509 . . . . 0.0 112.903 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -81.87 16.73 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.908 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.88 -169.12 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.877 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.18 -51.62 3.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.79 0.329 . . . . 0.0 111.5 -178.175 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.823 ' HD1' ' HG2' ' A' ' 71' ' ' GLN . 9.2 m-85 -84.46 22.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 0.0 111.494 -175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 p -89.95 -34.86 15.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.5 t30 -102.94 19.59 19.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.164 0.507 . . . . 0.0 111.082 -173.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 142' ' ' PHE . 11.5 mt -64.1 -5.99 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.01 -18.76 60.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.89 5.39 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.422 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -96.31 145.52 25.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.333 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.3 mptt -117.36 173.82 6.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.0 110.253 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -73.85 -3.17 27.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.756 177.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.7 25.38 4.73 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.466 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 75.7 m -78.16 -165.12 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.258 0.551 . . . . 0.0 110.443 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -131.35 120.3 22.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.813 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 18' ' ' ILE . 87.3 t -107.41 109.81 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.577 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.05 119.46 32.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.396 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -112.7 110.25 20.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.962 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.46 146.66 27.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 91' ' ' GLU . 3.4 p -156.78 112.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.25 0.548 . . . . 0.0 109.925 174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 -98.24 0.33 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -125.56 6.99 7.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.262 0.554 . . . . 0.0 109.881 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.551 ' HB2' HG13 ' A' ' 88' ' ' VAL . 20.1 mm-40 -90.11 139.11 30.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.468 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -145.86 120.57 9.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 3.3 mpt_? -122.14 153.93 38.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -102.83 126.64 50.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.186 -176.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 90.5 m-85 -124.84 155.83 38.81 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' SER . 24.7 ttmm -128.62 150.12 50.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.467 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 48.6 mtp -83.94 59.59 5.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.515 0.674 . . . . 0.0 109.959 -173.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -66.22 -45.43 80.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.175 -172.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.6 m -106.97 100.75 10.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.31 0.576 . . . . 0.0 110.745 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG2' ' HE3' ' A' ' 140' ' ' LYS . 59.7 mt -118.31 112.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.596 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.07 141.59 34.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 1.9 p-10 -108.68 121.12 44.37 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.437 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 139' ' ' ARG . 15.7 t -77.96 121.95 31.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.664 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.656 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -103.63 132.7 20.81 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.6 99.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.319 2.679 . . . . 0.0 113.728 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.3 m -126.98 -49.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.681 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.5 144.28 30.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.966 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.04 -28.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -94.85 35.39 1.26 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.667 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.24 8.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.239 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.81 153.27 38.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.594 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -130.09 154.83 47.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.722 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -100.58 6.51 44.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.056 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.18 98.13 9.2 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -96.23 33.5 1.74 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.631 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.88 87.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.416 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -135.22 -173.67 3.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 0.0 110.93 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.78 -161.91 0.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.91 103.18 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.659 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.61 146.84 52.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.529 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' HG ' ' HB ' ' A' ' 57' ' ' ILE . 6.2 mp -107.35 109.96 21.83 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.547 HG23 HG22 ' A' ' 143' ' ' VAL . 19.9 m -89.43 99.07 12.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.892 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 81.0 mt -80.05 108.28 13.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 0.0 110.464 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.484 HG22 HH21 ' A' ' 139' ' ' ARG . 58.5 mt -93.77 103.65 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.424 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' HD2' ' A' ' 72' ' ' PHE . 3.2 m -99.73 129.05 45.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.267 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 62' ' ' HIS . 9.9 m -87.12 96.32 10.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.029 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 138' ' ' LYS . 3.3 m-20 -89.99 161.68 15.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.52 -0.204 0 O-C-N 123.701 0.626 . . . . 0.0 111.361 170.083 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 127' ' ' ASP . 4.1 ttpm? -80.94 137.75 36.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 21.3 mmm-85 -125.9 86.43 2.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HE3' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -76.09 108.01 8.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 0.0 110.295 -176.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.8 mm -97.11 130.34 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.335 0.588 . . . . 0.0 110.659 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 81.5 m-85 -120.04 101.16 7.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.675 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.5 t -93.04 102.07 13.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -89.97 110.69 21.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.807 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 m -83.85 143.85 29.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.206 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 34.0 tt0 -62.97 129.73 41.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.815 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.82 155.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 pttp . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.456 -174.481 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 tttt . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CG ' ' HB ' ' A' ' 88' ' ' VAL . 31.5 Cg_endo -63.55 126.79 18.3 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.009 2.473 . . . . 0.0 113.147 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 1.7 tp60 -134.48 -171.98 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.181 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 62.7 mt -110.98 104.62 56.44 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.896 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 31' ' ' PRO . 86.7 Cg_endo -84.46 -170.52 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.122 2.548 . . . . 0.0 112.54 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 37.6 mtmt -84.37 -13.18 53.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 m-20 -94.84 106.58 18.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.729 -172.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.656 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -82.55 13.48 3.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.092 173.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 p -98.83 -7.93 26.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.661 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -91.34 179.85 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.741 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.77 109.04 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.753 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -88.74 -28.93 20.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.248 0.547 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.55 37.29 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.207 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 124.23 37.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tp -99.28 123.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 109.892 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.3 mt-10 -134.86 128.19 32.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.049 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.4 mt -129.25 96.84 27.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.2 Cg_endo -59.55 -25.31 78.38 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.4 2.733 . . . . 0.0 112.545 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.35 -24.72 67.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.8 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.94 7.14 9.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.712 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 58.21 25.42 12.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.299 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 61.3 mt -77.48 131.63 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.012 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -158.71 90.07 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.63 150.24 53.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.273 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.4 152.53 60.68 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.861 2.374 . . . . 0.0 112.045 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 43' ' ' VAL . 47.7 t -106.99 132.14 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.1 m-85 -91.39 111.07 47.02 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.744 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 Cg_endo -62.66 116.39 3.5 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.238 2.625 . . . . 0.0 112.63 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.48 -179.55 37.71 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.71 154.87 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.599 2.199 . . . . 0.0 112.073 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.86 131.52 44.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 111.072 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 38' ' ' GLN . 1.4 t -155.96 148.5 17.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.807 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.27 -37.69 24.8 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.797 2.998 . . . . 0.0 112.88 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 74.0 mm-40 -62.84 -52.12 64.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.125 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.474 ' NE2' ' HB2' ' A' ' 11' ' ' LYS . 13.1 mm100 -65.37 -42.91 92.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.699 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.23 -6.16 32.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.567 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -100.33 -10.13 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 0.0 109.934 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 62.8 mtt180 -111.65 -37.7 5.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.249 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.15 -166.78 36.51 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 29' ' ' VAL . 6.3 p -90.6 137.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.24 0.543 . . . . 0.0 111.074 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -134.6 -171.87 2.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.704 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 77.3 m-85 -99.25 156.0 17.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.003 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.69 -66.98 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.248 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 43.3 mt-10 -82.49 121.11 26.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.915 0.388 . . . . 0.0 110.879 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.88 -1.25 27.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.682 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -106.74 -6.66 17.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.187 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 22.5 tt0 -86.38 158.79 19.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.577 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.7 m -122.17 142.38 50.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.762 0.315 . . . . 0.0 111.712 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.792 ' HA ' HD11 ' A' ' 57' ' ' ILE . 14.3 mt -64.35 -12.49 42.88 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.024 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -119.39 26.28 9.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.859 0.838 . . . . 0.0 109.806 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 2.9 t70 -95.58 -166.58 1.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.296 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.781 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.7 pt20 -81.09 -34.08 32.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.719 0.295 . . . . 0.0 110.675 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -122.39 146.66 47.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 52' ' ' LEU . 7.9 mm -128.63 108.02 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.536 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -91.49 105.89 18.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.463 HG22 ' CG2' ' A' ' 43' ' ' VAL . 1.3 mt -103.59 140.03 22.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.96 126.01 48.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.793 0.33 . . . . 0.0 110.899 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -140.99 -177.32 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -138.07 122.15 17.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.547 0.674 . . . . 0.0 111.93 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 5.6 m -79.25 154.48 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.966 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ARG . 4.1 t80 -164.72 86.0 0.43 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.0 mt -59.19 -35.64 58.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.347 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -68.56 -23.13 64.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 0.0 111.717 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.526 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -116.14 102.42 53.74 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.889 -178.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.696 ' HA ' HG21 ' A' ' 73' ' ' THR . 32.2 Cg_exo -59.28 -23.93 72.01 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.994 2.463 . . . . 0.0 112.685 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -88.63 13.93 11.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.405 ' HD1' ' HB3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -92.8 -172.15 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.124 173.079 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.493 HE22 ' HB ' ' A' ' 43' ' ' VAL . 45.0 mt-30 -74.93 -81.44 0.07 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.558 0.694 . . . . 0.0 112.347 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 90.9 m-85 -89.82 37.11 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.211 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 68' ' ' PRO . 2.8 m -62.14 -29.13 70.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.975 0.417 . . . . 0.0 110.975 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -102.04 6.38 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.37 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 1.8 tm? -61.19 -27.53 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.362 0.601 . . . . 0.0 109.529 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -56.1 -24.42 40.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.945 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -87.31 0.19 55.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.04 165.33 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.78 -176.78 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.014 0.435 . . . . 0.0 110.744 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -1.61 25.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.495 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.92 27.28 5.44 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 74.9 m -82.67 155.59 24.28 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.381 0.61 . . . . 0.0 109.704 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.495 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -97.94 111.82 23.98 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.212 -176.515 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.29 116.5 36.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' HE2' ' HG3' ' A' ' 21' ' ' PRO . 75.0 m-85 -107.64 130.53 54.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.509 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -121.15 106.47 11.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 14.7 mtmm -86.25 136.8 33.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.93 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.2 m -139.87 93.14 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.0 -117.2 4.64 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -95.12 -9.54 33.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.505 0.669 . . . . 0.0 109.941 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.5 mm-40 -77.62 144.17 37.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.482 0.658 . . . . 0.0 111.218 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -141.47 97.54 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.471 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' A' ' 146' ' ' GLU . 3.9 mmp_? -80.3 135.39 36.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.316 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -103.48 125.17 49.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' GLU . 85.3 m-85 -123.22 150.6 43.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 25.3 ttpp -114.05 139.2 49.47 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 82' ' ' SER . 69.4 mtp -83.88 50.6 1.85 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 109.934 -174.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.43 2.46 18.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.253 -170.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.8 m -145.18 102.6 3.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.77 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.98 137.04 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.556 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 34.0 ttm-85 -154.02 157.89 39.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.369 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 7.1 p-10 -129.44 137.34 50.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 139' ' ' ARG . 26.5 m -117.57 -177.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.342 . . . . 0.0 111.456 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -90.65 154.92 46.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.334 -173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 137' ' ' GLU . 74.2 Cg_endo -77.51 178.84 7.13 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.874 2.383 . . . . 0.0 112.431 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.6 p 54.02 23.61 4.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.656 0.782 . . . . 0.0 111.92 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 109' ' ' GLU . 23.0 t70 -165.44 141.32 5.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.05 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.5 -2.99 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HA ' ' HB2' ' A' ' 112' ' ' ASP . 12.3 pt-20 -93.77 -3.1 52.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.528 -174.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 103' ' ' VAL . 4.9 p -56.04 -39.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 110' ' ' VAL . 4.5 mp -130.75 100.89 5.44 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.107 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 109' ' ' GLU . 37.9 t0 -152.93 -169.78 3.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.627 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 10.2 pt-20 42.27 63.69 1.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.138 0.899 . . . . 0.0 111.077 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.94 132.95 54.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.019 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.88 36.02 0.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.423 0.63 . . . . 0.0 109.921 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.58 143.59 10.95 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.372 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.54 168.77 18.97 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.4 t70 -127.41 -161.32 1.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -102.63 83.4 2.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.685 0.755 . . . . 0.0 109.511 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -165.37 177.12 7.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.794 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 15.7 mt -107.6 132.45 53.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.3 m -101.14 86.27 2.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.584 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.1 mp -79.95 110.87 15.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.361 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.6 mt -96.64 93.88 3.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.513 ' HB ' ' HE2' ' A' ' 142' ' ' PHE . 13.9 m -123.55 71.4 1.08 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.961 0.41 . . . . 0.0 110.699 -174.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.37 120.31 7.44 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 75.5 m-20 -65.73 -41.64 91.99 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.505 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.022 -179.394 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 105' ' ' PRO . 39.5 mt-10 . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 120.882 0.372 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ASP . 18.0 mtpp -79.85 96.34 6.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.376 0.608 . . . . 0.0 111.371 -174.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.665 ' HB2' HG23 ' A' ' 103' ' ' VAL . 40.1 mmm-85 -80.61 103.27 10.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.815 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 142' ' ' PHE . 8.3 mmtp -96.35 129.45 43.68 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 tp -123.33 123.24 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.624 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 70.7 m-85 -112.92 109.58 19.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.334 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 95.8 t -93.94 102.89 14.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.0 110.03 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -106.96 101.14 10.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.146 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' GLN . 3.1 m -83.81 143.51 29.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 44.9 tt0 -60.99 129.8 43.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.2 0.524 . . . . 0.0 111.593 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.6 p -101.48 160.49 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.324 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 147' ' ' VAL . 75.2 mttt . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.696 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.509 ' O ' HD21 ' A' ' 52' ' ' LEU . 61.7 Cg_endo -79.31 114.72 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.665 2.243 . . . . 0.0 113.273 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' A' ' 52' ' ' LEU . 11.0 tp60 -95.82 89.23 5.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.737 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 50' ' ' GLU . 76.8 mt 24.98 91.57 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 125.068 1.48 . . . . 0.0 113.657 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.5 -179.93 5.9 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.664 2.243 . . . . 0.0 112.581 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -75.09 -44.6 46.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.075 0.464 . . . . 0.0 110.897 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.99 140.71 37.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.851 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -109.67 18.9 19.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.807 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -90.9 -17.31 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.156 0.503 . . . . 0.0 110.37 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.82 154.78 19.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 28' ' ' PRO . 6.9 p -97.68 135.7 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.96 -21.14 13.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.637 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.78 174.9 37.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.249 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -126.73 139.95 52.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.217 0.207 . . . . 0.0 110.628 178.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.41 127.91 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 36.5 mt-10 -136.21 122.31 20.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.042 0.448 . . . . 0.0 111.561 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.501 HD12 HD12 ' A' ' 25' ' ' ILE . 67.7 mt -129.55 95.57 29.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -58.34 -33.59 97.9 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.082 2.522 . . . . 0.0 112.702 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.09 -15.66 63.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.131 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.38 4.87 9.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 60.63 26.17 15.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.982 0.42 . . . . 0.0 111.628 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.6 mt -86.26 120.2 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.528 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 22.8 ttmm -156.09 98.61 1.89 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 71' ' ' GLN . 12.5 pt-20 -152.0 156.89 34.3 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.585 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.477 ' CB ' HG21 ' A' ' 14' ' ' VAL . 57.3 Cg_endo -74.15 152.34 45.21 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.608 2.205 . . . . 0.0 112.043 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.05 132.79 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 18.6 m-85 -93.94 111.36 52.69 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.47 -175.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 12.2 Cg_endo -56.98 130.88 42.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.031 2.488 . . . . 0.0 111.848 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.9 174.33 16.08 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.55 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.24 169.94 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.432 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 39' ' ' LEU . . . -73.7 121.78 21.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.908 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.832 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.2 t -161.01 141.38 8.36 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -38.43 -66.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.487 3.458 . . . . 0.0 115.489 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -28.9 69.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 35' ' ' THR . 7.1 tp60 -72.55 -52.23 16.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.389 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.832 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -65.47 -20.95 66.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.469 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.37 -29.3 67.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.9 0.381 . . . . 0.0 110.412 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -82.35 -38.78 23.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.76 -158.63 21.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.611 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.424 HG23 ' OE2' ' A' ' 27' ' ' GLU . 41.0 t -77.41 141.31 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.714 0.293 . . . . 0.0 110.804 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -142.36 167.33 22.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m-85 -87.58 176.57 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.973 0.416 . . . . 0.0 111.405 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.73 -40.19 7.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.189 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 42.8 mt-10 -108.69 141.55 40.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.42 -0.86 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.141 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.19 -13.03 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.68 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 13.1 pt-20 -63.25 131.92 49.95 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 16.7 m -94.29 121.29 35.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.894 0.378 . . . . 0.0 110.745 -173.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.665 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -71.13 -5.56 32.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.48 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -110.84 2.76 18.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.109 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 12.0 t70 -108.08 -156.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.774 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.53 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 7.2 tt0 -91.46 -42.79 10.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.941 0.496 . . . . 0.0 111.88 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -91.75 123.33 35.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 111.489 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 52' ' ' LEU . 24.2 mm -132.4 132.75 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.153 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.466 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 7.2 p -139.67 84.83 2.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.268 0.556 . . . . 0.0 110.506 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.593 ' HB ' HD23 ' A' ' 123' ' ' LEU . 3.2 mt -92.36 140.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.667 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.12 154.12 17.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.323 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -157.79 156.47 27.34 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.071 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.403 ' HE1' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 p80 -150.08 168.86 22.68 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.423 -0.457 . . . . 0.0 111.059 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.86 5.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.631 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 27.8 m-85 -145.03 171.08 14.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 171.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.0 -20.72 5.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.369 0.604 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.88 -40.24 9.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.833 -175.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HG3' ' H ' ' A' ' 69' ' ' ASN . 18.1 tpt180 -96.61 127.04 41.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.057 -168.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 73' ' ' THR . 93.6 Cg_endo -91.12 7.96 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.986 2.457 . . . . 0.0 111.551 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.713 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 21.6 m120 -125.38 20.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.147 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 19.4 p90 -86.37 166.42 15.6 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.704 172.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 1.7 pt20 -25.46 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.554 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 50.6 m-85 -113.39 45.91 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.522 HG21 ' C ' ' A' ' 68' ' ' PRO . 32.5 p -72.98 -51.81 16.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.449 0.642 . . . . 0.0 110.835 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -88.69 17.25 5.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.65 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -60.25 -25.71 65.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.829 179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -65.6 -25.06 67.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.733 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.49 -11.1 59.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.805 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.658 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.05 140.98 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.862 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -105.79 176.79 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.308 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -75.25 0.45 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.281 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.09 21.92 5.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.822 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -85.6 165.02 17.38 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.466 0.651 . . . . 0.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.44 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -99.9 123.66 44.4 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.51 -174.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.887 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -115.2 127.03 72.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.747 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.9 m-85 -115.4 137.16 52.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -122.36 121.25 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 14.9 ttmm -108.6 140.42 41.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.454 -173.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 HD13 ' A' ' 52' ' ' LEU . 2.7 p -137.69 111.28 8.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.97 171.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.92 -104.43 1.02 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.073 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -116.28 -1.78 12.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 110.911 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -87.85 139.86 30.09 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 87' ' ' LYS . 36.5 m -145.71 116.81 7.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.645 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -91.02 152.14 20.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.604 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -111.18 123.16 49.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.354 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.64 152.58 39.16 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 36.5 ttmt -107.21 149.57 27.58 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.703 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 62.7 mtp -84.12 70.7 10.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 110.451 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.5 p -70.64 -46.5 63.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.784 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 10.5 m -118.48 110.33 17.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.971 0.415 . . . . 0.0 111.073 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.7 mt -126.32 89.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -125.87 143.4 51.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.2 0.524 . . . . 0.0 111.51 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 13.2 t70 -101.94 116.45 32.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.074 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.452 HG23 ' HD3' ' A' ' 105' ' ' PRO . 19.7 m -133.3 178.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 0.0 111.244 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 50.3 mtpt -133.17 81.26 57.05 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.72 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 139' ' ' ARG . 17.4 Cg_endo -93.98 107.39 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.476 2.784 . . . . 0.0 111.359 170.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -80.77 -24.21 38.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.878 0.37 . . . . 0.0 111.357 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' HG22 ' A' ' 110' ' ' VAL . 18.0 t70 -88.38 143.67 26.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.236 0.541 . . . . 0.0 111.431 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.63 19.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.49 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.83 -47.9 2.39 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' OD1' ' A' ' 107' ' ' ASP . 20.1 m -76.44 -4.31 6.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.7 60.33 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.425 . . . . 0.0 111.328 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.06 149.79 32.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.475 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.37 33.57 20.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.864 0.84 . . . . 0.0 110.05 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.614 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -72.37 96.0 1.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.857 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 115' ' ' LYS . 13.4 ptpt -76.56 151.58 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.534 -175.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.76 84.73 1.81 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.869 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.84 161.33 25.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -155.57 -176.68 6.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 90.1 3.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 15.6 pt20 -146.08 133.74 21.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 57' ' ' ILE . 37.5 mt -86.29 99.69 11.75 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 6.4 m -77.14 89.4 3.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.93 0.395 . . . . 0.0 109.987 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.593 HD23 ' HB ' ' A' ' 59' ' ' ILE . 23.7 mt -91.2 108.18 19.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.01 147.66 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' CG ' ' A' ' 140' ' ' LYS . 22.9 m -146.43 98.83 3.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.534 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 139' ' ' ARG . 3.4 m -56.74 109.14 0.58 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.658 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 2.1 t70 -89.21 -23.9 22.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.531 -170.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.828 178.513 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 21.3 ttpp -90.43 137.72 32.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.076 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.658 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 12.1 ptp180 -153.46 138.21 17.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.121 0.486 . . . . 0.0 110.408 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.602 ' CG ' ' HB ' ' A' ' 125' ' ' THR . 5.0 ptpp? -89.39 144.17 26.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -119.54 119.43 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 CA-C-O 121.938 0.875 . . . . 0.0 109.853 170.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.887 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.0 t80 -105.89 113.43 26.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.307 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.8 t -104.62 113.09 40.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.968 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -100.03 111.86 24.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.2 m -90.3 144.61 25.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.97 135.19 48.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.79 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.2 t -112.37 168.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.928 0 CA-C-O 118.936 -0.555 . . . . 0.0 110.359 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 68.7 Cg_endo -74.74 151.23 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.194 1.929 . . . . 0.0 111.841 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -132.22 172.51 12.32 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 52' ' ' LEU . 89.6 mt -114.72 103.51 54.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 111.714 -174.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -94.52 -159.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.468 2.779 . . . . 0.0 111.048 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -99.15 11.91 37.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.964 0.412 . . . . 0.0 110.525 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -78.38 98.91 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.189 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.2 16.72 21.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -93.95 -34.5 13.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.371 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.662 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -97.79 160.39 14.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.427 175.578 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.41 118.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' CB ' ' HG3' ' A' ' 31' ' ' PRO . . . -87.41 -42.44 12.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 109.963 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.83 171.32 23.62 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.005 -172.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.15 121.96 18.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.353 -0.423 . . . . 0.0 109.915 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.91 117.97 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.842 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 3.0 pt-20 -129.25 112.48 13.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.795 0.807 . . . . 0.0 111.806 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 55.7 mt -116.39 100.69 53.64 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.769 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.9 Cg_endo -58.88 -27.93 85.82 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.02 -21.26 63.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.724 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.89 15.3 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.31 26.93 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.89 0.852 . . . . 0.0 110.73 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.3 mt -95.72 118.52 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.99 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 40.4 mtpt -144.87 81.78 1.66 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.895 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 48.8 mm-40 -124.15 152.09 66.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.06 153.18 46.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.563 2.175 . . . . 0.0 112.835 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 48.7 t -113.26 130.97 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.21 112.29 62.87 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.951 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 26.2 Cg_exo -62.18 139.31 77.38 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.324 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.95 173.64 13.43 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.03 151.03 73.27 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.287 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.29 157.79 21.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.764 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.558 HG23 ' H ' ' A' ' 38' ' ' GLN . 2.8 t -176.11 150.94 1.1 Allowed Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -46.54 -37.23 19.75 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.102 2.535 . . . . 0.0 112.669 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.28 -46.75 85.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.26 0.552 . . . . 0.0 111.192 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.558 ' H ' HG23 ' A' ' 35' ' ' THR . 55.3 tp60 -72.75 -37.13 67.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.775 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -77.72 -15.06 59.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.135 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.55 -18.9 56.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.546 0.688 . . . . 0.0 109.209 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -90.58 -46.07 8.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.78 -138.66 2.99 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.275 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 60' ' ' ALA . 85.5 t -112.57 137.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.379 . . . . 0.0 110.402 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -150.28 165.95 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.908 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -71.99 134.5 45.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.311 -176.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.4 65.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -128.17 118.41 23.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.378 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 50' ' ' GLU . 2.5 mp0 -54.85 -38.44 67.46 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.493 0.495 . . . . 0.0 110.439 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.7 t-20 70.8 -22.67 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.738 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' GLU . 43.0 tt0 82.34 -22.7 0.24 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.559 1.143 . . . . 0.0 111.326 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -128.74 141.68 51.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.309 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -103.22 -14.86 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -99.15 25.15 7.07 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.934 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.49 -167.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.745 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -115.19 -29.03 6.74 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.174 -0.329 . . . . 0.0 111.495 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -108.18 97.33 7.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.069 0.938 . . . . 0.0 111.125 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.416 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 21.6 mm -116.62 138.36 47.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.985 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 t -128.67 113.71 15.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.858 0.361 . . . . 0.0 110.206 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 3.4 mt -111.1 128.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -101.52 142.86 32.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.85 27.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.282 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -124.14 144.65 49.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 127' ' ' ASP . 67.8 p -111.47 169.16 9.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.673 0.273 . . . . 0.0 110.747 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.517 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 22.7 t80 -154.55 134.87 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.7 mp -66.24 -48.19 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.37 . . . . 0.0 111.742 -172.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.8 t70 -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 53.8 mmm-85 -99.3 106.62 40.12 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 -174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 3.2 Cg_exo -76.83 -4.18 14.64 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.541 2.828 . . . . 0.0 111.206 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -74.27 -23.18 59.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.24 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.512 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 64.5 m-85 -74.21 116.26 14.64 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.069 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.895 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 5.1 pt20 -48.91 -41.92 35.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' CZ ' HD23 ' A' ' 123' ' ' LEU . 10.2 m-30 -78.64 -2.58 39.77 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.225 -0.297 . . . . 0.0 111.789 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 16.8 m -68.42 -34.74 76.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.693 0.282 . . . . 0.0 110.946 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.05 14.72 22.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.625 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.08 -15.3 59.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -22.44 62.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 111.015 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.81 -6.81 56.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.615 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.56 131.12 47.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -111.64 177.7 4.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.702 -175.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -56.06 -21.14 20.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.007 -175.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.49 43.53 1.45 Allowed Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.165 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 m -95.41 -177.27 4.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.142 0.496 . . . . 0.0 109.779 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.594 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.8 tpt -118.36 104.56 10.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.403 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.02 107.01 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.729 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.842 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . 58.8 m-85 -89.28 117.9 28.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.268 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -104.17 99.27 9.0 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -97.06 146.16 25.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.342 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.742 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 7.6 p -162.0 118.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.141 0.496 . . . . 0.0 109.686 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.625 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 60.63 -111.49 3.76 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -107.87 2.09 23.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.16 0.505 . . . . 0.0 110.089 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.98 141.52 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 m -141.47 98.01 3.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.242 0.544 . . . . 0.0 110.346 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.2 134.02 52.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.908 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 28.8 mtmt -103.58 140.4 37.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -169.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.642 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.7 m-85 -131.11 147.82 52.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.847 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -105.84 148.81 27.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.615 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 66.4 mtp -82.77 72.05 9.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.402 0.62 . . . . 0.0 110.478 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.4 p -72.3 -42.19 65.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.614 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.594 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 31.5 m -113.09 99.97 8.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 111.629 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.99 76.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -93.58 155.57 17.22 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.867 0.841 . . . . 0.0 112.831 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 138' ' ' LYS . 9.9 t70 -109.72 100.83 9.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.695 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.28 145.59 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.046 0.451 . . . . 0.0 110.659 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -95.19 140.42 22.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.52 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.96 127.91 19.58 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.53 2.154 . . . . 0.0 111.972 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.442 HG23 HG11 ' A' ' 110' ' ' VAL . 1.9 t -153.99 -55.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.586 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.689 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . 30.0 t70 -142.21 167.59 21.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.563 0.22 . . . . 0.0 110.623 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.37 -45.78 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.689 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.5 31.03 5.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.462 . . . . 0.0 111.207 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 p -81.02 -7.8 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.025 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.43 127.69 35.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.36 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.76 133.27 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.306 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.72 36.22 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.782 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -100.09 142.21 31.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.488 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -89.89 166.49 13.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 177.171 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.0 75.75 1.03 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.568 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.06 167.0 15.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.158 0.504 . . . . 0.0 111.457 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -155.5 -166.66 2.3 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 9.3 mttp -74.92 101.75 4.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.942 0.401 . . . . 0.0 110.163 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -142.18 145.67 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.896 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.416 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 12.4 mt -107.84 114.35 28.22 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 143' ' ' VAL . 23.7 m -89.08 95.64 10.4 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -83.35 120.35 25.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.527 0.68 . . . . 0.0 110.526 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.704 HG23 HH22 ' A' ' 139' ' ' ARG . 61.9 mt -79.6 86.1 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 1.9 m -98.04 100.15 11.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.536 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.9 m -81.32 -25.8 36.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -94.56 167.57 11.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 111.302 -174.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 25.6 t70 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.485 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.605 0.717 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 102' ' ' ASP . 29.2 mtmm -112.94 -172.81 2.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.811 -167.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.704 HH22 HG23 ' A' ' 124' ' ' ILE . 28.6 ttt-85 -114.58 66.33 0.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.819 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.633 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -69.53 96.86 0.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.231 0.539 . . . . 0.0 109.962 -179.057 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.6 tt -85.6 139.79 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 15.6 t80 -114.86 124.26 51.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.038 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.6 t -121.05 123.96 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -106.34 130.27 54.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.295 -176.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.8 m -99.58 137.25 38.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.993 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.429 ' OE1' ' HD3' ' A' ' 119' ' ' LYS . 37.6 tt0 -65.0 121.8 15.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.134 0.492 . . . . 0.0 111.181 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.12 161.23 4.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.69 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.424 ' HB3' ' H ' ' A' ' 3' ' ' ALA . 27.2 mp0 -122.68 -164.7 1.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.466 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 2' ' ' GLN . . . -163.22 -179.43 6.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -70.11 120.19 76.56 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.202 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.82 161.48 36.28 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.617 2.211 . . . . 0.0 112.555 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -114.24 173.42 6.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 70.8 mt -106.92 101.11 35.61 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.776 0.322 . . . . 0.0 111.129 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 97.9 Cg_endo -87.59 178.4 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.846 2.364 . . . . 0.0 112.272 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -86.61 -30.74 21.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.1 t70 -60.51 129.54 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.192 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 43.1 mmtm -96.55 13.21 28.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.896 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -91.74 -21.86 20.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.343 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 45.6 mmtm -91.65 163.31 14.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.651 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.91 116.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.52 -33.92 15.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.19 152.82 24.88 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.729 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.24 122.91 48.88 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 27' ' ' GLU . 9.6 tp -93.55 115.08 31.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.698 0.761 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 42.5 mt-10 -127.92 115.69 18.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.033 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 66.2 mt -122.96 102.49 37.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.652 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -59.23 -33.92 98.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.414 2.743 . . . . 0.0 113.552 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.12 -24.46 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.712 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.47 7.74 16.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.266 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 59.89 25.81 14.98 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.178 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.4 mt -84.61 124.63 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.991 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -144.15 80.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.0 mm-40 -125.43 142.42 41.68 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.161 0.505 . . . . 0.0 111.899 -172.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.69 138.57 38.37 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.064 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 64.1 t -98.38 132.81 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -92.85 105.34 14.47 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.397 0.618 . . . . 0.0 110.51 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 47.2 Cg_endo -69.22 145.94 61.93 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.276 2.651 . . . . 0.0 113.071 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 11' ' ' LYS . . . 129.08 -168.95 20.6 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.804 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.42 162.18 33.75 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.769 2.313 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.8 126.21 31.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.973 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.504 ' O ' HD23 ' A' ' 39' ' ' LEU . 47.6 p -132.05 133.94 24.55 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.89 -36.6 27.29 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.471 2.781 . . . . 0.0 113.362 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' HD2' ' A' ' 41' ' ' ARG . 38.7 tt0 -66.28 -54.25 27.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.56 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 51.1 tp60 -65.43 -34.41 78.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 35' ' ' THR . 4.4 mm? -68.54 -7.87 36.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -101.61 -7.11 23.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.749 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HD2' ' HG2' ' A' ' 37' ' ' GLU . 53.8 mtp180 -104.32 -32.64 8.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.949 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -154.99 9.75 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.241 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.502 HG21 ' CE2' ' A' ' 72' ' ' PHE . 59.4 t -105.96 133.82 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.83 0.348 . . . . 0.0 110.472 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -135.72 162.04 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 86.5 m-85 -74.01 149.46 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.244 0.545 . . . . 0.0 111.561 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.82 -14.0 23.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.877 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -79.9 133.6 36.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.228 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -83.42 -6.37 59.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.838 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -90.28 128.76 36.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -74.98 17.67 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.059 0.457 . . . . 0.0 112.167 -176.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 m -104.15 107.7 18.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.223 0.535 . . . . 0.0 111.618 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -91.05 6.27 45.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.784 0.802 . . . . 0.0 109.433 172.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.43 -9.11 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.625 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.22 159.39 28.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.237 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 3.9 pm0 -86.34 -13.34 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 0.0 110.899 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -105.44 105.94 16.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.123 0.487 . . . . 0.0 110.545 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 52' ' ' LEU . 19.9 mm -115.79 101.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.532 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -93.87 125.72 38.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.44 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -127.37 142.67 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.57 147.13 43.1 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.086 -0.384 . . . . 0.0 111.467 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.21 -171.62 22.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.014 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -136.63 157.68 46.2 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.565 -0.373 . . . . 0.0 110.818 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 6.7 t -79.07 -172.05 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.584 -175.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 35.4 p90 -109.04 142.09 40.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.329 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.28 -90.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.68 -23.73 16.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 109.873 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.39 114.58 65.03 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.189 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HA ' HG21 ' A' ' 73' ' ' THR . 88.5 Cg_endo -82.43 8.78 4.33 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.841 2.36 . . . . 0.0 111.476 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -94.76 14.61 20.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.902 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 73' ' ' THR . 40.5 m-85 -89.53 143.14 27.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -69.03 -8.03 41.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' VAL . 43.5 m-85 -130.1 33.06 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.72 0.295 . . . . 0.0 111.392 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 68' ' ' PRO . 13.4 p -64.73 -34.94 79.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.396 . . . . 0.0 111.645 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -99.9 13.13 34.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.5 -12.21 50.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 110.494 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 64' ' ' PHE . 20.1 pttp -63.69 -26.7 68.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.233 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.13 -41.44 25.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.529 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.81 137.76 54.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.073 -173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.4 mptt -103.66 173.62 6.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.05 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -74.31 -1.92 22.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.741 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.35 34.04 3.16 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.443 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.6 t -97.78 -172.71 2.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -119.05 121.7 40.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.297 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 96.8 t -107.6 110.26 31.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.525 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -95.08 113.85 25.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -102.98 98.71 8.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -94.57 113.06 24.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.214 -172.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.96 101.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.595 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.53 -94.52 0.28 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.147 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -119.2 -14.71 9.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.73 125.25 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -101.4 107.1 18.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.852 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -97.04 117.17 30.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.528 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.6 125.46 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 110.959 -176.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 64.0 m-85 -121.09 148.81 43.67 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -110.0 138.64 46.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.562 ' HB3' HD11 ' A' ' 100' ' ' ILE . 61.2 mtp -76.88 54.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.966 -173.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.1 p -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 7.5 m -116.4 102.0 9.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.012 0.434 . . . . 0.0 111.028 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.4 mt -126.76 125.28 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.648 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 101' ' ' ARG . 14.2 ttp180 -165.68 144.27 6.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.162 0.506 . . . . 0.0 109.865 170.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.996 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 3.1 p-10 -101.7 110.59 22.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.668 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 139' ' ' ARG . 27.0 m -98.63 175.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.449 0.643 . . . . 0.0 112.112 -172.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -85.28 155.41 60.17 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.905 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.47 -174.97 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.735 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m 74.3 -59.49 0.55 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.499 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.13 103.79 10.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.477 . . . . 0.0 111.282 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.48 -21.41 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.448 0.642 . . . . 0.0 109.433 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -90.82 27.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.835 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 103' ' ' VAL . 10.2 p -61.9 -28.59 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.76 141.27 51.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.366 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -85.76 120.14 26.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.69 141.38 32.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 110.868 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 173.54 13.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.415 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -90.91 -3.54 57.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.0 111.768 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.76 80.44 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -129.46 179.69 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 111.038 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.38 -172.75 2.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.46 ' HD3' ' CD ' ' A' ' 146' ' ' GLU . 41.9 mttt -71.3 100.84 2.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -135.34 138.06 43.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.088 0.47 . . . . 0.0 111.134 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.5 mt -95.62 114.41 26.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m -96.89 95.08 7.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.94 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.5 mp -93.82 125.83 38.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 0.0 111.619 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.75 91.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.71 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -101.33 98.07 8.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 0.0 110.867 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 122.86 18.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.638 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.738 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -88.11 25.08 1.67 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.25 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -169.11 160.23 9.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -171.82 103.11 0.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.423 . . . . 0.0 111.719 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -113.04 107.96 16.68 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 168.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.93 -24.08 66.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.735 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.09 -58.22 5.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.479 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 p -92.32 -16.2 26.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 111.116 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.03 49.07 8.96 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.046 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.41 152.96 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -147.17 123.55 10.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.307 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.85 -9.26 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.996 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 39.4 ttmt -162.4 142.37 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.736 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' NH2' ' O2 ' ' A' ' 201' ' ' 2W7 . 8.4 ptp85 -119.0 108.93 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.256 171.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 1.2 tmtp? -87.86 102.57 14.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -87.8 128.15 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.664 0.745 . . . . 0.0 110.65 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -127.73 116.92 20.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 78.7 t -113.65 117.83 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.503 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -105.34 118.64 37.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.522 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 m -92.04 141.17 28.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.191 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.46 ' CD ' ' HD3' ' A' ' 119' ' ' LYS . 29.3 tt0 -65.63 134.52 53.43 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 111.488 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.02 165.57 3.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.042 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttp . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.213 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.55 ' O2 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.891 0.377 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.93 -9.16 26.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.78 -179.92 3.77 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.142 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -56.32 143.93 63.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.89 138.31 62.4 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 111.954 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.8 tp60 -152.55 159.12 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.88 102.06 5.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 89.4 Cg_endo -83.52 172.47 10.28 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.634 2.223 . . . . 0.0 112.967 -174.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.61 -24.55 19.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -75.07 102.5 4.9 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.062 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -80.46 8.9 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.219 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 p -89.21 -9.4 50.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.401 0.619 . . . . 0.0 109.494 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -91.47 157.51 17.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.415 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -98.96 104.9 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -67.85 -37.34 81.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.936 0.398 . . . . 0.0 110.991 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.35 174.65 41.19 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.264 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.99 130.87 53.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.67 109.98 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.639 0.733 . . . . 0.0 109.417 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 39.0 mt-10 -123.1 109.27 13.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.628 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 25' ' ' ILE . 65.0 mt -122.53 101.89 39.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.599 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.44 -23.49 75.05 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 123.022 2.482 . . . . 0.0 112.394 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -68.43 -20.3 64.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.666 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.08 14.38 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.37 32.32 21.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.021 0.439 . . . . 0.0 111.426 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.67 HG23 ' HB2' ' A' ' 71' ' ' GLN . 64.1 mt -87.53 129.29 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.253 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 23.7 ttmm -161.95 81.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.119 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 35.9 mt-10 -143.58 158.46 56.99 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.292 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 58.3 Cg_endo -70.91 156.89 59.52 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.683 2.256 . . . . 0.0 112.605 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -112.07 132.32 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.84 111.99 57.79 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-O 121.404 0.621 . . . . 0.0 111.245 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 60.9 Cg_endo -73.82 133.58 18.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.179 2.586 . . . . 0.0 112.396 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.5 -168.51 29.13 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.589 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.03 153.94 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.846 2.364 . . . . 0.0 111.831 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.08 101.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.353 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.6 p -132.32 152.21 79.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.656 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.12 -37.94 95.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.984 2.456 . . . . 0.0 112.67 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.26 -51.23 68.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -75.72 -37.65 59.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.11 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 62' ' ' HIS . 90.5 mt -76.51 -2.77 33.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -94.19 -10.33 33.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.659 0.742 . . . . 0.0 109.352 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.637 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 2.4 mmp_? -105.03 -25.56 12.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.429 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.65 -129.89 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.965 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 59' ' ' ILE . 20.7 t -95.62 126.69 48.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.786 0.327 . . . . 0.0 110.183 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 m -139.87 150.02 44.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 35.0 m-85 -66.26 168.17 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -103.2 -55.02 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.315 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.79 163.1 12.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.417 . . . . 0.0 110.647 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.4 -23.72 17.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.185 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -76.96 -29.4 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.191 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.87 149.57 49.28 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.065 0.46 . . . . 0.0 110.465 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -154.59 150.13 27.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.55 -7.53 33.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.785 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.27 -30.1 25.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t70 -90.02 -160.51 0.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 20.6 pt20 -109.5 -25.37 10.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.334 -0.229 . . . . 0.0 111.273 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -93.01 120.99 33.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.811 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 121' ' ' LEU . 34.2 mm -127.83 129.09 69.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.912 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.3 t -133.51 87.93 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -103.62 127.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.05 36.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.892 0.377 . . . . 0.0 110.779 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.29 165.18 17.34 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 39' ' ' LEU . 14.7 m-70 -130.99 142.62 50.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.936 0.368 . . . . 0.0 111.19 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.973 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.1 m -117.78 120.69 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.35 106.93 17.65 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.89 -26.86 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.874 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -98.9 5.77 47.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.191 0.52 . . . . 0.0 110.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.68 87.82 51.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.043 0.449 . . . . 0.0 110.03 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 73' ' ' THR . 73.3 Cg_endo -77.09 2.78 7.27 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.177 2.585 . . . . 0.0 113.371 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -102.12 1.68 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.151 0.501 . . . . 0.0 110.228 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.491 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.3 t80 -78.13 138.22 38.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.67 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -57.96 -44.07 86.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -167.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 71' ' ' GLN . 3.9 m-30 -88.91 6.35 39.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.013 -0.43 . . . . 0.0 112.125 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.973 ' HA ' HG23 ' A' ' 63' ' ' THR . 86.0 m -76.37 -33.93 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.452 . . . . 0.0 110.512 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 76' ' ' LYS . 62.6 t30 -92.23 14.92 14.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.09 21.77 0.17 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.471 0.653 . . . . 0.0 110.868 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -101.52 -23.41 14.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.69 172.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -73.98 -31.84 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.004 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.17 156.86 29.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.045 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -130.83 -173.8 3.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.338 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -11.8 52.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.613 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.95 55.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.355 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.511 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 70.0 m -109.11 145.42 35.72 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.208 0.528 . . . . 0.0 109.827 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 108.71 15.11 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.811 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 93.7 t -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.438 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -100.96 117.04 34.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 110.92 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -105.47 101.68 11.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.5 ttpt -98.07 117.54 32.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.08 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.4 m -113.28 99.87 9.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.343 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.71 -101.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.794 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -111.81 -2.88 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 109.996 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.622 ' HB2' HG23 ' A' ' 88' ' ' VAL . 7.8 mm-40 -96.61 148.71 22.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.207 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.9 m -134.89 112.4 10.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.765 0.317 . . . . 0.0 110.69 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -101.75 138.89 38.13 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -99.96 130.02 46.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 86.3 m-85 -127.79 147.17 50.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.547 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 12.1 tppt? -109.34 140.53 42.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.572 ' HB3' HD11 ' A' ' 100' ' ' ILE . 50.2 mtp -77.63 60.16 2.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.206 0.527 . . . . 0.0 110.404 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.0 p -63.51 -36.88 85.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.094 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 73.9 m -124.45 97.37 5.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.502 . . . . 0.0 111.451 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 97' ' ' MET . 69.4 mt -113.18 110.49 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.537 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -146.67 151.65 37.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.828 0.347 . . . . 0.0 110.255 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.43 93.22 5.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.745 0.783 . . . . 0.0 110.475 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.705 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 14.7 m -97.26 95.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.368 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.651 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -109.06 90.81 8.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.344 0.592 . . . . 0.0 112.417 -170.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 103' ' ' VAL . 94.4 Cg_endo -104.13 -158.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.763 2.975 . . . . 0.0 111.335 172.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -126.48 11.84 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.44 163.99 29.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.303 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 -21.61 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.45 17.11 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 110.936 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 105' ' ' PRO . 19.1 m -66.86 -20.25 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.733 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -90.87 -178.65 5.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 3.5 p30 -79.18 167.29 21.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.497 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.53 15.02 22.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.816 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 112' ' ' ASP . 1.7 mp0 -66.75 110.67 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.746 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -73.57 2.59 7.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.262 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.81 64.96 3.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.636 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -108.48 178.73 4.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.88 -176.79 3.18 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -80.14 93.83 5.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.6 148.84 46.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.581 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 57' ' ' ILE . 19.5 mt -94.13 104.25 16.28 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -77.27 84.02 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.4 mt -86.79 102.1 13.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.536 0.684 . . . . 0.0 110.784 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.491 HD13 ' N4 ' ' A' ' 201' ' ' 2W7 . 40.7 mt -79.73 99.9 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 m -87.35 91.78 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.21 0.529 . . . . 0.0 110.12 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.34 101.43 7.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.5 158.28 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.422 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . 18.2 t0 55.76 93.62 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.755 0.659 . . . . 0.0 111.798 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.678 ' HB2' ' O ' ' A' ' 135' ' ' VAL . 38.4 p90 -167.81 170.45 10.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.794 ' H ' ' HB ' ' A' ' 135' ' ' VAL . 21.5 t-20 -104.45 134.0 48.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.4 -35.68 68.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.201 0.524 . . . . 0.0 111.289 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -86.87 -55.53 3.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.235 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.3 p -75.83 -10.38 59.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.35 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.59 71.24 1.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.319 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.794 ' HB ' ' H ' ' A' ' 130' ' ' ASN . 61.6 t -118.36 146.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.32 79.08 1.63 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HG2' HG12 ' A' ' 135' ' ' VAL . 23.5 mm-40 -81.57 -75.48 0.29 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 128' ' ' ASP . 46.9 mmtm -79.52 98.64 6.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.679 0.752 . . . . 0.0 111.026 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.689 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 11.5 mmm-85 -89.86 76.73 7.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.356 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -83.16 112.74 20.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tp -93.25 127.8 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 121.814 0.816 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.714 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -118.08 100.56 7.62 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.963 178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.0 t -98.68 112.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.88 116.09 31.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.404 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.7 m -89.03 139.84 30.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.146 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.01 130.11 42.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.94 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.85 162.45 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 46.8 pttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.503 -0.76 . . . . 0.0 110.66 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.491 ' N4 ' HD13 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.504 0.193 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 2' ' ' GLN . 13.9 mm-40 -92.5 25.9 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.351 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.16 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.373 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -62.29 152.4 79.26 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 123.484 0.49 . . . . 0.0 110.699 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.84 107.1 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.978 2.452 . . . . 0.0 113.054 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -140.63 169.31 17.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.934 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.713 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 90.1 mt -121.88 102.62 40.96 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-O 120.75 0.31 . . . . 0.0 110.525 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 5.8 Cg_exo -78.36 144.79 20.73 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.664 2.243 . . . . 0.0 110.606 172.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 40.1 pttt -89.51 34.08 0.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.35 0.595 . . . . 0.0 110.987 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.42 141.82 30.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.976 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 9.0 mptt -96.0 6.95 47.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.604 -173.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -113.09 -44.93 3.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.14 126.75 31.67 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.494 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.53 116.88 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.576 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . . . -84.89 -37.73 20.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.48 168.32 27.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.86 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.27 135.95 39.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -103.61 125.04 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 37.0 mt-10 -128.68 109.52 11.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.27 0.557 . . . . 0.0 111.29 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.1 mt -121.52 103.07 41.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.95 -43.64 41.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.299 2.666 . . . . 0.0 113.938 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 3.1 p-10 -76.3 -10.69 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.22 2.09 16.47 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.979 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.65 26.22 15.96 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 79.4 mt -93.04 104.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.429 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 51.3 mttt -137.27 81.23 1.86 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -126.85 150.62 72.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.54 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.77 144.08 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.623 2.215 . . . . 0.0 112.309 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 87.9 t -94.45 132.63 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.06 105.68 14.72 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 121.304 0.573 . . . . 0.0 110.453 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 97.7 Cg_endo -80.6 140.75 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.001 2.467 . . . . 0.0 112.75 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.4 -170.36 29.64 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 72.1 Cg_endo -76.9 149.06 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.468 2.112 . . . . 0.0 111.802 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -63.8 98.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.566 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -134.34 142.0 41.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.19 -30.81 43.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.363 2.709 . . . . 0.0 113.208 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 38' ' ' GLN . 10.2 pt-20 -59.99 -30.92 69.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.709 0.29 . . . . 0.0 111.59 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 16.0 mm100 -101.06 -42.57 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.837 0.351 . . . . 0.0 111.024 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 3.9 mm? -74.15 -2.7 25.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -99.88 -9.52 22.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -93.43 -55.88 3.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.886 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.99 -120.83 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.833 -175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 t -109.71 126.63 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.881 0.372 . . . . 0.0 110.688 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -146.54 158.03 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.928 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.064 0.459 . . . . 0.0 111.018 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.74 -12.04 54.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.207 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 46.7 mt-10 -101.08 121.32 41.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.773 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 43.6 mt-10 -65.06 -33.59 76.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.296 -172.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -83.05 125.52 31.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.164 0.507 . . . . 0.0 110.653 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 2.7 mp0 -63.27 108.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.481 -175.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -150.35 139.99 21.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 7' ' ' ILE . 1.5 pp -130.17 6.8 4.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.923 0.392 . . . . 0.0 111.237 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.86 33.49 1.98 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.74 179.94 4.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -72.5 -47.48 48.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.11 126.21 51.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.257 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.74 95.07 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.239 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 7.5 m -86.95 111.54 20.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -122.96 120.24 60.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.49 142.75 31.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.724 0.297 . . . . 0.0 110.437 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.58 124.16 4.57 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 39' ' ' LEU . 28.8 t-80 -84.75 132.76 34.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 127' ' ' ASP . 15.1 t -153.25 175.32 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 m-85 -140.95 138.0 33.48 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.224 0.327 . . . . 0.0 110.122 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -69.57 -17.31 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.835 0.826 . . . . 0.0 108.933 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -83.88 -21.05 32.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.089 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 9.6 mmt180 -124.54 111.99 27.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 5.5 Cg_exo -78.57 1.58 8.93 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.233 2.622 . . . . 0.0 110.876 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -86.88 14.01 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.334 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.52 -177.29 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.051 0.453 . . . . 0.0 111.639 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -93.97 -31.01 14.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.837 -170.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.38 24.01 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.475 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 68' ' ' PRO . 23.9 p -73.96 -38.06 64.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.863 0.364 . . . . 0.0 111.657 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -93.14 18.73 8.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.085 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.07 -10.86 57.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.982 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -77.19 -22.15 52.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.23 176.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.63 -4.29 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.621 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.71 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.79 159.6 15.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.086 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.9 mptt -121.04 172.59 7.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 111.025 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -74.56 -4.84 39.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.132 -176.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.64 24.92 5.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.792 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -84.74 -173.78 4.91 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.331 0.586 . . . . 0.0 110.3 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.15 107.76 12.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.401 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.6 t -93.11 106.05 17.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.014 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 85.5 m-85 -90.18 128.01 36.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.673 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.08 108.22 15.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -92.36 140.14 29.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.123 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 52' ' ' LEU . 8.5 p -163.67 128.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.903 0.382 . . . . 0.0 111.327 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.85 -87.94 0.08 OUTLIER Glycine 0 C--N 1.329 0.169 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.979 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -135.78 0.23 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.095 0.158 . . . . 0.0 111.391 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.34 169.06 11.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 m -148.05 110.73 4.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.913 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 92.5 mtt180 -95.51 154.55 17.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.511 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.47 117.44 34.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.535 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 63.2 m-85 -109.4 153.61 23.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.719 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 96' ' ' LYS . 39.6 ttmt -112.95 150.75 31.4 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.731 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 57.5 mtp -86.72 66.13 9.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.388 0.613 . . . . 0.0 109.978 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -70.44 -37.66 74.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.213 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.4 m -127.07 95.79 4.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.099 0.476 . . . . 0.0 111.482 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 42.9 mt -110.31 111.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.614 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -139.07 151.24 46.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.842 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.92 126.01 39.97 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.922 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 25.3 t -131.52 93.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.115 0.483 . . . . 0.0 110.933 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 4.3 mtmt -90.44 153.28 46.11 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 6.8 Cg_exo -74.56 14.69 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.272 2.648 . . . . 0.0 113.346 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -70.89 -30.89 67.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.518 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.98 107.88 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.867 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 109' ' ' GLU . 26.9 m -92.93 -176.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 108' ' ' VAL . 44.3 mt-10 67.73 6.75 5.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.034 0.533 . . . . 0.0 111.31 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.698 HG13 ' HG ' ' A' ' 111' ' ' LEU . 5.8 p -64.32 -34.11 67.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.698 ' HG ' HG13 ' A' ' 110' ' ' VAL . 1.2 pp -138.31 147.74 43.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.738 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.649 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 9.5 m-20 -112.23 165.21 12.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 111.203 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -98.17 72.76 2.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.399 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.649 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 0.3 OUTLIER -117.77 157.24 26.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.327 -177.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -82.74 -170.23 2.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.692 177.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.86 6.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.423 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 29.2 mmtp -131.54 -165.01 1.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -104.89 -157.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -68.11 95.39 0.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.12 0.486 . . . . 0.0 110.708 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 16.0 pt20 -105.5 126.56 52.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.107 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 106.06 18.06 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 m -83.26 91.48 7.29 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.572 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 142' ' ' PHE . 32.1 mt -84.25 97.52 9.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.378 0.609 . . . . 0.0 110.271 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mt -80.76 96.22 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -96.52 86.53 4.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.664 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.2 m -73.03 108.53 5.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 63' ' ' THR . 19.7 t70 -83.61 -21.93 32.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.183 -168.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 38.3 m-20 -139.27 138.89 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -152.99 134.72 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -118.64 120.97 39.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -68.07 -48.87 64.36 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.698 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -59.44 -63.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.103 0.478 . . . . 0.0 111.331 -170.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.2 p -73.89 -12.04 60.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.424 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.84 57.15 10.2 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.777 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.64 146.51 32.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.487 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.494 ' CD1' ' HD3' ' A' ' 139' ' ' ARG . 2.7 p90 -129.5 104.13 7.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.57 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 12.9 mm-40 -57.04 -57.84 10.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.011 -172.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -121.57 136.89 54.92 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.773 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 15.7 mtm180 -123.49 127.87 48.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.6 105.01 14.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.28 121.75 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.703 0.763 . . . . 0.0 110.53 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.731 ' HE1' ' HA ' ' A' ' 97' ' ' MET . 6.2 t80 -119.33 109.85 16.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.988 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 53.9 t -102.09 107.19 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.952 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -94.56 134.29 37.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.5 m -103.66 136.13 43.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.301 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.415 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 31.7 tt0 -67.92 121.87 16.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.247 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.4 164.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.699 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.452 179.612 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.5 ' O2 ' ' HD2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.204 0.526 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -123.49 -96.84 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.725 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.0 -178.48 2.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.559 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -62.47 116.27 21.94 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 123.413 0.445 . . . . 0.0 110.581 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 150.97 25.41 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.467 2.112 . . . . 0.0 112.136 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.442 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 mm-40 -118.65 179.25 4.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 52' ' ' LEU . 3.8 mp -91.37 106.39 16.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 77.8 Cg_endo -96.63 -168.7 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.269 2.646 . . . . 0.0 113.391 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -74.9 -20.92 59.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.607 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -79.37 105.25 10.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.457 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 23.4 mttp -87.71 -29.34 21.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 110.661 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.4 p -73.9 -13.11 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.542 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.524 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 32.1 mmtp -87.18 80.74 8.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.58 113.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.511 0.672 . . . . 0.0 111.189 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.57 -34.12 41.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.79 26.7 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.461 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.82 124.09 41.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.76 118.91 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.541 0.686 . . . . 0.0 110.104 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 46.6 mt-10 -132.32 123.76 27.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.972 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.78 101.34 29.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.59 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.1 -27.62 85.27 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.958 2.438 . . . . 0.0 112.513 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 82' ' ' SER . 8.9 m-20 -63.07 -27.52 69.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -121.47 10.45 10.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.426 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.31 28.82 18.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 23' ' ' ALA . 75.8 mt -85.56 129.21 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.487 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 22.7 ttmm -152.52 78.03 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -133.24 148.08 67.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.277 -172.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.71 162.11 30.19 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.783 2.322 . . . . 0.0 112.436 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 63.8 t -114.56 129.39 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.41 110.7 53.96 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.822 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 16.9 Cg_exo -66.43 110.76 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.071 2.514 . . . . 0.0 112.069 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.62 168.5 35.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.582 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.15 144.94 38.36 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.873 2.382 . . . . 0.0 111.899 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -57.95 109.93 0.83 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.996 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -139.65 147.0 50.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.94 -42.33 67.64 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.063 2.508 . . . . 0.0 113.228 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.38 -18.54 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -86.52 -43.3 12.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.78 -8.16 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.515 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -70.0 -17.5 63.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.638 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.0 -64.86 1.02 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.638 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.14 -113.32 0.29 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.95 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.79 130.53 57.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.1 m -144.34 158.08 43.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 87.9 m-85 -69.71 150.94 46.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 111.347 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -86.43 -62.79 1.43 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -170.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.927 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.28 39.12 1.12 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.59 90.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.89 -18.36 65.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.764 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.712 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 17.9 m -96.85 110.23 22.77 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.102 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' ' 7' ' ' ILE . 3.6 pp -81.91 -10.0 59.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.59 0.709 . . . . 0.0 109.494 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -100.6 11.07 40.27 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.003 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.6 t70 -82.04 177.41 8.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -83.09 -44.04 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.74 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -97.29 117.93 32.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.776 . . . . 0.0 111.034 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.0 136.47 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 m -125.69 112.8 16.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.442 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' HB ' HD23 ' A' ' 123' ' ' LEU . 2.8 mt -121.38 139.07 49.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.992 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 121.57 44.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -123.27 77.07 0.36 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.306 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.772 ' CE1' ' HB2' ' A' ' 129' ' ' TYR . 3.5 t-80 -74.46 121.68 21.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.002 0.43 . . . . 0.0 110.438 -175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 70' ' ' TYR . 21.7 m -112.71 166.73 11.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.824 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' A' ' 129' ' ' TYR . 63.7 m-85 -127.99 116.5 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 tt -55.8 -31.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.527 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 34.3 t70 -66.87 -24.73 66.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 80.2 mtt180 -111.56 93.04 18.22 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 26.5 Cg_exo -62.1 -21.76 73.02 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.369 2.712 . . . . 0.0 113.516 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -91.24 22.43 3.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.835 0.35 . . . . 0.0 111.617 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.1 OUTLIER -84.2 173.41 11.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 172.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 19.2 pm0 -65.84 -59.07 4.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.598 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 56.3 m-85 -99.97 26.58 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.925 -0.484 . . . . 0.0 112.143 -171.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 p -67.22 -37.4 83.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.122 0.487 . . . . 0.0 111.32 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.1 t30 -98.6 13.8 30.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.46 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.86 -7.89 13.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.49 0.662 . . . . 0.0 110.56 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 19.9 pttp -68.34 -23.84 64.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.737 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 -5.28 58.63 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.443 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.27 170.4 16.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.04 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -143.99 177.67 8.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.018 0.437 . . . . 0.0 110.854 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.52 1.17 17.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.294 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -150.15 48.68 0.58 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.094 176.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 17.4 p -86.26 -158.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.222 0.534 . . . . 0.0 110.635 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -129.11 112.0 13.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.991 176.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.9 t -105.74 119.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.189 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.41 118.32 36.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.95 0.405 . . . . 0.0 110.935 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -106.54 107.2 18.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.765 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -94.9 139.07 31.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 113.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.527 0.68 . . . . 0.0 110.883 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 -86.5 0.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.021 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -140.25 2.14 1.86 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.19 0.519 . . . . 0.0 110.506 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.87 145.89 37.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.502 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 m -131.02 109.41 10.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.914 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE1' ' A' ' 95' ' ' TYR . 4.7 ptm180 -106.77 148.39 28.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.291 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -105.6 141.55 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 95.5 m-85 -129.74 150.06 51.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -116.44 128.22 55.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.303 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -71.43 79.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.981 0.419 . . . . 0.0 110.198 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -82.92 -20.53 35.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.784 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.6 t -128.68 111.69 13.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -120.14 113.79 41.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.515 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -151.43 163.05 39.85 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.56 133.93 47.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.999 0.428 . . . . 0.0 110.19 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.72 137.9 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.232 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.89 150.79 74.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.313 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.81 71.86 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.729 2.286 . . . . 0.0 111.181 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -143.26 93.8 2.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.312 0.577 . . . . 0.0 110.954 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 54.46 51.45 14.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.333 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -13.24 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.518 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.93 30.64 4.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.076 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.58 -8.46 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.633 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.29 134.53 48.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.799 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.493 ' OD1' ' HG2' ' A' ' 114' ' ' GLN . 11.6 p30 -107.87 -164.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.53 20.22 14.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 112' ' ' ASP . 58.0 mm-40 -71.72 115.95 11.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.113 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.62 69.9 3.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.231 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.35 45.54 3.28 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -93.49 163.77 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.289 -0.455 . . . . 0.0 110.602 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.45 -166.72 1.02 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.528 ' N ' ' HE3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -76.44 101.96 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 161.78 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.536 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -118.47 115.55 24.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -82.7 102.29 11.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.517 HD23 ' HB ' ' A' ' 59' ' ' ILE . 84.8 mt -98.16 107.51 20.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.266 0.555 . . . . 0.0 111.248 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mt -81.18 96.43 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.553 ' HG1' ' HD1' ' A' ' 142' ' ' PHE . 8.9 p -105.61 52.25 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.301 0.572 . . . . 0.0 111.762 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 35.2 m -73.83 152.6 40.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.295 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.532 ' HB2' ' HE ' ' A' ' 139' ' ' ARG . 14.9 t0 -118.82 -54.62 2.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.75 0.786 . . . . 0.0 109.273 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.62 ' OD1' ' HB2' ' A' ' 139' ' ' ARG . 4.3 p-10 -54.02 121.32 7.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.581 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.772 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 84.0 t80 -168.13 114.07 0.67 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.713 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' HB3' HG12 ' A' ' 135' ' ' VAL . 40.1 t30 -87.88 109.21 19.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.617 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 8.2 pt-20 -64.26 -18.57 64.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -64.49 -49.37 71.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.963 0.411 . . . . 0.0 110.401 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.3 p -102.96 -34.97 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.884 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.491 ' HA2' ' CE1' ' A' ' 129' ' ' TYR . . . 89.26 44.97 4.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.473 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 130' ' ' ASN . 11.0 p -95.93 144.81 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -126.07 139.18 53.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.733 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.39 -64.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.558 0.218 . . . . 0.0 111.486 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -176.86 130.54 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.62 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 20.5 tpt180 -161.28 -82.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HD2' ' CE1' ' A' ' 142' ' ' PHE . 14.5 mmtp -157.67 143.35 17.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -167.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.8 tt -135.59 139.39 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.775 166.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.553 ' HD1' ' HG1' ' A' ' 125' ' ' THR . 66.6 m-85 -128.2 125.09 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 46.5 t -110.96 107.84 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.571 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.71 113.64 26.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.967 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.8 m -83.67 141.63 31.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.21 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -67.89 128.07 35.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.104 0.478 . . . . 0.0 111.007 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 96' ' ' LYS . 2.0 t -92.77 166.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.765 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.349 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.521 ' S2 ' ' N3 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.764 0.316 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -99.12 -8.48 25.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.904 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.98 156.41 30.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.709 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -89.84 128.23 51.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.493 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 55.4 Cg_endo -71.2 113.34 3.56 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.532 2.155 . . . . 0.0 112.212 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 32.8 mm-40 -121.13 -166.03 1.3 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.613 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 52' ' ' LEU . 36.0 mt -106.85 96.61 15.03 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 86.6 Cg_endo -95.77 -169.39 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.029 2.486 . . . . 0.0 113.13 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -82.88 12.59 4.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.64 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 9.5 t70 -108.64 125.65 52.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -109.78 12.39 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.948 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.5 t -106.99 -2.72 20.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.368 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 49.4 mmtm -97.24 178.38 5.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.482 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.66 117.27 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -88.14 -34.21 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.1 31.06 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.607 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.06 129.97 40.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.3 123.67 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.29 0.567 . . . . 0.0 110.346 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 30.5 mt-10 -121.43 121.69 38.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.361 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.2 mt -129.34 94.12 33.97 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.904 172.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.4 Cg_endo -54.7 -33.37 79.81 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.288 2.659 . . . . 0.0 112.407 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.6 -31.43 69.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.45 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.38 11.79 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.917 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.35 27.24 16.91 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.401 0.438 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 64.2 mt -91.24 119.9 39.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -139.3 58.16 1.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.799 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 21.1 mm-40 -108.8 145.01 30.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.281 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 157.9 33.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.828 2.352 . . . . 0.0 112.406 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.489 ' HA ' HG13 ' A' ' 43' ' ' VAL . 60.7 t -111.71 131.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.3 m-85 -87.62 114.21 57.87 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.918 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -67.07 140.2 53.41 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.099 2.533 . . . . 0.0 112.201 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -168.08 24.98 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.731 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.35 160.23 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.436 2.758 . . . . 0.0 112.038 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.145 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.58 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.1 t -161.82 144.87 9.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.315 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -41.1 -50.63 4.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.527 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -62.5 -46.07 90.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.921 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.411 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 14.7 mm100 -64.65 -48.83 73.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.879 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -78.69 20.65 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.18 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.67 -4.62 8.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 41' ' ' ARG . 46.0 mtp85 -124.85 -32.49 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.346 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.09 -162.1 14.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.074 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 6.8 p -95.82 140.5 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 50.3 m -138.9 176.6 8.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -90.51 140.5 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.077 0.465 . . . . 0.0 111.262 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.5 -3.68 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.88 154.86 28.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.318 -172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.32 19.25 14.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.62 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -71.34 172.12 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.422 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.41 7.86 35.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.358 0.599 . . . . 0.0 110.837 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 54.0 m -154.06 152.28 30.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.642 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -103.94 -7.07 20.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.205 0.526 . . . . 0.0 110.609 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' OD1' ' HB3' ' A' ' 51' ' ' SER . 9.8 p-10 -95.34 10.25 36.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.605 -178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.74 168.84 19.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.481 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.45 -32.58 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.351 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.38 111.61 24.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.868 0.842 . . . . 0.0 110.847 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 21.0 mm -135.43 102.33 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.839 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 17.1 m -83.06 106.85 15.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 6.4 mt -99.13 111.45 28.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.782 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.42 96.44 6.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -103.02 85.01 0.49 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.198 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 70' ' ' TYR . 86.1 t60 -55.58 138.77 46.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' PHE . 9.8 m -114.77 147.71 39.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.077 -174.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' HE2' ' HG2' ' A' ' 67' ' ' ARG . 17.0 t80 -143.82 83.45 1.75 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.741 ' HA ' HG23 ' A' ' 73' ' ' THR . 0.5 OUTLIER -67.56 -13.86 17.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.92 -172.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 23.3 t70 -67.04 -51.85 49.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.418 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG2' ' HE2' ' A' ' 64' ' ' PHE . 5.6 mmp_? -92.38 116.12 65.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.67 ' HA ' HG21 ' A' ' 73' ' ' THR . 39.5 Cg_endo -66.83 -15.66 47.83 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.187 2.591 . . . . 0.0 114.301 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.21 12.98 32.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 43.8 t80 -80.33 156.45 26.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 75.3 mt-30 -52.11 -49.09 64.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.826 0.345 . . . . 0.0 111.64 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.731 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 82.1 m-85 -116.34 92.64 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.049 0.452 . . . . 0.0 110.283 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 65' ' ' ILE . 24.3 m -133.3 -46.11 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.255 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.14 16.11 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -57.45 -25.09 59.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.748 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -55.8 -23.86 32.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.024 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.93 2.68 45.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.29 176.26 8.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.022 0.439 . . . . 0.0 110.642 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -148.75 -178.23 6.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.351 -178.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.05 -16.19 59.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 -175.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -139.34 45.24 1.03 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.308 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 5.7 p -85.67 -162.05 0.68 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 tpt -129.51 98.25 4.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.078 0.465 . . . . 0.0 109.819 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG21 ' SD ' ' A' ' 97' ' ' MET . 97.1 t -84.85 126.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.038 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.3 m-85 -104.98 116.73 32.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.931 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 52.6 t80 -110.3 111.68 23.14 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.483 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -102.46 140.63 36.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.448 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 52' ' ' LEU . 2.6 p -140.69 111.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.246 0.546 . . . . 0.0 109.881 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 63.82 -98.06 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.501 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -120.38 0.35 10.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.209 0.528 . . . . 0.0 110.414 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HB2' HG13 ' A' ' 88' ' ' VAL . 33.1 mm-40 -94.27 157.43 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.389 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -150.2 129.92 13.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.75 152.92 32.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -103.04 137.98 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.58 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 96.8 m-85 -128.58 145.48 51.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.06 0.457 . . . . 0.0 111.286 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 11.6 tppt? -112.04 129.17 56.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.493 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.562 ' SD ' HG21 ' A' ' 84' ' ' VAL . 75.6 mmm -78.87 48.29 0.82 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.259 0.552 . . . . 0.0 110.329 -176.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 98' ' ' THR . 3.5 t -84.58 6.81 22.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.955 -171.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 58.8 m -136.25 106.72 6.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.013 171.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.87 96.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 101' ' ' ARG . 25.3 mtm180 -145.17 138.24 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.566 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 8.2 p-10 -108.2 175.12 5.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.342 0.591 . . . . 0.0 111.659 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.21 147.59 14.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.744 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -110.61 132.55 21.52 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 5.9 Cg_exo -78.98 67.7 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 112.876 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 p -67.54 -28.49 67.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.61 0.719 . . . . 0.0 109.647 172.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.98 160.33 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.082 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG23 ' HG3' ' A' ' 109' ' ' GLU . 34.8 m -83.61 -23.63 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.346 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 108' ' ' VAL . 41.0 mt-10 -100.85 29.19 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 111.047 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.664 HG23 ' HG ' ' A' ' 111' ' ' LEU . 29.8 m -66.64 -17.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.261 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 110' ' ' VAL . 72.0 mt -131.33 -175.31 3.66 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.4 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' A' ' 114' ' ' GLN . 2.5 t70 -146.73 -167.91 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.96 88.62 7.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.07 0.462 . . . . 0.0 110.101 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 112' ' ' ASP . 1.8 mp0 -74.95 105.99 6.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.743 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.03 -15.55 61.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.021 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.44 80.71 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.039 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -96.78 168.08 10.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.3 0.571 . . . . 0.0 110.911 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.92 -166.86 2.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -78.16 94.71 4.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.57 137.99 16.72 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.5 mt -101.5 122.72 44.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.7 m -84.0 82.67 8.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.297 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 7.7 mp -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.788 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mt -83.99 78.56 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 23.0 m -78.19 88.26 4.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 139' ' ' ARG . 31.0 p -109.6 112.71 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.365 0.602 . . . . 0.0 112.202 -173.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 26.7 t70 -108.08 164.45 12.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 127' ' ' ASP . 3.5 t70 76.22 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.424 0.63 . . . . 0.0 112.145 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -176.36 157.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.066 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.464 ' HB3' HG12 ' A' ' 135' ' ' VAL . 47.3 t-20 -123.31 119.52 30.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.36 -31.48 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.692 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -72.19 -65.12 0.82 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.274 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 p -79.35 -43.31 23.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.58 57.21 1.0 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.151 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG12 ' HB3' ' A' ' 130' ' ' ASN . 12.3 p -120.3 152.69 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -151.03 135.46 16.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.93 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -118.73 -76.23 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -78.45 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -164.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 126' ' ' CYS . 5.4 mpt_? -109.12 91.05 3.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.589 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.6 OUTLIER -90.11 96.81 10.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.81 -174.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -77.44 135.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.633 0.73 . . . . 0.0 110.499 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.01 109.23 15.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.657 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 51.1 t -97.5 102.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.04 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -99.73 112.6 24.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.132 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -77.74 139.0 39.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.909 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 119' ' ' LYS . 41.6 tt0 -65.05 132.97 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 110.977 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.04 153.4 11.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.1 pttp . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.33 -173.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -160.27 174.77 13.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.164 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.32 177.28 8.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.284 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -75.84 113.22 25.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.006 0.431 . . . . 0.0 110.15 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' HD11 ' A' ' 52' ' ' LEU . 66.5 Cg_endo -78.72 133.74 11.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.706 2.27 . . . . 0.0 112.821 -175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.583 HE22 ' HB2' ' A' ' 53' ' ' ASP . 87.6 mm-40 -94.01 160.58 14.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.669 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 31' ' ' PRO . 58.4 mt -59.9 109.84 2.31 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.712 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 96.8 Cg_endo -96.16 -178.66 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.508 2.806 . . . . 0.0 114.238 -170.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 33.3 ttmt -64.01 -44.55 92.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.009 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 1.6 m-20 -75.64 108.6 8.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.414 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.629 ' HD2' ' HA2' ' A' ' 32' ' ' GLY . 45.7 mmtm -83.67 5.25 25.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.01 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -97.86 -4.05 37.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.2 mmtp -91.9 105.41 17.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG21 ' CB ' ' A' ' 28' ' ' PRO . 5.1 p -62.14 121.27 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.734 0.778 . . . . 0.0 111.101 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 52' ' ' LEU . . . -89.15 -28.63 19.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.464 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.12 27.62 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.659 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -117.6 141.23 48.61 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 84' ' ' VAL . 10.0 tp -117.3 127.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.089 0.471 . . . . 0.0 109.848 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 41.1 mt-10 -134.97 122.93 22.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 -176.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 71.9 mt -128.36 104.7 19.72 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 16.7 Cg_endo -59.73 -32.92 96.42 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.359 2.706 . . . . 0.0 113.811 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.56 -29.97 70.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.961 0.41 . . . . 0.0 111.559 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.24 2.14 16.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.074 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.07 27.48 17.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.699 0.762 . . . . 0.0 110.184 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 60.7 mt -81.71 118.08 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.663 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -141.05 83.79 1.9 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.415 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.61 150.36 76.1 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.086 0.47 . . . . 0.0 111.36 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CB ' HG21 ' A' ' 14' ' ' VAL . 60.4 Cg_endo -73.46 140.11 29.6 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.864 2.376 . . . . 0.0 112.433 175.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.568 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.4 t -88.7 134.62 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.51 104.02 18.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.398 0.618 . . . . 0.0 111.097 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 61.7 Cg_endo -76.76 109.39 2.84 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.83 2.353 . . . . 0.0 111.442 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 11' ' ' LYS . . . 177.18 -162.0 29.88 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.452 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.31 149.39 17.0 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.182 2.588 . . . . 0.0 112.028 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -73.41 120.21 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.495 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -159.61 135.35 6.05 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.01 -47.81 11.68 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.935 3.09 . . . . 0.0 113.93 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -56.21 -46.78 79.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.315 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -77.22 -35.63 55.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.337 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 44' ' ' SER . 96.1 mt -71.27 -14.24 62.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -87.97 -15.6 36.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.154 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 41' ' ' ARG . 63.2 mtt180 -87.28 -40.31 14.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.92 -172.55 44.04 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.224 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' ALA . 2.1 m -67.77 125.01 24.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.703 0.763 . . . . 0.0 111.973 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.422 ' HB2' HD23 ' A' ' 39' ' ' LEU . 14.9 m -130.17 146.03 51.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.925 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 63.8 m-85 -59.25 135.89 57.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.207 0.527 . . . . 0.0 111.664 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -92.92 3.12 56.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.803 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 42.6 mt-10 -121.32 147.94 45.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.1 pm0 -88.22 80.36 7.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.758 0.79 . . . . 0.0 109.827 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -114.95 149.31 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.313 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.5 mp0 -94.4 7.12 46.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.217 0.532 . . . . 0.0 110.734 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -149.77 151.68 34.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.119 0.485 . . . . 0.0 111.56 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -120.71 16.89 11.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.726 174.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HB2' HE22 ' A' ' 6' ' ' GLN . 26.8 t70 -88.19 -11.9 45.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.151 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -77.9 -167.48 1.0 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.58 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -117.6 -11.63 10.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -137.22 90.07 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.745 HG22 HD12 ' A' ' 121' ' ' LEU . 4.0 tt -121.92 148.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 -175.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -99.51 122.09 42.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.526 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.0 mt -123.53 131.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' VAL . . . -102.15 146.05 28.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.673 0.273 . . . . 0.0 110.613 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.78 171.43 29.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.181 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -127.75 138.42 52.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.642 HG21 ' HZ1' ' A' ' 140' ' ' LYS . 1.2 p -94.26 -86.1 0.28 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 43.1 p90 -161.6 155.1 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.534 0.683 . . . . 0.0 112.684 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 mm -127.49 -72.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.262 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 2.3 m-20 -129.24 14.44 6.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.1 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -104.31 101.0 24.32 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.508 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.819 ' HA ' HG21 ' A' ' 73' ' ' THR . 97.4 Cg_endo -89.7 0.56 5.74 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.413 2.742 . . . . 0.0 112.685 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -104.33 22.81 14.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.392 0.615 . . . . 0.0 110.026 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 20.5 t80 -104.47 155.98 18.34 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.403 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -61.73 -56.25 21.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.311 -174.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 65.8 m-85 -79.9 9.19 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.819 HG21 ' HA ' ' A' ' 68' ' ' PRO . 7.0 m -72.71 -26.44 61.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.154 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -94.87 4.91 53.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.51 -16.0 63.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.476 . . . . 0.0 110.509 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -22.66 65.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.804 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.47 -14.66 59.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.027 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.44 173.61 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -177.71 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.249 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -66.47 -10.95 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.973 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.28 55.12 0.66 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.189 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 62.3 m -111.11 137.68 48.48 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.214 0.531 . . . . 0.0 109.734 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.448 ' HE2' ' HA ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -80.69 104.33 11.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.341 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 90.2 t -96.14 124.29 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.054 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 83.1 m-85 -99.42 122.98 43.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -116.05 116.52 28.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.524 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 9.1 ttmt -113.16 135.12 54.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.951 -172.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.0 m -141.77 100.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.625 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.25 -83.15 0.53 Allowed Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.612 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -14.21 6.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 109.648 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 88' ' ' VAL . 58.0 mt-10 -93.07 136.44 33.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.649 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 m -140.85 101.61 4.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.14 161.88 13.37 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.504 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -102.97 125.17 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 65.5 m-85 -121.54 144.95 48.43 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 98' ' ' THR . 36.7 ttmt -108.46 145.37 34.75 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.3 mtp -81.67 46.88 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.378 0.609 . . . . 0.0 109.604 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 4.4 t -81.67 8.67 9.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.448 -168.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.6 m -145.25 93.03 2.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.582 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.8 mt -126.73 137.04 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.762 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -165.43 147.78 7.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.786 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 24.8 t70 -89.85 93.11 9.3 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.45 86.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.872 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.45 126.24 78.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD3' ' HG2' ' A' ' 139' ' ' ARG . 77.1 Cg_endo -76.58 46.23 1.81 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.166 2.578 . . . . 0.0 113.727 -171.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 t -76.72 -14.28 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.6 144.67 25.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.093 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.19 4.88 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -119.67 24.61 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.426 0.631 . . . . 0.0 110.081 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.73 15.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.841 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.28 162.89 13.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.279 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 1.3 m-20 -64.89 149.24 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.33 -40.38 97.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 112' ' ' ASP . 23.8 pt20 -75.56 133.54 40.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.749 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -106.59 97.15 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.643 0.259 . . . . 0.0 110.857 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.75 134.8 24.19 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.97 167.21 9.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.884 0.85 . . . . 0.0 112.562 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 175.19 -164.99 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.103 -1.862 . . . . 0.0 106.483 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -95.72 96.08 8.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -145.0 113.12 6.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.457 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.26 114.67 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -88.04 128.53 35.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.389 0.614 . . . . 0.0 110.046 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 17.8 mt -107.86 105.2 14.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.337 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.51 85.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.604 ' HB ' HG23 ' A' ' 63' ' ' THR . 31.9 p -87.05 86.43 7.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.569 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 42.9 m -64.84 106.01 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.407 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.31 -67.29 0.79 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.498 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 7.8 t70 -81.55 126.2 31.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.018 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -151.97 124.33 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.751 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -87.71 136.37 32.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.64 -40.29 14.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.247 -168.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -64.92 -62.35 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.086 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -83.91 -14.8 50.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.94 59.82 4.52 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.535 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.08 152.78 33.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -136.92 129.33 29.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.326 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -95.76 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.14 0.495 . . . . 0.0 109.975 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.467 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 37.9 mtmm -80.67 89.33 5.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.215 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 5.8 ptt180 -106.22 81.41 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.642 ' HZ1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -62.21 118.03 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.308 -178.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.11 126.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.3 t80 -113.77 108.86 17.66 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.795 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.9 t -110.86 112.1 39.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -101.97 111.11 23.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.001 0.429 . . . . 0.0 110.549 177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.0 m -89.77 137.22 32.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.726 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 32.3 tt0 -59.8 124.53 20.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.829 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.6 155.21 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 122.21 1.005 . . . . 0.0 110.849 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.559 -168.334 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.47 ' O3 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 65.0 27.34 12.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.486 0.66 . . . . 0.0 110.256 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.45 173.31 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.194 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 147.16 79.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.589 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.17 113.99 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 111.318 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -151.5 159.28 44.23 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 77.8 mt -101.07 103.24 24.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 1.6 Cg_endo -84.34 167.49 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.04 2.494 . . . . 0.0 112.587 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -77.9 -12.87 60.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.291 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 18.5 t70 -84.65 123.37 30.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.138 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -95.67 12.31 30.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.655 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -93.86 -4.45 50.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.261 0.553 . . . . 0.0 110.154 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 49.9 mmtm -95.8 172.71 7.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.51 98.23 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.41 -32.27 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.077 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -148.73 156.13 26.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.902 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 1.0 OUTLIER -123.48 128.3 49.6 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.557 HD11 HG13 ' A' ' 84' ' ' VAL . 9.1 tp -102.31 117.82 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.525 0.678 . . . . 0.0 110.503 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.7 mt-10 -128.99 119.34 24.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.488 0.661 . . . . 0.0 111.466 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.67 102.06 39.14 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.753 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -25.68 75.48 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.023 2.482 . . . . 0.0 112.78 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.07 -3.16 54.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.19 10.99 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.541 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.21 20.79 10.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.769 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 67.6 mt -86.77 119.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 8.9 mtpm? -144.58 68.75 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.813 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 25.0 mm-40 -113.74 145.58 33.74 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.474 -172.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.28 149.73 57.8 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.652 2.235 . . . . 0.0 111.934 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.31 130.52 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -88.68 111.68 45.69 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.746 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 37.9 Cg_endo -67.62 152.83 77.63 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.021 2.481 . . . . 0.0 112.797 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.46 177.54 16.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.046 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.37 136.11 25.78 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.999 2.466 . . . . 0.0 111.448 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.1 115.06 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.773 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -128.71 151.7 77.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.494 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.3 -46.06 36.61 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.192 2.594 . . . . 0.0 113.404 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.53 -8.6 58.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.306 0.574 . . . . 0.0 111.26 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -101.69 -41.27 6.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.866 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.1 mt -67.74 -32.16 72.58 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.984 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.36 -12.98 57.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.207 0.527 . . . . 0.0 110.064 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -87.89 -40.06 14.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.503 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -127.17 0.91 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.018 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -122.29 138.06 53.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.7 p -135.9 174.79 10.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 0.0 110.988 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.6 m-85 -84.12 165.34 18.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.92 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.135 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 37.4 mt-10 -117.08 177.22 4.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.3 tt0 -114.6 13.88 17.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.998 0.904 . . . . 0.0 109.185 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.78 -34.97 11.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.645 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 1.7 pm0 -82.5 142.37 31.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.234 0.54 . . . . 0.0 111.233 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -86.68 152.02 22.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.342 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.83 9.28 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 111.272 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -119.96 -1.8 10.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.437 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -84.91 -173.77 4.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.122 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.18 41.53 1.22 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.625 0.25 . . . . 0.0 111.112 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -171.94 126.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.81 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 23.8 mm -118.93 104.66 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 m -98.29 99.19 10.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.093 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt -120.98 148.14 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB1' ' C7 ' ' A' ' 201' ' ' 2W7 . . . -142.04 140.07 32.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.702 0.287 . . . . 0.0 110.681 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -161.35 116.05 0.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.865 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -83.88 122.49 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 73' ' ' THR . 58.5 m -107.27 118.69 37.39 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.284 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' A' ' 67' ' ' ARG . 12.4 p90 -108.54 139.48 43.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.071 0.462 . . . . 0.0 111.368 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.402 ' HB ' ' HE1' ' A' ' 129' ' ' TYR . 82.0 mt -49.46 -34.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.302 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.44 -29.31 48.98 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 mmt85 -113.56 101.88 54.18 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.204 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.675 ' HA ' HG21 ' A' ' 73' ' ' THR . 8.2 Cg_exo -74.21 -10.73 22.77 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 123.097 2.532 . . . . 0.0 111.39 175.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -106.71 22.44 15.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.084 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -82.79 163.19 21.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.813 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 4.1 mp0 -52.08 -39.79 60.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 76.3 m-85 -128.88 25.53 5.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.675 HG21 ' HA ' ' A' ' 68' ' ' PRO . 3.0 m -68.24 -27.35 66.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.37 21.56 12.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 75' ' ' LEU . 11.7 mt -65.5 -11.64 45.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -71.43 -24.43 62.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.247 0.546 . . . . 0.0 110.76 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -81.2 -17.78 48.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.058 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.93 150.33 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -129.68 179.42 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -65.56 -6.55 11.23 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -171.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.52 23.74 7.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.1 m -87.87 130.68 34.82 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.92 113.05 6.78 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 18' ' ' ILE . 94.6 t -89.7 106.6 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.588 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.01 107.35 19.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.053 0.454 . . . . 0.0 110.323 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 31.8 t80 -108.65 101.0 10.17 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.283 0.564 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 54.5 mtmt -85.65 125.43 33.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.5 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 88' ' ' VAL . 17.8 m -107.9 92.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.822 0.82 . . . . 0.0 109.67 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.95 -89.0 1.42 Allowed Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -127.71 -17.92 4.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 111.138 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 26.1 mt-10 -84.24 142.42 30.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.741 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.3 m -108.78 112.24 24.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.529 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 12.9 mmt180 -89.11 130.75 35.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -100.8 125.89 47.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.936 0.398 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 78.7 m-85 -123.28 144.31 49.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.015 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HE2' HG11 ' A' ' 147' ' ' VAL . 5.4 tppt? -101.85 139.48 37.42 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 100' ' ' ILE . 70.1 mtp -77.64 59.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.43 . . . . 0.0 110.393 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.8 p -59.3 -44.55 92.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.282 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.9 m -113.16 98.89 7.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.981 0.42 . . . . 0.0 111.543 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 97' ' ' MET . 58.8 mt -122.31 105.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -149.8 150.53 32.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.71 127.81 38.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.509 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.44 148.14 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 104' ' ' LYS . 44.6 mtpt -57.74 123.29 62.35 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.22 -8.4 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.764 2.309 . . . . 0.0 112.544 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 p -93.75 -16.06 24.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.164 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.92 120.43 19.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.659 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 m -98.57 2.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -76.06 -20.77 57.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.04 7.1 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.72 -174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.37 113.64 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.252 0.548 . . . . 0.0 111.132 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.94 133.29 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.413 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.2 125.21 51.99 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.646 -169.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -120.23 139.46 52.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.938 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -83.38 51.79 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 110.113 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 145.29 15.64 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.154 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -133.51 168.75 18.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -175.23 -178.83 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.65 86.96 7.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.47 145.58 31.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.386 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -104.63 115.75 30.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.213 175.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.654 ' HA ' HG22 ' A' ' 143' ' ' VAL . 5.1 t -87.77 59.62 5.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.781 0.801 . . . . 0.0 110.436 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.499 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 5.7 mt -54.92 113.99 1.56 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.219 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.78 97.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.413 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 9.2 p -111.33 107.74 17.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -79.5 140.55 37.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.442 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 5.7 m-20 -89.14 -46.19 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.279 0.561 . . . . 0.0 111.086 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 137' ' ' GLU . 16.9 m-20 -88.42 169.11 12.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.158 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 16.6 p90 -156.23 127.57 7.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.701 172.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -93.59 109.01 20.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.02 -27.33 65.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.9 -171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 4.8 tmtt? -73.28 -79.77 0.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 111.35 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -97.63 -1.08 44.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.9 76.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.049 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 48.2 t -121.31 141.02 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.21 104.64 10.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 44.8 mt-10 -71.77 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 10.1 mtpm? -63.26 130.64 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.905 0.383 . . . . 0.0 111.167 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -118.43 98.53 6.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -78.53 127.86 32.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.21 131.3 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.712 0.767 . . . . 0.0 109.988 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.4 t80 -129.18 98.78 5.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.241 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 122' ' ' THR . 58.6 t -106.06 104.46 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.9 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.573 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -90.31 133.38 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.841 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.6 m -104.86 138.43 41.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.513 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 41.6 tt0 -64.97 113.87 4.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.244 0.545 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 96' ' ' LYS . 2.1 p -116.58 153.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.068 0.937 . . . . 0.0 112.367 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--N 1.308 -1.201 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.359 -178.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.469 ' O3 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.667 0.27 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.62 52.73 2.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.094 0.473 . . . . 0.0 110.145 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.23 155.25 5.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.414 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -67.14 147.34 99.03 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.793 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.686 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 26.0 Cg_endo -63.29 120.1 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.761 2.307 . . . . 0.0 112.309 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -141.89 159.21 42.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 31' ' ' PRO . 46.6 mt -103.49 110.93 64.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.63 0.253 . . . . 0.0 110.68 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.31 -176.22 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.681 2.254 . . . . 0.0 111.292 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.24 -19.77 21.85 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.412 0.625 . . . . 0.0 109.608 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 2.7 p-10 -92.32 165.1 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -116.46 16.33 15.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.092 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -89.33 -27.35 20.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 110.045 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 29.8 mmmt -84.0 113.84 21.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.14 97.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.899 0.38 . . . . 0.0 110.588 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 -30.38 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.734 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -146.99 157.74 27.51 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.948 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 2.4 t80 -137.77 124.98 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -95.06 121.58 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.152 0.501 . . . . 0.0 110.243 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.1 mt-10 -128.5 106.43 8.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.548 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.8 mt -120.42 98.78 48.36 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.185 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 -33.39 93.83 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.043 2.496 . . . . 0.0 112.486 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.36 -19.9 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.548 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -128.04 16.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.4 23.09 12.65 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.217 0.323 . . . . 0.0 111.636 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 81.1 mt -94.18 112.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.635 0.255 . . . . 0.0 111.342 -172.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 54.5 mtmt -141.05 86.16 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.668 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -123.61 141.33 36.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.65 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.3 146.24 56.28 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.262 1.975 . . . . 0.0 111.449 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 58.0 t -100.08 127.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.705 ' HB3' ' HB2' ' A' ' 11' ' ' LYS . 23.7 m-85 -95.48 105.18 18.74 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.592 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -66.61 143.43 68.41 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.996 2.464 . . . . 0.0 112.284 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.67 -134.26 6.15 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.434 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -95.87 155.05 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.406 2.737 . . . . 0.0 112.797 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.83 129.58 35.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.28 138.95 7.67 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.54 -31.97 80.85 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.178 2.586 . . . . 0.0 112.925 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.31 -35.41 77.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 111.354 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.9 tt0 -85.52 -34.7 21.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.892 0.377 . . . . 0.0 110.345 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.71 -16.64 61.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.599 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 65.8 t30 -82.29 3.74 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.727 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 11.7 ptp180 -137.11 -43.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.304 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' TYR . . . -139.15 169.7 24.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.192 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.63 140.03 16.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -139.29 174.52 10.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.05 144.8 25.89 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.325 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -83.96 -79.93 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.0 77.32 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.378 0.608 . . . . 0.0 111.122 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -16.67 35.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.6 36.11 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.758 -1.564 . . . . 0.0 111.976 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -156.97 -150.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.126 0.489 . . . . 0.0 111.224 -172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 68.8 m -103.03 159.47 15.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.312 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.41 2.12 4.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.761 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 51' ' ' SER . 1.2 p-10 -91.1 -5.77 54.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.56 166.35 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.943 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -85.71 -35.32 20.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.583 0.23 . . . . 0.0 111.432 -173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.34 85.81 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.648 0.737 . . . . 0.0 111.625 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.535 HG21 HD22 ' A' ' 121' ' ' LEU . 34.4 mm -82.82 132.61 30.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.675 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 p -130.55 107.85 9.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.325 0.583 . . . . 0.0 110.578 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 123' ' ' LEU . 4.0 mt -107.55 143.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -120.29 149.33 42.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.203 0.525 . . . . 0.0 111.887 -173.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.7 -165.15 21.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -145.34 137.72 25.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.434 0.617 . . . . 0.0 110.57 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -89.72 132.89 34.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.959 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.67 121.72 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.937 0.399 . . . . 0.0 111.057 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tt -88.55 -30.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.59 -42.2 82.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 76.0 mtt180 -105.85 104.47 49.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.198 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.43 -35.65 38.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.414 2.076 . . . . 0.0 112.568 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -87.71 52.35 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.438 0.637 . . . . 0.0 110.302 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 40' ' ' ASN . 15.6 t80 -104.25 -167.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.001 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 3.6 pt20 -82.16 -38.25 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.705 0.288 . . . . 0.0 111.171 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 71' ' ' GLN . 78.1 m-85 -131.19 97.86 4.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.116 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 70' ' ' TYR . 25.5 p -130.88 -48.96 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.6 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 62.3 t30 -84.77 16.85 3.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.1 tp -66.58 -13.87 61.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 110.781 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -68.56 -24.0 64.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 175.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.0 9.1 20.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.751 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -103.0 129.29 49.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.1 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 3.0 mppt? -112.84 -178.5 3.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.907 -172.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -66.49 -6.62 15.47 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 112.017 -175.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -132.0 19.93 4.59 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 49.9 m -74.12 115.27 13.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.2 tpt -65.01 112.64 3.42 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.757 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 95.2 t -96.71 123.41 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.391 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 63.0 m-85 -106.05 126.68 52.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.025 0.44 . . . . 0.0 110.663 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.507 ' HE1' HG21 ' A' ' 29' ' ' VAL . 24.9 t80 -115.76 103.86 11.09 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.413 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.513 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 12.0 ttmm -78.83 138.4 38.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.61 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.5 m -136.56 102.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.247 0.546 . . . . 0.0 110.559 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.33 -81.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.162 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.79 -5.12 2.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 110.324 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -101.58 156.97 17.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.372 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 m -123.35 125.16 44.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.65 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HB2' ' HE1' ' A' ' 95' ' ' TYR . 15.1 mmm180 -105.97 137.34 44.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -103.2 135.4 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.618 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 81.1 m-85 -132.52 146.72 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.254 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.554 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 9.9 tppt? -109.42 139.34 44.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 100' ' ' ILE . 68.4 mtp -77.63 79.76 4.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.9 p -80.77 -43.1 20.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 4.5 m -112.72 108.34 17.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 110.57 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.6 mt -128.66 102.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.713 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -153.6 174.08 14.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.8 143.18 50.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 t -111.36 148.67 14.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.147 -172.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 1.7 tmtp? -121.9 89.82 48.29 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -101.73 -150.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.778 2.985 . . . . 0.0 111.843 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.2 m -144.49 -46.92 0.25 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 108' ' ' VAL . 2.6 t70 -138.39 -154.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 109' ' ' GLU . 21.9 m -91.16 -173.8 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.328 -0.232 . . . . 0.0 111.282 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 108' ' ' VAL . 4.9 mm-40 69.41 -3.91 1.48 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.062 0.945 . . . . 0.0 113.011 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.65 -23.77 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.097 0.475 . . . . 0.0 110.815 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -114.22 131.32 56.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.805 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -89.65 130.7 35.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.67 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.439 ' CD ' ' HZ1' ' A' ' 117' ' ' LYS . 8.5 tp10 -102.16 141.15 35.46 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -154.49 157.24 38.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.075 -176.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -79.17 79.7 5.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.931 0.872 . . . . 0.0 111.163 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.26 43.19 0.49 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.996 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HZ1' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -102.53 -165.21 1.16 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.16 0.505 . . . . 0.0 110.86 -177.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.7 -174.35 4.13 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -78.25 96.93 5.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -134.67 146.44 49.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 57' ' ' ILE . 18.4 mt -95.26 100.49 12.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 90.19 3.37 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 59' ' ' ILE . 7.6 mt -84.16 114.46 21.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.771 0.796 . . . . 0.0 111.291 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.552 HG23 ' NH2' ' A' ' 139' ' ' ARG . 73.3 mt -91.91 94.13 4.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.906 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.4 p -115.81 85.56 2.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.499 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.63 ' HB3' ' O2 ' ' A' ' 201' ' ' 2W7 . 26.3 p -78.58 135.23 37.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' OD1' ' HB2' ' A' ' 140' ' ' LYS . 2.3 m-20 -89.72 -60.83 1.84 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.755 0.788 . . . . 0.0 109.688 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 4.7 t70 -86.56 138.31 31.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.163 -1.38 . . . . 0.0 111.132 -174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -160.97 142.23 11.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.72 110.48 22.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -57.56 -29.51 64.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.991 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -70.76 -62.03 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.8 p -83.12 -31.81 27.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.622 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.95 43.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.55 153.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -123.91 134.73 53.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.274 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 43.7 mt-10 -98.24 -54.74 2.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.332 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 28.5 mttp -104.37 97.46 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.265 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.552 ' NH2' HG23 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -119.92 117.59 28.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.638 0.732 . . . . 0.0 111.427 -177.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.543 ' HE3' HG23 ' A' ' 100' ' ' ILE . 2.3 tmtm? -77.5 124.56 28.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.72 121.78 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 121.597 0.713 . . . . 0.0 110.139 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.1 t80 -120.59 115.88 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.84 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.5 t -111.8 116.96 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.366 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -105.33 119.78 39.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.337 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 m -87.0 138.87 31.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.3 112.35 5.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 96' ' ' LYS . 2.6 p -122.57 150.49 26.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--N 1.31 -1.13 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.211 -174.24 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.63 ' O2 ' ' HB3' ' A' ' 126' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 66.63 24.98 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.546 0.529 . . . . 0.0 110.9 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.9 173.24 12.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.83 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.82 122.14 84.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.378 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 17.1 Cg_endo -56.95 145.84 82.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.25 2.633 . . . . 0.0 112.744 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' HA ' HD21 ' A' ' 52' ' ' LEU . 26.0 mm-40 -129.32 168.36 16.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.912 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.667 HG13 HD23 ' A' ' 52' ' ' LEU . 82.7 mt -100.02 105.77 37.25 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.02 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 10.8 Cg_endo -89.41 -93.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.959 2.439 . . . . 0.0 113.176 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 9' ' ' LYS . 13.4 ttpp -164.97 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.23 124.2 16.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.001 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 38' ' ' GLN . 77.4 mttt -90.09 13.34 15.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.266 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -120.13 6.7 10.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -105.88 144.16 33.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.412 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.83 102.5 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.825 0.345 . . . . 0.0 110.289 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -84.66 -31.69 24.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.235 0.541 . . . . 0.0 110.203 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.15 178.24 31.92 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.017 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.01 144.44 50.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tp -117.13 118.75 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.549 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.8 mt-10 -126.4 113.0 16.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.46 0.648 . . . . 0.0 111.671 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.54 99.66 45.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.45 -29.79 89.44 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.164 2.576 . . . . 0.0 112.673 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.28 -21.23 66.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.599 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -125.86 8.81 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.131 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 56.64 31.19 18.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.418 0.628 . . . . 0.0 111.121 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 78.0 mt -83.32 110.01 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.07 67.6 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 35.3 mm-40 -120.4 157.02 54.82 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.793 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.84 160.68 30.71 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.533 2.155 . . . . 0.0 112.563 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -112.43 132.93 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 35.4 m-85 -92.82 111.19 50.09 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 0.0 110.522 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 55.7 Cg_endo -70.38 98.69 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.364 2.709 . . . . 0.0 112.918 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.27 173.57 41.15 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 154.01 43.64 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.738 2.292 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 107.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.548 0.53 . . . . 0.0 111.034 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.477 ' HB ' ' OE1' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -136.58 142.23 38.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.915 -176.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -47.85 -49.54 13.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.981 3.12 . . . . 0.0 114.245 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.12 -28.28 39.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -174.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.824 ' HB2' ' HD3' ' A' ' 11' ' ' LYS . 9.3 tt0 -73.41 -39.57 64.96 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 35' ' ' THR . 91.1 mt -63.74 -36.64 84.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.752 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -32.89 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -86.75 -12.36 48.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.676 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 71' ' ' GLN . . . 162.05 -96.25 0.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.322 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 59' ' ' ILE . 5.0 p -154.28 140.86 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 120.78 0.324 . . . . 0.0 110.607 -175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . 19.8 p -125.05 174.75 7.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.09 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.44 164.07 24.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.908 0.385 . . . . 0.0 110.747 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' SER . . . -79.75 -55.13 5.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.064 0.459 . . . . 0.0 110.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -112.69 151.25 30.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.48 -177.011 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -74.27 -36.87 63.84 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.165 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -89.3 19.0 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.223 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 41.1 mt-10 -84.86 102.27 12.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 109.849 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 m -72.89 133.36 44.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 7' ' ' ILE . 2.0 pp -70.53 -2.46 14.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.54 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -109.07 -3.46 17.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.371 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.79 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.487 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 pt20 172.27 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' HD3' ' A' ' 117' ' ' LYS . 7.4 t30 -94.24 119.69 33.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.295 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 52' ' ' LEU . 17.2 mm -123.39 100.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.066 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' THR . 4.5 m -92.8 114.47 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 110.347 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.685 ' HB ' ' HG ' ' A' ' 123' ' ' LEU . 3.0 mt -111.52 108.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 121.62 33.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.803 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -99.14 175.48 28.47 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.517 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' THR . 23.2 t-160 -84.0 -84.16 0.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.381 0.134 . . . . 0.0 111.144 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 62' ' ' HIS . 15.2 t 171.75 -170.04 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.21 150.31 30.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.35 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.666 HG13 ' H ' ' A' ' 66' ' ' ASP . 10.7 tp -158.47 177.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.666 ' H ' HG13 ' A' ' 65' ' ' ILE . 38.8 t70 -76.77 34.65 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.689 0.757 . . . . 0.0 111.221 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -125.3 105.36 28.21 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 121.977 -0.452 . . . . 0.0 110.298 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 57.0 Cg_endo -72.32 -4.96 16.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -103.4 16.81 25.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.531 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.4 t80 -84.66 151.77 24.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.133 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 12.3 mp0 -46.55 -39.76 11.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.54 17.69 9.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -171.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 38.5 m -69.15 -39.7 78.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.491 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -99.0 7.4 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.086 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.18 -13.48 37.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 110.754 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -63.78 -23.84 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.232 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.49 -8.31 59.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.686 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -85.7 158.67 19.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.57 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -128.2 -178.16 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.277 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -72.06 -5.47 35.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.437 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.31 8.21 12.32 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.473 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.8 m -74.04 155.71 38.25 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.731 0.777 . . . . 0.0 110.915 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.92 120.05 35.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.102 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.755 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 72.1 t -103.23 108.68 24.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.323 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 42.0 m-85 -90.05 109.81 20.84 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.286 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HB2' HD11 ' A' ' 121' ' ' LEU . 38.9 t80 -99.07 110.39 22.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -109.1 142.54 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.256 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 52' ' ' LEU . 2.9 p -150.64 103.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.83 0.824 . . . . 0.0 110.091 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 62.58 -98.29 0.2 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.226 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.58 -7.16 17.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.45 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 6.4 mm-40 -92.89 145.06 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.443 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 m -150.04 99.93 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.225 0.536 . . . . 0.0 110.01 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -106.03 136.87 44.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.615 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -89.96 133.29 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.993 0.425 . . . . 0.0 110.336 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -126.94 147.35 50.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.27 148.31 30.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.56 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 68.3 mtp -80.65 56.6 2.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.199 0.523 . . . . 0.0 110.27 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.1 p -60.98 -38.5 86.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.187 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.1 m -119.42 95.59 4.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.014 0.435 . . . . 0.0 111.489 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 97' ' ' MET . 59.3 mt -115.66 103.39 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -132.33 147.17 52.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.957 0.408 . . . . 0.0 110.621 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 36.3 t70 -112.78 120.22 40.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.635 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 111' ' ' LEU . 15.7 t -123.43 154.88 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.223 -173.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 92.1 mttt -90.57 138.32 26.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 12.6 Cg_exo -74.06 42.92 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.84 3.027 . . . . 0.0 113.02 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -59.05 -48.51 81.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.411 0.624 . . . . 0.0 109.797 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -143.84 171.62 13.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.112 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.585 ' HB ' ' C26' ' A' ' 201' ' ' 2W7 . 31.0 m -88.68 -8.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.443 0.639 . . . . 0.0 109.476 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.44 -12.87 59.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.881 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 111' ' ' LEU . 12.5 p -69.88 -24.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.065 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 110' ' ' VAL . 90.6 mt -121.05 135.47 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -166.2 143.72 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.36 114.38 27.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.998 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -95.76 161.4 14.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.577 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.48 23.67 13.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 123.693 0.621 . . . . 0.0 111.343 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.26 -149.12 21.77 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -145.4 158.74 43.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.854 0.359 . . . . 0.0 111.583 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -111.98 -161.31 0.75 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 6.1 mptt -80.64 97.47 7.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.81 138.78 24.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.651 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.8 mt -96.28 101.77 13.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 143' ' ' VAL . 16.4 m -90.09 85.77 6.38 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.86 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.685 ' HG ' ' HB ' ' A' ' 59' ' ' ILE . 7.2 mp -77.3 104.11 7.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.239 0.543 . . . . 0.0 110.895 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.86 82.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.306 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.5 p -104.66 98.52 8.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.73 113.52 4.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.844 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 1.6 t70 -64.26 -39.1 93.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.77 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.72 137.99 46.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.964 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -156.84 118.46 3.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.23 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.471 ' HB3' HG12 ' A' ' 135' ' ' VAL . 2.0 t-20 -104.05 122.47 45.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -71.53 -29.06 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -76.39 -60.4 2.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.716 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.2 p -84.28 -8.72 58.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.517 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.02 95.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.309 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 130' ' ' ASN . 9.2 p -115.94 152.18 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 0.0 110.745 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.425 ' O ' ' HG2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -142.92 118.77 10.56 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.649 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.1 2.24 34.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -156.61 135.23 11.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.844 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 3.4 ptp180 -145.02 108.96 4.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.421 0.629 . . . . 0.0 111.569 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -88.62 109.96 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.666 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 141' ' ' ILE . 3.9 tp -88.69 127.14 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 110.31 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.755 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.7 t80 -118.54 114.57 23.03 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.32 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.9 t -112.44 115.01 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.104 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -97.03 117.77 31.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.385 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.1 m -89.83 142.31 27.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.185 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.44 138.34 56.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.6 t -111.11 161.85 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.309 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.585 ' C26' ' HB ' ' A' ' 108' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.641 0.258 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.88 -174.36 3.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.395 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.66 105.6 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 124.286 0.991 . . . . 0.0 111.658 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -105.45 140.1 20.82 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.0 116.99 4.92 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.251 1.968 . . . . 0.0 111.639 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -130.05 175.25 9.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.204 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 31' ' ' PRO . 48.0 mm -113.44 89.28 14.69 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -92.73 -176.84 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.202 2.601 . . . . 0.0 113.086 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -74.96 -25.41 58.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.63 118.5 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 56.4 mttp -87.1 -46.64 9.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -56.32 -36.27 68.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -167.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.611 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.56 142.38 58.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.247 0.546 . . . . 0.0 110.98 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.28 126.06 49.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -103.07 -22.74 13.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.908 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.35 160.72 28.68 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.531 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.32 127.48 53.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.54 118.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.334 0.588 . . . . 0.0 109.43 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 34.2 mt-10 -125.4 112.0 15.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.799 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 84' ' ' VAL . 76.2 mt -125.22 102.65 30.36 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.901 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 20.2 Cg_endo -62.09 -29.74 81.63 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.129 2.553 . . . . 0.0 113.095 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.37 -16.74 61.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.53 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.44 8.82 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.327 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 58.55 34.71 24.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.764 0.792 . . . . 0.0 110.722 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 71.3 mt -95.66 120.88 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.745 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -145.3 79.64 1.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 31.7 mm-40 -122.4 141.65 35.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.676 -169.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.21 134.4 21.03 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.575 2.183 . . . . 0.0 111.7 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.593 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.3 t -96.2 138.13 22.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.357 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -109.46 91.02 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -68.28 133.43 28.43 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.88 2.386 . . . . 0.0 112.272 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.38 175.79 34.7 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HG2' ' HE3' ' A' ' 11' ' ' LYS . 19.6 Cg_endo -59.84 118.09 4.93 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.662 2.241 . . . . 0.0 112.237 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -55.8 126.32 25.09 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -142.25 139.02 17.2 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.83 -35.43 88.56 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.023 2.482 . . . . 0.0 113.01 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.47 -17.51 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.419 ' CD ' ' HD3' ' A' ' 11' ' ' LYS . 37.6 tt0 -88.92 -48.59 7.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 35' ' ' THR . 4.5 mm? -60.49 -22.9 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.808 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.12 -15.09 60.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.209 0.528 . . . . 0.0 110.582 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -100.01 -20.98 15.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.944 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.89 178.55 41.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.057 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.84 123.87 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -136.17 153.06 51.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.368 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.38 168.94 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.99 -64.39 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -105.65 158.73 16.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.124 0.487 . . . . 0.0 111.174 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.25 5.01 52.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.786 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -98.53 -0.42 43.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -107.78 135.55 49.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.852 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 57' ' ' ILE . 27.6 t -118.72 157.95 26.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.277 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.78 -2.23 16.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.578 0.704 . . . . 0.0 110.219 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -92.25 -16.45 26.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.972 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.91 178.54 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.825 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 -26.93 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.96 124.13 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.852 0.358 . . . . 0.0 110.657 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 121' ' ' LEU . 25.4 mm -135.25 139.88 46.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.78 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 m -132.97 114.4 13.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 110.257 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -123.02 136.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.6 174.18 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.28 -172.45 40.87 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.773 ' CD2' ' HA ' ' A' ' 127' ' ' ASP . 10.4 t60 78.18 122.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.983 0.913 . . . . 0.0 111.651 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -153.98 151.3 29.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.701 171.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 130' ' ' ASN . 24.1 m-85 -82.49 83.89 7.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 11.2 tp -99.57 18.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.796 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 14.3 t70 83.33 -25.4 0.14 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.346 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -75.76 108.19 5.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 60.2 Cg_endo -77.4 0.35 9.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.511 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.14 9.78 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.17 101.64 0.93 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.837 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -1.17 -71.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 19.3 m-85 -79.47 6.46 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.7 p -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -92.73 10.41 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.228 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.93 1.22 5.85 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.569 0.7 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -75.77 -25.05 56.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.198 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.72 59.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.07 149.16 26.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -112.72 173.93 6.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.172 -176.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -77.83 -6.01 52.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.619 . . . . 0.0 110.665 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.11 10.66 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.975 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.582 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 24.3 m -73.86 129.76 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.519 0.676 . . . . 0.0 110.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.414 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -75.91 108.29 8.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.816 173.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.826 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -97.07 134.4 34.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.659 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.5 m-85 -108.53 127.5 53.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.038 0.447 . . . . 0.0 110.228 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.415 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 57.2 t80 -123.3 113.18 18.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.383 0.611 . . . . 0.0 109.361 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.6 ttmm -89.97 132.63 35.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.715 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.04 117.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.364 0.602 . . . . 0.0 109.843 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 -99.81 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.316 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -131.01 11.09 5.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.831 0.348 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -125.83 156.48 39.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 11.6 m -126.47 130.15 50.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 79.1 mmt-85 -101.56 153.71 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.145 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 44.2 mtmt -102.56 131.57 49.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 109.891 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.2 m-85 -127.36 145.1 50.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.678 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -107.39 143.87 35.09 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.607 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.9 mtp -83.5 44.61 0.98 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.766 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 98' ' ' THR . 1.8 t -74.72 -9.45 58.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.463 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.7 m -123.85 84.41 2.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.281 0.563 . . . . 0.0 110.892 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 97' ' ' MET . 64.4 mt -120.12 113.68 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.248 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 141' ' ' ILE . 50.9 ttt85 -127.87 155.22 44.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.307 . . . . 0.0 110.542 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 138' ' ' LYS . 27.1 t70 -81.18 122.26 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.026 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 46.6 t -129.29 98.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.032 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 32.0 mttp -76.33 166.81 42.08 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' HG2' ' CD1' ' A' ' 136' ' ' TRP . 34.7 Cg_exo -60.0 -13.19 21.93 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.257 1.971 . . . . 0.0 112.161 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 t -106.75 3.19 26.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.027 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 3.5 m-20 -112.12 29.26 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.342 0.591 . . . . 0.0 110.395 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 109' ' ' GLU . 16.5 t -71.24 169.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.509 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER 48.42 23.35 0.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.596 1.159 . . . . 0.0 113.414 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.437 HG13 HD22 ' A' ' 111' ' ' LEU . 8.9 p -90.56 -21.83 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.959 0.409 . . . . 0.0 110.098 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD22 HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -84.51 107.94 17.02 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -93.54 174.32 7.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.229 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.09 109.02 20.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -168.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -103.22 140.87 36.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.588 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.3 148.12 26.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.859 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.51 49.23 2.4 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.537 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -105.65 -170.62 1.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.561 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.65 -169.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.61 100.04 8.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -119.95 126.62 51.31 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.748 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.44 105.0 17.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.4 m -75.19 90.8 2.58 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 31.2 mt -84.95 112.42 20.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.591 0.71 . . . . 0.0 110.05 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.0 mt -84.27 91.44 2.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.006 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.4 m -77.32 88.32 3.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.698 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.4 75.41 7.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.135 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.773 ' HA ' ' CD2' ' A' ' 62' ' ' HIS . 4.5 t0 -83.52 -15.36 49.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.213 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' CG ' ' HE ' ' A' ' 139' ' ' ARG . 19.2 p-10 -90.49 23.89 2.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.965 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -115.29 92.94 4.08 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.159 -0.617 . . . . 0.0 111.296 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 64' ' ' PHE . 20.7 t-20 -102.69 96.9 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -57.56 -40.03 78.02 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -170.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -64.36 -58.4 6.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.881 0.372 . . . . 0.0 111.179 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.4 p -84.8 -23.84 28.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.844 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.99 40.89 29.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.248 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.07 142.8 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.86 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CD1' ' HG2' ' A' ' 105' ' ' PRO . 48.0 p90 -126.9 151.84 47.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.792 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' H ' ' CB ' ' A' ' 128' ' ' ASP . 39.4 mt-10 -129.21 -92.55 0.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.906 0.384 . . . . 0.0 111.265 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 2.9 mtpm? -145.5 138.55 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.989 -173.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' A' ' 128' ' ' ASP . 95.6 mtt180 -103.34 108.21 19.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.516 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -76.97 103.53 6.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 101' ' ' ARG . 16.0 tt -70.26 122.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.593 0.711 . . . . 0.0 109.783 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.826 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -103.37 96.05 6.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.747 -174.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 68.8 t -106.5 104.11 16.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.743 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -97.68 123.96 41.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.276 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 m -95.78 139.9 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.566 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 40.5 tt0 -61.84 123.03 16.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.229 0.537 . . . . 0.0 111.257 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 148' ' ' LYS . 6.4 p -131.64 165.33 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.82 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.9 pptp? . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.05 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.468 ' C7 ' HH22 ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -78.09 -20.12 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.418 0.628 . . . . 0.0 110.536 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.15 148.85 18.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.384 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.82 135.94 37.22 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 33.1 Cg_endo -65.21 116.4 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.276 1.984 . . . . 0.0 111.785 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.31 -166.69 1.29 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.922 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.57 104.49 56.16 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.877 0.37 . . . . 0.0 110.592 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.04 -176.57 2.91 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.749 2.3 . . . . 0.0 111.852 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -100.52 4.31 43.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.781 0.324 . . . . 0.0 110.974 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -107.72 152.77 23.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.817 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 3.1 mptt -102.44 -8.23 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.714 -169.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.4 p -73.35 -19.87 60.91 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.193 0.52 . . . . 0.0 110.744 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -96.09 106.22 18.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.792 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.07 102.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 110.221 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.02 63.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.06 35.93 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.047 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.82 144.96 49.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.312 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.79 113.19 42.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.669 0.747 . . . . 0.0 109.395 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -125.16 113.96 18.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.348 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 25' ' ' ILE . 51.9 mt -122.65 101.34 40.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 12.0 Cg_endo -57.82 -32.22 94.37 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.042 2.495 . . . . 0.0 112.343 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -29.05 69.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.633 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.03 9.37 12.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.706 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.02 19.48 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.357 0.411 . . . . 0.0 111.605 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 20' ' ' ILE . 67.8 mt -84.45 134.86 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.27 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -158.67 61.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 27.5 mm-40 -123.8 153.78 67.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.616 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 158.36 43.61 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.802 2.335 . . . . 0.0 112.386 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.32 133.52 53.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 33.4 m-85 -93.48 109.46 40.76 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 38.9 Cg_endo -68.07 148.43 75.5 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.501 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.45 -174.76 21.37 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.34 143.48 13.9 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.45 2.1 . . . . 0.0 112.001 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -64.79 131.98 48.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -166.07 145.49 5.11 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.676 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -42.32 -46.71 7.49 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.918 3.079 . . . . 0.0 114.17 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mp0 -54.47 -37.9 65.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.471 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -72.3 -60.29 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.355 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.8 mm? -69.05 -7.14 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.675 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -68.93 -33.7 74.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.289 0.566 . . . . 0.0 109.792 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -111.44 -37.27 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.138 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -159.15 -169.31 22.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.232 -175.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.846 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 7.9 p -88.42 148.56 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.017 0.437 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.7 m -144.26 -179.51 6.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 63.9 m-85 -93.38 147.62 22.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.924 0.393 . . . . 0.0 110.719 176.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -98.36 -58.27 2.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.932 -174.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -88.76 -169.64 2.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 111.961 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 50.49 0.53 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.625 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.87 94.96 5.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.3 -3.93 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.1 0.952 . . . . 0.0 110.033 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -143.99 130.67 20.17 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.755 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.85 1.77 46.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.682 0.753 . . . . 0.0 109.391 171.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.43 1.23 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.946 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.5 t70 -94.64 -157.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.692 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 13.2 pt20 -106.42 -41.5 5.28 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.81 118.58 26.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.539 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.75 104.41 14.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.923 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.7 m -102.14 99.23 9.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.016 0.436 . . . . 0.0 110.736 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -99.59 143.28 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 -178.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -121.37 133.37 55.1 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.06 156.39 26.89 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.357 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -102.0 101.62 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.592 HG22 ' HB ' ' A' ' 125' ' ' THR . 6.7 t -87.61 98.29 11.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.024 0.916 . . . . 0.0 110.124 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 12.6 t80 -111.91 92.38 4.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.837 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -58.72 -27.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 27.2 m-20 -67.46 -4.78 12.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.079 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.8 mmt85 -135.09 105.76 10.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 14.1 Cg_exo -69.78 -12.12 32.22 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.696 2.264 . . . . 0.0 111.84 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -88.24 5.9 39.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.404 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.32 151.93 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 177.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 95.7 mt-30 -62.29 -33.96 75.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.264 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.846 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 97.3 m-85 -122.84 78.74 1.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.205 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 5.2 t -113.07 -29.38 7.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.345 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -98.75 21.74 11.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -172.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 75' ' ' LEU . 13.4 mt -71.18 -5.12 29.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -23.37 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.24 0.543 . . . . 0.0 109.711 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.52 0.43 42.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.309 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.68 114.06 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.299 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.5 -175.41 2.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 -178.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -61.4 -5.11 1.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.503 ' CA ' ' HE3' ' A' ' 96' ' ' LYS . . . -141.38 31.64 2.13 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.961 -1.114 . . . . 0.0 112.448 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.1 m -78.3 117.56 19.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 94' ' ' LYS . 25.1 tpp -68.53 119.85 13.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.02 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 97' ' ' MET . 73.0 t -110.63 122.79 65.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.28 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -101.89 117.13 34.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.185 0.517 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -104.8 123.58 47.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -110.25 132.52 54.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -137.66 116.67 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.516 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 69.28 -82.39 0.26 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -135.3 -16.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.662 0.268 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.46 156.66 16.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.079 0.466 . . . . 0.0 110.916 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -135.49 119.99 18.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.025 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 89.1 mtt180 -104.79 154.77 19.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.628 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.671 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -104.15 125.67 50.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.582 -178.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 91.3 m-85 -123.73 150.42 44.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.259 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HE3' ' CA ' ' A' ' 81' ' ' GLY . 11.5 tttp -119.79 144.46 47.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 84' ' ' VAL . 76.5 mmm -77.36 81.33 3.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 p -83.83 -16.36 44.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.388 -171.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 47.1 m -147.05 104.98 3.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.35 0.595 . . . . 0.0 111.538 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.48 111.75 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.888 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -127.2 148.68 50.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.195 0.521 . . . . 0.0 111.349 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.404 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 30.8 m-20 -109.42 134.87 51.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.62 176.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.471 HG11 HG23 ' A' ' 108' ' ' VAL . 58.6 t -122.91 126.17 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 104' ' ' LYS . 16.1 pttp -78.35 146.76 71.05 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 175.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.15 -20.54 67.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.327 2.685 . . . . 0.0 113.953 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -81.82 -29.92 32.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.831 0.348 . . . . 0.0 111.681 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.22 81.63 2.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 HG11 ' A' ' 103' ' ' VAL . 6.4 p -101.47 -8.62 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.713 0.768 . . . . 0.0 109.935 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.67 34.68 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.2 m -82.15 16.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.238 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.74 171.0 14.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.462 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.533 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 7.5 m-20 -84.12 152.85 24.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.86 97.76 1.46 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.454 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 19.8 mt-30 -135.18 95.29 3.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -109.96 116.97 32.58 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.22 31.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.807 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 118' ' ' ASP . 24.9 tptt -76.19 -161.67 0.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 3.4 t70 -71.86 -168.23 0.35 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.762 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 3.2 mppt? -76.55 85.09 3.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -136.97 135.37 37.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.825 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.74 107.1 18.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -93.04 94.36 8.83 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.5 mp -83.36 110.26 17.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.562 HD13 ' O3 ' ' A' ' 201' ' ' 2W7 . 50.2 mt -88.77 99.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.763 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 14.4 p -114.31 104.44 12.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.744 -175.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.1 m -70.76 123.16 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.5 -79.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 2.2 t70 -95.53 -176.89 3.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.748 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -147.41 138.74 23.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.134 0.493 . . . . 0.0 111.448 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.582 ' HB2' ' HA ' ' A' ' 136' ' ' TRP . 52.0 t-20 -144.17 117.45 9.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.346 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.52 -17.04 64.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 132' ' ' LYS . 8.5 tmtm? -61.32 -40.23 93.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.566 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.79 -40.23 1.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.62 -42.2 0.76 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.67 158.73 42.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 29.0 t-105 -85.26 -42.92 14.22 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.931 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.789 ' HG3' ' H ' ' A' ' 138' ' ' LYS . 8.3 pt-20 -139.15 -84.28 0.26 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.789 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 14.0 ptmm? -117.64 166.13 12.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.548 ' NH2' ' O2 ' ' A' ' 201' ' ' 2W7 . 4.9 mpt_? -107.46 156.88 18.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.304 172.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.452 ' HG2' ' HZ1' ' A' ' 138' ' ' LYS . 5.9 tmtp? -133.92 127.85 33.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.998 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.39 128.41 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 120.986 0.422 . . . . 0.0 110.492 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 76.0 m-85 -121.73 107.61 12.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.218 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 52.9 t -102.24 107.18 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.0 110.599 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -101.62 107.42 18.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.396 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.7 m -85.78 140.18 30.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.194 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.493 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 30.9 tt0 -64.63 120.64 12.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.435 ' HB ' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t -84.49 165.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.184 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.562 ' O3 ' HD13 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 34.4 tt0 -87.5 111.9 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 2' ' ' GLN . . . 73.16 151.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 123.966 0.792 . . . . 0.0 110.69 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -126.17 145.27 51.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.459 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.79 158.2 52.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.617 2.211 . . . . 0.0 111.521 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 mm-40 -116.09 168.47 10.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.753 0.311 . . . . 0.0 110.588 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 31' ' ' PRO . 87.2 mt -98.04 102.25 13.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 79.0 Cg_endo -93.2 -173.84 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.069 2.512 . . . . 0.0 113.504 -174.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -81.44 -17.85 47.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.565 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.1 137.88 53.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.615 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 32.9 mmtp -88.56 -33.34 17.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.604 -167.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -101.23 8.57 42.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.869 0.366 . . . . 0.0 111.627 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -86.06 90.25 8.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.615 0.245 . . . . 0.0 110.836 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.78 115.57 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.88 -28.26 15.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.195 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.17 155.39 25.07 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.344 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 131.56 55.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -102.81 130.47 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 50.3 mt-10 -136.79 109.56 7.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.274 0.559 . . . . 0.0 111.049 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 55.9 mt -118.93 95.41 49.25 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.67 -36.36 98.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.152 2.568 . . . . 0.0 113.064 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.58 -30.06 70.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -111.18 5.04 19.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.068 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 58.4 25.43 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.297 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 58.9 mt -85.1 99.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 40.1 ttmt -134.98 88.12 2.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 5.7 mm-40 -144.97 153.39 53.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.884 -170.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.0 153.99 52.64 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.194 2.596 . . . . 0.0 112.918 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -107.26 139.15 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -113.08 103.12 55.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' HG23 ' A' ' 7' ' ' ILE . 77.8 Cg_exo -51.88 161.72 2.15 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.825 3.017 . . . . 0.0 113.421 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.73 165.87 12.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.48 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 11' ' ' LYS . 34.4 Cg_endo -65.22 141.08 67.5 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.515 2.143 . . . . 0.0 111.761 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.2 101.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.169 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -139.09 155.76 72.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.9 Cg_endo -54.26 -35.24 82.68 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.902 2.401 . . . . 0.0 112.6 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.67 -45.82 77.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.235 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 11.1 mm100 -72.71 -47.14 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.553 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.0 mm? -68.1 -9.51 46.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.44 . . . . 0.0 111.003 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 24.3 t-20 -78.5 -32.27 48.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.823 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -93.74 -46.37 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.89 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -160.29 -156.45 8.18 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.818 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 71' ' ' GLN . 87.0 t -97.13 135.22 32.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.536 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 67.6 m -127.72 151.32 49.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.834 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 97.0 m-85 -71.38 147.07 48.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.08 0.467 . . . . 0.0 111.59 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.99 -28.38 29.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.85 99.26 9.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.558 173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -83.15 17.11 2.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.302 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.65 172.68 12.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.776 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -82.52 14.31 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.212 -173.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -102.37 101.7 11.97 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -110.83 4.95 20.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.521 0.677 . . . . 0.0 109.874 172.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.54 20.99 7.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.581 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -74.6 -170.05 0.97 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.6 pt20 -93.22 -29.09 15.88 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -111.02 143.5 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 15.1 mm -138.07 100.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -93.79 116.04 28.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.6 mt -122.36 138.3 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -91.16 118.28 30.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 125' ' ' THR . . . -105.16 114.58 4.66 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.494 -175.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' HB3' HD12 ' A' ' 39' ' ' LEU . 25.1 p80 -73.62 141.76 46.54 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 129' ' ' TYR . 15.1 t -74.08 175.34 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.518 ' HB3' HG22 ' A' ' 73' ' ' THR . 42.1 p90 -82.86 161.27 21.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.46 -80.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.007 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -115.54 -10.93 11.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.075 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -98.11 109.76 53.15 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.736 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 -13.82 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.086 2.524 . . . . 0.0 111.949 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -116.92 61.82 0.73 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 109.764 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.74 179.46 4.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.599 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.719 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 14.9 mp0 -53.83 -40.91 66.82 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.498 0.499 . . . . 0.0 112.129 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 75' ' ' LEU . 71.5 t80 -131.57 101.59 5.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.0 109.923 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 64' ' ' PHE . 15.4 p -141.75 -62.84 0.45 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.209 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 66.2 t30 -94.15 27.01 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -167.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 72' ' ' PHE . 16.6 tp -62.86 -18.55 63.07 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.615 -0.678 . . . . 0.0 111.404 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -64.12 -22.23 66.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.49 -16.01 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.412 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.88 169.41 18.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.594 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -137.42 168.08 20.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 111.494 -176.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -68.26 -11.33 59.19 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.08 -173.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -131.47 39.34 1.78 Allowed Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.002 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.4 p -85.24 -150.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.967 0.413 . . . . 0.0 110.106 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.485 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.5 tpt -139.3 105.36 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.782 0.325 . . . . 0.0 110.187 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.9 t -96.19 120.99 46.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.044 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 80.8 m-85 -101.04 129.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.406 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 33.6 t80 -123.41 106.15 10.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 49.4 mtmt -102.02 114.85 29.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.398 -175.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.91 101.99 13.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.571 0.7 . . . . 0.0 109.122 173.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.77 -89.29 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -12.5 4.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.136 0.493 . . . . 0.0 109.818 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 3.5 mm-40 -76.91 117.67 18.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.803 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.4 m -103.16 112.49 25.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.112 0.482 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -102.23 136.17 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 21.6 mtmm -104.34 140.06 38.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.468 . . . . 0.0 110.629 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 74.8 m-85 -132.69 148.56 52.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 13.3 tppt? -107.76 137.89 44.97 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.531 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 69.3 mtp -79.06 61.91 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.8 p -68.63 -41.21 79.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.211 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -116.37 101.37 8.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.333 0.587 . . . . 0.0 111.343 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 97' ' ' MET . 57.0 mt -119.75 114.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.025 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -134.63 140.22 45.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.382 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.54 108.38 16.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.254 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 -169.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -130.3 155.85 80.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.562 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.69 106.48 2.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.617 2.212 . . . . 0.0 114.096 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -119.58 -51.38 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -109.34 120.43 42.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.068 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -104.04 -26.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.278 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.49 19.84 14.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.309 0.576 . . . . 0.0 110.804 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.16 -0.24 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.651 0.738 . . . . 0.0 110.046 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.75 12.21 26.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.551 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.44 5.06 18.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.993 0.901 . . . . 0.0 110.825 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 11.9 pt-20 -108.08 94.07 4.87 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.419 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.83 121.74 42.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.045 0.45 . . . . 0.0 110.674 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -106.62 -0.94 23.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.018 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.9 -162.6 21.72 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.644 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -153.54 177.6 10.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.169 0.485 . . . . 0.0 110.908 176.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.57 -171.51 2.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.663 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 27.8 mttm -85.58 96.14 9.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.893 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 14.0 pt20 -162.84 139.81 7.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.447 -173.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.475 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 17.2 mt -88.84 130.88 35.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 171.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 m -104.73 87.53 2.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 59' ' ' ILE . 26.3 mt -85.8 96.99 9.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.146 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.93 95.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 61' ' ' GLY . 50.7 p -109.18 99.34 8.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.875 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 34.6 m -61.99 116.3 4.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.577 0.703 . . . . 0.0 110.833 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 35.3 t70 -91.75 161.31 14.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.944 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 4.8 t0 67.25 108.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.767 0.667 . . . . 0.0 111.018 175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.453 ' HB3' HG21 ' A' ' 63' ' ' THR . 30.2 p90 -130.89 157.54 42.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.571 -170.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.515 ' HB3' HG12 ' A' ' 135' ' ' VAL . 23.9 t30 -106.3 107.37 18.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -57.08 -25.59 58.99 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -72.88 -59.58 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.373 0.606 . . . . 0.0 110.522 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.3 p -88.21 -49.62 6.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.297 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.02 41.32 2.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.634 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 130' ' ' ASN . 11.6 p -82.7 147.8 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 4.1 m-90 -106.59 113.82 27.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.061 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 6.3 mm-40 -91.12 -26.34 19.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.139 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 27.7 mttp -128.02 -178.84 4.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.172 0.51 . . . . 0.0 109.994 174.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.9 ptt180 -154.87 100.59 2.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.8 171.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 116.07 26.35 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 tt -100.42 117.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 CA-C-O 122.128 0.966 . . . . 0.0 110.443 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.3 t80 -101.64 113.95 27.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.291 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 94.7 t -109.36 112.09 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -103.93 116.38 32.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -79.23 136.05 36.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.307 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.46 122.95 15.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.836 0.35 . . . . 0.0 110.467 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.39 153.57 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.753 0.787 . . . . 0.0 111.166 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.296 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.652 ' N4 ' ' O2 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 65.52 25.65 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 110.576 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.0 158.0 43.95 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 19.6 ptmt -64.77 135.17 96.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.051 0.453 . . . . 0.0 110.274 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' HD21 ' A' ' 52' ' ' LEU . 68.6 Cg_endo -79.44 120.69 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.495 2.13 . . . . 0.0 113.362 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -106.81 128.74 54.51 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 165.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 31' ' ' PRO . 69.6 mt -51.04 107.24 0.78 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -168.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD2' ' HZ2' ' A' ' 13' ' ' LYS . 9.7 Cg_endo -90.82 -170.01 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.627 2.884 . . . . 0.0 113.048 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -68.46 -41.6 79.98 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 4.1 m-20 -59.62 149.55 30.0 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.737 0.415 . . . . 0.0 111.782 -171.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.849 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 90.9 mttt -95.05 -40.7 9.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.758 0.313 . . . . 0.0 110.735 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -73.15 -5.58 40.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.778 ' HE2' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -80.87 132.38 35.45 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.45 126.73 50.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.294 0.568 . . . . 0.0 110.592 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -106.75 -23.68 12.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.704 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.84 148.19 19.83 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.903 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.4 121.8 45.97 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.82 116.42 33.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.517 0.675 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.9 mt-10 -127.64 109.54 11.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.104 -173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.24 101.22 44.5 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.066 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 83' ' ' MET . 31.1 Cg_endo -63.12 -22.86 73.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 123.184 2.589 . . . . 0.0 112.964 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 82' ' ' SER . 9.3 m-20 -69.82 -29.78 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.78 13.37 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.26 23.13 11.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.497 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 69.6 mt -83.56 113.11 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.239 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -144.36 77.65 1.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -134.0 154.3 80.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.938 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.66 139.54 34.15 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.083 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.622 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.5 t -94.58 136.71 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.576 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 11' ' ' LYS . 44.9 m-85 -108.65 92.53 10.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.998 0.428 . . . . 0.0 110.549 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.778 ' HD2' ' HE2' ' A' ' 13' ' ' LYS . 7.4 Cg_exo -73.78 102.39 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.308 2.672 . . . . 0.0 112.616 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.74 -179.72 42.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.539 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.849 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 18.3 Cg_endo -62.07 99.62 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.293 1.995 . . . . 0.0 111.091 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.58 124.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.208 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.407 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 77.6 p -127.03 159.5 64.46 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.13 -37.72 58.83 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.916 2.411 . . . . 0.0 112.902 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -66.05 -41.02 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' OE1' ' HD3' ' A' ' 11' ' ' LYS . 14.7 pt20 -83.18 -21.56 33.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.271 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 93.3 mt -87.38 11.19 15.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.519 0.676 . . . . 0.0 110.095 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -13.94 13.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.845 177.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -121.69 -16.9 7.59 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.549 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -147.12 5.68 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG11 ' HE2' ' A' ' 72' ' ' PHE . 99.6 t -125.87 140.31 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.052 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -134.75 161.56 34.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 27.8 m-85 -72.6 160.43 32.27 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.274 175.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.31 68.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.5 170.61 7.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.041 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.17 -35.64 59.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 69.41 160.31 0.19 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.529 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.32 -3.77 1.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.322 0.582 . . . . 0.0 110.991 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -143.84 99.9 3.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -78.69 -6.22 55.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.838 0.828 . . . . 0.0 109.749 175.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.1 10.94 37.94 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.196 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -86.02 154.07 21.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 119' ' ' LYS . 3.5 pm0 -83.58 -19.83 34.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.17 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.33 93.43 4.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 110.398 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 19.9 mm -116.26 129.92 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 118.84 28.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 45' ' ' PHE . 2.0 mt -107.65 129.71 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.2 115.11 29.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.935 0.397 . . . . 0.0 110.973 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -111.17 86.69 0.44 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.202 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 85.4 t60 -87.79 128.3 35.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.065 0.46 . . . . 0.0 110.129 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 127' ' ' ASP . 87.7 m -146.39 133.77 20.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -146.74 17.55 1.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.368 0.604 . . . . 0.0 110.008 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.5 HG13 ' HG3' ' A' ' 67' ' ' ARG . 10.7 tp -88.73 -13.29 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.663 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.94 37.86 27.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.299 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' A' ' 65' ' ' ILE . 99.5 mtt180 -105.86 118.04 56.22 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.644 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.94 0.85 5.17 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.958 2.439 . . . . 0.0 113.439 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -115.17 24.98 11.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.026 0.441 . . . . 0.0 110.775 176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 179.83 6.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -62.18 -73.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.401 ' HE2' HG11 ' A' ' 43' ' ' VAL . 12.9 m-85 -91.13 14.76 13.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 m -80.61 -34.15 35.3 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.205 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.69 3.39 33.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.1 -8.78 18.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -62.95 -23.72 67.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.558 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.74 6.94 28.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.284 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.18 144.41 25.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 110.848 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.32 177.63 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.72 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -72.72 -15.03 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.643 0.735 . . . . 0.0 110.477 179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -130.14 57.24 0.73 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.497 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 13.1 m -86.18 -160.9 0.58 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.427 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 6.8 tpt -135.56 103.46 5.46 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.075 0.464 . . . . 0.0 109.975 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 97' ' ' MET . 96.7 t -97.55 125.12 50.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.476 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.4 m-85 -108.45 123.4 48.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.466 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -110.0 104.32 13.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 24.3 ttpp -99.96 105.51 17.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.721 0.772 . . . . 0.0 111.159 -173.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 91' ' ' GLU . 2.4 p -93.56 104.63 15.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.704 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.4 -103.05 0.74 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -113.68 -9.83 13.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 110.596 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HB2' HG13 ' A' ' 88' ' ' VAL . 37.9 mt-10 -79.94 131.39 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -108.32 117.22 33.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -175.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -99.65 145.02 28.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -110.82 129.29 55.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.383 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 82.3 m-85 -132.91 151.94 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.822 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -117.42 137.15 52.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 84' ' ' VAL . 90.1 mmm -78.02 43.35 0.43 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.166 0.508 . . . . 0.0 110.906 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -89.1 23.59 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.357 0.599 . . . . 0.0 112.023 -170.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 54.8 m -143.84 51.4 1.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.498 0.666 . . . . 0.0 110.274 174.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.1 mt -91.63 118.19 36.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.641 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.65 148.25 31.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.619 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -104.81 135.19 46.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.314 0.578 . . . . 0.0 111.017 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.94 147.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.215 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -138.9 86.6 15.15 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.48 0.657 . . . . 0.0 111.127 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -96.2 -158.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.352 2.701 . . . . 0.0 111.291 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -172.38 20.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.68 0.753 . . . . 0.0 110.243 171.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -145.08 154.3 42.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.97 170.29 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.663 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 64.61 -0.77 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.1 0.96 . . . . 0.0 112.823 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.6 -19.63 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 0.0 110.115 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.8 142.28 31.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.18 145.24 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.296 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.76 137.51 33.7 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -106.68 145.74 31.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.374 0.607 . . . . 0.0 111.84 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.7 mptt -104.09 150.54 24.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.088 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.99 50.39 1.48 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -94.06 176.13 6.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 0.0 111.546 -176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -117.46 -174.68 2.66 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 169.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 3.5 mppt? -74.39 100.25 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -141.23 132.84 27.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.018 0.437 . . . . 0.0 111.138 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 11.9 mt -99.26 115.23 28.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.61 HG23 HG22 ' A' ' 143' ' ' VAL . 14.3 m -97.19 96.67 8.58 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.321 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.47 104.1 14.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.8 mt -90.24 99.93 10.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.781 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 21.4 p -91.65 141.2 28.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.974 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 31.1 p -151.03 130.66 13.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.9 m-20 -97.11 -54.64 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 109.441 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.28 91.07 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.966 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 62.1 t80 -160.3 116.33 2.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.163 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -110.41 123.11 49.27 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.48 -24.38 62.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.258 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -58.94 -68.3 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.872 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.38 -17.54 19.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.481 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.8 82.58 0.71 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.177 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 14.4 p -131.54 146.35 33.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.714 0.292 . . . . 0.0 110.45 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -152.57 140.9 20.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.348 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -119.77 -70.0 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.714 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.583 ' O ' ' HD2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -165.26 153.64 11.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -170.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -172.47 139.93 1.03 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.447 ' HD3' ' CG2' ' A' ' 100' ' ' ILE . 5.4 tmmm? -78.86 128.62 33.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.96 140.02 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.025 0.441 . . . . 0.0 111.37 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.43 108.44 18.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.424 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 122' ' ' THR . 41.1 t -110.13 121.45 63.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.347 . . . . 0.0 110.43 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -112.12 118.59 35.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.703 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.8 m -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -62.66 124.49 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.58 154.68 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 41.8 pttt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.683 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.54 ' C11' ' N4 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.469 0.176 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -74.63 -177.48 3.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.647 0.737 . . . . 0.0 112.858 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.85 -179.28 4.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.047 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -92.58 146.27 32.03 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.203 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.37 125.44 10.74 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.447 2.098 . . . . 0.0 112.472 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.8 tp60 -150.7 165.79 32.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.04 104.29 35.23 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 110.434 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 10.9 Cg_endo -89.48 -179.82 2.05 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.177 2.585 . . . . 0.0 111.607 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -90.47 -6.15 55.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.839 0.352 . . . . 0.0 110.569 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.4 t0 -81.74 125.32 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.297 0.57 . . . . 0.0 109.917 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 13.8 mttp -92.7 1.64 57.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.321 -173.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.73 -16.16 28.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.064 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 32.2 mmmt -88.39 172.85 9.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.39 108.0 23.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.517 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.44 -31.61 22.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.141 0.496 . . . . 0.0 110.77 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.59 165.56 29.15 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.732 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -129.88 132.65 46.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -107.57 124.04 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.148 0.499 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 33.8 mt-10 -129.54 116.13 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.443 0.64 . . . . 0.0 111.637 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 63.5 mt -127.44 100.58 25.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.41 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.25 -38.38 95.15 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.156 2.571 . . . . 0.0 112.903 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.998 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -123.67 13.75 9.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.316 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 54.95 28.61 10.85 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 74.5 mt -89.9 116.07 30.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 27.8 mtpp -144.48 59.19 1.33 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.931 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 42.6 mm-40 -122.62 156.06 61.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.19 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.54 162.23 40.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.044 2.496 . . . . 0.0 113.166 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.68 134.11 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.2 m-85 -91.67 116.15 65.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.024 0.44 . . . . 0.0 111.095 -174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 36.9 Cg_endo -67.25 148.55 80.49 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.379 . . . . 0.0 112.043 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.93 172.91 13.18 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.348 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.29 166.84 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.909 2.406 . . . . 0.0 111.836 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -68.15 111.16 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.268 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 p -128.4 139.83 36.64 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.405 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.26 -47.54 19.47 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.592 2.861 . . . . 0.0 113.253 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.47 -42.23 92.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 111.03 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 43.1 tt0 -74.86 -36.97 62.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 34' ' ' ALA . 90.8 mt -79.75 -11.16 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.606 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -98.68 -21.28 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.0 110.114 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.95 -33.5 18.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.07 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -161.28 -145.19 4.23 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.415 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.821 HG22 HG22 ' A' ' 59' ' ' ILE . 11.6 p -115.13 138.95 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 58.5 m -150.03 158.2 43.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' SER . 96.3 m-85 -66.52 158.82 28.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.718 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -98.96 -46.27 5.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.561 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -96.68 144.21 26.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.638 0.733 . . . . 0.0 111.908 -174.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.6 -2.4 55.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.325 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -117.99 18.6 13.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.707 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 15.4 pt-20 -105.84 138.82 41.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.2 m -117.26 150.32 38.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.646 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 pp -73.92 -8.14 54.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.359 0.6 . . . . 0.0 110.419 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.74 2.59 21.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.416 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 5.9 t70 -92.09 -159.23 0.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -99.81 -36.23 9.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -95.43 132.43 40.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.111 0.482 . . . . 0.0 110.941 -175.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG21 HD22 ' A' ' 121' ' ' LEU . 28.0 mm -129.71 120.9 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.504 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 32.7 t -127.68 106.28 9.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.921 0.391 . . . . 0.0 110.334 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.821 HG22 HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -122.07 119.02 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.07 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.12 42.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.908 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.17 98.15 0.2 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 126' ' ' CYS . 10.4 p80 -116.19 159.79 21.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.322 0.561 . . . . 0.0 112.32 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 67' ' ' ARG . 12.9 t 176.7 -176.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -145.71 2.79 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.393 0.615 . . . . 0.0 109.934 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 67' ' ' ARG . 12.2 mm -91.32 47.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.139 0.495 . . . . 0.0 111.76 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.8 -29.9 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.168 0.987 . . . . 0.0 113.061 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.629 ' HD2' ' OD1' ' A' ' 127' ' ' ASP . 6.6 mtp85 60.56 67.55 1.54 Allowed Pre-proline 0 N--CA 1.465 0.305 0 C-N-CA 124.26 1.024 . . . . 0.0 111.903 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 10.6 Cg_endo -103.52 -12.97 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.005 2.47 . . . . 0.0 112.718 170.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -133.85 25.96 3.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.947 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 73' ' ' THR . 9.3 m-85 -100.33 172.9 6.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.775 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.2 pm0 -72.89 -22.1 60.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.797 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' CD2' ' HG2' ' A' ' 71' ' ' GLN . 69.3 m-85 -125.35 92.92 3.72 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 173.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 70' ' ' TYR . 34.2 p -107.33 -67.28 0.96 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.018 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.618 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.7 t30 -86.89 25.47 1.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.534 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -66.24 -2.45 4.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.624 0.726 . . . . 0.0 110.528 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 20.4 pttp -80.02 -30.22 39.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.172 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.55 -15.25 38.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.843 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -66.52 135.31 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.997 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -95.7 -175.87 3.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.006 0.431 . . . . 0.0 110.884 -176.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -80.97 -4.02 53.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . -123.07 28.56 5.58 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.89 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 3.8 m -85.85 131.91 34.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.311 0.577 . . . . 0.0 109.859 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 109.51 10.11 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.669 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.833 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 84.4 t -96.43 116.01 37.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.653 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -98.77 126.38 44.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.458 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -122.02 110.81 16.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.661 ' HG2' ' HB ' ' A' ' 92' ' ' THR . 46.4 mtmt -101.51 142.89 32.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.246 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.21 89.1 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.765 0.793 . . . . 0.0 109.171 169.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.06 -54.58 4.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.505 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.4 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.0 110.22 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.49 130.57 39.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.518 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.661 ' HB ' ' HG2' ' A' ' 87' ' ' LYS . 2.8 t -121.18 149.59 42.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.558 0.694 . . . . 0.0 111.864 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 146' ' ' GLU . 30.7 mmm180 -115.46 141.34 48.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.27 129.58 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 110.387 -177.295 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' A' ' 121' ' ' LEU . 54.7 m-85 -127.2 147.86 50.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 37.4 ttmt -111.35 149.35 31.28 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.774 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.608 ' HB3' HD11 ' A' ' 100' ' ' ILE . 49.7 mtp -79.77 64.16 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 0.0 110.296 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.3 p -73.45 -34.45 65.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.828 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 8.4 m -115.41 95.36 5.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.187 0.517 . . . . 0.0 110.818 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 63.2 mt -120.45 119.73 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -151.44 151.26 31.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.807 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -108.24 129.01 55.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.82 HG22 ' HD3' ' A' ' 105' ' ' PRO . 7.5 p -121.06 126.68 75.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.771 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 77.2 52.34 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 111.768 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.82 ' HD3' HG22 ' A' ' 103' ' ' VAL . 97.0 Cg_endo -97.34 170.99 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.268 2.646 . . . . 0.0 111.346 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -66.15 -51.46 57.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -133.54 121.41 22.08 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -61.26 150.87 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -65.71 -24.7 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 0.0 110.694 -175.145 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.601 ' H ' HG13 ' A' ' 108' ' ' VAL . 9.8 p 48.79 21.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.771 1.228 . . . . 0.0 113.588 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -82.66 176.46 9.34 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.933 -0.479 . . . . 0.0 110.171 174.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.83 152.23 42.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.965 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -94.08 137.01 33.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.64 168.23 9.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 110.388 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -73.38 161.84 30.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.4 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.4 36.52 0.64 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -131.98 -167.44 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -124.81 -168.14 1.77 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -68.22 104.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -130.22 136.98 49.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 57' ' ' ILE . 26.5 mt -92.11 100.26 12.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.1 m -78.53 88.88 4.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD12 ' CE2' ' A' ' 142' ' ' PHE . 39.4 mt -95.37 99.89 11.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.518 0.675 . . . . 0.0 110.262 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -99.56 97.38 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.053 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -92.71 91.76 7.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.917 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' HIS . 2.9 m -73.62 100.55 3.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 67' ' ' ARG . 28.8 t70 -115.52 47.13 1.37 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.937 0.875 . . . . 0.0 108.769 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.825 ' HB2' ' H ' ' A' ' 137' ' ' GLU . 4.5 p-10 -141.65 -1.47 1.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.933 -170.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.59 109.93 22.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.399 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.494 ' HB3' HG12 ' A' ' 135' ' ' VAL . 14.4 t30 -116.71 113.48 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -72.64 -34.93 67.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HE3' HG23 ' A' ' 133' ' ' THR . 0.1 OUTLIER -57.46 -50.75 72.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.318 0.58 . . . . 0.0 110.501 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.435 HG23 ' HE3' ' A' ' 132' ' ' LYS . 25.5 p -92.02 -22.29 20.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.399 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.63 41.23 29.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.611 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 130' ' ' ASN . 13.7 p -105.3 143.53 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.404 . . . . 0.0 110.93 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.496 ' HB3' ' NH2' ' A' ' 139' ' ' ARG . 2.6 m-90 -128.38 116.24 19.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.999 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.825 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 82.2 mt-10 -104.63 -95.31 0.33 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 137' ' ' GLU . 26.5 mttp -130.18 112.72 13.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.574 -169.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.74 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -104.47 129.97 52.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.343 0.592 . . . . 0.0 110.118 175.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HE3' HG23 ' A' ' 100' ' ' ILE . 1.8 tmtp? -95.46 126.64 40.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.524 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.63 131.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.054 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.833 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 4.3 t80 -132.14 110.75 10.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.143 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.1 t -114.89 105.95 19.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.922 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -92.58 125.38 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.249 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.4 m -97.27 140.83 31.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 42.0 tt0 -58.31 121.66 11.34 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.69 0.619 . . . . 0.0 111.009 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.7 p -124.03 162.9 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.832 0.825 . . . . 0.0 111.654 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.842 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.504 0.192 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -149.24 178.95 8.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.491 0.662 . . . . 0.0 111.434 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.84 -177.94 3.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.657 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -76.8 113.1 26.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.562 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.7 Cg_endo -73.8 136.89 23.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.234 1.956 . . . . 0.0 111.629 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 35.2 mm-40 -85.17 -167.72 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.3 mp -81.02 101.53 0.99 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 98.6 Cg_endo -94.32 -166.5 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.05 2.5 . . . . 0.0 113.081 -169.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -75.02 -23.41 58.19 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.554 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 29.4 m-20 -79.17 83.79 5.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.818 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 2.3 pptp? -85.48 -3.27 58.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.359 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.9 m -101.13 3.47 41.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 0.0 111.166 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.1 mmtp -90.6 173.82 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.071 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.17 95.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.802 0.334 . . . . 0.0 110.456 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -82.58 -27.87 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.343 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.29 31.01 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.95 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -135.36 132.94 38.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -103.31 125.57 57.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.3 mt-10 -135.57 104.49 5.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.46 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -116.51 100.23 53.31 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 83' ' ' MET . 17.8 Cg_endo -59.85 -30.74 92.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.034 2.489 . . . . 0.0 112.478 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.03 -12.76 61.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.696 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 4.36 3.8 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.551 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.48 27.94 17.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.163 0.506 . . . . 0.0 111.195 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 80.2 mt -88.0 107.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.122 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -139.27 86.38 2.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.276 . . . . 0.0 110.426 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' A' ' 71' ' ' GLN . 53.6 mt-10 -135.54 153.29 77.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.599 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.88 150.37 78.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.6 2.2 . . . . 0.0 112.152 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.09 129.46 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 47.2 m-85 -95.17 107.67 33.64 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.97 -177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 7' ' ' ILE . 11.3 Cg_endo -54.95 154.01 23.33 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.3 2.666 . . . . 0.0 112.194 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.31 -161.04 18.86 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.767 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.424 ' O ' HG22 ' A' ' 35' ' ' THR . 57.4 Cg_endo -93.09 157.86 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.163 2.575 . . . . 0.0 112.435 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 111.34 10.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.251 0.548 . . . . 0.0 110.162 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 33' ' ' PRO . 1.4 t -149.89 143.29 16.54 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.082 -175.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 -23.12 33.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.133 2.555 . . . . 0.0 112.503 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.14 -50.87 66.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 1.3 tt0 -88.56 -29.54 19.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.838 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.13 1.32 13.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 110.63 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.44 -18.54 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -99.03 -65.16 0.98 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.583 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.59 -148.88 4.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.386 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.57 140.98 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.672 0.272 . . . . 0.0 110.395 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 15.9 m -131.06 -170.55 2.38 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 56.9 m-85 -99.12 173.41 6.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.27 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.513 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 14.3 mm-40 -97.3 -174.48 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -134.84 27.81 3.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.765 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.6 -3.08 6.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.053 0.454 . . . . 0.0 111.009 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 15.1 mp0 -90.41 159.74 16.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.321 0.581 . . . . 0.0 111.717 -173.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 6' ' ' GLN . 45.2 m -107.22 147.79 29.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.224 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.562 HD21 ' O ' ' A' ' 5' ' ' PRO . 3.0 pp -85.62 2.59 44.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.384 0.611 . . . . 0.0 110.282 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.33 4.87 50.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.6 164.91 12.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -94.73 -9.47 34.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.719 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -106.7 90.79 3.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.165 0.507 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 4.2 mt -109.59 133.86 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.387 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -123.26 116.79 23.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 5.7 mt -108.74 133.23 54.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.69 123.9 46.04 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.899 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -112.66 -171.79 18.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.375 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -139.43 148.52 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.574 0.226 . . . . 0.0 110.728 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.589 ' H ' ' HE2' ' A' ' 129' ' ' TYR . 10.1 t -162.07 143.87 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.55 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.73 -158.81 0.66 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.67 -66.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.63 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.26 84.16 5.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.396 0.617 . . . . 0.0 110.316 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -161.29 105.14 1.23 Allowed Pre-proline 0 C--O 1.213 -0.863 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.381 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.584 ' HA ' HG21 ' A' ' 73' ' ' THR . 71.7 Cg_endo -100.47 -0.82 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.911 2.407 . . . . 0.0 111.908 169.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -118.71 11.99 12.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.928 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -82.94 160.29 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.676 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 3.7 pt20 -52.63 -41.67 63.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.386 0.429 . . . . 0.0 111.038 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.899 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 23.4 m-85 -113.66 90.12 3.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.104 0.478 . . . . 0.0 111.062 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 68' ' ' PRO . 6.6 m -150.55 -40.28 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.709 171.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.77 13.82 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.055 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 72' ' ' PHE . 16.7 mt -67.63 -10.96 56.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.127 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -75.41 -23.18 56.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.14 -13.4 50.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.168 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.82 20.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.676 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -132.42 176.39 8.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.184 0.516 . . . . 0.0 111.089 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 -1.98 54.65 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.828 0.823 . . . . 0.0 109.162 172.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -147.39 38.79 1.07 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.506 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -86.03 -169.89 2.85 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.558 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -115.04 109.29 17.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -177.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 82.0 t -103.34 121.33 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.034 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 67.3 m-85 -101.71 128.55 47.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.813 0.339 . . . . 0.0 110.622 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -116.87 111.39 19.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -100.18 135.71 41.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.838 -176.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 3.2 p -159.09 112.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.68 -101.82 0.44 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.865 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -112.99 1.47 15.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.947 0.403 . . . . 0.0 110.492 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 16.0 mm-40 -97.44 134.85 40.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.417 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 m -134.16 93.97 3.17 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 22.9 mmt85 -99.27 141.91 31.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 83' ' ' MET . 25.1 mtmm -102.78 132.16 49.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 86.6 m-85 -119.84 145.29 46.78 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.965 0.412 . . . . 0.0 111.06 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.498 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 17.7 tttt -102.04 133.42 46.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.995 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.3 mtp -86.59 53.37 2.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.503 0.668 . . . . 0.0 109.531 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.67 -14.95 59.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.266 -172.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.7 m -124.18 88.31 2.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.582 176.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.0 mt -107.69 108.75 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.973 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -134.09 150.0 51.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.174 0.511 . . . . 0.0 110.554 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.461 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 1.9 p-10 -116.27 144.44 44.22 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.5 134.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.574 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.6 mptt -79.78 130.65 66.55 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 9.3 Cg_exo -73.39 41.42 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.636 2.891 . . . . 0.0 113.034 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -71.42 -34.23 70.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.337 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -161.68 151.8 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.779 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.56 -22.02 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.923 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.92 -5.51 56.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.182 0.515 . . . . 0.0 110.628 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.98 -25.21 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.095 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 pp -105.56 153.12 22.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.104 0.478 . . . . 0.0 111.956 -172.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.31 160.07 42.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.72 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.52 -179.93 5.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -116.36 161.83 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.327 0.584 . . . . 0.0 112.077 -172.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -90.26 132.3 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.714 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.39 64.38 0.35 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.552 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -89.86 165.98 13.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.712 0.768 . . . . 0.0 111.863 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -108.89 -168.18 1.31 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.4 mppt? -74.52 102.88 4.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -137.92 142.51 40.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 14.8 mt -106.38 116.62 32.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m -96.48 94.12 7.2 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.701 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -82.13 107.32 14.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.752 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.73 81.71 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 24.5 m -91.87 96.67 10.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.606 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 95.4 m -71.45 90.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.647 ' OD2' ' HE2' ' A' ' 138' ' ' LYS . 25.9 t0 -80.14 9.32 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.048 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 15.9 t70 -164.81 106.8 0.84 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.574 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.589 ' HE2' ' H ' ' A' ' 63' ' ' THR . 32.1 p90 -146.11 137.11 24.48 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -97.97 115.13 27.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.38 -14.8 62.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.8 -174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -76.1 -67.78 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.216 0.531 . . . . 0.0 110.461 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -19.28 23.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.912 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.01 38.08 14.27 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.263 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.74 149.09 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.625 0.25 . . . . 0.0 110.334 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -140.87 123.34 15.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.598 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.32 -58.94 2.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.647 ' HE2' ' OD2' ' A' ' 127' ' ' ASP . 24.2 pttm -116.06 123.98 49.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 111.579 -174.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 37.8 ttm-85 -110.88 103.5 12.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.918 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -97.08 101.93 13.6 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 110.332 -177.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.26 130.13 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.626 0.727 . . . . 0.0 111.514 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 97.9 m-85 -106.16 119.55 39.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.117 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.8 t -105.4 102.33 13.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.17 120.91 43.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.735 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.6 m -92.32 140.26 29.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.59 116.66 6.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.902 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.57 157.33 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.807 0.813 . . . . 0.0 110.569 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.488 -172.257 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.683 ' HG3' ' H ' ' A' ' 2' ' ' GLN . 19.5 ptt? . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.44 0.162 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.683 ' H ' ' HG3' ' A' ' 1' ' ' MET . 43.0 mt-30 -142.62 -155.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.92 157.39 7.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.251 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HE3' ' OE1' ' A' ' 6' ' ' GLN . 62.9 pttt -72.34 146.33 89.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -55.23 117.64 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.984 2.456 . . . . 0.0 111.967 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.515 ' OE1' ' HE3' ' A' ' 4' ' ' LYS . 6.7 tp60 -141.29 169.79 16.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.934 HD11 ' HB3' ' A' ' 52' ' ' LEU . 16.0 mm -97.82 110.83 57.11 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 6.7 Cg_exo -73.78 173.32 14.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.62 2.213 . . . . 0.0 111.4 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -108.39 22.39 16.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.652 0.739 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.85 145.38 47.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.215 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.764 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 1.5 mptt -88.04 -14.23 39.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.655 0.264 . . . . 0.0 111.3 -171.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.0 t -89.16 -17.86 28.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.468 0.651 . . . . 0.0 109.712 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -80.08 86.34 5.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.55 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.43 104.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.743 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 -27.68 25.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -157.61 177.17 34.52 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.175 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 132.58 39.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.54 122.9 55.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.039 0.447 . . . . 0.0 109.862 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mt-10 -135.16 120.27 18.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.437 0.637 . . . . 0.0 111.751 -177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 74.1 mt -124.97 103.23 30.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.305 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.17 -22.72 72.97 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.164 2.576 . . . . 0.0 112.854 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.67 -31.38 72.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.041 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.26 3.96 10.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.928 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 63.33 24.65 14.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.606 0.717 . . . . 0.0 110.464 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.2 mt -75.97 112.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.97 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 61.0 mtpt -145.64 95.09 2.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.744 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 71' ' ' GLN . 11.9 pt-20 -152.13 155.69 33.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.25 154.41 74.23 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.485 2.123 . . . . 0.0 112.369 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 62.6 t -97.56 129.64 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -93.21 107.24 24.05 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.992 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 24.2 Cg_exo -64.95 144.69 83.61 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.01 2.474 . . . . 0.0 112.118 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.48 179.56 17.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.697 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.26 145.61 19.17 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.67 99.98 0.17 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -129.05 144.46 52.75 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.297 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.51 -41.05 76.41 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.143 2.562 . . . . 0.0 113.029 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.04 -43.39 87.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.717 0.294 . . . . 0.0 111.173 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.07 -40.25 65.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.81 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.46 -15.84 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.874 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.27 -9.84 58.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.246 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -104.54 -21.51 13.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 -167.19 40.16 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.542 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 59' ' ' ILE . 14.8 p -86.93 137.45 20.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.119 0.485 . . . . 0.0 110.242 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 m -139.28 171.67 13.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -82.1 171.13 14.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.396 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -123.67 -33.88 3.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.727 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 pm0 -81.02 -177.44 6.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.791 -169.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.88 -18.27 16.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.65 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -90.2 134.97 33.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.695 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.07 28.89 0.87 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.054 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.6 m -105.51 160.59 15.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.593 . . . . 0.0 111.078 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.5 pp -123.58 -1.97 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.425 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -149.16 54.46 0.97 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.408 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.79 -61.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.8 mt-30 178.82 -65.27 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 122.764 0.426 . . . . 0.0 110.688 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 97.17 7.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.546 0.689 . . . . 0.0 112.1 -172.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.44 140.5 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.704 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -127.91 96.59 4.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.091 0.472 . . . . 0.0 110.229 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 43' ' ' VAL . 1.1 mt -93.13 118.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 136.34 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.725 0.298 . . . . 0.0 111.541 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.74 134.38 7.54 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -136.46 19.83 3.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.408 0.604 . . . . 0.0 111.489 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -88.07 15.94 6.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.539 0.685 . . . . 0.0 111.132 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.628 ' HD1' HG22 ' A' ' 73' ' ' THR . 88.1 t80 -93.22 94.22 8.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.565 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 66' ' ' ASP . 7.6 tp -164.66 -51.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' N ' HG23 ' A' ' 65' ' ' ILE . 20.1 t70 -96.0 -28.12 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.226 -175.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.8 mmt180 -111.3 122.6 37.22 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.675 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -87.18 0.22 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.432 2.755 . . . . 0.0 111.425 171.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -124.94 50.8 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.71 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.717 ' HD2' ' HG2' ' A' ' 71' ' ' GLN . 2.0 t80 -132.17 -169.12 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.266 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.76 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 2.8 pt20 -33.06 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.76 ' H ' ' HG3' ' A' ' 71' ' ' GLN . 55.3 m-85 -96.15 29.8 2.68 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.95 -0.469 . . . . 0.0 111.7 -169.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.628 HG22 ' HD1' ' A' ' 64' ' ' PHE . 73.4 p -78.08 -41.13 36.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.233 0.539 . . . . 0.0 110.876 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.66 12.69 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.034 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 72' ' ' PHE . 24.0 tp -63.13 -15.31 56.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.007 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -62.92 -23.29 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.297 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.99 -10.09 59.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.417 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.8 133.87 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.25 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.04 -176.55 3.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.074 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -70.61 -0.75 9.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.847 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.66 62.66 0.54 Allowed Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 p -96.78 -159.1 0.71 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 tpt -139.35 89.94 2.38 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.1 t -77.23 117.19 21.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.004 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -98.1 109.35 22.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.293 0.568 . . . . 0.0 110.594 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 33.9 t80 -99.55 99.1 9.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 42.2 mtpt -94.93 140.49 29.87 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.452 -177.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 91' ' ' GLU . 2.9 m -143.83 108.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.857 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.89 -98.18 0.54 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.35 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -124.56 6.86 8.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 88' ' ' VAL . 14.4 mm-40 -85.04 142.95 29.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -126.1 112.71 16.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.101 0.477 . . . . 0.0 110.026 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 7.9 mmm180 -106.92 120.78 42.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -96.71 133.72 40.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.512 ' CD2' HD21 ' A' ' 121' ' ' LEU . 94.0 m-85 -130.52 146.21 52.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.187 0.518 . . . . 0.0 111.474 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 14.8 tptm -108.24 127.85 54.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.188 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.468 ' HB3' HD11 ' A' ' 100' ' ' ILE . 65.9 mtp -78.4 70.41 4.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.91 -175.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.3 p -67.92 -42.14 81.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.536 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.7 m -114.15 105.89 13.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.3 mt -126.83 95.05 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.623 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -145.49 152.31 39.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.868 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.824 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 9.3 p-10 -104.06 137.71 41.63 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.083 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.73 139.26 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.27 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 137' ' ' GLU . 82.7 tttt -112.49 90.67 15.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.896 0.379 . . . . 0.0 110.334 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 110' ' ' VAL . 97.3 Cg_endo -88.84 -31.85 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.2 m 72.57 -46.73 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.416 0.687 . . . . 0.0 112.16 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.36 162.89 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 110.24 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.4 -34.39 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.416 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.56 80.8 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.447 0.641 . . . . 0.0 111.444 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 105' ' ' PRO . 27.7 m -111.48 -6.2 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.972 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.733 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -146.36 170.1 17.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.654 0.264 . . . . 0.0 110.367 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.75 92.17 5.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.283 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.73 133.99 44.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.958 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mttp 52.3 -172.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.712 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.1 130.92 24.86 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -90.33 -178.65 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.76 -174.55 2.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 146' ' ' GLU . 17.4 mtpp -93.71 95.56 9.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.005 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -145.87 162.51 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.435 -172.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -112.66 120.69 42.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 171.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.5 m -83.16 89.72 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 92.2 mt -76.05 104.44 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.355 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.19 100.17 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.545 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.1 p -109.8 103.79 12.66 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.095 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.7 m -70.22 92.6 0.78 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -134.59 99.41 4.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.4 OUTLIER 175.61 93.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.593 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 52.9 p90 -74.18 137.97 43.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.724 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 132' ' ' LYS . 25.5 p-10 -81.0 12.05 3.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.305 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 130' ' ' ASN . 12.7 pt-20 53.8 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.445 1.898 . . . . 0.0 114.718 -178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 130' ' ' ASN . 9.3 tmtm? -61.24 -57.74 11.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.336 0.588 . . . . 0.0 110.053 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -126.78 -24.23 3.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.511 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 129' ' ' TYR . . . 98.21 44.05 2.66 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.18 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 p -94.16 148.34 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -80.63 94.14 6.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.22 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 39.6 mt-10 -84.4 -59.16 2.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.284 0.564 . . . . 0.0 111.513 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 32.8 ttmt -80.25 135.61 36.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 -172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' NH1' ' O3 ' ' A' ' 201' ' ' 2W7 . 0.0 OUTLIER -94.24 101.18 13.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 113.07 20.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.113 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.77 136.2 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.677 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 96.5 m-85 -117.16 112.22 20.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.474 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 89.5 t -99.89 111.62 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -110.9 114.11 27.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.545 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -90.69 146.64 23.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.934 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 119' ' ' LYS . 70.4 tt0 -62.92 141.11 58.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.217 0.532 . . . . 0.0 111.934 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 1.4 t -114.62 163.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.023 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.312 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.491 ' O3 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.48 135.94 45.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.33 87.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.871 0.732 . . . . 0.0 109.708 -170.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -62.01 141.53 95.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.988 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.36 109.57 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.846 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.89 160.9 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.904 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -70.39 116.88 49.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 31.5 Cg_exo -59.18 150.73 71.97 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.198 2.598 . . . . 0.0 113.376 -174.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -70.87 -27.42 63.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.064 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -84.5 159.35 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.77 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.62 22.93 14.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -172.138 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 t -120.56 -33.02 3.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.68 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -63.52 105.61 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 28' ' ' PRO . 1.3 p -58.2 112.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.999 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.07 24.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.588 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.98 157.6 24.89 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -121.45 131.48 54.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 8.1 tp -105.93 121.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.214 0.53 . . . . 0.0 110.334 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 94.8 mt-10 -129.78 109.64 11.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.468 0.652 . . . . 0.0 111.186 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' ILE . 66.5 mt -120.64 99.21 47.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.047 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.43 -35.54 98.57 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.049 2.499 . . . . 0.0 113.128 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.21 -33.57 71.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -111.6 7.21 20.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.949 -175.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.07 26.58 16.01 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.585 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 71' ' ' GLN . 61.6 mt -81.17 115.03 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 6.1 ttpm? -147.12 61.57 1.18 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 26.2 mm-40 -121.67 153.37 59.69 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.886 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' VAL . 7.8 Cg_exo -70.15 147.98 61.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.526 2.151 . . . . 0.0 111.84 175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.1 t -96.34 123.97 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.8 m-85 -97.03 102.32 11.79 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.831 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 11.5 Cg_endo -55.42 139.7 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.403 2.735 . . . . 0.0 112.735 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.34 170.22 11.94 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 162.0 37.51 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.71 2.273 . . . . 0.0 112.435 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -65.4 100.4 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.646 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 21.0 p -130.62 140.36 38.43 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.065 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 36.9 Cg_exo -61.53 -8.39 10.81 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.254 2.636 . . . . 0.0 113.319 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -94.75 -38.93 10.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.616 0.246 . . . . 0.0 110.795 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.08 -37.82 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.422 . . . . 0.0 110.171 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.09 -13.13 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.8 -38.96 92.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.367 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.4 -40.09 89.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.36 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.9 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.832 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 60' ' ' ALA . 2.6 p -138.45 139.59 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.306 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -140.09 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -74.22 140.24 44.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -87.35 -43.6 12.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.71 177.85 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.096 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.4 55.2 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.867 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.31 89.58 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.073 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.22 7.15 43.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.86 0.838 . . . . 0.0 109.764 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m -130.0 147.92 51.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.541 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.97 7.68 10.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.374 0.607 . . . . 0.0 110.505 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.27 35.71 2.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.617 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 5.9 p-10 -86.8 -95.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.442 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -173.45 -18.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 176.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -112.31 83.25 1.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.282 0.563 . . . . 0.0 109.715 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 40.8 mm -94.6 86.74 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.389 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -91.73 103.65 16.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.254 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 121' ' ' LEU . 1.1 mt -101.56 137.58 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -104.41 123.83 48.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.993 0.425 . . . . 0.0 111.205 -176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.68 -179.15 16.1 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 126' ' ' CYS . 30.3 p80 -159.79 155.97 26.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.428 0.614 . . . . 0.0 110.882 -177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.17 162.73 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.519 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 12.7 t80 -146.34 113.2 6.08 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 tp -83.67 -21.12 8.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.885 -170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.493 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 57.0 m-20 -82.3 -34.46 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.73 -176.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 32.0 mmm-85 -135.01 120.49 14.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.687 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 2.9 Cg_exo -77.74 -12.52 16.52 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.064 2.509 . . . . 0.0 112.903 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -81.87 16.73 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.908 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.88 -169.12 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.877 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.18 -51.62 3.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.79 0.329 . . . . 0.0 111.5 -178.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.823 ' HD1' ' HG2' ' A' ' 71' ' ' GLN . 9.2 m-85 -84.46 22.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 0.0 111.494 -175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 p -89.95 -34.86 15.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.5 t30 -102.94 19.59 19.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.164 0.507 . . . . 0.0 111.082 -173.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 142' ' ' PHE . 11.5 mt -64.1 -5.99 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.01 -18.76 60.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.89 5.39 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.422 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -96.31 145.52 25.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.333 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.3 mptt -117.36 173.82 6.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.0 110.253 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -73.85 -3.17 27.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.756 177.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.7 25.38 4.73 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.466 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 75.7 m -78.16 -165.12 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.258 0.551 . . . . 0.0 110.443 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -131.35 120.3 22.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.813 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 18' ' ' ILE . 87.3 t -107.41 109.81 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.577 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.05 119.46 32.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.396 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -112.7 110.25 20.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.962 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.46 146.66 27.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 91' ' ' GLU . 3.4 p -156.78 112.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.25 0.548 . . . . 0.0 109.925 174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 -98.24 0.33 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -125.56 6.99 7.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.262 0.554 . . . . 0.0 109.881 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.551 ' HB2' HG13 ' A' ' 88' ' ' VAL . 20.1 mm-40 -90.11 139.11 30.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.468 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -145.86 120.57 9.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 3.3 mpt_? -122.14 153.93 38.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -102.83 126.64 50.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.186 -176.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 90.5 m-85 -124.84 155.83 38.81 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' SER . 24.7 ttmm -128.62 150.12 50.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.467 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 48.6 mtp -83.94 59.59 5.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.515 0.674 . . . . 0.0 109.959 -173.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -66.22 -45.43 80.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.175 -172.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.6 m -106.97 100.75 10.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.31 0.576 . . . . 0.0 110.745 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG2' ' HE3' ' A' ' 140' ' ' LYS . 59.7 mt -118.31 112.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.596 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.07 141.59 34.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 1.9 p-10 -108.68 121.12 44.37 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.437 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 139' ' ' ARG . 15.7 t -77.96 121.95 31.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.664 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.656 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -103.63 132.7 20.81 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.6 99.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.319 2.679 . . . . 0.0 113.728 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.3 m -126.98 -49.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.681 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.5 144.28 30.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.966 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.04 -28.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -94.85 35.39 1.26 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.667 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.24 8.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.239 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.81 153.27 38.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.594 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -130.09 154.83 47.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.722 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -100.58 6.51 44.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.056 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.18 98.13 9.2 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -96.23 33.5 1.74 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.631 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.88 87.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.416 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -135.22 -173.67 3.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 0.0 110.93 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.78 -161.91 0.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.91 103.18 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.61 146.84 52.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.529 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' HG ' ' HB ' ' A' ' 57' ' ' ILE . 6.2 mp -107.35 109.96 21.83 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.547 HG23 HG22 ' A' ' 143' ' ' VAL . 19.9 m -89.43 99.07 12.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.892 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 81.0 mt -80.05 108.28 13.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 0.0 110.464 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.484 HG22 HH21 ' A' ' 139' ' ' ARG . 58.5 mt -93.77 103.65 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.424 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' HD2' ' A' ' 72' ' ' PHE . 3.2 m -99.73 129.05 45.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.267 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 62' ' ' HIS . 9.9 m -87.12 96.32 10.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.029 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 138' ' ' LYS . 3.3 m-20 -89.99 161.68 15.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 52.57 47.4 24.77 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.701 0.626 . . . . 0.0 111.361 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 19.8 p90 -82.48 144.02 30.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.731 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -112.26 107.4 16.25 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.09 -26.85 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.085 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -70.86 -55.93 7.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.609 0.242 . . . . 0.0 111.317 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 43.0 p -96.47 -22.18 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.98 32.87 9.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.599 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 87.6 t -89.13 139.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 110.824 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -133.19 114.61 14.04 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.849 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -91.54 -67.23 0.87 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.257 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 127' ' ' ASP . 4.1 ttpm? -80.94 137.75 36.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 21.3 mmm-85 -125.9 86.43 2.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HE3' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -76.09 108.01 8.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 0.0 110.295 -176.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.8 mm -97.11 130.34 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.335 0.588 . . . . 0.0 110.659 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 81.5 m-85 -120.04 101.16 7.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.675 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.5 t -93.04 102.07 13.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -89.97 110.69 21.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.807 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 m -83.85 143.85 29.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.206 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 34.0 tt0 -62.97 129.73 41.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.815 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.82 155.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 pttp . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.456 -174.481 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.582 ' O2 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.019 0.438 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -87.8 -179.46 6.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.892 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 -175.27 3.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.42 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -62.41 131.92 94.03 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.296 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CG ' ' HB ' ' A' ' 88' ' ' VAL . 31.5 Cg_endo -63.55 126.79 18.3 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.009 2.473 . . . . 0.0 113.147 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 1.7 tp60 -134.48 -171.98 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.181 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 62.7 mt -110.98 104.62 56.44 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.896 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 31' ' ' PRO . 86.7 Cg_endo -84.46 -170.52 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.122 2.548 . . . . 0.0 112.54 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 37.6 mtmt -84.37 -13.18 53.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 m-20 -94.84 106.58 18.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.729 -172.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.656 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -82.55 13.48 3.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.092 173.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 p -98.83 -7.93 26.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.661 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -91.34 179.85 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.741 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.77 109.04 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.753 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -88.74 -28.93 20.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.248 0.547 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.55 37.29 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.207 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 124.23 37.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tp -99.28 123.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 109.892 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.3 mt-10 -134.86 128.19 32.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.049 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.4 mt -129.25 96.84 27.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.2 Cg_endo -59.55 -25.31 78.38 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.4 2.733 . . . . 0.0 112.545 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.35 -24.72 67.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.8 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.94 7.14 9.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.712 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 58.21 25.42 12.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.299 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 61.3 mt -77.48 131.63 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.012 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -158.71 90.07 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.63 150.24 53.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.273 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.4 152.53 60.68 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.861 2.374 . . . . 0.0 112.045 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 43' ' ' VAL . 47.7 t -106.99 132.14 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.1 m-85 -91.39 111.07 47.02 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.744 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 Cg_endo -62.66 116.39 3.5 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.238 2.625 . . . . 0.0 112.63 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.48 -179.55 37.71 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.71 154.87 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.599 2.199 . . . . 0.0 112.073 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.86 131.52 44.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 111.072 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 38' ' ' GLN . 1.4 t -155.96 148.5 17.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.807 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.27 -37.69 24.8 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.797 2.998 . . . . 0.0 112.88 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 74.0 mm-40 -62.84 -52.12 64.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.125 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.474 ' NE2' ' HB2' ' A' ' 11' ' ' LYS . 13.1 mm100 -65.37 -42.91 92.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.699 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.23 -6.16 32.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.567 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -100.33 -10.13 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 0.0 109.934 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 62.8 mtt180 -111.65 -37.7 5.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.249 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.15 -166.78 36.51 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 29' ' ' VAL . 6.3 p -90.6 137.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.24 0.543 . . . . 0.0 111.074 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -134.6 -171.87 2.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.704 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 77.3 m-85 -99.25 156.0 17.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.003 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.69 -66.98 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.248 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 43.3 mt-10 -82.49 121.11 26.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.915 0.388 . . . . 0.0 110.879 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.88 -1.25 27.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.682 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -106.74 -6.66 17.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.187 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 22.5 tt0 -86.38 158.79 19.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.577 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.7 m -122.17 142.38 50.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.762 0.315 . . . . 0.0 111.712 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.792 ' HA ' HD11 ' A' ' 57' ' ' ILE . 14.3 mt -64.35 -12.49 42.88 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.024 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -119.39 26.28 9.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.859 0.838 . . . . 0.0 109.806 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 2.9 t70 -95.58 -166.58 1.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.296 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.781 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.7 pt20 -81.09 -34.08 32.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.719 0.295 . . . . 0.0 110.675 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -122.39 146.66 47.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 52' ' ' LEU . 7.9 mm -128.63 108.02 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.536 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -91.49 105.89 18.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.463 HG22 ' CG2' ' A' ' 43' ' ' VAL . 1.3 mt -103.59 140.03 22.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.96 126.01 48.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.793 0.33 . . . . 0.0 110.899 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -140.99 -177.32 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -138.07 122.15 17.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.547 0.674 . . . . 0.0 111.93 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 5.6 m -79.25 154.48 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.966 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ARG . 4.1 t80 -164.72 86.0 0.43 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.0 mt -59.19 -35.64 58.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.347 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -68.56 -23.13 64.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 0.0 111.717 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.526 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -116.14 102.42 53.74 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.889 -178.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.696 ' HA ' HG21 ' A' ' 73' ' ' THR . 32.2 Cg_exo -59.28 -23.93 72.01 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.994 2.463 . . . . 0.0 112.685 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -88.63 13.93 11.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.405 ' HD1' ' HB3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -92.8 -172.15 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.124 173.079 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.493 HE22 ' HB ' ' A' ' 43' ' ' VAL . 45.0 mt-30 -74.93 -81.44 0.07 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.558 0.694 . . . . 0.0 112.347 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 90.9 m-85 -89.82 37.11 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.211 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 68' ' ' PRO . 2.8 m -62.14 -29.13 70.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.975 0.417 . . . . 0.0 110.975 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -102.04 6.38 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.37 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 1.8 tm? -61.19 -27.53 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.362 0.601 . . . . 0.0 109.529 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -56.1 -24.42 40.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.945 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -87.31 0.19 55.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.04 165.33 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.78 -176.78 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.014 0.435 . . . . 0.0 110.744 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -1.61 25.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.495 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.92 27.28 5.44 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 74.9 m -82.67 155.59 24.28 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.381 0.61 . . . . 0.0 109.704 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.495 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -97.94 111.82 23.98 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.212 -176.515 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.29 116.5 36.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' HE2' ' HG3' ' A' ' 21' ' ' PRO . 75.0 m-85 -107.64 130.53 54.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.509 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -121.15 106.47 11.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 14.7 mtmm -86.25 136.8 33.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.93 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.2 m -139.87 93.14 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.0 -117.2 4.64 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -95.12 -9.54 33.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.505 0.669 . . . . 0.0 109.941 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.5 mm-40 -77.62 144.17 37.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.482 0.658 . . . . 0.0 111.218 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -141.47 97.54 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.471 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' A' ' 146' ' ' GLU . 3.9 mmp_? -80.3 135.39 36.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.316 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -103.48 125.17 49.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' GLU . 85.3 m-85 -123.22 150.6 43.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 25.3 ttpp -114.05 139.2 49.47 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 82' ' ' SER . 69.4 mtp -83.88 50.6 1.85 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 109.934 -174.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.43 2.46 18.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.253 -170.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.8 m -145.18 102.6 3.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.77 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.98 137.04 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.556 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 34.0 ttm-85 -154.02 157.89 39.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.369 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 7.1 p-10 -129.44 137.34 50.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 139' ' ' ARG . 26.5 m -117.57 -177.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.342 . . . . 0.0 111.456 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -90.65 154.92 46.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.334 -173.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HB3' ' O ' ' A' ' 136' ' ' TRP . 74.2 Cg_endo -77.51 178.84 7.13 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.874 2.383 . . . . 0.0 112.431 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.6 p 54.02 23.61 4.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.656 0.782 . . . . 0.0 111.92 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 109' ' ' GLU . 23.0 t70 -165.44 141.32 5.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.05 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.5 -2.99 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HA ' ' HB2' ' A' ' 112' ' ' ASP . 12.3 pt-20 -93.77 -3.1 52.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.528 -174.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 103' ' ' VAL . 4.9 p -56.04 -39.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 110' ' ' VAL . 4.5 mp -130.75 100.89 5.44 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.107 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 109' ' ' GLU . 37.9 t0 -152.93 -169.78 3.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.627 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 10.2 pt-20 42.27 63.69 1.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.138 0.899 . . . . 0.0 111.077 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.94 132.95 54.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.019 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.88 36.02 0.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.423 0.63 . . . . 0.0 109.921 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.58 143.59 10.95 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.372 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.54 168.77 18.97 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.4 t70 -127.41 -161.32 1.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -102.63 83.4 2.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.685 0.755 . . . . 0.0 109.511 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -165.37 177.12 7.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.794 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 15.7 mt -107.6 132.45 53.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.3 m -101.14 86.27 2.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.584 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.1 mp -79.95 110.87 15.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.361 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.6 mt -96.64 93.88 3.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.513 ' HB ' ' HE2' ' A' ' 142' ' ' PHE . 13.9 m -123.55 71.4 1.08 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.961 0.41 . . . . 0.0 110.699 -174.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.37 120.31 7.44 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 75.5 m-20 -65.73 -41.64 91.99 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.505 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.07 149.74 21.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.022 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -179.14 102.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.832 0.708 . . . . 0.0 110.22 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.33 98.41 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -166.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 1.4 tmtp? -62.53 -61.02 2.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.284 0.564 . . . . 0.0 110.551 -176.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.1 p -75.83 -28.85 58.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.43 40.91 9.52 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.148 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.18 133.92 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.367 0.603 . . . . 0.0 111.323 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.556 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 4.5 p90 -146.9 85.8 1.63 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.672 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 105' ' ' PRO . 39.5 mt-10 -65.01 -67.0 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.789 -172.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ASP . 18.0 mtpp -79.85 96.34 6.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.376 0.608 . . . . 0.0 111.371 -174.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.686 HH21 ' C11' ' A' ' 201' ' ' 2W7 . 40.1 mmm-85 -80.61 103.27 10.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.815 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 142' ' ' PHE . 8.3 mmtp -96.35 129.45 43.68 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 tp -123.33 123.24 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.624 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 70.7 m-85 -112.92 109.58 19.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.334 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 95.8 t -93.94 102.89 14.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.0 110.03 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -106.96 101.14 10.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.146 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' GLN . 3.1 m -83.81 143.51 29.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 44.9 tt0 -60.99 129.8 43.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.2 0.524 . . . . 0.0 111.593 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.6 p -101.48 160.49 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.324 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 147' ' ' VAL . 75.2 mttt . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.696 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.686 ' C11' HH21 ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.571 ' SD ' ' HA2' ' A' ' 89' ' ' GLY . 21.5 ptp . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.694 0.283 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.25 -14.73 16.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.66 174.29 12.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.192 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -74.69 117.41 62.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.557 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.509 ' O ' HD21 ' A' ' 52' ' ' LEU . 61.7 Cg_endo -79.31 114.72 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.665 2.243 . . . . 0.0 113.273 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' A' ' 52' ' ' LEU . 11.0 tp60 -95.82 89.23 5.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.737 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 50' ' ' GLU . 76.8 mt 24.98 91.57 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 125.068 1.48 . . . . 0.0 113.657 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.5 -179.93 5.9 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.664 2.243 . . . . 0.0 112.581 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -75.09 -44.6 46.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.075 0.464 . . . . 0.0 110.897 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.99 140.71 37.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.851 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -109.67 18.9 19.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.807 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -90.9 -17.31 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.156 0.503 . . . . 0.0 110.37 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.82 154.78 19.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 28' ' ' PRO . 6.9 p -97.68 135.7 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.96 -21.14 13.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.637 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.78 174.9 37.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.249 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -126.73 139.95 52.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.217 0.207 . . . . 0.0 110.628 178.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.41 127.91 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 36.5 mt-10 -136.21 122.31 20.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.042 0.448 . . . . 0.0 111.561 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.501 HD12 HD12 ' A' ' 25' ' ' ILE . 67.7 mt -129.55 95.57 29.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -58.34 -33.59 97.9 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.082 2.522 . . . . 0.0 112.702 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.09 -15.66 63.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.131 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.38 4.87 9.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 60.63 26.17 15.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.982 0.42 . . . . 0.0 111.628 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.6 mt -86.26 120.2 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.528 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 22.8 ttmm -156.09 98.61 1.89 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 71' ' ' GLN . 12.5 pt-20 -152.0 156.89 34.3 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.585 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.477 ' CB ' HG21 ' A' ' 14' ' ' VAL . 57.3 Cg_endo -74.15 152.34 45.21 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.608 2.205 . . . . 0.0 112.043 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.05 132.79 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 18.6 m-85 -93.94 111.36 52.69 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.47 -175.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 12.2 Cg_endo -56.98 130.88 42.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.031 2.488 . . . . 0.0 111.848 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.9 174.33 16.08 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.55 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.24 169.94 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.432 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 39' ' ' LEU . . . -73.7 121.78 21.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.908 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.832 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.2 t -161.01 141.38 8.36 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -38.43 -66.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.487 3.458 . . . . 0.0 115.489 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -28.9 69.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 35' ' ' THR . 7.1 tp60 -72.55 -52.23 16.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.389 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.832 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -65.47 -20.95 66.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.469 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.37 -29.3 67.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.9 0.381 . . . . 0.0 110.412 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -82.35 -38.78 23.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.76 -158.63 21.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.611 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.424 HG23 ' OE2' ' A' ' 27' ' ' GLU . 41.0 t -77.41 141.31 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.714 0.293 . . . . 0.0 110.804 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -142.36 167.33 22.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m-85 -87.58 176.57 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.973 0.416 . . . . 0.0 111.405 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.73 -40.19 7.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.189 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 42.8 mt-10 -108.69 141.55 40.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.42 -0.86 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.141 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.19 -13.03 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.68 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 13.1 pt-20 -63.25 131.92 49.95 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 16.7 m -94.29 121.29 35.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.894 0.378 . . . . 0.0 110.745 -173.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.665 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -71.13 -5.56 32.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.48 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -110.84 2.76 18.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.109 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 12.0 t70 -108.08 -156.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.774 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.53 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 7.2 tt0 -91.46 -42.79 10.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.941 0.496 . . . . 0.0 111.88 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -91.75 123.33 35.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 111.489 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 52' ' ' LEU . 24.2 mm -132.4 132.75 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.153 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.466 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 7.2 p -139.67 84.83 2.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.268 0.556 . . . . 0.0 110.506 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.593 ' HB ' HD23 ' A' ' 123' ' ' LEU . 3.2 mt -92.36 140.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.667 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.12 154.12 17.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.323 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -157.79 156.47 27.34 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.071 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' HE1' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 p80 -150.08 168.86 22.68 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.423 -0.457 . . . . 0.0 111.059 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.86 5.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.631 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 27.8 m-85 -145.03 171.08 14.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 171.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.0 -20.72 5.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.369 0.604 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.88 -40.24 9.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.833 -175.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HG3' ' H ' ' A' ' 69' ' ' ASN . 18.1 tpt180 -96.61 127.04 41.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.057 -168.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 73' ' ' THR . 93.6 Cg_endo -91.12 7.96 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.986 2.457 . . . . 0.0 111.551 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.713 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 21.6 m120 -125.38 20.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.147 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 19.4 p90 -86.37 166.42 15.6 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.704 172.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 1.7 pt20 -25.46 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.554 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 50.6 m-85 -113.39 45.91 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.522 HG21 ' C ' ' A' ' 68' ' ' PRO . 32.5 p -72.98 -51.81 16.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.449 0.642 . . . . 0.0 110.835 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -88.69 17.25 5.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.65 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -60.25 -25.71 65.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.829 179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -65.6 -25.06 67.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.733 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.49 -11.1 59.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.805 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.658 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.05 140.98 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.862 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -105.79 176.79 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.308 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -75.25 0.45 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.281 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.09 21.92 5.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.822 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -85.6 165.02 17.38 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.466 0.651 . . . . 0.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.44 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -99.9 123.66 44.4 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.51 -174.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.887 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -115.2 127.03 72.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.747 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.9 m-85 -115.4 137.16 52.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -122.36 121.25 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 14.9 ttmm -108.6 140.42 41.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.454 -173.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 HD13 ' A' ' 52' ' ' LEU . 2.7 p -137.69 111.28 8.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.97 171.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.571 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 65.92 -104.43 1.02 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.073 -172.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -116.28 -1.78 12.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 110.911 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -87.85 139.86 30.09 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 87' ' ' LYS . 36.5 m -145.71 116.81 7.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.645 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -91.02 152.14 20.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.604 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -111.18 123.16 49.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.354 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.64 152.58 39.16 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 36.5 ttmt -107.21 149.57 27.58 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.703 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 62.7 mtp -84.12 70.7 10.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 110.451 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.5 p -70.64 -46.5 63.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.784 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 10.5 m -118.48 110.33 17.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.971 0.415 . . . . 0.0 111.073 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.7 mt -126.32 89.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -125.87 143.4 51.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.2 0.524 . . . . 0.0 111.51 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 13.2 t70 -101.94 116.45 32.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.074 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.452 HG23 ' HD3' ' A' ' 105' ' ' PRO . 19.7 m -133.3 178.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 0.0 111.244 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 50.3 mtpt -133.17 81.26 57.05 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.72 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 139' ' ' ARG . 17.4 Cg_endo -93.98 107.39 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.476 2.784 . . . . 0.0 111.359 170.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -80.77 -24.21 38.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.878 0.37 . . . . 0.0 111.357 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' HG22 ' A' ' 110' ' ' VAL . 18.0 t70 -88.38 143.67 26.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.236 0.541 . . . . 0.0 111.431 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.63 19.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.49 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.83 -47.9 2.39 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' OD1' ' A' ' 107' ' ' ASP . 20.1 m -76.44 -4.31 6.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.7 60.33 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.425 . . . . 0.0 111.328 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.06 149.79 32.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.475 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.37 33.57 20.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.864 0.84 . . . . 0.0 110.05 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.614 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -72.37 96.0 1.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.857 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 115' ' ' LYS . 13.4 ptpt -76.56 151.58 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.534 -175.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.76 84.73 1.81 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.869 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.84 161.33 25.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -155.57 -176.68 6.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 90.1 3.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 15.6 pt20 -146.08 133.74 21.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 57' ' ' ILE . 37.5 mt -86.29 99.69 11.75 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 6.4 m -77.14 89.4 3.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.93 0.395 . . . . 0.0 109.987 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.593 HD23 ' HB ' ' A' ' 59' ' ' ILE . 23.7 mt -91.2 108.18 19.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.01 147.66 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' CG ' ' A' ' 140' ' ' LYS . 22.9 m -146.43 98.83 3.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.534 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 129' ' ' TYR . 3.4 m -56.74 109.14 0.58 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.658 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 2.1 t70 -89.21 -23.9 22.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.531 -170.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -145.33 117.2 8.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.828 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.508 ' HD2' ' HB3' ' A' ' 126' ' ' CYS . 17.0 p90 -162.18 173.41 14.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -122.3 131.75 54.07 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.45 41.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 2.9 tmtp? -90.81 -58.03 2.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 110.816 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -77.94 -9.72 59.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.491 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.77 65.26 2.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.873 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 12.9 p -139.02 145.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -142.26 136.06 29.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.071 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.38 -78.99 0.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 21.3 ttpp -90.43 137.72 32.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.076 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.658 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 12.1 ptp180 -153.46 138.21 17.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.121 0.486 . . . . 0.0 110.408 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.602 ' CG ' ' HB ' ' A' ' 125' ' ' THR . 5.0 ptpp? -89.39 144.17 26.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -119.54 119.43 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 CA-C-O 121.938 0.875 . . . . 0.0 109.853 170.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.887 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.0 t80 -105.89 113.43 26.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.307 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.8 t -104.62 113.09 40.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.968 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -100.03 111.86 24.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.2 m -90.3 144.61 25.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.97 135.19 48.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.79 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.2 t -112.37 168.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.928 0 CA-C-O 118.936 -0.555 . . . . 0.0 110.359 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.526 ' O2 ' ' N ' ' A' ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.18 -36.86 85.04 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.263 0.554 . . . . 0.0 111.352 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.54 82.36 6.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.306 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -146.9 138.16 13.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.963 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 68.7 Cg_endo -74.74 151.23 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.194 1.929 . . . . 0.0 111.841 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -132.22 172.51 12.32 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 52' ' ' LEU . 89.6 mt -114.72 103.51 54.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 111.714 -174.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -94.52 -159.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.468 2.779 . . . . 0.0 111.048 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -99.15 11.91 37.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.964 0.412 . . . . 0.0 110.525 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -78.38 98.91 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.189 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.2 16.72 21.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -93.95 -34.5 13.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.371 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.662 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -97.79 160.39 14.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.427 175.578 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.41 118.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' CB ' ' HG3' ' A' ' 31' ' ' PRO . . . -87.41 -42.44 12.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 109.963 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.83 171.32 23.62 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.005 -172.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.15 121.96 18.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.353 -0.423 . . . . 0.0 109.915 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.91 117.97 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.842 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 3.0 pt-20 -129.25 112.48 13.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.795 0.807 . . . . 0.0 111.806 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 55.7 mt -116.39 100.69 53.64 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.769 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.9 Cg_endo -58.88 -27.93 85.82 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.02 -21.26 63.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.724 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.89 15.3 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.31 26.93 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.89 0.852 . . . . 0.0 110.73 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.3 mt -95.72 118.52 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.99 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 40.4 mtpt -144.87 81.78 1.66 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.895 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 48.8 mm-40 -124.15 152.09 66.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.06 153.18 46.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.563 2.175 . . . . 0.0 112.835 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 48.7 t -113.26 130.97 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.21 112.29 62.87 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.951 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 26.2 Cg_exo -62.18 139.31 77.38 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.324 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.95 173.64 13.43 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.03 151.03 73.27 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.287 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.29 157.79 21.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.764 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.558 HG23 ' H ' ' A' ' 38' ' ' GLN . 2.8 t -176.11 150.94 1.1 Allowed Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -46.54 -37.23 19.75 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.102 2.535 . . . . 0.0 112.669 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.28 -46.75 85.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.26 0.552 . . . . 0.0 111.192 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.558 ' H ' HG23 ' A' ' 35' ' ' THR . 55.3 tp60 -72.75 -37.13 67.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.775 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -77.72 -15.06 59.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.135 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.55 -18.9 56.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.546 0.688 . . . . 0.0 109.209 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -90.58 -46.07 8.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.78 -138.66 2.99 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.275 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 60' ' ' ALA . 85.5 t -112.57 137.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.379 . . . . 0.0 110.402 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -150.28 165.95 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.908 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -71.99 134.5 45.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.311 -176.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.4 65.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -128.17 118.41 23.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.378 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 50' ' ' GLU . 2.5 mp0 -54.85 -38.44 67.46 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.493 0.495 . . . . 0.0 110.439 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.7 t-20 70.8 -22.67 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.738 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' GLU . 43.0 tt0 82.34 -22.7 0.24 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.559 1.143 . . . . 0.0 111.326 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.9 m -128.74 141.68 51.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.309 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -103.22 -14.86 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -99.15 25.15 7.07 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.934 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.49 -167.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.745 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -115.19 -29.03 6.74 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.174 -0.329 . . . . 0.0 111.495 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -108.18 97.33 7.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.069 0.938 . . . . 0.0 111.125 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.416 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 21.6 mm -116.62 138.36 47.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.985 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 t -128.67 113.71 15.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.858 0.361 . . . . 0.0 110.206 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 3.4 mt -111.1 128.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -101.52 142.86 32.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.85 27.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.282 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -124.14 144.65 49.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 127' ' ' ASP . 67.8 p -111.47 169.16 9.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.673 0.273 . . . . 0.0 110.747 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.517 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 22.7 t80 -154.55 134.87 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.76 HG13 ' HB2' ' A' ' 129' ' ' TYR . 3.7 mp -66.24 -48.19 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.37 . . . . 0.0 111.742 -172.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.8 t70 -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 53.8 mmm-85 -99.3 106.62 40.12 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 -174.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 3.2 Cg_exo -76.83 -4.18 14.64 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.541 2.828 . . . . 0.0 111.206 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -74.27 -23.18 59.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.24 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.512 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 64.5 m-85 -74.21 116.26 14.64 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.069 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.895 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 5.1 pt20 -48.91 -41.92 35.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' CZ ' HD23 ' A' ' 123' ' ' LEU . 10.2 m-30 -78.64 -2.58 39.77 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.225 -0.297 . . . . 0.0 111.789 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 16.8 m -68.42 -34.74 76.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.693 0.282 . . . . 0.0 110.946 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.05 14.72 22.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.625 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.08 -15.3 59.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -22.44 62.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 111.015 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.81 -6.81 56.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.615 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.56 131.12 47.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -111.64 177.7 4.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.702 -175.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -56.06 -21.14 20.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.007 -175.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.49 43.53 1.45 Allowed Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.165 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 m -95.41 -177.27 4.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.142 0.496 . . . . 0.0 109.779 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.594 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.8 tpt -118.36 104.56 10.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.403 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.02 107.01 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.729 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.842 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . 58.8 m-85 -89.28 117.9 28.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.268 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -104.17 99.27 9.0 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -97.06 146.16 25.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.342 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.742 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 7.6 p -162.0 118.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.141 0.496 . . . . 0.0 109.686 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.625 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 60.63 -111.49 3.76 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -107.87 2.09 23.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.16 0.505 . . . . 0.0 110.089 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.98 141.52 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 m -141.47 98.01 3.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.242 0.544 . . . . 0.0 110.346 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.2 134.02 52.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.908 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 28.8 mtmt -103.58 140.4 37.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -169.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.642 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.7 m-85 -131.11 147.82 52.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.847 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -105.84 148.81 27.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.615 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 66.4 mtp -82.77 72.05 9.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.402 0.62 . . . . 0.0 110.478 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.4 p -72.3 -42.19 65.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.614 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.594 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 31.5 m -113.09 99.97 8.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 111.629 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.99 76.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -93.58 155.57 17.22 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.867 0.841 . . . . 0.0 112.831 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 138' ' ' LYS . 9.9 t70 -109.72 100.83 9.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.695 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.28 145.59 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.046 0.451 . . . . 0.0 110.659 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -95.19 140.42 22.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.52 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.96 127.91 19.58 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.53 2.154 . . . . 0.0 111.972 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.442 HG23 HG11 ' A' ' 110' ' ' VAL . 1.9 t -153.99 -55.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.586 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.689 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . 30.0 t70 -142.21 167.59 21.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.563 0.22 . . . . 0.0 110.623 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.37 -45.78 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.689 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.5 31.03 5.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.462 . . . . 0.0 111.207 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 p -81.02 -7.8 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.025 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.43 127.69 35.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.36 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.76 133.27 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.306 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.72 36.22 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.782 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -100.09 142.21 31.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.488 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -89.89 166.49 13.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 177.171 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.0 75.75 1.03 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.568 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.06 167.0 15.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.158 0.504 . . . . 0.0 111.457 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -155.5 -166.66 2.3 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 9.3 mttp -74.92 101.75 4.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.942 0.401 . . . . 0.0 110.163 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -142.18 145.67 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.896 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 12.4 mt -107.84 114.35 28.22 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 143' ' ' VAL . 23.7 m -89.08 95.64 10.4 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -83.35 120.35 25.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.527 0.68 . . . . 0.0 110.526 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.704 HG23 HH22 ' A' ' 139' ' ' ARG . 61.9 mt -79.6 86.1 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 1.9 m -98.04 100.15 11.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.536 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.9 m -81.32 -25.8 36.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -94.56 167.57 11.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 111.302 -174.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 25.6 t70 -155.16 103.41 2.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.485 171.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.76 ' HB2' HG13 ' A' ' 65' ' ' ILE . 7.7 p90 -69.81 133.84 47.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.209 0.528 . . . . 0.0 111.411 -170.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.42 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 2.1 t-20 -98.43 106.49 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.27 -36.16 60.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.207 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 4.3 tmtm? -59.32 -62.87 1.56 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -175.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 135' ' ' VAL . 0.8 OUTLIER -108.57 3.05 22.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.209 -169.121 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.7 49.64 62.97 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.301 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG12 HG23 ' A' ' 133' ' ' THR . 14.3 p -136.39 156.14 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -90.42 123.76 34.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 48.8 mt-10 -92.11 -70.65 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.605 0.717 . . . . 0.0 112.092 -174.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 102' ' ' ASP . 29.2 mtmm -112.94 -172.81 2.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.811 -167.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.704 HH22 HG23 ' A' ' 124' ' ' ILE . 28.6 ttt-85 -114.58 66.33 0.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.819 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.633 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -69.53 96.86 0.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.231 0.539 . . . . 0.0 109.962 -179.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.6 tt -85.6 139.79 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 15.6 t80 -114.86 124.26 51.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.038 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.6 t -121.05 123.96 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -106.34 130.27 54.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.295 -176.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.8 m -99.58 137.25 38.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.993 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.429 ' OE1' ' HD3' ' A' ' 119' ' ' LYS . 37.6 tt0 -65.0 121.8 15.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.134 0.492 . . . . 0.0 111.181 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.12 161.23 4.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.69 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' 2W7 . . . . . 0.755 ' N4 ' ' O2 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.727 0.298 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.82 161.48 36.28 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.617 2.211 . . . . 0.0 112.555 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -114.24 173.42 6.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 70.8 mt -106.92 101.11 35.61 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.776 0.322 . . . . 0.0 111.129 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 97.9 Cg_endo -87.59 178.4 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.846 2.364 . . . . 0.0 112.272 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -86.61 -30.74 21.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.1 t70 -60.51 129.54 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.192 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 43.1 mmtm -96.55 13.21 28.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.896 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -91.74 -21.86 20.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.343 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 45.6 mmtm -91.65 163.31 14.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.651 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.91 116.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.52 -33.92 15.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.19 152.82 24.88 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.729 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.24 122.91 48.88 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 27' ' ' GLU . 9.6 tp -93.55 115.08 31.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.698 0.761 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 42.5 mt-10 -127.92 115.69 18.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.033 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 66.2 mt -122.96 102.49 37.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.652 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -59.23 -33.92 98.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.414 2.743 . . . . 0.0 113.552 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.12 -24.46 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.712 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.47 7.74 16.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.266 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 59.89 25.81 14.98 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.178 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.4 mt -84.61 124.63 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.991 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -144.15 80.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.0 mm-40 -125.43 142.42 41.68 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.161 0.505 . . . . 0.0 111.899 -172.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.69 138.57 38.37 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.064 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 64.1 t -98.38 132.81 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -92.85 105.34 14.47 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.397 0.618 . . . . 0.0 110.51 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 47.2 Cg_endo -69.22 145.94 61.93 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.276 2.651 . . . . 0.0 113.071 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 11' ' ' LYS . . . 129.08 -168.95 20.6 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.804 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.42 162.18 33.75 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.769 2.313 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.8 126.21 31.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.973 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.504 ' O ' HD23 ' A' ' 39' ' ' LEU . 47.6 p -132.05 133.94 24.55 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.89 -36.6 27.29 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.471 2.781 . . . . 0.0 113.362 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' HD2' ' A' ' 41' ' ' ARG . 38.7 tt0 -66.28 -54.25 27.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.56 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 51.1 tp60 -65.43 -34.41 78.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 35' ' ' THR . 4.4 mm? -68.54 -7.87 36.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -101.61 -7.11 23.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.749 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HD2' ' HG2' ' A' ' 37' ' ' GLU . 53.8 mtp180 -104.32 -32.64 8.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.949 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -154.99 9.75 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.241 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.502 HG21 ' CE2' ' A' ' 72' ' ' PHE . 59.4 t -105.96 133.82 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.83 0.348 . . . . 0.0 110.472 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -135.72 162.04 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 86.5 m-85 -74.01 149.46 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.244 0.545 . . . . 0.0 111.561 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.82 -14.0 23.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.877 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -79.9 133.6 36.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.228 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -83.42 -6.37 59.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.838 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.28 128.76 36.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -74.98 17.67 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.059 0.457 . . . . 0.0 112.167 -176.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 m -104.15 107.7 18.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.223 0.535 . . . . 0.0 111.618 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -91.05 6.27 45.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.784 0.802 . . . . 0.0 109.433 172.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.43 -9.11 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.625 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.22 159.39 28.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.237 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 3.9 pm0 -86.34 -13.34 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 0.0 110.899 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -105.44 105.94 16.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.123 0.487 . . . . 0.0 110.545 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 52' ' ' LEU . 19.9 mm -115.79 101.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.532 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -93.87 125.72 38.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.44 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -127.37 142.67 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.57 147.13 43.1 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.086 -0.384 . . . . 0.0 111.467 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.21 -171.62 22.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.014 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -136.63 157.68 46.2 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.565 -0.373 . . . . 0.0 110.818 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 6.7 t -79.07 -172.05 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.584 -175.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 35.4 p90 -109.04 142.09 40.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.329 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.28 -90.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.68 -23.73 16.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 109.873 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.39 114.58 65.03 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.189 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HA ' HG21 ' A' ' 73' ' ' THR . 88.5 Cg_endo -82.43 8.78 4.33 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.841 2.36 . . . . 0.0 111.476 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.76 14.61 20.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.902 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 73' ' ' THR . 40.5 m-85 -89.53 143.14 27.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -69.03 -8.03 41.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' VAL . 43.5 m-85 -130.1 33.06 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.72 0.295 . . . . 0.0 111.392 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 68' ' ' PRO . 13.4 p -64.73 -34.94 79.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.396 . . . . 0.0 111.645 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -99.9 13.13 34.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.5 -12.21 50.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 110.494 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 64' ' ' PHE . 20.1 pttp -63.69 -26.7 68.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.233 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.13 -41.44 25.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.529 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.81 137.76 54.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.073 -173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.4 mptt -103.66 173.62 6.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.05 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -74.31 -1.92 22.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.741 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.35 34.04 3.16 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.443 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.6 t -97.78 -172.71 2.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -119.05 121.7 40.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.297 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 96.8 t -107.6 110.26 31.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.525 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -95.08 113.85 25.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -102.98 98.71 8.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -94.57 113.06 24.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.214 -172.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.96 101.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.595 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.53 -94.52 0.28 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.147 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -119.2 -14.71 9.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.73 125.25 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -101.4 107.1 18.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.852 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -97.04 117.17 30.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.528 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.6 125.46 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 110.959 -176.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 64.0 m-85 -121.09 148.81 43.67 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -110.0 138.64 46.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.562 ' HB3' HD11 ' A' ' 100' ' ' ILE . 61.2 mtp -76.88 54.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.966 -173.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.1 p -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 7.5 m -116.4 102.0 9.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.012 0.434 . . . . 0.0 111.028 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.4 mt -126.76 125.28 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.648 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 101' ' ' ARG . 14.2 ttp180 -165.68 144.27 6.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.162 0.506 . . . . 0.0 109.865 170.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.996 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 3.1 p-10 -101.7 110.59 22.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.668 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 139' ' ' ARG . 27.0 m -98.63 175.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.449 0.643 . . . . 0.0 112.112 -172.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -85.28 155.41 60.17 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.905 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.47 -174.97 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.735 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m 74.3 -59.49 0.55 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.499 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.13 103.79 10.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.477 . . . . 0.0 111.282 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.48 -21.41 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.448 0.642 . . . . 0.0 109.433 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -90.82 27.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.835 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 103' ' ' VAL . 10.2 p -61.9 -28.59 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.76 141.27 51.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.366 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -85.76 120.14 26.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.69 141.38 32.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 110.868 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 173.54 13.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.415 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -90.91 -3.54 57.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.0 111.768 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.76 80.44 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -129.46 179.69 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 111.038 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.38 -172.75 2.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.46 ' HD3' ' CD ' ' A' ' 146' ' ' GLU . 41.9 mttt -71.3 100.84 2.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -135.34 138.06 43.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.088 0.47 . . . . 0.0 111.134 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.5 mt -95.62 114.41 26.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m -96.89 95.08 7.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.94 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.5 mp -93.82 125.83 38.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 0.0 111.619 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.75 91.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.71 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -101.33 98.07 8.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 0.0 110.867 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 122.86 18.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.638 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.738 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -88.11 25.08 1.67 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.25 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.4 t0 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.333 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.996 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 39.4 ttmt -162.4 142.37 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.736 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.469 ' HG3' HG23 ' A' ' 103' ' ' VAL . 8.4 ptp85 -119.0 108.93 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.256 171.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 1.2 tmtp? -87.86 102.57 14.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -87.8 128.15 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.664 0.745 . . . . 0.0 110.65 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -127.73 116.92 20.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 78.7 t -113.65 117.83 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.503 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -105.34 118.64 37.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.522 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 m -92.04 141.17 28.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.191 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.46 ' CD ' ' HD3' ' A' ' 119' ' ' LYS . 29.3 tt0 -65.63 134.52 53.43 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 111.488 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.02 165.57 3.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.042 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttp . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.213 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 pttt . . . . . 0 C--O 1.237 0.399 0 CA-C-O 120.787 0.327 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.89 138.31 62.4 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 111.954 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.8 tp60 -152.55 159.12 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.88 102.06 5.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 89.4 Cg_endo -83.52 172.47 10.28 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.634 2.223 . . . . 0.0 112.967 -174.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.61 -24.55 19.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -75.07 102.5 4.9 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.062 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -80.46 8.9 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.219 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 p -89.21 -9.4 50.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.401 0.619 . . . . 0.0 109.494 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -91.47 157.51 17.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.415 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -98.96 104.9 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -67.85 -37.34 81.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.936 0.398 . . . . 0.0 110.991 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.35 174.65 41.19 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.264 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.99 130.87 53.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.67 109.98 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.639 0.733 . . . . 0.0 109.417 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 39.0 mt-10 -123.1 109.27 13.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.628 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 25' ' ' ILE . 65.0 mt -122.53 101.89 39.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.599 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.44 -23.49 75.05 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 123.022 2.482 . . . . 0.0 112.394 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -68.43 -20.3 64.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.666 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.08 14.38 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.37 32.32 21.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.021 0.439 . . . . 0.0 111.426 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.67 HG23 ' HB2' ' A' ' 71' ' ' GLN . 64.1 mt -87.53 129.29 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.253 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 23.7 ttmm -161.95 81.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.119 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 35.9 mt-10 -143.58 158.46 56.99 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.292 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 58.3 Cg_endo -70.91 156.89 59.52 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.683 2.256 . . . . 0.0 112.605 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -112.07 132.32 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.84 111.99 57.79 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-O 121.404 0.621 . . . . 0.0 111.245 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 60.9 Cg_endo -73.82 133.58 18.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.179 2.586 . . . . 0.0 112.396 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.5 -168.51 29.13 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.589 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.03 153.94 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.846 2.364 . . . . 0.0 111.831 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.08 101.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.353 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.6 p -132.32 152.21 79.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.656 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.12 -37.94 95.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.984 2.456 . . . . 0.0 112.67 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.26 -51.23 68.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -75.72 -37.65 59.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.11 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 62' ' ' HIS . 90.5 mt -76.51 -2.77 33.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -94.19 -10.33 33.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.659 0.742 . . . . 0.0 109.352 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.637 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 2.4 mmp_? -105.03 -25.56 12.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.429 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.65 -129.89 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.965 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 59' ' ' ILE . 20.7 t -95.62 126.69 48.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.786 0.327 . . . . 0.0 110.183 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 m -139.87 150.02 44.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 35.0 m-85 -66.26 168.17 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -103.2 -55.02 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.315 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.79 163.1 12.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.417 . . . . 0.0 110.647 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.4 -23.72 17.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.185 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -76.96 -29.4 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.191 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.87 149.57 49.28 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.065 0.46 . . . . 0.0 110.465 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -154.59 150.13 27.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.55 -7.53 33.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.785 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.27 -30.1 25.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t70 -90.02 -160.51 0.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 20.6 pt20 -109.5 -25.37 10.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.334 -0.229 . . . . 0.0 111.273 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -93.01 120.99 33.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.811 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 121' ' ' LEU . 34.2 mm -127.83 129.09 69.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.912 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.3 t -133.51 87.93 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -103.62 127.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.05 36.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.892 0.377 . . . . 0.0 110.779 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.29 165.18 17.34 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 39' ' ' LEU . 14.7 m-70 -130.99 142.62 50.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.936 0.368 . . . . 0.0 111.19 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.973 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.1 m -117.78 120.69 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.35 106.93 17.65 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.89 -26.86 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.874 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -98.9 5.77 47.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.191 0.52 . . . . 0.0 110.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.68 87.82 51.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.043 0.449 . . . . 0.0 110.03 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 73' ' ' THR . 73.3 Cg_endo -77.09 2.78 7.27 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.177 2.585 . . . . 0.0 113.371 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.12 1.68 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.151 0.501 . . . . 0.0 110.228 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.491 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.3 t80 -78.13 138.22 38.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.67 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -57.96 -44.07 86.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -167.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 71' ' ' GLN . 3.9 m-30 -88.91 6.35 39.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.013 -0.43 . . . . 0.0 112.125 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.973 ' HA ' HG23 ' A' ' 63' ' ' THR . 86.0 m -76.37 -33.93 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.452 . . . . 0.0 110.512 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 76' ' ' LYS . 62.6 t30 -92.23 14.92 14.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.09 21.77 0.17 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.471 0.653 . . . . 0.0 110.868 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -101.52 -23.41 14.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.69 172.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -73.98 -31.84 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.004 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.17 156.86 29.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.045 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -130.83 -173.8 3.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.338 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -11.8 52.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.613 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.95 55.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.355 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.511 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 70.0 m -109.11 145.42 35.72 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.208 0.528 . . . . 0.0 109.827 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 108.71 15.11 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.811 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 93.7 t -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.438 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -100.96 117.04 34.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 110.92 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -105.47 101.68 11.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.5 ttpt -98.07 117.54 32.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.08 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.4 m -113.28 99.87 9.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.343 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.71 -101.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.794 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.81 -2.88 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 109.996 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.622 ' HB2' HG23 ' A' ' 88' ' ' VAL . 7.8 mm-40 -96.61 148.71 22.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.207 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.9 m -134.89 112.4 10.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.765 0.317 . . . . 0.0 110.69 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -101.75 138.89 38.13 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -99.96 130.02 46.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 86.3 m-85 -127.79 147.17 50.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.547 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 12.1 tppt? -109.34 140.53 42.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.572 ' HB3' HD11 ' A' ' 100' ' ' ILE . 50.2 mtp -77.63 60.16 2.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.206 0.527 . . . . 0.0 110.404 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.0 p -63.51 -36.88 85.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.094 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 73.9 m -124.45 97.37 5.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.502 . . . . 0.0 111.451 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 97' ' ' MET . 69.4 mt -113.18 110.49 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.537 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -146.67 151.65 37.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.828 0.347 . . . . 0.0 110.255 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.43 93.22 5.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.745 0.783 . . . . 0.0 110.475 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.705 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 14.7 m -97.26 95.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.368 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.651 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -109.06 90.81 8.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.344 0.592 . . . . 0.0 112.417 -170.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 103' ' ' VAL . 94.4 Cg_endo -104.13 -158.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.763 2.975 . . . . 0.0 111.335 172.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -126.48 11.84 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.44 163.99 29.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.303 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 -21.61 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.45 17.11 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 110.936 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 105' ' ' PRO . 19.1 m -66.86 -20.25 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.733 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -90.87 -178.65 5.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 3.5 p30 -79.18 167.29 21.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.497 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.53 15.02 22.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.816 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 112' ' ' ASP . 1.7 mp0 -66.75 110.67 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.746 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -73.57 2.59 7.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.262 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.81 64.96 3.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.636 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -108.48 178.73 4.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.88 -176.79 3.18 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -80.14 93.83 5.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.6 148.84 46.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.581 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 57' ' ' ILE . 19.5 mt -94.13 104.25 16.28 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -77.27 84.02 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.4 mt -86.79 102.1 13.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.536 0.684 . . . . 0.0 110.784 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.7 mt -79.73 99.9 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.738 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 m -87.35 91.78 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.21 0.529 . . . . 0.0 110.12 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.34 101.43 7.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.5 158.28 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.422 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . 18.2 t0 . . . . . 0 C--O 1.236 0.365 0 O-C-N 123.755 0.659 . . . . 0.0 111.798 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 128' ' ' ASP . 46.9 mmtm -79.52 98.64 6.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.679 0.752 . . . . 0.0 111.026 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.689 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 11.5 mmm-85 -89.86 76.73 7.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.356 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -83.16 112.74 20.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tp -93.25 127.8 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 121.814 0.816 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.714 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -118.08 100.56 7.62 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.963 178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.0 t -98.68 112.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.88 116.09 31.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.404 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.7 m -89.03 139.84 30.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.146 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.01 130.11 42.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.94 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.85 162.45 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 46.8 pttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.503 -0.76 . . . . 0.0 110.66 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.428 0.156 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.84 107.1 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.978 2.452 . . . . 0.0 113.054 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -140.63 169.31 17.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.934 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.713 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 90.1 mt -121.88 102.62 40.96 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-O 120.75 0.31 . . . . 0.0 110.525 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 5.8 Cg_exo -78.36 144.79 20.73 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.664 2.243 . . . . 0.0 110.606 172.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 40.1 pttt -89.51 34.08 0.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.35 0.595 . . . . 0.0 110.987 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.42 141.82 30.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.976 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 9.0 mptt -96.0 6.95 47.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.604 -173.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -113.09 -44.93 3.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.14 126.75 31.67 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.494 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.53 116.88 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.576 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . . . -84.89 -37.73 20.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.48 168.32 27.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.86 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.27 135.95 39.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -103.61 125.04 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 37.0 mt-10 -128.68 109.52 11.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.27 0.557 . . . . 0.0 111.29 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.1 mt -121.52 103.07 41.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.95 -43.64 41.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.299 2.666 . . . . 0.0 113.938 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 3.1 p-10 -76.3 -10.69 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.22 2.09 16.47 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.979 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.65 26.22 15.96 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 79.4 mt -93.04 104.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.429 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 51.3 mttt -137.27 81.23 1.86 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -126.85 150.62 72.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.54 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.77 144.08 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.623 2.215 . . . . 0.0 112.309 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 87.9 t -94.45 132.63 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.06 105.68 14.72 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 121.304 0.573 . . . . 0.0 110.453 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 97.7 Cg_endo -80.6 140.75 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.001 2.467 . . . . 0.0 112.75 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.4 -170.36 29.64 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 72.1 Cg_endo -76.9 149.06 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.468 2.112 . . . . 0.0 111.802 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -63.8 98.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.566 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -134.34 142.0 41.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.19 -30.81 43.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.363 2.709 . . . . 0.0 113.208 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 38' ' ' GLN . 10.2 pt-20 -59.99 -30.92 69.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.709 0.29 . . . . 0.0 111.59 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 16.0 mm100 -101.06 -42.57 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.837 0.351 . . . . 0.0 111.024 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 3.9 mm? -74.15 -2.7 25.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -99.88 -9.52 22.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -93.43 -55.88 3.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.886 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.99 -120.83 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.833 -175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.413 HG23 ' NE2' ' A' ' 71' ' ' GLN . 35.1 t -109.71 126.63 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.881 0.372 . . . . 0.0 110.688 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -146.54 158.03 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.928 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.064 0.459 . . . . 0.0 111.018 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.74 -12.04 54.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.207 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 46.7 mt-10 -101.08 121.32 41.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.773 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 43.6 mt-10 -65.06 -33.59 76.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.296 -172.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.05 125.52 31.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.164 0.507 . . . . 0.0 110.653 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 2.7 mp0 -63.27 108.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.481 -175.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -150.35 139.99 21.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 7' ' ' ILE . 1.5 pp -130.17 6.8 4.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.923 0.392 . . . . 0.0 111.237 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.86 33.49 1.98 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.74 179.94 4.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -72.5 -47.48 48.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.11 126.21 51.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.257 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.74 95.07 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.239 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 7.5 m -86.95 111.54 20.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -122.96 120.24 60.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.49 142.75 31.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.724 0.297 . . . . 0.0 110.437 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.58 124.16 4.57 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 39' ' ' LEU . 28.8 t-80 -84.75 132.76 34.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 127' ' ' ASP . 15.1 t -153.25 175.32 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 m-85 -140.95 138.0 33.48 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.224 0.327 . . . . 0.0 110.122 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -69.57 -17.31 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.835 0.826 . . . . 0.0 108.933 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -83.88 -21.05 32.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.089 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 9.6 mmt180 -124.54 111.99 27.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 5.5 Cg_exo -78.57 1.58 8.93 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.233 2.622 . . . . 0.0 110.876 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -86.88 14.01 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.334 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.52 -177.29 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.051 0.453 . . . . 0.0 111.639 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' NE2' HG23 ' A' ' 43' ' ' VAL . 10.8 mt-30 -93.97 -31.01 14.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.837 -170.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.38 24.01 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.475 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 68' ' ' PRO . 23.9 p -73.96 -38.06 64.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.863 0.364 . . . . 0.0 111.657 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -93.14 18.73 8.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.085 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.07 -10.86 57.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.982 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -77.19 -22.15 52.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.23 176.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.63 -4.29 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.621 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.71 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.79 159.6 15.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.086 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.9 mptt -121.04 172.59 7.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 111.025 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -74.56 -4.84 39.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.132 -176.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.64 24.92 5.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.792 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -84.74 -173.78 4.91 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.331 0.586 . . . . 0.0 110.3 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.15 107.76 12.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.401 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.6 t -93.11 106.05 17.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.014 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 85.5 m-85 -90.18 128.01 36.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.673 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.08 108.22 15.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -92.36 140.14 29.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.123 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 52' ' ' LEU . 8.5 p -163.67 128.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.903 0.382 . . . . 0.0 111.327 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.85 -87.94 0.08 OUTLIER Glycine 0 C--N 1.329 0.169 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.979 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -135.78 0.23 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.095 0.158 . . . . 0.0 111.391 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.34 169.06 11.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 m -148.05 110.73 4.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.913 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 92.5 mtt180 -95.51 154.55 17.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.511 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.47 117.44 34.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.535 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 63.2 m-85 -109.4 153.61 23.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.719 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 96' ' ' LYS . 39.6 ttmt -112.95 150.75 31.4 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.731 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 57.5 mtp -86.72 66.13 9.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.388 0.613 . . . . 0.0 109.978 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -70.44 -37.66 74.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.213 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.4 m -127.07 95.79 4.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.099 0.476 . . . . 0.0 111.482 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 42.9 mt -110.31 111.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.614 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -139.07 151.24 46.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.842 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.92 126.01 39.97 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.922 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 25.3 t -131.52 93.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.115 0.483 . . . . 0.0 110.933 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 4.3 mtmt -90.44 153.28 46.11 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 6.8 Cg_exo -74.56 14.69 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.272 2.648 . . . . 0.0 113.346 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -70.89 -30.89 67.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.518 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.98 107.88 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.867 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 109' ' ' GLU . 26.9 m -92.93 -176.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 108' ' ' VAL . 44.3 mt-10 67.73 6.75 5.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.034 0.533 . . . . 0.0 111.31 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.698 HG13 ' HG ' ' A' ' 111' ' ' LEU . 5.8 p -64.32 -34.11 67.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.698 ' HG ' HG13 ' A' ' 110' ' ' VAL . 1.2 pp -138.31 147.74 43.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.738 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 9.5 m-20 -112.23 165.21 12.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 111.203 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -98.17 72.76 2.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.399 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -117.77 157.24 26.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.327 -177.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -82.74 -170.23 2.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.692 177.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.86 6.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.423 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 29.2 mmtp -131.54 -165.01 1.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -104.89 -157.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -68.11 95.39 0.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.12 0.486 . . . . 0.0 110.708 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 16.0 pt20 -105.5 126.56 52.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.107 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 106.06 18.06 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 m -83.26 91.48 7.29 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.572 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 142' ' ' PHE . 32.1 mt -84.25 97.52 9.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.378 0.609 . . . . 0.0 110.271 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mt -80.76 96.22 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -96.52 86.53 4.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.664 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.2 m -73.03 108.53 5.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 63' ' ' THR . 19.7 t70 -83.61 -21.93 32.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.183 -168.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 38.3 m-20 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 12.9 mm-40 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -121.57 136.89 54.92 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.773 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 15.7 mtm180 -123.49 127.87 48.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.6 105.01 14.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.28 121.75 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.703 0.763 . . . . 0.0 110.53 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.731 ' HE1' ' HA ' ' A' ' 97' ' ' MET . 6.2 t80 -119.33 109.85 16.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.988 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 53.9 t -102.09 107.19 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.952 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -94.56 134.29 37.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.5 m -103.66 136.13 43.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.301 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.415 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 31.7 tt0 -67.92 121.87 16.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.247 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.4 164.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.699 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.452 179.612 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 150.97 25.41 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.467 2.112 . . . . 0.0 112.136 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.442 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 mm-40 -118.65 179.25 4.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 52' ' ' LEU . 3.8 mp -91.37 106.39 16.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 77.8 Cg_endo -96.63 -168.7 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.269 2.646 . . . . 0.0 113.391 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -74.9 -20.92 59.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.607 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -79.37 105.25 10.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.457 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 23.4 mttp -87.71 -29.34 21.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 110.661 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.4 p -73.9 -13.11 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.542 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.524 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 32.1 mmtp -87.18 80.74 8.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.58 113.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.511 0.672 . . . . 0.0 111.189 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.57 -34.12 41.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.79 26.7 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.461 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.82 124.09 41.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.76 118.91 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.541 0.686 . . . . 0.0 110.104 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 46.6 mt-10 -132.32 123.76 27.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.972 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.78 101.34 29.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.59 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.1 -27.62 85.27 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.958 2.438 . . . . 0.0 112.513 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 82' ' ' SER . 8.9 m-20 -63.07 -27.52 69.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -121.47 10.45 10.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.426 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.31 28.82 18.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 23' ' ' ALA . 75.8 mt -85.56 129.21 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.487 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 22.7 ttmm -152.52 78.03 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -133.24 148.08 67.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.277 -172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.71 162.11 30.19 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.783 2.322 . . . . 0.0 112.436 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 63.8 t -114.56 129.39 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.41 110.7 53.96 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.822 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 16.9 Cg_exo -66.43 110.76 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.071 2.514 . . . . 0.0 112.069 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.62 168.5 35.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.582 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.15 144.94 38.36 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.873 2.382 . . . . 0.0 111.899 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -57.95 109.93 0.83 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.996 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -139.65 147.0 50.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.94 -42.33 67.64 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.063 2.508 . . . . 0.0 113.228 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.38 -18.54 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -86.52 -43.3 12.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.78 -8.16 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.515 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.0 -17.5 63.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.638 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.0 -64.86 1.02 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.638 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.14 -113.32 0.29 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.95 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.79 130.53 57.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.1 m -144.34 158.08 43.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 87.9 m-85 -69.71 150.94 46.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 111.347 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -86.43 -62.79 1.43 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -170.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.927 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.28 39.12 1.12 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.59 90.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.89 -18.36 65.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.764 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.712 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 17.9 m -96.85 110.23 22.77 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.102 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' ' 7' ' ' ILE . 3.6 pp -81.91 -10.0 59.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.59 0.709 . . . . 0.0 109.494 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -100.6 11.07 40.27 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.003 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.6 t70 -82.04 177.41 8.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -83.09 -44.04 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.74 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.535 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -97.29 117.93 32.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.776 . . . . 0.0 111.034 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.0 136.47 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 m -125.69 112.8 16.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.442 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' HB ' HD23 ' A' ' 123' ' ' LEU . 2.8 mt -121.38 139.07 49.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.992 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 121.57 44.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -123.27 77.07 0.36 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.306 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -74.46 121.68 21.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.002 0.43 . . . . 0.0 110.438 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 70' ' ' TYR . 21.7 m -112.71 166.73 11.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.824 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' N ' HG22 ' A' ' 63' ' ' THR . 63.7 m-85 -127.99 116.5 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 tt -55.8 -31.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.527 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 34.3 t70 -66.87 -24.73 66.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 80.2 mtt180 -111.56 93.04 18.22 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 26.5 Cg_exo -62.1 -21.76 73.02 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.369 2.712 . . . . 0.0 113.516 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -91.24 22.43 3.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.835 0.35 . . . . 0.0 111.617 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.1 OUTLIER -84.2 173.41 11.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 172.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 19.2 pm0 -65.84 -59.07 4.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.598 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 56.3 m-85 -99.97 26.58 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.925 -0.484 . . . . 0.0 112.143 -171.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 p -67.22 -37.4 83.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.122 0.487 . . . . 0.0 111.32 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.1 t30 -98.6 13.8 30.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.46 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.86 -7.89 13.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.49 0.662 . . . . 0.0 110.56 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 19.9 pttp -68.34 -23.84 64.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.737 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 -5.28 58.63 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.443 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.27 170.4 16.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.04 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -143.99 177.67 8.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.018 0.437 . . . . 0.0 110.854 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.52 1.17 17.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.294 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -150.15 48.68 0.58 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.094 176.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 17.4 p -86.26 -158.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.222 0.534 . . . . 0.0 110.635 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -129.11 112.0 13.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.991 176.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.9 t -105.74 119.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.189 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.41 118.32 36.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.95 0.405 . . . . 0.0 110.935 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -106.54 107.2 18.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.765 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -94.9 139.07 31.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 113.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.527 0.68 . . . . 0.0 110.883 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 -86.5 0.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.021 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.25 2.14 1.86 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.19 0.519 . . . . 0.0 110.506 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.87 145.89 37.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.502 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 m -131.02 109.41 10.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.914 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE1' ' A' ' 95' ' ' TYR . 4.7 ptm180 -106.77 148.39 28.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.291 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -105.6 141.55 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 95.5 m-85 -129.74 150.06 51.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -116.44 128.22 55.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.303 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -71.43 79.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.981 0.419 . . . . 0.0 110.198 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -82.92 -20.53 35.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.784 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.6 t -128.68 111.69 13.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -120.14 113.79 41.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.515 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -151.43 163.05 39.85 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.56 133.93 47.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.999 0.428 . . . . 0.0 110.19 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.72 137.9 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.232 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.89 150.79 74.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.313 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.81 71.86 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.729 2.286 . . . . 0.0 111.181 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -143.26 93.8 2.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.312 0.577 . . . . 0.0 110.954 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 54.46 51.45 14.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.333 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -13.24 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.518 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.93 30.64 4.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.076 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.58 -8.46 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.633 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.29 134.53 48.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.799 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.493 ' OD1' ' HG2' ' A' ' 114' ' ' GLN . 11.6 p30 -107.87 -164.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.53 20.22 14.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 112' ' ' ASP . 58.0 mm-40 -71.72 115.95 11.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.113 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.62 69.9 3.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.231 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.35 45.54 3.28 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -93.49 163.77 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.289 -0.455 . . . . 0.0 110.602 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.45 -166.72 1.02 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.528 ' N ' ' HE3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -76.44 101.96 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 161.78 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.536 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -118.47 115.55 24.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -82.7 102.29 11.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.517 HD23 ' HB ' ' A' ' 59' ' ' ILE . 84.8 mt -98.16 107.51 20.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.266 0.555 . . . . 0.0 111.248 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mt -81.18 96.43 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.553 ' HG1' ' HD1' ' A' ' 142' ' ' PHE . 8.9 p -105.61 52.25 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.301 0.572 . . . . 0.0 111.762 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 35.2 m -73.83 152.6 40.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.295 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.532 ' HB2' ' HE ' ' A' ' 139' ' ' ARG . 14.9 t0 -118.82 -54.62 2.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.75 0.786 . . . . 0.0 109.273 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.62 ' OD1' ' HB2' ' A' ' 139' ' ' ARG . 4.3 p-10 . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.581 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.558 0.218 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -176.86 130.54 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.62 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 20.5 tpt180 -161.28 -82.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HD2' ' CE1' ' A' ' 142' ' ' PHE . 14.5 mmtp -157.67 143.35 17.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -167.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.8 tt -135.59 139.39 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.775 166.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.553 ' HD1' ' HG1' ' A' ' 125' ' ' THR . 66.6 m-85 -128.2 125.09 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 46.5 t -110.96 107.84 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.571 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.71 113.64 26.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.967 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.8 m -83.67 141.63 31.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.21 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -67.89 128.07 35.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.104 0.478 . . . . 0.0 111.007 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 96' ' ' LYS . 2.0 t -92.77 166.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.765 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.349 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.604 0.24 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 55.4 Cg_endo -71.2 113.34 3.56 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.532 2.155 . . . . 0.0 112.212 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 32.8 mm-40 -121.13 -166.03 1.3 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.613 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 52' ' ' LEU . 36.0 mt -106.85 96.61 15.03 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 86.6 Cg_endo -95.77 -169.39 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.029 2.486 . . . . 0.0 113.13 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -82.88 12.59 4.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.64 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 9.5 t70 -108.64 125.65 52.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -109.78 12.39 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.948 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.5 t -106.99 -2.72 20.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.368 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 49.4 mmtm -97.24 178.38 5.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.482 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.66 117.27 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -88.14 -34.21 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.1 31.06 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.607 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.06 129.97 40.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.3 123.67 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.29 0.567 . . . . 0.0 110.346 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 30.5 mt-10 -121.43 121.69 38.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.361 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.2 mt -129.34 94.12 33.97 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.904 172.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.4 Cg_endo -54.7 -33.37 79.81 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.288 2.659 . . . . 0.0 112.407 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.6 -31.43 69.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.45 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.38 11.79 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.917 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.35 27.24 16.91 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.401 0.438 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 64.2 mt -91.24 119.9 39.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -139.3 58.16 1.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.799 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 21.1 mm-40 -108.8 145.01 30.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.281 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 157.9 33.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.828 2.352 . . . . 0.0 112.406 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.489 ' HA ' HG13 ' A' ' 43' ' ' VAL . 60.7 t -111.71 131.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.3 m-85 -87.62 114.21 57.87 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.918 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -67.07 140.2 53.41 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.099 2.533 . . . . 0.0 112.201 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -168.08 24.98 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.731 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.35 160.23 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.436 2.758 . . . . 0.0 112.038 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.145 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.58 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.1 t -161.82 144.87 9.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.315 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -41.1 -50.63 4.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.527 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -62.5 -46.07 90.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.921 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.411 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 14.7 mm100 -64.65 -48.83 73.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.879 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -78.69 20.65 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.18 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.67 -4.62 8.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 41' ' ' ARG . 46.0 mtp85 -124.85 -32.49 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.346 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.09 -162.1 14.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.074 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 6.8 p -95.82 140.5 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 50.3 m -138.9 176.6 8.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -90.51 140.5 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.077 0.465 . . . . 0.0 111.262 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.5 -3.68 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.88 154.86 28.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.318 -172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.32 19.25 14.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.62 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -71.34 172.12 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.422 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.41 7.86 35.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.358 0.599 . . . . 0.0 110.837 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 54.0 m -154.06 152.28 30.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.642 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -103.94 -7.07 20.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.205 0.526 . . . . 0.0 110.609 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' OD1' ' HB3' ' A' ' 51' ' ' SER . 9.8 p-10 -95.34 10.25 36.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.605 -178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.74 168.84 19.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.481 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.45 -32.58 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.351 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.38 111.61 24.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.868 0.842 . . . . 0.0 110.847 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 21.0 mm -135.43 102.33 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.839 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 17.1 m -83.06 106.85 15.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 6.4 mt -99.13 111.45 28.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.782 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.42 96.44 6.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.425 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -103.02 85.01 0.49 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.198 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 70' ' ' TYR . 86.1 t60 -55.58 138.77 46.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' PHE . 9.8 m -114.77 147.71 39.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.077 -174.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.54 ' HE2' ' HG2' ' A' ' 67' ' ' ARG . 17.0 t80 -143.82 83.45 1.75 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.741 ' HA ' HG23 ' A' ' 73' ' ' THR . 0.5 OUTLIER -67.56 -13.86 17.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.92 -172.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 23.3 t70 -67.04 -51.85 49.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.418 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG2' ' HE2' ' A' ' 64' ' ' PHE . 5.6 mmp_? -92.38 116.12 65.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.67 ' HA ' HG21 ' A' ' 73' ' ' THR . 39.5 Cg_endo -66.83 -15.66 47.83 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.187 2.591 . . . . 0.0 114.301 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.21 12.98 32.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 43.8 t80 -80.33 156.45 26.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 75.3 mt-30 -52.11 -49.09 64.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.826 0.345 . . . . 0.0 111.64 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.731 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 82.1 m-85 -116.34 92.64 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.049 0.452 . . . . 0.0 110.283 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 65' ' ' ILE . 24.3 m -133.3 -46.11 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.255 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.14 16.11 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -57.45 -25.09 59.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.748 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -55.8 -23.86 32.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.024 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.93 2.68 45.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.29 176.26 8.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.022 0.439 . . . . 0.0 110.642 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -148.75 -178.23 6.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.351 -178.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.05 -16.19 59.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 -175.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -139.34 45.24 1.03 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.308 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 5.7 p -85.67 -162.05 0.68 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 tpt -129.51 98.25 4.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.078 0.465 . . . . 0.0 109.819 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG21 ' SD ' ' A' ' 97' ' ' MET . 97.1 t -84.85 126.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.038 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.3 m-85 -104.98 116.73 32.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.931 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 52.6 t80 -110.3 111.68 23.14 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.483 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -102.46 140.63 36.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.448 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 52' ' ' LEU . 2.6 p -140.69 111.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.246 0.546 . . . . 0.0 109.881 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.57 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 63.82 -98.06 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.501 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.38 0.35 10.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.209 0.528 . . . . 0.0 110.414 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HB2' HG13 ' A' ' 88' ' ' VAL . 33.1 mm-40 -94.27 157.43 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.389 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -150.2 129.92 13.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.75 152.92 32.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -103.04 137.98 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.58 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 96.8 m-85 -128.58 145.48 51.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.06 0.457 . . . . 0.0 111.286 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 11.6 tppt? -112.04 129.17 56.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.493 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.562 ' SD ' HG21 ' A' ' 84' ' ' VAL . 75.6 mmm -78.87 48.29 0.82 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.259 0.552 . . . . 0.0 110.329 -176.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 98' ' ' THR . 3.5 t -84.58 6.81 22.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.955 -171.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 58.8 m -136.25 106.72 6.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.013 171.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.87 96.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 101' ' ' ARG . 25.3 mtm180 -145.17 138.24 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.566 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 8.2 p-10 -108.2 175.12 5.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.342 0.591 . . . . 0.0 111.659 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.21 147.59 14.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.744 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -110.61 132.55 21.52 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 5.9 Cg_exo -78.98 67.7 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 112.876 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 p -67.54 -28.49 67.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.61 0.719 . . . . 0.0 109.647 172.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.98 160.33 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.082 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.438 HG23 ' HG3' ' A' ' 109' ' ' GLU . 34.8 m -83.61 -23.63 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.346 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 108' ' ' VAL . 41.0 mt-10 -100.85 29.19 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 111.047 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.664 HG23 ' HG ' ' A' ' 111' ' ' LEU . 29.8 m -66.64 -17.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.261 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 110' ' ' VAL . 72.0 mt -131.33 -175.31 3.66 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.4 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' A' ' 114' ' ' GLN . 2.5 t70 -146.73 -167.91 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.96 88.62 7.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.07 0.462 . . . . 0.0 110.101 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 112' ' ' ASP . 1.8 mp0 -74.95 105.99 6.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.743 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.03 -15.55 61.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.021 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.44 80.71 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.039 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -96.78 168.08 10.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.3 0.571 . . . . 0.0 110.911 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.92 -166.86 2.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -78.16 94.71 4.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.57 137.99 16.72 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.5 mt -101.5 122.72 44.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.7 m -84.0 82.67 8.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.297 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 7.7 mp -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.788 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mt -83.99 78.56 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 23.0 m -78.19 88.26 4.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 139' ' ' ARG . 31.0 p -109.6 112.71 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.365 0.602 . . . . 0.0 112.202 -173.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 26.7 t70 -108.08 164.45 12.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 127' ' ' ASP . 3.5 t70 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.424 0.63 . . . . 0.0 112.145 177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -78.45 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -164.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 126' ' ' CYS . 5.4 mpt_? -109.12 91.05 3.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.589 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.6 OUTLIER -90.11 96.81 10.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.81 -174.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -77.44 135.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.633 0.73 . . . . 0.0 110.499 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.01 109.23 15.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.657 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 51.1 t -97.5 102.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.04 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -99.73 112.6 24.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.132 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -77.74 139.0 39.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.909 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 119' ' ' LYS . 41.6 tt0 -65.05 132.97 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 110.977 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.04 153.4 11.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.1 pttp . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.33 -173.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.006 0.431 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' HD11 ' A' ' 52' ' ' LEU . 66.5 Cg_endo -78.72 133.74 11.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.706 2.27 . . . . 0.0 112.821 -175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.583 HE22 ' HB2' ' A' ' 53' ' ' ASP . 87.6 mm-40 -94.01 160.58 14.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.669 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 31' ' ' PRO . 58.4 mt -59.9 109.84 2.31 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.712 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 96.8 Cg_endo -96.16 -178.66 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.508 2.806 . . . . 0.0 114.238 -170.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 33.3 ttmt -64.01 -44.55 92.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.009 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 1.6 m-20 -75.64 108.6 8.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.414 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.629 ' HD2' ' HA2' ' A' ' 32' ' ' GLY . 45.7 mmtm -83.67 5.25 25.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.01 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -97.86 -4.05 37.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.2 mmtp -91.9 105.41 17.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG21 ' CB ' ' A' ' 28' ' ' PRO . 5.1 p -62.14 121.27 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.734 0.778 . . . . 0.0 111.101 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 52' ' ' LEU . . . -89.15 -28.63 19.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.464 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.12 27.62 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.659 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -117.6 141.23 48.61 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 84' ' ' VAL . 10.0 tp -117.3 127.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.089 0.471 . . . . 0.0 109.848 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 41.1 mt-10 -134.97 122.93 22.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 -176.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 71.9 mt -128.36 104.7 19.72 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 16.7 Cg_endo -59.73 -32.92 96.42 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.359 2.706 . . . . 0.0 113.811 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.56 -29.97 70.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.961 0.41 . . . . 0.0 111.559 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.24 2.14 16.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.074 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.07 27.48 17.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.699 0.762 . . . . 0.0 110.184 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 60.7 mt -81.71 118.08 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.663 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -141.05 83.79 1.9 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.415 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.61 150.36 76.1 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.086 0.47 . . . . 0.0 111.36 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CB ' HG21 ' A' ' 14' ' ' VAL . 60.4 Cg_endo -73.46 140.11 29.6 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.864 2.376 . . . . 0.0 112.433 175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.568 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.4 t -88.7 134.62 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.51 104.02 18.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.398 0.618 . . . . 0.0 111.097 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 61.7 Cg_endo -76.76 109.39 2.84 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.83 2.353 . . . . 0.0 111.442 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 11' ' ' LYS . . . 177.18 -162.0 29.88 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.452 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.31 149.39 17.0 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.182 2.588 . . . . 0.0 112.028 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -73.41 120.21 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.495 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -159.61 135.35 6.05 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.01 -47.81 11.68 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.935 3.09 . . . . 0.0 113.93 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -56.21 -46.78 79.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.315 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -77.22 -35.63 55.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.337 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 44' ' ' SER . 96.1 mt -71.27 -14.24 62.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -87.97 -15.6 36.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.154 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 41' ' ' ARG . 63.2 mtt180 -87.28 -40.31 14.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.92 -172.55 44.04 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.224 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' ALA . 2.1 m -67.77 125.01 24.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.703 0.763 . . . . 0.0 111.973 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.422 ' HB2' HD23 ' A' ' 39' ' ' LEU . 14.9 m -130.17 146.03 51.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.925 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 63.8 m-85 -59.25 135.89 57.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.207 0.527 . . . . 0.0 111.664 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -92.92 3.12 56.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.803 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 42.6 mt-10 -121.32 147.94 45.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.1 pm0 -88.22 80.36 7.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.758 0.79 . . . . 0.0 109.827 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -114.95 149.31 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.313 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.5 mp0 -94.4 7.12 46.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.217 0.532 . . . . 0.0 110.734 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -149.77 151.68 34.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.119 0.485 . . . . 0.0 111.56 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -120.71 16.89 11.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.726 174.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HB2' HE22 ' A' ' 6' ' ' GLN . 26.8 t70 -88.19 -11.9 45.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.151 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -77.9 -167.48 1.0 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.58 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -117.6 -11.63 10.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.547 HD22 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -137.22 90.07 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -174.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.745 HG22 HD12 ' A' ' 121' ' ' LEU . 4.0 tt -121.92 148.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 -175.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -99.51 122.09 42.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.526 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.0 mt -123.53 131.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' VAL . . . -102.15 146.05 28.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.673 0.273 . . . . 0.0 110.613 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.78 171.43 29.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.181 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -127.75 138.42 52.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.642 HG21 ' HZ1' ' A' ' 140' ' ' LYS . 1.2 p -94.26 -86.1 0.28 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 43.1 p90 -161.6 155.1 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.534 0.683 . . . . 0.0 112.684 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 mm -127.49 -72.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.262 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 2.3 m-20 -129.24 14.44 6.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.1 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -104.31 101.0 24.32 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.508 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.819 ' HA ' HG21 ' A' ' 73' ' ' THR . 97.4 Cg_endo -89.7 0.56 5.74 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.413 2.742 . . . . 0.0 112.685 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -104.33 22.81 14.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.392 0.615 . . . . 0.0 110.026 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 20.5 t80 -104.47 155.98 18.34 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.403 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -61.73 -56.25 21.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.311 -174.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 65.8 m-85 -79.9 9.19 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.819 HG21 ' HA ' ' A' ' 68' ' ' PRO . 7.0 m -72.71 -26.44 61.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.154 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -94.87 4.91 53.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.51 -16.0 63.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.476 . . . . 0.0 110.509 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -22.66 65.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.804 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.47 -14.66 59.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.027 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.44 173.61 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -177.71 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.249 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -66.47 -10.95 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.973 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.28 55.12 0.66 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.189 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 62.3 m -111.11 137.68 48.48 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.214 0.531 . . . . 0.0 109.734 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.448 ' HE2' ' HA ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -80.69 104.33 11.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.341 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 90.2 t -96.14 124.29 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.054 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 83.1 m-85 -99.42 122.98 43.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -116.05 116.52 28.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.524 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 9.1 ttmt -113.16 135.12 54.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.951 -172.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.0 m -141.77 100.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.625 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.25 -83.15 0.53 Allowed Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.612 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -14.21 6.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 109.648 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 88' ' ' VAL . 58.0 mt-10 -93.07 136.44 33.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.649 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 m -140.85 101.61 4.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.14 161.88 13.37 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.504 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -102.97 125.17 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 65.5 m-85 -121.54 144.95 48.43 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 98' ' ' THR . 36.7 ttmt -108.46 145.37 34.75 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.3 mtp -81.67 46.88 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.378 0.609 . . . . 0.0 109.604 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 4.4 t -81.67 8.67 9.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.448 -168.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.6 m -145.25 93.03 2.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.582 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.8 mt -126.73 137.04 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.762 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -165.43 147.78 7.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.786 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 24.8 t70 -89.85 93.11 9.3 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.45 86.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.872 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.45 126.24 78.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD3' ' HG2' ' A' ' 139' ' ' ARG . 77.1 Cg_endo -76.58 46.23 1.81 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.166 2.578 . . . . 0.0 113.727 -171.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 t -76.72 -14.28 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.6 144.67 25.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.093 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.19 4.88 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -119.67 24.61 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.426 0.631 . . . . 0.0 110.081 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.73 15.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.841 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.28 162.89 13.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.279 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 1.3 m-20 -64.89 149.24 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.33 -40.38 97.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 112' ' ' ASP . 23.8 pt20 -75.56 133.54 40.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.749 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -106.59 97.15 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.643 0.259 . . . . 0.0 110.857 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.75 134.8 24.19 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.97 167.21 9.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.884 0.85 . . . . 0.0 112.562 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 175.19 -164.99 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.103 -1.862 . . . . 0.0 106.483 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -95.72 96.08 8.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -145.0 113.12 6.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.457 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.26 114.67 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -88.04 128.53 35.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.389 0.614 . . . . 0.0 110.046 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 17.8 mt -107.86 105.2 14.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.337 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.51 85.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.604 ' HB ' HG23 ' A' ' 63' ' ' THR . 31.9 p -87.05 86.43 7.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.569 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 42.9 m -64.84 106.01 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.407 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.31 -67.29 0.79 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.498 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 7.8 t70 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.018 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 . . . . . 0 CA--C 1.518 -0.263 0 CA-C-O 121.14 0.495 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.467 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 37.9 mtmm -80.67 89.33 5.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.215 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 5.8 ptt180 -106.22 81.41 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.642 ' HZ1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -62.21 118.03 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.308 -178.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.11 126.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.3 t80 -113.77 108.86 17.66 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.795 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.9 t -110.86 112.1 39.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -101.97 111.11 23.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.001 0.429 . . . . 0.0 110.549 177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.0 m -89.77 137.22 32.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.726 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 32.3 tt0 -59.8 124.53 20.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.829 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.6 155.21 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 122.21 1.005 . . . . 0.0 110.849 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.559 -168.334 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.775 0.322 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.17 113.99 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 111.318 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -151.5 159.28 44.23 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 77.8 mt -101.07 103.24 24.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 1.6 Cg_endo -84.34 167.49 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.04 2.494 . . . . 0.0 112.587 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -77.9 -12.87 60.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.291 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 18.5 t70 -84.65 123.37 30.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.138 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -95.67 12.31 30.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.655 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -93.86 -4.45 50.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.261 0.553 . . . . 0.0 110.154 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 49.9 mmtm -95.8 172.71 7.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.51 98.23 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.41 -32.27 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.077 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -148.73 156.13 26.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.902 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.497 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 1.0 OUTLIER -123.48 128.3 49.6 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.557 HD11 HG13 ' A' ' 84' ' ' VAL . 9.1 tp -102.31 117.82 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.525 0.678 . . . . 0.0 110.503 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.7 mt-10 -128.99 119.34 24.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.488 0.661 . . . . 0.0 111.466 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.67 102.06 39.14 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.753 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -25.68 75.48 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.023 2.482 . . . . 0.0 112.78 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.07 -3.16 54.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.19 10.99 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.541 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.21 20.79 10.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.769 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 67.6 mt -86.77 119.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 8.9 mtpm? -144.58 68.75 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.813 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 25.0 mm-40 -113.74 145.58 33.74 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.474 -172.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.28 149.73 57.8 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.652 2.235 . . . . 0.0 111.934 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.31 130.52 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HB3' HE21 ' A' ' 38' ' ' GLN . 27.6 m-85 -88.68 111.68 45.69 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.746 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 37.9 Cg_endo -67.62 152.83 77.63 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.021 2.481 . . . . 0.0 112.797 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.46 177.54 16.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.046 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.37 136.11 25.78 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.999 2.466 . . . . 0.0 111.448 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.1 115.06 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.773 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -128.71 151.7 77.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.494 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.3 -46.06 36.61 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.192 2.594 . . . . 0.0 113.404 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.53 -8.6 58.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.306 0.574 . . . . 0.0 111.26 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 30' ' ' TYR . 56.4 tt0 -101.69 -41.27 6.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.866 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.1 mt -67.74 -32.16 72.58 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.984 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.36 -12.98 57.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.207 0.527 . . . . 0.0 110.064 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -87.89 -40.06 14.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.503 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -127.17 0.91 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.018 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -122.29 138.06 53.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.7 p -135.9 174.79 10.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 0.0 110.988 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.6 m-85 -84.12 165.34 18.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.92 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.135 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 37.4 mt-10 -117.08 177.22 4.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.3 tt0 -114.6 13.88 17.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.998 0.904 . . . . 0.0 109.185 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.78 -34.97 11.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.645 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 1.7 pm0 -82.5 142.37 31.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.234 0.54 . . . . 0.0 111.233 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -86.68 152.02 22.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.342 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.83 9.28 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 111.272 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -119.96 -1.8 10.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.437 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -84.91 -173.77 4.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.122 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -102.18 41.53 1.22 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.625 0.25 . . . . 0.0 111.112 -173.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -171.94 126.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.81 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 23.8 mm -118.93 104.66 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 m -98.29 99.19 10.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.093 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt -120.98 148.14 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.04 140.07 32.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.702 0.287 . . . . 0.0 110.681 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -161.35 116.05 0.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.865 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -83.88 122.49 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 73' ' ' THR . 58.5 m -107.27 118.69 37.39 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.284 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' A' ' 67' ' ' ARG . 12.4 p90 -108.54 139.48 43.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.071 0.462 . . . . 0.0 111.368 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -49.46 -34.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.302 -173.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.44 -29.31 48.98 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 mmt85 -113.56 101.88 54.18 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.204 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.675 ' HA ' HG21 ' A' ' 73' ' ' THR . 8.2 Cg_exo -74.21 -10.73 22.77 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 123.097 2.532 . . . . 0.0 111.39 175.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -106.71 22.44 15.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.084 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -82.79 163.19 21.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.813 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 4.1 mp0 -52.08 -39.79 60.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 76.3 m-85 -128.88 25.53 5.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.675 HG21 ' HA ' ' A' ' 68' ' ' PRO . 3.0 m -68.24 -27.35 66.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.37 21.56 12.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 75' ' ' LEU . 11.7 mt -65.5 -11.64 45.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -71.43 -24.43 62.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.247 0.546 . . . . 0.0 110.76 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -81.2 -17.78 48.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.058 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.93 150.33 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -129.68 179.42 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -65.56 -6.55 11.23 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -171.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.52 23.74 7.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.1 m -87.87 130.68 34.82 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.92 113.05 6.78 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 18' ' ' ILE . 94.6 t -89.7 106.6 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.588 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.01 107.35 19.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.053 0.454 . . . . 0.0 110.323 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 31.8 t80 -108.65 101.0 10.17 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.283 0.564 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 54.5 mtmt -85.65 125.43 33.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.5 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 88' ' ' VAL . 17.8 m -107.9 92.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.822 0.82 . . . . 0.0 109.67 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.95 -89.0 1.42 Allowed Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -127.71 -17.92 4.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 111.138 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 26.1 mt-10 -84.24 142.42 30.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.741 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.3 m -108.78 112.24 24.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.529 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 12.9 mmt180 -89.11 130.75 35.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -100.8 125.89 47.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.936 0.398 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 78.7 m-85 -123.28 144.31 49.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.015 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HE2' HG11 ' A' ' 147' ' ' VAL . 5.4 tppt? -101.85 139.48 37.42 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 100' ' ' ILE . 70.1 mtp -77.64 59.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.43 . . . . 0.0 110.393 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.8 p -59.3 -44.55 92.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.282 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.9 m -113.16 98.89 7.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.981 0.42 . . . . 0.0 111.543 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 97' ' ' MET . 58.8 mt -122.31 105.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -149.8 150.53 32.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.71 127.81 38.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.509 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.44 148.14 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 104' ' ' LYS . 44.6 mtpt -57.74 123.29 62.35 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.22 -8.4 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.764 2.309 . . . . 0.0 112.544 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 p -93.75 -16.06 24.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.164 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.92 120.43 19.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.659 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 m -98.57 2.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -76.06 -20.77 57.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.04 7.1 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.72 -174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.37 113.64 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.252 0.548 . . . . 0.0 111.132 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.94 133.29 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.413 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.2 125.21 51.99 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.646 -169.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -120.23 139.46 52.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.938 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -83.38 51.79 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 110.113 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 145.29 15.64 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.154 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -133.51 168.75 18.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -175.23 -178.83 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.65 86.96 7.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.47 145.58 31.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.386 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -104.63 115.75 30.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.213 175.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.654 ' HA ' HG22 ' A' ' 143' ' ' VAL . 5.1 t -87.77 59.62 5.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.781 0.801 . . . . 0.0 110.436 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.499 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 5.7 mt -54.92 113.99 1.56 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.219 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.78 97.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.413 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 9.2 p -111.33 107.74 17.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -79.5 140.55 37.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.442 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 5.7 m-20 -89.14 -46.19 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.279 0.561 . . . . 0.0 111.086 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.158 -172.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 10.1 mtpm? -63.26 130.64 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.905 0.383 . . . . 0.0 111.167 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -118.43 98.53 6.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -78.53 127.86 32.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.21 131.3 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.712 0.767 . . . . 0.0 109.988 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.4 t80 -129.18 98.78 5.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.241 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 122' ' ' THR . 58.6 t -106.06 104.46 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.9 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.573 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -90.31 133.38 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.841 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.6 m -104.86 138.43 41.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.513 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 41.6 tt0 -64.97 113.87 4.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.244 0.545 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 96' ' ' LYS . 2.1 p -116.58 153.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.068 0.937 . . . . 0.0 112.367 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--N 1.308 -1.201 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.359 -178.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.827 0.346 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.686 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 26.0 Cg_endo -63.29 120.1 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.761 2.307 . . . . 0.0 112.309 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -141.89 159.21 42.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 31' ' ' PRO . 46.6 mt -103.49 110.93 64.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.63 0.253 . . . . 0.0 110.68 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.31 -176.22 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.681 2.254 . . . . 0.0 111.292 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.24 -19.77 21.85 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.412 0.625 . . . . 0.0 109.608 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 2.7 p-10 -92.32 165.1 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -116.46 16.33 15.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.092 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -89.33 -27.35 20.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 110.045 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 29.8 mmmt -84.0 113.84 21.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.14 97.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.899 0.38 . . . . 0.0 110.588 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 -30.38 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.734 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -146.99 157.74 27.51 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.948 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 2.4 t80 -137.77 124.98 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -95.06 121.58 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.152 0.501 . . . . 0.0 110.243 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.1 mt-10 -128.5 106.43 8.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.548 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.8 mt -120.42 98.78 48.36 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.185 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 -33.39 93.83 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.043 2.496 . . . . 0.0 112.486 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.36 -19.9 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.548 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -128.04 16.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.4 23.09 12.65 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.217 0.323 . . . . 0.0 111.636 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 81.1 mt -94.18 112.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.635 0.255 . . . . 0.0 111.342 -172.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 54.5 mtmt -141.05 86.16 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.668 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -123.61 141.33 36.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.65 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.3 146.24 56.28 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.262 1.975 . . . . 0.0 111.449 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 58.0 t -100.08 127.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.705 ' HB3' ' HB2' ' A' ' 11' ' ' LYS . 23.7 m-85 -95.48 105.18 18.74 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.592 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -66.61 143.43 68.41 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.996 2.464 . . . . 0.0 112.284 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.67 -134.26 6.15 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.434 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -95.87 155.05 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.406 2.737 . . . . 0.0 112.797 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.83 129.58 35.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.28 138.95 7.67 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.54 -31.97 80.85 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.178 2.586 . . . . 0.0 112.925 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.31 -35.41 77.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 111.354 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.9 tt0 -85.52 -34.7 21.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.892 0.377 . . . . 0.0 110.345 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.71 -16.64 61.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.599 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 65.8 t30 -82.29 3.74 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.727 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 11.7 ptp180 -137.11 -43.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.304 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' TYR . . . -139.15 169.7 24.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.192 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.63 140.03 16.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -139.29 174.52 10.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.05 144.8 25.89 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.325 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -83.96 -79.93 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.0 77.32 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.378 0.608 . . . . 0.0 111.122 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -16.67 35.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.6 36.11 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.758 -1.564 . . . . 0.0 111.976 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -156.97 -150.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.126 0.489 . . . . 0.0 111.224 -172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 68.8 m -103.03 159.47 15.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.312 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.41 2.12 4.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.761 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 51' ' ' SER . 1.2 p-10 -91.1 -5.77 54.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.56 166.35 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.943 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -85.71 -35.32 20.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.583 0.23 . . . . 0.0 111.432 -173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.34 85.81 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.648 0.737 . . . . 0.0 111.625 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.535 HG21 HD22 ' A' ' 121' ' ' LEU . 34.4 mm -82.82 132.61 30.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.675 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 p -130.55 107.85 9.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.325 0.583 . . . . 0.0 110.578 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 123' ' ' LEU . 4.0 mt -107.55 143.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -120.29 149.33 42.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.203 0.525 . . . . 0.0 111.887 -173.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.7 -165.15 21.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -145.34 137.72 25.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.434 0.617 . . . . 0.0 110.57 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -89.72 132.89 34.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.959 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.67 121.72 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.937 0.399 . . . . 0.0 111.057 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tt -88.55 -30.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.59 -42.2 82.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 76.0 mtt180 -105.85 104.47 49.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.198 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.43 -35.65 38.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.414 2.076 . . . . 0.0 112.568 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -87.71 52.35 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.438 0.637 . . . . 0.0 110.302 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 40' ' ' ASN . 15.6 t80 -104.25 -167.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.001 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 3.6 pt20 -82.16 -38.25 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.705 0.288 . . . . 0.0 111.171 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 71' ' ' GLN . 78.1 m-85 -131.19 97.86 4.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.116 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 70' ' ' TYR . 25.5 p -130.88 -48.96 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.6 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.551 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 62.3 t30 -84.77 16.85 3.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.1 tp -66.58 -13.87 61.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 110.781 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -68.56 -24.0 64.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 175.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.0 9.1 20.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.751 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -103.0 129.29 49.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.1 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 3.0 mppt? -112.84 -178.5 3.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.907 -172.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -66.49 -6.62 15.47 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 112.017 -175.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -132.0 19.93 4.59 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.456 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 49.9 m -74.12 115.27 13.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.2 tpt -65.01 112.64 3.42 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.757 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 95.2 t -96.71 123.41 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.391 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 63.0 m-85 -106.05 126.68 52.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.025 0.44 . . . . 0.0 110.663 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.507 ' HE1' HG21 ' A' ' 29' ' ' VAL . 24.9 t80 -115.76 103.86 11.09 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.413 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.513 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 12.0 ttmm -78.83 138.4 38.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.61 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.5 m -136.56 102.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.247 0.546 . . . . 0.0 110.559 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.33 -81.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.162 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -135.79 -5.12 2.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 110.324 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -101.58 156.97 17.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.372 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 m -123.35 125.16 44.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.65 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HB2' ' HE1' ' A' ' 95' ' ' TYR . 15.1 mmm180 -105.97 137.34 44.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -103.2 135.4 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.618 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 81.1 m-85 -132.52 146.72 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.254 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.554 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 9.9 tppt? -109.42 139.34 44.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 100' ' ' ILE . 68.4 mtp -77.63 79.76 4.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.9 p -80.77 -43.1 20.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 4.5 m -112.72 108.34 17.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 110.57 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.6 mt -128.66 102.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.713 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -153.6 174.08 14.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.8 143.18 50.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 t -111.36 148.67 14.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.147 -172.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 1.7 tmtp? -121.9 89.82 48.29 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -101.73 -150.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.778 2.985 . . . . 0.0 111.843 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.2 m -144.49 -46.92 0.25 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 108' ' ' VAL . 2.6 t70 -138.39 -154.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 109' ' ' GLU . 21.9 m -91.16 -173.8 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.328 -0.232 . . . . 0.0 111.282 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 108' ' ' VAL . 4.9 mm-40 69.41 -3.91 1.48 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.062 0.945 . . . . 0.0 113.011 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.65 -23.77 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.097 0.475 . . . . 0.0 110.815 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -114.22 131.32 56.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.805 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -89.65 130.7 35.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.67 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.468 ' C ' HE21 ' A' ' 114' ' ' GLN . 8.5 tp10 -102.16 141.15 35.46 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.663 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -154.49 157.24 38.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.075 -176.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -79.17 79.7 5.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.931 0.872 . . . . 0.0 111.163 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.26 43.19 0.49 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.996 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HZ1' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -102.53 -165.21 1.16 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.16 0.505 . . . . 0.0 110.86 -177.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.7 -174.35 4.13 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -78.25 96.93 5.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -134.67 146.44 49.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 57' ' ' ILE . 18.4 mt -95.26 100.49 12.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 90.19 3.37 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 59' ' ' ILE . 7.6 mt -84.16 114.46 21.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.771 0.796 . . . . 0.0 111.291 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.552 HG23 ' NH2' ' A' ' 139' ' ' ARG . 73.3 mt -91.91 94.13 4.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.906 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.4 p -115.81 85.56 2.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.499 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.3 p -78.58 135.23 37.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.512 ' OD1' ' HB2' ' A' ' 140' ' ' LYS . 2.3 m-20 -89.72 -60.83 1.84 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.755 0.788 . . . . 0.0 109.688 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 4.7 t70 . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 114.163 -1.38 . . . . 0.0 111.132 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 43.7 mt-10 . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.043 0.449 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 28.5 mttp -104.37 97.46 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.265 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.552 ' NH2' HG23 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -119.92 117.59 28.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.638 0.732 . . . . 0.0 111.427 -177.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.543 ' HE3' HG23 ' A' ' 100' ' ' ILE . 2.3 tmtm? -77.5 124.56 28.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.72 121.78 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 121.597 0.713 . . . . 0.0 110.139 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.1 t80 -120.59 115.88 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.84 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.5 t -111.8 116.96 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.366 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -105.33 119.78 39.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.337 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 m -87.0 138.87 31.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.3 112.35 5.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 96' ' ' LYS . 2.6 p -122.57 150.49 26.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--N 1.31 -1.13 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.211 -174.24 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm . . . . . 0 C--O 1.232 0.182 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 17.1 Cg_endo -56.95 145.84 82.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.25 2.633 . . . . 0.0 112.744 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.468 ' HA ' HD21 ' A' ' 52' ' ' LEU . 26.0 mm-40 -129.32 168.36 16.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.912 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.667 HG13 HD23 ' A' ' 52' ' ' LEU . 82.7 mt -100.02 105.77 37.25 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.02 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 10.8 Cg_endo -89.41 -93.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.959 2.439 . . . . 0.0 113.176 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 9' ' ' LYS . 13.4 ttpp -164.97 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.23 124.2 16.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.001 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 38' ' ' GLN . 77.4 mttt -90.09 13.34 15.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.266 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -120.13 6.7 10.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -105.88 144.16 33.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.412 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.83 102.5 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.825 0.345 . . . . 0.0 110.289 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -84.66 -31.69 24.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.235 0.541 . . . . 0.0 110.203 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.15 178.24 31.92 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.017 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.01 144.44 50.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tp -117.13 118.75 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.549 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.8 mt-10 -126.4 113.0 16.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.46 0.648 . . . . 0.0 111.671 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.54 99.66 45.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.45 -29.79 89.44 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.164 2.576 . . . . 0.0 112.673 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.28 -21.23 66.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.599 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -125.86 8.81 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.131 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 56.64 31.19 18.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.418 0.628 . . . . 0.0 111.121 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 78.0 mt -83.32 110.01 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.07 67.6 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 35.3 mm-40 -120.4 157.02 54.82 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.793 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.84 160.68 30.71 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.533 2.155 . . . . 0.0 112.563 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -112.43 132.93 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 35.4 m-85 -92.82 111.19 50.09 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 0.0 110.522 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 55.7 Cg_endo -70.38 98.69 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.364 2.709 . . . . 0.0 112.918 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.27 173.57 41.15 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 154.01 43.64 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.738 2.292 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 107.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.548 0.53 . . . . 0.0 111.034 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.477 ' HB ' ' OE1' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -136.58 142.23 38.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.915 -176.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -47.85 -49.54 13.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.981 3.12 . . . . 0.0 114.245 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.12 -28.28 39.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -174.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.824 ' HB2' ' HD3' ' A' ' 11' ' ' LYS . 9.3 tt0 -73.41 -39.57 64.96 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 35' ' ' THR . 91.1 mt -63.74 -36.64 84.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.752 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -32.89 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -86.75 -12.36 48.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.676 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 71' ' ' GLN . . . 162.05 -96.25 0.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.322 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 59' ' ' ILE . 5.0 p -154.28 140.86 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 120.78 0.324 . . . . 0.0 110.607 -175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . 19.8 p -125.05 174.75 7.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.09 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.44 164.07 24.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.908 0.385 . . . . 0.0 110.747 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' SER . . . -79.75 -55.13 5.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.064 0.459 . . . . 0.0 110.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -112.69 151.25 30.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.48 -177.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -74.27 -36.87 63.84 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.165 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -89.3 19.0 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.223 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 41.1 mt-10 -84.86 102.27 12.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 109.849 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 m -72.89 133.36 44.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 7' ' ' ILE . 2.0 pp -70.53 -2.46 14.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.54 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -109.07 -3.46 17.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.371 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.79 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.487 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 pt20 172.27 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' HD3' ' A' ' 117' ' ' LYS . 7.4 t30 -94.24 119.69 33.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.295 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 52' ' ' LEU . 17.2 mm -123.39 100.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.066 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' THR . 4.5 m -92.8 114.47 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 110.347 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.685 ' HB ' ' HG ' ' A' ' 123' ' ' LEU . 3.0 mt -111.52 108.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 121.62 33.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.803 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.487 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -99.14 175.48 28.47 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.517 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' THR . 23.2 t-160 -84.0 -84.16 0.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.381 0.134 . . . . 0.0 111.144 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 62' ' ' HIS . 15.2 t 171.75 -170.04 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.21 150.31 30.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.35 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.666 HG13 ' H ' ' A' ' 66' ' ' ASP . 10.7 tp -158.47 177.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.666 ' H ' HG13 ' A' ' 65' ' ' ILE . 38.8 t70 -76.77 34.65 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.689 0.757 . . . . 0.0 111.221 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -125.3 105.36 28.21 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 121.977 -0.452 . . . . 0.0 110.298 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 57.0 Cg_endo -72.32 -4.96 16.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -103.4 16.81 25.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.531 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.4 t80 -84.66 151.77 24.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.133 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 12.3 mp0 -46.55 -39.76 11.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.54 17.69 9.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -171.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 38.5 m -69.15 -39.7 78.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.491 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -99.0 7.4 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.086 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.18 -13.48 37.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 110.754 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -63.78 -23.84 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.232 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.49 -8.31 59.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.686 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -85.7 158.67 19.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.57 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -128.2 -178.16 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.277 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -72.06 -5.47 35.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.437 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.31 8.21 12.32 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.473 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.8 m -74.04 155.71 38.25 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.731 0.777 . . . . 0.0 110.915 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.92 120.05 35.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.102 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.755 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 72.1 t -103.23 108.68 24.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.323 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 42.0 m-85 -90.05 109.81 20.84 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.286 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HB2' HD11 ' A' ' 121' ' ' LEU . 38.9 t80 -99.07 110.39 22.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -109.1 142.54 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.256 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 52' ' ' LEU . 2.9 p -150.64 103.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.83 0.824 . . . . 0.0 110.091 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 62.58 -98.29 0.2 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.226 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.58 -7.16 17.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.45 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 6.4 mm-40 -92.89 145.06 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.443 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 m -150.04 99.93 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.225 0.536 . . . . 0.0 110.01 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -106.03 136.87 44.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.615 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -89.96 133.29 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.993 0.425 . . . . 0.0 110.336 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -126.94 147.35 50.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.27 148.31 30.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.56 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 68.3 mtp -80.65 56.6 2.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.199 0.523 . . . . 0.0 110.27 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.1 p -60.98 -38.5 86.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.187 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.1 m -119.42 95.59 4.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.014 0.435 . . . . 0.0 111.489 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 97' ' ' MET . 59.3 mt -115.66 103.39 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -132.33 147.17 52.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.957 0.408 . . . . 0.0 110.621 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 36.3 t70 -112.78 120.22 40.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.635 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 111' ' ' LEU . 15.7 t -123.43 154.88 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.223 -173.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 92.1 mttt -90.57 138.32 26.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 12.6 Cg_exo -74.06 42.92 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.84 3.027 . . . . 0.0 113.02 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -59.05 -48.51 81.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.411 0.624 . . . . 0.0 109.797 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -143.84 171.62 13.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.112 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.0 m -88.68 -8.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.443 0.639 . . . . 0.0 109.476 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.44 -12.87 59.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.881 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 111' ' ' LEU . 12.5 p -69.88 -24.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.065 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 110' ' ' VAL . 90.6 mt -121.05 135.47 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -166.2 143.72 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.36 114.38 27.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.998 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.47 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -95.76 161.4 14.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.577 -176.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.48 23.67 13.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 123.693 0.621 . . . . 0.0 111.343 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.26 -149.12 21.77 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -145.4 158.74 43.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.854 0.359 . . . . 0.0 111.583 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -111.98 -161.31 0.75 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 6.1 mptt -80.64 97.47 7.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.81 138.78 24.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.651 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.8 mt -96.28 101.77 13.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 143' ' ' VAL . 16.4 m -90.09 85.77 6.38 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.86 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.685 ' HG ' ' HB ' ' A' ' 59' ' ' ILE . 7.2 mp -77.3 104.11 7.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.239 0.543 . . . . 0.0 110.895 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.86 82.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.306 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.5 p -104.66 98.52 8.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.73 113.52 4.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.844 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 1.6 t70 -64.26 -39.1 93.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.77 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.964 176.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -156.61 135.23 11.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.844 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 3.4 ptp180 -145.02 108.96 4.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.421 0.629 . . . . 0.0 111.569 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -88.62 109.96 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.666 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 141' ' ' ILE . 3.9 tp -88.69 127.14 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 110.31 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.755 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.7 t80 -118.54 114.57 23.03 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.32 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.9 t -112.44 115.01 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.104 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -97.03 117.77 31.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.385 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.1 m -89.83 142.31 27.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.185 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.44 138.34 56.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.6 t -111.11 161.85 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.309 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.666 0.27 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.0 116.99 4.92 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.251 1.968 . . . . 0.0 111.639 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -130.05 175.25 9.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.204 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 31' ' ' PRO . 48.0 mm -113.44 89.28 14.69 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -92.73 -176.84 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.202 2.601 . . . . 0.0 113.086 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -74.96 -25.41 58.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.63 118.5 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 56.4 mttp -87.1 -46.64 9.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -56.32 -36.27 68.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -167.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.611 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.56 142.38 58.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.247 0.546 . . . . 0.0 110.98 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.28 126.06 49.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -103.07 -22.74 13.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.908 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.35 160.72 28.68 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.531 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.32 127.48 53.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.54 118.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.334 0.588 . . . . 0.0 109.43 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 34.2 mt-10 -125.4 112.0 15.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.799 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 84' ' ' VAL . 76.2 mt -125.22 102.65 30.36 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.901 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 20.2 Cg_endo -62.09 -29.74 81.63 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.129 2.553 . . . . 0.0 113.095 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.37 -16.74 61.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.53 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.44 8.82 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.327 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 58.55 34.71 24.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.764 0.792 . . . . 0.0 110.722 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 71.3 mt -95.66 120.88 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.745 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -145.3 79.64 1.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 31.7 mm-40 -122.4 141.65 35.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.676 -169.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.21 134.4 21.03 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.575 2.183 . . . . 0.0 111.7 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.593 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.3 t -96.2 138.13 22.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.357 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -109.46 91.02 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -68.28 133.43 28.43 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.88 2.386 . . . . 0.0 112.272 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.38 175.79 34.7 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HG2' ' HE3' ' A' ' 11' ' ' LYS . 19.6 Cg_endo -59.84 118.09 4.93 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.662 2.241 . . . . 0.0 112.237 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -55.8 126.32 25.09 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -142.25 139.02 17.2 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.83 -35.43 88.56 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.023 2.482 . . . . 0.0 113.01 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.47 -17.51 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.419 ' CD ' ' HD3' ' A' ' 11' ' ' LYS . 37.6 tt0 -88.92 -48.59 7.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 35' ' ' THR . 4.5 mm? -60.49 -22.9 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.808 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.12 -15.09 60.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.209 0.528 . . . . 0.0 110.582 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -100.01 -20.98 15.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.944 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.89 178.55 41.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.057 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.84 123.87 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -136.17 153.06 51.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.368 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.38 168.94 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.99 -64.39 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -105.65 158.73 16.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.124 0.487 . . . . 0.0 111.174 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.25 5.01 52.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.786 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -98.53 -0.42 43.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -107.78 135.55 49.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.852 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 57' ' ' ILE . 27.6 t -118.72 157.95 26.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.277 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.78 -2.23 16.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.578 0.704 . . . . 0.0 110.219 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -92.25 -16.45 26.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.972 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.91 178.54 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.825 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 -26.93 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.96 124.13 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.852 0.358 . . . . 0.0 110.657 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 121' ' ' LEU . 25.4 mm -135.25 139.88 46.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.78 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 m -132.97 114.4 13.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 110.257 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -123.02 136.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.6 174.18 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.28 -172.45 40.87 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.773 ' CD2' ' HA ' ' A' ' 127' ' ' ASP . 10.4 t60 78.18 122.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.983 0.913 . . . . 0.0 111.651 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -153.98 151.3 29.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.701 171.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.49 83.89 7.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.694 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 11.2 tp -99.57 18.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.796 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 14.3 t70 83.33 -25.4 0.14 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.346 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -75.76 108.19 5.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 60.2 Cg_endo -77.4 0.35 9.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.511 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -111.14 9.78 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 175.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.17 101.64 0.93 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.837 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -1.17 -71.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 19.3 m-85 -79.47 6.46 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.7 p -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -92.73 10.41 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.228 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.93 1.22 5.85 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.569 0.7 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -75.77 -25.05 56.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.198 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.72 59.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.07 149.16 26.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -112.72 173.93 6.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.172 -176.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -77.83 -6.01 52.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.619 . . . . 0.0 110.665 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.11 10.66 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.975 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.582 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 24.3 m -73.86 129.76 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.519 0.676 . . . . 0.0 110.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.414 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -75.91 108.29 8.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.816 173.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.826 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -97.07 134.4 34.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.659 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.5 m-85 -108.53 127.5 53.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.038 0.447 . . . . 0.0 110.228 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.415 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 57.2 t80 -123.3 113.18 18.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.383 0.611 . . . . 0.0 109.361 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.6 ttmm -89.97 132.63 35.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.715 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.04 117.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.364 0.602 . . . . 0.0 109.843 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 -99.81 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.316 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -131.01 11.09 5.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.831 0.348 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -125.83 156.48 39.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 11.6 m -126.47 130.15 50.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 79.1 mmt-85 -101.56 153.71 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.145 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 44.2 mtmt -102.56 131.57 49.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 109.891 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.2 m-85 -127.36 145.1 50.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.678 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -107.39 143.87 35.09 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.607 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.9 mtp -83.5 44.61 0.98 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.766 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 98' ' ' THR . 1.8 t -74.72 -9.45 58.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.463 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.7 m -123.85 84.41 2.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.281 0.563 . . . . 0.0 110.892 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 97' ' ' MET . 64.4 mt -120.12 113.68 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.248 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 141' ' ' ILE . 50.9 ttt85 -127.87 155.22 44.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.307 . . . . 0.0 110.542 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 138' ' ' LYS . 27.1 t70 -81.18 122.26 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.026 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 46.6 t -129.29 98.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.032 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 32.0 mttp -76.33 166.81 42.08 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.0 -13.19 21.93 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.257 1.971 . . . . 0.0 112.161 174.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 t -106.75 3.19 26.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.027 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 3.5 m-20 -112.12 29.26 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.342 0.591 . . . . 0.0 110.395 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 109' ' ' GLU . 16.5 t -71.24 169.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.509 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER 48.42 23.35 0.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.596 1.159 . . . . 0.0 113.414 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.437 HG13 HD22 ' A' ' 111' ' ' LEU . 8.9 p -90.56 -21.83 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.959 0.409 . . . . 0.0 110.098 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.437 HD22 HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -84.51 107.94 17.02 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -93.54 174.32 7.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.229 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.09 109.02 20.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -168.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -103.22 140.87 36.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.588 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.3 148.12 26.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.859 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.51 49.23 2.4 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.537 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -105.65 -170.62 1.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.561 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.65 -169.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.61 100.04 8.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -119.95 126.62 51.31 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.748 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.44 105.0 17.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.4 m -75.19 90.8 2.58 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 31.2 mt -84.95 112.42 20.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.591 0.71 . . . . 0.0 110.05 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.0 mt -84.27 91.44 2.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.006 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.4 m -77.32 88.32 3.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.698 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.4 75.41 7.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.135 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.773 ' HA ' ' CD2' ' A' ' 62' ' ' HIS . 4.5 t0 -83.52 -15.36 49.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.213 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' CG ' ' HE ' ' A' ' 139' ' ' ARG . 19.2 p-10 . . . . . 0 C--N 1.316 -0.865 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.965 -171.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 2.9 mtpm? -145.5 138.55 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.989 -173.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' A' ' 128' ' ' ASP . 95.6 mtt180 -103.34 108.21 19.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.516 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -76.97 103.53 6.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 101' ' ' ARG . 16.0 tt -70.26 122.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.593 0.711 . . . . 0.0 109.783 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.826 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -103.37 96.05 6.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.747 -174.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 68.8 t -106.5 104.11 16.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.743 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -97.68 123.96 41.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.276 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 m -95.78 139.9 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.566 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 40.5 tt0 -61.84 123.03 16.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.229 0.537 . . . . 0.0 111.257 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 148' ' ' LYS . 6.4 p -131.64 165.33 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.82 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.9 pptp? . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.05 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 pttt . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 33.1 Cg_endo -65.21 116.4 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.276 1.984 . . . . 0.0 111.785 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.31 -166.69 1.29 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.922 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.57 104.49 56.16 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.877 0.37 . . . . 0.0 110.592 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.04 -176.57 2.91 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.749 2.3 . . . . 0.0 111.852 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -100.52 4.31 43.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.781 0.324 . . . . 0.0 110.974 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -107.72 152.77 23.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.817 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 3.1 mptt -102.44 -8.23 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.714 -169.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.4 p -73.35 -19.87 60.91 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.193 0.52 . . . . 0.0 110.744 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -96.09 106.22 18.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.792 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.07 102.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 110.221 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.02 63.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.06 35.93 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.047 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.82 144.96 49.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.312 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.79 113.19 42.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.669 0.747 . . . . 0.0 109.395 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -125.16 113.96 18.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.348 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 25' ' ' ILE . 51.9 mt -122.65 101.34 40.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 12.0 Cg_endo -57.82 -32.22 94.37 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.042 2.495 . . . . 0.0 112.343 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -29.05 69.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.633 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.03 9.37 12.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.706 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.02 19.48 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.357 0.411 . . . . 0.0 111.605 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 20' ' ' ILE . 67.8 mt -84.45 134.86 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.27 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -158.67 61.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 27.5 mm-40 -123.8 153.78 67.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.616 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 158.36 43.61 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.802 2.335 . . . . 0.0 112.386 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.32 133.52 53.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 33.4 m-85 -93.48 109.46 40.76 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 38.9 Cg_endo -68.07 148.43 75.5 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.501 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.45 -174.76 21.37 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.34 143.48 13.9 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.45 2.1 . . . . 0.0 112.001 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -64.79 131.98 48.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -166.07 145.49 5.11 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.676 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -42.32 -46.71 7.49 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.918 3.079 . . . . 0.0 114.17 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mp0 -54.47 -37.9 65.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.471 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.529 ' NE2' ' HG2' ' A' ' 11' ' ' LYS . 15.9 mm100 -72.3 -60.29 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.355 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.8 mm? -69.05 -7.14 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.675 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -68.93 -33.7 74.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.289 0.566 . . . . 0.0 109.792 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -111.44 -37.27 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.138 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -159.15 -169.31 22.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.232 -175.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.846 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 7.9 p -88.42 148.56 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.017 0.437 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.7 m -144.26 -179.51 6.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 63.9 m-85 -93.38 147.62 22.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.924 0.393 . . . . 0.0 110.719 176.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -98.36 -58.27 2.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.932 -174.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -88.76 -169.64 2.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 111.961 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 50.49 0.53 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.625 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.87 94.96 5.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.3 -3.93 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.1 0.952 . . . . 0.0 110.033 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -143.99 130.67 20.17 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.755 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.85 1.77 46.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.682 0.753 . . . . 0.0 109.391 171.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.43 1.23 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.946 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.5 t70 -94.64 -157.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.692 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 13.2 pt20 -106.42 -41.5 5.28 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.81 118.58 26.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.539 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.75 104.41 14.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.923 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.7 m -102.14 99.23 9.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.016 0.436 . . . . 0.0 110.736 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -99.59 143.28 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 -178.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -121.37 133.37 55.1 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.06 156.39 26.89 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.357 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -102.0 101.62 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.592 HG22 ' HB ' ' A' ' 125' ' ' THR . 6.7 t -87.61 98.29 11.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.024 0.916 . . . . 0.0 110.124 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 12.6 t80 -111.91 92.38 4.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.837 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -58.72 -27.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 27.2 m-20 -67.46 -4.78 12.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.079 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.8 mmt85 -135.09 105.76 10.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 14.1 Cg_exo -69.78 -12.12 32.22 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.696 2.264 . . . . 0.0 111.84 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -88.24 5.9 39.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.404 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.32 151.93 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 177.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 95.7 mt-30 -62.29 -33.96 75.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.264 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.846 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 97.3 m-85 -122.84 78.74 1.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.205 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 5.2 t -113.07 -29.38 7.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.345 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -98.75 21.74 11.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -172.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 75' ' ' LEU . 13.4 mt -71.18 -5.12 29.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -23.37 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.24 0.543 . . . . 0.0 109.711 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.52 0.43 42.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.309 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.68 114.06 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.299 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.5 -175.41 2.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 -178.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -61.4 -5.11 1.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.503 ' CA ' ' HE3' ' A' ' 96' ' ' LYS . . . -141.38 31.64 2.13 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.961 -1.114 . . . . 0.0 112.448 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.1 m -78.3 117.56 19.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 94' ' ' LYS . 25.1 tpp -68.53 119.85 13.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.02 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 97' ' ' MET . 73.0 t -110.63 122.79 65.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.28 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -101.89 117.13 34.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.185 0.517 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -104.8 123.58 47.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -110.25 132.52 54.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -137.66 116.67 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.516 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 69.28 -82.39 0.26 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -135.3 -16.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.662 0.268 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.46 156.66 16.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.079 0.466 . . . . 0.0 110.916 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -135.49 119.99 18.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.025 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 89.1 mtt180 -104.79 154.77 19.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.628 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.671 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -104.15 125.67 50.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.582 -178.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 91.3 m-85 -123.73 150.42 44.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.259 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HE3' ' CA ' ' A' ' 81' ' ' GLY . 11.5 tttp -119.79 144.46 47.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 84' ' ' VAL . 76.5 mmm -77.36 81.33 3.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 p -83.83 -16.36 44.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.388 -171.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 47.1 m -147.05 104.98 3.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.35 0.595 . . . . 0.0 111.538 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.48 111.75 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.888 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -127.2 148.68 50.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.195 0.521 . . . . 0.0 111.349 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.404 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 30.8 m-20 -109.42 134.87 51.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.62 176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.471 HG11 HG23 ' A' ' 108' ' ' VAL . 58.6 t -122.91 126.17 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 104' ' ' LYS . 16.1 pttp -78.35 146.76 71.05 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.15 -20.54 67.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.327 2.685 . . . . 0.0 113.953 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -81.82 -29.92 32.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.831 0.348 . . . . 0.0 111.681 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.22 81.63 2.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 HG11 ' A' ' 103' ' ' VAL . 6.4 p -101.47 -8.62 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.713 0.768 . . . . 0.0 109.935 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.67 34.68 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.2 m -82.15 16.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.238 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.74 171.0 14.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.462 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.533 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 7.5 m-20 -84.12 152.85 24.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.86 97.76 1.46 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.454 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 19.8 mt-30 -135.18 95.29 3.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -109.96 116.97 32.58 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.22 31.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.807 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 118' ' ' ASP . 24.9 tptt -76.19 -161.67 0.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 3.4 t70 -71.86 -168.23 0.35 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.762 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 3.2 mppt? -76.55 85.09 3.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -136.97 135.37 37.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.825 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.74 107.1 18.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -93.04 94.36 8.83 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.5 mp -83.36 110.26 17.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.2 mt -88.77 99.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.763 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 14.4 p -114.31 104.44 12.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.744 -175.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.1 m -70.76 123.16 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.5 -79.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.748 -177.326 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.789 ' HG3' ' H ' ' A' ' 138' ' ' LYS . 8.3 pt-20 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.789 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 14.0 ptmm? -117.64 166.13 12.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -107.46 156.88 18.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.304 172.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.452 ' HG2' ' HZ1' ' A' ' 138' ' ' LYS . 5.9 tmtp? -133.92 127.85 33.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.998 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.39 128.41 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 120.986 0.422 . . . . 0.0 110.492 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 76.0 m-85 -121.73 107.61 12.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.218 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 52.9 t -102.24 107.18 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.0 110.599 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -101.62 107.42 18.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.396 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.7 m -85.78 140.18 30.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.194 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.493 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 30.9 tt0 -64.63 120.64 12.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.435 ' HB ' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t -84.49 165.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.184 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 110.459 -0.201 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.79 158.2 52.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.617 2.211 . . . . 0.0 111.521 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 mm-40 -116.09 168.47 10.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.753 0.311 . . . . 0.0 110.588 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 31' ' ' PRO . 87.2 mt -98.04 102.25 13.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 79.0 Cg_endo -93.2 -173.84 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.069 2.512 . . . . 0.0 113.504 -174.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -81.44 -17.85 47.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.565 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.1 137.88 53.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.615 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 32.9 mmtp -88.56 -33.34 17.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.604 -167.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -101.23 8.57 42.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.869 0.366 . . . . 0.0 111.627 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -86.06 90.25 8.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.615 0.245 . . . . 0.0 110.836 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.78 115.57 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.88 -28.26 15.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.195 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.17 155.39 25.07 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.344 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 131.56 55.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -102.81 130.47 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 50.3 mt-10 -136.79 109.56 7.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.274 0.559 . . . . 0.0 111.049 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 55.9 mt -118.93 95.41 49.25 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.67 -36.36 98.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.152 2.568 . . . . 0.0 113.064 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.58 -30.06 70.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -111.18 5.04 19.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.068 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 58.4 25.43 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.297 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 58.9 mt -85.1 99.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 40.1 ttmt -134.98 88.12 2.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 5.7 mm-40 -144.97 153.39 53.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.884 -170.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.0 153.99 52.64 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.194 2.596 . . . . 0.0 112.918 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -107.26 139.15 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -113.08 103.12 55.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' HG23 ' A' ' 7' ' ' ILE . 77.8 Cg_exo -51.88 161.72 2.15 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.825 3.017 . . . . 0.0 113.421 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.73 165.87 12.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.48 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 11' ' ' LYS . 34.4 Cg_endo -65.22 141.08 67.5 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.515 2.143 . . . . 0.0 111.761 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.2 101.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.169 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -139.09 155.76 72.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.9 Cg_endo -54.26 -35.24 82.68 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.902 2.401 . . . . 0.0 112.6 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.67 -45.82 77.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.235 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 11.1 mm100 -72.71 -47.14 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.553 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.0 mm? -68.1 -9.51 46.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.44 . . . . 0.0 111.003 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 24.3 t-20 -78.5 -32.27 48.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.823 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -93.74 -46.37 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.89 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -160.29 -156.45 8.18 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.818 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 71' ' ' GLN . 87.0 t -97.13 135.22 32.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.536 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 67.6 m -127.72 151.32 49.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.834 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 97.0 m-85 -71.38 147.07 48.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.08 0.467 . . . . 0.0 111.59 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.99 -28.38 29.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.85 99.26 9.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.558 173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -83.15 17.11 2.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.302 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.65 172.68 12.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.776 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -82.52 14.31 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.212 -173.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -102.37 101.7 11.97 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -110.83 4.95 20.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.521 0.677 . . . . 0.0 109.874 172.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.54 20.99 7.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.581 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -74.6 -170.05 0.97 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.6 pt20 -93.22 -29.09 15.88 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -111.02 143.5 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 15.1 mm -138.07 100.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -93.79 116.04 28.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.6 mt -122.36 138.3 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -91.16 118.28 30.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 125' ' ' THR . . . -105.16 114.58 4.66 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.494 -175.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' HB3' HD12 ' A' ' 39' ' ' LEU . 25.1 p80 -73.62 141.76 46.54 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.1 t -74.08 175.34 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.518 ' HB3' HG22 ' A' ' 73' ' ' THR . 42.1 p90 -82.86 161.27 21.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.46 -80.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.007 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -115.54 -10.93 11.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.075 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -98.11 109.76 53.15 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.736 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 -13.82 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.086 2.524 . . . . 0.0 111.949 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 69' ' ' ASN . 8.1 m120 -116.92 61.82 0.73 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 109.764 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.74 179.46 4.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.599 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.719 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 14.9 mp0 -53.83 -40.91 66.82 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.498 0.499 . . . . 0.0 112.129 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 75' ' ' LEU . 71.5 t80 -131.57 101.59 5.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.0 109.923 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 64' ' ' PHE . 15.4 p -141.75 -62.84 0.45 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.209 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 66.2 t30 -94.15 27.01 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -167.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 72' ' ' PHE . 16.6 tp -62.86 -18.55 63.07 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.615 -0.678 . . . . 0.0 111.404 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -64.12 -22.23 66.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.49 -16.01 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.412 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.88 169.41 18.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.594 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -137.42 168.08 20.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 111.494 -176.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -68.26 -11.33 59.19 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.08 -173.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -131.47 39.34 1.78 Allowed Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.002 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.4 p -85.24 -150.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.967 0.413 . . . . 0.0 110.106 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.485 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.5 tpt -139.3 105.36 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.782 0.325 . . . . 0.0 110.187 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.5 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.9 t -96.19 120.99 46.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.044 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 80.8 m-85 -101.04 129.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.406 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 33.6 t80 -123.41 106.15 10.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 49.4 mtmt -102.02 114.85 29.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.398 -175.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.91 101.99 13.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.571 0.7 . . . . 0.0 109.122 173.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.77 -89.29 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -12.5 4.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.136 0.493 . . . . 0.0 109.818 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 3.5 mm-40 -76.91 117.67 18.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.803 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.4 m -103.16 112.49 25.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.112 0.482 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -102.23 136.17 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 21.6 mtmm -104.34 140.06 38.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.468 . . . . 0.0 110.629 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 74.8 m-85 -132.69 148.56 52.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 13.3 tppt? -107.76 137.89 44.97 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.531 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 69.3 mtp -79.06 61.91 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.8 p -68.63 -41.21 79.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.211 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -116.37 101.37 8.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.333 0.587 . . . . 0.0 111.343 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 97' ' ' MET . 57.0 mt -119.75 114.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.025 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -134.63 140.22 45.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.382 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.54 108.38 16.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.254 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 -169.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -130.3 155.85 80.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.562 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.69 106.48 2.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.617 2.212 . . . . 0.0 114.096 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -119.58 -51.38 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -109.34 120.43 42.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.068 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -104.04 -26.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.278 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.49 19.84 14.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.309 0.576 . . . . 0.0 110.804 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.16 -0.24 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.651 0.738 . . . . 0.0 110.046 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.75 12.21 26.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.551 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.44 5.06 18.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.993 0.901 . . . . 0.0 110.825 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 11.9 pt-20 -108.08 94.07 4.87 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.419 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.83 121.74 42.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.045 0.45 . . . . 0.0 110.674 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -106.62 -0.94 23.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.9 -162.6 21.72 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.644 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -153.54 177.6 10.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.169 0.485 . . . . 0.0 110.908 176.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.57 -171.51 2.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.663 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 27.8 mttm -85.58 96.14 9.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.893 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 14.0 pt20 -162.84 139.81 7.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.447 -173.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.475 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 17.2 mt -88.84 130.88 35.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 171.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 m -104.73 87.53 2.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 59' ' ' ILE . 26.3 mt -85.8 96.99 9.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.146 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.93 95.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 61' ' ' GLY . 50.7 p -109.18 99.34 8.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.875 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 34.6 m -61.99 116.3 4.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.577 0.703 . . . . 0.0 110.833 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 35.3 t70 -91.75 161.31 14.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.944 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 4.8 t0 . . . . . 0 N--CA 1.466 0.352 0 O-C-N 123.767 0.667 . . . . 0.0 111.018 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 6.3 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.753 0.311 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 27.7 mttp -128.02 -178.84 4.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.172 0.51 . . . . 0.0 109.994 174.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.9 ptt180 -154.87 100.59 2.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.8 171.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 116.07 26.35 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 tt -100.42 117.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 CA-C-O 122.128 0.966 . . . . 0.0 110.443 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.3 t80 -101.64 113.95 27.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.291 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 94.7 t -109.36 112.09 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -103.93 116.38 32.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -79.23 136.05 36.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.307 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.46 122.95 15.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.836 0.35 . . . . 0.0 110.467 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.39 153.57 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.753 0.787 . . . . 0.0 111.166 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.296 -177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 19.6 ptmt . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.051 0.453 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' HD21 ' A' ' 52' ' ' LEU . 68.6 Cg_endo -79.44 120.69 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.495 2.13 . . . . 0.0 113.362 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -106.81 128.74 54.51 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 165.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 31' ' ' PRO . 69.6 mt -51.04 107.24 0.78 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -168.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD2' ' HZ2' ' A' ' 13' ' ' LYS . 9.7 Cg_endo -90.82 -170.01 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.627 2.884 . . . . 0.0 113.048 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -68.46 -41.6 79.98 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.49 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 4.1 m-20 -59.62 149.55 30.0 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.737 0.415 . . . . 0.0 111.782 -171.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.849 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 90.9 mttt -95.05 -40.7 9.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.758 0.313 . . . . 0.0 110.735 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -73.15 -5.58 40.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.778 ' HE2' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -80.87 132.38 35.45 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.45 126.73 50.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.294 0.568 . . . . 0.0 110.592 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -106.75 -23.68 12.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.704 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.84 148.19 19.83 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.903 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.4 121.8 45.97 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.82 116.42 33.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.517 0.675 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.9 mt-10 -127.64 109.54 11.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.104 -173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.24 101.22 44.5 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.066 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 83' ' ' MET . 31.1 Cg_endo -63.12 -22.86 73.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 123.184 2.589 . . . . 0.0 112.964 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 82' ' ' SER . 9.3 m-20 -69.82 -29.78 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.78 13.37 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.26 23.13 11.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.497 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 69.6 mt -83.56 113.11 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.239 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -144.36 77.65 1.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -134.0 154.3 80.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.938 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.66 139.54 34.15 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.083 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.622 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.5 t -94.58 136.71 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.576 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 11' ' ' LYS . 44.9 m-85 -108.65 92.53 10.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.998 0.428 . . . . 0.0 110.549 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.778 ' HD2' ' HE2' ' A' ' 13' ' ' LYS . 7.4 Cg_exo -73.78 102.39 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.308 2.672 . . . . 0.0 112.616 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.74 -179.72 42.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.539 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.849 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 18.3 Cg_endo -62.07 99.62 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.293 1.995 . . . . 0.0 111.091 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.58 124.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.208 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.407 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 77.6 p -127.03 159.5 64.46 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.13 -37.72 58.83 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.916 2.411 . . . . 0.0 112.902 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -66.05 -41.02 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' OE1' ' HD3' ' A' ' 11' ' ' LYS . 14.7 pt20 -83.18 -21.56 33.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.271 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 93.3 mt -87.38 11.19 15.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.519 0.676 . . . . 0.0 110.095 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -112.44 -13.94 13.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.845 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -121.69 -16.9 7.59 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.549 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -147.12 5.68 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.401 HG11 ' HE2' ' A' ' 72' ' ' PHE . 99.6 t -125.87 140.31 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.052 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -134.75 161.56 34.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 27.8 m-85 -72.6 160.43 32.27 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.274 175.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.31 68.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.5 170.61 7.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.041 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.17 -35.64 59.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 69.41 160.31 0.19 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.529 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.32 -3.77 1.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.322 0.582 . . . . 0.0 110.991 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -143.84 99.9 3.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -78.69 -6.22 55.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.838 0.828 . . . . 0.0 109.749 175.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.1 10.94 37.94 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.196 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -86.02 154.07 21.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 119' ' ' LYS . 3.5 pm0 -83.58 -19.83 34.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.17 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.33 93.43 4.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 110.398 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 19.9 mm -116.26 129.92 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 118.84 28.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 45' ' ' PHE . 2.0 mt -107.65 129.71 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.2 115.11 29.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.935 0.397 . . . . 0.0 110.973 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -111.17 86.69 0.44 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.202 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 85.4 t60 -87.79 128.3 35.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.065 0.46 . . . . 0.0 110.129 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 127' ' ' ASP . 87.7 m -146.39 133.77 20.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -146.74 17.55 1.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.368 0.604 . . . . 0.0 110.008 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.5 HG13 ' HG3' ' A' ' 67' ' ' ARG . 10.7 tp -88.73 -13.29 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.663 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.94 37.86 27.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.299 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' A' ' 65' ' ' ILE . 99.5 mtt180 -105.86 118.04 56.22 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.644 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.94 0.85 5.17 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.958 2.439 . . . . 0.0 113.439 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 24.98 11.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.026 0.441 . . . . 0.0 110.775 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 179.83 6.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.18 -73.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.401 ' HE2' HG11 ' A' ' 43' ' ' VAL . 12.9 m-85 -91.13 14.76 13.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 m -80.61 -34.15 35.3 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.205 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.69 3.39 33.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.1 -8.78 18.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -62.95 -23.72 67.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.558 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.74 6.94 28.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.284 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.18 144.41 25.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 110.848 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.32 177.63 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.72 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -72.72 -15.03 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.643 0.735 . . . . 0.0 110.477 179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -130.14 57.24 0.73 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.497 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 13.1 m -86.18 -160.9 0.58 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.427 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 6.8 tpt -135.56 103.46 5.46 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.075 0.464 . . . . 0.0 109.975 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 97' ' ' MET . 96.7 t -97.55 125.12 50.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.476 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.4 m-85 -108.45 123.4 48.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.466 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -110.0 104.32 13.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 24.3 ttpp -99.96 105.51 17.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.721 0.772 . . . . 0.0 111.159 -173.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 91' ' ' GLU . 2.4 p -93.56 104.63 15.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.704 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.4 -103.05 0.74 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -113.68 -9.83 13.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 110.596 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HB2' HG13 ' A' ' 88' ' ' VAL . 37.9 mt-10 -79.94 131.39 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -108.32 117.22 33.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -175.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -99.65 145.02 28.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -110.82 129.29 55.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.383 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 82.3 m-85 -132.91 151.94 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.822 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -117.42 137.15 52.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 84' ' ' VAL . 90.1 mmm -78.02 43.35 0.43 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.166 0.508 . . . . 0.0 110.906 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -89.1 23.59 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.357 0.599 . . . . 0.0 112.023 -170.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 54.8 m -143.84 51.4 1.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.498 0.666 . . . . 0.0 110.274 174.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.1 mt -91.63 118.19 36.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.641 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.65 148.25 31.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.619 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -104.81 135.19 46.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.314 0.578 . . . . 0.0 111.017 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.94 147.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.215 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -138.9 86.6 15.15 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.48 0.657 . . . . 0.0 111.127 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -96.2 -158.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.352 2.701 . . . . 0.0 111.291 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -172.38 20.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.68 0.753 . . . . 0.0 110.243 171.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -145.08 154.3 42.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.97 170.29 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.663 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 64.61 -0.77 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.1 0.96 . . . . 0.0 112.823 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.6 -19.63 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 0.0 110.115 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.8 142.28 31.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.18 145.24 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.296 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.76 137.51 33.7 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -106.68 145.74 31.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.374 0.607 . . . . 0.0 111.84 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.7 mptt -104.09 150.54 24.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.088 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.99 50.39 1.48 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -94.06 176.13 6.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 0.0 111.546 -176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -117.46 -174.68 2.66 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 169.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 3.5 mppt? -74.39 100.25 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -141.23 132.84 27.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.018 0.437 . . . . 0.0 111.138 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 11.9 mt -99.26 115.23 28.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.61 HG23 HG22 ' A' ' 143' ' ' VAL . 14.3 m -97.19 96.67 8.58 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.321 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.47 104.1 14.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.8 mt -90.24 99.93 10.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.781 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 21.4 p -91.65 141.2 28.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.974 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 31.1 p -151.03 130.66 13.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.9 m-20 -97.11 -54.64 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 109.441 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.966 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.583 ' O ' ' HD2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -165.26 153.64 11.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -170.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -172.47 139.93 1.03 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.447 ' HD3' ' CG2' ' A' ' 100' ' ' ILE . 5.4 tmmm? -78.86 128.62 33.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.96 140.02 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.025 0.441 . . . . 0.0 111.37 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.43 108.44 18.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.424 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 122' ' ' THR . 41.1 t -110.13 121.45 63.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.347 . . . . 0.0 110.43 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -112.12 118.59 35.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.703 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.8 m -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -62.66 124.49 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.58 154.68 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 41.8 pttt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.683 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.37 125.44 10.74 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.447 2.098 . . . . 0.0 112.472 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.8 tp60 -150.7 165.79 32.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.04 104.29 35.23 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 110.434 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 10.9 Cg_endo -89.48 -179.82 2.05 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.177 2.585 . . . . 0.0 111.607 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -90.47 -6.15 55.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.839 0.352 . . . . 0.0 110.569 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.4 t0 -81.74 125.32 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.297 0.57 . . . . 0.0 109.917 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 13.8 mttp -92.7 1.64 57.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.321 -173.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.73 -16.16 28.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.064 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 32.2 mmmt -88.39 172.85 9.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.39 108.0 23.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.517 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.44 -31.61 22.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.141 0.496 . . . . 0.0 110.77 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.59 165.56 29.15 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.732 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -129.88 132.65 46.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -107.57 124.04 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.148 0.499 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 33.8 mt-10 -129.54 116.13 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.443 0.64 . . . . 0.0 111.637 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 63.5 mt -127.44 100.58 25.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.41 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.25 -38.38 95.15 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.156 2.571 . . . . 0.0 112.903 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.998 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -123.67 13.75 9.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.316 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 54.95 28.61 10.85 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 74.5 mt -89.9 116.07 30.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 27.8 mtpp -144.48 59.19 1.33 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.931 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 42.6 mm-40 -122.62 156.06 61.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.19 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.54 162.23 40.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.044 2.496 . . . . 0.0 113.166 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.68 134.11 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.2 m-85 -91.67 116.15 65.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.024 0.44 . . . . 0.0 111.095 -174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 36.9 Cg_endo -67.25 148.55 80.49 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.379 . . . . 0.0 112.043 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.93 172.91 13.18 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.348 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.29 166.84 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.909 2.406 . . . . 0.0 111.836 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -68.15 111.16 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.268 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 p -128.4 139.83 36.64 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.405 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.26 -47.54 19.47 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.592 2.861 . . . . 0.0 113.253 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.47 -42.23 92.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 111.03 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 43.1 tt0 -74.86 -36.97 62.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 34' ' ' ALA . 90.8 mt -79.75 -11.16 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.606 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -98.68 -21.28 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.0 110.114 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.95 -33.5 18.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.07 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -161.28 -145.19 4.23 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.415 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.821 HG22 HG22 ' A' ' 59' ' ' ILE . 11.6 p -115.13 138.95 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 58.5 m -150.03 158.2 43.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' SER . 96.3 m-85 -66.52 158.82 28.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.718 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -98.96 -46.27 5.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.561 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -96.68 144.21 26.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.638 0.733 . . . . 0.0 111.908 -174.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.6 -2.4 55.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.325 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -117.99 18.6 13.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.707 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 15.4 pt-20 -105.84 138.82 41.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.2 m -117.26 150.32 38.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.646 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 pp -73.92 -8.14 54.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.359 0.6 . . . . 0.0 110.419 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.74 2.59 21.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.416 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 5.9 t70 -92.09 -159.23 0.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 55' ' ' GLN . 2.1 tt0 -99.81 -36.23 9.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -95.43 132.43 40.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.111 0.482 . . . . 0.0 110.941 -175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG21 HD22 ' A' ' 121' ' ' LEU . 28.0 mm -129.71 120.9 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.504 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 32.7 t -127.68 106.28 9.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.921 0.391 . . . . 0.0 110.334 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.821 HG22 HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -122.07 119.02 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.07 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.12 42.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.908 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.17 98.15 0.2 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 126' ' ' CYS . 3.6 p-80 -116.19 159.79 21.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.322 0.561 . . . . 0.0 112.32 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 67' ' ' ARG . 12.9 t 176.7 -176.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -145.71 2.79 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.393 0.615 . . . . 0.0 109.934 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 67' ' ' ARG . 12.2 mm -91.32 47.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.139 0.495 . . . . 0.0 111.76 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.8 -29.9 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.168 0.987 . . . . 0.0 113.061 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.629 ' HD2' ' OD1' ' A' ' 127' ' ' ASP . 6.6 mtp85 60.56 67.55 1.54 Allowed Pre-proline 0 N--CA 1.465 0.305 0 C-N-CA 124.26 1.024 . . . . 0.0 111.903 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 10.6 Cg_endo -103.52 -12.97 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.005 2.47 . . . . 0.0 112.718 170.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -133.85 25.96 3.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.947 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 73' ' ' THR . 9.3 m-85 -100.33 172.9 6.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.775 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.2 pm0 -72.89 -22.1 60.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.797 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' CD2' ' HG2' ' A' ' 71' ' ' GLN . 69.3 m-85 -125.35 92.92 3.72 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 173.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 70' ' ' TYR . 34.2 p -107.33 -67.28 0.96 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.018 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.618 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.7 t30 -86.89 25.47 1.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.534 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -66.24 -2.45 4.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.624 0.726 . . . . 0.0 110.528 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 20.4 pttp -80.02 -30.22 39.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.172 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.55 -15.25 38.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.843 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -66.52 135.31 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.997 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -95.7 -175.87 3.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.006 0.431 . . . . 0.0 110.884 -176.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -80.97 -4.02 53.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . -123.07 28.56 5.58 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.89 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 3.8 m -85.85 131.91 34.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.311 0.577 . . . . 0.0 109.859 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 109.51 10.11 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.669 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.833 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 84.4 t -96.43 116.01 37.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.653 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -98.77 126.38 44.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.458 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -122.02 110.81 16.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.661 ' HG2' ' HB ' ' A' ' 92' ' ' THR . 46.4 mtmt -101.51 142.89 32.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.246 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.21 89.1 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.765 0.793 . . . . 0.0 109.171 169.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.06 -54.58 4.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.505 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.4 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.0 110.22 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.49 130.57 39.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.518 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.661 ' HB ' ' HG2' ' A' ' 87' ' ' LYS . 2.8 t -121.18 149.59 42.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.558 0.694 . . . . 0.0 111.864 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 146' ' ' GLU . 30.7 mmm180 -115.46 141.34 48.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.27 129.58 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 110.387 -177.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' A' ' 121' ' ' LEU . 54.7 m-85 -127.2 147.86 50.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 37.4 ttmt -111.35 149.35 31.28 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.774 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.608 ' HB3' HD11 ' A' ' 100' ' ' ILE . 49.7 mtp -79.77 64.16 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 0.0 110.296 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.3 p -73.45 -34.45 65.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.828 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 8.4 m -115.41 95.36 5.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.187 0.517 . . . . 0.0 110.818 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 63.2 mt -120.45 119.73 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -151.44 151.26 31.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.807 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -108.24 129.01 55.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.82 HG22 ' HD3' ' A' ' 105' ' ' PRO . 7.5 p -121.06 126.68 75.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.771 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 77.2 52.34 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 111.768 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.82 ' HD3' HG22 ' A' ' 103' ' ' VAL . 97.0 Cg_endo -97.34 170.99 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.268 2.646 . . . . 0.0 111.346 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -66.15 -51.46 57.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -133.54 121.41 22.08 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -61.26 150.87 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -65.71 -24.7 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 0.0 110.694 -175.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.601 ' H ' HG13 ' A' ' 108' ' ' VAL . 9.8 p 48.79 21.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.771 1.228 . . . . 0.0 113.588 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -82.66 176.46 9.34 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.933 -0.479 . . . . 0.0 110.171 174.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.83 152.23 42.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.965 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -94.08 137.01 33.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.64 168.23 9.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 110.388 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -73.38 161.84 30.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.4 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.4 36.52 0.64 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -131.98 -167.44 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -124.81 -168.14 1.77 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -68.22 104.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -130.22 136.98 49.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 57' ' ' ILE . 26.5 mt -92.11 100.26 12.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.1 m -78.53 88.88 4.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.534 HD12 ' CE2' ' A' ' 142' ' ' PHE . 39.4 mt -95.37 99.89 11.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.518 0.675 . . . . 0.0 110.262 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -99.56 97.38 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.053 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -92.71 91.76 7.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.917 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' HIS . 2.9 m -73.62 100.55 3.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 67' ' ' ARG . 28.8 t70 -115.52 47.13 1.37 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.937 0.875 . . . . 0.0 108.769 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.651 ' HB2' ' N ' ' A' ' 137' ' ' GLU . 4.5 p-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.933 -170.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.651 ' N ' ' HB2' ' A' ' 128' ' ' ASP . 82.2 mt-10 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 137' ' ' GLU . 26.5 mttp -130.18 112.72 13.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.574 -169.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.74 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -104.47 129.97 52.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.343 0.592 . . . . 0.0 110.118 175.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HE3' HG23 ' A' ' 100' ' ' ILE . 1.8 tmtp? -95.46 126.64 40.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.524 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.63 131.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.054 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.833 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 4.3 t80 -132.14 110.75 10.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.143 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.1 t -114.89 105.95 19.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.922 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -92.58 125.38 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.249 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.4 m -97.27 140.83 31.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 42.0 tt0 -58.31 121.66 11.34 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.69 0.619 . . . . 0.0 111.009 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.7 p -124.03 162.9 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.832 0.825 . . . . 0.0 111.654 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.842 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.562 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.7 Cg_endo -73.8 136.89 23.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.234 1.956 . . . . 0.0 111.629 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 35.2 mm-40 -85.17 -167.72 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.3 mp -81.02 101.53 0.99 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 98.6 Cg_endo -94.32 -166.5 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.05 2.5 . . . . 0.0 113.081 -169.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -75.02 -23.41 58.19 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.554 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 29.4 m-20 -79.17 83.79 5.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.818 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 2.3 pptp? -85.48 -3.27 58.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.359 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.9 m -101.13 3.47 41.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 0.0 111.166 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.1 mmtp -90.6 173.82 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.071 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.17 95.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.802 0.334 . . . . 0.0 110.456 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -82.58 -27.87 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.343 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.29 31.01 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.95 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -135.36 132.94 38.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -103.31 125.57 57.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.3 mt-10 -135.57 104.49 5.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.46 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -116.51 100.23 53.31 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 83' ' ' MET . 17.8 Cg_endo -59.85 -30.74 92.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.034 2.489 . . . . 0.0 112.478 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.03 -12.76 61.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.696 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 4.36 3.8 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.551 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.48 27.94 17.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.163 0.506 . . . . 0.0 111.195 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 80.2 mt -88.0 107.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.122 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -139.27 86.38 2.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.276 . . . . 0.0 110.426 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' A' ' 71' ' ' GLN . 53.6 mt-10 -135.54 153.29 77.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.599 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.88 150.37 78.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.6 2.2 . . . . 0.0 112.152 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.09 129.46 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 47.2 m-85 -95.17 107.67 33.64 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.97 -177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 7' ' ' ILE . 11.3 Cg_endo -54.95 154.01 23.33 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.3 2.666 . . . . 0.0 112.194 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.31 -161.04 18.86 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.767 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.424 ' O ' HG22 ' A' ' 35' ' ' THR . 57.4 Cg_endo -93.09 157.86 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.163 2.575 . . . . 0.0 112.435 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 111.34 10.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.251 0.548 . . . . 0.0 110.162 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 33' ' ' PRO . 1.4 t -149.89 143.29 16.54 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.082 -175.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 -23.12 33.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.133 2.555 . . . . 0.0 112.503 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.14 -50.87 66.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 1.3 tt0 -88.56 -29.54 19.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.838 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.13 1.32 13.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 110.63 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.44 -18.54 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -99.03 -65.16 0.98 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.583 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.59 -148.88 4.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.386 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.57 140.98 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.672 0.272 . . . . 0.0 110.395 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 15.9 m -131.06 -170.55 2.38 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 56.9 m-85 -99.12 173.41 6.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.27 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.513 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 14.3 mm-40 -97.3 -174.48 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -134.84 27.81 3.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.765 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.6 -3.08 6.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.053 0.454 . . . . 0.0 111.009 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 15.1 mp0 -90.41 159.74 16.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.321 0.581 . . . . 0.0 111.717 -173.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 6' ' ' GLN . 45.2 m -107.22 147.79 29.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.224 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.562 HD21 ' O ' ' A' ' 5' ' ' PRO . 3.0 pp -85.62 2.59 44.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.384 0.611 . . . . 0.0 110.282 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.33 4.87 50.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.6 164.91 12.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -94.73 -9.47 34.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.719 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -106.7 90.79 3.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.165 0.507 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 4.2 mt -109.59 133.86 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.387 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -123.26 116.79 23.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 5.7 mt -108.74 133.23 54.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.69 123.9 46.04 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.899 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -112.66 -171.79 18.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.375 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -139.43 148.52 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.574 0.226 . . . . 0.0 110.728 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.568 ' OG1' ' HD3' ' A' ' 67' ' ' ARG . 10.1 t -162.07 143.87 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.55 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.73 -158.81 0.66 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.67 -66.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.63 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.26 84.16 5.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.396 0.617 . . . . 0.0 110.316 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -161.29 105.14 1.23 Allowed Pre-proline 0 C--O 1.213 -0.863 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.381 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.584 ' HA ' HG21 ' A' ' 73' ' ' THR . 71.7 Cg_endo -100.47 -0.82 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.911 2.407 . . . . 0.0 111.908 169.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -118.71 11.99 12.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.928 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -82.94 160.29 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.676 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 3.7 pt20 -52.63 -41.67 63.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.386 0.429 . . . . 0.0 111.038 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.899 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 23.4 m-85 -113.66 90.12 3.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.104 0.478 . . . . 0.0 111.062 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 68' ' ' PRO . 6.6 m -150.55 -40.28 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.709 171.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.77 13.82 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.055 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 72' ' ' PHE . 16.7 mt -67.63 -10.96 56.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.127 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -75.41 -23.18 56.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.14 -13.4 50.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.168 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.82 20.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.676 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -132.42 176.39 8.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.184 0.516 . . . . 0.0 111.089 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 -1.98 54.65 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.828 0.823 . . . . 0.0 109.162 172.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -147.39 38.79 1.07 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.506 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -86.03 -169.89 2.85 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.558 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -115.04 109.29 17.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -177.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 82.0 t -103.34 121.33 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.034 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 67.3 m-85 -101.71 128.55 47.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.813 0.339 . . . . 0.0 110.622 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -116.87 111.39 19.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -100.18 135.71 41.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.838 -176.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 3.2 p -159.09 112.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.68 -101.82 0.44 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.865 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -112.99 1.47 15.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.947 0.403 . . . . 0.0 110.492 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 16.0 mm-40 -97.44 134.85 40.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.417 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 m -134.16 93.97 3.17 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 22.9 mmt85 -99.27 141.91 31.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 83' ' ' MET . 25.1 mtmm -102.78 132.16 49.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 86.6 m-85 -119.84 145.29 46.78 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.965 0.412 . . . . 0.0 111.06 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.498 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 17.7 tttt -102.04 133.42 46.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.995 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.3 mtp -86.59 53.37 2.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.503 0.668 . . . . 0.0 109.531 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.67 -14.95 59.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.266 -172.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.7 m -124.18 88.31 2.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.582 176.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.0 mt -107.69 108.75 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.973 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -134.09 150.0 51.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.174 0.511 . . . . 0.0 110.554 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.461 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 1.9 p-10 -116.27 144.44 44.22 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.5 134.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.574 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.6 mptt -79.78 130.65 66.55 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 9.3 Cg_exo -73.39 41.42 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.636 2.891 . . . . 0.0 113.034 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -71.42 -34.23 70.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.337 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -161.68 151.8 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.779 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.56 -22.02 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.923 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.92 -5.51 56.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.182 0.515 . . . . 0.0 110.628 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.98 -25.21 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.095 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 pp -105.56 153.12 22.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.104 0.478 . . . . 0.0 111.956 -172.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.31 160.07 42.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.72 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.52 -179.93 5.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -116.36 161.83 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.327 0.584 . . . . 0.0 112.077 -172.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -90.26 132.3 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.714 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.39 64.38 0.35 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.552 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -89.86 165.98 13.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.712 0.768 . . . . 0.0 111.863 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -108.89 -168.18 1.31 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.4 mppt? -74.52 102.88 4.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -137.92 142.51 40.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 14.8 mt -106.38 116.62 32.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m -96.48 94.12 7.2 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.701 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -82.13 107.32 14.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.752 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.73 81.71 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 24.5 m -91.87 96.67 10.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.606 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 95.4 m -71.45 90.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.647 ' OD2' ' HE2' ' A' ' 138' ' ' LYS . 25.9 t0 -80.14 9.32 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.048 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 15.9 t70 . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.574 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.23 0.073 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.647 ' HE2' ' OD2' ' A' ' 127' ' ' ASP . 24.2 pttm -116.06 123.98 49.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 111.579 -174.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 37.8 ttm-85 -110.88 103.5 12.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.918 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -97.08 101.93 13.6 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 110.332 -177.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.26 130.13 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.626 0.727 . . . . 0.0 111.514 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 97.9 m-85 -106.16 119.55 39.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.117 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.8 t -105.4 102.33 13.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.17 120.91 43.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.735 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.6 m -92.32 140.26 29.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.59 116.66 6.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.902 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.57 157.33 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.807 0.813 . . . . 0.0 110.569 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.488 -172.257 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HE3' ' OE1' ' A' ' 6' ' ' GLN . 62.9 pttt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.787 0.327 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -55.23 117.64 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.984 2.456 . . . . 0.0 111.967 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.515 ' OE1' ' HE3' ' A' ' 4' ' ' LYS . 6.7 tp60 -141.29 169.79 16.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.934 HD11 ' HB3' ' A' ' 52' ' ' LEU . 16.0 mm -97.82 110.83 57.11 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 6.7 Cg_exo -73.78 173.32 14.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.62 2.213 . . . . 0.0 111.4 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -108.39 22.39 16.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.652 0.739 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.85 145.38 47.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.215 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.764 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 1.5 mptt -88.04 -14.23 39.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.655 0.264 . . . . 0.0 111.3 -171.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.0 t -89.16 -17.86 28.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.468 0.651 . . . . 0.0 109.712 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -80.08 86.34 5.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.55 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.43 104.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.743 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 -27.68 25.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -157.61 177.17 34.52 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.175 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 132.58 39.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.54 122.9 55.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.039 0.447 . . . . 0.0 109.862 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mt-10 -135.16 120.27 18.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.437 0.637 . . . . 0.0 111.751 -177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 74.1 mt -124.97 103.23 30.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.305 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.17 -22.72 72.97 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.164 2.576 . . . . 0.0 112.854 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.67 -31.38 72.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.041 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.26 3.96 10.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.928 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 63.33 24.65 14.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.606 0.717 . . . . 0.0 110.464 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.2 mt -75.97 112.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.97 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 61.0 mtpt -145.64 95.09 2.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.744 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 71' ' ' GLN . 11.9 pt-20 -152.13 155.69 33.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.25 154.41 74.23 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.485 2.123 . . . . 0.0 112.369 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.613 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 62.6 t -97.56 129.64 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -93.21 107.24 24.05 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.992 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 24.2 Cg_exo -64.95 144.69 83.61 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.01 2.474 . . . . 0.0 112.118 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.48 179.56 17.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.697 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.26 145.61 19.17 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.67 99.98 0.17 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -129.05 144.46 52.75 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.297 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.51 -41.05 76.41 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.143 2.562 . . . . 0.0 113.029 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.04 -43.39 87.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.717 0.294 . . . . 0.0 111.173 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.07 -40.25 65.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.81 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.46 -15.84 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.874 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.27 -9.84 58.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.246 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -104.54 -21.51 13.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 -167.19 40.16 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.542 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 59' ' ' ILE . 14.8 p -86.93 137.45 20.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.119 0.485 . . . . 0.0 110.242 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 m -139.28 171.67 13.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -82.1 171.13 14.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.396 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -123.67 -33.88 3.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.727 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 pm0 -81.02 -177.44 6.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.791 -169.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.88 -18.27 16.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.65 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -90.2 134.97 33.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.695 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.07 28.89 0.87 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.054 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.6 m -105.51 160.59 15.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.593 . . . . 0.0 111.078 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.5 pp -123.58 -1.97 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.425 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -149.16 54.46 0.97 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.408 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.79 -61.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER 178.82 -65.27 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 122.764 0.426 . . . . 0.0 110.688 178.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 97.17 7.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.546 0.689 . . . . 0.0 112.1 -172.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.44 140.5 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.704 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -127.91 96.59 4.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.091 0.472 . . . . 0.0 110.229 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 43' ' ' VAL . 1.1 mt -93.13 118.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 136.34 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.725 0.298 . . . . 0.0 111.541 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.74 134.38 7.54 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -136.46 19.83 3.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.408 0.604 . . . . 0.0 111.489 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -88.07 15.94 6.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.539 0.685 . . . . 0.0 111.132 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.628 ' HD1' HG22 ' A' ' 73' ' ' THR . 88.1 t80 -93.22 94.22 8.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.565 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 66' ' ' ASP . 7.6 tp -164.66 -51.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.426 ' N ' HG23 ' A' ' 65' ' ' ILE . 20.1 t70 -96.0 -28.12 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.226 -175.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.8 mmt180 -111.3 122.6 37.22 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.675 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -87.18 0.22 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.432 2.755 . . . . 0.0 111.425 171.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.94 50.8 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.71 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.717 ' HD2' ' HG2' ' A' ' 71' ' ' GLN . 2.0 t80 -132.17 -169.12 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.266 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.76 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 2.8 pt20 -33.06 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.76 ' H ' ' HG3' ' A' ' 71' ' ' GLN . 55.3 m-85 -96.15 29.8 2.68 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.95 -0.469 . . . . 0.0 111.7 -169.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.628 HG22 ' HD1' ' A' ' 64' ' ' PHE . 73.4 p -78.08 -41.13 36.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.233 0.539 . . . . 0.0 110.876 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.66 12.69 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.034 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 72' ' ' PHE . 24.0 tp -63.13 -15.31 56.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.007 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -62.92 -23.29 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.297 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.99 -10.09 59.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.417 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.8 133.87 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.25 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.04 -176.55 3.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.074 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -70.61 -0.75 9.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.847 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.66 62.66 0.54 Allowed Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 p -96.78 -159.1 0.71 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 tpt -139.35 89.94 2.38 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.1 t -77.23 117.19 21.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.004 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -98.1 109.35 22.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.293 0.568 . . . . 0.0 110.594 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 33.9 t80 -99.55 99.1 9.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 42.2 mtpt -94.93 140.49 29.87 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.452 -177.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 91' ' ' GLU . 2.9 m -143.83 108.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.857 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.89 -98.18 0.54 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.35 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -124.56 6.86 8.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 88' ' ' VAL . 14.4 mm-40 -85.04 142.95 29.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -126.1 112.71 16.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.101 0.477 . . . . 0.0 110.026 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 7.9 mmm180 -106.92 120.78 42.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -96.71 133.72 40.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.512 ' CD2' HD21 ' A' ' 121' ' ' LEU . 94.0 m-85 -130.52 146.21 52.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.187 0.518 . . . . 0.0 111.474 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 14.8 tptm -108.24 127.85 54.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.188 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.468 ' HB3' HD11 ' A' ' 100' ' ' ILE . 65.9 mtp -78.4 70.41 4.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.91 -175.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.3 p -67.92 -42.14 81.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.536 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.7 m -114.15 105.89 13.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.3 mt -126.83 95.05 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.623 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -145.49 152.31 39.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.868 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.824 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 9.3 p-10 -104.06 137.71 41.63 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.083 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.73 139.26 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.27 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 137' ' ' GLU . 82.7 tttt -112.49 90.67 15.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.896 0.379 . . . . 0.0 110.334 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 110' ' ' VAL . 97.3 Cg_endo -88.84 -31.85 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.2 m 72.57 -46.73 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.416 0.687 . . . . 0.0 112.16 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.36 162.89 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 110.24 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.4 -34.39 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.416 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.56 80.8 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.447 0.641 . . . . 0.0 111.444 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 105' ' ' PRO . 27.7 m -111.48 -6.2 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.972 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.733 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -146.36 170.1 17.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.654 0.264 . . . . 0.0 110.367 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.75 92.17 5.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.283 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.73 133.99 44.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.958 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mttp 52.3 -172.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.712 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.1 130.92 24.86 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -90.33 -178.65 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.76 -174.55 2.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 146' ' ' GLU . 17.4 mtpp -93.71 95.56 9.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.005 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -145.87 162.51 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.435 -172.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -112.66 120.69 42.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 171.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.5 m -83.16 89.72 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 92.2 mt -76.05 104.44 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.355 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.19 100.17 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.545 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.1 p -109.8 103.79 12.66 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.095 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.7 m -70.22 92.6 0.78 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -134.59 99.41 4.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 39.6 mt-10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.284 0.564 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 32.8 ttmt -80.25 135.61 36.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 -172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.24 101.18 13.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 113.07 20.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.113 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.77 136.2 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.677 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 96.5 m-85 -117.16 112.22 20.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.474 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 89.5 t -99.89 111.62 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -110.9 114.11 27.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.545 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -90.69 146.64 23.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.934 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 119' ' ' LYS . 70.4 tt0 -62.92 141.11 58.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.217 0.532 . . . . 0.0 111.934 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 1.4 t -114.62 163.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.023 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.312 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.36 109.57 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.846 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.89 160.9 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.904 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -70.39 116.88 49.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 31.5 Cg_exo -59.18 150.73 71.97 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.198 2.598 . . . . 0.0 113.376 -174.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -70.87 -27.42 63.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.064 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -84.5 159.35 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.77 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.62 22.93 14.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -172.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 t -120.56 -33.02 3.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.68 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -63.52 105.61 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 28' ' ' PRO . 1.3 p -58.2 112.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.999 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.07 24.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.588 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.98 157.6 24.89 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -121.45 131.48 54.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 8.1 tp -105.93 121.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.214 0.53 . . . . 0.0 110.334 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 94.8 mt-10 -129.78 109.64 11.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.468 0.652 . . . . 0.0 111.186 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' ILE . 66.5 mt -120.64 99.21 47.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.047 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.43 -35.54 98.57 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.049 2.499 . . . . 0.0 113.128 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.21 -33.57 71.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -111.6 7.21 20.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.949 -175.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.07 26.58 16.01 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.585 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 71' ' ' GLN . 61.6 mt -81.17 115.03 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 6.1 ttpm? -147.12 61.57 1.18 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 26.2 mm-40 -121.67 153.37 59.69 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.886 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' VAL . 7.8 Cg_exo -70.15 147.98 61.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.526 2.151 . . . . 0.0 111.84 175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.1 t -96.34 123.97 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.8 m-85 -97.03 102.32 11.79 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.831 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 11.5 Cg_endo -55.42 139.7 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.403 2.735 . . . . 0.0 112.735 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.34 170.22 11.94 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 162.0 37.51 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.71 2.273 . . . . 0.0 112.435 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -65.4 100.4 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.646 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 21.0 p -130.62 140.36 38.43 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.065 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 36.9 Cg_exo -61.53 -8.39 10.81 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.254 2.636 . . . . 0.0 113.319 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -94.75 -38.93 10.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.616 0.246 . . . . 0.0 110.795 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.08 -37.82 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.422 . . . . 0.0 110.171 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.09 -13.13 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.8 -38.96 92.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.367 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.4 -40.09 89.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.36 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.9 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.832 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 60' ' ' ALA . 2.6 p -138.45 139.59 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.306 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -140.09 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -74.22 140.24 44.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -87.35 -43.6 12.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.71 177.85 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.096 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.4 55.2 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.867 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.31 89.58 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.073 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.22 7.15 43.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.86 0.838 . . . . 0.0 109.764 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m -130.0 147.92 51.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.541 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.97 7.68 10.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.374 0.607 . . . . 0.0 110.505 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.27 35.71 2.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.617 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 5.9 p-10 -86.8 -95.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.442 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -173.45 -18.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 176.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -112.31 83.25 1.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.282 0.563 . . . . 0.0 109.715 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 40.8 mm -94.6 86.74 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.389 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -91.73 103.65 16.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.254 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 121' ' ' LEU . 1.1 mt -101.56 137.58 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -104.41 123.83 48.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.993 0.425 . . . . 0.0 111.205 -176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.68 -179.15 16.1 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 126' ' ' CYS . 30.3 p80 -159.79 155.97 26.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.428 0.614 . . . . 0.0 110.882 -177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.17 162.73 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.519 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 12.7 t80 -146.34 113.2 6.08 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 tp -83.67 -21.12 8.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.885 -170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.493 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 57.0 m-20 -82.3 -34.46 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.73 -176.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 32.0 mmm-85 -135.01 120.49 14.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.687 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 2.9 Cg_exo -77.74 -12.52 16.52 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.064 2.509 . . . . 0.0 112.903 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -81.87 16.73 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.908 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.88 -169.12 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.877 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.18 -51.62 3.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.79 0.329 . . . . 0.0 111.5 -178.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.823 ' HD1' ' HG2' ' A' ' 71' ' ' GLN . 9.2 m-85 -84.46 22.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 0.0 111.494 -175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 p -89.95 -34.86 15.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.5 t30 -102.94 19.59 19.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.164 0.507 . . . . 0.0 111.082 -173.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 142' ' ' PHE . 11.5 mt -64.1 -5.99 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.01 -18.76 60.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.89 5.39 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.422 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -96.31 145.52 25.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.333 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.3 mptt -117.36 173.82 6.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.0 110.253 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -73.85 -3.17 27.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.756 177.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.7 25.38 4.73 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.466 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 75.7 m -78.16 -165.12 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.258 0.551 . . . . 0.0 110.443 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -131.35 120.3 22.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.813 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 18' ' ' ILE . 87.3 t -107.41 109.81 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.577 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.05 119.46 32.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.396 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -112.7 110.25 20.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.962 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.46 146.66 27.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 91' ' ' GLU . 3.4 p -156.78 112.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.25 0.548 . . . . 0.0 109.925 174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 -98.24 0.33 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 90' ' ' ASN . 9.8 m120 -125.56 6.99 7.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.262 0.554 . . . . 0.0 109.881 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.551 ' HB2' HG13 ' A' ' 88' ' ' VAL . 20.1 mm-40 -90.11 139.11 30.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.468 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -145.86 120.57 9.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 3.3 mpt_? -122.14 153.93 38.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -102.83 126.64 50.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.186 -176.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 90.5 m-85 -124.84 155.83 38.81 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' SER . 24.7 ttmm -128.62 150.12 50.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.467 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 48.6 mtp -83.94 59.59 5.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.515 0.674 . . . . 0.0 109.959 -173.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -66.22 -45.43 80.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.175 -172.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.6 m -106.97 100.75 10.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.31 0.576 . . . . 0.0 110.745 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG2' ' HE3' ' A' ' 140' ' ' LYS . 59.7 mt -118.31 112.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.596 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.07 141.59 34.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 1.9 p-10 -108.68 121.12 44.37 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.437 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 139' ' ' ARG . 15.7 t -77.96 121.95 31.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.664 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.656 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -103.63 132.7 20.81 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.6 99.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.319 2.679 . . . . 0.0 113.728 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.3 m -126.98 -49.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.681 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.5 144.28 30.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.966 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.04 -28.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -94.85 35.39 1.26 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.667 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.24 8.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.239 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.81 153.27 38.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.594 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -130.09 154.83 47.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.722 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -100.58 6.51 44.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.056 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.18 98.13 9.2 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -96.23 33.5 1.74 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.631 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.88 87.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.416 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -135.22 -173.67 3.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 0.0 110.93 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.78 -161.91 0.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.91 103.18 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.61 146.84 52.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.529 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' HG ' ' HB ' ' A' ' 57' ' ' ILE . 6.2 mp -107.35 109.96 21.83 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.547 HG23 HG22 ' A' ' 143' ' ' VAL . 19.9 m -89.43 99.07 12.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.892 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 81.0 mt -80.05 108.28 13.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 0.0 110.464 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.484 HG22 HH21 ' A' ' 139' ' ' ARG . 58.5 mt -93.77 103.65 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.424 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' HD2' ' A' ' 72' ' ' PHE . 3.2 m -99.73 129.05 45.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.267 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 62' ' ' HIS . 9.9 m -87.12 96.32 10.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.029 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 138' ' ' LYS . 3.3 m-20 -89.99 161.68 15.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.52 -0.204 0 O-C-N 123.701 0.626 . . . . 0.0 111.361 170.083 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.729 0.299 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 127' ' ' ASP . 4.1 ttpm? -80.94 137.75 36.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 21.3 mmm-85 -125.9 86.43 2.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HE3' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -76.09 108.01 8.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 0.0 110.295 -176.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.8 mm -97.11 130.34 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.335 0.588 . . . . 0.0 110.659 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 81.5 m-85 -120.04 101.16 7.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.675 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.5 t -93.04 102.07 13.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -89.97 110.69 21.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.807 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 m -83.85 143.85 29.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.206 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 34.0 tt0 -62.97 129.73 41.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.815 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.82 155.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 pttp . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.456 -174.481 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 tttt . . . . . 0 N--CA 1.446 -0.66 0 CA-C-O 120.778 0.323 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CG ' ' HB ' ' A' ' 88' ' ' VAL . 31.5 Cg_endo -63.55 126.79 18.3 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.009 2.473 . . . . 0.0 113.147 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 1.7 tp60 -134.48 -171.98 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.181 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 62.7 mt -110.98 104.62 56.44 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.896 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 31' ' ' PRO . 86.7 Cg_endo -84.46 -170.52 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.122 2.548 . . . . 0.0 112.54 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 37.6 mtmt -84.37 -13.18 53.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 m-20 -94.84 106.58 18.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.729 -172.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.656 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -82.55 13.48 3.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.092 173.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 p -98.83 -7.93 26.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.661 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -91.34 179.85 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.741 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.77 109.04 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.753 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -88.74 -28.93 20.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.248 0.547 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.55 37.29 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.207 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 124.23 37.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tp -99.28 123.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 109.892 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.3 mt-10 -134.86 128.19 32.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.049 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.4 mt -129.25 96.84 27.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.2 Cg_endo -59.55 -25.31 78.38 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.4 2.733 . . . . 0.0 112.545 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.35 -24.72 67.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.8 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.94 7.14 9.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.712 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 58.21 25.42 12.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.299 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 61.3 mt -77.48 131.63 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.012 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -158.71 90.07 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.63 150.24 53.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.273 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.4 152.53 60.68 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.861 2.374 . . . . 0.0 112.045 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 43' ' ' VAL . 47.7 t -106.99 132.14 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.1 m-85 -91.39 111.07 47.02 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.744 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 Cg_endo -62.66 116.39 3.5 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.238 2.625 . . . . 0.0 112.63 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.48 -179.55 37.71 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.71 154.87 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.599 2.199 . . . . 0.0 112.073 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.86 131.52 44.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 111.072 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 38' ' ' GLN . 1.4 t -155.96 148.5 17.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.807 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.27 -37.69 24.8 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.797 2.998 . . . . 0.0 112.88 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 74.0 mm-40 -62.84 -52.12 64.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.125 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.474 ' NE2' ' HB2' ' A' ' 11' ' ' LYS . 13.1 mm100 -65.37 -42.91 92.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.699 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.23 -6.16 32.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.567 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -100.33 -10.13 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 0.0 109.934 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 62.8 mtt180 -111.65 -37.7 5.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.249 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.15 -166.78 36.51 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 29' ' ' VAL . 6.3 p -90.6 137.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.24 0.543 . . . . 0.0 111.074 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -134.6 -171.87 2.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.704 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 77.3 m-85 -99.25 156.0 17.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.003 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.69 -66.98 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.248 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 43.3 mt-10 -82.49 121.11 26.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.915 0.388 . . . . 0.0 110.879 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.88 -1.25 27.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.682 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.74 -6.66 17.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.187 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 22.5 tt0 -86.38 158.79 19.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.577 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.7 m -122.17 142.38 50.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.762 0.315 . . . . 0.0 111.712 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.792 ' HA ' HD11 ' A' ' 57' ' ' ILE . 14.3 mt -64.35 -12.49 42.88 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.024 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -119.39 26.28 9.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.859 0.838 . . . . 0.0 109.806 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 2.9 t70 -95.58 -166.58 1.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.296 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.781 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.7 pt20 -81.09 -34.08 32.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.719 0.295 . . . . 0.0 110.675 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -122.39 146.66 47.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 52' ' ' LEU . 7.9 mm -128.63 108.02 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.536 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -91.49 105.89 18.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.463 HG22 ' CG2' ' A' ' 43' ' ' VAL . 1.3 mt -103.59 140.03 22.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.96 126.01 48.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.793 0.33 . . . . 0.0 110.899 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -140.99 -177.32 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -138.07 122.15 17.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.547 0.674 . . . . 0.0 111.93 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 5.6 m -79.25 154.48 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.966 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ARG . 4.1 t80 -164.72 86.0 0.43 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.0 mt -59.19 -35.64 58.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.347 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -68.56 -23.13 64.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 0.0 111.717 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.526 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -116.14 102.42 53.74 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.889 -178.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.696 ' HA ' HG21 ' A' ' 73' ' ' THR . 32.2 Cg_exo -59.28 -23.93 72.01 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.994 2.463 . . . . 0.0 112.685 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -88.63 13.93 11.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.405 ' HD1' ' HB3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -92.8 -172.15 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.124 173.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.493 HE22 ' HB ' ' A' ' 43' ' ' VAL . 45.0 mt-30 -74.93 -81.44 0.07 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.558 0.694 . . . . 0.0 112.347 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 90.9 m-85 -89.82 37.11 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.211 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 68' ' ' PRO . 2.8 m -62.14 -29.13 70.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.975 0.417 . . . . 0.0 110.975 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -102.04 6.38 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.37 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 1.8 tm? -61.19 -27.53 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.362 0.601 . . . . 0.0 109.529 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -56.1 -24.42 40.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.945 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -87.31 0.19 55.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.04 165.33 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.78 -176.78 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.014 0.435 . . . . 0.0 110.744 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -1.61 25.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.495 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.92 27.28 5.44 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 74.9 m -82.67 155.59 24.28 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.381 0.61 . . . . 0.0 109.704 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.495 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -97.94 111.82 23.98 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.212 -176.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.29 116.5 36.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' HE2' ' HG3' ' A' ' 21' ' ' PRO . 75.0 m-85 -107.64 130.53 54.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.509 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -121.15 106.47 11.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 14.7 mtmm -86.25 136.8 33.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.93 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.2 m -139.87 93.14 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.0 -117.2 4.64 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.12 -9.54 33.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.505 0.669 . . . . 0.0 109.941 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.5 mm-40 -77.62 144.17 37.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.482 0.658 . . . . 0.0 111.218 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -141.47 97.54 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.471 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' A' ' 146' ' ' GLU . 3.9 mmp_? -80.3 135.39 36.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.316 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -103.48 125.17 49.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' GLU . 85.3 m-85 -123.22 150.6 43.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 25.3 ttpp -114.05 139.2 49.47 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 82' ' ' SER . 69.4 mtp -83.88 50.6 1.85 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 109.934 -174.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.43 2.46 18.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.253 -170.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.8 m -145.18 102.6 3.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.77 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.98 137.04 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.556 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 34.0 ttm-85 -154.02 157.89 39.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.369 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 7.1 p-10 -129.44 137.34 50.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 139' ' ' ARG . 26.5 m -117.57 -177.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.342 . . . . 0.0 111.456 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -90.65 154.92 46.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.334 -173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 137' ' ' GLU . 74.2 Cg_endo -77.51 178.84 7.13 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.874 2.383 . . . . 0.0 112.431 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.6 p 54.02 23.61 4.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.656 0.782 . . . . 0.0 111.92 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 109' ' ' GLU . 23.0 t70 -165.44 141.32 5.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.05 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.5 -2.99 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HA ' ' HB2' ' A' ' 112' ' ' ASP . 12.3 pt-20 -93.77 -3.1 52.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.528 -174.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 103' ' ' VAL . 4.9 p -56.04 -39.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 110' ' ' VAL . 4.5 mp -130.75 100.89 5.44 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.107 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 109' ' ' GLU . 37.9 t0 -152.93 -169.78 3.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.627 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 10.2 pt-20 42.27 63.69 1.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.138 0.899 . . . . 0.0 111.077 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.94 132.95 54.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.019 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.88 36.02 0.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.423 0.63 . . . . 0.0 109.921 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.58 143.59 10.95 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.372 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.54 168.77 18.97 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.4 t70 -127.41 -161.32 1.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -102.63 83.4 2.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.685 0.755 . . . . 0.0 109.511 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -165.37 177.12 7.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.794 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 15.7 mt -107.6 132.45 53.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.3 m -101.14 86.27 2.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.584 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.1 mp -79.95 110.87 15.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.361 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.6 mt -96.64 93.88 3.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.513 ' HB ' ' HE2' ' A' ' 142' ' ' PHE . 13.9 m -123.55 71.4 1.08 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.961 0.41 . . . . 0.0 110.699 -174.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.37 120.31 7.44 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 75.5 m-20 -65.73 -41.64 91.99 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.505 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.022 -179.394 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 105' ' ' PRO . 39.5 mt-10 . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 120.882 0.372 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ASP . 18.0 mtpp -79.85 96.34 6.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.376 0.608 . . . . 0.0 111.371 -174.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.665 ' HB2' HG23 ' A' ' 103' ' ' VAL . 40.1 mmm-85 -80.61 103.27 10.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.815 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 142' ' ' PHE . 8.3 mmtp -96.35 129.45 43.68 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 tp -123.33 123.24 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.624 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 70.7 m-85 -112.92 109.58 19.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.334 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 95.8 t -93.94 102.89 14.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.0 110.03 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -106.96 101.14 10.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.146 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' GLN . 3.1 m -83.81 143.51 29.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 44.9 tt0 -60.99 129.8 43.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.2 0.524 . . . . 0.0 111.593 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.6 p -101.48 160.49 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.324 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 147' ' ' VAL . 75.2 mttt . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.696 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.846 0.355 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.509 ' O ' HD21 ' A' ' 52' ' ' LEU . 61.7 Cg_endo -79.31 114.72 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.665 2.243 . . . . 0.0 113.273 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' A' ' 52' ' ' LEU . 11.0 tp60 -95.82 89.23 5.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.737 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 50' ' ' GLU . 76.8 mt 24.98 91.57 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 125.068 1.48 . . . . 0.0 113.657 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.5 -179.93 5.9 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.664 2.243 . . . . 0.0 112.581 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -75.09 -44.6 46.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.075 0.464 . . . . 0.0 110.897 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.99 140.71 37.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.851 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -109.67 18.9 19.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.807 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -90.9 -17.31 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.156 0.503 . . . . 0.0 110.37 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.82 154.78 19.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 28' ' ' PRO . 6.9 p -97.68 135.7 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.96 -21.14 13.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.637 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.78 174.9 37.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.249 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -126.73 139.95 52.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.217 0.207 . . . . 0.0 110.628 178.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.41 127.91 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 36.5 mt-10 -136.21 122.31 20.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.042 0.448 . . . . 0.0 111.561 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.501 HD12 HD12 ' A' ' 25' ' ' ILE . 67.7 mt -129.55 95.57 29.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -58.34 -33.59 97.9 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.082 2.522 . . . . 0.0 112.702 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.09 -15.66 63.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.131 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.38 4.87 9.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 60.63 26.17 15.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.982 0.42 . . . . 0.0 111.628 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.6 mt -86.26 120.2 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.528 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 22.8 ttmm -156.09 98.61 1.89 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 71' ' ' GLN . 12.5 pt-20 -152.0 156.89 34.3 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.585 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.477 ' CB ' HG21 ' A' ' 14' ' ' VAL . 57.3 Cg_endo -74.15 152.34 45.21 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.608 2.205 . . . . 0.0 112.043 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.05 132.79 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 18.6 m-85 -93.94 111.36 52.69 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.47 -175.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 12.2 Cg_endo -56.98 130.88 42.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.031 2.488 . . . . 0.0 111.848 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.9 174.33 16.08 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.55 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.24 169.94 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.432 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 39' ' ' LEU . . . -73.7 121.78 21.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.908 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.832 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.2 t -161.01 141.38 8.36 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -38.43 -66.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.487 3.458 . . . . 0.0 115.489 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -28.9 69.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 35' ' ' THR . 7.1 tp60 -72.55 -52.23 16.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.389 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.832 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -65.47 -20.95 66.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.469 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.37 -29.3 67.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.9 0.381 . . . . 0.0 110.412 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -82.35 -38.78 23.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.76 -158.63 21.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.611 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.424 HG23 ' OE2' ' A' ' 27' ' ' GLU . 41.0 t -77.41 141.31 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.714 0.293 . . . . 0.0 110.804 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -142.36 167.33 22.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m-85 -87.58 176.57 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.973 0.416 . . . . 0.0 111.405 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.73 -40.19 7.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.189 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 42.8 mt-10 -108.69 141.55 40.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.42 -0.86 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.141 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.19 -13.03 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.68 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 13.1 pt-20 -63.25 131.92 49.95 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 16.7 m -94.29 121.29 35.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.894 0.378 . . . . 0.0 110.745 -173.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.665 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -71.13 -5.56 32.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.48 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -110.84 2.76 18.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.109 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 12.0 t70 -108.08 -156.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.774 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.53 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 48.7 tt0 -91.46 -42.79 10.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.941 0.496 . . . . 0.0 111.88 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -91.75 123.33 35.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 111.489 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 52' ' ' LEU . 24.2 mm -132.4 132.75 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.153 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.466 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 7.2 p -139.67 84.83 2.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.268 0.556 . . . . 0.0 110.506 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.593 ' HB ' HD23 ' A' ' 123' ' ' LEU . 3.2 mt -92.36 140.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.667 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.12 154.12 17.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.323 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -157.79 156.47 27.34 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.071 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.403 ' HE1' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 p80 -150.08 168.86 22.68 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.423 -0.457 . . . . 0.0 111.059 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.86 5.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.631 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 27.8 m-85 -145.03 171.08 14.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 171.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.0 -20.72 5.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.369 0.604 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.88 -40.24 9.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.833 -175.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HG3' ' H ' ' A' ' 69' ' ' ASN . 18.1 tpt180 -96.61 127.04 41.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.057 -168.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 73' ' ' THR . 93.6 Cg_endo -91.12 7.96 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.986 2.457 . . . . 0.0 111.551 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.713 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 21.6 m120 -125.38 20.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.147 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 19.4 p90 -86.37 166.42 15.6 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.704 172.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 1.7 pt20 -25.46 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.554 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 50.6 m-85 -113.39 45.91 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.522 HG21 ' C ' ' A' ' 68' ' ' PRO . 32.5 p -72.98 -51.81 16.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.449 0.642 . . . . 0.0 110.835 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -88.69 17.25 5.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.65 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -60.25 -25.71 65.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.829 179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -65.6 -25.06 67.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.733 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.49 -11.1 59.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.805 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.658 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.05 140.98 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.862 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -105.79 176.79 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.308 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -75.25 0.45 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.281 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.09 21.92 5.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.822 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -85.6 165.02 17.38 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.466 0.651 . . . . 0.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.44 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -99.9 123.66 44.4 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.51 -174.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.887 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -115.2 127.03 72.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.747 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.9 m-85 -115.4 137.16 52.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -122.36 121.25 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 14.9 ttmm -108.6 140.42 41.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.454 -173.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 HD13 ' A' ' 52' ' ' LEU . 2.7 p -137.69 111.28 8.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.97 171.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.92 -104.43 1.02 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.073 -172.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -116.28 -1.78 12.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 110.911 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -87.85 139.86 30.09 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 87' ' ' LYS . 36.5 m -145.71 116.81 7.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.645 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -91.02 152.14 20.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.604 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -111.18 123.16 49.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.354 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.64 152.58 39.16 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 36.5 ttmt -107.21 149.57 27.58 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.703 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 62.7 mtp -84.12 70.7 10.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 110.451 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.5 p -70.64 -46.5 63.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.784 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 10.5 m -118.48 110.33 17.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.971 0.415 . . . . 0.0 111.073 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.7 mt -126.32 89.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -125.87 143.4 51.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.2 0.524 . . . . 0.0 111.51 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 13.2 t70 -101.94 116.45 32.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.074 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.452 HG23 ' HD3' ' A' ' 105' ' ' PRO . 19.7 m -133.3 178.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 0.0 111.244 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 50.3 mtpt -133.17 81.26 57.05 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.72 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 139' ' ' ARG . 17.4 Cg_endo -93.98 107.39 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.476 2.784 . . . . 0.0 111.359 170.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -80.77 -24.21 38.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.878 0.37 . . . . 0.0 111.357 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' HG22 ' A' ' 110' ' ' VAL . 18.0 t70 -88.38 143.67 26.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.236 0.541 . . . . 0.0 111.431 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.63 19.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.49 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.83 -47.9 2.39 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' OD1' ' A' ' 107' ' ' ASP . 20.1 m -76.44 -4.31 6.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.7 60.33 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.425 . . . . 0.0 111.328 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.06 149.79 32.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.475 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.37 33.57 20.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.864 0.84 . . . . 0.0 110.05 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.614 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -72.37 96.0 1.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.857 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 115' ' ' LYS . 13.4 ptpt -76.56 151.58 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.534 -175.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.76 84.73 1.81 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.869 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.84 161.33 25.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -155.57 -176.68 6.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 90.1 3.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 15.6 pt20 -146.08 133.74 21.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 57' ' ' ILE . 37.5 mt -86.29 99.69 11.75 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 6.4 m -77.14 89.4 3.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.93 0.395 . . . . 0.0 109.987 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.593 HD23 ' HB ' ' A' ' 59' ' ' ILE . 23.7 mt -91.2 108.18 19.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.01 147.66 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' CG ' ' A' ' 140' ' ' LYS . 22.9 m -146.43 98.83 3.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.534 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 139' ' ' ARG . 3.4 m -56.74 109.14 0.58 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.658 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 2.1 t70 -89.21 -23.9 22.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.531 -170.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.828 178.513 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 21.3 ttpp -90.43 137.72 32.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.076 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.658 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 12.1 ptp180 -153.46 138.21 17.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.121 0.486 . . . . 0.0 110.408 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.602 ' CG ' ' HB ' ' A' ' 125' ' ' THR . 5.0 ptpp? -89.39 144.17 26.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -119.54 119.43 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 CA-C-O 121.938 0.875 . . . . 0.0 109.853 170.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.887 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.0 t80 -105.89 113.43 26.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.307 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.8 t -104.62 113.09 40.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.968 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -100.03 111.86 24.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.2 m -90.3 144.61 25.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.97 135.19 48.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.79 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.2 t -112.37 168.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.928 0 CA-C-O 118.936 -0.555 . . . . 0.0 110.359 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 68.7 Cg_endo -74.74 151.23 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.194 1.929 . . . . 0.0 111.841 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 51' ' ' SER . 6.6 tp60 -132.22 172.51 12.32 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 52' ' ' LEU . 89.6 mt -114.72 103.51 54.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 111.714 -174.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -94.52 -159.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.468 2.779 . . . . 0.0 111.048 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -99.15 11.91 37.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.964 0.412 . . . . 0.0 110.525 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -78.38 98.91 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.189 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.2 16.72 21.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -93.95 -34.5 13.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.371 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.662 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -97.79 160.39 14.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.427 175.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.41 118.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' CB ' ' HG3' ' A' ' 31' ' ' PRO . . . -87.41 -42.44 12.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 109.963 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.83 171.32 23.62 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.005 -172.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.15 121.96 18.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.353 -0.423 . . . . 0.0 109.915 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.91 117.97 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.842 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 3.0 pt-20 -129.25 112.48 13.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.795 0.807 . . . . 0.0 111.806 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 55.7 mt -116.39 100.69 53.64 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.769 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.9 Cg_endo -58.88 -27.93 85.82 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.02 -21.26 63.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.724 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.89 15.3 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.31 26.93 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.89 0.852 . . . . 0.0 110.73 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.3 mt -95.72 118.52 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.99 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 40.4 mtpt -144.87 81.78 1.66 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.895 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 48.8 mm-40 -124.15 152.09 66.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.06 153.18 46.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.563 2.175 . . . . 0.0 112.835 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 48.7 t -113.26 130.97 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.21 112.29 62.87 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.951 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 26.2 Cg_exo -62.18 139.31 77.38 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.324 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.95 173.64 13.43 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.03 151.03 73.27 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.287 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.29 157.79 21.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.764 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.558 HG23 ' H ' ' A' ' 38' ' ' GLN . 2.8 t -176.11 150.94 1.1 Allowed Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -46.54 -37.23 19.75 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.102 2.535 . . . . 0.0 112.669 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.28 -46.75 85.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.26 0.552 . . . . 0.0 111.192 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.558 ' H ' HG23 ' A' ' 35' ' ' THR . 55.3 tp60 -72.75 -37.13 67.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.775 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -77.72 -15.06 59.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.135 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.55 -18.9 56.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.546 0.688 . . . . 0.0 109.209 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -90.58 -46.07 8.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.78 -138.66 2.99 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.275 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 60' ' ' ALA . 85.5 t -112.57 137.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.379 . . . . 0.0 110.402 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -150.28 165.95 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.908 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -71.99 134.5 45.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.311 -176.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.4 65.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -128.17 118.41 23.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.378 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 50' ' ' GLU . 2.5 mp0 -54.85 -38.44 67.46 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.493 0.495 . . . . 0.0 110.439 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.7 t-20 70.8 -22.67 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.738 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' GLU . 43.0 tt0 82.34 -22.7 0.24 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.559 1.143 . . . . 0.0 111.326 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.529 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 66.9 m -128.74 141.68 51.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.309 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -103.22 -14.86 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -99.15 25.15 7.07 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.934 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.49 -167.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.745 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -115.19 -29.03 6.74 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.174 -0.329 . . . . 0.0 111.495 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -108.18 97.33 7.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.069 0.938 . . . . 0.0 111.125 -178.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.416 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 21.6 mm -116.62 138.36 47.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.985 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 t -128.67 113.71 15.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.858 0.361 . . . . 0.0 110.206 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 3.4 mt -111.1 128.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -101.52 142.86 32.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.85 27.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.282 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -124.14 144.65 49.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 127' ' ' ASP . 67.8 p -111.47 169.16 9.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.673 0.273 . . . . 0.0 110.747 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.517 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 22.7 t80 -154.55 134.87 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' ' 65' ' ' ILE . 3.7 mp -66.24 -48.19 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.37 . . . . 0.0 111.742 -172.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.8 t70 -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 53.8 mmm-85 -99.3 106.62 40.12 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 -174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 3.2 Cg_exo -76.83 -4.18 14.64 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.541 2.828 . . . . 0.0 111.206 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -74.27 -23.18 59.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.24 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.512 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 64.5 m-85 -74.21 116.26 14.64 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.069 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.895 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 5.1 pt20 -48.91 -41.92 35.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' CZ ' HD23 ' A' ' 123' ' ' LEU . 10.2 m-30 -78.64 -2.58 39.77 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.225 -0.297 . . . . 0.0 111.789 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 16.8 m -68.42 -34.74 76.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.693 0.282 . . . . 0.0 110.946 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.05 14.72 22.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.625 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.08 -15.3 59.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -22.44 62.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 111.015 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.81 -6.81 56.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.615 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.56 131.12 47.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -111.64 177.7 4.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.702 -175.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -56.06 -21.14 20.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.007 -175.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.49 43.53 1.45 Allowed Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.165 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 m -95.41 -177.27 4.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.142 0.496 . . . . 0.0 109.779 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.594 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.8 tpt -118.36 104.56 10.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.403 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.02 107.01 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.729 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.842 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . 58.8 m-85 -89.28 117.9 28.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.268 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -104.17 99.27 9.0 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -97.06 146.16 25.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.342 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.742 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 7.6 p -162.0 118.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.141 0.496 . . . . 0.0 109.686 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.625 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 60.63 -111.49 3.76 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -107.87 2.09 23.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.16 0.505 . . . . 0.0 110.089 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.98 141.52 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 m -141.47 98.01 3.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.242 0.544 . . . . 0.0 110.346 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.2 134.02 52.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.908 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 28.8 mtmt -103.58 140.4 37.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -169.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.642 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.7 m-85 -131.11 147.82 52.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.847 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -105.84 148.81 27.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.615 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 66.4 mtp -82.77 72.05 9.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.402 0.62 . . . . 0.0 110.478 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.4 p -72.3 -42.19 65.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.614 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.594 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 31.5 m -113.09 99.97 8.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 111.629 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.99 76.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -93.58 155.57 17.22 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.867 0.841 . . . . 0.0 112.831 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 138' ' ' LYS . 9.9 t70 -109.72 100.83 9.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.695 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.28 145.59 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.046 0.451 . . . . 0.0 110.659 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -95.19 140.42 22.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.52 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.96 127.91 19.58 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.53 2.154 . . . . 0.0 111.972 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.442 HG23 HG11 ' A' ' 110' ' ' VAL . 1.9 t -153.99 -55.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.586 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.689 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . 30.0 t70 -142.21 167.59 21.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.563 0.22 . . . . 0.0 110.623 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.37 -45.78 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.689 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.5 31.03 5.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.462 . . . . 0.0 111.207 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 p -81.02 -7.8 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.025 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.43 127.69 35.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.36 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.76 133.27 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.306 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.72 36.22 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.782 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -100.09 142.21 31.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.488 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -89.89 166.49 13.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 177.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.0 75.75 1.03 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.568 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.06 167.0 15.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.158 0.504 . . . . 0.0 111.457 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -155.5 -166.66 2.3 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 9.3 mttp -74.92 101.75 4.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.942 0.401 . . . . 0.0 110.163 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -142.18 145.67 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.896 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.416 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 12.4 mt -107.84 114.35 28.22 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 143' ' ' VAL . 23.7 m -89.08 95.64 10.4 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -83.35 120.35 25.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.527 0.68 . . . . 0.0 110.526 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.704 HG23 HH22 ' A' ' 139' ' ' ARG . 61.9 mt -79.6 86.1 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 1.9 m -98.04 100.15 11.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.536 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.9 m -81.32 -25.8 36.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -94.56 167.57 11.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 111.302 -174.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 25.6 t70 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.485 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.605 0.717 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 102' ' ' ASP . 29.2 mtmm -112.94 -172.81 2.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.811 -167.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.704 HH22 HG23 ' A' ' 124' ' ' ILE . 28.6 ttt-85 -114.58 66.33 0.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.819 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.633 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -69.53 96.86 0.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.231 0.539 . . . . 0.0 109.962 -179.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.6 tt -85.6 139.79 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 15.6 t80 -114.86 124.26 51.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.038 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.6 t -121.05 123.96 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -106.34 130.27 54.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.295 -176.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.8 m -99.58 137.25 38.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.993 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.429 ' OE1' ' HD3' ' A' ' 119' ' ' LYS . 37.6 tt0 -65.0 121.8 15.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.134 0.492 . . . . 0.0 111.181 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.12 161.23 4.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.69 -172.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.424 ' HB3' ' H ' ' A' ' 3' ' ' ALA . 2.4 mp0 -122.68 -164.7 1.21 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.466 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' H ' ' HB3' ' A' ' 2' ' ' GLN . . . -163.22 -179.43 6.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.158 -174.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -70.11 120.19 76.56 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.202 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.82 161.48 36.28 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.617 2.211 . . . . 0.0 112.555 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -114.24 173.42 6.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 50' ' ' GLU . 70.8 mt -106.92 101.11 35.61 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.776 0.322 . . . . 0.0 111.129 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 97.9 Cg_endo -87.59 178.4 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.846 2.364 . . . . 0.0 112.272 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -86.61 -30.74 21.57 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.736 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.541 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.1 t70 -60.51 129.54 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.192 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 43.1 mmtm -96.55 13.21 28.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.896 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -91.74 -21.86 20.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.343 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 45.6 mmtm -91.65 163.31 14.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.651 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.91 116.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.054 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.52 -33.92 15.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.19 152.82 24.88 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.729 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.24 122.91 48.88 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 27' ' ' GLU . 9.6 tp -93.55 115.08 31.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.698 0.761 . . . . 0.0 109.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 42.5 mt-10 -127.92 115.69 18.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.033 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 66.2 mt -122.96 102.49 37.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.652 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -59.23 -33.92 98.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.414 2.743 . . . . 0.0 113.552 -173.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.12 -24.46 65.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.712 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -114.47 7.74 16.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.266 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 59.89 25.81 14.98 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.178 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.4 mt -84.61 124.63 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.991 -177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -144.15 80.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.0 mm-40 -125.43 142.42 41.68 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.161 0.505 . . . . 0.0 111.899 -172.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.69 138.57 38.37 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.064 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 64.1 t -98.38 132.81 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -92.85 105.34 14.47 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.397 0.618 . . . . 0.0 110.51 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 47.2 Cg_endo -69.22 145.94 61.93 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.276 2.651 . . . . 0.0 113.071 -175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' NZ ' ' A' ' 11' ' ' LYS . . . 129.08 -168.95 20.6 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.804 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.42 162.18 33.75 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.769 2.313 . . . . 0.0 111.705 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.8 126.21 31.57 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.973 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.504 ' O ' HD23 ' A' ' 39' ' ' LEU . 47.6 p -132.05 133.94 24.55 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.956 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.89 -36.6 27.29 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.471 2.781 . . . . 0.0 113.362 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.598 ' HG2' ' HD2' ' A' ' 41' ' ' ARG . 38.7 tt0 -66.28 -54.25 27.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.224 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.56 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 51.1 tp60 -65.43 -34.41 78.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 35' ' ' THR . 4.4 mm? -68.54 -7.87 36.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -101.61 -7.11 23.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.578 0.704 . . . . 0.0 109.749 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HD2' ' HG2' ' A' ' 37' ' ' GLU . 53.8 mtp180 -104.32 -32.64 8.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.949 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -154.99 9.75 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.241 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.502 HG21 ' CE2' ' A' ' 72' ' ' PHE . 59.4 t -105.96 133.82 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.83 0.348 . . . . 0.0 110.472 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -135.72 162.04 33.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 86.5 m-85 -74.01 149.46 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.244 0.545 . . . . 0.0 111.561 -177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.82 -14.0 23.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.877 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -79.9 133.6 36.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.228 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -83.42 -6.37 59.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.838 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.28 128.76 36.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.9 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -74.98 17.67 0.22 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.059 0.457 . . . . 0.0 112.167 -176.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 m -104.15 107.7 18.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.223 0.535 . . . . 0.0 111.618 -174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -91.05 6.27 45.53 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.784 0.802 . . . . 0.0 109.433 172.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.43 -9.11 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.625 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.22 159.39 28.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.237 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 3.9 pm0 -86.34 -13.34 46.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.71 0.291 . . . . 0.0 110.899 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -105.44 105.94 16.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.123 0.487 . . . . 0.0 110.545 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 52' ' ' LEU . 19.9 mm -115.79 101.81 12.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.532 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.2 m -93.87 125.72 38.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.44 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -127.37 142.67 42.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.57 147.13 43.1 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.086 -0.384 . . . . 0.0 111.467 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.21 -171.62 22.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.014 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -136.63 157.68 46.2 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 122.565 -0.373 . . . . 0.0 110.818 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 6.7 t -79.07 -172.05 2.93 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.584 -175.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 35.4 p90 -109.04 142.09 40.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.329 -178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.28 -90.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.68 -23.73 16.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 109.873 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.39 114.58 65.03 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.189 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HA ' HG21 ' A' ' 73' ' ' THR . 88.5 Cg_endo -82.43 8.78 4.33 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.841 2.36 . . . . 0.0 111.476 175.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.76 14.61 20.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.902 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.56 ' HB2' HG23 ' A' ' 73' ' ' THR . 40.5 m-85 -89.53 143.14 27.05 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -69.03 -8.03 41.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -168.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 43' ' ' VAL . 43.5 m-85 -130.1 33.06 4.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.72 0.295 . . . . 0.0 111.392 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.591 HG21 ' HA ' ' A' ' 68' ' ' PRO . 13.4 p -64.73 -34.94 79.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.396 . . . . 0.0 111.645 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -99.9 13.13 34.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.5 -12.21 50.58 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.216 0.531 . . . . 0.0 110.494 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HD3' ' CZ ' ' A' ' 64' ' ' PHE . 20.1 pttp -63.69 -26.7 68.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.233 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.13 -41.44 25.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.529 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.81 137.76 54.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.073 -173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.4 mptt -103.66 173.62 6.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.05 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -74.31 -1.92 22.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.741 -177.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.35 34.04 3.16 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.443 176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.6 t -97.78 -172.71 2.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.438 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -119.05 121.7 40.44 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.297 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 96.8 t -107.6 110.26 31.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.525 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -95.08 113.85 25.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -102.98 98.71 8.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -94.57 113.06 24.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.214 -172.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 m -100.96 101.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.595 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.53 -94.52 0.28 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.147 -172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -119.2 -14.71 9.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.762 0.315 . . . . 0.0 110.949 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -83.73 125.25 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 0.0 110.463 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -101.4 107.1 18.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.852 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -97.04 117.17 30.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.528 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.6 125.46 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.423 . . . . 0.0 110.959 -176.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 64.0 m-85 -121.09 148.81 43.67 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.841 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -110.0 138.64 46.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.562 ' HB3' HD11 ' A' ' 100' ' ' ILE . 61.2 mtp -76.88 54.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.966 -173.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.1 p -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 7.5 m -116.4 102.0 9.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.012 0.434 . . . . 0.0 111.028 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.4 mt -126.76 125.28 66.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.648 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 101' ' ' ARG . 14.2 ttp180 -165.68 144.27 6.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.162 0.506 . . . . 0.0 109.865 170.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.996 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 3.1 p-10 -101.7 110.59 22.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.668 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 139' ' ' ARG . 27.0 m -98.63 175.78 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.449 0.643 . . . . 0.0 112.112 -172.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -85.28 155.41 60.17 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.905 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.47 -174.97 1.82 Allowed 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.735 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m 74.3 -59.49 0.55 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.499 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.13 103.79 10.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.477 . . . . 0.0 111.282 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.48 -21.41 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.448 0.642 . . . . 0.0 109.433 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -90.82 27.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.835 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 103' ' ' VAL . 10.2 p -61.9 -28.59 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.76 141.27 51.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.366 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -85.76 120.14 26.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -99.69 141.38 32.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.366 0.603 . . . . 0.0 110.868 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.78 173.54 13.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.415 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -90.91 -3.54 57.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.864 0.364 . . . . 0.0 111.768 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -86.76 80.44 1.75 Allowed Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -129.46 179.69 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 111.038 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.38 -172.75 2.14 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.46 ' HD3' ' CD ' ' A' ' 146' ' ' GLU . 41.9 mttt -71.3 100.84 2.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -135.34 138.06 43.02 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.088 0.47 . . . . 0.0 111.134 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.5 mt -95.62 114.41 26.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m -96.89 95.08 7.6 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.94 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.612 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.5 mp -93.82 125.83 38.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 0.0 111.619 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.75 91.73 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.71 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.9 p -101.33 98.07 8.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 0.0 110.867 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 122.86 18.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.638 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.738 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 31.5 t70 -88.11 25.08 1.67 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.25 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -169.11 160.23 9.66 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -171.82 103.11 0.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.423 . . . . 0.0 111.719 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -113.04 107.96 16.68 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 168.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.93 -24.08 66.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.735 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -67.09 -58.22 5.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.479 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 p -92.32 -16.2 26.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.995 0.426 . . . . 0.0 111.116 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.03 49.07 8.96 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.046 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.41 152.96 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 0.0 111.393 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -147.17 123.55 10.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.307 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.85 -9.26 58.07 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.996 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 39.4 ttmt -162.4 142.37 9.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 0.0 111.736 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' NH2' ' O2 ' ' A' ' 201' ' ' 2W7 . 8.4 ptp85 -119.0 108.93 15.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.256 171.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 1.2 tmtp? -87.86 102.57 14.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -87.8 128.15 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 121.664 0.745 . . . . 0.0 110.65 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -127.73 116.92 20.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.838 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 78.7 t -113.65 117.83 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.503 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -105.34 118.64 37.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.522 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 m -92.04 141.17 28.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.191 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.46 ' CD ' ' HD3' ' A' ' 119' ' ' LYS . 29.3 tt0 -65.63 134.52 53.43 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.288 0.566 . . . . 0.0 111.488 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.02 165.57 3.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.042 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttp . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.726 -0.655 . . . . 0.0 110.213 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.55 ' O2 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.891 0.377 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -97.93 -9.16 26.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 109.841 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.78 -179.92 3.77 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.142 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -56.32 143.93 63.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.89 138.31 62.4 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 111.954 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 11.8 tp60 -152.55 159.12 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.88 102.06 5.55 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 89.4 Cg_endo -83.52 172.47 10.28 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.634 2.223 . . . . 0.0 112.967 -174.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -91.61 -24.55 19.53 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.737 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -75.07 102.5 4.9 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.062 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -80.46 8.9 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.219 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 p -89.21 -9.4 50.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.401 0.619 . . . . 0.0 109.494 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -91.47 157.51 17.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.415 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -98.96 104.9 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -67.85 -37.34 81.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.936 0.398 . . . . 0.0 110.991 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.35 174.65 41.19 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.264 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.99 130.87 53.98 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.67 109.98 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.639 0.733 . . . . 0.0 109.417 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 39.0 mt-10 -123.1 109.27 13.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.628 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 25' ' ' ILE . 65.0 mt -122.53 101.89 39.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.599 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.44 -23.49 75.05 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 123.022 2.482 . . . . 0.0 112.394 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -68.43 -20.3 64.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.666 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.08 14.38 4.24 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.37 32.32 21.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.021 0.439 . . . . 0.0 111.426 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.67 HG23 ' HB2' ' A' ' 71' ' ' GLN . 64.1 mt -87.53 129.29 39.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.253 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 26' ' ' LYS . 23.7 ttmm -161.95 81.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.119 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 35.9 mt-10 -143.58 158.46 56.99 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.292 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 58.3 Cg_endo -70.91 156.89 59.52 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.683 2.256 . . . . 0.0 112.605 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -112.07 132.32 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -95.84 111.99 57.79 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-O 121.404 0.621 . . . . 0.0 111.245 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 60.9 Cg_endo -73.82 133.58 18.68 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.179 2.586 . . . . 0.0 112.396 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 148.5 -168.51 29.13 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.589 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.03 153.94 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.846 2.364 . . . . 0.0 111.831 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.08 101.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.353 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.6 p -132.32 152.21 79.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.656 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.12 -37.94 95.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.984 2.456 . . . . 0.0 112.67 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.26 -51.23 68.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.067 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -75.72 -37.65 59.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.11 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 62' ' ' HIS . 90.5 mt -76.51 -2.77 33.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -94.19 -10.33 33.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.659 0.742 . . . . 0.0 109.352 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.637 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 2.4 mmp_? -105.03 -25.56 12.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.429 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.65 -129.89 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.965 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.536 HG12 HG22 ' A' ' 59' ' ' ILE . 20.7 t -95.62 126.69 48.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.786 0.327 . . . . 0.0 110.183 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 m -139.87 150.02 44.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 35.0 m-85 -66.26 168.17 9.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -103.2 -55.02 2.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.315 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -98.79 163.1 12.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.417 . . . . 0.0 110.647 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.4 -23.72 17.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.185 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -76.96 -29.4 55.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.191 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.87 149.57 49.28 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.065 0.46 . . . . 0.0 110.465 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -154.59 150.13 27.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.55 -7.53 33.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.785 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.27 -30.1 25.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.432 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t70 -90.02 -160.51 0.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 -175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 20.6 pt20 -109.5 -25.37 10.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.334 -0.229 . . . . 0.0 111.273 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -93.01 120.99 33.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.811 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 121' ' ' LEU . 34.2 mm -127.83 129.09 69.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.912 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.3 t -133.51 87.93 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.17 0.51 . . . . 0.0 110.23 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -103.62 127.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.05 36.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.892 0.377 . . . . 0.0 110.779 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.29 165.18 17.34 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 39' ' ' LEU . 14.7 m-70 -130.99 142.62 50.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.936 0.368 . . . . 0.0 111.19 -176.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.973 HG23 ' HA ' ' A' ' 73' ' ' THR . 82.1 m -117.78 120.69 38.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.327 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.35 106.93 17.65 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.89 -26.86 41.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.874 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -98.9 5.77 47.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.191 0.52 . . . . 0.0 110.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.68 87.82 51.41 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 121.043 0.449 . . . . 0.0 110.03 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 73' ' ' THR . 73.3 Cg_endo -77.09 2.78 7.27 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.177 2.585 . . . . 0.0 113.371 -174.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.12 1.68 36.54 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.151 0.501 . . . . 0.0 110.228 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.491 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.3 t80 -78.13 138.22 38.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.67 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -57.96 -44.07 86.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -167.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.451 ' CD1' ' HG2' ' A' ' 71' ' ' GLN . 3.9 m-30 -88.91 6.35 39.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.013 -0.43 . . . . 0.0 112.125 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.973 ' HA ' HG23 ' A' ' 63' ' ' THR . 86.0 m -76.37 -33.93 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.452 . . . . 0.0 110.512 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 76' ' ' LYS . 62.6 t30 -92.23 14.92 14.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.09 21.77 0.17 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.471 0.653 . . . . 0.0 110.868 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -101.52 -23.41 14.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.69 172.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -73.98 -31.84 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.004 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.17 156.86 29.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.045 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -130.83 -173.8 3.19 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.338 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -11.8 52.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.613 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.95 55.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.355 177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.511 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 70.0 m -109.11 145.42 35.72 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.208 0.528 . . . . 0.0 109.827 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.25 108.71 15.11 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.811 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 93.7 t -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.438 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -100.96 117.04 34.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.064 0.459 . . . . 0.0 110.92 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -105.47 101.68 11.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.5 ttpt -98.07 117.54 32.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.08 -173.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.4 m -113.28 99.87 9.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.343 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.71 -101.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.794 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.81 -2.88 15.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.235 0.541 . . . . 0.0 109.996 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.622 ' HB2' HG23 ' A' ' 88' ' ' VAL . 7.8 mm-40 -96.61 148.71 22.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.207 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.9 m -134.89 112.4 10.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.765 0.317 . . . . 0.0 110.69 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 44.2 mtp85 -101.75 138.89 38.13 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -99.96 130.02 46.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 86.3 m-85 -127.79 147.17 50.42 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.547 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 12.1 tppt? -109.34 140.53 42.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.572 ' HB3' HD11 ' A' ' 100' ' ' ILE . 50.2 mtp -77.63 60.16 2.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.206 0.527 . . . . 0.0 110.404 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.0 p -63.51 -36.88 85.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.094 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 73.9 m -124.45 97.37 5.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.153 0.502 . . . . 0.0 111.451 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 97' ' ' MET . 69.4 mt -113.18 110.49 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.537 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -146.67 151.65 37.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.828 0.347 . . . . 0.0 110.255 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -102.43 93.22 5.04 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.745 0.783 . . . . 0.0 110.475 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.705 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 14.7 m -97.26 95.87 4.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.368 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.651 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -109.06 90.81 8.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.344 0.592 . . . . 0.0 112.417 -170.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 103' ' ' VAL . 94.4 Cg_endo -104.13 -158.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 123.763 2.975 . . . . 0.0 111.335 172.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.9 t -126.48 11.84 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.44 163.99 29.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.303 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 -21.61 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.45 17.11 18.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.423 . . . . 0.0 110.936 -174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 105' ' ' PRO . 19.1 m -66.86 -20.25 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.733 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -90.87 -178.65 5.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.66 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.44 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 3.5 p30 -79.18 167.29 21.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.497 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.53 15.02 22.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.816 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 112' ' ' ASP . 1.7 mp0 -66.75 110.67 3.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.746 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -73.57 2.59 7.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.262 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.81 64.96 3.57 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.636 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -108.48 178.73 4.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.88 -176.79 3.18 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -80.14 93.83 5.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 171.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -137.6 148.84 46.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.581 -170.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 57' ' ' ILE . 19.5 mt -94.13 104.25 16.28 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -77.27 84.02 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 30.4 mt -86.79 102.1 13.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.536 0.684 . . . . 0.0 110.784 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.491 HD13 ' N4 ' ' A' ' 201' ' ' 2W7 . 40.7 mt -79.73 99.9 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 m -87.35 91.78 8.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.21 0.529 . . . . 0.0 110.12 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 68.7 m -78.34 101.43 7.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -118.5 158.28 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.422 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . 18.2 t0 55.76 93.62 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.755 0.659 . . . . 0.0 111.798 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.678 ' HB2' ' O ' ' A' ' 135' ' ' VAL . 38.4 p90 -167.81 170.45 10.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.794 ' H ' ' HB ' ' A' ' 135' ' ' VAL . 21.5 t-20 -104.45 134.0 48.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.4 -35.68 68.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.201 0.524 . . . . 0.0 111.289 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -86.87 -55.53 3.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.235 -170.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.3 p -75.83 -10.38 59.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.35 -169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.59 71.24 1.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.319 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.794 ' HB ' ' H ' ' A' ' 130' ' ' ASN . 61.6 t -118.36 146.42 22.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.32 79.08 1.63 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HG2' HG12 ' A' ' 135' ' ' VAL . 23.5 mm-40 -81.57 -75.48 0.29 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 128' ' ' ASP . 46.9 mmtm -79.52 98.64 6.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.679 0.752 . . . . 0.0 111.026 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.689 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 11.5 mmm-85 -89.86 76.73 7.1 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.356 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -83.16 112.74 20.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.94 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.0 tp -93.25 127.8 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-O 121.814 0.816 . . . . 0.0 110.747 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.714 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -118.08 100.56 7.62 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.963 178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.0 t -98.68 112.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.88 116.09 31.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.404 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.7 m -89.03 139.84 30.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.146 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.01 130.11 42.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.049 0.452 . . . . 0.0 110.94 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.85 162.45 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 46.8 pttt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.503 -0.76 . . . . 0.0 110.66 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.491 ' N4 ' HD13 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.504 0.193 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 2' ' ' GLN . 13.9 mm-40 -92.5 25.9 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.351 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.16 22.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.373 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -62.29 152.4 79.26 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 123.484 0.49 . . . . 0.0 110.699 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.84 107.1 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.978 2.452 . . . . 0.0 113.054 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -140.63 169.31 17.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.934 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.713 ' HB ' ' HB3' ' A' ' 50' ' ' GLU . 90.1 mt -121.88 102.62 40.96 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-O 120.75 0.31 . . . . 0.0 110.525 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 15' ' ' ALA . 5.8 Cg_exo -78.36 144.79 20.73 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.664 2.243 . . . . 0.0 110.606 172.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 9' ' ' LYS . 40.1 pttt -89.51 34.08 0.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.35 0.595 . . . . 0.0 110.987 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.42 141.82 30.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.976 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 9.0 mptt -96.0 6.95 47.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.604 -173.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -113.09 -44.93 3.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.905 0.383 . . . . 0.0 110.752 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.14 126.75 31.67 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.494 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.53 116.88 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.576 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . . . -84.89 -37.73 20.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.933 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.48 168.32 27.9 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.86 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.27 135.95 39.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -103.61 125.04 58.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 37.0 mt-10 -128.68 109.52 11.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.27 0.557 . . . . 0.0 111.29 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.1 mt -121.52 103.07 41.59 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.95 -43.64 41.56 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.299 2.666 . . . . 0.0 113.938 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.71 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 3.1 p-10 -76.3 -10.69 59.59 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.22 2.09 16.47 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.979 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 60.65 26.22 15.96 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 79.4 mt -93.04 104.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.429 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 51.3 mttt -137.27 81.23 1.86 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -126.85 150.62 72.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.54 -173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.77 144.08 76.33 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.623 2.215 . . . . 0.0 112.309 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 87.9 t -94.45 132.63 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -92.06 105.68 14.72 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-O 121.304 0.573 . . . . 0.0 110.453 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 97.7 Cg_endo -80.6 140.75 13.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.001 2.467 . . . . 0.0 112.75 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.4 -170.36 29.64 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 72.1 Cg_endo -76.9 149.06 28.81 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.468 2.112 . . . . 0.0 111.802 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -63.8 98.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.566 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -134.34 142.0 41.29 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.507 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.19 -30.81 43.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.363 2.709 . . . . 0.0 113.208 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' HG3' ' HG2' ' A' ' 38' ' ' GLN . 10.2 pt-20 -59.99 -30.92 69.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.709 0.29 . . . . 0.0 111.59 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' HG2' ' HG3' ' A' ' 37' ' ' GLU . 16.0 mm100 -101.06 -42.57 6.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.837 0.351 . . . . 0.0 111.024 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 62' ' ' HIS . 3.9 mm? -74.15 -2.7 25.78 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -99.88 -9.52 22.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -93.43 -55.88 3.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.886 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.99 -120.83 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.833 -175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG23 ' NE2' ' A' ' 71' ' ' GLN . 35.1 t -109.71 126.63 66.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.881 0.372 . . . . 0.0 110.688 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -146.54 158.03 43.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.928 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -66.1 134.09 52.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.064 0.459 . . . . 0.0 111.018 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -84.74 -12.04 54.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.207 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 46.7 mt-10 -101.08 121.32 41.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.773 175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 43.6 mt-10 -65.06 -33.59 76.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.296 -172.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.05 125.52 31.55 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.164 0.507 . . . . 0.0 110.653 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . 2.7 mp0 -63.27 108.75 1.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.481 -175.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.6 m -150.35 139.99 21.64 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 172.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 7' ' ' ILE . 1.5 pp -130.17 6.8 4.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.923 0.392 . . . . 0.0 111.237 -177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.86 33.49 1.98 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.74 179.94 4.94 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 117' ' ' LYS . 1.0 OUTLIER -72.5 -47.48 48.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -104.11 126.21 51.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.257 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.74 95.07 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.239 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 7.5 m -86.95 111.54 20.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.7 mt -122.96 120.24 60.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.49 142.75 31.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.724 0.297 . . . . 0.0 110.437 -177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.58 124.16 4.57 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 39' ' ' LEU . 28.8 t-80 -84.75 132.76 34.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 127' ' ' ASP . 15.1 t -153.25 175.32 13.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 m-85 -140.95 138.0 33.48 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.224 0.327 . . . . 0.0 110.122 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 65' ' ' ILE . 0.3 OUTLIER -69.57 -17.31 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.835 0.826 . . . . 0.0 108.933 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -83.88 -21.05 32.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.089 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 9.6 mmt180 -124.54 111.99 27.75 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 5.5 Cg_exo -78.57 1.58 8.93 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 123.233 2.622 . . . . 0.0 110.876 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -86.88 14.01 8.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.334 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.52 -177.29 3.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.051 0.453 . . . . 0.0 111.639 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' NE2' HG23 ' A' ' 43' ' ' VAL . 10.8 mt-30 -93.97 -31.01 14.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.837 -170.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -102.38 24.01 10.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.665 0.269 . . . . 0.0 111.475 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.409 HG21 ' HA ' ' A' ' 68' ' ' PRO . 23.9 p -73.96 -38.06 64.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.863 0.364 . . . . 0.0 111.657 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -93.14 18.73 8.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.031 0.443 . . . . 0.0 111.085 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.07 -10.86 57.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.982 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HD3' ' H ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -77.19 -22.15 52.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.23 176.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.63 -4.29 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.621 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.71 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.79 159.6 15.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.086 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.9 mptt -121.04 172.59 7.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 111.025 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -74.56 -4.84 39.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.132 -176.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.64 24.92 5.44 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.792 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 m -84.74 -173.78 4.91 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.331 0.586 . . . . 0.0 110.3 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -121.15 107.76 12.97 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.995 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.401 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.6 t -93.11 106.05 17.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.014 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 85.5 m-85 -90.18 128.01 36.25 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.673 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -117.08 108.22 15.46 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.085 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -92.36 140.14 29.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.123 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 52' ' ' LEU . 8.5 p -163.67 128.9 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.903 0.382 . . . . 0.0 111.327 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.85 -87.94 0.08 OUTLIER Glycine 0 C--N 1.329 0.169 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.979 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -135.78 0.23 2.66 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 122.095 0.158 . . . . 0.0 111.391 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.34 169.06 11.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.036 0.446 . . . . 0.0 111.161 -174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.8 m -148.05 110.73 4.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.913 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 92.5 mtt180 -95.51 154.55 17.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.511 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.47 117.44 34.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.535 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 63.2 m-85 -109.4 153.61 23.74 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.719 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 96' ' ' LYS . 39.6 ttmt -112.95 150.75 31.4 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.731 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 57.5 mtp -86.72 66.13 9.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.388 0.613 . . . . 0.0 109.978 -175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -70.44 -37.66 74.38 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.213 -170.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.4 m -127.07 95.79 4.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.099 0.476 . . . . 0.0 111.482 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 42.9 mt -110.31 111.1 34.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.614 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -139.07 151.24 46.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.23 0.538 . . . . 0.0 110.842 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -94.92 126.01 39.97 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.922 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 25.3 t -131.52 93.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.115 0.483 . . . . 0.0 110.933 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 4.3 mtmt -90.44 153.28 46.11 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.458 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 6.8 Cg_exo -74.56 14.69 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.272 2.648 . . . . 0.0 113.346 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p -70.89 -30.89 67.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.957 0.408 . . . . 0.0 110.518 176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.98 107.88 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.867 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 109' ' ' GLU . 26.9 m -92.93 -176.95 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.747 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 108' ' ' VAL . 44.3 mt-10 67.73 6.75 5.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.034 0.533 . . . . 0.0 111.31 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.698 HG13 ' HG ' ' A' ' 111' ' ' LEU . 5.8 p -64.32 -34.11 67.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.698 ' HG ' HG13 ' A' ' 110' ' ' VAL . 1.2 pp -138.31 147.74 43.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.738 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HB2' ' OE1' ' A' ' 114' ' ' GLN . 9.5 m-20 -112.23 165.21 12.37 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.086 0.469 . . . . 0.0 111.203 -174.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -98.17 72.76 2.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.399 176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.4 OUTLIER -117.77 157.24 26.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.327 -177.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -82.74 -170.23 2.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.692 177.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.68 24.86 6.82 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.423 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 29.2 mmtp -131.54 -165.01 1.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -104.89 -157.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -68.11 95.39 0.56 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.12 0.486 . . . . 0.0 110.708 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 120' ' ' GLN . 16.0 pt20 -105.5 126.56 52.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.107 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mt -93.42 106.06 18.06 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 m -83.26 91.48 7.29 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.572 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 142' ' ' PHE . 32.1 mt -84.25 97.52 9.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.378 0.609 . . . . 0.0 110.271 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.4 mt -80.76 96.22 2.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.732 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -96.52 86.53 4.16 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.664 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.2 m -73.03 108.53 5.98 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 63' ' ' THR . 19.7 t70 -83.61 -21.93 32.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.183 -168.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 38.3 m-20 -139.27 138.89 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -152.99 134.72 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.345 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -118.64 120.97 39.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -68.07 -48.87 64.36 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.698 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -59.44 -63.06 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.103 0.478 . . . . 0.0 111.331 -170.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.2 p -73.89 -12.04 60.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.424 -174.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.84 57.15 10.2 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.974 -0.632 . . . . 0.0 111.777 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.6 p -132.64 146.51 32.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.487 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.494 ' CD1' ' HD3' ' A' ' 139' ' ' ARG . 2.7 p90 -129.5 104.13 7.29 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.57 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 12.9 mm-40 -57.04 -57.84 10.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.011 -172.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -121.57 136.89 54.92 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.773 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 103' ' ' VAL . 15.7 mtm180 -123.49 127.87 48.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.6 105.01 14.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.28 121.75 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.703 0.763 . . . . 0.0 110.53 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.731 ' HE1' ' HA ' ' A' ' 97' ' ' MET . 6.2 t80 -119.33 109.85 16.28 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.988 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 53.9 t -102.09 107.19 21.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.952 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -94.56 134.29 37.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.758 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.5 m -103.66 136.13 43.94 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.301 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.415 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 31.7 tt0 -67.92 121.87 16.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.247 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.4 164.09 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.699 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.3 pttp . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.515 -0.755 . . . . 0.0 110.452 179.612 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.5 ' O2 ' ' HD2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.204 0.526 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -123.49 -96.84 0.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.725 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.0 -178.48 2.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.559 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -62.47 116.27 21.94 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 123.413 0.445 . . . . 0.0 110.581 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 150.97 25.41 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.467 2.112 . . . . 0.0 112.136 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.442 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 27.5 mm-40 -118.65 179.25 4.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.856 HD11 ' HB3' ' A' ' 52' ' ' LEU . 3.8 mp -91.37 106.39 16.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 77.8 Cg_endo -96.63 -168.7 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.269 2.646 . . . . 0.0 113.391 -175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -74.9 -20.92 59.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.607 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB3' ' CG ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -79.37 105.25 10.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.457 -178.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 23.4 mttp -87.71 -29.34 21.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 110.661 -176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.4 p -73.9 -13.11 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.542 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.524 ' CG ' ' HB3' ' A' ' 10' ' ' ASP . 32.1 mmtp -87.18 80.74 8.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.58 113.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.511 0.672 . . . . 0.0 111.189 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.57 -34.12 41.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.92 162.79 26.7 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.773 -1.203 . . . . 0.0 113.461 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.82 124.09 41.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -101.76 118.91 49.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.541 0.686 . . . . 0.0 110.104 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 46.6 mt-10 -132.32 123.76 27.48 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.972 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.2 mt -125.78 101.34 29.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.59 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.1 -27.62 85.27 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.958 2.438 . . . . 0.0 112.513 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' OD2' ' HB2' ' A' ' 82' ' ' SER . 8.9 m-20 -63.07 -27.52 69.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -121.47 10.45 10.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.426 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 61.31 28.82 18.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.571 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 23' ' ' ALA . 75.8 mt -85.56 129.21 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.487 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 22.7 ttmm -152.52 78.03 1.2 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -133.24 148.08 67.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.277 -172.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.71 162.11 30.19 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.783 2.322 . . . . 0.0 112.436 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 63.8 t -114.56 129.39 70.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.41 110.7 53.96 Favored Pre-proline 0 C--N 1.316 -0.878 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.822 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 16.9 Cg_exo -66.43 110.76 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.071 2.514 . . . . 0.0 112.069 176.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 174.62 168.5 35.44 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.582 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.15 144.94 38.36 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.873 2.382 . . . . 0.0 111.899 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -57.95 109.93 0.83 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.996 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 p -139.65 147.0 50.12 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.047 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.94 -42.33 67.64 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.063 2.508 . . . . 0.0 113.228 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.38 -18.54 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -86.52 -43.3 12.84 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.78 -8.16 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.515 173.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.0 -17.5 63.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.638 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.0 -64.86 1.02 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.638 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.14 -113.32 0.29 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.95 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.79 130.53 57.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.0 110.609 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.1 m -144.34 158.08 43.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 87.9 m-85 -69.71 150.94 46.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 111.347 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -86.43 -62.79 1.43 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.625 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -170.53 1.67 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.927 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.28 39.12 1.12 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.59 90.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.89 -18.36 65.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.764 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.712 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 17.9 m -96.85 110.23 22.77 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.102 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HD11 ' A' ' 7' ' ' ILE . 3.6 pp -81.91 -10.0 59.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.59 0.709 . . . . 0.0 109.494 177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -100.6 11.07 40.27 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.003 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.712 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.6 t70 -82.04 177.41 8.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -83.09 -44.04 15.59 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.74 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.535 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -97.29 117.93 32.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.731 0.776 . . . . 0.0 111.034 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.9 mm -127.0 136.47 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 m -125.69 112.8 16.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.442 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' HB ' HD23 ' A' ' 123' ' ' LEU . 2.8 mt -121.38 139.07 49.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.992 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.09 121.57 44.41 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -123.27 77.07 0.36 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.306 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.772 ' CE1' ' HB2' ' A' ' 129' ' ' TYR . 3.5 t-80 -74.46 121.68 21.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.002 0.43 . . . . 0.0 110.438 -175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 70' ' ' TYR . 21.7 m -112.71 166.73 11.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.824 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' A' ' 129' ' ' TYR . 63.7 m-85 -127.99 116.5 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 tt -55.8 -31.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.527 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 34.3 t70 -66.87 -24.73 66.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 80.2 mtt180 -111.56 93.04 18.22 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 26.5 Cg_exo -62.1 -21.76 73.02 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.369 2.712 . . . . 0.0 113.516 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -91.24 22.43 3.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.835 0.35 . . . . 0.0 111.617 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.715 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.1 OUTLIER -84.2 173.41 11.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 172.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 72' ' ' PHE . 19.2 pm0 -65.84 -59.07 4.24 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -170.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.598 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 56.3 m-85 -99.97 26.58 6.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.925 -0.484 . . . . 0.0 112.143 -171.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 p -67.22 -37.4 83.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.122 0.487 . . . . 0.0 111.32 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.1 t30 -98.6 13.8 30.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.46 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 tp -64.86 -7.89 13.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.49 0.662 . . . . 0.0 110.56 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 19.9 pttp -68.34 -23.84 64.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.737 174.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 -5.28 58.63 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.443 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.27 170.4 16.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.04 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -143.99 177.67 8.4 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.018 0.437 . . . . 0.0 110.854 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.52 1.17 17.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.294 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -150.15 48.68 0.58 Allowed Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.094 176.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 17.4 p -86.26 -158.36 0.4 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.222 0.534 . . . . 0.0 110.635 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.4 OUTLIER -129.11 112.0 13.53 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.991 176.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.9 t -105.74 119.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.189 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.41 118.32 36.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.95 0.405 . . . . 0.0 110.935 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -106.54 107.2 18.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.765 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -94.9 139.07 31.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.146 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 113.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.527 0.68 . . . . 0.0 110.883 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 -86.5 0.66 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.021 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -140.25 2.14 1.86 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.19 0.519 . . . . 0.0 110.506 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.87 145.89 37.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.502 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.2 m -131.02 109.41 10.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.914 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE1' ' A' ' 95' ' ' TYR . 4.7 ptm180 -106.77 148.39 28.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.291 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -105.6 141.55 36.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 95.5 m-85 -129.74 150.06 51.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.175 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -116.44 128.22 55.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.303 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -71.43 79.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.981 0.419 . . . . 0.0 110.198 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -82.92 -20.53 35.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.784 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.6 t -128.68 111.69 13.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.18 0.514 . . . . 0.0 110.458 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.5 mt -120.14 113.79 41.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.515 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -151.43 163.05 39.85 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.56 133.93 47.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.999 0.428 . . . . 0.0 110.19 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.72 137.9 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.232 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -134.89 150.79 74.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.313 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.81 71.86 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.729 2.286 . . . . 0.0 111.181 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -143.26 93.8 2.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.312 0.577 . . . . 0.0 110.954 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 54.46 51.45 14.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.333 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -13.24 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.518 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.93 30.64 4.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.076 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.58 -8.46 10.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.633 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.29 134.53 48.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.799 -174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.493 ' OD1' ' HG2' ' A' ' 114' ' ' GLN . 11.6 p30 -107.87 -164.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.367 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.53 20.22 14.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.493 ' HG2' ' OD1' ' A' ' 112' ' ' ASP . 58.0 mm-40 -71.72 115.95 11.52 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.113 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -77.62 69.9 3.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.231 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.35 45.54 3.28 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -93.49 163.77 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.289 -0.455 . . . . 0.0 110.602 -174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -165.45 -166.72 1.02 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.528 ' N ' ' HE3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -76.44 101.96 5.79 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 161.78 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.536 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -118.47 115.55 24.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m -82.7 102.29 11.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.517 HD23 ' HB ' ' A' ' 59' ' ' ILE . 84.8 mt -98.16 107.51 20.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.266 0.555 . . . . 0.0 111.248 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.0 mt -81.18 96.43 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.186 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.553 ' HG1' ' HD1' ' A' ' 142' ' ' PHE . 8.9 p -105.61 52.25 0.74 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.301 0.572 . . . . 0.0 111.762 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 139' ' ' ARG . 35.2 m -73.83 152.6 40.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.295 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.532 ' HB2' ' HE ' ' A' ' 139' ' ' ARG . 14.9 t0 -118.82 -54.62 2.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.75 0.786 . . . . 0.0 109.273 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.62 ' OD1' ' HB2' ' A' ' 139' ' ' ARG . 4.3 p-10 -54.02 121.32 7.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.581 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.772 ' HB2' ' CE1' ' A' ' 62' ' ' HIS . 84.0 t80 -168.13 114.07 0.67 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.713 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' HB3' HG12 ' A' ' 135' ' ' VAL . 40.1 t30 -87.88 109.21 19.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 170.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.617 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 8.2 pt-20 -64.26 -18.57 64.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -64.49 -49.37 71.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.963 0.411 . . . . 0.0 110.401 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 37.3 p -102.96 -34.97 8.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.884 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.491 ' HA2' ' CE1' ' A' ' 129' ' ' TYR . . . 89.26 44.97 4.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.473 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG12 ' HB3' ' A' ' 130' ' ' ASN . 11.0 p -95.93 144.81 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.084 0.469 . . . . 0.0 111.797 -175.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -126.07 139.18 53.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.733 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.39 -64.04 1.34 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.558 0.218 . . . . 0.0 111.486 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -176.86 130.54 0.18 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.62 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 20.5 tpt180 -161.28 -82.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' HD2' ' CE1' ' A' ' 142' ' ' PHE . 14.5 mmtp -157.67 143.35 17.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -167.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.8 tt -135.59 139.39 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.775 166.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.553 ' HD1' ' HG1' ' A' ' 125' ' ' THR . 66.6 m-85 -128.2 125.09 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.772 0.32 . . . . 0.0 110.871 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 46.5 t -110.96 107.84 23.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.571 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -100.71 113.64 26.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.967 -178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.8 m -83.67 141.63 31.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.21 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -67.89 128.07 35.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.104 0.478 . . . . 0.0 111.007 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 96' ' ' LYS . 2.0 t -92.77 166.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.765 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.349 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.521 ' S2 ' ' N3 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.764 0.316 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -99.12 -8.48 25.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.904 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.98 156.41 30.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.709 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -89.84 128.23 51.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.493 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 55.4 Cg_endo -71.2 113.34 3.56 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.532 2.155 . . . . 0.0 112.212 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 32.8 mm-40 -121.13 -166.03 1.3 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.613 176.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 52' ' ' LEU . 36.0 mt -106.85 96.61 15.03 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 86.6 Cg_endo -95.77 -169.39 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.029 2.486 . . . . 0.0 113.13 -176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -82.88 12.59 4.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.64 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 9.5 t70 -108.64 125.65 52.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -109.78 12.39 24.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.948 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.5 t -106.99 -2.72 20.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.368 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 49.4 mmtm -97.24 178.38 5.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.482 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.66 117.27 53.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -88.14 -34.21 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.52 170.1 31.06 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.607 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.06 129.97 40.69 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.3 123.67 59.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.29 0.567 . . . . 0.0 110.346 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 30.5 mt-10 -121.43 121.69 38.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.361 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.2 mt -129.34 94.12 33.97 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.904 172.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.4 Cg_endo -54.7 -33.37 79.81 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.288 2.659 . . . . 0.0 112.407 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -59.6 -31.43 69.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.45 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.38 11.79 15.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.917 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.35 27.24 16.91 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.401 0.438 . . . . 0.0 111.282 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 64.2 mt -91.24 119.9 39.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 0.0 111.33 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -139.3 58.16 1.63 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.799 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 21.1 mm-40 -108.8 145.01 30.77 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.281 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.25 157.9 33.46 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.828 2.352 . . . . 0.0 112.406 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.489 ' HA ' HG13 ' A' ' 43' ' ' VAL . 60.7 t -111.71 131.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.424 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 20.3 m-85 -87.62 114.21 57.87 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.918 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -67.07 140.2 53.41 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.099 2.533 . . . . 0.0 112.201 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -168.08 24.98 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.731 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.35 160.23 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.436 2.758 . . . . 0.0 112.038 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.88 33.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.145 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.58 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.1 t -161.82 144.87 9.13 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.315 -174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -41.1 -50.63 4.18 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.575 3.517 . . . . 0.0 115.527 -172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -62.5 -46.07 90.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.921 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.411 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 14.7 mm100 -64.65 -48.83 73.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.879 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -78.69 20.65 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.18 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -123.67 -4.62 8.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 41' ' ' ARG . 46.0 mtp85 -124.85 -32.49 3.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.346 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.09 -162.1 14.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.074 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.731 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 6.8 p -95.82 140.5 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 50.3 m -138.9 176.6 8.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.054 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -90.51 140.5 29.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.077 0.465 . . . . 0.0 111.262 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.5 -3.68 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.891 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -79.88 154.86 28.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.318 -172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.32 19.25 14.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.62 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -71.34 172.12 9.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.422 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.41 7.86 35.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.358 0.599 . . . . 0.0 110.837 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.53 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 54.0 m -154.06 152.28 30.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.642 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -103.94 -7.07 20.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.205 0.526 . . . . 0.0 110.609 176.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' OD1' ' HB3' ' A' ' 51' ' ' SER . 9.8 p-10 -95.34 10.25 36.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.605 -178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -78.74 168.84 19.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.481 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -73.45 -32.58 64.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.351 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.38 111.61 24.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.868 0.842 . . . . 0.0 110.847 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 21.0 mm -135.43 102.33 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.839 -178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 17.1 m -83.06 106.85 15.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.03 0.443 . . . . 0.0 110.384 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 6.4 mt -99.13 111.45 28.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.782 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.42 96.44 6.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -103.02 85.01 0.49 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.198 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 70' ' ' TYR . 86.1 t60 -55.58 138.77 46.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.04 0.448 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 72' ' ' PHE . 9.8 m -114.77 147.71 39.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.077 -174.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.54 ' HE2' ' HG2' ' A' ' 67' ' ' ARG . 17.0 t80 -143.82 83.45 1.75 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.741 ' HA ' HG23 ' A' ' 73' ' ' THR . 0.5 OUTLIER -67.56 -13.86 17.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.92 -172.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 23.3 t70 -67.04 -51.85 49.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.418 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' HG2' ' HE2' ' A' ' 64' ' ' PHE . 5.6 mmp_? -92.38 116.12 65.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.67 ' HA ' HG21 ' A' ' 73' ' ' THR . 39.5 Cg_endo -66.83 -15.66 47.83 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.187 2.591 . . . . 0.0 114.301 -174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -98.21 12.98 32.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 43.8 t80 -80.33 156.45 26.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 75.3 mt-30 -52.11 -49.09 64.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.826 0.345 . . . . 0.0 111.64 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.731 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 82.1 m-85 -116.34 92.64 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.049 0.452 . . . . 0.0 110.283 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.741 HG23 ' HA ' ' A' ' 65' ' ' ILE . 24.3 m -133.3 -46.11 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.255 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.14 16.11 2.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.506 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -57.45 -25.09 59.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.748 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -55.8 -23.86 32.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.024 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.93 2.68 45.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.29 176.26 8.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.022 0.439 . . . . 0.0 110.642 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 0.0 OUTLIER -148.75 -178.23 6.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.351 -178.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -76.05 -16.19 59.98 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.22 -175.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -139.34 45.24 1.03 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.308 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 5.7 p -85.67 -162.05 0.68 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 tpt -129.51 98.25 4.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.078 0.465 . . . . 0.0 109.819 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG21 ' SD ' ' A' ' 97' ' ' MET . 97.1 t -84.85 126.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.038 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.3 m-85 -104.98 116.73 32.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.931 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 52.6 t80 -110.3 111.68 23.14 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.483 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -102.46 140.63 36.48 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.448 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 52' ' ' LEU . 2.6 p -140.69 111.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.246 0.546 . . . . 0.0 109.881 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.57 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 63.82 -98.06 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.501 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -120.38 0.35 10.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.209 0.528 . . . . 0.0 110.414 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HB2' HG13 ' A' ' 88' ' ' VAL . 33.1 mm-40 -94.27 157.43 16.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.389 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -150.2 129.92 13.22 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.681 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.75 152.92 32.33 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -103.04 137.98 40.5 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.58 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 96.8 m-85 -128.58 145.48 51.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.06 0.457 . . . . 0.0 111.286 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 11.6 tppt? -112.04 129.17 56.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.493 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.562 ' SD ' HG21 ' A' ' 84' ' ' VAL . 75.6 mmm -78.87 48.29 0.82 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.259 0.552 . . . . 0.0 110.329 -176.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 98' ' ' THR . 3.5 t -84.58 6.81 22.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.955 -171.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.593 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 58.8 m -136.25 106.72 6.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.013 171.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.3 mt -128.87 96.44 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.294 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 101' ' ' ARG . 25.3 mtm180 -145.17 138.24 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.566 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.585 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 8.2 p-10 -108.2 175.12 5.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.342 0.591 . . . . 0.0 111.659 -176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.21 147.59 14.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.744 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -110.61 132.55 21.52 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 5.9 Cg_exo -78.98 67.7 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.086 2.524 . . . . 0.0 112.876 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 p -67.54 -28.49 67.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.61 0.719 . . . . 0.0 109.647 172.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.98 160.33 42.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.082 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.438 HG23 ' HG3' ' A' ' 109' ' ' GLU . 34.8 m -83.61 -23.63 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.346 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 108' ' ' VAL . 41.0 mt-10 -100.85 29.19 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.21 0.528 . . . . 0.0 111.047 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.664 HG23 ' HG ' ' A' ' 111' ' ' LEU . 29.8 m -66.64 -17.84 23.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.261 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.664 ' HG ' HG23 ' A' ' 110' ' ' VAL . 72.0 mt -131.33 -175.31 3.66 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.4 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' A' ' 114' ' ' GLN . 2.5 t70 -146.73 -167.91 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.96 88.62 7.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.07 0.462 . . . . 0.0 110.101 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 112' ' ' ASP . 1.8 mp0 -74.95 105.99 6.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.743 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.03 -15.55 61.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.021 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.44 80.71 0.63 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.039 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -96.78 168.08 10.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.3 0.571 . . . . 0.0 110.911 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.92 -166.86 2.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -78.16 94.71 4.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 174.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -153.57 137.99 16.72 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.687 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 10.5 mt -101.5 122.72 44.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.7 m -84.0 82.67 8.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.297 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 7.7 mp -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.788 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mt -83.99 78.56 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 23.0 m -78.19 88.26 4.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.653 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.43 ' HB3' ' HG3' ' A' ' 139' ' ' ARG . 31.0 p -109.6 112.71 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.365 0.602 . . . . 0.0 112.202 -173.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 26.7 t70 -108.08 164.45 12.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 127' ' ' ASP . 3.5 t70 76.22 128.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.424 0.63 . . . . 0.0 112.145 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -176.36 157.31 1.7 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.066 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.464 ' HB3' HG12 ' A' ' 135' ' ' VAL . 47.3 t-20 -123.31 119.52 30.36 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.36 -31.48 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.692 -177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -72.19 -65.12 0.82 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.274 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 p -79.35 -43.31 23.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.58 57.21 1.0 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.151 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.464 HG12 ' HB3' ' A' ' 130' ' ' ASN . 12.3 p -120.3 152.69 23.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -151.03 135.46 16.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.93 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -118.73 -76.23 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -78.45 100.54 6.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -164.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 126' ' ' CYS . 5.4 mpt_? -109.12 91.05 3.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.589 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.6 OUTLIER -90.11 96.81 10.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.81 -174.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.5 mt -77.44 135.83 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.633 0.73 . . . . 0.0 110.499 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.01 109.23 15.25 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.657 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 51.1 t -97.5 102.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.04 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -99.73 112.6 24.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.132 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -77.74 139.0 39.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.909 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 119' ' ' LYS . 41.6 tt0 -65.05 132.97 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.022 0.439 . . . . 0.0 110.977 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.04 153.4 11.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.1 pttp . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.33 -173.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -160.27 174.77 13.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.164 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.32 177.28 8.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.284 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -75.84 113.22 25.12 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.006 0.431 . . . . 0.0 110.15 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' HD11 ' A' ' 52' ' ' LEU . 66.5 Cg_endo -78.72 133.74 11.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.706 2.27 . . . . 0.0 112.821 -175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.583 HE22 ' HB2' ' A' ' 53' ' ' ASP . 87.6 mm-40 -94.01 160.58 14.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.669 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.587 HG23 ' HB2' ' A' ' 31' ' ' PRO . 58.4 mt -59.9 109.84 2.31 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.712 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 96.8 Cg_endo -96.16 -178.66 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.508 2.806 . . . . 0.0 114.238 -170.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 33.3 ttmt -64.01 -44.55 92.27 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.009 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 1.6 m-20 -75.64 108.6 8.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.414 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.629 ' HD2' ' HA2' ' A' ' 32' ' ' GLY . 45.7 mmtm -83.67 5.25 25.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.01 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m -97.86 -4.05 37.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 110.518 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.2 mmtp -91.9 105.41 17.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG21 ' CB ' ' A' ' 28' ' ' PRO . 5.1 p -62.14 121.27 10.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.734 0.778 . . . . 0.0 111.101 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 52' ' ' LEU . . . -89.15 -28.63 19.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.464 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.72 158.12 27.62 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.659 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -117.6 141.23 48.61 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 84' ' ' VAL . 10.0 tp -117.3 127.57 74.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.089 0.471 . . . . 0.0 109.848 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 41.1 mt-10 -134.97 122.93 22.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 -176.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 71.9 mt -128.36 104.7 19.72 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 16.7 Cg_endo -59.73 -32.92 96.42 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.359 2.706 . . . . 0.0 113.811 -174.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -64.56 -29.97 70.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.961 0.41 . . . . 0.0 111.559 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.24 2.14 16.47 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.074 -176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.07 27.48 17.31 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.699 0.762 . . . . 0.0 110.184 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 60.7 mt -81.71 118.08 28.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.663 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -141.05 83.79 1.9 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.415 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.61 150.36 76.1 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.086 0.47 . . . . 0.0 111.36 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CB ' HG21 ' A' ' 14' ' ' VAL . 60.4 Cg_endo -73.46 140.11 29.6 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.864 2.376 . . . . 0.0 112.433 175.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.568 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.4 t -88.7 134.62 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.51 104.02 18.75 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.398 0.618 . . . . 0.0 111.097 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB2' HG23 ' A' ' 7' ' ' ILE . 61.7 Cg_endo -76.76 109.39 2.84 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.83 2.353 . . . . 0.0 111.442 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.629 ' HA2' ' HD2' ' A' ' 11' ' ' LYS . . . 177.18 -162.0 29.88 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.452 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.31 149.39 17.0 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.182 2.588 . . . . 0.0 112.028 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -73.41 120.21 18.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.495 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -159.61 135.35 6.05 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.989 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.01 -47.81 11.68 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.935 3.09 . . . . 0.0 113.93 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -56.21 -46.78 79.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 111.315 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -77.22 -35.63 55.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.337 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 44' ' ' SER . 96.1 mt -71.27 -14.24 62.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.269 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -87.97 -15.6 36.05 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.065 0.46 . . . . 0.0 110.154 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 41' ' ' ARG . 63.2 mtt180 -87.28 -40.31 14.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.466 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.92 -172.55 44.04 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.224 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 60' ' ' ALA . 2.1 m -67.77 125.01 24.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.703 0.763 . . . . 0.0 111.973 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.422 ' HB2' HD23 ' A' ' 39' ' ' LEU . 14.9 m -130.17 146.03 51.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.925 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 63.8 m-85 -59.25 135.89 57.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.207 0.527 . . . . 0.0 111.664 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -92.92 3.12 56.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.803 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 58' ' ' SER . 42.6 mt-10 -121.32 147.94 45.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.1 pm0 -88.22 80.36 7.6 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.758 0.79 . . . . 0.0 109.827 174.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -114.95 149.31 37.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.313 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.5 mp0 -94.4 7.12 46.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.217 0.532 . . . . 0.0 110.734 -176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -149.77 151.68 34.0 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.119 0.485 . . . . 0.0 111.56 -175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -120.71 16.89 11.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.726 174.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' HB2' HE22 ' A' ' 6' ' ' GLN . 26.8 t70 -88.19 -11.9 45.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.151 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -77.9 -167.48 1.0 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.58 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -117.6 -11.63 10.42 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.547 HD22 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -137.22 90.07 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -174.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.745 HG22 HD12 ' A' ' 121' ' ' LEU . 4.0 tt -121.92 148.09 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 -175.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HB2' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -99.51 122.09 42.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.526 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 2.0 mt -123.53 131.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' VAL . . . -102.15 146.05 28.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.673 0.273 . . . . 0.0 110.613 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.78 171.43 29.1 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.181 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -127.75 138.42 52.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.642 HG21 ' HZ1' ' A' ' 140' ' ' LYS . 1.2 p -94.26 -86.1 0.28 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 43.1 p90 -161.6 155.1 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.534 0.683 . . . . 0.0 112.684 -173.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.1 mm -127.49 -72.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.262 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 2.3 m-20 -129.24 14.44 6.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.1 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -104.31 101.0 24.32 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.508 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.819 ' HA ' HG21 ' A' ' 73' ' ' THR . 97.4 Cg_endo -89.7 0.56 5.74 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.413 2.742 . . . . 0.0 112.685 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -104.33 22.81 14.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.392 0.615 . . . . 0.0 110.026 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.473 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 20.5 t80 -104.47 155.98 18.34 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.403 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -61.73 -56.25 21.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.311 -174.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.548 ' HB2' ' HA ' ' A' ' 63' ' ' THR . 65.8 m-85 -79.9 9.19 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.819 HG21 ' HA ' ' A' ' 68' ' ' PRO . 7.0 m -72.71 -26.44 61.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.154 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -94.87 4.91 53.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.2 tp -65.51 -16.0 63.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.476 . . . . 0.0 110.509 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -22.66 65.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.804 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.47 -14.66 59.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.027 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.44 173.61 11.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.08 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -177.71 5.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.015 0.436 . . . . 0.0 111.249 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -66.47 -10.95 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.973 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.28 55.12 0.66 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.189 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.637 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 62.3 m -111.11 137.68 48.48 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 121.214 0.531 . . . . 0.0 109.734 176.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.448 ' HE2' ' HA ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -80.69 104.33 11.14 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.341 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 90.2 t -96.14 124.29 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.054 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 83.1 m-85 -99.42 122.98 43.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -116.05 116.52 28.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.524 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 9.1 ttmt -113.16 135.12 54.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.951 -172.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.0 m -141.77 100.43 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.625 177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.25 -83.15 0.53 Allowed Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.612 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -14.21 6.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.388 0.613 . . . . 0.0 109.648 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 88' ' ' VAL . 58.0 mt-10 -93.07 136.44 33.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.649 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 m -140.85 101.61 4.1 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.14 161.88 13.37 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.504 -177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -102.97 125.17 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.927 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 146' ' ' GLU . 65.5 m-85 -121.54 144.95 48.43 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HD2' ' HB ' ' A' ' 98' ' ' THR . 36.7 ttmt -108.46 145.37 34.75 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.3 mtp -81.67 46.88 1.01 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.378 0.609 . . . . 0.0 109.604 -177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 96' ' ' LYS . 4.4 t -81.67 8.67 9.32 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.448 -168.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.6 m -145.25 93.03 2.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.582 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.8 mt -126.73 137.04 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.762 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -165.43 147.78 7.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.843 0.354 . . . . 0.0 110.786 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 24.8 t70 -89.85 93.11 9.3 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.45 86.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.872 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -58.45 126.24 78.41 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD3' ' HG2' ' A' ' 139' ' ' ARG . 77.1 Cg_endo -76.58 46.23 1.81 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.166 2.578 . . . . 0.0 113.727 -171.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.5 t -76.72 -14.28 59.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -150.6 144.67 25.41 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.093 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.19 4.88 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -119.67 24.61 10.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.426 0.631 . . . . 0.0 110.081 -175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.73 15.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.841 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.28 162.89 13.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.279 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.413 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 1.3 m-20 -64.89 149.24 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.33 -40.38 97.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.413 ' HG2' ' HB3' ' A' ' 112' ' ' ASP . 23.8 pt20 -75.56 133.54 40.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.749 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -106.59 97.15 6.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.643 0.259 . . . . 0.0 110.857 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.75 134.8 24.19 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -105.97 167.21 9.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.884 0.85 . . . . 0.0 112.562 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 175.19 -164.99 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 113.103 -1.862 . . . . 0.0 106.483 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -95.72 96.08 8.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -145.0 113.12 6.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.457 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.745 HD12 HG22 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.26 114.67 26.38 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.0 t -88.04 128.53 35.4 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.389 0.614 . . . . 0.0 110.046 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 17.8 mt -107.86 105.2 14.9 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.337 177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.51 85.09 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.604 ' HB ' HG23 ' A' ' 63' ' ' THR . 31.9 p -87.05 86.43 7.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.569 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 42.9 m -64.84 106.01 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.407 176.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.31 -67.29 0.79 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.498 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 7.8 t70 -81.55 126.2 31.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.018 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -151.97 124.33 8.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.751 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -87.71 136.37 32.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 174.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.64 -40.29 14.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.247 -168.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -64.92 -62.35 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.086 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.2 p -83.91 -14.8 50.1 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.94 59.82 4.52 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.535 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.9 p -135.08 152.78 33.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -136.92 129.33 29.98 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.326 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -95.76 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.14 0.495 . . . . 0.0 109.975 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.467 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 37.9 mtmm -80.67 89.33 5.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.215 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 5.8 ptt180 -106.22 81.41 1.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.642 ' HZ1' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -62.21 118.03 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.308 -178.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.11 126.97 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.206 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.687 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.3 t80 -113.77 108.86 17.66 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.795 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.9 t -110.86 112.1 39.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -101.97 111.11 23.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.001 0.429 . . . . 0.0 110.549 177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.0 m -89.77 137.22 32.52 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.726 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 32.3 tt0 -59.8 124.53 20.44 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.115 0.483 . . . . 0.0 110.829 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.2 p -110.6 155.21 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 122.21 1.005 . . . . 0.0 110.849 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt . . . . . 0 C--N 1.302 -1.485 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.559 -168.334 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.47 ' O3 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 111.191 0.071 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 65.0 27.34 12.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.486 0.66 . . . . 0.0 110.256 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.45 173.31 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.194 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.27 147.16 79.14 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.589 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.17 113.99 1.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 111.318 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -151.5 159.28 44.23 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 77.8 mt -101.07 103.24 24.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 1.6 Cg_endo -84.34 167.49 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.04 2.494 . . . . 0.0 112.587 -177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -77.9 -12.87 60.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.291 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 18.5 t70 -84.65 123.37 30.28 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.138 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -95.67 12.31 30.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.655 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -93.86 -4.45 50.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.261 0.553 . . . . 0.0 110.154 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 49.9 mmtm -95.8 172.71 7.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.51 98.23 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.41 -32.27 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.077 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -148.73 156.13 26.7 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.902 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 1.0 OUTLIER -123.48 128.3 49.6 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.557 HD11 HG13 ' A' ' 84' ' ' VAL . 9.1 tp -102.31 117.82 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.525 0.678 . . . . 0.0 110.503 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.7 mt-10 -128.99 119.34 24.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.488 0.661 . . . . 0.0 111.466 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.4 mt -122.67 102.06 39.14 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.753 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.61 -25.68 75.48 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.023 2.482 . . . . 0.0 112.78 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -82.07 -3.16 54.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.19 10.99 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.541 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 60.21 20.79 10.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.041 0.448 . . . . 0.0 111.769 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 67.6 mt -86.77 119.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.577 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 8.9 mtpm? -144.58 68.75 1.25 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.813 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 25.0 mm-40 -113.74 145.58 33.74 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.474 -172.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.28 149.73 57.8 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.652 2.235 . . . . 0.0 111.934 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.31 130.52 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HB3' HE21 ' A' ' 38' ' ' GLN . 27.6 m-85 -88.68 111.68 45.69 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.746 -174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 37.9 Cg_endo -67.62 152.83 77.63 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.021 2.481 . . . . 0.0 112.797 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.46 177.54 16.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.046 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -72.37 136.11 25.78 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.999 2.466 . . . . 0.0 111.448 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.1 115.06 1.52 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.773 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -128.71 151.7 77.53 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.494 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.3 -46.06 36.61 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.192 2.594 . . . . 0.0 113.404 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.53 -8.6 58.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.306 0.574 . . . . 0.0 111.26 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 30' ' ' TYR . 56.4 tt0 -101.69 -41.27 6.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.866 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 34' ' ' ALA . 71.1 mt -67.74 -32.16 72.58 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.984 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -82.36 -12.98 57.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.207 0.527 . . . . 0.0 110.064 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -87.89 -40.06 14.28 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.503 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -127.17 0.91 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.018 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -122.29 138.06 53.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.7 p -135.9 174.79 10.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 0.0 110.988 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.6 m-85 -84.12 165.34 18.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.34 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.92 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.135 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 37.4 mt-10 -117.08 177.22 4.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 48' ' ' GLU . 26.3 tt0 -114.6 13.88 17.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.998 0.904 . . . . 0.0 109.185 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -95.78 -34.97 11.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.645 -169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 1.7 pm0 -82.5 142.37 31.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.234 0.54 . . . . 0.0 111.233 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -86.68 152.02 22.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.342 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.83 9.28 2.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 111.272 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -119.96 -1.8 10.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.437 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -84.91 -173.77 4.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.122 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -102.18 41.53 1.22 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.625 0.25 . . . . 0.0 111.112 -173.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -171.94 126.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.81 171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 121' ' ' LEU . 23.8 mm -118.93 104.66 16.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.7 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 m -98.29 99.19 10.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.093 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt -120.98 148.14 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.412 ' HB1' ' C7 ' ' A' ' 201' ' ' 2W7 . . . -142.04 140.07 32.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.702 0.287 . . . . 0.0 110.681 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -161.35 116.05 0.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.865 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -83.88 122.49 28.78 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 73' ' ' THR . 58.5 m -107.27 118.69 37.39 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.284 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' A' ' 67' ' ' ARG . 12.4 p90 -108.54 139.48 43.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.071 0.462 . . . . 0.0 111.368 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.402 ' HB ' ' HE1' ' A' ' 129' ' ' TYR . 82.0 mt -49.46 -34.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.592 -1.185 . . . . 0.0 113.302 -173.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.44 -29.31 48.98 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HG2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 mmt85 -113.56 101.88 54.18 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.204 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.675 ' HA ' HG21 ' A' ' 73' ' ' THR . 8.2 Cg_exo -74.21 -10.73 22.77 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 123.097 2.532 . . . . 0.0 111.39 175.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -106.71 22.44 15.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.084 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -82.79 163.19 21.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.813 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 4.1 mp0 -52.08 -39.79 60.26 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' A' ' 75' ' ' LEU . 76.3 m-85 -128.88 25.53 5.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.675 HG21 ' HA ' ' A' ' 68' ' ' PRO . 3.0 m -68.24 -27.35 66.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.24 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -100.37 21.56 12.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.179 -175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 75' ' ' LEU . 11.7 mt -65.5 -11.64 45.36 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -71.43 -24.43 62.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.247 0.546 . . . . 0.0 110.76 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -81.2 -17.78 48.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.058 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.93 150.33 21.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -129.68 179.42 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -178.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -65.56 -6.55 11.23 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -171.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.52 23.74 7.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.086 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.1 m -87.87 130.68 34.82 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.92 113.05 6.78 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG13 HD11 ' A' ' 18' ' ' ILE . 94.6 t -89.7 106.6 17.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.588 175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.01 107.35 19.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.053 0.454 . . . . 0.0 110.323 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 31.8 t80 -108.65 101.0 10.17 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.283 0.564 . . . . 0.0 109.587 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 54.5 mtmt -85.65 125.43 33.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.5 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 88' ' ' VAL . 17.8 m -107.9 92.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 121.822 0.82 . . . . 0.0 109.67 176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.95 -89.0 1.42 Allowed Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -127.71 -17.92 4.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.786 0.327 . . . . 0.0 111.138 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 26.1 mt-10 -84.24 142.42 30.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.741 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.3 m -108.78 112.24 24.41 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.529 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.413 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 12.9 mmt180 -89.11 130.75 35.5 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -100.8 125.89 47.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.936 0.398 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 78.7 m-85 -123.28 144.31 49.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.015 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HE2' HG11 ' A' ' 147' ' ' VAL . 5.4 tppt? -101.85 139.48 37.42 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB3' HD11 ' A' ' 100' ' ' ILE . 70.1 mtp -77.64 59.27 1.95 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.43 . . . . 0.0 110.393 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.8 p -59.3 -44.55 92.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.282 -173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 5.9 m -113.16 98.89 7.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.981 0.42 . . . . 0.0 111.543 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 97' ' ' MET . 58.8 mt -122.31 105.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -149.8 150.53 32.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.71 127.81 38.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.509 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.44 148.14 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 104' ' ' LYS . 44.6 mtpt -57.74 123.29 62.35 Favored Pre-proline 0 C--N 1.333 -0.123 0 CA-C-O 121.048 0.451 . . . . 0.0 111.43 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -85.22 -8.4 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.764 2.309 . . . . 0.0 112.544 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.0 p -93.75 -16.06 24.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.164 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -134.92 120.43 19.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.659 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.6 m -98.57 2.75 10.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -76.06 -20.77 57.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.04 7.1 2.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.72 -174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.37 113.64 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.252 0.548 . . . . 0.0 111.132 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.94 133.29 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.413 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.2 125.21 51.99 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.646 -169.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -120.23 139.46 52.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.938 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -83.38 51.79 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 110.113 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.06 145.29 15.64 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.154 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -133.51 168.75 18.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -175.23 -178.83 1.23 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.65 86.96 7.26 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.47 145.58 31.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.386 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -104.63 115.75 30.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.213 175.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.654 ' HA ' HG22 ' A' ' 143' ' ' VAL . 5.1 t -87.77 59.62 5.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.781 0.801 . . . . 0.0 110.436 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.499 ' CD2' ' HB ' ' A' ' 59' ' ' ILE . 5.7 mt -54.92 113.99 1.56 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.219 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.78 97.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.413 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 9.2 p -111.33 107.74 17.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -79.5 140.55 37.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.442 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 5.7 m-20 -89.14 -46.19 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.279 0.561 . . . . 0.0 111.086 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.468 ' HB2' ' H ' ' A' ' 137' ' ' GLU . 16.9 m-20 -88.42 169.11 12.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.158 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 16.6 p90 -156.23 127.57 7.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.701 172.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -93.59 109.01 20.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.02 -27.33 65.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.9 -171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 4.8 tmtt? -73.28 -79.77 0.08 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 111.35 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -97.63 -1.08 44.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.9 76.11 1.14 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.049 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 48.2 t -121.31 141.02 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.21 104.64 10.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 44.8 mt-10 -71.77 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 10.1 mtpm? -63.26 130.64 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.905 0.383 . . . . 0.0 111.167 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 1.0 OUTLIER -118.43 98.53 6.31 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 169.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -78.53 127.86 32.75 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.21 131.3 37.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.712 0.767 . . . . 0.0 109.988 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.4 t80 -129.18 98.78 5.01 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.22 -1.355 . . . . 0.0 109.241 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.654 HG22 ' HA ' ' A' ' 122' ' ' THR . 58.6 t -106.06 104.46 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.9 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.573 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -90.31 133.38 35.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.841 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.6 m -104.86 138.43 41.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.513 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 41.6 tt0 -64.97 113.87 4.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.244 0.545 . . . . 0.0 110.576 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG11 ' HE2' ' A' ' 96' ' ' LYS . 2.1 p -116.58 153.24 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 122.068 0.937 . . . . 0.0 112.367 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--N 1.308 -1.201 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.359 -178.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.469 ' O3 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttp . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.667 0.27 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.62 52.73 2.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.094 0.473 . . . . 0.0 110.145 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.23 155.25 5.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.414 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -67.14 147.34 99.03 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.793 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.686 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 26.0 Cg_endo -63.29 120.1 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.761 2.307 . . . . 0.0 112.309 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 -141.89 159.21 42.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 31' ' ' PRO . 46.6 mt -103.49 110.93 64.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 120.63 0.253 . . . . 0.0 110.68 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.31 -176.22 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.681 2.254 . . . . 0.0 111.292 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.24 -19.77 21.85 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.412 0.625 . . . . 0.0 109.608 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD1' ' HG2' ' A' ' 13' ' ' LYS . 2.7 p-10 -92.32 165.1 13.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -116.46 16.33 15.63 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.092 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.2 p -89.33 -27.35 20.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 110.045 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' A' ' 10' ' ' ASP . 29.8 mmmt -84.0 113.84 21.29 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.14 97.16 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.899 0.38 . . . . 0.0 110.588 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 -30.38 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.734 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -146.99 157.74 27.51 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.948 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 2.4 t80 -137.77 124.98 21.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.8 tp -95.06 121.58 45.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.152 0.501 . . . . 0.0 110.243 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.1 mt-10 -128.5 106.43 8.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.548 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 61.8 mt -120.42 98.78 48.36 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.185 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.53 -33.39 93.83 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.043 2.496 . . . . 0.0 112.486 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.36 -19.9 65.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.548 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -128.04 16.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.4 23.09 12.65 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.217 0.323 . . . . 0.0 111.636 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 81.1 mt -94.18 112.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.635 0.255 . . . . 0.0 111.342 -172.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 54.5 mtmt -141.05 86.16 2.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.668 171.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -123.61 141.33 36.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.65 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.3 146.24 56.28 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.262 1.975 . . . . 0.0 111.449 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 58.0 t -100.08 127.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.705 ' HB3' ' HB2' ' A' ' 11' ' ' LYS . 23.7 m-85 -95.48 105.18 18.74 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.592 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -66.61 143.43 68.41 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.996 2.464 . . . . 0.0 112.284 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 141.67 -134.26 6.15 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.434 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -95.87 155.05 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 123.406 2.737 . . . . 0.0 112.797 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.83 129.58 35.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.431 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.28 138.95 7.67 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.54 -31.97 80.85 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.178 2.586 . . . . 0.0 112.925 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.31 -35.41 77.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 111.354 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 21.9 tt0 -85.52 -34.7 21.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.892 0.377 . . . . 0.0 110.345 -177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.71 -16.64 61.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.599 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 65.8 t30 -82.29 3.74 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.727 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 11.7 ptp180 -137.11 -43.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.304 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' TYR . . . -139.15 169.7 24.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.192 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.63 140.03 16.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -139.29 174.52 10.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.05 144.8 25.89 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.325 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -83.96 -79.93 0.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.587 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -160.0 77.32 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.378 0.608 . . . . 0.0 111.122 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -16.67 35.81 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 165.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.6 36.11 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 113.758 -1.564 . . . . 0.0 111.976 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -156.97 -150.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.126 0.489 . . . . 0.0 111.224 -172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.442 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 68.8 m -103.03 159.47 15.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.312 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -70.41 2.12 4.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.761 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 51' ' ' SER . 1.2 p-10 -91.1 -5.77 54.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.56 166.35 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.943 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -85.71 -35.32 20.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.583 0.23 . . . . 0.0 111.432 -173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.34 85.81 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.648 0.737 . . . . 0.0 111.625 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.535 HG21 HD22 ' A' ' 121' ' ' LEU . 34.4 mm -82.82 132.61 30.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.675 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 p -130.55 107.85 9.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.325 0.583 . . . . 0.0 110.578 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 123' ' ' LEU . 4.0 mt -107.55 143.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -120.29 149.33 42.48 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.203 0.525 . . . . 0.0 111.887 -173.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.7 -165.15 21.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -145.34 137.72 25.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.434 0.617 . . . . 0.0 110.57 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -89.72 132.89 34.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.959 177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.67 121.72 24.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.937 0.399 . . . . 0.0 111.057 -176.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.0 tt -88.55 -30.71 5.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.867 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -67.59 -42.2 82.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 76.0 mtt180 -105.85 104.47 49.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.198 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.43 -35.65 38.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.414 2.076 . . . . 0.0 112.568 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -87.71 52.35 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.438 0.637 . . . . 0.0 110.302 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 40' ' ' ASN . 15.6 t80 -104.25 -167.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.001 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HG3' ' CD2' ' A' ' 72' ' ' PHE . 3.6 pt20 -82.16 -38.25 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.705 0.288 . . . . 0.0 111.171 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.534 ' CD2' ' HG3' ' A' ' 71' ' ' GLN . 78.1 m-85 -131.19 97.86 4.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.015 0.436 . . . . 0.0 110.116 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.525 HG23 ' HB3' ' A' ' 70' ' ' TYR . 25.5 p -130.88 -48.96 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.6 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.551 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 62.3 t30 -84.77 16.85 3.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.1 tp -66.58 -13.87 61.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 110.781 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -68.56 -24.0 64.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.427 175.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.0 9.1 20.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.751 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -103.0 129.29 49.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.1 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.431 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 3.0 mppt? -112.84 -178.5 3.4 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.907 -172.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -66.49 -6.62 15.47 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.13 0.491 . . . . 0.0 112.017 -175.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -132.0 19.93 4.59 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.261 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 49.9 m -74.12 115.27 13.41 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.2 tpt -65.01 112.64 3.42 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.757 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 95.2 t -96.71 123.41 48.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.391 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 63.0 m-85 -106.05 126.68 52.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.025 0.44 . . . . 0.0 110.663 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.507 ' HE1' HG21 ' A' ' 29' ' ' VAL . 24.9 t80 -115.76 103.86 11.09 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.413 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.513 ' HE2' ' HB3' ' A' ' 17' ' ' TYR . 12.0 ttmm -78.83 138.4 38.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.61 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.5 m -136.56 102.27 2.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.247 0.546 . . . . 0.0 110.559 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.33 -81.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.162 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -135.79 -5.12 2.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 110.324 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -101.58 156.97 17.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.372 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 m -123.35 125.16 44.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.65 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HB2' ' HE1' ' A' ' 95' ' ' TYR . 15.1 mmm180 -105.97 137.34 44.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -103.2 135.4 44.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.618 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 81.1 m-85 -132.52 146.72 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.254 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.554 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 9.9 tppt? -109.42 139.34 44.51 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 100' ' ' ILE . 68.4 mtp -77.63 79.76 4.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.9 p -80.77 -43.1 20.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.977 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 4.5 m -112.72 108.34 17.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.888 0.375 . . . . 0.0 110.57 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.6 mt -128.66 102.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.713 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -153.6 174.08 14.93 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.8 143.18 50.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.5 t -111.36 148.67 14.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.147 -172.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 1.7 tmtp? -121.9 89.82 48.29 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -101.73 -150.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.778 2.985 . . . . 0.0 111.843 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.2 m -144.49 -46.92 0.25 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.401 ' OD1' HG22 ' A' ' 108' ' ' VAL . 2.6 t70 -138.39 -154.98 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 109' ' ' GLU . 21.9 m -91.16 -173.8 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 122.328 -0.232 . . . . 0.0 111.282 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 108' ' ' VAL . 4.9 mm-40 69.41 -3.91 1.48 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.062 0.945 . . . . 0.0 113.011 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.65 -23.77 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.097 0.475 . . . . 0.0 110.815 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 111' ' ' LEU . 3.8 mm? -114.22 131.32 56.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.805 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -89.65 130.7 35.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.67 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.468 ' C ' HE21 ' A' ' 114' ' ' GLN . 8.5 tp10 -102.16 141.15 35.46 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.663 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -154.49 157.24 38.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.075 -176.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -79.17 79.7 5.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.931 0.872 . . . . 0.0 111.163 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -158.26 43.19 0.49 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.996 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HZ1' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -102.53 -165.21 1.16 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.16 0.505 . . . . 0.0 110.86 -177.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -142.7 -174.35 4.13 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -78.25 96.93 5.37 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -134.67 146.44 49.5 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 57' ' ' ILE . 18.4 mt -95.26 100.49 12.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 171.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 90.19 3.37 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 59' ' ' ILE . 7.6 mt -84.16 114.46 21.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.771 0.796 . . . . 0.0 111.291 -177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.552 HG23 ' NH2' ' A' ' 139' ' ' ARG . 73.3 mt -91.91 94.13 4.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.906 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.4 p -115.81 85.56 2.31 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.499 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.63 ' HB3' ' O2 ' ' A' ' 201' ' ' 2W7 . 26.3 p -78.58 135.23 37.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' OD1' ' HB2' ' A' ' 140' ' ' LYS . 2.3 m-20 -89.72 -60.83 1.84 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.755 0.788 . . . . 0.0 109.688 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 4.7 t70 -86.56 138.31 31.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.163 -1.38 . . . . 0.0 111.132 -174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -160.97 142.23 11.79 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -94.72 110.48 22.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -57.56 -29.51 64.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.991 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -70.76 -62.03 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.188 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.8 p -83.12 -31.81 27.05 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.622 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.95 43.6 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.993 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.55 153.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -123.91 134.73 53.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.274 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 43.7 mt-10 -98.24 -54.74 2.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.043 0.449 . . . . 0.0 110.332 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 28.5 mttp -104.37 97.46 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.265 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.552 ' NH2' HG23 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -119.92 117.59 28.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.638 0.732 . . . . 0.0 111.427 -177.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.543 ' HE3' HG23 ' A' ' 100' ' ' ILE . 2.3 tmtm? -77.5 124.56 28.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.669 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 tp -106.72 121.78 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-O 121.597 0.713 . . . . 0.0 110.139 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.1 t80 -120.59 115.88 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.84 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.5 t -111.8 116.96 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.366 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -105.33 119.78 39.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.337 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 m -87.0 138.87 31.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.3 112.35 5.14 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.277 0.56 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 96' ' ' LYS . 2.6 p -122.57 150.49 26.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.995 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.2 pttp . . . . . 0 C--N 1.31 -1.13 0 CA-C-N 114.86 -1.063 . . . . 0.0 111.211 -174.24 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.63 ' O2 ' ' HB3' ' A' ' 126' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 66.63 24.98 10.0 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.546 0.529 . . . . 0.0 110.9 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.9 173.24 12.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.83 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.82 122.14 84.94 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.378 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 17.1 Cg_endo -56.95 145.84 82.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.25 2.633 . . . . 0.0 112.744 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' HA ' HD21 ' A' ' 52' ' ' LEU . 26.0 mm-40 -129.32 168.36 16.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.912 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.667 HG13 HD23 ' A' ' 52' ' ' LEU . 82.7 mt -100.02 105.77 37.25 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.02 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 31' ' ' PRO . 10.8 Cg_endo -89.41 -93.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.959 2.439 . . . . 0.0 113.176 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 9' ' ' LYS . 13.4 ttpp -164.97 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 120.871 0.367 . . . . 0.0 110.93 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.23 124.2 16.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.001 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 38' ' ' GLN . 77.4 mttt -90.09 13.34 15.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.266 -169.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -120.13 6.7 10.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -105.88 144.16 33.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.412 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.3 t -96.83 102.5 13.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.825 0.345 . . . . 0.0 110.289 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -84.66 -31.69 24.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.235 0.541 . . . . 0.0 110.203 177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.15 178.24 31.92 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.017 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.01 144.44 50.78 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tp -117.13 118.75 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.549 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.8 mt-10 -126.4 113.0 16.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.46 0.648 . . . . 0.0 111.671 -174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -121.54 99.66 45.01 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.45 -29.79 89.44 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.164 2.576 . . . . 0.0 112.673 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.28 -21.23 66.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.599 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -125.86 8.81 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.131 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 56.64 31.19 18.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.418 0.628 . . . . 0.0 111.121 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 78.0 mt -83.32 110.01 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.644 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.07 67.6 1.46 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 35.3 mm-40 -120.4 157.02 54.82 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.793 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.84 160.68 30.71 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.533 2.155 . . . . 0.0 112.563 175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.6 t -112.43 132.93 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.409 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 35.4 m-85 -92.82 111.19 50.09 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-O 121.352 0.596 . . . . 0.0 110.522 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 55.7 Cg_endo -70.38 98.69 0.76 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.364 2.709 . . . . 0.0 112.918 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.27 173.57 41.15 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.72 154.01 43.64 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.738 2.292 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.98 107.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 123.548 0.53 . . . . 0.0 111.034 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.477 ' HB ' ' OE1' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -136.58 142.23 38.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.915 -176.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -47.85 -49.54 13.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.981 3.12 . . . . 0.0 114.245 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.12 -28.28 39.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -174.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.824 ' HB2' ' HD3' ' A' ' 11' ' ' LYS . 9.3 tt0 -73.41 -39.57 64.96 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 35' ' ' THR . 91.1 mt -63.74 -36.64 84.55 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.752 174.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -32.89 72.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.903 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -86.75 -12.36 48.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.676 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 71' ' ' GLN . . . 162.05 -96.25 0.14 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.322 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 59' ' ' ILE . 5.0 p -154.28 140.86 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-O 120.78 0.324 . . . . 0.0 110.607 -175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 38' ' ' GLN . 19.8 p -125.05 174.75 7.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.09 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.44 164.07 24.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.908 0.385 . . . . 0.0 110.747 174.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' SER . . . -79.75 -55.13 5.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.064 0.459 . . . . 0.0 110.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -112.69 151.25 30.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.48 -177.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -74.27 -36.87 63.84 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.165 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -89.3 19.0 4.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.223 -172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' HB3' ' A' ' 47' ' ' GLU . 41.1 mt-10 -84.86 102.27 12.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 109.849 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.3 m -72.89 133.36 44.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 7' ' ' ILE . 2.0 pp -70.53 -2.46 14.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.54 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -109.07 -3.46 17.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.187 0.518 . . . . 0.0 110.371 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.79 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.487 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 pt20 172.27 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' HD3' ' A' ' 117' ' ' LYS . 7.4 t30 -94.24 119.69 33.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.295 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 52' ' ' LEU . 17.2 mm -123.39 100.63 8.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.066 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' THR . 4.5 m -92.8 114.47 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 110.347 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.685 ' HB ' ' HG ' ' A' ' 123' ' ' LEU . 3.0 mt -111.52 108.5 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.26 121.62 33.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.803 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -99.14 175.48 28.47 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.517 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' THR . 23.2 t-160 -84.0 -84.16 0.14 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.381 0.134 . . . . 0.0 111.144 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 62' ' ' HIS . 15.2 t 171.75 -170.04 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.21 150.31 30.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.866 0.365 . . . . 0.0 110.35 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.666 HG13 ' H ' ' A' ' 66' ' ' ASP . 10.7 tp -158.47 177.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.666 ' H ' HG13 ' A' ' 65' ' ' ILE . 38.8 t70 -76.77 34.65 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.689 0.757 . . . . 0.0 111.221 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -125.3 105.36 28.21 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 121.977 -0.452 . . . . 0.0 110.298 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 57.0 Cg_endo -72.32 -4.96 16.22 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -103.4 16.81 25.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.531 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 3.4 t80 -84.66 151.77 24.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.133 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 12.3 mp0 -46.55 -39.76 11.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -173.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.54 17.69 9.64 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -171.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 38.5 m -69.15 -39.7 78.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.491 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -99.0 7.4 46.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.086 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.18 -13.48 37.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.321 0.581 . . . . 0.0 110.754 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -63.78 -23.84 67.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.232 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.49 -8.31 59.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.686 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -85.7 158.67 19.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.57 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -128.2 -178.16 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.277 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -72.06 -5.47 35.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.437 -177.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.31 8.21 12.32 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.473 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.8 m -74.04 155.71 38.25 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.731 0.777 . . . . 0.0 110.915 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.92 120.05 35.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.102 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.755 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 72.1 t -103.23 108.68 24.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.323 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 42.0 m-85 -90.05 109.81 20.84 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.286 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HB2' HD11 ' A' ' 121' ' ' LEU . 38.9 t80 -99.07 110.39 22.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -109.1 142.54 39.7 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.256 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 52' ' ' LEU . 2.9 p -150.64 103.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.83 0.824 . . . . 0.0 110.091 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 62.58 -98.29 0.2 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.226 -175.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.58 -7.16 17.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.45 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 6.4 mm-40 -92.89 145.06 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.443 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.8 m -150.04 99.93 2.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.225 0.536 . . . . 0.0 110.01 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -106.03 136.87 44.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.615 -178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -89.96 133.29 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.993 0.425 . . . . 0.0 110.336 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -126.94 147.35 50.1 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.27 148.31 30.18 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.56 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 68.3 mtp -80.65 56.6 2.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.199 0.523 . . . . 0.0 110.27 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 64.1 p -60.98 -38.5 86.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.187 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.1 m -119.42 95.59 4.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.014 0.435 . . . . 0.0 111.489 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 97' ' ' MET . 59.3 mt -115.66 103.39 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -132.33 147.17 52.38 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.957 0.408 . . . . 0.0 110.621 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 36.3 t70 -112.78 120.22 40.72 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.635 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.644 HG21 HD21 ' A' ' 111' ' ' LEU . 15.7 t -123.43 154.88 29.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.223 -173.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 92.1 mttt -90.57 138.32 26.79 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 12.6 Cg_exo -74.06 42.92 0.78 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.84 3.027 . . . . 0.0 113.02 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.2 p -59.05 -48.51 81.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.411 0.624 . . . . 0.0 109.797 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -143.84 171.62 13.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.112 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.585 ' HB ' ' C26' ' A' ' 201' ' ' 2W7 . 31.0 m -88.68 -8.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.443 0.639 . . . . 0.0 109.476 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -80.44 -12.87 59.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.881 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' A' ' 111' ' ' LEU . 12.5 p -69.88 -24.23 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.065 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' A' ' 110' ' ' VAL . 90.6 mt -121.05 135.47 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.342 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -166.2 143.72 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -100.36 114.38 27.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.998 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.47 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -95.76 161.4 14.04 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.577 -176.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.48 23.67 13.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 123.693 0.621 . . . . 0.0 111.343 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.26 -149.12 21.77 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.73 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -145.4 158.74 43.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.854 0.359 . . . . 0.0 111.583 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -111.98 -161.31 0.75 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 6.1 mptt -80.64 97.47 7.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.81 138.78 24.59 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.651 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 11.8 mt -96.28 101.77 13.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 143' ' ' VAL . 16.4 m -90.09 85.77 6.38 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.86 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.685 ' HG ' ' HB ' ' A' ' 59' ' ' ILE . 7.2 mp -77.3 104.11 7.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.239 0.543 . . . . 0.0 110.895 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.5 mt -82.86 82.55 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.306 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.5 p -104.66 98.52 8.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.13 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.73 113.52 4.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.844 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 1.6 t70 -64.26 -39.1 93.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.77 -170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.72 137.99 46.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.964 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -156.84 118.46 3.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.23 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.471 ' HB3' HG12 ' A' ' 135' ' ' VAL . 39.9 t30 -104.05 122.47 45.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -71.53 -29.06 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -171.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -76.39 -60.4 2.36 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.716 -173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.2 p -84.28 -8.72 58.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.517 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.02 95.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.309 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 130' ' ' ASN . 9.2 p -115.94 152.18 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.148 0.499 . . . . 0.0 110.745 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.425 ' O ' ' HG2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -142.92 118.77 10.56 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.649 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.1 2.24 34.41 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -156.61 135.23 11.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.844 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 3.4 ptp180 -145.02 108.96 4.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.421 0.629 . . . . 0.0 111.569 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -88.62 109.96 20.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.666 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 141' ' ' ILE . 3.9 tp -88.69 127.14 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 110.31 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.755 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.7 t80 -118.54 114.57 23.03 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.32 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.9 t -112.44 115.01 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.104 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -97.03 117.77 31.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.385 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.1 m -89.83 142.31 27.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.185 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.44 138.34 56.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.28 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.6 t -111.11 161.85 9.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.971 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.309 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.585 ' C26' ' HB ' ' A' ' 108' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.641 0.258 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.88 -174.36 3.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.395 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.66 105.6 0.05 Allowed 'General case' 0 N--CA 1.464 0.234 0 O-C-N 124.286 0.991 . . . . 0.0 111.658 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -105.45 140.1 20.82 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.516 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.0 116.99 4.92 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.251 1.968 . . . . 0.0 111.639 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -130.05 175.25 9.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.204 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 31' ' ' PRO . 48.0 mm -113.44 89.28 14.69 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -92.73 -176.84 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.202 2.601 . . . . 0.0 113.086 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -74.96 -25.41 58.85 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.63 118.5 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 56.4 mttp -87.1 -46.64 9.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -56.32 -36.27 68.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -167.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.611 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.56 142.38 58.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.247 0.546 . . . . 0.0 110.98 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.2 p -96.28 126.06 49.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.918 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -103.07 -22.74 13.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.908 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.35 160.72 28.68 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.531 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.32 127.48 53.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tp -97.54 118.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.334 0.588 . . . . 0.0 109.43 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 34.2 mt-10 -125.4 112.0 15.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.799 -174.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG12 HG13 ' A' ' 84' ' ' VAL . 76.2 mt -125.22 102.65 30.36 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.901 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 20.2 Cg_endo -62.09 -29.74 81.63 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 123.129 2.553 . . . . 0.0 113.095 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.37 -16.74 61.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.53 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.44 8.82 7.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.327 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.9 t70 58.55 34.71 24.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.764 0.792 . . . . 0.0 110.722 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 71.3 mt -95.66 120.88 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.745 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -145.3 79.64 1.59 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 31.7 mm-40 -122.4 141.65 35.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.676 -169.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.21 134.4 21.03 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.575 2.183 . . . . 0.0 111.7 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.593 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.3 t -96.2 138.13 22.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.357 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -109.46 91.02 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 17.4 Cg_exo -68.28 133.43 28.43 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.88 2.386 . . . . 0.0 112.272 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.38 175.79 34.7 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HG2' ' HE3' ' A' ' 11' ' ' LYS . 19.6 Cg_endo -59.84 118.09 4.93 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.662 2.241 . . . . 0.0 112.237 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -55.8 126.32 25.09 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.068 -176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 39' ' ' LEU . 2.5 p -142.25 139.02 17.2 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.817 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.83 -35.43 88.56 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.023 2.482 . . . . 0.0 113.01 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -74.47 -17.51 60.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.419 ' CD ' ' HD3' ' A' ' 11' ' ' LYS . 37.6 tt0 -88.92 -48.59 7.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 35' ' ' THR . 4.5 mm? -60.49 -22.9 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.808 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.12 -15.09 60.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.209 0.528 . . . . 0.0 110.582 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -100.01 -20.98 15.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.944 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.89 178.55 41.0 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.057 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 t -65.84 123.87 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -136.17 153.06 51.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.368 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.38 168.94 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.99 -64.39 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -105.65 158.73 16.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.124 0.487 . . . . 0.0 111.174 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.25 5.01 52.89 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.786 173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -98.53 -0.42 43.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -107.78 135.55 49.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.852 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 57' ' ' ILE . 27.6 t -118.72 157.95 26.49 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.277 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.78 -2.23 16.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.578 0.704 . . . . 0.0 110.219 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -92.25 -16.45 26.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.972 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.91 178.54 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.825 -177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.62 -26.93 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -104.96 124.13 48.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.852 0.358 . . . . 0.0 110.657 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.489 HG21 HD12 ' A' ' 121' ' ' LEU . 25.4 mm -135.25 139.88 46.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.78 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.8 m -132.97 114.4 13.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.198 0.523 . . . . 0.0 110.257 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -123.02 136.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.6 174.18 6.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.28 -172.45 40.87 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.773 ' CD2' ' HA ' ' A' ' 127' ' ' ASP . 10.4 t60 78.18 122.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.983 0.913 . . . . 0.0 111.651 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -153.98 151.3 29.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.701 171.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 130' ' ' ASN . 24.1 m-85 -82.49 83.89 7.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.401 0.619 . . . . 0.0 110.694 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 66' ' ' ASP . 11.2 tp -99.57 18.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.796 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 14.3 t70 83.33 -25.4 0.14 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.09 -1.414 . . . . 0.0 111.346 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -75.76 108.19 5.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 60.2 Cg_endo -77.4 0.35 9.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.519 2.146 . . . . 0.0 112.511 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -111.14 9.78 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 175.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.17 101.64 0.93 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.837 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -1.17 -71.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -166.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' N ' ' HG2' ' A' ' 71' ' ' GLN . 19.3 m-85 -79.47 6.46 10.25 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.7 p -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.17 0.51 . . . . 0.0 110.353 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -92.73 10.41 30.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.228 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.93 1.22 5.85 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.569 0.7 . . . . 0.0 110.46 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -75.77 -25.05 56.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.198 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.72 59.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.251 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.07 149.16 26.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -112.72 173.93 6.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.172 -176.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -77.83 -6.01 52.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.399 0.619 . . . . 0.0 110.665 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.87 18.11 10.66 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.975 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.582 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 24.3 m -73.86 129.76 38.54 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 121.519 0.676 . . . . 0.0 110.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.414 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -75.91 108.29 8.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.816 173.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.826 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -97.07 134.4 34.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.659 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.5 m-85 -108.53 127.5 53.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.038 0.447 . . . . 0.0 110.228 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.415 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 57.2 t80 -123.3 113.18 18.53 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.383 0.611 . . . . 0.0 109.361 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 15.6 ttmm -89.97 132.63 35.24 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.715 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.04 117.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.364 0.602 . . . . 0.0 109.843 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 -99.81 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.316 -173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -131.01 11.09 5.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.831 0.348 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -125.83 156.48 39.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 11.6 m -126.47 130.15 50.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.738 0.304 . . . . 0.0 110.923 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 79.1 mmt-85 -101.56 153.71 19.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.145 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 44.2 mtmt -102.56 131.57 49.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 109.891 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.2 m-85 -127.36 145.1 50.92 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.678 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -107.39 143.87 35.09 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.607 ' HB3' HD11 ' A' ' 100' ' ' ILE . 56.9 mtp -83.5 44.61 0.98 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.766 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 98' ' ' THR . 1.8 t -74.72 -9.45 58.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.463 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.7 m -123.85 84.41 2.27 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.281 0.563 . . . . 0.0 110.892 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 97' ' ' MET . 64.4 mt -120.12 113.68 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.248 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.497 ' O ' HG22 ' A' ' 141' ' ' ILE . 50.9 ttt85 -127.87 155.22 44.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.307 . . . . 0.0 110.542 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 138' ' ' LYS . 27.1 t70 -81.18 122.26 27.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.026 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 46.6 t -129.29 98.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.032 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 138' ' ' LYS . 32.0 mttp -76.33 166.81 42.08 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' HG2' ' CD1' ' A' ' 136' ' ' TRP . 34.7 Cg_exo -60.0 -13.19 21.93 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.257 1.971 . . . . 0.0 112.161 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 t -106.75 3.19 26.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.027 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 3.5 m-20 -112.12 29.26 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.342 0.591 . . . . 0.0 110.395 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 109' ' ' GLU . 16.5 t -71.24 169.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.509 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER 48.42 23.35 0.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.596 1.159 . . . . 0.0 113.414 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.437 HG13 HD22 ' A' ' 111' ' ' LEU . 8.9 p -90.56 -21.83 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.959 0.409 . . . . 0.0 110.098 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.437 HD22 HG13 ' A' ' 110' ' ' VAL . 3.0 mm? -84.51 107.94 17.02 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -93.54 174.32 7.25 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.229 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.09 109.02 20.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -168.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -103.22 140.87 36.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.588 172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -103.3 148.12 26.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.859 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.51 49.23 2.4 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.537 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -105.65 -170.62 1.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.561 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -110.65 -169.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.61 100.04 8.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -119.95 126.62 51.31 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.748 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.489 HD12 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -90.44 105.0 17.52 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.4 m -75.19 90.8 2.58 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 31.2 mt -84.95 112.42 20.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.591 0.71 . . . . 0.0 110.05 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.0 mt -84.27 91.44 2.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.006 -176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.4 m -77.32 88.32 3.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.698 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.4 75.41 7.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.746 0.784 . . . . 0.0 109.135 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.773 ' HA ' ' CD2' ' A' ' 62' ' ' HIS . 4.5 t0 -83.52 -15.36 49.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.213 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' CG ' ' HE ' ' A' ' 139' ' ' ARG . 19.2 p-10 -90.49 23.89 2.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.965 -171.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -115.29 92.94 4.08 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.159 -0.617 . . . . 0.0 111.296 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -102.69 96.9 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 171.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -57.56 -40.03 78.02 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -170.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -64.36 -58.4 6.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.881 0.372 . . . . 0.0 111.179 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 34.4 p -84.8 -23.84 28.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.844 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.99 40.89 29.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.248 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -113.07 142.8 24.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 0.0 111.86 -177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CD1' ' HG2' ' A' ' 105' ' ' PRO . 48.0 p90 -126.9 151.84 47.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.792 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' H ' ' CB ' ' A' ' 128' ' ' ASP . 39.4 mt-10 -129.21 -92.55 0.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.906 0.384 . . . . 0.0 111.265 177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 2.9 mtpm? -145.5 138.55 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.989 -173.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' A' ' 128' ' ' ASP . 95.6 mtt180 -103.34 108.21 19.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 0.0 110.516 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -76.97 103.53 6.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 101' ' ' ARG . 16.0 tt -70.26 122.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 CA-C-O 121.593 0.711 . . . . 0.0 109.783 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.826 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -103.37 96.05 6.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.747 -174.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 68.8 t -106.5 104.11 16.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.743 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . . . -97.68 123.96 41.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.276 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 m -95.78 139.9 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.566 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 40.5 tt0 -61.84 123.03 16.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.229 0.537 . . . . 0.0 111.257 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 148' ' ' LYS . 6.4 p -131.64 165.33 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.82 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 147' ' ' VAL . 2.9 pptp? . . . . . 0 C--N 1.305 -1.365 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.05 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.468 ' C7 ' HH22 ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -78.09 -20.12 52.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.418 0.628 . . . . 0.0 110.536 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.15 148.85 18.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.384 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -85.82 135.94 37.22 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 33.1 Cg_endo -65.21 116.4 3.85 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.276 1.984 . . . . 0.0 111.785 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -119.31 -166.69 1.29 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.922 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 69.4 mt -111.57 104.49 56.16 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.877 0.37 . . . . 0.0 110.592 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.04 -176.57 2.91 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.749 2.3 . . . . 0.0 111.852 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -100.52 4.31 43.48 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.781 0.324 . . . . 0.0 110.974 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -107.72 152.77 23.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.817 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 3.1 mptt -102.44 -8.23 21.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.714 -169.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.4 p -73.35 -19.87 60.91 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.193 0.52 . . . . 0.0 110.744 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -96.09 106.22 18.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.792 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.07 102.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 110.221 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.2 -34.02 63.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.431 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.06 35.93 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.047 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.82 144.96 49.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.312 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -115.79 113.19 42.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.669 0.747 . . . . 0.0 109.395 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -125.16 113.96 18.38 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.348 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 25' ' ' ILE . 51.9 mt -122.65 101.34 40.03 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 12.0 Cg_endo -57.82 -32.22 94.37 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.042 2.495 . . . . 0.0 112.343 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -29.05 69.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.633 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -118.03 9.37 12.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.706 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.02 19.48 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.357 0.411 . . . . 0.0 111.605 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.558 HD12 HD12 ' A' ' 20' ' ' ILE . 67.8 mt -84.45 134.86 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.27 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -158.67 61.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 27.5 mm-40 -123.8 153.78 67.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.616 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.64 158.36 43.61 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.802 2.335 . . . . 0.0 112.386 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.32 133.52 53.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 33.4 m-85 -93.48 109.46 40.76 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 38.9 Cg_endo -68.07 148.43 75.5 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.86 2.373 . . . . 0.0 112.501 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.45 -174.76 21.37 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -81.34 143.48 13.9 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.45 2.1 . . . . 0.0 112.001 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -64.79 131.98 48.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.956 0.408 . . . . 0.0 110.674 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -166.07 145.49 5.11 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.676 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -42.32 -46.71 7.49 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.918 3.079 . . . . 0.0 114.17 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 2.7 mp0 -54.47 -37.9 65.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.471 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.529 ' NE2' ' HG2' ' A' ' 11' ' ' LYS . 15.9 mm100 -72.3 -60.29 2.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.355 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.8 mm? -69.05 -7.14 32.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.675 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -68.93 -33.7 74.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.289 0.566 . . . . 0.0 109.792 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -111.44 -37.27 5.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.138 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -159.15 -169.31 22.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.232 -175.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.846 ' HB ' ' HE2' ' A' ' 72' ' ' PHE . 7.9 p -88.42 148.56 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.017 0.437 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.7 m -144.26 -179.51 6.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 63.9 m-85 -93.38 147.62 22.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.924 0.393 . . . . 0.0 110.719 176.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -98.36 -58.27 2.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.932 -174.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -88.76 -169.64 2.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.113 0.483 . . . . 0.0 111.961 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 50.49 0.53 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.625 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.87 94.96 5.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -92.3 -3.93 54.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 122.1 0.952 . . . . 0.0 110.033 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -143.99 130.67 20.17 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.755 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.85 1.77 46.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.682 0.753 . . . . 0.0 109.391 171.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -94.43 1.23 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.946 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 12.5 t70 -94.64 -157.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.692 -178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 13.2 pt20 -106.42 -41.5 5.28 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -86.81 118.58 26.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.539 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.75 104.41 14.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.923 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.7 m -102.14 99.23 9.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.016 0.436 . . . . 0.0 110.736 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 4.8 mt -99.59 143.28 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 -178.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.757 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -121.37 133.37 55.1 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -148.06 156.39 26.89 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.357 -176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -102.0 101.62 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.592 HG22 ' HB ' ' A' ' 125' ' ' THR . 6.7 t -87.61 98.29 11.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 122.024 0.916 . . . . 0.0 110.124 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 12.6 t80 -111.91 92.38 4.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.837 -176.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -58.72 -27.96 35.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 27.2 m-20 -67.46 -4.78 12.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.079 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' TYR . 18.8 mmt85 -135.09 105.76 10.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 73' ' ' THR . 14.1 Cg_exo -69.78 -12.12 32.22 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.696 2.264 . . . . 0.0 111.84 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -88.24 5.9 39.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.404 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.32 151.93 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.931 177.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 95.7 mt-30 -62.29 -33.96 75.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.264 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.846 ' HE2' ' HB ' ' A' ' 43' ' ' VAL . 97.3 m-85 -122.84 78.74 1.57 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.205 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 68' ' ' PRO . 5.2 t -113.07 -29.38 7.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.345 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -98.75 21.74 11.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -172.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 75' ' ' LEU . 13.4 mt -71.18 -5.12 29.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -23.37 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.24 0.543 . . . . 0.0 109.711 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.52 0.43 42.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.309 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.68 114.06 26.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.299 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.5 -175.41 2.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.867 -178.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 80' ' ' LYS . 0.1 OUTLIER -61.4 -5.11 1.51 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.503 ' CA ' ' HE3' ' A' ' 96' ' ' LYS . . . -141.38 31.64 2.13 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.961 -1.114 . . . . 0.0 112.448 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.1 m -78.3 117.56 19.66 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 94' ' ' LYS . 25.1 tpp -68.53 119.85 13.64 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.02 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.485 HG21 ' SD ' ' A' ' 97' ' ' MET . 73.0 t -110.63 122.79 65.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.28 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -101.89 117.13 34.19 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.185 0.517 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -104.8 123.58 47.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -110.25 132.52 54.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.285 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -137.66 116.67 14.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.516 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 69.28 -82.39 0.26 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.329 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -135.3 -16.09 1.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.662 0.268 . . . . 0.0 111.414 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.46 156.66 16.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.079 0.466 . . . . 0.0 110.916 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -135.49 119.99 18.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.025 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 89.1 mtt180 -104.79 154.77 19.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.628 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.671 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -104.15 125.67 50.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.582 -178.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 91.3 m-85 -123.73 150.42 44.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.259 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HE3' ' CA ' ' A' ' 81' ' ' GLY . 11.5 tttp -119.79 144.46 47.29 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.485 ' SD ' HG21 ' A' ' 84' ' ' VAL . 76.5 mmm -77.36 81.33 3.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 110.167 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 p -83.83 -16.36 44.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.388 -171.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 47.1 m -147.05 104.98 3.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.35 0.595 . . . . 0.0 111.538 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.1 mt -105.48 111.75 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.888 173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -127.2 148.68 50.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.195 0.521 . . . . 0.0 111.349 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.404 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 30.8 m-20 -109.42 134.87 51.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.62 176.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.471 HG11 HG23 ' A' ' 108' ' ' VAL . 58.6 t -122.91 126.17 73.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.824 0.345 . . . . 0.0 111.207 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 104' ' ' LYS . 16.1 pttp -78.35 146.76 71.05 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.296 175.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.15 -20.54 67.35 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.327 2.685 . . . . 0.0 113.953 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 p -81.82 -29.92 32.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.831 0.348 . . . . 0.0 111.681 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -129.22 81.63 2.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 HG11 ' A' ' 103' ' ' VAL . 6.4 p -101.47 -8.62 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.713 0.768 . . . . 0.0 109.935 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -96.67 34.68 1.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.2 m -82.15 16.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.238 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.74 171.0 14.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.462 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.533 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 7.5 m-20 -84.12 152.85 24.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -70.86 97.76 1.46 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.454 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 112' ' ' ASP . 19.8 mt-30 -135.18 95.29 3.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -109.96 116.97 32.58 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 170.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.22 31.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.807 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 118' ' ' ASP . 24.9 tptt -76.19 -161.67 0.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 3.4 t70 -71.86 -168.23 0.35 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.762 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 3.2 mppt? -76.55 85.09 3.24 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -136.97 135.37 37.61 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.825 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.74 107.1 18.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 m -93.04 94.36 8.83 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.5 mp -83.36 110.26 17.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.102 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.562 HD13 ' O3 ' ' A' ' 201' ' ' 2W7 . 50.2 mt -88.77 99.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.763 173.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 14.4 p -114.31 104.44 12.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.744 -175.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 26.1 m -70.76 123.16 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.5 -79.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 2.2 t70 -95.53 -176.89 3.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.748 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -147.41 138.74 23.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.134 0.493 . . . . 0.0 111.448 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.582 ' HB2' ' HA ' ' A' ' 136' ' ' TRP . 52.0 t-20 -144.17 117.45 9.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.346 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -65.52 -17.04 64.26 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 132' ' ' LYS . 8.5 tmtm? -61.32 -40.23 93.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.043 0.449 . . . . 0.0 110.566 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.79 -40.23 1.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.62 -42.2 0.76 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.67 158.73 42.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.842 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 29.0 t-105 -85.26 -42.92 14.22 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.931 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.789 ' HG3' ' H ' ' A' ' 138' ' ' LYS . 8.3 pt-20 -139.15 -84.28 0.26 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.789 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 14.0 ptmm? -117.64 166.13 12.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.548 ' NH2' ' O2 ' ' A' ' 201' ' ' 2W7 . 4.9 mpt_? -107.46 156.88 18.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.304 172.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.452 ' HG2' ' HZ1' ' A' ' 138' ' ' LYS . 5.9 tmtp? -133.92 127.85 33.31 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.998 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.3 mm -114.39 128.41 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 120.986 0.422 . . . . 0.0 110.492 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.558 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 76.0 m-85 -121.73 107.61 12.54 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.218 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 52.9 t -102.24 107.18 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 0.0 110.599 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -101.62 107.42 18.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.396 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.7 m -85.78 140.18 30.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.194 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.493 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 30.9 tt0 -64.63 120.64 12.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.64 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.435 ' HB ' ' HE3' ' A' ' 94' ' ' LYS . 1.5 t -84.49 165.48 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.184 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.562 ' O3 ' HD13 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 mtt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 34.4 tt0 -87.5 111.9 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 2' ' ' GLN . . . 73.16 151.14 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 123.966 0.792 . . . . 0.0 110.69 -176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -126.17 145.27 51.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.459 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.79 158.2 52.09 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.617 2.211 . . . . 0.0 111.521 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 mm-40 -116.09 168.47 10.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.753 0.311 . . . . 0.0 110.588 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.664 HG23 ' HB3' ' A' ' 31' ' ' PRO . 87.2 mt -98.04 102.25 13.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.806 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 79.0 Cg_endo -93.2 -173.84 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.069 2.512 . . . . 0.0 113.504 -174.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -81.44 -17.85 47.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.565 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.1 137.88 53.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.615 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 32.9 mmtp -88.56 -33.34 17.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.604 -167.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -101.23 8.57 42.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.869 0.366 . . . . 0.0 111.627 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -86.06 90.25 8.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.615 0.245 . . . . 0.0 110.836 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.78 115.57 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.88 -28.26 15.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.195 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.17 155.39 25.07 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.344 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.62 131.56 55.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 tp -102.81 130.47 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 50.3 mt-10 -136.79 109.56 7.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.274 0.559 . . . . 0.0 111.049 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 55.9 mt -118.93 95.41 49.25 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.67 -36.36 98.5 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.152 2.568 . . . . 0.0 113.064 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.58 -30.06 70.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -111.18 5.04 19.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.068 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 58.4 25.43 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.297 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 58.9 mt -85.1 99.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.538 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 40.1 ttmt -134.98 88.12 2.4 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 5.7 mm-40 -144.97 153.39 53.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.884 -170.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.0 153.99 52.64 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.194 2.596 . . . . 0.0 112.918 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.3 t -107.26 139.15 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -113.08 103.12 55.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.938 0.399 . . . . 0.0 111.076 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' HG23 ' A' ' 7' ' ' ILE . 77.8 Cg_exo -51.88 161.72 2.15 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.825 3.017 . . . . 0.0 113.421 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.73 165.87 12.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.48 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD2' ' HE2' ' A' ' 11' ' ' LYS . 34.4 Cg_endo -65.22 141.08 67.5 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.515 2.143 . . . . 0.0 111.761 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.2 101.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.169 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 p -139.09 155.76 72.57 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 10.9 Cg_endo -54.26 -35.24 82.68 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.902 2.401 . . . . 0.0 112.6 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.67 -45.82 77.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.235 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 11.1 mm100 -72.71 -47.14 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.553 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.0 mm? -68.1 -9.51 46.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.025 0.44 . . . . 0.0 111.003 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 24.3 t-20 -78.5 -32.27 48.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.823 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -93.74 -46.37 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.89 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -160.29 -156.45 8.18 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.818 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 71' ' ' GLN . 87.0 t -97.13 135.22 32.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.536 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 67.6 m -127.72 151.32 49.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.834 -174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 97.0 m-85 -71.38 147.07 48.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.08 0.467 . . . . 0.0 111.59 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.99 -28.38 29.75 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.85 99.26 9.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.558 173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -83.15 17.11 2.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.302 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.65 172.68 12.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.776 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -82.52 14.31 3.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.212 -173.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -102.37 101.7 11.97 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.027 0.441 . . . . 0.0 111.483 -174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.588 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -110.83 4.95 20.26 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.521 0.677 . . . . 0.0 109.874 172.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.54 20.99 7.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.581 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -74.6 -170.05 0.97 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.6 pt20 -93.22 -29.09 15.88 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -111.02 143.5 41.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 15.1 mm -138.07 100.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -93.79 116.04 28.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.343 0.592 . . . . 0.0 110.685 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.6 mt -122.36 138.3 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -91.16 118.28 30.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 125' ' ' THR . . . -105.16 114.58 4.66 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.494 -175.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' HB3' HD12 ' A' ' 39' ' ' LEU . 25.1 p80 -73.62 141.76 46.54 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 129' ' ' TYR . 15.1 t -74.08 175.34 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.763 0.316 . . . . 0.0 110.474 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.518 ' HB3' HG22 ' A' ' 73' ' ' THR . 42.1 p90 -82.86 161.27 21.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.46 -80.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 110.007 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -115.54 -10.93 11.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.075 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -98.11 109.76 53.15 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.736 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.14 -13.82 5.26 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.086 2.524 . . . . 0.0 111.949 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 69' ' ' ASN . 8.1 m120 -116.92 61.82 0.73 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 109.764 175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.74 179.46 4.34 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.599 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.719 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 14.9 mp0 -53.83 -40.91 66.82 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.498 0.499 . . . . 0.0 112.129 -172.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 75' ' ' LEU . 71.5 t80 -131.57 101.59 5.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.033 0.444 . . . . 0.0 109.923 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 64' ' ' PHE . 15.4 p -141.75 -62.84 0.45 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.209 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 66.2 t30 -94.15 27.01 3.01 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -167.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 72' ' ' PHE . 16.6 tp -62.86 -18.55 63.07 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.615 -0.678 . . . . 0.0 111.404 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -64.12 -22.23 66.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.49 -16.01 40.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.412 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.88 169.41 18.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.594 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -137.42 168.08 20.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.105 0.479 . . . . 0.0 111.494 -176.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -68.26 -11.33 59.19 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.08 -173.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -131.47 39.34 1.78 Allowed Glycine 0 C--N 1.314 -0.69 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.002 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.4 p -85.24 -150.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.967 0.413 . . . . 0.0 110.106 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.485 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.5 tpt -139.3 105.36 5.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.782 0.325 . . . . 0.0 110.187 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.5 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 97.9 t -96.19 120.99 46.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.044 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 80.8 m-85 -101.04 129.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.679 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.406 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . 33.6 t80 -123.41 106.15 10.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 49.4 mtmt -102.02 114.85 29.32 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.398 -175.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 m -94.91 101.99 13.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.571 0.7 . . . . 0.0 109.122 173.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.77 -89.29 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -170.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -12.5 4.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.136 0.493 . . . . 0.0 109.818 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' LYS . 3.5 mm-40 -76.91 117.67 18.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.803 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.4 m -103.16 112.49 25.37 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.112 0.482 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -102.23 136.17 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 21.6 mtmm -104.34 140.06 38.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.084 0.468 . . . . 0.0 110.629 -175.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 74.8 m-85 -132.69 148.56 52.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.919 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 13.3 tppt? -107.76 137.89 44.97 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.531 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 69.3 mtp -79.06 61.91 3.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 111.022 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.8 p -68.63 -41.21 79.76 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.211 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -116.37 101.37 8.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.333 0.587 . . . . 0.0 111.343 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 97' ' ' MET . 57.0 mt -119.75 114.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.025 176.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -134.63 140.22 45.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.382 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.54 108.38 16.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.254 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.21 -169.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -130.3 155.85 80.31 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.562 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.69 106.48 2.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.617 2.212 . . . . 0.0 114.096 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -119.58 -51.38 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.362 170.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -109.34 120.43 42.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.068 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.4 m -104.04 -26.03 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 111.278 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.49 19.84 14.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.309 0.576 . . . . 0.0 110.804 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.16 -0.24 2.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.651 0.738 . . . . 0.0 110.046 177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.75 12.21 26.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.551 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.44 5.06 18.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.993 0.901 . . . . 0.0 110.825 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 11.9 pt-20 -108.08 94.07 4.87 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.419 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.83 121.74 42.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.045 0.45 . . . . 0.0 110.674 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -106.62 -0.94 23.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.9 -162.6 21.72 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.644 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -153.54 177.6 10.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.169 0.485 . . . . 0.0 110.908 176.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -129.57 -171.51 2.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.663 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 27.8 mttm -85.58 96.14 9.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.893 174.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 14.0 pt20 -162.84 139.81 7.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.447 -173.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.475 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 17.2 mt -88.84 130.88 35.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 171.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 m -104.73 87.53 2.7 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.089 0.471 . . . . 0.0 109.817 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 59' ' ' ILE . 26.3 mt -85.8 96.99 9.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.146 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.93 95.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 61' ' ' GLY . 50.7 p -109.18 99.34 8.64 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.875 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.848 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 34.6 m -61.99 116.3 4.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.577 0.703 . . . . 0.0 110.833 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 35.3 t70 -91.75 161.31 14.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.944 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . 4.8 t0 67.25 108.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.767 0.667 . . . . 0.0 111.018 175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.453 ' HB3' HG21 ' A' ' 63' ' ' THR . 30.2 p90 -130.89 157.54 42.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.571 -170.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.515 ' HB3' HG12 ' A' ' 135' ' ' VAL . 23.9 t30 -106.3 107.37 18.34 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 166.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -57.08 -25.59 58.99 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -72.88 -59.58 2.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.373 0.606 . . . . 0.0 110.522 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.3 p -88.21 -49.62 6.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.297 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.02 41.32 2.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.634 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 130' ' ' ASN . 11.6 p -82.7 147.8 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 176.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 4.1 m-90 -106.59 113.82 27.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.061 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 6.3 mm-40 -91.12 -26.34 19.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.139 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 27.7 mttp -128.02 -178.84 4.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.172 0.51 . . . . 0.0 109.994 174.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.848 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.9 ptt180 -154.87 100.59 2.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.8 171.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 116.07 26.35 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 tt -100.42 117.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 CA-C-O 122.128 0.966 . . . . 0.0 110.443 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 3.3 t80 -101.64 113.95 27.57 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.291 -177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 94.7 t -109.36 112.09 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -103.93 116.38 32.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.688 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -79.23 136.05 36.95 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.307 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -60.46 122.95 15.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.836 0.35 . . . . 0.0 110.467 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.39 153.57 14.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.753 0.787 . . . . 0.0 111.166 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.296 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.652 ' N4 ' ' O2 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 65.52 25.65 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.46 0.648 . . . . 0.0 110.576 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.0 158.0 43.95 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 19.6 ptmt -64.77 135.17 96.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.051 0.453 . . . . 0.0 110.274 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' HD21 ' A' ' 52' ' ' LEU . 68.6 Cg_endo -79.44 120.69 4.5 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.495 2.13 . . . . 0.0 113.362 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -106.81 128.74 54.51 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 165.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 31' ' ' PRO . 69.6 mt -51.04 107.24 0.78 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -168.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.678 ' HD2' ' HZ2' ' A' ' 13' ' ' LYS . 9.7 Cg_endo -90.82 -170.01 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.627 2.884 . . . . 0.0 113.048 176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -68.46 -41.6 79.98 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' HB2' ' HG2' ' A' ' 13' ' ' LYS . 4.1 m-20 -59.62 149.55 30.0 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.737 0.415 . . . . 0.0 111.782 -171.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.849 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 90.9 mttt -95.05 -40.7 9.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.758 0.313 . . . . 0.0 110.735 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -73.15 -5.58 40.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.778 ' HE2' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -80.87 132.38 35.45 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.45 126.73 50.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.294 0.568 . . . . 0.0 110.592 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' ' HG2' ' A' ' 31' ' ' PRO . . . -106.75 -23.68 12.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.704 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.84 148.19 19.83 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.903 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.4 121.8 45.97 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 tp -92.82 116.42 33.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.517 0.675 . . . . 0.0 109.559 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 12.9 mt-10 -127.64 109.54 11.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.104 -173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.24 101.22 44.5 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.066 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 83' ' ' MET . 31.1 Cg_endo -63.12 -22.86 73.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 123.184 2.589 . . . . 0.0 112.964 -175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 82' ' ' SER . 9.3 m-20 -69.82 -29.78 67.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -117.78 13.37 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.991 -178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 59.26 23.13 11.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.497 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 69.6 mt -83.56 113.11 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.239 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -144.36 77.65 1.55 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -134.0 154.3 80.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.938 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.66 139.54 34.15 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 122.868 2.379 . . . . 0.0 113.083 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.622 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 90.5 t -94.58 136.71 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.576 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 11' ' ' LYS . 44.9 m-85 -108.65 92.53 10.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.998 0.428 . . . . 0.0 110.549 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.778 ' HD2' ' HE2' ' A' ' 13' ' ' LYS . 7.4 Cg_exo -73.78 102.39 1.5 Allowed 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 123.308 2.672 . . . . 0.0 112.616 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -171.74 -179.72 42.91 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.539 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.849 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 18.3 Cg_endo -62.07 99.62 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.293 1.995 . . . . 0.0 111.091 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.58 124.35 19.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.208 -174.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.407 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 77.6 p -127.03 159.5 64.46 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.099 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.13 -37.72 58.83 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.916 2.411 . . . . 0.0 112.902 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -66.05 -41.02 91.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' OE1' ' HD3' ' A' ' 11' ' ' LYS . 14.7 pt20 -83.18 -21.56 33.47 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.271 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 93.3 mt -87.38 11.19 15.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.519 0.676 . . . . 0.0 110.095 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -112.44 -13.94 13.32 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.845 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 mtt-85 -121.69 -16.9 7.59 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.549 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -147.12 5.68 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG11 ' HE2' ' A' ' 72' ' ' PHE . 99.6 t -125.87 140.31 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.971 0.415 . . . . 0.0 111.052 -175.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.3 t -134.75 161.56 34.82 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 27.8 m-85 -72.6 160.43 32.27 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.274 175.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.77 -29.31 68.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.294 0.568 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -107.5 170.61 7.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.041 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.453 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -76.17 -35.64 59.06 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 69.41 160.31 0.19 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.529 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -139.32 -3.77 1.52 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.322 0.582 . . . . 0.0 110.991 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.9 m -143.84 99.9 3.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 -174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -78.69 -6.22 55.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.838 0.828 . . . . 0.0 109.749 175.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.1 10.94 37.94 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.196 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -86.02 154.07 21.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' HB2' ' HA ' ' A' ' 119' ' ' LYS . 3.5 pm0 -83.58 -19.83 34.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.17 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -104.33 93.43 4.81 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 110.398 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 19.9 mm -116.26 129.92 71.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.668 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -123.26 118.84 28.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 45' ' ' PHE . 2.0 mt -107.65 129.71 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.2 115.11 29.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.935 0.397 . . . . 0.0 110.973 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -111.17 86.69 0.44 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.202 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 39' ' ' LEU . 85.4 t60 -87.79 128.3 35.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.065 0.46 . . . . 0.0 110.129 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 127' ' ' ASP . 87.7 m -146.39 133.77 20.73 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -146.74 17.55 1.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.368 0.604 . . . . 0.0 110.008 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.5 HG13 ' HG3' ' A' ' 67' ' ' ARG . 10.7 tp -88.73 -13.29 9.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.663 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.94 37.86 27.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.299 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HG3' HG13 ' A' ' 65' ' ' ILE . 99.5 mtt180 -105.86 118.04 56.22 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.644 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.94 0.85 5.17 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.958 2.439 . . . . 0.0 113.439 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 24.98 11.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.026 0.441 . . . . 0.0 110.775 176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 179.83 6.0 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.18 -73.05 0.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.401 ' HE2' HG11 ' A' ' 43' ' ' VAL . 12.9 m-85 -91.13 14.76 13.25 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.7 m -80.61 -34.15 35.3 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.205 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.69 3.39 33.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.1 -8.78 18.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -62.95 -23.72 67.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.558 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.74 6.94 28.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.284 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.18 144.41 25.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 110.848 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -109.32 177.63 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.72 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -72.72 -15.03 61.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.643 0.735 . . . . 0.0 110.477 179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -130.14 57.24 0.73 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.497 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 13.1 m -86.18 -160.9 0.58 Allowed 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.427 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 6.8 tpt -135.56 103.46 5.46 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.075 0.464 . . . . 0.0 109.975 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 97' ' ' MET . 96.7 t -97.55 125.12 50.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.476 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.4 m-85 -108.45 123.4 48.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.466 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -110.0 104.32 13.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 24.3 ttpp -99.96 105.51 17.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.721 0.772 . . . . 0.0 111.159 -173.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 91' ' ' GLU . 2.4 p -93.56 104.63 15.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.704 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.4 -103.05 0.74 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -167.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -113.68 -9.83 13.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.808 0.337 . . . . 0.0 110.596 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HB2' HG13 ' A' ' 88' ' ' VAL . 37.9 mt-10 -79.94 131.39 35.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.4 m -108.32 117.22 33.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.729 0.3 . . . . 0.0 111.278 -175.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -99.65 145.02 28.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -110.82 129.29 55.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.383 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 82.3 m-85 -132.91 151.94 51.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.822 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.456 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 14.2 tppt? -117.42 137.15 52.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 84' ' ' VAL . 90.1 mmm -78.02 43.35 0.43 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.166 0.508 . . . . 0.0 110.906 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -89.1 23.59 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.357 0.599 . . . . 0.0 112.023 -170.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 54.8 m -143.84 51.4 1.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.498 0.666 . . . . 0.0 110.274 174.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' MET . 71.1 mt -91.63 118.19 36.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.641 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.65 148.25 31.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.619 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -104.81 135.19 46.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.314 0.578 . . . . 0.0 111.017 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 m -133.94 147.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.215 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -138.9 86.6 15.15 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.48 0.657 . . . . 0.0 111.127 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -96.2 -158.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.352 2.701 . . . . 0.0 111.291 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 t -172.38 20.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.68 0.753 . . . . 0.0 110.243 171.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -145.08 154.3 42.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.97 170.29 11.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.998 0.427 . . . . 0.0 111.663 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 64.61 -0.77 0.89 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.1 0.96 . . . . 0.0 112.823 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -84.6 -19.63 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 0.0 110.115 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.8 142.28 31.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -113.18 145.24 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.296 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.76 137.51 33.7 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -106.68 145.74 31.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.374 0.607 . . . . 0.0 111.84 -169.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.7 mptt -104.09 150.54 24.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.088 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 98.99 50.39 1.48 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -94.06 176.13 6.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 0.0 111.546 -176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -117.46 -174.68 2.66 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 169.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 3.5 mppt? -74.39 100.25 3.74 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -141.23 132.84 27.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.018 0.437 . . . . 0.0 111.138 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 11.9 mt -99.26 115.23 28.67 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.61 HG23 HG22 ' A' ' 143' ' ' VAL . 14.3 m -97.19 96.67 8.58 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.321 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.47 104.1 14.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.8 mt -90.24 99.93 10.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.781 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 21.4 p -91.65 141.2 28.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.974 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 31.1 p -151.03 130.66 13.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 63' ' ' THR . 5.9 m-20 -97.11 -54.64 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 109.441 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.28 91.07 0.71 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.966 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 62.1 t80 -160.3 116.33 2.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.163 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -110.41 123.11 49.27 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.48 -24.38 62.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.258 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -58.94 -68.3 0.28 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.872 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.38 -17.54 19.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.481 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.8 82.58 0.71 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.177 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 14.4 p -131.54 146.35 33.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.714 0.292 . . . . 0.0 110.45 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.7 p90 -152.57 140.9 20.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.348 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -119.77 -70.0 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.714 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.583 ' O ' ' HD2' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -165.26 153.64 11.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -170.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 126' ' ' CYS . 0.7 OUTLIER -172.47 139.93 1.03 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 175.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.447 ' HD3' ' CG2' ' A' ' 100' ' ' ILE . 5.4 tmmm? -78.86 128.62 33.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.801 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.8 mm -91.96 140.02 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.025 0.441 . . . . 0.0 111.37 -173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.43 108.44 18.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.424 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 122' ' ' THR . 41.1 t -110.13 121.45 63.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.347 . . . . 0.0 110.43 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -112.12 118.59 35.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.703 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.8 m -92.74 144.78 24.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -62.66 124.49 21.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.03 0.443 . . . . 0.0 110.78 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.58 154.68 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.697 0.76 . . . . 0.0 110.878 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 41.8 pttt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.683 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.54 ' C11' ' N4 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 120.469 0.176 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -74.63 -177.48 3.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.647 0.737 . . . . 0.0 112.858 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.85 -179.28 4.66 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.047 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -92.58 146.27 32.03 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.203 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.37 125.44 10.74 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.447 2.098 . . . . 0.0 112.472 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 5.8 tp60 -150.7 165.79 32.38 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.04 104.29 35.23 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.727 0.299 . . . . 0.0 110.434 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 10.9 Cg_endo -89.48 -179.82 2.05 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.177 2.585 . . . . 0.0 111.607 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -90.47 -6.15 55.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.839 0.352 . . . . 0.0 110.569 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 13' ' ' LYS . 21.4 t0 -81.74 125.32 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.297 0.57 . . . . 0.0 109.917 176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 13.8 mttp -92.7 1.64 57.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.321 -173.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.73 -16.16 28.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.064 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG2' ' OD2' ' A' ' 10' ' ' ASP . 32.2 mmmt -88.39 172.85 9.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.778 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.39 108.0 23.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.517 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.44 -31.61 22.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.141 0.496 . . . . 0.0 110.77 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.59 165.56 29.15 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.732 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 0.8 OUTLIER -129.88 132.65 46.49 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -107.57 124.04 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.148 0.499 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 33.8 mt-10 -129.54 116.13 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.443 0.64 . . . . 0.0 111.637 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 63.5 mt -127.44 100.58 25.69 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.41 175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.25 -38.38 95.15 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.156 2.571 . . . . 0.0 112.903 -176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.998 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -123.67 13.75 9.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.316 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 54.95 28.61 10.85 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.716 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 74.5 mt -89.9 116.07 30.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 27.8 mtpp -144.48 59.19 1.33 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.931 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 42.6 mm-40 -122.62 156.06 61.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.19 -169.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.54 162.23 40.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.044 2.496 . . . . 0.0 113.166 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.68 134.11 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.2 m-85 -91.67 116.15 65.9 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.024 0.44 . . . . 0.0 111.095 -174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 36.9 Cg_endo -67.25 148.55 80.49 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.379 . . . . 0.0 112.043 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.93 172.91 13.18 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.348 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -78.29 166.84 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.909 2.406 . . . . 0.0 111.836 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -68.15 111.16 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.268 -178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.6 p -128.4 139.83 36.64 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.405 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -48.26 -47.54 19.47 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.592 2.861 . . . . 0.0 113.253 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -65.47 -42.23 92.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.182 0.515 . . . . 0.0 111.03 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 43.1 tt0 -74.86 -36.97 62.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.775 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.59 HD11 ' HB1' ' A' ' 34' ' ' ALA . 90.8 mt -79.75 -11.16 59.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.606 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -98.68 -21.28 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.0 110.114 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.95 -33.5 18.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.07 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA2' ' OE1' ' A' ' 71' ' ' GLN . . . -161.28 -145.19 4.23 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.415 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.821 HG22 HG22 ' A' ' 59' ' ' ILE . 11.6 p -115.13 138.95 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 58.5 m -150.03 158.2 43.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.091 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 58' ' ' SER . 96.3 m-85 -66.52 158.82 28.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.718 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.599 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -98.96 -46.27 5.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.561 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -96.68 144.21 26.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.638 0.733 . . . . 0.0 111.908 -174.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.6 -2.4 55.99 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.325 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -117.99 18.6 13.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.707 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 15.4 pt-20 -105.84 138.82 41.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.2 m -117.26 150.32 38.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.646 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 pp -73.92 -8.14 54.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.359 0.6 . . . . 0.0 110.419 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.74 2.59 21.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.416 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 5.9 t70 -92.09 -159.23 0.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 55' ' ' GLN . 2.1 tt0 -99.81 -36.23 9.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -95.43 132.43 40.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.111 0.482 . . . . 0.0 110.941 -175.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG21 HD22 ' A' ' 121' ' ' LEU . 28.0 mm -129.71 120.9 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.504 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 32.7 t -127.68 106.28 9.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.921 0.391 . . . . 0.0 110.334 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.821 HG22 HG22 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -122.07 119.02 57.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.935 0.398 . . . . 0.0 110.07 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.12 42.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.908 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.17 98.15 0.2 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 126' ' ' CYS . 3.6 p-80 -116.19 159.79 21.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.322 0.561 . . . . 0.0 112.32 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 67' ' ' ARG . 12.9 t 176.7 -176.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.785 177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -145.71 2.79 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.393 0.615 . . . . 0.0 109.934 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 67' ' ' ARG . 12.2 mm -91.32 47.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.139 0.495 . . . . 0.0 111.76 -172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.8 -29.9 0.19 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.168 0.987 . . . . 0.0 113.061 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.629 ' HD2' ' OD1' ' A' ' 127' ' ' ASP . 6.6 mtp85 60.56 67.55 1.54 Allowed Pre-proline 0 N--CA 1.465 0.305 0 C-N-CA 124.26 1.024 . . . . 0.0 111.903 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 10.6 Cg_endo -103.52 -12.97 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.005 2.47 . . . . 0.0 112.718 170.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -133.85 25.96 3.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.947 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' O ' HG23 ' A' ' 73' ' ' THR . 9.3 m-85 -100.33 172.9 6.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.775 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.931 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.2 pm0 -72.89 -22.1 60.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.797 178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' CD2' ' HG2' ' A' ' 71' ' ' GLN . 69.3 m-85 -125.35 92.92 3.72 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 173.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 70' ' ' TYR . 34.2 p -107.33 -67.28 0.96 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.018 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.618 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.7 t30 -86.89 25.47 1.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.534 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -66.24 -2.45 4.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.624 0.726 . . . . 0.0 110.528 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 76' ' ' LYS . 20.4 pttp -80.02 -30.22 39.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.172 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.55 -15.25 38.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.843 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.547 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -66.52 135.31 54.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.997 -178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -95.7 -175.87 3.57 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.006 0.431 . . . . 0.0 110.884 -176.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -80.97 -4.02 53.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.429 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 96' ' ' LYS . . . -123.07 28.56 5.58 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.89 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.512 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 3.8 m -85.85 131.91 34.21 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.311 0.577 . . . . 0.0 109.859 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.35 109.51 10.11 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.669 175.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.833 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 84.4 t -96.43 116.01 37.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.653 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -98.77 126.38 44.38 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.458 -178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -122.02 110.81 16.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.661 ' HG2' ' HB ' ' A' ' 92' ' ' THR . 46.4 mtmt -101.51 142.89 32.2 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.246 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 m -116.21 89.1 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.765 0.793 . . . . 0.0 109.171 169.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.06 -54.58 4.56 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.505 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.4 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.341 0.591 . . . . 0.0 110.22 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -74.49 130.57 39.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.518 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.661 ' HB ' ' HG2' ' A' ' 87' ' ' LYS . 2.8 t -121.18 149.59 42.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.558 0.694 . . . . 0.0 111.864 -175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 146' ' ' GLU . 30.7 mmm180 -115.46 141.34 48.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.27 129.58 43.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 110.387 -177.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.403 ' CD1' HD11 ' A' ' 121' ' ' LEU . 54.7 m-85 -127.2 147.86 50.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' HD3' ' HA2' ' A' ' 81' ' ' GLY . 37.4 ttmt -111.35 149.35 31.28 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.774 176.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.608 ' HB3' HD11 ' A' ' 100' ' ' ILE . 49.7 mtp -79.77 64.16 4.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.19 0.519 . . . . 0.0 110.296 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.3 p -73.45 -34.45 65.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.828 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.606 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 8.4 m -115.41 95.36 5.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.187 0.517 . . . . 0.0 110.818 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.608 HD11 ' HB3' ' A' ' 97' ' ' MET . 63.2 mt -120.45 119.73 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 177.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -151.44 151.26 31.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.807 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -108.24 129.01 55.22 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.82 HG22 ' HD3' ' A' ' 105' ' ' PRO . 7.5 p -121.06 126.68 75.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.771 -177.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.69 77.2 52.34 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.045 0.45 . . . . 0.0 111.768 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.82 ' HD3' HG22 ' A' ' 103' ' ' VAL . 97.0 Cg_endo -97.34 170.99 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.268 2.646 . . . . 0.0 111.346 172.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -66.15 -51.46 57.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.871 0.367 . . . . 0.0 110.738 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -133.54 121.41 22.08 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.014 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -61.26 150.87 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.492 ' O ' HD22 ' A' ' 111' ' ' LEU . 1.0 OUTLIER -65.71 -24.7 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 0.0 110.694 -175.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.601 ' H ' HG13 ' A' ' 108' ' ' VAL . 9.8 p 48.79 21.81 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.771 1.228 . . . . 0.0 113.588 174.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 109' ' ' GLU . 0.4 OUTLIER -82.66 176.46 9.34 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.933 -0.479 . . . . 0.0 110.171 174.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -71.83 152.23 42.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.965 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -94.08 137.01 33.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.64 168.23 9.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.957 0.408 . . . . 0.0 110.388 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -73.38 161.84 30.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.4 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.4 36.52 0.64 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -131.98 -167.44 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -124.81 -168.14 1.77 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -68.22 104.67 1.88 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -130.22 136.98 49.81 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.434 HD22 HG21 ' A' ' 57' ' ' ILE . 26.5 mt -92.11 100.26 12.92 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.45 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 3.1 m -78.53 88.88 4.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD12 ' CE2' ' A' ' 142' ' ' PHE . 39.4 mt -95.37 99.89 11.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.518 0.675 . . . . 0.0 110.262 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -99.56 97.38 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.053 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 p -92.71 91.76 7.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.917 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 62' ' ' HIS . 2.9 m -73.62 100.55 3.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 67' ' ' ARG . 28.8 t70 -115.52 47.13 1.37 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.937 0.875 . . . . 0.0 108.769 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.825 ' HB2' ' H ' ' A' ' 137' ' ' GLU . 4.5 p-10 -141.65 -1.47 1.29 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.933 -170.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.59 109.93 22.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.399 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.494 ' HB3' HG12 ' A' ' 135' ' ' VAL . 14.4 t30 -116.71 113.48 22.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -72.64 -34.93 67.63 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -168.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HE3' HG23 ' A' ' 133' ' ' THR . 0.1 OUTLIER -57.46 -50.75 72.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.318 0.58 . . . . 0.0 110.501 -177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.435 HG23 ' HE3' ' A' ' 132' ' ' LYS . 25.5 p -92.02 -22.29 20.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.399 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.63 41.23 29.9 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.611 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 130' ' ' ASN . 13.7 p -105.3 143.53 16.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.404 . . . . 0.0 110.93 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.496 ' HB3' ' NH2' ' A' ' 139' ' ' ARG . 2.6 m-90 -128.38 116.24 19.47 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.999 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.825 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 82.2 mt-10 -104.63 -95.31 0.33 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 137' ' ' GLU . 26.5 mttp -130.18 112.72 13.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.574 -169.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.74 ' H ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -104.47 129.97 52.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.343 0.592 . . . . 0.0 110.118 175.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HE3' HG23 ' A' ' 100' ' ' ILE . 1.8 tmtp? -95.46 126.64 40.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.524 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.63 131.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.054 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.833 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 4.3 t80 -132.14 110.75 10.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.143 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.1 t -114.89 105.95 19.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.922 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -92.58 125.38 37.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.249 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.4 m -97.27 140.83 31.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 42.0 tt0 -58.31 121.66 11.34 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.69 0.619 . . . . 0.0 111.009 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.7 p -124.03 162.9 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-O 121.832 0.825 . . . . 0.0 111.654 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.842 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.504 0.192 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -149.24 178.95 8.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.491 0.662 . . . . 0.0 111.434 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.84 -177.94 3.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.657 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -76.8 113.1 26.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 174.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.562 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.7 Cg_endo -73.8 136.89 23.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.234 1.956 . . . . 0.0 111.629 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.481 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 35.2 mm-40 -85.17 -167.72 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.3 mp -81.02 101.53 0.99 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 98.6 Cg_endo -94.32 -166.5 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.05 2.5 . . . . 0.0 113.081 -169.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -75.02 -23.41 58.19 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.554 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 29.4 m-20 -79.17 83.79 5.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.818 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 2.3 pptp? -85.48 -3.27 58.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.359 -176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.9 m -101.13 3.47 41.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.027 0.441 . . . . 0.0 111.166 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 34.1 mmtp -90.6 173.82 7.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.071 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.17 95.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.802 0.334 . . . . 0.0 110.456 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -82.58 -27.87 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.343 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.47 169.29 31.01 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.95 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' HB2' ' HE2' ' A' ' 87' ' ' LYS . 0.6 OUTLIER -135.36 132.94 38.23 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -103.31 125.57 57.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 46.3 mt-10 -135.57 104.49 5.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.857 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.46 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -116.51 100.23 53.31 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HD2' ' O ' ' A' ' 83' ' ' MET . 17.8 Cg_endo -59.85 -30.74 92.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.034 2.489 . . . . 0.0 112.478 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.03 -12.76 61.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.696 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 4.36 3.8 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.551 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 60.48 27.94 17.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.163 0.506 . . . . 0.0 111.195 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 80.2 mt -88.0 107.11 17.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.122 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -139.27 86.38 2.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.679 0.276 . . . . 0.0 110.426 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' A' ' 71' ' ' GLN . 53.6 mt-10 -135.54 153.29 77.57 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.599 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.88 150.37 78.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.6 2.2 . . . . 0.0 112.152 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.09 129.46 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 47.2 m-85 -95.17 107.67 33.64 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.97 -177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 7' ' ' ILE . 11.3 Cg_endo -54.95 154.01 23.33 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.3 2.666 . . . . 0.0 112.194 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.31 -161.04 18.86 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.767 177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.424 ' O ' HG22 ' A' ' 35' ' ' THR . 57.4 Cg_endo -93.09 157.86 2.64 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.163 2.575 . . . . 0.0 112.435 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 111.34 10.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.251 0.548 . . . . 0.0 110.162 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 33' ' ' PRO . 1.4 t -149.89 143.29 16.54 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.082 -175.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.97 -23.12 33.37 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.133 2.555 . . . . 0.0 112.503 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.14 -50.87 66.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.791 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.57 ' HG2' ' OG ' ' A' ' 44' ' ' SER . 1.3 tt0 -88.56 -29.54 19.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.838 -175.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.13 1.32 13.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.198 0.523 . . . . 0.0 110.63 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -83.44 -18.54 38.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -99.03 -65.16 0.98 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.583 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.59 -148.88 4.98 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.386 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.57 140.98 15.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.672 0.272 . . . . 0.0 110.395 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.57 ' OG ' ' HG2' ' A' ' 38' ' ' GLN . 15.9 m -131.06 -170.55 2.38 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 56.9 m-85 -99.12 173.41 6.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.27 -68.71 0.68 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.513 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HB2' ' OE1' ' A' ' 50' ' ' GLU . 14.3 mm-40 -97.3 -174.48 2.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -134.84 27.81 3.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.765 -170.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.6 -3.08 6.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.053 0.454 . . . . 0.0 111.009 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 47' ' ' GLU . 15.1 mp0 -90.41 159.74 16.42 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.321 0.581 . . . . 0.0 111.717 -173.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 6' ' ' GLN . 45.2 m -107.22 147.79 29.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.224 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.562 HD21 ' O ' ' A' ' 5' ' ' PRO . 3.0 pp -85.62 2.59 44.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.384 0.611 . . . . 0.0 110.282 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.33 4.87 50.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.6 164.91 12.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -94.73 -9.47 34.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.719 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -106.7 90.79 3.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.165 0.507 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 4.2 mt -109.59 133.86 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.387 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -123.26 116.79 23.95 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 5.7 mt -108.74 133.23 54.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -177.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.69 123.9 46.04 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.899 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -112.66 -171.79 18.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.375 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -139.43 148.52 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.574 0.226 . . . . 0.0 110.728 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.589 ' H ' ' HE2' ' A' ' 129' ' ' TYR . 10.1 t -162.07 143.87 11.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 110.55 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.73 -158.81 0.66 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.67 -66.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.63 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.26 84.16 5.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.396 0.617 . . . . 0.0 110.316 -176.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -161.29 105.14 1.23 Allowed Pre-proline 0 C--O 1.213 -0.863 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.381 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.584 ' HA ' HG21 ' A' ' 73' ' ' THR . 71.7 Cg_endo -100.47 -0.82 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.911 2.407 . . . . 0.0 111.908 169.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -118.71 11.99 12.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.928 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -82.94 160.29 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.676 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.55 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 3.7 pt20 -52.63 -41.67 63.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.386 0.429 . . . . 0.0 111.038 177.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.899 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 23.4 m-85 -113.66 90.12 3.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.104 0.478 . . . . 0.0 111.062 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 68' ' ' PRO . 6.6 m -150.55 -40.28 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.709 171.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -83.77 13.82 4.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.055 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.433 HD11 ' CD1' ' A' ' 72' ' ' PHE . 16.7 mt -67.63 -10.96 56.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.127 176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -75.41 -23.18 56.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.14 -13.4 50.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.168 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.96 167.82 20.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.676 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -132.42 176.39 8.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.184 0.516 . . . . 0.0 111.089 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 -1.98 54.65 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.828 0.823 . . . . 0.0 109.162 172.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 96' ' ' LYS . . . -147.39 38.79 1.07 Allowed Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.506 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 p -86.03 -169.89 2.85 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.558 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -115.04 109.29 17.85 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -177.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 82.0 t -103.34 121.33 54.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.034 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 67.3 m-85 -101.71 128.55 47.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.813 0.339 . . . . 0.0 110.622 177.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -116.87 111.39 19.62 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -100.18 135.71 41.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.838 -176.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 3.2 p -159.09 112.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.68 -101.82 0.44 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.865 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -112.99 1.47 15.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.947 0.403 . . . . 0.0 110.492 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 88' ' ' VAL . 16.0 mm-40 -97.44 134.85 40.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.417 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 m -134.16 93.97 3.17 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 22.9 mmt85 -99.27 141.91 31.44 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 83' ' ' MET . 25.1 mtmm -102.78 132.16 49.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 93' ' ' ARG . 86.6 m-85 -119.84 145.29 46.78 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.965 0.412 . . . . 0.0 111.06 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.498 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 17.7 tttt -102.04 133.42 46.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.995 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.3 mtp -86.59 53.37 2.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.503 0.668 . . . . 0.0 109.531 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.67 -14.95 59.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.266 -172.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.605 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 70.7 m -124.18 88.31 2.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.582 176.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 73.0 mt -107.69 108.75 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.973 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -134.09 150.0 51.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.174 0.511 . . . . 0.0 110.554 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.461 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 1.9 p-10 -116.27 144.44 44.22 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.1 p -123.5 134.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.574 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.6 mptt -79.78 130.65 66.55 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 104' ' ' LYS . 9.3 Cg_exo -73.39 41.42 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.636 2.891 . . . . 0.0 113.034 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 m -71.42 -34.23 70.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.337 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -161.68 151.8 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.779 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.56 -22.02 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.923 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.92 -5.51 56.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.182 0.515 . . . . 0.0 110.628 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.98 -25.21 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.095 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 pp -105.56 153.12 22.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.104 0.478 . . . . 0.0 111.956 -172.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.31 160.07 42.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.72 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.52 -179.93 5.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -116.36 161.83 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.327 0.584 . . . . 0.0 112.077 -172.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -90.26 132.3 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.714 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 116.39 64.38 0.35 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.552 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -89.86 165.98 13.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.712 0.768 . . . . 0.0 111.863 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -108.89 -168.18 1.31 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.4 mppt? -74.52 102.88 4.65 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -137.92 142.51 40.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.231 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 14.8 mt -106.38 116.62 32.25 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m -96.48 94.12 7.2 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.701 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -82.13 107.32 14.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.752 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.73 81.71 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 24.5 m -91.87 96.67 10.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.606 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 95.4 m -71.45 90.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.647 ' OD2' ' HE2' ' A' ' 138' ' ' LYS . 25.9 t0 -80.14 9.32 5.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.048 -170.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 15.9 t70 -164.81 106.8 0.84 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.574 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.589 ' HE2' ' H ' ' A' ' 63' ' ' THR . 32.1 p90 -146.11 137.11 24.48 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 173.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -97.97 115.13 27.54 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -66.38 -14.8 62.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.8 -174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -76.1 -67.78 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.216 0.531 . . . . 0.0 110.461 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -19.28 23.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.912 -172.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.01 38.08 14.27 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.263 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.74 149.09 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.625 0.25 . . . . 0.0 110.334 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -140.87 123.34 15.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.598 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.32 -58.94 2.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.647 ' HE2' ' OD2' ' A' ' 127' ' ' ASP . 24.2 pttm -116.06 123.98 49.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 111.579 -174.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 139' ' ' ARG . 37.8 ttm-85 -110.88 103.5 12.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.918 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' ' HB ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -97.08 101.93 13.6 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 110.332 -177.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.26 130.13 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 CA-C-O 121.626 0.727 . . . . 0.0 111.514 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 97.9 m-85 -106.16 119.55 39.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.117 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 46.8 t -105.4 102.33 13.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.17 120.91 43.04 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.735 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.6 m -92.32 140.26 29.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -64.59 116.66 6.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.902 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.57 157.33 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.807 0.813 . . . . 0.0 110.569 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 C--N 1.302 -1.496 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.488 -172.257 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.683 ' HG3' ' H ' ' A' ' 2' ' ' GLN . 19.5 ptt? . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.44 0.162 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.683 ' H ' ' HG3' ' A' ' 1' ' ' MET . 43.0 mt-30 -142.62 -155.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.92 157.39 7.78 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.954 0.407 . . . . 0.0 111.251 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HE3' ' OE1' ' A' ' 6' ' ' GLN . 62.9 pttt -72.34 146.33 89.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -55.23 117.64 4.26 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.984 2.456 . . . . 0.0 111.967 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.515 ' OE1' ' HE3' ' A' ' 4' ' ' LYS . 6.7 tp60 -141.29 169.79 16.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.934 HD11 ' HB3' ' A' ' 52' ' ' LEU . 16.0 mm -97.82 110.83 57.11 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 6.7 Cg_exo -73.78 173.32 14.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.62 2.213 . . . . 0.0 111.4 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -108.39 22.39 16.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.652 0.739 . . . . 0.0 110.507 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.85 145.38 47.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.215 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.764 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 1.5 mptt -88.04 -14.23 39.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.655 0.264 . . . . 0.0 111.3 -171.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.0 t -89.16 -17.86 28.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.468 0.651 . . . . 0.0 109.712 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -80.08 86.34 5.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.55 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.7 t -61.43 104.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.743 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.65 -27.68 25.23 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.964 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -157.61 177.17 34.52 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.175 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 132.58 39.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -102.54 122.9 55.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.039 0.447 . . . . 0.0 109.862 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mt-10 -135.16 120.27 18.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.437 0.637 . . . . 0.0 111.751 -177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 HD12 HD12 ' A' ' 25' ' ' ILE . 74.1 mt -124.97 103.23 30.71 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.305 174.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.17 -22.72 72.97 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.164 2.576 . . . . 0.0 112.854 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.67 -31.38 72.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.041 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -121.26 3.96 10.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.928 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.2 t70 63.33 24.65 14.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.606 0.717 . . . . 0.0 110.464 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 70.2 mt -75.97 112.46 13.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.97 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 61.0 mtpt -145.64 95.09 2.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.744 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 71' ' ' GLN . 11.9 pt-20 -152.13 155.69 33.48 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.87 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.25 154.41 74.23 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.485 2.123 . . . . 0.0 112.369 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 62.6 t -97.56 129.64 47.41 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -93.21 107.24 24.05 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.992 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.613 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 24.2 Cg_exo -64.95 144.69 83.61 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.01 2.474 . . . . 0.0 112.118 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.48 179.56 17.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.697 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.26 145.61 19.17 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -62.67 99.98 0.17 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.2 p -129.05 144.46 52.75 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.297 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.51 -41.05 76.41 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.143 2.562 . . . . 0.0 113.029 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.04 -43.39 87.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.717 0.294 . . . . 0.0 111.173 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -73.07 -40.25 65.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.81 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.46 -15.84 63.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.093 0.473 . . . . 0.0 110.874 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.27 -9.84 58.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.246 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -104.54 -21.51 13.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.49 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 -167.19 40.16 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.542 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 59' ' ' ILE . 14.8 p -86.93 137.45 20.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.119 0.485 . . . . 0.0 110.242 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.0 m -139.28 171.67 13.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.762 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -82.1 171.13 14.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.396 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -123.67 -33.88 3.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.727 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 1.5 pm0 -81.02 -177.44 6.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.791 -169.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.88 -18.27 16.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.65 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -90.2 134.97 33.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.695 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.07 28.89 0.87 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.054 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.6 m -105.51 160.59 15.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.593 . . . . 0.0 111.078 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' A' ' 7' ' ' ILE . 1.5 pp -123.58 -1.97 8.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.425 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -149.16 54.46 0.97 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.408 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.79 -61.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 0.7 OUTLIER 178.82 -65.27 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 122.764 0.426 . . . . 0.0 110.688 178.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 97.17 7.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.546 0.689 . . . . 0.0 112.1 -172.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.4 mm -103.44 140.5 21.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.704 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.1 t -127.91 96.59 4.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.091 0.472 . . . . 0.0 110.229 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 43' ' ' VAL . 1.1 mt -93.13 118.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 136.34 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.725 0.298 . . . . 0.0 111.541 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.74 134.38 7.54 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -136.46 19.83 3.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.408 0.604 . . . . 0.0 111.489 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -88.07 15.94 6.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.539 0.685 . . . . 0.0 111.132 -176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.628 ' HD1' HG22 ' A' ' 73' ' ' THR . 88.1 t80 -93.22 94.22 8.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.565 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 66' ' ' ASP . 7.6 tp -164.66 -51.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.426 ' N ' HG23 ' A' ' 65' ' ' ILE . 20.1 t70 -96.0 -28.12 14.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 0.0 111.226 -175.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.8 mmt180 -111.3 122.6 37.22 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.675 -175.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -87.18 0.22 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.432 2.755 . . . . 0.0 111.425 171.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.94 50.8 1.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.71 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.717 ' HD2' ' HG2' ' A' ' 71' ' ' GLN . 2.0 t80 -132.17 -169.12 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.266 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.76 ' HG3' ' H ' ' A' ' 72' ' ' PHE . 2.8 pt20 -33.06 -88.18 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.76 ' H ' ' HG3' ' A' ' 71' ' ' GLN . 55.3 m-85 -96.15 29.8 2.68 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.95 -0.469 . . . . 0.0 111.7 -169.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.628 HG22 ' HD1' ' A' ' 64' ' ' PHE . 73.4 p -78.08 -41.13 36.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.233 0.539 . . . . 0.0 110.876 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.66 12.69 30.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.034 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 72' ' ' PHE . 24.0 tp -63.13 -15.31 56.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.007 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -62.92 -23.29 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.297 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.99 -10.09 59.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.417 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.8 133.87 34.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.25 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -104.04 -176.55 3.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.074 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -70.61 -0.75 9.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.847 -179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.66 62.66 0.54 Allowed Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 p -96.78 -159.1 0.71 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 174.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.2 tpt -139.35 89.94 2.38 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.1 t -77.23 117.19 21.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.004 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -98.1 109.35 22.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.293 0.568 . . . . 0.0 110.594 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 33.9 t80 -99.55 99.1 9.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 42.2 mtpt -94.93 140.49 29.87 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.452 -177.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 91' ' ' GLU . 2.9 m -143.83 108.54 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.857 175.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.89 -98.18 0.54 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.35 -172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -124.56 6.86 8.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.629 ' HB2' HG23 ' A' ' 88' ' ' VAL . 14.4 mm-40 -85.04 142.95 29.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -126.1 112.71 16.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.101 0.477 . . . . 0.0 110.026 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 7.9 mmm180 -106.92 120.78 42.97 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -96.71 133.72 40.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.512 ' CD2' HD21 ' A' ' 121' ' ' LEU . 94.0 m-85 -130.52 146.21 52.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.187 0.518 . . . . 0.0 111.474 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 14.8 tptm -108.24 127.85 54.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.188 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.468 ' HB3' HD11 ' A' ' 100' ' ' ILE . 65.9 mtp -78.4 70.41 4.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.91 -175.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.3 p -67.92 -42.14 81.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.536 -171.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 3.7 m -114.15 105.89 13.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 97' ' ' MET . 66.3 mt -126.83 95.05 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.623 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm-85 -145.49 152.31 39.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.868 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.824 ' HB2' ' HD3' ' A' ' 138' ' ' LYS . 9.3 p-10 -104.06 137.71 41.63 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.083 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.73 139.26 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.27 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 137' ' ' GLU . 82.7 tttt -112.49 90.67 15.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.896 0.379 . . . . 0.0 110.334 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HB2' HG11 ' A' ' 110' ' ' VAL . 97.3 Cg_endo -88.84 -31.85 0.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 60.2 m 72.57 -46.73 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.416 0.687 . . . . 0.0 112.16 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -77.36 162.89 26.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 110.24 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 t -84.4 -34.39 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.416 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.56 80.8 1.49 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.447 0.641 . . . . 0.0 111.444 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 105' ' ' PRO . 27.7 m -111.48 -6.2 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.972 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 pp -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.733 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -146.36 170.1 17.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.654 0.264 . . . . 0.0 110.367 -175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -79.75 92.17 5.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.283 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.73 133.99 44.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.958 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mttp 52.3 -172.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.712 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.1 130.92 24.86 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.13 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -90.33 -178.65 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.76 -174.55 2.9 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 146' ' ' GLU . 17.4 mtpp -93.71 95.56 9.24 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.005 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -145.87 162.51 37.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.435 -172.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -112.66 120.69 42.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 171.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.5 m -83.16 89.72 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 92.2 mt -76.05 104.44 6.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.355 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 60.7 mt -91.19 100.17 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.545 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 41.1 p -109.8 103.79 12.66 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.095 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.7 m -70.22 92.6 0.78 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -134.59 99.41 4.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.909 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 0.4 OUTLIER 175.61 93.99 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.593 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 52.9 p90 -74.18 137.97 43.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.724 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 132' ' ' LYS . 25.5 p-10 -81.0 12.05 3.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.305 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 130' ' ' ASN . 12.7 pt-20 53.8 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.445 1.898 . . . . 0.0 114.718 -178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 130' ' ' ASN . 9.3 tmtm? -61.24 -57.74 11.15 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.336 0.588 . . . . 0.0 110.053 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -126.78 -24.23 3.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.511 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 129' ' ' TYR . . . 98.21 44.05 2.66 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.18 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 p -94.16 148.34 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -80.63 94.14 6.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.22 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 39.6 mt-10 -84.4 -59.16 2.47 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.284 0.564 . . . . 0.0 111.513 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.824 ' HD3' ' HB2' ' A' ' 102' ' ' ASP . 32.8 ttmt -80.25 135.61 36.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 -172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' NH1' ' O3 ' ' A' ' 201' ' ' 2W7 . 0.0 OUTLIER -94.24 101.18 13.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.73 113.07 20.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.113 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.77 136.2 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.677 -172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 96.5 m-85 -117.16 112.22 20.55 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.474 173.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 89.5 t -99.89 111.62 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.804 0.335 . . . . 0.0 110.799 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -110.9 114.11 27.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.545 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -90.69 146.64 23.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.934 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 119' ' ' LYS . 70.4 tt0 -62.92 141.11 58.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.217 0.532 . . . . 0.0 111.934 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 1.4 t -114.62 163.24 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.023 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.312 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.491 ' O3 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -72.48 135.94 45.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.33 87.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.871 0.732 . . . . 0.0 109.708 -170.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -62.01 141.53 95.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.988 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.36 109.57 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.163 2.575 . . . . 0.0 112.846 -174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -136.89 160.9 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.959 -1.018 . . . . 0.0 108.904 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -70.39 116.88 49.54 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 31.5 Cg_exo -59.18 150.73 71.97 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 123.198 2.598 . . . . 0.0 113.376 -174.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -70.87 -27.42 63.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.064 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -84.5 159.35 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.77 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -110.62 22.93 14.85 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.607 0.242 . . . . 0.0 111.349 -172.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 t -120.56 -33.02 3.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.68 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -63.52 105.61 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 28' ' ' PRO . 1.3 p -58.2 112.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.999 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.07 24.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.588 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.98 157.6 24.89 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.012 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -121.45 131.48 54.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 8.1 tp -105.93 121.87 58.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.214 0.53 . . . . 0.0 110.334 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 94.8 mt-10 -129.78 109.64 11.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.468 0.652 . . . . 0.0 111.186 -176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' ILE . 66.5 mt -120.64 99.21 47.68 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.047 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.43 -35.54 98.57 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.049 2.499 . . . . 0.0 113.128 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.21 -33.57 71.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.262 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HB3' HG13 ' A' ' 25' ' ' ILE . . . -111.6 7.21 20.45 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.949 -175.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.07 26.58 16.01 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.585 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 71' ' ' GLN . 61.6 mt -81.17 115.03 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.602 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 6.1 ttpm? -147.12 61.57 1.18 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 26.2 mm-40 -121.67 153.37 59.69 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.886 -172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' A' ' 14' ' ' VAL . 7.8 Cg_exo -70.15 147.98 61.52 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.526 2.151 . . . . 0.0 111.84 175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.1 t -96.34 123.97 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.8 m-85 -97.03 102.32 11.79 Favored Pre-proline 0 C--N 1.308 -1.202 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.831 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 30' ' ' TYR . 11.5 Cg_endo -55.42 139.7 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.403 2.735 . . . . 0.0 112.735 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.34 170.22 11.94 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.12 162.0 37.51 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.71 2.273 . . . . 0.0 112.435 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -65.4 100.4 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.646 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 21.0 p -130.62 140.36 38.43 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.065 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 36.9 Cg_exo -61.53 -8.39 10.81 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.254 2.636 . . . . 0.0 113.319 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -94.75 -38.93 10.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.616 0.246 . . . . 0.0 110.795 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -79.08 -37.82 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.422 . . . . 0.0 110.171 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -69.09 -13.13 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.8 -38.96 92.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.367 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.4 -40.09 89.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.36 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.9 -82.39 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.832 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 60' ' ' ALA . 2.6 p -138.45 139.59 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.306 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.9 m -140.09 172.18 13.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -74.22 140.24 44.92 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.974 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 60' ' ' ALA . . . -87.35 -43.6 12.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.209 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -92.71 177.85 5.97 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.096 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.4 55.2 0.98 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.867 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.31 89.58 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.073 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.22 7.15 43.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.86 0.838 . . . . 0.0 109.764 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 35.7 m -130.0 147.92 51.8 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.541 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 pp -119.97 7.68 10.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.374 0.607 . . . . 0.0 110.505 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -139.27 35.71 2.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.617 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 5.9 p-10 -86.8 -95.09 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.442 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -173.45 -18.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 176.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -112.31 83.25 1.77 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.282 0.563 . . . . 0.0 109.715 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 40.8 mm -94.6 86.74 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.389 -177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.2 m -91.73 103.65 16.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.254 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 121' ' ' LEU . 1.1 mt -101.56 137.58 28.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . . . -104.41 123.83 48.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.993 0.425 . . . . 0.0 111.205 -176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.68 -179.15 16.1 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 126' ' ' CYS . 30.3 p80 -159.79 155.97 26.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 117.428 0.614 . . . . 0.0 110.882 -177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.17 162.73 29.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.519 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 12.7 t80 -146.34 113.2 6.08 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 tp -83.67 -21.12 8.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.885 -170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.493 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 57.0 m-20 -82.3 -34.46 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.73 -176.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 32.0 mmm-85 -135.01 120.49 14.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.687 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 2.9 Cg_exo -77.74 -12.52 16.52 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.064 2.509 . . . . 0.0 112.903 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -81.87 16.73 1.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.908 -171.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.88 -169.12 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.877 ' HB2' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.18 -51.62 3.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.79 0.329 . . . . 0.0 111.5 -178.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.823 ' HD1' ' HG2' ' A' ' 71' ' ' GLN . 9.2 m-85 -84.46 22.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.054 0.454 . . . . 0.0 111.494 -175.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 p -89.95 -34.86 15.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.342 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.5 t30 -102.94 19.59 19.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.164 0.507 . . . . 0.0 111.082 -173.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' A' ' 142' ' ' PHE . 11.5 mt -64.1 -5.99 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.01 -18.76 60.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 110.69 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.89 5.39 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.422 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -96.31 145.52 25.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.333 178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 8.3 mptt -117.36 173.82 6.48 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.0 110.253 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' CD ' ' H ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -73.85 -3.17 27.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.756 177.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.7 25.38 4.73 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.466 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 75.7 m -78.16 -165.12 0.62 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.258 0.551 . . . . 0.0 110.443 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 tpt -131.35 120.3 22.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.813 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 18' ' ' ILE . 87.3 t -107.41 109.81 29.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.577 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.05 119.46 32.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.396 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -112.7 110.25 20.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.962 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.46 146.66 27.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 91' ' ' GLU . 3.4 p -156.78 112.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.25 0.548 . . . . 0.0 109.925 174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 -98.24 0.33 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 90' ' ' ASN . 9.8 m120 -125.56 6.99 7.57 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.262 0.554 . . . . 0.0 109.881 174.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.551 ' HB2' HG13 ' A' ' 88' ' ' VAL . 20.1 mm-40 -90.11 139.11 30.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.468 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -145.86 120.57 9.85 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 3.3 mpt_? -122.14 153.93 38.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.928 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -102.83 126.64 50.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.186 -176.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 90.5 m-85 -124.84 155.83 38.81 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' SER . 24.7 ttmm -128.62 150.12 50.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.467 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 48.6 mtp -83.94 59.59 5.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.515 0.674 . . . . 0.0 109.959 -173.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -66.22 -45.43 80.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.175 -172.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.6 m -106.97 100.75 10.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.31 0.576 . . . . 0.0 110.745 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG2' ' HE3' ' A' ' 140' ' ' LYS . 59.7 mt -118.31 112.74 39.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.596 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -141.07 141.59 34.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 1.9 p-10 -108.68 121.12 44.37 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.437 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.795 ' HB ' ' HB2' ' A' ' 139' ' ' ARG . 15.7 t -77.96 121.95 31.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.664 -175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.656 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -103.63 132.7 20.81 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.6 99.96 0.06 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.319 2.679 . . . . 0.0 113.728 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.3 m -126.98 -49.56 1.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.681 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -145.5 144.28 30.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.966 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -92.04 -28.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 -177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -94.85 35.39 1.26 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.667 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.24 8.07 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.239 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.81 153.27 38.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.594 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -130.09 154.83 47.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.722 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -100.58 6.51 44.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.056 -173.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -83.18 98.13 9.2 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -96.23 33.5 1.74 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.631 -170.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.88 87.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.416 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -135.22 -173.67 3.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 0.0 110.93 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -117.78 -161.91 0.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -74.91 103.18 5.02 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -131.61 146.84 52.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.529 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' HG ' ' HB ' ' A' ' 57' ' ' ILE . 6.2 mp -107.35 109.96 21.83 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.547 HG23 HG22 ' A' ' 143' ' ' VAL . 19.9 m -89.43 99.07 12.15 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.892 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 81.0 mt -80.05 108.28 13.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.288 0.566 . . . . 0.0 110.464 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.484 HG22 HH21 ' A' ' 139' ' ' ARG . 58.5 mt -93.77 103.65 14.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.424 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.416 HG23 ' HD2' ' A' ' 72' ' ' PHE . 3.2 m -99.73 129.05 45.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.267 -175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 62' ' ' HIS . 9.9 m -87.12 96.32 10.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.029 170.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 138' ' ' LYS . 3.3 m-20 -89.99 161.68 15.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.221 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 52.57 47.4 24.77 Favored 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.701 0.626 . . . . 0.0 111.361 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 19.8 p90 -82.48 144.02 30.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.731 -176.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -112.26 107.4 16.25 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -60.09 -26.85 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.085 -173.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -70.86 -55.93 7.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.609 0.242 . . . . 0.0 111.317 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 43.0 p -96.47 -22.18 17.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.98 32.87 9.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.599 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 129' ' ' TYR . 87.6 t -89.13 139.71 16.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.942 0.401 . . . . 0.0 110.824 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -133.19 114.61 14.04 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.849 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -91.54 -67.23 0.87 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.257 -174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 127' ' ' ASP . 4.1 ttpm? -80.94 137.75 36.12 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 21.3 mmm-85 -125.9 86.43 2.53 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HE3' ' CG2' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -76.09 108.01 8.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 0.0 110.295 -176.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 50.8 mm -97.11 130.34 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-O 121.335 0.588 . . . . 0.0 110.659 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.549 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 81.5 m-85 -120.04 101.16 7.65 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.675 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 58.5 t -93.04 102.07 13.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.153 0.501 . . . . 0.0 110.017 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -89.97 110.69 21.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.807 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 m -83.85 143.85 29.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.206 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.48 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 34.0 tt0 -62.97 129.73 41.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.815 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.82 155.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.9 pttp . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.456 -174.481 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.582 ' O2 ' ' NH2' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.019 0.438 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -87.8 -179.46 6.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.892 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.79 -175.27 3.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.42 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -62.41 131.92 94.03 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.296 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CG ' ' HB ' ' A' ' 88' ' ' VAL . 31.5 Cg_endo -63.55 126.79 18.3 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.009 2.473 . . . . 0.0 113.147 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 6' ' ' GLN . 1.7 tp60 -134.48 -171.98 2.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.181 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' CG1' ' HG ' ' A' ' 52' ' ' LEU . 62.7 mt -110.98 104.62 56.44 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.896 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 31' ' ' PRO . 86.7 Cg_endo -84.46 -170.52 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.122 2.548 . . . . 0.0 112.54 177.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 37.6 mtmt -84.37 -13.18 53.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 31' ' ' PRO . 8.9 m-20 -94.84 106.58 18.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.729 -172.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.656 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -82.55 13.48 3.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.092 173.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 p -98.83 -7.93 26.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.661 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -91.34 179.85 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.741 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.77 109.04 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.753 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -88.74 -28.93 20.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.248 0.547 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.55 37.29 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.207 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.5 124.23 37.81 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.8 tp -99.28 123.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 109.892 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 38.3 mt-10 -134.86 128.19 32.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.049 -175.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 73.4 mt -129.25 96.84 27.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.2 Cg_endo -59.55 -25.31 78.38 Favored 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.4 2.733 . . . . 0.0 112.545 -176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -64.35 -24.72 67.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.8 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.94 7.14 9.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.712 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 58.21 25.42 12.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.299 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 61.3 mt -77.48 131.63 34.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.012 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -158.71 90.07 0.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.63 150.24 53.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.273 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.4 152.53 60.68 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.861 2.374 . . . . 0.0 112.045 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 43' ' ' VAL . 47.7 t -106.99 132.14 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 29.1 m-85 -91.39 111.07 47.02 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.744 -174.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 Cg_endo -62.66 116.39 3.5 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.238 2.625 . . . . 0.0 112.63 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.48 -179.55 37.71 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.71 154.87 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.599 2.199 . . . . 0.0 112.073 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.86 131.52 44.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 111.072 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 38' ' ' GLN . 1.4 t -155.96 148.5 17.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.807 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.27 -37.69 24.8 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.797 2.998 . . . . 0.0 112.88 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 74.0 mm-40 -62.84 -52.12 64.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.125 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.474 ' NE2' ' HB2' ' A' ' 11' ' ' LYS . 13.1 mm100 -65.37 -42.91 92.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.699 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.23 -6.16 32.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 111.567 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -100.33 -10.13 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 0.0 109.934 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 62.8 mtt180 -111.65 -37.7 5.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.249 -175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.15 -166.78 36.51 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.422 -177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 29' ' ' VAL . 6.3 p -90.6 137.21 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.24 0.543 . . . . 0.0 111.074 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.0 m -134.6 -171.87 2.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.704 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 77.3 m-85 -99.25 156.0 17.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.003 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.69 -66.98 0.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.248 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 43.3 mt-10 -82.49 121.11 26.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.915 0.388 . . . . 0.0 110.879 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.88 -1.25 27.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.682 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -106.74 -6.66 17.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.187 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 22.5 tt0 -86.38 158.79 19.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.577 -176.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.7 m -122.17 142.38 50.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.762 0.315 . . . . 0.0 111.712 -172.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.792 ' HA ' HD11 ' A' ' 57' ' ' ILE . 14.3 mt -64.35 -12.49 42.88 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.024 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -119.39 26.28 9.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.859 0.838 . . . . 0.0 109.806 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 2.9 t70 -95.58 -166.58 1.47 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.296 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.781 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 17.7 pt20 -81.09 -34.08 32.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.719 0.295 . . . . 0.0 110.675 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -122.39 146.66 47.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.68 0.276 . . . . 0.0 110.903 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.792 HD11 ' HA ' ' A' ' 52' ' ' LEU . 7.9 mm -128.63 108.02 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.536 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -91.49 105.89 18.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.463 HG22 ' CG2' ' A' ' 43' ' ' VAL . 1.3 mt -103.59 140.03 22.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.96 126.01 48.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.793 0.33 . . . . 0.0 110.899 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 125' ' ' THR . . . -140.99 -177.32 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -138.07 122.15 17.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.547 0.674 . . . . 0.0 111.93 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 127' ' ' ASP . 5.6 m -79.25 154.48 29.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.966 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ARG . 4.1 t80 -164.72 86.0 0.43 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.0 mt -59.19 -35.64 58.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.347 -173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -68.56 -23.13 64.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 0.0 111.717 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.526 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -116.14 102.42 53.74 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.889 -178.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.696 ' HA ' HG21 ' A' ' 73' ' ' THR . 32.2 Cg_exo -59.28 -23.93 72.01 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.994 2.463 . . . . 0.0 112.685 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -88.63 13.93 11.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.405 ' HD1' ' HB3' ' A' ' 67' ' ' ARG . 0.9 OUTLIER -92.8 -172.15 2.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.124 173.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.493 HE22 ' HB ' ' A' ' 43' ' ' VAL . 45.0 mt-30 -74.93 -81.44 0.07 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.558 0.694 . . . . 0.0 112.347 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 75' ' ' LEU . 90.9 m-85 -89.82 37.11 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.211 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 68' ' ' PRO . 2.8 m -62.14 -29.13 70.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.975 0.417 . . . . 0.0 110.975 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -102.04 6.38 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.37 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 72' ' ' PHE . 1.8 tm? -61.19 -27.53 68.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.362 0.601 . . . . 0.0 109.529 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -56.1 -24.42 40.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.945 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -87.31 0.19 55.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.929 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.04 165.33 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.78 -176.78 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.014 0.435 . . . . 0.0 110.744 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -1.61 25.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.495 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.92 27.28 5.44 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 74.9 m -82.67 155.59 24.28 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.381 0.61 . . . . 0.0 109.704 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.495 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -97.94 111.82 23.98 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.212 -176.515 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -95.29 116.5 36.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.469 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' HE2' ' HG3' ' A' ' 21' ' ' PRO . 75.0 m-85 -107.64 130.53 54.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.509 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -121.15 106.47 11.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.779 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 14.7 mtmm -86.25 136.8 33.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.93 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 91' ' ' GLU . 3.2 m -139.87 93.14 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.0 -117.2 4.64 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -172.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -95.12 -9.54 33.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.505 0.669 . . . . 0.0 109.941 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 88' ' ' VAL . 1.5 mm-40 -77.62 144.17 37.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.482 0.658 . . . . 0.0 111.218 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -141.47 97.54 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.471 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HD3' ' OE2' ' A' ' 146' ' ' GLU . 3.9 mmp_? -80.3 135.39 36.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.316 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -103.48 125.17 49.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' GLU . 85.3 m-85 -123.22 150.6 43.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.259 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 25.3 ttpp -114.05 139.2 49.47 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 82' ' ' SER . 69.4 mtp -83.88 50.6 1.85 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.509 0.671 . . . . 0.0 109.934 -174.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.43 2.46 18.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.253 -170.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.567 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 66.8 m -145.18 102.6 3.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.77 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.98 137.04 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.556 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 34.0 ttm-85 -154.02 157.89 39.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.369 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 101' ' ' ARG . 7.1 p-10 -129.44 137.34 50.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 139' ' ' ARG . 26.5 m -117.57 -177.18 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.342 . . . . 0.0 111.456 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -90.65 154.92 46.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.334 -173.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HB3' ' O ' ' A' ' 136' ' ' TRP . 74.2 Cg_endo -77.51 178.84 7.13 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.874 2.383 . . . . 0.0 112.431 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.6 p 54.02 23.61 4.15 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.656 0.782 . . . . 0.0 111.92 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 109' ' ' GLU . 23.0 t70 -165.44 141.32 5.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.05 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.5 -2.99 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.663 ' HA ' ' HB2' ' A' ' 112' ' ' ASP . 12.3 pt-20 -93.77 -3.1 52.73 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.528 -174.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 103' ' ' VAL . 4.9 p -56.04 -39.9 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 110' ' ' VAL . 4.5 mp -130.75 100.89 5.44 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.107 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.663 ' HB2' ' HA ' ' A' ' 109' ' ' GLU . 37.9 t0 -152.93 -169.78 3.44 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.627 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 10.2 pt-20 42.27 63.69 1.32 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.138 0.899 . . . . 0.0 111.077 -175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.94 132.95 54.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.019 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -82.88 36.02 0.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.423 0.63 . . . . 0.0 109.921 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.58 143.59 10.95 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.372 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.54 168.77 18.97 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 119' ' ' LYS . 4.4 t70 -127.41 -161.32 1.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -102.63 83.4 2.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.685 0.755 . . . . 0.0 109.511 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -165.37 177.12 7.74 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.794 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.526 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 15.7 mt -107.6 132.45 53.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.3 m -101.14 86.27 2.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.584 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 7.1 mp -79.95 110.87 15.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.361 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.6 mt -96.64 93.88 3.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.513 ' HB ' ' HE2' ' A' ' 142' ' ' PHE . 13.9 m -123.55 71.4 1.08 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.961 0.41 . . . . 0.0 110.699 -174.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 65.5 m -56.37 120.31 7.44 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 63' ' ' THR . 75.5 m-20 -65.73 -41.64 91.99 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.505 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.07 149.74 21.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.022 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -179.14 102.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.832 0.708 . . . . 0.0 110.22 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -112.5 112.62 24.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -41.33 98.41 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -166.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 1.4 tmtp? -62.53 -61.02 2.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.284 0.564 . . . . 0.0 110.551 -176.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.1 p -75.83 -28.85 58.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.528 -173.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.43 40.91 9.52 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.148 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.18 133.92 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.367 0.603 . . . . 0.0 111.323 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.556 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 4.5 p90 -146.9 85.8 1.63 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.672 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 105' ' ' PRO . 39.5 mt-10 -65.01 -67.0 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.789 -172.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 127' ' ' ASP . 18.0 mtpp -79.85 96.34 6.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.376 0.608 . . . . 0.0 111.371 -174.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.686 HH21 ' C11' ' A' ' 201' ' ' 2W7 . 40.1 mmm-85 -80.61 103.27 10.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.815 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 142' ' ' PHE . 8.3 mmtp -96.35 129.45 43.68 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -171.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 tp -123.33 123.24 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.098 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.624 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 70.7 m-85 -112.92 109.58 19.1 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.334 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 95.8 t -93.94 102.89 14.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.304 0.573 . . . . 0.0 110.03 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -106.96 101.14 10.59 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.146 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' GLN . 3.1 m -83.81 143.51 29.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.897 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 44.9 tt0 -60.99 129.8 43.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.2 0.524 . . . . 0.0 111.593 -174.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 148' ' ' LYS . 2.6 p -101.48 160.49 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.324 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 147' ' ' VAL . 75.2 mttt . . . . . 0 C--N 1.306 -1.292 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.696 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.686 ' C11' HH21 ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.571 ' SD ' ' HA2' ' A' ' 89' ' ' GLY . 21.5 ptp . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.694 0.283 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -102.25 -14.73 16.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.66 174.29 12.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.192 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -74.69 117.41 62.13 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.557 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.509 ' O ' HD21 ' A' ' 52' ' ' LEU . 61.7 Cg_endo -79.31 114.72 3.35 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.665 2.243 . . . . 0.0 113.273 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' A' ' 52' ' ' LEU . 11.0 tp60 -95.82 89.23 5.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.737 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 50' ' ' GLU . 76.8 mt 24.98 91.57 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 125.068 1.48 . . . . 0.0 113.657 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.5 -179.93 5.9 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.664 2.243 . . . . 0.0 112.581 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -75.09 -44.6 46.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.075 0.464 . . . . 0.0 110.897 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.99 140.71 37.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.851 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -109.67 18.9 19.78 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.807 -169.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 m -90.9 -17.31 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.156 0.503 . . . . 0.0 110.37 173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -90.82 154.78 19.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.527 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 28' ' ' PRO . 6.9 p -97.68 135.7 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.0 0.429 . . . . 0.0 110.146 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -103.96 -21.14 13.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.637 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.78 174.9 37.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.249 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -126.73 139.95 52.76 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.217 0.207 . . . . 0.0 110.628 178.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 tp -110.41 127.91 67.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 36.5 mt-10 -136.21 122.31 20.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.042 0.448 . . . . 0.0 111.561 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.501 HD12 HD12 ' A' ' 25' ' ' ILE . 67.7 mt -129.55 95.57 29.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 172.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 83' ' ' MET . 19.3 Cg_endo -58.34 -33.59 97.9 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.082 2.522 . . . . 0.0 112.702 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.09 -15.66 63.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.131 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.38 4.87 9.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 60.63 26.17 15.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.982 0.42 . . . . 0.0 111.628 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.6 mt -86.26 120.2 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.528 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 22.8 ttmm -156.09 98.61 1.89 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' OE1' ' HA ' ' A' ' 71' ' ' GLN . 12.5 pt-20 -152.0 156.89 34.3 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.585 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.477 ' CB ' HG21 ' A' ' 14' ' ' VAL . 57.3 Cg_endo -74.15 152.34 45.21 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.608 2.205 . . . . 0.0 112.043 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.05 132.79 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 18.6 m-85 -93.94 111.36 52.69 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.47 -175.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 12.2 Cg_endo -56.98 130.88 42.14 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.031 2.488 . . . . 0.0 111.848 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.9 174.33 16.08 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.55 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.24 169.94 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.693 2.262 . . . . 0.0 112.432 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 39' ' ' LEU . . . -73.7 121.78 21.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.908 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.832 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.2 t -161.01 141.38 8.36 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -38.43 -66.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.487 3.458 . . . . 0.0 115.489 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -28.9 69.09 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -171.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 35' ' ' THR . 7.1 tp60 -72.55 -52.23 16.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.389 177.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.832 HD23 ' H ' ' A' ' 35' ' ' THR . 4.1 mm? -65.47 -20.95 66.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.469 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.37 -29.3 67.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.9 0.381 . . . . 0.0 110.412 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -82.35 -38.78 23.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.772 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.76 -158.63 21.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.611 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.424 HG23 ' OE2' ' A' ' 27' ' ' GLU . 41.0 t -77.41 141.31 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.714 0.293 . . . . 0.0 110.804 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -142.36 167.33 22.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 94.4 m-85 -87.58 176.57 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.973 0.416 . . . . 0.0 111.405 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.73 -40.19 7.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.189 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 42.8 mt-10 -108.69 141.55 40.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.42 -0.86 56.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.103 0.478 . . . . 0.0 110.141 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.19 -13.03 13.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.68 -176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' HD12 ' A' ' 7' ' ' ILE . 13.1 pt-20 -63.25 131.92 49.95 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 16.7 m -94.29 121.29 35.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.894 0.378 . . . . 0.0 110.745 -173.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.665 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.3 pp -71.13 -5.56 32.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.48 -176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -110.84 2.76 18.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.109 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 12.0 t70 -108.08 -156.44 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.774 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.53 ' H ' ' CG ' ' A' ' 54' ' ' ASP . 48.7 tt0 -91.46 -42.79 10.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.941 0.496 . . . . 0.0 111.88 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -91.75 123.33 35.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 111.489 -174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 52' ' ' LEU . 24.2 mm -132.4 132.75 60.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.153 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.466 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 7.2 p -139.67 84.83 2.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.268 0.556 . . . . 0.0 110.506 178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.593 ' HB ' HD23 ' A' ' 123' ' ' LEU . 3.2 mt -92.36 140.89 15.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.667 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.12 154.12 17.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.323 -174.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -157.79 156.47 27.34 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.071 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' HE1' ' CZ ' ' A' ' 64' ' ' PHE . 9.7 p80 -150.08 168.86 22.68 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.423 -0.457 . . . . 0.0 111.059 -175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -102.61 175.86 5.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.631 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 27.8 m-85 -145.03 171.08 14.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 171.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.0 tp -114.0 -20.72 5.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.369 0.604 . . . . 0.0 110.42 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.88 -40.24 9.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.833 -175.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HG3' ' H ' ' A' ' 69' ' ' ASN . 18.1 tpt180 -96.61 127.04 41.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 120.584 -0.447 . . . . 0.0 112.057 -168.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' C ' HG21 ' A' ' 73' ' ' THR . 93.6 Cg_endo -91.12 7.96 3.38 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.986 2.457 . . . . 0.0 111.551 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.713 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 21.6 m120 -125.38 20.7 8.01 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.147 -176.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 64' ' ' PHE . 19.4 p90 -86.37 166.42 15.6 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.704 172.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' A' ' 27' ' ' GLU . 1.7 pt20 -25.46 -67.75 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.554 ' HE2' ' HA3' ' A' ' 61' ' ' GLY . 50.6 m-85 -113.39 45.91 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.522 HG21 ' C ' ' A' ' 68' ' ' PRO . 32.5 p -72.98 -51.81 16.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.449 0.642 . . . . 0.0 110.835 176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -88.69 17.25 5.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.65 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -60.25 -25.71 65.89 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.829 179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -65.6 -25.06 67.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.733 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.49 -11.1 59.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.805 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.658 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -84.05 140.98 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.862 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -105.79 176.79 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.308 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' H ' ' HD3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -75.25 0.45 16.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.281 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.09 21.92 5.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.822 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -85.6 165.02 17.38 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.466 0.651 . . . . 0.0 110.232 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.44 ' O ' ' HD2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -99.9 123.66 44.4 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.51 -174.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.887 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 75.1 t -115.2 127.03 72.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.747 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.9 m-85 -115.4 137.16 52.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.051 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -122.36 121.25 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 14.9 ttmm -108.6 140.42 41.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.454 -173.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 HD13 ' A' ' 52' ' ' LEU . 2.7 p -137.69 111.28 8.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.97 171.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.571 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 65.92 -104.43 1.02 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.073 -172.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -116.28 -1.78 12.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 110.911 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -87.85 139.86 30.09 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 87' ' ' LYS . 36.5 m -145.71 116.81 7.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.717 0.294 . . . . 0.0 110.645 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -91.02 152.14 20.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.604 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -111.18 123.16 49.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.354 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.64 152.58 39.16 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.107 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 36.5 ttmt -107.21 149.57 27.58 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.703 ' HA ' ' HE1' ' A' ' 142' ' ' PHE . 62.7 mtp -84.12 70.7 10.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 110.451 -177.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.5 p -70.64 -46.5 63.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.784 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 10.5 m -118.48 110.33 17.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.971 0.415 . . . . 0.0 111.073 -176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.601 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.7 mt -126.32 89.7 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -125.87 143.4 51.09 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.2 0.524 . . . . 0.0 111.51 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 13.2 t70 -101.94 116.45 32.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.074 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.452 HG23 ' HD3' ' A' ' 105' ' ' PRO . 19.7 m -133.3 178.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 0.0 111.244 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 138' ' ' LYS . 50.3 mtpt -133.17 81.26 57.05 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.72 177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 139' ' ' ARG . 17.4 Cg_endo -93.98 107.39 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.476 2.784 . . . . 0.0 111.359 170.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -80.77 -24.21 38.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.878 0.37 . . . . 0.0 111.357 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' OD1' HG22 ' A' ' 110' ' ' VAL . 18.0 t70 -88.38 143.67 26.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.236 0.541 . . . . 0.0 111.431 -177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.63 19.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.49 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.83 -47.9 2.39 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG22 ' OD1' ' A' ' 107' ' ' ASP . 20.1 m -76.44 -4.31 6.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -169.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.7 60.33 5.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.425 . . . . 0.0 111.328 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.06 149.79 32.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.475 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 60.37 33.57 20.76 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.864 0.84 . . . . 0.0 110.05 -173.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.614 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -72.37 96.0 1.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.857 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 115' ' ' LYS . 13.4 ptpt -76.56 151.58 36.27 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.534 -175.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.76 84.73 1.81 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.869 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -123.84 161.33 25.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -155.57 -176.68 6.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 90.1 3.54 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' ALA . 15.6 pt20 -146.08 133.74 21.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 57' ' ' ILE . 37.5 mt -86.29 99.69 11.75 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 6.4 m -77.14 89.4 3.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.93 0.395 . . . . 0.0 109.987 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.593 HD23 ' HB ' ' A' ' 59' ' ' ILE . 23.7 mt -91.2 108.18 19.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.648 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.8 mt -89.01 147.66 5.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' CG ' ' A' ' 140' ' ' LYS . 22.9 m -146.43 98.83 3.13 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.534 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 129' ' ' TYR . 3.4 m -56.74 109.14 0.58 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.658 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 2.1 t70 -89.21 -23.9 22.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.531 -170.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -145.33 117.2 8.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.828 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.508 ' HD2' ' HB3' ' A' ' 126' ' ' CYS . 17.0 p90 -162.18 173.41 14.32 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -122.3 131.75 54.07 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.45 41.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 2.9 tmtp? -90.81 -58.03 2.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 110.816 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -77.94 -9.72 59.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.491 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.77 65.26 2.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.873 176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 12.9 p -139.02 145.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -142.26 136.06 29.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.071 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -123.38 -78.99 0.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.441 0.638 . . . . 0.0 111.213 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HA ' ' HG2' ' A' ' 104' ' ' LYS . 21.3 ttpp -90.43 137.72 32.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.076 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.658 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 12.1 ptp180 -153.46 138.21 17.02 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.121 0.486 . . . . 0.0 110.408 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.602 ' CG ' ' HB ' ' A' ' 125' ' ' THR . 5.0 ptpp? -89.39 144.17 26.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 174.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.8 tt -119.54 119.43 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 CA-C-O 121.938 0.875 . . . . 0.0 109.853 170.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.887 ' HZ ' HG21 ' A' ' 84' ' ' VAL . 2.0 t80 -105.89 113.43 26.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.307 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 97.8 t -104.62 113.09 40.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.968 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -100.03 111.86 24.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.2 m -90.3 144.61 25.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.97 135.19 48.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.79 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.429 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.2 t -112.37 168.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.928 0 CA-C-O 118.936 -0.555 . . . . 0.0 110.359 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.526 ' O2 ' ' N ' ' A' ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -63.18 -36.86 85.04 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.263 0.554 . . . . 0.0 111.352 -175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.54 82.36 6.94 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.306 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -146.9 138.16 13.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.963 173.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HG3' ' HA3' ' A' ' 89' ' ' GLY . 68.7 Cg_endo -74.74 151.23 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.194 1.929 . . . . 0.0 111.841 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 51' ' ' SER . 6.6 tp60 -132.22 172.51 12.32 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 52' ' ' LEU . 89.6 mt -114.72 103.51 54.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.896 0.379 . . . . 0.0 111.714 -174.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -94.52 -159.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.468 2.779 . . . . 0.0 111.048 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -99.15 11.91 37.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.964 0.412 . . . . 0.0 110.525 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -78.38 98.91 6.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.189 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -99.2 16.72 21.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.401 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -93.95 -34.5 13.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.371 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.662 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -97.79 160.39 14.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.427 175.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.41 118.18 38.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' CB ' ' HG3' ' A' ' 31' ' ' PRO . . . -87.41 -42.44 12.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.949 0.404 . . . . 0.0 109.963 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 88' ' ' VAL . . . -138.83 171.32 23.62 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.005 -172.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.15 121.96 18.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.353 -0.423 . . . . 0.0 109.915 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.91 117.97 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.842 ' HG3' ' HB2' ' A' ' 85' ' ' TYR . 3.0 pt-20 -129.25 112.48 13.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.795 0.807 . . . . 0.0 111.806 -176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 55.7 mt -116.39 100.69 53.64 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.769 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 83' ' ' MET . 18.9 Cg_endo -58.88 -27.93 85.82 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.02 -21.26 63.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.724 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.89 15.3 8.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 t70 61.31 26.93 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.89 0.852 . . . . 0.0 110.73 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.3 mt -95.72 118.52 42.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.99 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 40.4 mtpt -144.87 81.78 1.66 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.895 ' HG3' ' HB3' ' A' ' 71' ' ' GLN . 48.8 mm-40 -124.15 152.09 66.72 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -171.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.06 153.18 46.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.563 2.175 . . . . 0.0 112.835 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 48.7 t -113.26 130.97 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.21 112.29 62.87 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.951 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 29' ' ' VAL . 26.2 Cg_exo -62.18 139.31 77.38 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 123.367 2.711 . . . . 0.0 112.324 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.95 173.64 13.43 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.401 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.03 151.03 73.27 Favored 'Trans proline' 0 C--O 1.24 0.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.287 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.29 157.79 21.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.764 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.558 HG23 ' H ' ' A' ' 38' ' ' GLN . 2.8 t -176.11 150.94 1.1 Allowed Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -46.54 -37.23 19.75 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.102 2.535 . . . . 0.0 112.669 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.28 -46.75 85.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.26 0.552 . . . . 0.0 111.192 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.558 ' H ' HG23 ' A' ' 35' ' ' THR . 55.3 tp60 -72.75 -37.13 67.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.775 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.6 mt -77.72 -15.06 59.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.135 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -77.55 -18.9 56.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.546 0.688 . . . . 0.0 109.209 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -90.58 -46.07 8.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.78 -138.66 2.99 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.275 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 60' ' ' ALA . 85.5 t -112.57 137.2 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.897 0.379 . . . . 0.0 110.402 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -150.28 165.95 31.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.908 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -71.99 134.5 45.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.007 0.432 . . . . 0.0 111.311 -176.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.4 -39.4 65.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -128.17 118.41 23.33 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.378 171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 50' ' ' GLU . 2.5 mp0 -54.85 -38.44 67.46 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.493 0.495 . . . . 0.0 110.439 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 10.7 t-20 70.8 -22.67 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.738 176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' GLU . 43.0 tt0 82.34 -22.7 0.24 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.559 1.143 . . . . 0.0 111.326 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.529 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 66.9 m -128.74 141.68 51.24 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.309 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.5 OUTLIER -103.22 -14.86 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -99.15 25.15 7.07 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.934 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.49 -167.08 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.745 175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -115.19 -29.03 6.74 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.174 -0.329 . . . . 0.0 111.495 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -108.18 97.33 7.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.069 0.938 . . . . 0.0 111.125 -178.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.416 ' HB ' ' CD2' ' A' ' 121' ' ' LEU . 21.6 mm -116.62 138.36 47.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.985 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 t -128.67 113.71 15.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.858 0.361 . . . . 0.0 110.206 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 123' ' ' LEU . 3.4 mt -111.1 128.37 67.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -101.52 142.86 32.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.642 0.258 . . . . 0.0 110.863 -176.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.85 27.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.282 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -124.14 144.65 49.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 127' ' ' ASP . 67.8 p -111.47 169.16 9.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.673 0.273 . . . . 0.0 110.747 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.517 ' HD2' ' H ' ' A' ' 67' ' ' ARG . 22.7 t80 -154.55 134.87 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.76 HG13 ' HB2' ' A' ' 129' ' ' TYR . 3.7 mp -66.24 -48.19 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.878 0.37 . . . . 0.0 111.742 -172.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.8 t70 -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' H ' ' HD2' ' A' ' 64' ' ' PHE . 53.8 mmm-85 -99.3 106.62 40.12 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.713 0.292 . . . . 0.0 111.56 -174.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 3.2 Cg_exo -76.83 -4.18 14.64 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 123.541 2.828 . . . . 0.0 111.206 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -74.27 -23.18 59.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.24 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.512 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 64.5 m-85 -74.21 116.26 14.64 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.069 172.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.895 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 5.1 pt20 -48.91 -41.92 35.27 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' CZ ' HD23 ' A' ' 123' ' ' LEU . 10.2 m-30 -78.64 -2.58 39.77 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.225 -0.297 . . . . 0.0 111.789 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 70' ' ' TYR . 16.8 m -68.42 -34.74 76.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.693 0.282 . . . . 0.0 110.946 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.05 14.72 22.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.625 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.08 -15.3 59.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.305 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -22.44 62.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.824 0.345 . . . . 0.0 111.015 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.81 -6.81 56.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.815 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.615 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.56 131.12 47.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -111.64 177.7 4.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.702 -175.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -56.06 -21.14 20.11 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.007 -175.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.49 43.53 1.45 Allowed Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.165 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.7 m -95.41 -177.27 4.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.142 0.496 . . . . 0.0 109.779 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.594 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 1.8 tpt -118.36 104.56 10.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.403 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.02 107.01 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.729 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.842 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . 58.8 m-85 -89.28 117.9 28.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.268 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -104.17 99.27 9.0 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -97.06 146.16 25.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.342 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.742 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 7.6 p -162.0 118.89 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-O 121.141 0.496 . . . . 0.0 109.686 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.625 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . 60.63 -111.49 3.76 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -107.87 2.09 23.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.16 0.505 . . . . 0.0 110.089 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.98 141.52 31.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.236 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 m -141.47 98.01 3.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.242 0.544 . . . . 0.0 110.346 175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.2 134.02 52.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.908 -177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 28.8 mtmt -103.58 140.4 37.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -169.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.642 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 83.7 m-85 -131.11 147.82 52.66 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.847 -178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -105.84 148.81 27.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.615 ' SD ' ' HB1' ' A' ' 78' ' ' ALA . 66.4 mtp -82.77 72.05 9.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.402 0.62 . . . . 0.0 110.478 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.4 p -72.3 -42.19 65.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.614 -174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.594 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 31.5 m -113.09 99.97 8.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.231 0.539 . . . . 0.0 111.629 -177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.9 mt -119.99 76.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -93.58 155.57 17.22 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.867 0.841 . . . . 0.0 112.831 -169.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 138' ' ' LYS . 9.9 t70 -109.72 100.83 9.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.695 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.28 145.59 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.046 0.451 . . . . 0.0 110.659 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -95.19 140.42 22.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.52 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.96 127.91 19.58 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.53 2.154 . . . . 0.0 111.972 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.442 HG23 HG11 ' A' ' 110' ' ' VAL . 1.9 t -153.99 -55.47 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.586 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.689 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . 30.0 t70 -142.21 167.59 21.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.563 0.22 . . . . 0.0 110.623 -176.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.37 -45.78 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.689 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -108.5 31.03 5.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.071 0.462 . . . . 0.0 111.207 -175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 107' ' ' ASP . 8.1 p -81.02 -7.8 10.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.025 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.43 127.69 35.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.36 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -80.76 133.27 35.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.306 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.03 135.72 36.22 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.782 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -100.09 142.21 31.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.488 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -89.89 166.49 13.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 177.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.0 75.75 1.03 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.568 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.06 167.0 15.39 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.158 0.504 . . . . 0.0 111.457 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -155.5 -166.66 2.3 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' HD3' ' OE1' ' A' ' 146' ' ' GLU . 9.3 mttp -74.92 101.75 4.53 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.942 0.401 . . . . 0.0 110.163 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -142.18 145.67 34.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.896 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' CD2' ' HB ' ' A' ' 57' ' ' ILE . 12.4 mt -107.84 114.35 28.22 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 143' ' ' VAL . 23.7 m -89.08 95.64 10.4 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 6.7 mp -83.35 120.35 25.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.527 0.68 . . . . 0.0 110.526 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.704 HG23 HH22 ' A' ' 139' ' ' ARG . 61.9 mt -79.6 86.1 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 140' ' ' LYS . 1.9 m -98.04 100.15 11.46 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.536 173.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 42.9 m -81.32 -25.8 36.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 1.4 m-20 -94.56 167.57 11.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.705 0.764 . . . . 0.0 111.302 -174.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 138' ' ' LYS . 25.6 t70 -155.16 103.41 2.37 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.485 171.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.76 ' HB2' HG13 ' A' ' 65' ' ' ILE . 7.7 p90 -69.81 133.84 47.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.209 0.528 . . . . 0.0 111.411 -170.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.42 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 2.1 t-20 -98.43 106.49 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -53.27 -36.16 60.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.207 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 132' ' ' LYS . 4.3 tmtm? -59.32 -62.87 1.56 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.312 -175.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 135' ' ' VAL . 0.8 OUTLIER -108.57 3.05 22.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.209 -169.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.7 49.64 62.97 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.301 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG12 HG23 ' A' ' 133' ' ' THR . 14.3 p -136.39 156.14 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -90.42 123.76 34.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.34 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 48.8 mt-10 -92.11 -70.65 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.605 0.717 . . . . 0.0 112.092 -174.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 102' ' ' ASP . 29.2 mtmm -112.94 -172.81 2.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.811 -167.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.704 HH22 HG23 ' A' ' 124' ' ' ILE . 28.6 ttt-85 -114.58 66.33 0.68 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.819 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.633 ' HB3' ' NZ ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -69.53 96.86 0.95 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.231 0.539 . . . . 0.0 109.962 -179.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.6 tt -85.6 139.79 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.707 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.658 ' CZ ' ' HB2' ' A' ' 144' ' ' ALA . 15.6 t80 -114.86 124.26 51.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.038 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.6 t -121.05 123.96 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.658 ' HB2' ' CZ ' ' A' ' 142' ' ' PHE . . . -106.34 130.27 54.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.295 -176.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.8 m -99.58 137.25 38.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.993 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.429 ' OE1' ' HD3' ' A' ' 119' ' ' LYS . 37.6 tt0 -65.0 121.8 15.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.134 0.492 . . . . 0.0 111.181 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.3 p -104.12 161.23 4.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.623 0.725 . . . . 0.0 110.912 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.69 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' 2W7 . . . . . 0.755 ' N4 ' ' O2 ' ' A' ' 201' ' ' 2W7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_